Citrus Sinensis ID: 044846
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 290 | 2.2.26 [Sep-21-2011] | |||||||
| Q7X8C5 | 748 | Wall-associated receptor | yes | no | 0.948 | 0.367 | 0.512 | 2e-81 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.948 | 0.361 | 0.495 | 3e-77 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.831 | 0.304 | 0.544 | 6e-76 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.8 | 0.317 | 0.558 | 1e-74 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.972 | 0.391 | 0.488 | 2e-74 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.8 | 0.317 | 0.545 | 2e-74 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.8 | 0.308 | 0.537 | 3e-74 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.8 | 0.301 | 0.54 | 6e-74 | |
| Q9S9M1 | 731 | Wall-associated receptor | no | no | 0.8 | 0.317 | 0.521 | 1e-73 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.8 | 0.294 | 0.571 | 4e-71 |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 302 bits (773), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 158/308 (51%), Positives = 211/308 (68%), Gaps = 33/308 (10%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K+SK+V E VE+FINEVV+L+QINHRN+VK+LGCCLETEVP+LVYEF+PNG L + +H
Sbjct: 443 VKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLH 502
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+++DD +TWE+RL I +E++ LSYLHS AS PIYH DIK+ NILL ++ +AK+SDF
Sbjct: 503 DESDDYT-MTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFG 561
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVD 185
T +S ID+THLTTQV TFGYVDP+YF+SS+FTEKSDVYSF VVLVE L KP V
Sbjct: 562 TSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVR 621
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
EENR LAA+F E ++V++ A +A+RCLN GKK+P M+E
Sbjct: 622 SEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMRE 681
Query: 229 VTLELAGIRASIGASVL---------LQCEEINFVDYDNARHFKTSSSSTGSFFNNVTFS 279
V++EL IR+S S + Q E+NF D ++ +++ S FNN + +
Sbjct: 682 VSIELEMIRSSHYDSGIHIEDDDEEDDQAMELNFNDT-----WEVGATAPASMFNNASPT 736
Query: 280 VDGDPLLP 287
D +PL+P
Sbjct: 737 SDAEPLVP 744
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 288 bits (737), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 155/313 (49%), Positives = 205/313 (65%), Gaps = 38/313 (12%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K+SK++ E VE+FINEVV+L+QINHRN+VK+LGCCLETEVP+LVYEF+PNG L + +
Sbjct: 451 VKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLR 510
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
++ DD + +TWE+RL I +E++ LSYLHS AS PIYH DIK+ NILL +KYQ K+SDF
Sbjct: 511 DECDDYI-MTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFG 569
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTK-PIHLVD 185
T +S ID+THLTTQV TFGYVDP+YF+SS+FT+KSDVYSF VVLVEL K P V
Sbjct: 570 TSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQ 629
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
EENR AA+F E ++V+ A +AKRCLN GKK+P M+E
Sbjct: 630 SEENRGFAAHFVAAVKENRFLDIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMRE 689
Query: 229 VTLELAGIRASIGASVL--------------LQCEEINFVDYDNARHFKTSSSSTGSFFN 274
V++EL IR+S S + Q E+N + + ++ S FN
Sbjct: 690 VSVELERIRSSSYKSEIHNDDDDDDDDDDEDDQAMELNIEE-----TWDVGMTAPASMFN 744
Query: 275 NVTFSVDGDPLLP 287
N + + D +PL+P
Sbjct: 745 NGSPASDVEPLVP 757
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 284 bits (726), Expect = 6e-76, Method: Compositional matrix adjust.
Identities = 142/261 (54%), Positives = 188/261 (72%), Gaps = 20/261 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK V E +E+FINEVVILSQINHRN+VK+LGCCLET+VP+LVYEFIPNG+L++++H
Sbjct: 474 VKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLH 533
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
++ D+ + TW +RLRI ++++ LSYLHS AS PIYH D+KS NI+L +KY+AK+SDF
Sbjct: 534 DEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFG 593
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
T ++ +D THLTT V T GY+DP+YF+SSQFT+KSDVYSF VVLVEL K I +
Sbjct: 594 TSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLR 653
Query: 186 VEENRSLAAYFSKEAEKE------------------EVITFAMVAKRCLNLNGKKQPTMK 227
+ENR+LA YF A KE +V A VA++CLNL G+K+P+M+
Sbjct: 654 SQENRTLATYFIL-AMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMR 712
Query: 228 EVTLELAGIRASIGASVLLQC 248
EV++EL IR G L +C
Sbjct: 713 EVSMELDSIRMPCGDMQLQEC 733
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 279 bits (714), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 139/249 (55%), Positives = 183/249 (73%), Gaps = 17/249 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K+SK V E +E+FINE+V+LSQINHRN+VK+LGCCLETEVP+LVYE+IPNG L++ +H
Sbjct: 455 VKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLH 514
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
++ DD + +TWE+RLRI VE++ LSY+HS AS PI+H DIK+ NILL +KY+AKISDF
Sbjct: 515 DEYDDYM-MTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAKISDFG 573
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
T +S A D+THLTT V TFGY+DP+YF SSQ+T KSDVYSF VVLVEL KP+ V
Sbjct: 574 TSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPMSRVR 633
Query: 186 VEENRSLAAYFSK---------------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230
EE LA YF + + E ++V+ A +A+RCLN G K+P M+EV+
Sbjct: 634 SEEGIGLATYFLEAMKENRAVDIIDIRIKDESKQVMAVAKLARRCLNRKGNKRPNMREVS 693
Query: 231 LELAGIRAS 239
++L IR+S
Sbjct: 694 IKLERIRSS 702
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 279 bits (713), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 148/303 (48%), Positives = 202/303 (66%), Gaps = 21/303 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK++ E N+E+FINE+++LSQINHRNVVKILGCCLETEVP+LVYEFIPN +L+ ++H
Sbjct: 417 VKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLH 476
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
++D P++WE+RL I EV+ LSYLHS SIPIYH D+KS NILL +K++AK+SDF
Sbjct: 477 NPSED-FPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFG 535
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVD 185
+S AID THLTT V+ T GYVDP+Y +S+ FT KSDVYSF V+L+E L KP+ L+
Sbjct: 536 ISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLR 595
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
+E R L AYF +E ++EEV+ A +A+RCL+LN + +PTM++
Sbjct: 596 RQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRD 655
Query: 229 VTLELAGIRASIGA--SVLLQCEEINFVDYDNARHFKTSSSSTGSFFNNVTFSVDGDPLL 286
V +EL +++ S EE + S SS N +FS+D PL+
Sbjct: 656 VFIELDRMQSKRKGTQSQAQNGEEHAHIQIAMPESMSLSYSSPNIVVENSSFSLDTKPLM 715
Query: 287 PNK 289
P+K
Sbjct: 716 PHK 718
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 279 bits (713), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 137/251 (54%), Positives = 183/251 (72%), Gaps = 19/251 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K+SK V E +E+FINE+V+LSQINHRN+VK+LGCCLETEVP+LVYE+IPNG L++ +H
Sbjct: 456 VKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLH 515
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+++DD +TWE+RLRI +E++ L+Y+HS AS PI+H DIK+ NILL +KY+AK+SDF
Sbjct: 516 DESDDYT-MTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFG 574
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
T +S +D+THLTT V TFGY+DP+YF SSQ+T KSDVYSF VVLVEL KP+ V
Sbjct: 575 TSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVR 634
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
EE R LA +F E++ E+V+ A +A++CLN GK +P MKE
Sbjct: 635 SEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKE 694
Query: 229 VTLELAGIRAS 239
V+ EL IR+S
Sbjct: 695 VSNELERIRSS 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 3e-74, Method: Compositional matrix adjust.
Identities = 135/251 (53%), Positives = 187/251 (74%), Gaps = 19/251 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K+SK + E VE+FINEV +LSQINHRN+VK++GCCLETEVP+LVYE IPNG L++ +H
Sbjct: 448 VKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLH 507
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+DD +TW++RLRI+VE++ L+YLHS AS P+YH D+K+ NILL +KY+AK+SDF
Sbjct: 508 HDSDDYT-MTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFG 566
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
T +S +D+THLTT V TFGY+DP+YF++SQFT+KSDVYSF VVLVEL KP ++
Sbjct: 567 TSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMR 626
Query: 186 VEENRSLAAYFSKEAEK-----------------EEVITFAMVAKRCLNLNGKKQPTMKE 228
EENR L ++F++ ++ E+V+ A +A+RCL+L GKK+P M+E
Sbjct: 627 PEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMRE 686
Query: 229 VTLELAGIRAS 239
V++EL IR+S
Sbjct: 687 VSVELERIRSS 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (709), Expect = 6e-74, Method: Compositional matrix adjust.
Identities = 135/250 (54%), Positives = 184/250 (73%), Gaps = 18/250 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK V E +E+FINEVVILSQINHRN+VK+LGCCLET+VP+LVYEFIPNG+L++++H
Sbjct: 460 VKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLH 519
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ +DD TWE+RLRI V+++ LSYLHS AS PIYH DIKS NI+L +K++AK+SDF
Sbjct: 520 DDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFG 579
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
T ++ +D THLTT V T GY+DP+YF+SSQFT+KSDVYSF VVL EL K + +
Sbjct: 580 TSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLR 639
Query: 186 VEENRSLAAYFS---KEAEKEEVI--------------TFAMVAKRCLNLNGKKQPTMKE 228
+E R+LA YF+ KE ++I A +A++CLN+ G+K+P+M++
Sbjct: 640 SQEYRTLATYFTLAMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQ 699
Query: 229 VTLELAGIRA 238
V++EL IR+
Sbjct: 700 VSMELEKIRS 709
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M1|WAKLE_ARATH Wall-associated receptor kinase-like 5 OS=Arabidopsis thaliana GN=WAKL5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 131/251 (52%), Positives = 184/251 (73%), Gaps = 19/251 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K+SK V E +E+FINE+++LSQINHRN+VK++GCCLETEVP+LVYE+IPNG +++ +H
Sbjct: 459 VKRSKVVDEDKLEKFINEIILLSQINHRNIVKLIGCCLETEVPILVYEYIPNGDMFKRLH 518
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+++DD +TWE+RLRI +E++ L+Y+HS AS PIYH DIK+ NILL +KY AK+SDF
Sbjct: 519 DESDD-YAMTWEVRLRIAIEIAGALTYMHSAASFPIYHRDIKTTNILLDEKYGAKVSDFG 577
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
T +S ID+THLTT V TFGY+DP+YF SSQ+T+KSDVYSF VVLVEL KP+ +
Sbjct: 578 TSRSVTIDQTHLTTMVAGTFGYMDPEYFLSSQYTDKSDVYSFGVVLVELITGEKPLSRIR 637
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
EE R LA +F +E++ ++++ A +A++CL+ G K+P M+E
Sbjct: 638 SEEGRGLATHFLEAMKENRVIDIIDIRIKEESKLDQLMAVAKLARKCLSRKGIKRPNMRE 697
Query: 229 VTLELAGIRAS 239
+LEL IR+S
Sbjct: 698 ASLELERIRSS 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. May be involved in plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 144/252 (57%), Positives = 179/252 (71%), Gaps = 20/252 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK V E +E+FINEVVILSQINHR+VVK+LGCCLETEVP LVYEFIPNG+L+Q+IH
Sbjct: 478 VKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIH 537
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
E++DD TW MRLRI V+++ LSYLHS AS PIYH DIKS NILL +KY+ K+SDF
Sbjct: 538 EESDDYTK-TWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFG 596
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLV- 184
T +S ID TH TT + T GYVDP+Y+ SSQ+T+KSDVYSF VVLVEL KP+ V
Sbjct: 597 TSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVS 656
Query: 185 DVEENRSLAAYFS---KE--------------AEKEEVITFAMVAKRCLNLNGKKQPTMK 227
+ +E R LA +F KE + E+V+ A +A+RCLN GKK+P M+
Sbjct: 657 NSQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMR 716
Query: 228 EVTLELAGIRAS 239
+V +L I AS
Sbjct: 717 KVFTDLEKILAS 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 290 | ||||||
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.965 | 0.385 | 0.582 | 2e-87 | |
| 147852023 | 413 | hypothetical protein VITISV_028337 [Viti | 0.972 | 0.682 | 0.564 | 8e-86 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.8 | 0.312 | 0.641 | 1e-84 | |
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.806 | 0.337 | 0.624 | 2e-83 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.779 | 0.274 | 0.644 | 3e-83 | |
| 225455808 | 718 | PREDICTED: wall-associated receptor kina | 0.941 | 0.380 | 0.560 | 1e-82 | |
| 147790565 | 386 | hypothetical protein VITISV_043466 [Viti | 0.806 | 0.606 | 0.624 | 2e-82 | |
| 224053058 | 682 | predicted protein [Populus trichocarpa] | 0.944 | 0.401 | 0.579 | 2e-82 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.806 | 0.344 | 0.624 | 5e-82 | |
| 297734146 | 1029 | unnamed protein product [Vitis vinifera] | 0.8 | 0.225 | 0.633 | 1e-81 |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 328 bits (841), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 177/304 (58%), Positives = 218/304 (71%), Gaps = 24/304 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK V E ++QFINEVVILSQINHRNVVK+ GCCLETEVPLLVYEFIPNG+L+QYI
Sbjct: 422 IKKSKLVDEDKLDQFINEVVILSQINHRNVVKLTGCCLETEVPLLVYEFIPNGTLFQYI- 480
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ + + PITWEMRLRI EV+ L+YLHS AS+PIYH DIKS+NILL +KY+AK++DF
Sbjct: 481 QNPNKEFPITWEMRLRIATEVAGALAYLHSAASMPIYHRDIKSSNILLDEKYRAKVADFG 540
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVD 185
T KS AI++TH+TT V+ TFGY+DP+YF+SSQFTEKSDVYSF VVLVE L KPI +
Sbjct: 541 TSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSLR 600
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
E RSLA YF KE +EE+I A +A++CLNLNGKK+P MK
Sbjct: 601 SVEERSLATYFLMTMEENRLFEILDARVLKEGGREEIIAMAKMAEKCLNLNGKKRPKMKT 660
Query: 229 VTLELAGIRASIGASVLLQ--CEEINFVDYDNARHFKTSSSSTGSFFNNVTFSV--DGDP 284
V +EL GIR+S G S +Q EE+++V D + +SSSTGS N+ T D P
Sbjct: 661 VAIELEGIRSSQGVSSTIQQDYEEVDYVVGDYTASWDVASSSTGS-LNSTTIRARFDVKP 719
Query: 285 LLPN 288
LLP+
Sbjct: 720 LLPS 723
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852023|emb|CAN82287.1| hypothetical protein VITISV_028337 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 322 bits (826), Expect = 8e-86, Method: Compositional matrix adjust.
Identities = 171/303 (56%), Positives = 215/303 (70%), Gaps = 21/303 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KK K V + +EQFINEVVILSQINHRNVVK+LGCCLE EVPLLVYE+IPNG+L ++IH
Sbjct: 110 VKKLKIVGDGKLEQFINEVVILSQINHRNVVKLLGCCLEIEVPLLVYEYIPNGTLSEHIH 169
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+Q +++ PITW+MRL+I EV+ LSYLHS ASIPIYH DIKS NILL DKY+AK++DF
Sbjct: 170 DQ-NEEFPITWKMRLQIATEVAGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFG 228
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVD 185
T KS AID+THLTT+V+ TFGY+DP+YF+SSQFTEKSDVYSF +VL+E L KPI +
Sbjct: 229 TSKSVAIDQTHLTTKVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSIG 288
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
E +SLA+YF KE KEE+ A +AKRC+NLNGKK+PTM E
Sbjct: 289 SGEGKSLASYFIMSMKEDRLSDLLDARVVKEGRKEEINAIAFLAKRCINLNGKKRPTMME 348
Query: 229 VTLELAGIRASIGA-SVLLQCEEINFVDYDNARHFKTSSSSTGSFFN-NVTFSVDGDPLL 286
V +EL IR G + +E+ + + R + +S+STGS FN N + +D PLL
Sbjct: 349 VAMELERIRKCEGDFNAQENSDEVEYDTIELTRPWDVASTSTGSCFNTNASPPLDVQPLL 408
Query: 287 PNK 289
K
Sbjct: 409 FQK 411
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 318 bits (816), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 161/251 (64%), Positives = 189/251 (75%), Gaps = 19/251 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK ES EQFINEVVILSQINHRNVVK+LGCCLETEVPLLVYEFIPNG+LYQ++H
Sbjct: 429 IKKSKIADESKTEQFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLH 488
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ ++ + PITWEMRLRI +E LSYLHS AS+PIYH DIKS NILL DKY+AK+SDF
Sbjct: 489 DPSE-EFPITWEMRLRIAIETGSALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVSDFG 547
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVD 185
T KS A+D+TH+TT+V+ TFGY+DP+YF+SSQFTEKSDVYSF VVLVE L KPI
Sbjct: 548 TSKSIAVDQTHVTTRVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSAR 607
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
E RSLA YF KE KEE++ A +A+RCLNLNGKK+PTM+
Sbjct: 608 AVEERSLAMYFLLSMEQNRLFEILDARVLKEGGKEEILAVAKLARRCLNLNGKKRPTMRT 667
Query: 229 VTLELAGIRAS 239
V E+ IRAS
Sbjct: 668 VVTEVERIRAS 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 314 bits (805), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 158/253 (62%), Positives = 193/253 (76%), Gaps = 19/253 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK V E ++QFINEVVILSQINHRNVVK++GCCLETEVPLLVYEFIPNG+LYQYIH
Sbjct: 427 IKKSKVVDEDKLDQFINEVVILSQINHRNVVKLIGCCLETEVPLLVYEFIPNGTLYQYIH 486
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+++ P+TWEMRLRI EV+ L+YLH+ AS+PIYH DIKS+NILL +KY+AK++DF
Sbjct: 487 -NPNEEFPVTWEMRLRIATEVAGALAYLHAAASMPIYHRDIKSSNILLDEKYRAKVADFG 545
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVD 185
T KS +ID+TH+TT+V+ TFGY+DP+YF+SSQFTEKSDVYSF VVLVE L KPI
Sbjct: 546 TSKSISIDQTHVTTRVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSYR 605
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
E RSLA YF KE +EE+I A +A++CLNLNGKK+P MK
Sbjct: 606 SVEERSLATYFLMTMEESRLFEILDARVLKEGGREEIIAMAKLAEKCLNLNGKKRPKMKT 665
Query: 229 VTLELAGIRASIG 241
V +EL GIR+S G
Sbjct: 666 VAIELEGIRSSQG 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 314 bits (804), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 158/245 (64%), Positives = 189/245 (77%), Gaps = 19/245 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KK K V + VEQFINEVVILSQINHRNVVK+LGCCLET VPLLVYEFIPNG+L ++IH
Sbjct: 556 VKKLKIVGDGKVEQFINEVVILSQINHRNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIH 615
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+Q +++ PITWEMRLRI +EV+ LSYLHS ASIPIYH DIKS NILL DKY+AK++DF
Sbjct: 616 DQ-NEEFPITWEMRLRIAIEVAGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFG 674
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVD 185
T KS AID+THLTTQV+ TFGY+DP+YF+SSQFTEKSDVYSF +VL+E L KPI
Sbjct: 675 TSKSVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTA 734
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
EE +SLA+YF KE +KEE+ A +A+RC+NLNGKK+PTM E
Sbjct: 735 SEEGKSLASYFILSMNEDRLSDLLDAQVVKEGKKEEINAIAFLARRCINLNGKKRPTMME 794
Query: 229 VTLEL 233
V +EL
Sbjct: 795 VAMEL 799
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 311 bits (798), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 175/312 (56%), Positives = 213/312 (68%), Gaps = 39/312 (12%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK V E+ +E FINE+VILSQINHRNVV ILGCCLETEVPLLVYEFI NG+L+Q IH
Sbjct: 414 VKKSKIVDENQLEHFINEIVILSQINHRNVVGILGCCLETEVPLLVYEFISNGTLFQLIH 473
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+Q + + P++WEMRLRI +EVS LSYLHS SIPIYH DIKS NILL DKY+AK+SDF
Sbjct: 474 DQ-NSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYHRDIKSTNILLDDKYKAKVSDFG 532
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVD 185
T +S +ID+THLTT V+ TFGY+DP+YF+SSQFTEKSDVYSF VVLVE L KPI
Sbjct: 533 TSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSTR 592
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
E +SLA +F KE KE+++TFA +A RCLNLNG+K+PTMKE
Sbjct: 593 SPEEKSLATHFILSLQESRLFDILDARVVKEGRKEDIMTFAKLAGRCLNLNGRKRPTMKE 652
Query: 229 VTLELAGIRASI-----------GASVLLQCEEINFVDYDNARHFKTSSSSTGSFFNNVT 277
VT E+ IR S A V+ + E F+D D+ +S+S GS ++
Sbjct: 653 VTTEIDNIRVSALHLNVDQNFQENACVVTEITE--FLDMDD------TSTSRGSCLDDTK 704
Query: 278 -FSVDGDPLLPN 288
S D PLL N
Sbjct: 705 ESSFDVQPLLFN 716
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147790565|emb|CAN65309.1| hypothetical protein VITISV_043466 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 311 bits (798), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 158/253 (62%), Positives = 190/253 (75%), Gaps = 19/253 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KK K +++S +EQFINEVVIL QINHRNVVK+LGCCLETEVPLLVYEFIPNG+L+++IH
Sbjct: 114 VKKLKIMNDSKLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFEHIH 173
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
Q +++ PITWEMRLRI EV+R LSYLHS ASIPIYH DIKS NILL DKY+AK++DF
Sbjct: 174 GQ-NEEFPITWEMRLRIATEVARALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFG 232
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVD 185
T K +ID+THLTTQV+ TFGY+DP+YF+SSQFTEKSDVYSF VVL+E L KPI
Sbjct: 233 TSKFFSIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLIELLTGKKPILSTR 292
Query: 186 VEENRSLAAYFS-----------------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
EE +SLA YF KE E++ A +A+RC+NLNGKK+PTM E
Sbjct: 293 SEERKSLALYFKISMKEDHLSDLLDARVVKEGMXEDINEIAFLARRCINLNGKKRPTMME 352
Query: 229 VTLELAGIRASIG 241
V +EL IR G
Sbjct: 353 VAMELERIRKCQG 365
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053058|ref|XP_002297686.1| predicted protein [Populus trichocarpa] gi|222844944|gb|EEE82491.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 311 bits (797), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 175/302 (57%), Positives = 212/302 (70%), Gaps = 28/302 (9%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKS V E +E+FINEVV+LSQINHRNVVK+LGCCLETEVPLLVYEFIPNG+LY+YIH
Sbjct: 378 VKKSMVVDEGKLEEFINEVVVLSQINHRNVVKLLGCCLETEVPLLVYEFIPNGNLYKYIH 437
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+Q +D L ++WEMRLRI +EV+ LSYLHS SIPIYH DIKS NILL +KY+AK+SDF
Sbjct: 438 DQNEDFL-LSWEMRLRIAIEVAGALSYLHSATSIPIYHRDIKSTNILLDEKYRAKVSDFG 496
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
+ +S +ID+THLTT V+ TFGY+DP+YF+SSQFTEKSDVYSF VVLVEL + KPI V
Sbjct: 497 SSRSISIDQTHLTTLVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELISGQKPIFSVS 556
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
E RSLA +F + + EEVI+ A +AKRCLNLNGK +PTM+E
Sbjct: 557 QTETRSLATHFIMLMEDNRLSDVLDARVKEGCQNEEVISVANLAKRCLNLNGKNRPTMRE 616
Query: 229 VTLELAGIRASIGASV-LLQCEEI-----NFVDYDNARHFKTSSSSTGSFFNNVTFSVDG 282
VT EL I IG S LL +E N +D + S+S TG F T S DG
Sbjct: 617 VTSELERI---IGLSQKLLNIQENCKISENTMDDASNDWDAVSTSITGDFDTGRTPSSDG 673
Query: 283 DP 284
+P
Sbjct: 674 EP 675
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 310 bits (794), Expect = 5e-82, Method: Compositional matrix adjust.
Identities = 158/253 (62%), Positives = 189/253 (74%), Gaps = 19/253 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KK K + +S +EQFINEVVIL QINHRNVVK+LGCCLETEVPLLVYEFIPNG+L ++IH
Sbjct: 385 VKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIH 444
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
Q +++ PITWEMRLRI EV LSYLHS ASIPIYH DIKS NILL DKY+AK++DF
Sbjct: 445 GQ-NEEFPITWEMRLRIATEVXGALSYLHSXASIPIYHRDIKSTNILLBDKYRAKVADFG 503
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVD 185
K AID+THLTTQV+ TFGY+DP+YF+SSQFTEKSDVYSF +VL+E L KPI +
Sbjct: 504 ISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSIA 563
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
EE +SLA+YF KE+ KEE+ A +A+RC+NLNGKK+PTM E
Sbjct: 564 SEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPTMME 623
Query: 229 VTLELAGIRASIG 241
V +EL IR G
Sbjct: 624 VAMELERIRKCQG 636
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734146|emb|CBI15393.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 309 bits (791), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 159/251 (63%), Positives = 189/251 (75%), Gaps = 19/251 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK V E+ +E FINE+VILSQINHRNVV ILGCCLETEVPLLVYEFI NG+L+Q IH
Sbjct: 294 VKKSKIVDENQLEHFINEIVILSQINHRNVVGILGCCLETEVPLLVYEFISNGTLFQLIH 353
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+Q + + P++WEMRLRI +EVS LSYLHS SIPIYH DIKS NILL DKY+AK+SDF
Sbjct: 354 DQ-NSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYHRDIKSTNILLDDKYKAKVSDFG 412
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVD 185
T +S +ID+THLTT V+ TFGY+DP+YF+SSQFTEKSDVYSF VVLVE L KPI
Sbjct: 413 TSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSTR 472
Query: 186 VEENRSLAAYF-----------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
E +SLA +F KE KE+++TFA +A RCLNLNG+K+PTMKE
Sbjct: 473 SPEEKSLATHFILSLQESRLFDILDARVVKEGRKEDIMTFAKLAGRCLNLNGRKRPTMKE 532
Query: 229 VTLELAGIRAS 239
VT E+ IR S
Sbjct: 533 VTTEIDNIRVS 543
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 290 | ||||||
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.720 | 0.263 | 0.574 | 6e-72 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.724 | 0.273 | 0.578 | 9.8e-70 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.672 | 0.247 | 0.638 | 6e-68 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.689 | 0.252 | 0.591 | 3.7e-66 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.710 | 0.262 | 0.583 | 3.3e-65 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.879 | 0.340 | 0.517 | 7.6e-64 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.686 | 0.272 | 0.592 | 1e-61 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.686 | 0.264 | 0.577 | 5.5e-61 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.717 | 0.288 | 0.566 | 1.3e-59 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.717 | 0.272 | 0.577 | 3.2e-58 |
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 636 (228.9 bits), Expect = 6.0e-72, Sum P(2) = 6.0e-72
Identities = 123/214 (57%), Positives = 164/214 (76%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK V E +E+FINEVVILSQINHRN+VK+LGCCLET+VP+LVYEFIPNG+L++++H
Sbjct: 474 VKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLH 533
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
++ D+ + TW +RLRI ++++ LSYLHS AS PIYH D+KS NI+L +KY+AK+SDF
Sbjct: 534 DEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFG 593
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
T ++ +D THLTT V T GY+DP+YF+SSQFT+KSDVYSF VVLVEL K I +
Sbjct: 594 TSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLR 653
Query: 186 VEENRSLAAYF---SKEAEKEEVITFAMVAKRCL 216
+ENR+LA YF KE + ++I A + C+
Sbjct: 654 SQENRTLATYFILAMKENKLFDIID-ARIRDGCM 686
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 9.8e-70, Sum P(2) = 9.8e-70
Identities = 125/216 (57%), Positives = 163/216 (75%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK V E +E+FINEVVILSQINHRN+VK+LGCCLET+VP+LVYEFIPNG+L++++H
Sbjct: 460 VKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLH 519
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ +DD TWE+RLRI V+++ LSYLHS AS PIYH DIKS NI+L +K++AK+SDF
Sbjct: 520 DDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFG 579
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
T ++ +D THLTT V T GY+DP+YF+SSQFT+KSDVYSF VVL EL K + +
Sbjct: 580 TSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLR 639
Query: 186 VEENRSLAAYFS---KEAEKEEVITFAMVAKRC-LN 217
+E R+LA YF+ KE ++I A + C LN
Sbjct: 640 SQEYRTLATYFTLAMKENRLSDIID-ARIRDGCKLN 674
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 618 (222.6 bits), Expect = 6.0e-68, Sum P(2) = 6.0e-68
Identities = 127/199 (63%), Positives = 154/199 (77%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK V E +E+FINEVVILSQINHR+VVK+LGCCLETEVP LVYEFIPNG+L+Q+IH
Sbjct: 478 VKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIH 537
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
E++DD TW MRLRI V+++ LSYLHS AS PIYH DIKS NILL +KY+ K+SDF
Sbjct: 538 EESDDYTK-TWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFG 596
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLV- 184
T +S ID TH TT + T GYVDP+Y+ SSQ+T+KSDVYSF VVLVEL KP+ V
Sbjct: 597 TSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVS 656
Query: 185 DVEENRSLAAYFSKEAEKE 203
+ +E R LA +F + A KE
Sbjct: 657 NSQEIRGLADHF-RVAMKE 674
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 605 (218.0 bits), Expect = 3.7e-66, Sum P(2) = 3.7e-66
Identities = 120/203 (59%), Positives = 158/203 (77%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK + E +++FINEVVILSQINHR+VVK+LGCCLETEVP+LVYEFI NG+L+++IH
Sbjct: 480 VKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIH 539
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
E+ D + W MRLRI V+++ LSYLHS AS PIYH DIKS NILL +KY+AK++DF
Sbjct: 540 EEESDDYTMLWGMRLRIAVDIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFG 599
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLV- 184
T +S ID+TH TT + T GYVDP+Y++SSQ+TEKSDVYSF V+L EL KP+ +V
Sbjct: 600 TSRSVTIDQTHWTTVISGTVGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVIMVQ 659
Query: 185 DVEENRSLAAYFSKEAEKEEVIT 207
+ +E +LA +F + A KE+ +T
Sbjct: 660 NTQEIVALAEHF-RVAMKEKRLT 681
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 608 (219.1 bits), Expect = 3.3e-65, Sum P(2) = 3.3e-65
Identities = 122/209 (58%), Positives = 160/209 (76%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK + E +++FINEVVILSQINHR+VVK+LGCCLETEVP+LVYEFI NG+L+++IH
Sbjct: 471 VKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIH 530
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
E+ D + W MRLRI V+++ LSYLHS AS PIYH DIKS NILL +KY+AK++DF
Sbjct: 531 EEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFG 590
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLV- 184
T +S ID+TH TT + T GYVDP+Y+RSSQ+TEKSDVYSF V+L EL KP+ +V
Sbjct: 591 TSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQ 650
Query: 185 DVEENRSLAAYFSKEAEKEEVITFAMVAK 213
+ +E +LA +F + A KE ++ M A+
Sbjct: 651 NTQEIIALAEHF-RVAMKERRLSDIMDAR 678
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 651 (234.2 bits), Expect = 7.6e-64, P = 7.6e-64
Identities = 135/261 (51%), Positives = 179/261 (68%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K+SK+V E VE+FINEVV+L+QINHRN+VK+LGCCLETEVP+LVYEF+PNG L + +H
Sbjct: 443 VKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLH 502
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+++DD +TWE+RL I +E++ LSYLHS AS PIYH DIK+ NILL ++ +AK+SDF
Sbjct: 503 DESDDYT-MTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFG 561
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
T +S ID+THLTTQV TFGYVDP+YF+SS+FTEKSDVYSF VVLVEL KP V
Sbjct: 562 TSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVR 621
Query: 186 VEENRSLAAYFSKEAEKEEVITFA--MVAKRCLNLNGKKQ-PTMKEVTLELAGIRASIGA 242
EENR LAA+F + ++ V+ + C N++ + L G +
Sbjct: 622 SEENRGLAAHFVEAVKENRVLDIVDDRIKDEC-NMDQVMSVANLARRCLNRKGKKRPNMR 680
Query: 243 SVLLQCEEINFVDYDNARHFK 263
V ++ E I YD+ H +
Sbjct: 681 EVSIELEMIRSSHYDSGIHIE 701
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 631 (227.2 bits), Expect = 1.0e-61, P = 1.0e-61
Identities = 119/201 (59%), Positives = 158/201 (78%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K+SK V E +E+FINE+V+LSQINHRN+VK+LGCCLETEVP+LVYE+IPNG L++ +H
Sbjct: 456 VKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLH 515
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+++DD +TWE+RLRI +E++ L+Y+HS AS PI+H DIK+ NILL +KY+AK+SDF
Sbjct: 516 DESDDYT-MTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFG 574
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
T +S +D+THLTT V TFGY+DP+YF SSQ+T KSDVYSF VVLVEL KP+ V
Sbjct: 575 TSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVR 634
Query: 186 VEENRSLAAYFSKEAEKEEVI 206
EE R LA +F + ++ VI
Sbjct: 635 SEEGRGLATHFLEAMKENRVI 655
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 624 (224.7 bits), Expect = 5.5e-61, P = 5.5e-61
Identities = 116/201 (57%), Positives = 159/201 (79%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K+SK + E VE+FINEV +LSQINHRN+VK++GCCLETEVP+LVYE IPNG L++ +H
Sbjct: 448 VKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLH 507
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+DD +TW++RLRI+VE++ L+YLHS AS P+YH D+K+ NILL +KY+AK+SDF
Sbjct: 508 HDSDDYT-MTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFG 566
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
T +S +D+THLTT V TFGY+DP+YF++SQFT+KSDVYSF VVLVEL KP ++
Sbjct: 567 TSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMR 626
Query: 186 VEENRSLAAYFSKEAEKEEVI 206
EENR L ++F++ ++ V+
Sbjct: 627 PEENRGLVSHFNEAMKQNRVL 647
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 1.3e-59, P = 1.3e-59
Identities = 120/212 (56%), Positives = 159/212 (75%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKSK++ E N+E+FINE+++LSQINHRNVVKILGCCLETEVP+LVYEFIPN +L+ ++H
Sbjct: 417 VKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLH 476
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
++D P++WE+RL I EV+ LSYLHS SIPIYH D+KS NILL +K++AK+SDF
Sbjct: 477 NPSED-FPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFG 535
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVD 185
+S AID THLTT V+ T GYVDP+Y +S+ FT KSDVYSF V+L+EL KP+ L+
Sbjct: 536 ISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLR 595
Query: 186 VEENRSLAAYFSKEAEKEEV--ITFAMVAKRC 215
+E R L AYF + + + I A + + C
Sbjct: 596 RQEVRMLGAYFLEAMRNDRLHEILDARIKEEC 627
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 3.2e-58, P = 3.2e-58
Identities = 123/213 (57%), Positives = 157/213 (73%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+KKS V E +++FINEV+ILSQINHR+VVK+LGCCLETEVP+LVYEFIPNG+L+Q++H
Sbjct: 481 VKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLH 540
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
E+ DD + W +R+RI V++S SYLH+ A PIYH DIKS NILL +KY+AK+SDF
Sbjct: 541 EEFDDYTAL-WGVRMRIAVDISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFG 599
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKP-IHLV 184
T +S +ID TH TT + T GYVDP+Y+ SS FTEKSDVYSF VVLVEL KP I L
Sbjct: 600 TSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLS 659
Query: 185 DVEENRSLAAYFSKEAEKEEVITFAMVAKRCLN 217
+ +E LA YF + A +E + F ++ R N
Sbjct: 660 ETQEITGLADYF-RLAMRENRL-FEIIDARIRN 690
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 290 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-30 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-29 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-14 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-13 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-12 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-07 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-04 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.001 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 0.002 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.002 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.003 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-37
Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 11/173 (6%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT 69
K S +E+ + E+ IL ++NH N+VK+ G + LV E+ GSL + E
Sbjct: 27 KKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN- 85
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISDFRTF 128
+ ++ + LRI +++ L YLH S I H D+K NILL D + K++DF
Sbjct: 86 --EGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGL- 139
Query: 129 KSRAIDRTHLTTQVKV-TFGYVDPKYFRSSQ-FTEKSDVYSFSVVLVELNWTK 179
S+ + + V T Y+ P+ ++EKSD++S V+L EL K
Sbjct: 140 -SKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELK 191
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 26/238 (10%)
Query: 8 KKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
K K E +E+F+ E I+ +++H NVVK+LG C E E +V E++ G L Y+
Sbjct: 34 KTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR 93
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ ++ L ++++R + YL S H D+ + N L+ + KISDF
Sbjct: 94 KNRP---KLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFG 147
Query: 127 TFKSRAIDRTHLTTQV--KVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL--------N 176
SR + + K+ ++ P+ + +FT KSDV+SF V+L E+
Sbjct: 148 L--SRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP 205
Query: 177 WTKPIHLV-DVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233
++ ++ L + E + +C + + +PT E+ L
Sbjct: 206 GMSNEEVLEYLKNGYRLPQPPNCPPE------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 59/238 (24%), Positives = 108/238 (45%), Gaps = 26/238 (10%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LK+ S E +E+F+ E I+ +++H N+VK+LG C E E ++V E++P G L Y+
Sbjct: 36 LKEDAS--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR 93
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ ++ L ++++R + YL S H D+ + N L+ + KISDF
Sbjct: 94 KNRPK--ELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFG 148
Query: 127 TFKSRAIDRTHLTT--QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL--------N 176
SR + K+ ++ P+ + +FT KSDV+SF V+L E+
Sbjct: 149 L--SRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP 206
Query: 177 WTKPIHLV-DVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233
++ +++ L + E + +C + + +PT E+ L
Sbjct: 207 GMSNAEVLEYLKKGYRLPKPPNCPPE------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 48/175 (27%), Positives = 90/175 (51%), Gaps = 16/175 (9%)
Query: 7 LKKSK-SVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+K K E E+F+ E I+ +++H N+V++LG C + E +V E++P G L ++
Sbjct: 33 VKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL 92
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ + +T + L++ +++++ + YL S H D+ + N L+ + KISDF
Sbjct: 93 RKHGE---KLTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDF 146
Query: 126 ---RTFKSRAIDRTHLTTQ--VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
R R + +K ++ P+ + +FT KSDV+SF V+L E+
Sbjct: 147 GLSRDIYEDDYYRKRGGGKLPIK----WMAPESLKDGKFTSKSDVWSFGVLLWEI 197
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 17/230 (7%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K +S + E+ IL +++H N+V+++ + + LV E+ G L+ Y+
Sbjct: 33 KKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG 92
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
P++ + +I +++ R L YLHS I H D+K NILL + KI+DF
Sbjct: 93 G----PLSEDEAKKIALQILRGLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLA 145
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPK-YFRSSQFTEKSDVYSFSVVLVEL--------NWTK 179
K + LTT V T Y+ P+ + + K DV+S V+L EL
Sbjct: 146 KKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENI 204
Query: 180 PIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
L + F + + K+CLN + K+PT +E+
Sbjct: 205 LDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-29
Identities = 49/175 (28%), Positives = 84/175 (48%), Gaps = 11/175 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LK+ S E + F+ E ++ ++ H NVV++LG C E E LV E++ G L Y+
Sbjct: 31 LKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLR 88
Query: 67 EQTDDQL-----PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
+ ++ + L +++++ + YL S H D+ + N L+ + K
Sbjct: 89 KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVK 145
Query: 122 ISDF-RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
ISDF + D T K+ ++ P+ + FT KSDV+SF V+L E+
Sbjct: 146 ISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-28
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 10/170 (5%)
Query: 7 LKK-SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+K K + + E+ + E+ IL ++ H N+V++ + + LV E+ G L+ +
Sbjct: 29 IKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL 88
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
++ ++ + ++ L YLH S I H D+K NILL + K++DF
Sbjct: 89 KKRG----RLSEDEARFYLRQILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADF 141
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+R +D T T Y+ P+ + + D++S V+L EL
Sbjct: 142 GL--ARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYEL 189
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 6e-21
Identities = 56/182 (30%), Positives = 83/182 (45%), Gaps = 20/182 (10%)
Query: 3 ELWLLKKS--KSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGS 60
+L++LK+ ++ E E +NEV IL ++NH N++K E +V E+ G
Sbjct: 26 KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85
Query: 61 LYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
L Q I +Q + P E L V++ L YLHS I H DIK NI L
Sbjct: 86 LSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLV 142
Query: 121 KISDF---RTFKSRAIDRTHLTTQVKVTF-G---YVDPKYFRSSQFTEKSDVYSFSVVLV 173
K+ DF + S T + T G Y+ P+ ++ + KSD++S VL
Sbjct: 143 KLGDFGISKVLSS--------TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLY 194
Query: 174 EL 175
EL
Sbjct: 195 EL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-20
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75
++ F+ E I+ ++H N++++ G L T ++V E P GSL + + I
Sbjct: 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLI 96
Query: 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR 135
+ V+++ + YL S I H D+ + NILL + KI DF ++ +
Sbjct: 97 S--TLCDYAVQIANGMRYLESKRFI---HRDLAARNILLASDDKVKIGDFGLMRALPQNE 151
Query: 136 THLTTQ--VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
H + +KV F + P+ R+ F+ SDV+ F V L E+
Sbjct: 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-20
Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 18/180 (10%)
Query: 3 ELWLLKKSK--SVHESNVEQFINEVVILSQINHRNVVK-----ILGCCLETEVPLLVYEF 55
+ + LK+ S+ + E +NE+ IL+ +NH N++ + G L +V E+
Sbjct: 26 QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL-----CIVMEY 80
Query: 56 IPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV 115
P G L + I ++ + I + RI +++ R L LH I H D+KSANILLV
Sbjct: 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLV 137
Query: 116 DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
KI D S+ + + TQ+ Y+ P+ ++ ++ KSD++S +L E+
Sbjct: 138 ANDLVKIGDLGI--SKVLKKNMAKTQIGTPH-YMAPEVWKGRPYSYKSDIWSLGCLLYEM 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 7e-20
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 32/231 (13%)
Query: 11 KSVHESNVEQFINEVVILSQINHRNVVKILGCCL-ETEVPLLVY-EFIPNGSLYQYIHEQ 68
E +E E+ ILS + H N+V+ G E + L ++ E++ GSL +
Sbjct: 36 SGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-- 93
Query: 69 TDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
+LP E +R T ++ L+YLHS I H DIK ANIL+ K++DF
Sbjct: 94 KFGKLP---EPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGC 147
Query: 128 FKSRA-IDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL--------NWT 178
K I+ T V+ T ++ P+ R ++ +D++S ++E+
Sbjct: 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207
Query: 179 KPIHLV----DVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPT 225
P+ + E + + S+EA K+ F +CL + KK+PT
Sbjct: 208 NPMAALYKIGSSGEPPEIPEHLSEEA-KD----FLR---KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 7e-19
Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 20/175 (11%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQ--- 63
+K K + E+ INE+ IL + H N+VK G L+ + +V EF GSL
Sbjct: 30 IKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLK 89
Query: 64 -YIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
T+ Q+ + E+ + L YLH S I H DIK+ANILL + K+
Sbjct: 90 STNQTLTESQIAY-------VCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKL 139
Query: 123 SDF--RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
DF S R + T ++ P+ + K+D++S + +EL
Sbjct: 140 IDFGLSAQLSDTKARNTMVG----TPYWMAPEVINGKPYDYKADIWSLGITAIEL 190
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-18
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 16/212 (7%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP--IT 76
E+ I+E +L++++ +++ L+ +V E+ NG L++ + Q LP
Sbjct: 44 EEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV 103
Query: 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT 136
W ++I + L++LHS I H DIKS N+ L KI D K + D T
Sbjct: 104 WRFFIQILLG----LAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNT 155
Query: 137 HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF 196
+ + T Y+ P+ + EKSDV++ VVL E K H D +L
Sbjct: 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK--HPFDANNQGALILKI 213
Query: 197 SKEAEKEEVITF----AMVAKRCLNLNGKKQP 224
+ + A + +CL + +++P
Sbjct: 214 IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 57/266 (21%), Positives = 112/266 (42%), Gaps = 57/266 (21%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+LK++ S S + ++E +L Q+NH +V+K+ G C + LL+ E+ GSL ++
Sbjct: 37 MLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFL 94
Query: 66 HEQ--------------------TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHL 105
E D+ +T + ++SR + YL A + + H
Sbjct: 95 RESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHR 151
Query: 106 DIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT-TQVKVTFGYVDPKYFRSSQFTEKSD 164
D+ + N+L+ + + KISDF + + +++ ++ ++ ++ + +T +SD
Sbjct: 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSD 211
Query: 165 VYSFSVVLVEL-----------------NWTKPIHLVDVEENRSLAAYFSKEAEKEEVIT 207
V+SF V+L E+ N K + ++ EN S Y
Sbjct: 212 VWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMY------------ 259
Query: 208 FAMVAKRCLNLNGKKQPTMKEVTLEL 233
+ C K+PT +++ EL
Sbjct: 260 --NLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-17
Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 30/181 (16%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LK+ + ++F+ E +++Q++H +V+++G C E +LV E P G L +Y+
Sbjct: 31 LKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYL- 86
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIY-------HLDIKSANILLVDKYQ 119
+ R + VS + H VA Y H D+ + N+LLV+++Q
Sbjct: 87 -------------KKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ 133
Query: 120 AKISDFRTFKSRAI----DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
AKISDF SRA+ D TT + + P+ +F+ KSDV+S+ V L E
Sbjct: 134 AKISDFGM--SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEA 191
Query: 176 N 176
Sbjct: 192 F 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-17
Identities = 50/162 (30%), Positives = 89/162 (54%), Gaps = 10/162 (6%)
Query: 18 VEQFINEVVILSQINHRNVVKILGCCLETE-VPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76
VEQF+ E +I+ +H NV+ +LG CL +E PL+V ++ +G L +I +T + P
Sbjct: 40 VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN--PTV 97
Query: 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAI 133
++ + ++V++ + YL AS H D+ + N +L + + K++DF R +
Sbjct: 98 KDL-IGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153
Query: 134 DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
H T K+ ++ + ++ +FT KSDV+SF V+L EL
Sbjct: 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 55/174 (31%), Positives = 84/174 (48%), Gaps = 16/174 (9%)
Query: 11 KSVHESNVEQ----FINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQY 64
KS++ S EQ F E+ IL ++H N+VK G C + L+ E++P+GSL Y
Sbjct: 39 KSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDY 98
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ D L + ++ + + YL S I H D+ + NIL+ + KISD
Sbjct: 99 LQRHRDQINLKR---LLLFSSQICKGMDYLGSQRYI---HRDLAARNILVESEDLVKISD 152
Query: 125 FRTFKSRAIDRTHLTTQVK---VTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
F K D+ + + F Y P+ R+S+F+ SDV+SF V L EL
Sbjct: 153 FGLAKVLPEDKDYYYVKEPGESPIFWYA-PECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-16
Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 10/169 (5%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K K + + F+ E +++ + H N+V++LG L+ +V E++ GSL Y+
Sbjct: 34 VKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL- 91
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
++ + IT +L ++V + YL H D+ + N+L+ + AK+SDF
Sbjct: 92 -RSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFG 147
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
K + + VK T P+ R +F+ KSDV+SF ++L E+
Sbjct: 148 LAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-16
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 18/170 (10%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH----------EQ 68
+ F E +L+ H N+VK G C E + P++V+E++ +G L +++
Sbjct: 53 KDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSP 112
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF--- 125
+T L+I V+++ + YL AS H D+ + N L+ KI DF
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
R + R T + + ++ P+ +FT +SDV+SF VVL E+
Sbjct: 170 RDVYTTDYYRVGGHTMLPIR--WMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 22/217 (10%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
+NE+VILS + H N++ ++ L+ E+ G+LY I Q EM L
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVL 104
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQ 141
++ +SY+H I H DIK+ NI L K+ DF K + + T
Sbjct: 105 WYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV 161
Query: 142 VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-------NWTKPIHLVD--VEENRSL 192
V + Y+ P+ + ++ KSD+++ VL EL + T P++LV V+ N +
Sbjct: 162 VGTPY-YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP 220
Query: 193 AAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
E+I + L + +K+PT EV
Sbjct: 221 V----VSVYSSELI---SLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 39/180 (21%), Positives = 89/180 (49%), Gaps = 9/180 (5%)
Query: 2 EELWLLKKSKSVHESNVEQ-FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGS 60
E L L+K + + N++ F E+ + +++H+NVV++LG C E E ++ E+ G
Sbjct: 35 ETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGD 94
Query: 61 LYQYI-----HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV 115
L Q++ ++ P++ + ++ + +++ + +L ++ H D+ + N L+
Sbjct: 95 LKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVS 151
Query: 116 DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ + K+S K + + ++ P+ + F+ KSDV+SF V++ E+
Sbjct: 152 SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-15
Identities = 51/176 (28%), Positives = 90/176 (51%), Gaps = 11/176 (6%)
Query: 5 WLLKKS---KSVHESNV--EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNG 59
WL K+ K++ E + E FI E ++ +++H +V++ G C E LV+EF+ +G
Sbjct: 25 WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84
Query: 60 SLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ 119
L Y+ Q + E L + ++V ++YL S I H D+ + N L+ +
Sbjct: 85 CLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESSNVI---HRDLAARNCLVGENQV 138
Query: 120 AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
K+SDF + D+ +T K + P+ F S+++ KSDV+SF V++ E+
Sbjct: 139 VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-15
Identities = 44/163 (26%), Positives = 90/163 (55%), Gaps = 10/163 (6%)
Query: 14 HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQTDDQ 72
+++ + F+ E +++Q+ H N+V++LG +E + L +V E++ GSL Y+ ++ +
Sbjct: 39 NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGR 96
Query: 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRA 132
+ + L+ +++V + YL + + H D+ + N+L+ + AK+SDF K
Sbjct: 97 SVLGGDCLLKFSLDVCEAMEYLEANNFV---HRDLAARNVLVSEDNVAKVSDFGLTKE-- 151
Query: 133 IDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T T ++ V + P+ R +F+ KSDV+SF ++L E+
Sbjct: 152 ASSTQDTGKLPVK--WTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-15
Identities = 67/278 (24%), Positives = 128/278 (46%), Gaps = 46/278 (16%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD--- 71
++NVE F++E +I++ ++H ++V++LG CL + LV + +P+G L Y+HE D+
Sbjct: 51 KANVE-FMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGS 108
Query: 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTF 128
QL + W V++++ + YL + H D+ + N+L+ KI+DF R
Sbjct: 109 QLLLNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW--TKPIHLVDV 186
+ + ++ + + ++ ++R +FT +SDV+S+ V + EL KP +
Sbjct: 160 EGDEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217
Query: 187 EENRSLAAYFSKEAEKEE--------VITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238
E L EK E I MV +C ++ +P KE+ E + +
Sbjct: 218 REIPDL-------LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270
Query: 239 SIGASVLLQCEEINFVDYDNARHFKTSSSSTGSFFNNV 276
+++Q ++ K S + FF N+
Sbjct: 271 DPQRYLVIQGDD----------RMKLPSPNDSKFFQNL 298
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 73.6 bits (179), Expect = 7e-15
Identities = 53/180 (29%), Positives = 79/180 (43%), Gaps = 16/180 (8%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINH-RNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
L K VE+F+ E+ IL+ +NH N+VK+ + LV E++ GSL +
Sbjct: 30 LAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL 89
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISD 124
+ + P++ L I ++ L YLH S I H DIK NILL D K+ D
Sbjct: 90 KK-IGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLID 145
Query: 125 F------RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF---TEKSDVYSFSVVLVEL 175
F S + +T V T GY+ P+ + SD++S + L EL
Sbjct: 146 FGLAKLLPDPGSTSSIPALPSTSV-GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-15
Identities = 43/159 (27%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
+F+ E IL Q +H N+VK++G C++ + +V E +P GSL ++ ++ ++L + +
Sbjct: 37 RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK-NRLTV--K 93
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138
L+++++ + + YL S I H D+ + N L+ + KISDF SR +
Sbjct: 94 KLLQMSLDAAAGMEYLESKNCI---HRDLAARNCLVGENNVLKISDFGM--SREEEGGIY 148
Query: 139 TTQVK---VTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
T + + P+ ++T +SDV+S+ ++L E
Sbjct: 149 TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 47/186 (25%), Positives = 91/186 (48%), Gaps = 21/186 (11%)
Query: 6 LLKKSKSVHESNVEQ-FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY 64
+K K E V+Q F E ++S + H N+V +LG C + + +++E++ +G L+++
Sbjct: 39 AIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEF 98
Query: 65 I--HEQTDD----------QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANI 112
+ + D + + L I ++++ + YL +S H D+ + N
Sbjct: 99 LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNC 155
Query: 113 LLVDKYQAKISDFRTFKSRAI---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFS 169
L+ + KISDF SR I D + ++ + ++ P+ +FT +SD++SF
Sbjct: 156 LVGEGLTVKISDFGL--SRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFG 213
Query: 170 VVLVEL 175
VVL E+
Sbjct: 214 VVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 58/238 (24%), Positives = 110/238 (46%), Gaps = 28/238 (11%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
+ ++ ++N E ++E +++ ++H +VV++LG CL + L+ + +P G L Y+
Sbjct: 45 REETSPKANKE-ILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNH 102
Query: 69 TDD---QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
D+ Q + W V++++ +SYL + H D+ + N+L+ KI+DF
Sbjct: 103 KDNIGSQYLLNW------CVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDF 153
Query: 126 RTFKSRAIDRTHL-TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWT---KPI 181
K +D KV ++ + +T KSDV+S+ V + EL T KP
Sbjct: 154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL-MTFGAKPY 212
Query: 182 HLVDVEENRSLAAYFSKEAEKEE-----VITFAMVAKRCLNLNGKKQPTMKEVTLELA 234
+ E L ++ E+ I MV +C ++ + +PT KE+ E +
Sbjct: 213 EGIPAVEIPDLL----EKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 45/169 (26%), Positives = 84/169 (49%), Gaps = 11/169 (6%)
Query: 11 KSVHESN--VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K++ E VE+F+ E ++ +I H N+V++LG C ++ EF+ G+L Y+ E
Sbjct: 37 KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 96
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
++ + L + ++S + YL I H D+ + N L+ + + K++DF
Sbjct: 97 NRQEVNAV--VLLYMATQISSAMEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGL- 150
Query: 129 KSRAIDRTHLTTQVKVTF--GYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
SR + T F + P+ ++F+ KSDV++F V+L E+
Sbjct: 151 -SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 9/160 (5%)
Query: 18 VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77
E F+ E I+ ++ H +V++ C E E +V E++ GSL ++ +L +
Sbjct: 45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP- 103
Query: 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH 137
+ + +++ ++YL S I H D+ + NIL+ + KI+DF +R I+
Sbjct: 104 -QLVDMAAQIAEGMAYLESRNYI---HRDLAARNILVGENLVCKIADFGL--ARLIEDDE 157
Query: 138 LTTQVKVTF--GYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T + F + P+ +FT KSDV+SF ++L E+
Sbjct: 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 46/167 (27%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 11 KSVHES--NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K + E + + FI E ++ +++H N+V++ G C + +V E++ NG L Y+ E+
Sbjct: 34 KMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER 93
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ E L + +V + YL S I H D+ + N L+ + K+SDF
Sbjct: 94 KGK---LGTEWLLDMCSDVCEAMEYLESNGFI---HRDLAARNCLVGEDNVVKVSDFGLA 147
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ D+ + K + P+ F S+F+ KSDV+SF V++ E+
Sbjct: 148 RYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-14
Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 10/167 (5%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E ++ + E+ +L + H N+VK +G ++ ++ E+ NGSL Q I + P
Sbjct: 40 EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP--FP 97
Query: 75 ITWEMRLRITV-EVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI 133
E + + V +V + L+YLH I H DIK+ANIL K++DF ++
Sbjct: 98 ---ESLVAVYVYQVLQGLAYLHEQGVI---HRDIKAANILTTKDGVVKLADFGV-ATKLN 150
Query: 134 DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
D + V T ++ P+ S + SD++S ++EL P
Sbjct: 151 DVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 25/225 (11%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCL--ETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76
+Q ++EV IL ++ H N+V+ + + +V E+ G L Q I + ++ I
Sbjct: 44 QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIE 103
Query: 77 WEMRLRITVEVSRVLSYLH--SVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
E RI ++ L H S + H D+K ANI L K+ DF ++ +
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL--AKILG 161
Query: 135 RTHLTTQVKV-TFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP----------IHL 183
+ V T Y+ P+ + EKSD++S ++ EL P
Sbjct: 162 HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK 221
Query: 184 VDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
+ + R + +S E EVI K LN++ K+P+ +E
Sbjct: 222 IKEGKFRRIPYRYSSEL--NEVI------KSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-14
Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHE 67
+ + S E VE E+ +++++NH +++++LG E L E++ GS+ +
Sbjct: 37 RNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS- 95
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK--YQAKISDF 125
+ + T ++ R LSYLH I H D+K AN+ L+D + +I+DF
Sbjct: 96 ---KYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANL-LIDSTGQRLRIADF 148
Query: 126 RTFKSRAIDRT---HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
A T Q+ T ++ P+ R Q+ DV+S V++E+ KP
Sbjct: 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 39/155 (25%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 21 FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80
F+ E I+ Q +H N++++ G ++ +++ E++ NGSL +++ E D + T
Sbjct: 52 FLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE-NDGKF--TVGQL 108
Query: 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF-RTFKSRAIDRTHLT 139
+ + ++ + YL + + H D+ + NIL+ K+SDF + + + T+ T
Sbjct: 109 VGMLRGIASGMKYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165
Query: 140 TQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
K+ + P+ +FT SDV+SF +V+ E
Sbjct: 166 KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 41/164 (25%), Positives = 79/164 (48%), Gaps = 11/164 (6%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI--HEQTDD----- 71
E F+ EV ILS+++ N+ ++LG C ++ E++ NG L Q++ H
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKS- 130
+++ L + +++ + YL S+ H D+ + N L+ Y KI+DF ++
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 131 RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
+ D + + + ++ + +FT KSDV++F V L E
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYI--HEQTD 70
+ N + E+ IL + H N+VK GCC E + L+ E++P GSL Y+ H+
Sbjct: 47 QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL 106
Query: 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130
QL L ++ ++YLHS I H D+ + N+LL + KI DF K
Sbjct: 107 AQL-------LLFAQQICEGMAYLHSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAK- 155
Query: 131 RAIDRTHLTTQVK-----VTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
A+ H +V+ F Y + + ++F+ SDV+SF V L EL
Sbjct: 156 -AVPEGHEYYRVREDGDSPVFWYA-VECLKENKFSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 46/171 (26%), Positives = 91/171 (53%), Gaps = 10/171 (5%)
Query: 7 LKKSKSVHESNV-EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+K K+ +E +V ++ + E I+ Q+++ +V+++G C E E +LV E G L +++
Sbjct: 27 IKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFL 85
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ D+ IT + + +VS + YL + H D+ + N+LLV+++ AKISDF
Sbjct: 86 SGKKDE---ITVSNVVELMHQVSMGMKYLEGKNFV---HRDLAARNVLLVNQHYAKISDF 139
Query: 126 RTFKSRAIDRTHLTTQV--KVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
K+ D ++ + K + P+ +F+ +SDV+S+ + + E
Sbjct: 140 GLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 54/182 (29%), Positives = 87/182 (47%), Gaps = 26/182 (14%)
Query: 11 KSVHESNVEQ----FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
K++ ES EQ F+ E +I+S+ NH+N+V+++G E ++ E + G L ++
Sbjct: 42 KTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLR 101
Query: 67 E---QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK---YQA 120
E + + +T + L +V++ YL I H DI + N LL K A
Sbjct: 102 ENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVA 158
Query: 121 KISDF-------RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLV 173
KI+DF R R R L +K ++ P+ F FT K+DV+SF V+L
Sbjct: 159 KIADFGMARDIYRASYYRKGGRAMLP--IK----WMPPEAFLDGIFTSKTDVWSFGVLLW 212
Query: 174 EL 175
E+
Sbjct: 213 EI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-13
Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E FI E ++ +++H +V++ G C + + +V EF+ NG L Y+ ++ Q ++ +
Sbjct: 44 EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKD 100
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138
M L + +V + YL + I H D+ + N L+ K+SDF + D
Sbjct: 101 MLLSMCQDVCEGMEYLERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157
Query: 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
++ K + P+ F S+++ KSDV+SF V++ E+
Sbjct: 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 19/183 (10%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY-- 64
+K K ES + F E +L+ + H+++V+ G C E L+V+E++ +G L ++
Sbjct: 40 VKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLR 99
Query: 65 -------IHEQTDDQL--PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV 115
I +D +T L I +++ + YL AS+ H D+ + N L+
Sbjct: 100 SHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVG 156
Query: 116 DKYQAKISDFRTFKSRAI---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
KI DF SR I D + + + ++ P+ +FT +SD++SF VVL
Sbjct: 157 QGLVVKIGDFGM--SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214
Query: 173 VEL 175
E+
Sbjct: 215 WEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-13
Identities = 41/159 (25%), Positives = 88/159 (55%), Gaps = 14/159 (8%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
+ F+ E ++++++H+N+V++LG L + +V E + G+L ++ +T + ++
Sbjct: 44 QAFLEETAVMTKLHHKNLVRLLGVILHNGL-YIVMELMSKGNLVNFL--RTRGRALVSVI 100
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK--SRAIDRT 136
L+ +++V+ + YL S + H D+ + NIL+ + AK+SDF + S +D +
Sbjct: 101 QLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157
Query: 137 HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
L + + P+ + +F+ KSDV+S+ V+L E+
Sbjct: 158 KLPVK------WTAPEALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-13
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 12/166 (7%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQ 72
+++ E+ IL + H N+VK G C E L+ EF+P+GSL +Y+ +
Sbjct: 47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK- 105
Query: 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRA 132
I + +L+ V++ + + YL S + H D+ + N+L+ ++Q KI DF K+
Sbjct: 106 --INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIE 160
Query: 133 IDRTHLTTQVKV---TFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
D+ + T + + F Y P+ S+F SDV+SF V L EL
Sbjct: 161 TDKEYYTVKDDLDSPVFWYA-PECLIQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 5e-13
Identities = 52/170 (30%), Positives = 77/170 (45%), Gaps = 10/170 (5%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
LKK K + VE + E ILS+INH +VK L +TE L LV E+ P G L+ ++
Sbjct: 26 LKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LHYAFQTEEKLYLVLEYAPGGELFSHL 84
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ + + E E+ L YLHS+ I + D+K NILL K++DF
Sbjct: 85 SK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDF 137
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
K T T Y+ P+ + + D +S V+L E+
Sbjct: 138 GLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEM 186
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 6e-13
Identities = 59/228 (25%), Positives = 91/228 (39%), Gaps = 45/228 (19%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSL----YQYIHEQTDDQLPITW 77
INE++I+ H N+V L + +V E++ GSL Q + Q+
Sbjct: 63 INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA--- 119
Query: 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH 137
+ EV + L YLHS I H DIKS NILL K++DF F
Sbjct: 120 ----YVCREVLQGLEYLHSQNVI---HRDIKSDNILLSKDGSVKLADF-GFA------AQ 165
Query: 138 LTTQVKVTFGYVDPKYF------RSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS 191
LT + V Y+ + + K D++S ++ +E+ +P +L
Sbjct: 166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL----REPP 221
Query: 192 LAAYFS---------KEAEK--EEVITFAMVAKRCLNLNGKKQPTMKE 228
L A F K EK E F +CL + +K+P+ +E
Sbjct: 222 LRALFLITTKGIPPLKNPEKWSPEFKDF---LNKCLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-13
Identities = 38/162 (23%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 17 NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76
+ + F+ E I+ ++ H ++++ C E +V E + GSL +Y+ Q +
Sbjct: 44 DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL--QGGAGRALK 101
Query: 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAI 133
+ + +V+ ++YL + I H D+ + N+L+ + K++DF R K
Sbjct: 102 LPQLIDMAAQVASGMAYLEAQNYI---HRDLAARNVLVGENNICKVADFGLARVIKE--- 155
Query: 134 DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
D K + P+ ++F+ KSDV+SF ++L E+
Sbjct: 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-13
Identities = 41/159 (25%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E F+ E ++ Q+ H +V+ L + E ++ E++ NGSL ++ +T + + +T
Sbjct: 46 EAFLAEANLMKQLQHPRLVR-LYAVVTQEPIYIITEYMENGSLVDFL--KTPEGIKLTIN 102
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138
+ + +++ ++++ I H D+++ANIL+ + KI+DF +R I+
Sbjct: 103 KLIDMAAQIAEGMAFIERKNYI---HRDLRAANILVSETLCCKIADFGL--ARLIEDNEY 157
Query: 139 TTQ--VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T + K + P+ FT KSDV+SF ++L E+
Sbjct: 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 196
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-13
Identities = 38/156 (24%), Positives = 83/156 (53%), Gaps = 8/156 (5%)
Query: 20 QFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79
+F++E IL Q +H N+VK++G C + + +V E +P G ++ ++ D+ + +
Sbjct: 38 KFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQ 94
Query: 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT 139
++ ++ + ++YL S I H D+ + N L+ + KISDF + D + +
Sbjct: 95 LVKFALDAAAGMAYLESKNCI---HRDLAARNCLVGENNVLKISDFGMSRQED-DGIYSS 150
Query: 140 TQVK-VTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
+ +K + + P+ +++ +SDV+S+ ++L E
Sbjct: 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 13/163 (7%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQTDDQLP 74
S E+F+ E I+ Q +H ++VK++G TE P+ +V E P G L Y+ + L
Sbjct: 49 SVREKFLQEAYIMRQFDHPHIVKLIGVI--TENPVWIVMELAPLGELRSYL-QVNKYSLD 105
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
+ + + ++S L+YL S H DI + N+L+ K+ DF SR ++
Sbjct: 106 L--ASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGL--SRYLE 158
Query: 135 RT--HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ ++ K+ ++ P+ +FT SDV+ F V + E+
Sbjct: 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 18/183 (9%)
Query: 2 EELWL------LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEF 55
E LW +K KS + F EV L ++ H++++ + C E ++ E
Sbjct: 24 EGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83
Query: 56 IPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV 115
+ GSL ++ LP+ + + +V+ ++YL SI H D+ + NIL+
Sbjct: 84 MEKGSLLAFLRSPEGQVLPV--ASLIDMACQVAEGMAYLEEQNSI---HRDLAARNILVG 138
Query: 116 DKYQAKISDF---RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
+ K++DF R K + +L++ K+ + + P+ F+ KSDV+SF ++L
Sbjct: 139 EDLVCKVADFGLARLIK----EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILL 194
Query: 173 VEL 175
E+
Sbjct: 195 YEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 42/165 (25%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E + F++E I+ Q +H N++++ G + + +++ E++ NG+L +Y+ + +
Sbjct: 47 EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS 106
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
LR + LS ++ V H D+ + NIL+ + K+SDF SR ++
Sbjct: 107 YQLVGMLRGIAAGMKYLSDMNYV------HRDLAARNILVNSNLECKVSDFGL--SRVLE 158
Query: 135 R----THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T+ T+ K+ + P+ +FT SDV+SF +V+ E+
Sbjct: 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-12
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 27/225 (12%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E +E E+ +LSQ + V K G L+ ++ E++ GS + D+
Sbjct: 43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ 102
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
I ++ E+ + L YLHS I H DIK+AN+LL ++ K++DF
Sbjct: 103 IATMLK-----EILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP----------IHLV 184
+ T V F ++ P+ + S + K+D++S + +EL +P + L+
Sbjct: 155 QIKRNTFVGTPF-WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
Query: 185 DVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
+L FSK F CLN + +PT KE+
Sbjct: 214 PKNNPPTLTGEFSK--------PFKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-12
Identities = 40/171 (23%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQT 69
S +E+F++E + +H NV+K++G C E P+++ F+ +G L+ ++
Sbjct: 43 SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR 102
Query: 70 DDQLP--ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
LP + + L+ V+++ + YL + I H D+ + N +L + ++DF
Sbjct: 103 LGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGL 159
Query: 128 FKSRAI---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
S+ I D K+ ++ + +T KSDV++F V + E+
Sbjct: 160 --SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-12
Identities = 46/173 (26%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
SK S ++ E+ +L ++ H N+V+ LG L+ + + E++P GS+ +
Sbjct: 41 SSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL--- 97
Query: 69 TDDQLPITWEMRLRITV-EVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
+ E +R V ++ + L+YLH+ I H DIK ANIL+ +K KISDF
Sbjct: 98 --NNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI 152
Query: 128 FKSRAIDRTHLTTQ-----VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
K + T ++ + ++ P+ + + +T K+D++S ++VE+
Sbjct: 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 18/178 (10%)
Query: 11 KSVHE----SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
K+V+E +F+NE ++ + N +VV++LG + L+V E + G L Y+
Sbjct: 42 KTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLR 101
Query: 67 ------EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
E P T + +++ E++ ++YL A+ H D+ + N ++ +
Sbjct: 102 SRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTV 158
Query: 121 KISDFRTFKSRAI---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
KI DF +R I D + + ++ P+ + FT KSDV+SF VVL E+
Sbjct: 159 KIGDFGM--TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 57/241 (23%), Positives = 93/241 (38%), Gaps = 38/241 (15%)
Query: 7 LKKSKSVHESNVEQFI-NEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
LKK + + + E+ L VVK G + +V E++ GSL
Sbjct: 31 LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSL---- 86
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ I + I ++ + L YLH+ I H DIK +N+L+ K + KI+DF
Sbjct: 87 ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI--IHRDIKPSNLLINSKGEVKIADF 144
Query: 126 RTFKSRAIDRTHLTTQVKVTF-G---YVDPKYFRSSQFTEKSDVYSFSVVLVELNWTK-P 180
S+ ++ T TF G Y+ P+ + ++ +D++S + L+E K P
Sbjct: 145 GI--SKVLEN---TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
Query: 181 I-------------HLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227
+ D A FS E F CL + KK+P+
Sbjct: 200 FLPPGQPSFFELMQAICDGPPPSLPAEEFSPE--------FRDFISACLQKDPKKRPSAA 251
Query: 228 E 228
E
Sbjct: 252 E 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-12
Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 12/178 (6%)
Query: 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVP--LLVYEFIPNGS 60
E+ +KK + ++ F E+ IL + H N+VK G C LV E++P GS
Sbjct: 34 EVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGS 93
Query: 61 LYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
L Y+ + + + L ++ + + YL S + H D+ + NIL+ + +
Sbjct: 94 LRDYLQKHRER---LDHRKLLLYASQICKGMEYLGSKRYV---HRDLATRNILVESENRV 147
Query: 121 KISDFRTFKSRAIDRTHLTTQ---VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
KI DF K D+ + + F Y P+ S+F+ SDV+SF VVL EL
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-12
Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 10/155 (6%)
Query: 23 NEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82
NE +L ++H N+++ LE + ++V E+ P G+L +YI ++ + L + L
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD--EDTILH 105
Query: 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ--AKISDFRTFKSRAIDRTHLTT 140
V+ +L LH V + I H D+K+ NILL DK++ KI DF S+ +
Sbjct: 106 FFVQ---ILLALHHVHTKLILHRDLKTQNILL-DKHKMVVKIGDFGI--SKILSSKSKAY 159
Query: 141 QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
V T Y+ P+ + +KSD+++ VL EL
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E INE++++ + H N+V L L + +V E++ GSL + E D+ I
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 120
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138
R E + L +LHS I H DIKS NILL K++DF +++
Sbjct: 121 CR-----ECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF-- 196
+T V + ++ P+ + K D++S ++ +E+ +P +L EN A Y
Sbjct: 173 STMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL---NENPLRALYLIA 228
Query: 197 ---SKEAEKEEVIT--FAMVAKRCLNLNGKKQPTMKEV 229
+ E + E ++ F RCL ++ +K+ + KE+
Sbjct: 229 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-11
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E +E E+ +LSQ + V K G L+ ++ E++ GS + D+
Sbjct: 43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ 102
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
I +R E+ + L YLHS I H DIK+AN+LL + + K++DF
Sbjct: 103 IATILR-----EILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIH----------LV 184
+ T V F ++ P+ + S + K+D++S + +EL +P H L+
Sbjct: 155 QIKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
Query: 185 DVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
+L +SK ++ + CLN +PT KE+
Sbjct: 214 PKNNPPTLEGNYSKPLKE--------FVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 51/181 (28%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
L+K + E ++F+ E ++S NH N+VK+LG CL E ++ E + G L Y+
Sbjct: 34 LRKGATDQEK--KEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLR 91
Query: 67 EQTDDQLP---ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-YQA-- 120
+ ++ +T + L I ++V++ YL + I H D+ + N L+ +K Y A
Sbjct: 92 DARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFI---HRDLAARNCLVSEKGYDADR 148
Query: 121 --KISDF----RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
KI DF +KS D + + ++ P+ +FT +SDV+SF V++ E
Sbjct: 149 VVKIGDFGLARDIYKS---DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWE 205
Query: 175 L 175
+
Sbjct: 206 I 206
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 38/166 (22%), Positives = 71/166 (42%), Gaps = 13/166 (7%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75
+++ +E+ +L + H N+VK G + E + E+ G+L + +
Sbjct: 41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDE-- 98
Query: 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR 135
+ T+++ L+YLHS I H DIK ANI L K+ DF +
Sbjct: 99 --HVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153
Query: 136 THLTTQVKVTFG---YVDPKYFRSSQFTEK---SDVYSFSVVLVEL 175
T + +V+ G Y+ P+ + +D++S V++E+
Sbjct: 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEM 199
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 42/160 (26%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E F+ E ++ ++ H +V++ E + +V E++ GSL ++ + L
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYL----- 99
Query: 79 MRLRITVEV-SRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH 137
RL V++ +++ S + V + H D+++ANIL+ + K++DF +R I+
Sbjct: 100 -RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL--ARLIEDNE 156
Query: 138 LTTQ--VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T + K + P+ +FT KSDV+SF ++L EL
Sbjct: 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 45/159 (28%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
++FI E ++ +++H +V++ G C + +V E++ NG L Y+ E P
Sbjct: 44 DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL- 102
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138
L + +V ++YL S I H D+ + N L+ D+ K+SDF SR +
Sbjct: 103 --LEMCKDVCEGMAYLESKQFI---HRDLAARNCLVDDQGCVKVSDFGL--SRYVLDDEY 155
Query: 139 TTQVKVTF--GYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T+ V F + P+ S+F+ KSDV++F V++ E+
Sbjct: 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 12/171 (7%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E E+ EV +L + H N+V+ LG CL+ + EF+P GS+ ++ P
Sbjct: 43 EKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG----P 98
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
+ + + T ++ ++YLH+ + H DIK N++L+ K+ DF + A
Sbjct: 99 LPEPVFCKYTKQILDGVAYLHNNCVV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155
Query: 135 RTHLT-----TQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
H T + T ++ P+ S + KSD++S + E+ KP
Sbjct: 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 43/171 (25%), Positives = 86/171 (50%), Gaps = 19/171 (11%)
Query: 21 FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI-HEQTDD-------- 71
F+ EV ILS++ N++++LG C++ + ++ E++ NG L Q++ DD
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 72 -----QLP-ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
LP I++ L + ++++ + YL +S+ H D+ + N L+ + KI+DF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 126 RTFKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
++ A D + + + ++ + +FT SDV++F V L E+
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 62/242 (25%), Positives = 99/242 (40%), Gaps = 54/242 (22%)
Query: 17 NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP-- 74
+ E E+ +L + H N+V G L + +V E+ GSL Q I++ T L
Sbjct: 43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLSEL 101
Query: 75 -ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF-------R 126
I + + E + L+YLH I H DIK ANILL + K++DF
Sbjct: 102 QIAY-----VCRETLKGLAYLHETGKI---HRDIKGANILLTEDGDVKLADFGVSAQLTA 153
Query: 127 TFKSRAIDRTHLTT---------QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW 177
T R ++ + T V+ GY K D+++ + +EL
Sbjct: 154 TIAKR---KSFIGTPYWMAPEVAAVERKGGY-----------DGKCDIWALGITAIELAE 199
Query: 178 TKPIHLVDVEENRSLAAYF-SKEA-------EKEE-VITFAMVAKRCLNLNGKKQPTMKE 228
+P D+ R+L + SK +KE+ F K+CL + KK+PT +
Sbjct: 200 LQPPMF-DLHPMRAL--FLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATK 256
Query: 229 VT 230
+
Sbjct: 257 LL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E INE++++ ++ + N+V L L + +V E++ GSL + E D+ I
Sbjct: 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV 120
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138
R E + L +LH+ I H DIKS N+LL K++DF +++
Sbjct: 121 CR-----ECLQALEFLHANQVI---HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF-- 196
+T V + ++ P+ + K D++S ++ +E+ +P +L EN A Y
Sbjct: 173 STMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL---NENPLRALYLIA 228
Query: 197 ---SKEAEKEEVIT--FAMVAKRCLNLNGKKQPTMKEV 229
+ E + E ++ F RCL ++ +K+ + KE+
Sbjct: 229 TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 10/172 (5%)
Query: 12 SVHESN-VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD 70
S V E+ +L + H +V+ GC + E + E++P GS + +Q
Sbjct: 41 SPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGS----VKDQLK 96
Query: 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130
+T + + T ++ + YLHS I H DIK ANIL K+ DF K
Sbjct: 97 AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 153
Query: 131 RAIDRTHLTTQVKV--TFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
+ T V T ++ P+ + K+DV+S +VE+ KP
Sbjct: 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 41/166 (24%), Positives = 87/166 (52%), Gaps = 16/166 (9%)
Query: 21 FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT-------DDQL 73
F+ E+ I+S++ + N++++LG C+ + ++ E++ NG L Q++ ++ + +
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 74 P-ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRA 132
P ++ L + V+++ + YL AS+ H D+ + N L+ + Y KI+DF SR
Sbjct: 124 PSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGM--SRN 178
Query: 133 I---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ D + + + ++ + +FT SDV++F V L E+
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 5e-11
Identities = 47/192 (24%), Positives = 77/192 (40%), Gaps = 33/192 (17%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
L K + + E V+ E +L+++N H ++K+ + E V E+ PNG L QYI
Sbjct: 34 LDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI 93
Query: 66 HEQTD-DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ D+ + E+ L YLHS I H D+K NILL KI+D
Sbjct: 94 RKYGSLDEKCTRF-----YAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITD 145
Query: 125 FRTFKSRAIDRTHLTTQVKV---------------------TFGYVDPKYFRSSQFTEKS 163
F T ++ +D K T YV P+ + S
Sbjct: 146 FGT--AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSS 203
Query: 164 DVYSFSVVLVEL 175
D+++ ++ ++
Sbjct: 204 DLWALGCIIYQM 215
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 41/175 (23%), Positives = 86/175 (49%), Gaps = 17/175 (9%)
Query: 15 ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73
E ++ ++E+ ++ I H+N++ +LG C + ++ E+ G+L +Y+ + +
Sbjct: 61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120
Query: 74 ------------PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
+T++ + T +V+R + YL S I H D+ + N+L+ + K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMK 177
Query: 122 ISDFRTFKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
I+DF + ID TT ++ ++ P+ +T +SDV+SF V++ E+
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 11/178 (6%)
Query: 7 LKKSKSVHESNVEQFIN--EVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY 64
+KK K ES E+ +L ++NH N++K+L LV+EF+ + LY+
Sbjct: 29 IKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKL 87
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
I D Q + + ++ + L++ HS I H D+K N+L+ + K++D
Sbjct: 88 IK---DRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLAD 141
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPK-YFRSSQFTEKSDVYSFSVVLVELNWTKPI 181
F +S T V VT Y P+ ++ D++S + EL +P+
Sbjct: 142 FGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-11
Identities = 57/248 (22%), Positives = 104/248 (41%), Gaps = 27/248 (10%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E +E E+ +LSQ + + + G L+ ++ E++ GS + ++
Sbjct: 43 EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETY 102
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
I +R E+ + L YLHS I H DIK+AN+LL ++ K++DF
Sbjct: 103 IATILR-----EILKGLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP----------IHLV 184
+ T V F ++ P+ + S + K+D++S + +EL +P + L+
Sbjct: 155 QIKRNTFVGTPF-WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
Query: 185 DVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRASIGASV 244
+L +SK F + CLN + + +PT KE+ R + S
Sbjct: 214 PKNSPPTLEGQYSK--------PFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSF 265
Query: 245 LLQCEEIN 252
L + +
Sbjct: 266 LTELIDRY 273
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 39/178 (21%), Positives = 77/178 (43%), Gaps = 38/178 (21%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+ S+ S + ++ H N+VK++G C + L++E+I +L + +
Sbjct: 723 INDVNSIPSSEIADM-------GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL- 774
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI---- 122
++WE R +I + +++ L +LH S + ++ I++ K + +
Sbjct: 775 ------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSL 828
Query: 123 -----SDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+D + F S A YV P+ + TEKSD+Y F ++L+EL
Sbjct: 829 PGLLCTDTKCFISSA---------------YVAPETRETKDITEKSDIYGFGLILIEL 871
|
Length = 968 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-11
Identities = 43/176 (24%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 14 HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI------- 65
E ++ ++E+ ++ I H+N++ +LG C + +V E+ +G+L ++
Sbjct: 55 TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPG 114
Query: 66 -HEQTDDQLPITWEMRLRITV----EVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
+ DD P + + V +V+R + +L AS H D+ + N+L+ + +
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVM 171
Query: 121 KISDFRTFKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
KI+DF + ID TT ++ ++ P+ +T +SDV+SF V+L E+
Sbjct: 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 43/179 (24%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K K ++ + F E +L+ + H ++VK G C+E + ++V+E++ +G L +++
Sbjct: 40 VKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLR 99
Query: 67 EQTDDQL---------PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK 117
D + +T L I +++ + YL AS H D+ + N L+ +
Sbjct: 100 AHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGEN 156
Query: 118 YQAKISDFRTFKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
KI DF + + D + + ++ P+ +FT +SDV+S VVL E+
Sbjct: 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 8e-11
Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 24/186 (12%)
Query: 7 LKKSKSVHESN--VEQFINEVVILSQINHRNVVKILGCCLETEVP--LLVYEFIP---NG 59
LKK + +E I E+ +L ++ H N+V++ +V+E++ G
Sbjct: 29 LKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG 88
Query: 60 SLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ 119
L + T+ Q+ ++ L YLHS I H DIK +NIL+ +
Sbjct: 89 LLDSPEVKFTESQIK-------CYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGV 138
Query: 120 AKISDF---RTFKSRAIDRTHLTTQVKVTFGYVDPK-YFRSSQFTEKSDVYSFSVVLVEL 175
K++DF R + R T +V +T Y P+ ++++ + D++S +L EL
Sbjct: 139 LKLADFGLARPYTKRNSAD--YTNRV-ITLWYRPPELLLGATRYGPEVDMWSVGCILAEL 195
Query: 176 NWTKPI 181
KPI
Sbjct: 196 FLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-11
Identities = 43/168 (25%), Positives = 84/168 (50%), Gaps = 10/168 (5%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K+ + + ++ + E ++ Q+++ +V+++G C E E +LV E G L +++ +
Sbjct: 31 KNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKN 89
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+T + + +VS + YL + H D+ + N+LLV ++ AKISDF
Sbjct: 90 KH----VTEKNITELVHQVSMGMKYLEETNFV---HRDLAARNVLLVTQHYAKISDFGLS 142
Query: 129 KSRAIDRTHLTTQV--KVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
K+ D + + K + P+ +F+ KSDV+SF V++ E
Sbjct: 143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 45/175 (25%), Positives = 83/175 (47%), Gaps = 5/175 (2%)
Query: 7 LKKSKSVHESNVEQFINEVVIL-SQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
K K + ++ ++EV I+ Q+ H N+V+ LE + +V + I L ++
Sbjct: 41 FGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF 100
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ + + T E I V++ L YLH I H D+ NI+L + + I+DF
Sbjct: 101 NSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDF 158
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
K + + LT+ V T Y P+ ++ + EK+DV++F +L ++ +P
Sbjct: 159 GLAKQKQ-PESKLTSVVG-TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 37/161 (22%), Positives = 81/161 (50%), Gaps = 9/161 (5%)
Query: 17 NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76
+V+ F+ E ++ + H +V++ + E ++ E++ GSL ++ ++D+ +
Sbjct: 44 SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL--KSDEGGKVL 101
Query: 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT 136
+ + +++ ++Y+ I H D+++AN+L+ + KI+DF +R I+
Sbjct: 102 LPKLIDFSAQIAEGMAYIERKNYI---HRDLRAANVLVSESLMCKIADFGL--ARVIEDN 156
Query: 137 HLTTQ--VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T + K + P+ FT KSDV+SF ++L E+
Sbjct: 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEI 197
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 50/168 (29%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI-HEQTDDQLP 74
++V++ EV +SQ NH NVVK + + LV ++ GSL + L
Sbjct: 41 TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD 100
Query: 75 ---ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF--RTFK 129
I ++ EV + L YLHS I H DIK+ NILL + KI+DF
Sbjct: 101 EAIIATVLK-----EVLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASL 152
Query: 130 SRAIDRTHLTTQVKV-TFGYVDPKYFRSSQ-FTEKSDVYSFSVVLVEL 175
+ DRT + V T ++ P+ + K+D++SF + +EL
Sbjct: 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 60/246 (24%), Positives = 116/246 (47%), Gaps = 30/246 (12%)
Query: 15 ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ----- 68
E ++ I+E+ ++ I H+N++ +LG C + ++ E+ G+L +Y+ +
Sbjct: 64 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 123
Query: 69 ----TDDQLP---ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
Q+P ++++ + +V+R + YL S I H D+ + N+L+ + K
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMK 180
Query: 122 ISDFRTFKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWT-- 178
I+DF + ID TT ++ ++ P+ +T +SDV+SF V+L E+ +T
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI-FTLG 239
Query: 179 -KPIHLVDVEENRSLAAYFSKEAEKEEVIT-----FAMVAKRCLNLNGKKQPTMKEVTLE 232
P V VEE L KE + + + M+ + C + ++PT K++ +
Sbjct: 240 GSPYPGVPVEELFKLL----KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295
Query: 233 LAGIRA 238
L I A
Sbjct: 296 LDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 10/159 (6%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E F+ E I+ ++ H +V + E + +V EF+ GSL ++ E L +
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLP-- 102
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138
+ + +++ ++Y+ + I H D+++ANIL+ D KI+DF +R I+
Sbjct: 103 QLVDMAAQIADGMAYIERMNYI---HRDLRAANILVGDNLVCKIADFGL--ARLIEDNEY 157
Query: 139 TTQ--VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T + K + P+ +FT KSDV+SF ++L EL
Sbjct: 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 22/224 (9%)
Query: 18 VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ----TDDQL 73
V+ E+ + S + HRN+V+ LG E + E +P GSL + + D++
Sbjct: 49 VQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ 108
Query: 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA--KISDFRTFKSR 131
I + T ++ L YLH I H DIK N+ LV+ Y KISDF T K R
Sbjct: 109 TIIF-----YTKQILEGLKYLHDNQ---IVHRDIKGDNV-LVNTYSGVVKISDFGTSK-R 158
Query: 132 AIDRTHLTTQVKVTFGYVDPKYFRSSQ--FTEKSDVYSFSVVLVELNWTKP--IHLVDVE 187
T T Y+ P+ + +D++S +VE+ KP I L + +
Sbjct: 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ 218
Query: 188 ENRSLAAYFSKEAEKEEVITFAMVA--KRCLNLNGKKQPTMKEV 229
F E E ++ RC + K+ + ++
Sbjct: 219 AAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 40/163 (24%), Positives = 80/163 (49%), Gaps = 10/163 (6%)
Query: 20 QFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH------EQTDDQL 73
+F+NE ++ + N +VV++LG + + L++ E + G L Y+ E Q
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF-RTFKSRA 132
P + + +++ E++ ++YL++ + H D+ + N ++ + + KI DF T
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 133 IDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
D + + ++ P+ + FT SDV+SF VVL E+
Sbjct: 172 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-10
Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH--EQTDDQLPIT 76
E F+ E I+ ++ H +V++ E + +V E++ GSL ++ E +LP
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNL 104
Query: 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT 136
+M +V+ ++Y+ + I H D++SANIL+ D KI+DF +R I+
Sbjct: 105 VDM----AAQVAAGMAYIERMNYI---HRDLRSANILVGDGLVCKIADFGL--ARLIEDN 155
Query: 137 HLTTQ--VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T + K + P+ +FT KSDV+SF ++L EL
Sbjct: 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 17/223 (7%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD---DQLPI 75
++ ++E +++ + V ++LG CL + V L V + +P G L Y+ E D Q +
Sbjct: 54 KEILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLL 112
Query: 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR 135
W V++++ +SYL V + H D+ + N+L+ KI+DF + ID
Sbjct: 113 NW------CVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163
Query: 136 THLTTQV-KVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW--TKPIHLVDVEENRSL 192
T KV ++ + +FT +SDV+S+ V + EL KP + E L
Sbjct: 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL 223
Query: 193 AAYFSKEAEKEE-VITFAMVAKRCLNLNGKKQPTMKEVTLELA 234
+ + I M+ +C ++ + +P +E+ E +
Sbjct: 224 LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 12/109 (11%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD--DQLPIT 76
E NEVVI+ H N+V++ L + +V EF+ G+L TD +
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL-------TDIVTHTRMN 113
Query: 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
E + + V + LS+LH+ I H DIKS +ILL + K+SDF
Sbjct: 114 EEQIATVCLAVLKALSFLHAQGVI---HRDIKSDSILLTSDGRVKLSDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 57/249 (22%), Positives = 106/249 (42%), Gaps = 49/249 (19%)
Query: 11 KSVHES----NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
K+V+ES +F+NE ++ +VV++LG + + L+V E + +G L Y+
Sbjct: 42 KTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR 101
Query: 67 ------EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
E + P T + +++ E++ ++YL++ + H D+ + N ++ +
Sbjct: 102 SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTV 158
Query: 121 KISDFRTFKSRAIDRTHLTTQVK---VTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW 177
KI DF +R I T + + ++ P+ + FT SD++SF VVL E+
Sbjct: 159 KIGDFGM--TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT- 215
Query: 178 TKPIHLVDVEENRSLAAYFSKEAEKEEVITFAM-----------------VAKRCLNLNG 220
SLA + E+V+ F M + + C N
Sbjct: 216 -------------SLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNP 262
Query: 221 KKQPTMKEV 229
K +PT E+
Sbjct: 263 KMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 39/159 (24%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 20 QFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79
+F+ E IL Q +H N+V+++G C + + +V E + G ++ + + +
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKE 95
Query: 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT 139
+++ + + YL S I H D+ + N L+ +K KISDF + D + +
Sbjct: 96 LIQMVENAAAGMEYLESKHCI---HRDLAARNCLVTEKNVLKISDFGMSREEE-DGVYAS 151
Query: 140 T----QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
T Q+ V + P+ +++ +SDV+SF ++L E
Sbjct: 152 TGGMKQIPVK--WTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 9e-10
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 19/230 (8%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K+ + E INE++++ + + N+V L L + +V E++ GSL +
Sbjct: 49 IKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 108
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
E D+ I R E + L +LHS I H DIKS NILL K++DF
Sbjct: 109 ETCMDEGQIAAVCR-----ECLQALDFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFG 160
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDV 186
+++ +T V + ++ P+ + K D++S ++ +E+ +P +L
Sbjct: 161 FCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--- 216
Query: 187 EENRSLAAYF-----SKEAEKEEVIT--FAMVAKRCLNLNGKKQPTMKEV 229
EN A Y + E + E ++ F RCL ++ ++ + KE+
Sbjct: 217 NENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-10
Identities = 54/235 (22%), Positives = 108/235 (45%), Gaps = 25/235 (10%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQY-IHEQ 68
S +E F++E V + + +H NV++++G CL+T P+++ F+ +G L+ + ++ +
Sbjct: 42 SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR 101
Query: 69 TDDQ---LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
D LP +M ++ +++ + YL S + I H D+ + N +L + ++DF
Sbjct: 102 LGDCPQYLPT--QMLVKFMTDIASGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADF 156
Query: 126 RTFKSRAIDRTHLTTQ---VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIH 182
S+ I Q K+ ++ + +T KSDV+SF V + E+
Sbjct: 157 GL--SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
Query: 183 LVDVEENRSLAAYFSKEAEKEE----VITFAMVAKRCLNLNGKKQPTMKEVTLEL 233
V EN + Y + ++ + + C LN K +P+ + + EL
Sbjct: 215 YPGV-ENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 28/173 (16%)
Query: 21 FINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHE----QTDDQLPI 75
F E+ +L ++ H N++ +LG C L E+ P+G+L ++ + +TD I
Sbjct: 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 113
Query: 76 --------TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
+ + L +V+R + YL I H D+ + NIL+ + Y AKI+DF
Sbjct: 114 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGL 170
Query: 128 FKSRAIDRTHLTTQVKVTFGYVDPKY-----FRSSQFTEKSDVYSFSVVLVEL 175
+ + + VK T G + ++ S +T SDV+S+ V+L E+
Sbjct: 171 SRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-10
Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 18/161 (11%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI-HEQTDDQL---PITW 77
+ E+ +L Q++H NV+K L +E +V E G L + I H + +L W
Sbjct: 50 LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW 109
Query: 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAID 134
+ V++ L ++HS I H DIK AN+ + K+ D R F S+
Sbjct: 110 ----KYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
L T Y+ P+ + + KSD++S +L E+
Sbjct: 163 AHSLVG----TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E INE++++ + + N+V L L + +V E++ GSL + E D+ I
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV 121
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138
R E + L +LHS I H DIKS NILL K++DF +++
Sbjct: 122 CR-----ECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF-- 196
+T V + ++ P+ + K D++S ++ +E+ +P +L EN A Y
Sbjct: 174 STMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALYLIA 229
Query: 197 ---SKEAEKEEVIT--FAMVAKRCLNLNGKKQPTMKEV 229
+ E + E ++ F RCL+++ +K+ + KE+
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 40/172 (23%), Positives = 76/172 (44%), Gaps = 13/172 (7%)
Query: 15 ESNVEQFINEVVILSQINH---RNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD 71
+ +V EV +LSQ+ N+ K G L+ ++ E+ GS+ +
Sbjct: 40 DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA 99
Query: 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSR 131
+ I+ +R EV L Y+H V + H DIK+ANIL+ + K+ DF
Sbjct: 100 EKYISVIIR-----EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL 151
Query: 132 AIDRTHLTTQVKVTFGYVDPKYFRSSQ-FTEKSDVYSFSVVLVELNWTKPIH 182
+ + +T V + ++ P+ + + K+D++S + + E+ P +
Sbjct: 152 NQNSSKRSTFVGTPY-WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 52/227 (22%), Positives = 106/227 (46%), Gaps = 25/227 (11%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
++ ++E +++ +++ +V ++LG CL + V L+ + +P G L Y+ E D+ I +
Sbjct: 54 KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN---IGSQ 109
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID-RTH 137
L V++++ ++YL + H D+ + N+L+ KI+DF K D + +
Sbjct: 110 YLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166
Query: 138 LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW--TKPIHLVDVEENRSLAAY 195
KV ++ + +T +SDV+S+ V + EL +KP + E S+
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI--- 223
Query: 196 FSKEAEKEE--------VITFAMVAKRCLNLNGKKQPTMKEVTLELA 234
EK E I M+ +C ++ +P +E+ +E +
Sbjct: 224 ----LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 54/232 (23%), Positives = 95/232 (40%), Gaps = 42/232 (18%)
Query: 20 QFINEVVILSQINHRNVVKILGCCL-ETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
Q + E+ IL + N +V G ++ + + E++ GSL + + E I
Sbjct: 45 QILRELDILHKCNSPYIVGFYGAFYNNGDISICM-EYMDGGSLDKILKEVQG---RIPER 100
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138
+ +I V V + L+YLH I H D+K +NIL+ + Q K+ DF L
Sbjct: 101 ILGKIAVAVLKGLTYLHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGV-------SGQL 151
Query: 139 TTQVKVTF----GYVDPKYFRSSQFTEKSDVYSFSVVLVEL------------NWTKPIH 182
+ TF Y+ P+ + + ++ KSD++S + L+EL
Sbjct: 152 VNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211
Query: 183 L----VDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230
L V+ R + FS + F CL + +++P+ KE+
Sbjct: 212 LLQYIVNEPPPRLPSGKFSPD--------FQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 13/176 (7%)
Query: 1 MEELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNG 59
M+E+ L K S S VE E V+L+++ H N+V E + L +V E+ G
Sbjct: 30 MKEIRLPKSS-----SAVEDSRKEAVLLAKMKHPNIVAFKES-FEADGHLYIVMEYCDGG 83
Query: 60 SLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ 119
L Q I Q P + L+ V++ + ++H + H DIKS NI L +
Sbjct: 84 DLMQKIKLQRGKLFP--EDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGK 138
Query: 120 AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
K+ DF + + + T V + YV P+ + + + KSD++S +L EL
Sbjct: 139 VKLGDFGSARLLTSPGAYACTYVGTPY-YVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 9/167 (5%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E NEVVI+ H+NVV++ L E ++ EF+ G+L + Q + E
Sbjct: 63 ELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEE 117
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138
+ V + L YLHS I H DIKS +ILL + K+SDF + D
Sbjct: 118 QIATVCESVLQALCYLHSQGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174
Query: 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVD 185
+ V + ++ P+ + + + D++S ++++E+ +P + D
Sbjct: 175 KSLVGTPY-WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 63/278 (22%), Positives = 123/278 (44%), Gaps = 31/278 (11%)
Query: 15 ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD-- 71
+ ++ ++E+ ++ I H+N++ +LG C + ++ E+ G+L +Y+ +
Sbjct: 58 DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117
Query: 72 -------QLP---ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
+LP +T++ + +V+R + YL S I H D+ + N+L+ + K
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVTEDNVMK 174
Query: 122 ISDFRTFKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWT-- 178
I+DF + ID TT ++ ++ P+ +T +SDV+SF V+L E+ +T
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI-FTLG 233
Query: 179 -KPIHLVDVEENRSLAAYFSKEAEKEE-----VITFAMVAKRCLNLNGKKQPTMKEVTLE 232
P + VEE L KE + + M+ + C + ++PT K++ +
Sbjct: 234 GSPYPGIPVEELFKLL----KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
Query: 233 LAGIRASIGASVLLQCEEINFVDYDNARHFKTSSSSTG 270
L + L + F Y SS S+G
Sbjct: 290 LDRVLTVTSTDEYLDL-SVPFEQYSPGCPDSPSSCSSG 326
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 47/169 (27%), Positives = 73/169 (43%), Gaps = 29/169 (17%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEF-IPNGSLYQYIHEQTDDQLPITWEMR 80
I EV L Q+ H N ++ GC L LV E+ + + S +H++ ++ I
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA---- 118
Query: 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTT 140
I + L+YLHS I H DIK+ NILL + K++DF S ++
Sbjct: 119 -AICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADF---GSASL------- 164
Query: 141 QVKVTFGYVDPKYFRS---------SQFTEKSDVYSFSVVLVELNWTKP 180
V +V Y+ + Q+ K DV+S + +EL KP
Sbjct: 165 -VSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 38/159 (23%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 21 FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80
F++E I+ Q +H N++ + G +++ ++V E++ NGSL ++ + D Q +
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTV----- 105
Query: 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI----DRT 136
+++ + + S + ++ + H D+ + NIL+ K+SDF SR + +
Sbjct: 106 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGL--SRVLEDDPEAA 163
Query: 137 HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ T K+ + P+ +FT SDV+S+ +V+ E+
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 15/163 (9%)
Query: 24 EVVILSQINHRNVVKILGCCLE-TEVPLLVY-EFIPNGSLYQYIHEQTDDQLPITWEMRL 81
E+ +L + H +V+ GC + E L ++ E++P GS I +Q +T +
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTR 109
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT-T 140
R T ++ + +SYLHS I H DIK ANIL K+ DF S+ I ++ T
Sbjct: 110 RYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGA--SKRIQTICMSGT 164
Query: 141 QVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
+K G ++ P+ + K+DV+S + +VE+ KP
Sbjct: 165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 11 KSVH----ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
K VH S +Q + E+ I+ + +V G L + EF+ GSL +
Sbjct: 36 KVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK 95
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ PI E+ +I V V L+YL++V I H DIK +NIL+ + Q K+ DF
Sbjct: 96 KGG----PIPVEILGKIAVAVVEGLTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFG 149
Query: 127 TFKS--RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+I T + T Y+ P+ + ++T KSDV+S + ++EL
Sbjct: 150 VSGELINSIADTFVGTST-----YMSPERIQGGKYTVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 12/166 (7%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E F++E I+ Q +H N++ + G ++ +++ EF+ NG+L ++ Q D Q
Sbjct: 46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFT 104
Query: 75 ITWEM-RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKS 130
+ + LR + LS ++ V H D+ + NIL+ K+SDF R +
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYV------HRDLAARNILVNSNLVCKVSDFGLSRFLED 158
Query: 131 RAIDRTHLTT-QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
D T+ ++ K+ + P+ +FT SDV+S+ +V+ E+
Sbjct: 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 43/166 (25%), Positives = 84/166 (50%), Gaps = 7/166 (4%)
Query: 12 SVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD 70
+ H S E ++E+ I+S + NH N+V +LG C L++ E+ G L ++ + +
Sbjct: 76 TAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135
Query: 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130
L T E L + +V++ +++L S I H D+ + N+LL KI DF +
Sbjct: 136 SFL--TLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNVLLTHGKIVKICDFGLARD 190
Query: 131 RAIDRTHLTT-QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
D ++ ++ ++ P+ + +T +SDV+S+ ++L E+
Sbjct: 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 41/176 (23%), Positives = 84/176 (47%), Gaps = 26/176 (14%)
Query: 21 FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ------------ 68
F E ++++ +H N+VK+LG C + L++E++ G L +++ +
Sbjct: 55 FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114
Query: 69 ------TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
+ LP++ +L I +V+ ++YL + H D+ + N L+ + KI
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKI 171
Query: 123 SDFRTFKSRAI---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+DF SR I D + + ++ P+ +++T +SDV+++ VVL E+
Sbjct: 172 ADFGL--SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 57/254 (22%), Positives = 120/254 (47%), Gaps = 32/254 (12%)
Query: 15 ESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLV-YEFIPNGSLYQYIH------ 66
+ ++ I+E+ ++ I H+N++ +LG C + E PL V E+ G+L +++
Sbjct: 58 DKDLADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPG 116
Query: 67 -EQTDD-----QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
+ T D + ++++ + +V+R + YL S I H D+ + N+L+ +
Sbjct: 117 PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVTEDNVM 173
Query: 121 KISDFRTFKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWT- 178
KI+DF + ID T+ ++ ++ P+ +T +SDV+SF +++ E+ +T
Sbjct: 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI-FTL 232
Query: 179 --KPIHLVDVEENRSLAAYFSKEAEKEEVIT-----FAMVAKRCLNLNGKKQPTMKEVTL 231
P + VEE L +E + + + M+ + C + ++PT K++
Sbjct: 233 GGSPYPGIPVEELFKLL----REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
Query: 232 ELAGIRASIGASVL 245
L + A++ L
Sbjct: 289 ALDKVLAAVSEEYL 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 40/170 (23%), Positives = 84/170 (49%), Gaps = 16/170 (9%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI-----HE---QTD 70
E+F +E ++ S++ H N+V +LG + + +++ + + L++++ H TD
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112
Query: 71 DQLPITWEMR----LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
D + + + I +++ + +L +S + H D+ + N+L+ DK KISD
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLG 169
Query: 127 TFKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
F+ A D L + ++ P+ +F+ SD++S+ VVL E+
Sbjct: 170 LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 41/161 (25%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 17 NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76
+VE F+ E ++ + H +VK L + E ++ EF+ GSL ++ + P+
Sbjct: 44 SVEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP 102
Query: 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT 136
+ + +++ ++++ I H D+++ANIL+ KI+DF +R I+
Sbjct: 103 --KLIDFSAQIAEGMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGL--ARVIEDN 155
Query: 137 HLTTQ--VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T + K + P+ FT KSDV+SF ++L+E+
Sbjct: 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 196
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-09
Identities = 48/182 (26%), Positives = 77/182 (42%), Gaps = 22/182 (12%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI- 65
L+ S + E F+ EV ++NH NV++ LG C+E+ LLV EF P G L Y+
Sbjct: 30 LRASATPDEQ--LLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLR 87
Query: 66 ----HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
Q ++ R+ EV+ L +LH I H D+ N L K
Sbjct: 88 SNRGMVAQMAQK----DVLQRMACEVASGLLWLHQADFI---HSDLALRNCQLTADLSVK 140
Query: 122 ISDFRTFKSRAIDRTHLTTQVK-VTFGYVDPKYFRSSQ-------FTEKSDVYSFSVVLV 173
I D+ + + ++T V ++ P+ T+KS+++S V +
Sbjct: 141 IGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMW 200
Query: 174 EL 175
EL
Sbjct: 201 EL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 45/187 (24%), Positives = 92/187 (49%), Gaps = 14/187 (7%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
LLK H + E F ++SQ++H+++V G C+ + ++V E++ GSL Y+
Sbjct: 31 LLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL 90
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSY-LHSVASIPIYHLDIKSANILLVDKYQAKISD 124
++ + + I+W++ EV++ L++ LH + + H ++ + N+LL+ + K +
Sbjct: 91 -KKNKNLINISWKL------EVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGN 143
Query: 125 --FRTFKSRAIDRTHLTTQVKVT-FGYVDPKYFRSSQ-FTEKSDVYSFSVVLVEL--NWT 178
F I T L ++ + +V P+ + Q + +D +SF L E+
Sbjct: 144 PPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGD 203
Query: 179 KPIHLVD 185
KP+ +D
Sbjct: 204 KPLSALD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 35/126 (27%), Positives = 62/126 (49%), Gaps = 10/126 (7%)
Query: 1 MEELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVY-EFIPNG 59
++E+ L ++ E+ V+Q E+ +LS++ H N+V+ LG E + L ++ E +P G
Sbjct: 30 VKEVSLADDGQTGQEA-VKQLEQEIALLSKLQHPNIVQYLGTEREED-NLYIFLELVPGG 87
Query: 60 SLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ 119
S + + + T ++ L YLH ++ H DIK ANIL+
Sbjct: 88 S----LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV---HRDIKGANILVDTNGV 140
Query: 120 AKISDF 125
K++DF
Sbjct: 141 VKLADF 146
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 51/242 (21%), Positives = 103/242 (42%), Gaps = 37/242 (15%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL----LVYEFIPNGSL 61
KK H+ ++ NE+ L +I+ N++KI G ++ L L+ E+ G L
Sbjct: 50 TFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYL 109
Query: 62 YQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
+ + ++ D ++++ +L + ++ + L L+ + P + ++ S + L+ + Y+ K
Sbjct: 110 REVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLK 163
Query: 122 I---SDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS--SQFTEKSDVYSFSVVLVEL- 175
I + S + Y K S++T K D+YS VVL E+
Sbjct: 164 IICHGLEKILSSPPFKNVN-------FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
Query: 176 --------NWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227
TK I+ + + +N SL E + ++ C + + K+P +K
Sbjct: 217 TGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVE------ACTSHDSIKRPNIK 270
Query: 228 EV 229
E+
Sbjct: 271 EI 272
|
Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 41/169 (24%), Positives = 80/169 (47%), Gaps = 14/169 (8%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
+ F E +L+ + H ++VK G C + + ++V+E++ +G L +++ D + +
Sbjct: 52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 79 MRLRITVE--VSRVLSYLHSVASIPIY-------HLDIKSANILLVDKYQAKISDFRTFK 129
+ E +S++L +AS +Y H D+ + N L+ KI DF
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM-- 169
Query: 130 SRAI---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
SR + D + + ++ P+ +FT +SDV+SF V+L E+
Sbjct: 170 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 39/115 (33%), Positives = 61/115 (53%), Gaps = 10/115 (8%)
Query: 89 RVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFG- 147
+VL +H V S + H DIKSANILL K+ DF K A ++ V TF
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA---ATVSDDVGRTFCG 207
Query: 148 ---YVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVDVEE--NRSLAAYF 196
YV P+ +R +++K+D++S V+L E L +P ++EE +++LA +
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262
|
Length = 496 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 5e-09
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E ++++ I E+ IL Q + +VK G + +V E+ GS+ I + T+ L
Sbjct: 39 EEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTL- 96
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
T E I + + L YLHS I H DIK+ NILL ++ QAK++DF + D
Sbjct: 97 -TEEEIAAILYQTLKGLEYLHSNKKI---HRDIKAGNILLNEEGQAKLADFGV-SGQLTD 151
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA 194
V T ++ P+ + + K+D++S + +E+ KP + D+ R++
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPY-SDIHPMRAIFM 210
Query: 195 Y-------------FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
+S E F K+CL + +++P+ +
Sbjct: 211 IPNKPPPTLSDPEKWSPE--------FNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-09
Identities = 47/210 (22%), Positives = 94/210 (44%), Gaps = 11/210 (5%)
Query: 28 LSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEV 87
+ ++H +V++LG C + L V + P GSL ++ + D P + L V++
Sbjct: 63 MGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDP---QRLLNWCVQI 118
Query: 88 SRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK-SRAIDRTHLTTQVKVTF 146
++ + YL + H ++ + NILL +I+DF D+ + ++ K
Sbjct: 119 AKGMYYLEEHRMV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 147 GYVDPKYFRSSQFTEKSDVYSFSVVLVELN--WTKPIHLVDVEENRSLAAYFSKEAEKEE 204
++ + ++T +SDV+S+ V + E+ +P + E L + A+ +
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQI 235
Query: 205 -VITFAMVAKRCLNLNGKKQPTMKEVTLEL 233
I MV +C ++ +PT KE+ E
Sbjct: 236 CTIDVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 18/174 (10%)
Query: 11 KSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEF-IPNGSLYQYIHEQT 69
K +E + I EV L Q+ H N ++ GC L+ LV E+ + + S +H++
Sbjct: 59 KQTNE-KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKP 117
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129
++ I IT + L+YLHS I H DIK+ NILL + Q K++DF +
Sbjct: 118 LQEVEIA-----AITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSAS 169
Query: 130 SRAIDRTHLTTQVKVTFGYVDPKYFRS---SQFTEKSDVYSFSVVLVELNWTKP 180
+ + + T ++ P+ + Q+ K DV+S + +EL KP
Sbjct: 170 KSSPANSFVGTPY-----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-09
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 19/160 (11%)
Query: 23 NEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ-----TDDQLPITW 77
EV++L+++ H N+V E +V E+ G L + I+ Q ++DQ+ ++W
Sbjct: 48 KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI-LSW 106
Query: 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ-AKISDFRTFKSRAI-DR 135
V++S L ++H I H DIKS NI L AK+ DF +R + D
Sbjct: 107 ------FVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI--ARQLNDS 155
Query: 136 THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
L T Y+ P+ ++ + K+D++S VL EL
Sbjct: 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 11/170 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI- 65
+KK + E NEVVI+ +H NVV + L + +V EF+ G+L +
Sbjct: 52 VKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT 111
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
H + +++ T + + V R LSYLH+ I H DIKS +ILL + K+SDF
Sbjct: 112 HTRMNEEQIAT------VCLSVLRALSYLHNQGVI---HRDIKSDSILLTSDGRIKLSDF 162
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
F ++ + T ++ P+ + + D++S ++++E+
Sbjct: 163 -GFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 46/173 (26%), Positives = 84/173 (48%), Gaps = 16/173 (9%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVY-EFIPNGSLYQYI-- 65
+ S + V+ +E+ L ++H N+V+ LG TE L ++ E++P GS+ +
Sbjct: 43 RHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRT 101
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ + ++QL T +V L+YLHS I H D+K+ N+L+ KISDF
Sbjct: 102 YGRFEEQLVRF------FTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDF 152
Query: 126 RTFK-SRAIDRTHLTTQVKVTFGYVDPKYFRSSQ--FTEKSDVYSFSVVLVEL 175
K S I ++ + ++ P+ S ++ K D++S V++E+
Sbjct: 153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 34/111 (30%), Positives = 50/111 (45%), Gaps = 8/111 (7%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E +E E+ LSQ + K G L+ ++ E+ GS + D+
Sbjct: 40 EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY 99
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
I + +R EV L YLH I H DIK+ANILL ++ K++DF
Sbjct: 100 IAFILR-----EVLLGLEYLHEEGKI---HRDIKAANILLSEEGDVKLADF 142
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 40/172 (23%), Positives = 86/172 (50%), Gaps = 21/172 (12%)
Query: 20 QFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI-----HE----QTD 70
+F E ++++++H N+V +LG + + +++E++ G L++++ H +D
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 71 DQLPITWEMR----LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ + + L I ++++ + YL +S H D+ + NIL+ ++ KISD
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLG 169
Query: 127 TFKSRAI---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
SR I D + + + ++ P+ +F+ SD++SF VVL E+
Sbjct: 170 L--SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 30/188 (15%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY 64
+LK+ S E++ F E+ +L ++ +H N++ +LG C + E+ P G+L +
Sbjct: 36 MLKEFAS--ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDF 93
Query: 65 IHE----QTDDQLP--------ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANI 112
+ + +TD +T + L+ +V+ + YL I H D+ + N+
Sbjct: 94 LRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFI---HRDLAARNV 150
Query: 113 LLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY-----FRSSQFTEKSDVYS 167
L+ + +KI+DF + + VK T G + ++ S +T KSDV+S
Sbjct: 151 LVGENLASKIADFGLSRGEEV-------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWS 203
Query: 168 FSVVLVEL 175
F V+L E+
Sbjct: 204 FGVLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 11/174 (6%)
Query: 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLY 62
+L +KK + E NEVVI+ H NVV++ L + +V EF+ G+L
Sbjct: 46 KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105
Query: 63 QYI-HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
+ H + +++ + + V + LS LH+ I H DIKS +ILL + K
Sbjct: 106 DIVTHTRMNEEQIAA------VCLAVLKALSVLHAQGVI---HRDIKSDSILLTHDGRVK 156
Query: 122 ISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+SDF F ++ + T ++ P+ + + D++S ++++E+
Sbjct: 157 LSDF-GFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 51/217 (23%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 24 EVVILSQINHRNVVKILGCCLE-TEVPLLVY-EFIPNGSLYQYIHEQTDDQLPITWEMRL 81
E+ +L + H +V+ GC + E L ++ E++P GS + +Q +T +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGS----VKDQLKAYGALTESVTR 109
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDRTHL 138
+ T ++ +SYLHS I H DIK ANIL K+ DF + ++ + T +
Sbjct: 110 KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK 198
+ V T ++ P+ + K+DV+S +VE+ KP E ++AA F
Sbjct: 167 RS-VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP----PWAEYEAMAAIFKI 221
Query: 199 EAEKEEVITFAMVAK------RCLNLNGKKQPTMKEV 229
+ + +++ C+ + + +P+ +E+
Sbjct: 222 ATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 43/172 (25%), Positives = 81/172 (47%), Gaps = 10/172 (5%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E +E ++ E+ IL+ NH +VK+LG ++ EF P G++ I + D L
Sbjct: 50 EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGL- 107
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF----RTFKS 130
+I V ++L L + S+ I H D+K+ N+LL K++DF + K+
Sbjct: 108 ----TEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163
Query: 131 RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIH 182
+ + T + V + + + + K+D++S + L+E+ +P H
Sbjct: 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 215
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 4e-08
Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 16/129 (12%)
Query: 7 LKKSKSVHESNVEQF----INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLY 62
LKK + +E E + E+ +L ++ H N+VK+L LV+E+ L
Sbjct: 29 LKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLK 85
Query: 63 QYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
+Y+ ++ P++ + I ++ R L+Y HS I H D+K NIL+ K+
Sbjct: 86 KYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKL 139
Query: 123 SDF---RTF 128
+DF R F
Sbjct: 140 ADFGLARAF 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ----TD 70
E +E F+ E+ ILS+ H N+V + ++ EF G+L + E T+
Sbjct: 43 EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTE 102
Query: 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF----- 125
Q+ + ++ L++LHS I H D+K+ NILL K++DF
Sbjct: 103 PQIRY-------VCRQMLEALNFLHSHKVI---HRDLKAGNILLTLDGDVKLADFGVSAK 152
Query: 126 --RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIH 182
T + R T + T + V + F+ + + K+D++S + L+EL +P H
Sbjct: 153 NKSTLQKRD---TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH 208
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 5e-08
Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 19/179 (10%)
Query: 8 KKSKSVHESNV--EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEF-IPNGSLYQY 64
K S S +SN + I EV L +I H N ++ GC L LV E+ + + S
Sbjct: 57 KMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLE 116
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+H++ ++ I IT + L+YLHS I H DIK+ NILL + Q K++D
Sbjct: 117 VHKKPLQEVEIA-----AITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLAD 168
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS---SQFTEKSDVYSFSVVLVELNWTKP 180
F + + + + T ++ P+ + Q+ K DV+S + +EL KP
Sbjct: 169 FGSASIASPANSFVGTPY-----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 40/175 (22%), Positives = 74/175 (42%), Gaps = 16/175 (9%)
Query: 7 LKK--SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY 64
LKK + + Q + E+ L H VVK+L +LV E++P L +
Sbjct: 30 LKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEV 88
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ ++ P+ + + ++Y+H+ I H D+K AN+L+ KI+D
Sbjct: 89 LRDEER---PLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIAD 142
Query: 125 F---RTFKSRAIDRTHLTTQVKVTFGYVDPK-YFRSSQFTEKSDVYSFSVVLVEL 175
F R F + + QV T Y P+ + + ++ D+++ + EL
Sbjct: 143 FGLARLFSEE--EPRLYSHQV-ATRWYRAPELLYGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-08
Identities = 57/236 (24%), Positives = 111/236 (47%), Gaps = 30/236 (12%)
Query: 21 FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI--HE-----QTDDQL 73
F+ E+ I+S++ N++++L C+ ++ ++ E++ NG L Q++ HE + D +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI 133
I++ + + +++ + YL +S+ H D+ + N L+ Y KI+DF SR +
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGM--SRNL 180
Query: 134 ---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKP---IHLVD- 185
D + + + ++ + +FT SDV++F V L E L K L D
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
Query: 186 -VEEN-------RSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233
V EN + Y K A + + M++ C N K++P+ +E+ L
Sbjct: 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS--CWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-08
Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI 83
E++++ H N+V G L + + EF GSL Q I+ T P++ +
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTG---PLSESQIAYV 111
Query: 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVK 143
+ E + L YLHS + H DIK ANILL D K++DF +T +
Sbjct: 112 SRETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGV-------SAQITATIA 161
Query: 144 VTFGYVDPKYF---------RSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL-- 192
++ Y+ R + + D+++ + +EL +P + D+ R+L
Sbjct: 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP-PMFDLHPMRALFL 220
Query: 193 --AAYFSKEAEKEEVI---TFAMVAKRCLNLNGKKQPTMKEV 229
+ F K+++ +F K L N KK+PT +++
Sbjct: 221 MTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-08
Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 22 INEVVILSQIN---HRNVVKILGCCL------ETEVPLLVYEFIPNGSLYQYIHEQTDDQ 72
I EV +L + H NVV++ C ET++ L V+E + + L Y+ + +
Sbjct: 49 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL-VFEHV-DQDLTTYLDKVPEPG 106
Query: 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRA 132
+P E + ++ R L +LHS + H D+K NIL+ Q K++DF +R
Sbjct: 107 VPT--ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL--ARI 159
Query: 133 IDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPI 181
T V VT Y P+ S + D++S + E+ KP+
Sbjct: 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 9e-08
Identities = 45/186 (24%), Positives = 84/186 (45%), Gaps = 33/186 (17%)
Query: 8 KKSKSVHESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
KK S E + EV L ++N H N+VK+ E + V+E++ G+LYQ +
Sbjct: 34 KKFYSWEECMN---LREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMK 89
Query: 67 EQTDDQLPITWEMRLR-ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
++ E +R I ++ + L+++H +H D+K N+L+ KI+DF
Sbjct: 90 DRKGKPFS---ESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADF 143
Query: 126 ---RTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVEL 175
R +SR T YV +++R S+ ++ D+++ ++ EL
Sbjct: 144 GLAREIRSRP----PYTD-------YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAEL 192
Query: 176 NWTKPI 181
+P+
Sbjct: 193 YTLRPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 13/180 (7%)
Query: 20 QFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79
Q I E+ +L + N +V G + E + GSL Q + E I E+
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEI 104
Query: 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT 139
++++ V R L+YL I H D+K +NIL+ + + K+ DF + ID +
Sbjct: 105 LGKVSIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDS--MA 159
Query: 140 TQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTK-PIHLVDVEENRSLAAYFSK 198
T Y+ P+ + + ++ +SD++S + LVEL + PI D +E L A F +
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGR 216
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 23/173 (13%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKIL--GCCLETEVPLL--VYEFIPNGSLYQYIHEQTD 70
E +F E + +++ H N+V +L G E LL V+E++P +L + + D
Sbjct: 19 EHQRARFRRETALCARLYHPNIVALLDSG---EAPPGLLFAVFEYVPGRTLREVL--AAD 73
Query: 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV---DKYQAKISDF-- 125
LP RL + +VL L + I H D+K NI++ + AK+ DF
Sbjct: 74 GALPAGETGRL-----MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
Query: 126 RTFKS--RAIDRTHLT--TQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
T R D LT T+V T Y P+ R T SD+Y++ ++ +E
Sbjct: 129 GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 41/169 (24%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYIHEQTDDQL 73
E V + E +L ++H+N++ IL C+E E P ++Y ++ G+L ++ + +
Sbjct: 49 EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEA 108
Query: 74 PITWEMRLRITVE----VSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129
+ + V ++ +SYLH + H DI + N ++ ++ Q KI+D
Sbjct: 109 NNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD--NAL 163
Query: 130 SRAI---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
SR + D L ++ + + +++ SDV+SF V+L EL
Sbjct: 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 47/188 (25%), Positives = 87/188 (46%), Gaps = 30/188 (15%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHR-NVVKILGCCLETEVPLLVYEFIPNGSLYQY 64
+K+ S + + F E+ +L ++ H N++ +LG C L E+ P+G+L +
Sbjct: 29 RMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 86
Query: 65 IHE----QTDDQLP--------ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANI 112
+ + +TD ++ + L +V+R + YL I H D+ + NI
Sbjct: 87 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI---HRDLAARNI 143
Query: 113 LLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY-----FRSSQFTEKSDVYS 167
L+ + Y AKI+DF + + + VK T G + ++ S +T SDV+S
Sbjct: 144 LVGENYVAKIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 196
Query: 168 FSVVLVEL 175
+ V+L E+
Sbjct: 197 YGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 20/162 (12%)
Query: 21 FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80
F+ E + L Q +H N+V++ G ++V E++ NG+L ++ + + QL
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQL------- 104
Query: 81 LRITVEVSRVLSYLHSVASIPIY-------HLDIKSANILLVDKYQAKISDFRTFKSRAI 133
+++ L +AS Y H + + +L+ KIS FR +
Sbjct: 105 -----VAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159
Query: 134 DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ + T K + P+ + F+ SDV+SF +V+ E+
Sbjct: 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 20/179 (11%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+KK+ + ++ V+Q + E ILSQ VVK+ + + L LV E++P G L +
Sbjct: 26 IKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLL 84
Query: 66 H--EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKIS 123
D+ ++ E+ L YLHS I H D+K NIL+ K++
Sbjct: 85 ENVGSLDE------DVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLT 135
Query: 124 DF----RTFKSRAIDRTHLTTQVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
DF R I+ + K G Y+ P+ ++ D +S +L E
Sbjct: 136 DFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEF 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 39/178 (21%), Positives = 86/178 (48%), Gaps = 16/178 (8%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLY 62
K+ S++E+F+ E + + +H NV+K++G L + +P+++ F+ +G L+
Sbjct: 36 KADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLH 95
Query: 63 QYIHEQTDDQLPITWEMR--LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
++ + P T ++ +R ++++ + YL S I H D+ + N +L +
Sbjct: 96 TFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFI---HRDLAARNCMLNENMTV 152
Query: 121 KISDFRTFKSRAI---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
++DF S+ I D K+ ++ + + +T SDV++F V + E+
Sbjct: 153 CVADFGL--SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 19/179 (10%)
Query: 8 KKSKSVHESNV--EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEF-IPNGSLYQY 64
K S S +SN + I EV L ++ H N ++ GC L LV E+ + + S
Sbjct: 47 KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 106
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+H++ ++ I +T + L+YLHS I H D+K+ NILL + K+ D
Sbjct: 107 VHKKPLQEVEIA-----AVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGD 158
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS---SQFTEKSDVYSFSVVLVELNWTKP 180
F + A + T ++ P+ + Q+ K DV+S + +EL KP
Sbjct: 159 FGSASIMAPANXFVGTPY-----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 16/160 (10%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
+ E+ +L Q+NH NV+K L +E +V E G L Q I + I
Sbjct: 50 VKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDRTHL 138
+ V++ + ++HS + H DIK AN+ + K+ D R F S+
Sbjct: 110 KYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------- 159
Query: 139 TTQVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
TT G Y+ P+ + + KSD++S +L E+
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 16/160 (10%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
I E+ +L Q+NH NV+K +E +V E G L + I + I +
Sbjct: 50 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDRTHL 138
+ V++ L ++HS + H DIK AN+ + K+ D R F S+
Sbjct: 110 KYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------- 159
Query: 139 TTQVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
TT G Y+ P+ + + KSD++S +L E+
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 26/167 (15%)
Query: 20 QFINEVVILSQINHRNVVKILGCCL---ETEVPLLVYEFIPNGSL---YQYIHEQTDDQL 73
Q + E+ I +VK G L + + + + E+ GSL Y+ + ++
Sbjct: 45 QILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGG--- 100
Query: 74 PITWEMRL-RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRA 132
E L +I V + LSYLHS I H DIK +NILL K Q K+ DF
Sbjct: 101 -RIGEKVLGKIAESVLKGLSYLHSRKII---HRDIKPSNILLTRKGQVKLCDFGV----- 151
Query: 133 IDRTHLTTQVKVTFG----YVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
L + TF Y+ P+ + ++ SDV+S + L+E+
Sbjct: 152 --SGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 13/162 (8%)
Query: 24 EVVILSQINHRNVVKILGCCLET-EVPLLVY-EFIPNGSLYQYIHEQTDDQLPITWEMRL 81
E+ +L + H +V+ GC + E L ++ E +P GS I +Q +T +
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTR 109
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDRTHL 138
+ T ++ +SYLHS I H DIK ANIL K+ DF + ++ + T +
Sbjct: 110 KYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166
Query: 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
+ V T ++ P+ + K+D++S +VE+ KP
Sbjct: 167 KS-VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD--DQLPITWEMRL 81
E+ ++ + H N+V G L E + E+ GSL Q I+ T +L I + R
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAYVCR- 113
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQ 141
E + L+YLHS + H DIK ANILL D K++DF +T
Sbjct: 114 ----ETLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGV-------AAKITAT 159
Query: 142 VKVTFGYVDPKYFRSSQ---------FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL 192
+ ++ Y+ + + + + D+++ + +EL +P + D+ R+L
Sbjct: 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP-PMFDLHPMRAL 218
Query: 193 ----AAYFSKEAEKEEV---ITFAMVAKRCLNLNGKKQPTMKEV 229
+ F K++ TF K L N KK+PT + +
Sbjct: 219 FLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ-----TDDQLPITWE 78
EV +LS + H N+V+ E +V ++ G LY+ I+ Q +DQ+ + W
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDW- 106
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-H 137
V++ L ++H I H DIKS NI L K+ DF +R ++ T
Sbjct: 107 -----FVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGI--ARVLNSTVE 156
Query: 138 LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
L T Y+ P+ + + KSD+++ VL E+
Sbjct: 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 50/236 (21%), Positives = 100/236 (42%), Gaps = 18/236 (7%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+LK H F ++ Q++H+++V + G C+ ++V EF+ G L ++
Sbjct: 36 ILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM 95
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISD 124
H ++D +T + ++ +++ LSYL + H ++ + NILL + +
Sbjct: 96 HRKSD---VLTTPWKFKVAKQLASALSYLEDKDLV---HGNVCTKNILLAREGIDGECGP 149
Query: 125 FRTFKSRAIDRTHLTTQVKVT-FGYVDPKYFRSSQ-FTEKSDVYSFSVVLVELNWTKPIH 182
F I T L+ Q V ++ P+ S+ + +D +SF L E+ + I
Sbjct: 150 FIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209
Query: 183 LVD---VEENRSLAAYFSKEAE--KEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233
L D E+ R KE A + C+N + ++P + + ++
Sbjct: 210 LKDKTLAEKERFYEGQCMLVTPSCKE----LADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 20/178 (11%)
Query: 7 LKKSKSVHESNVEQFIN-----EVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSL 61
+KK K + IN E+ +L ++ H N++ +L LV+EF+ L
Sbjct: 30 IKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDL 88
Query: 62 YQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
+ I D + +T + R L YLHS I H D+K N+L+ K
Sbjct: 89 EKVIK---DKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLK 142
Query: 122 ISDF---RTFKSRAIDRTHLTTQVKVTFGYVDPK-YFRSSQFTEKSDVYSFSVVLVEL 175
++DF R+F S +T QV VT Y P+ F + + D++S + EL
Sbjct: 143 LADFGLARSFGS---PNRKMTHQV-VTRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 5e-07
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 11/168 (6%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K K V + +V +NE IL ++NH +V + + E LV + + G L ++
Sbjct: 35 KQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL--- 91
Query: 69 TDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
Q E +++ E+ L YLHS I H DIK NILL ++ I+DF
Sbjct: 92 --SQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNI 146
Query: 128 FKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ + LTT T GY+ P+ ++ D +S V E
Sbjct: 147 --ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYEC 192
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-07
Identities = 53/230 (23%), Positives = 82/230 (35%), Gaps = 95/230 (41%)
Query: 22 INEVVILSQI-NHRNVVKILGCCLETEVPLLV-YEFIPNGSLYQYI-------------- 65
+ E+ IL I +H NVV +LG C + PL+V E+ G+L Y+
Sbjct: 58 MTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKS 117
Query: 66 --------------------------------------HEQTDD-----QLPITWEMRLR 82
E+ ++ + P+T E +
Sbjct: 118 TRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLIS 177
Query: 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQV 142
+ +V+R + +L S I H D+ + NILL + KI DF +R I
Sbjct: 178 YSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGL--ARDI--------- 223
Query: 143 KVTFGYVDPKYFRSSQ-----------------FTEKSDVYSFSVVLVEL 175
Y DP Y R +T +SDV+SF V+L E+
Sbjct: 224 -----YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 9e-07
Identities = 39/169 (23%), Positives = 70/169 (41%), Gaps = 21/169 (12%)
Query: 7 LKKSKSVHESNV--EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY 64
+KK K + + + EV +L Q+ H N+V + LV+E++ +L +
Sbjct: 31 IKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLEL 89
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ LP + ++ + ++Y HS I H DIK NIL+ + K+ D
Sbjct: 90 LEASPGG-LPP--DAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCD 143
Query: 125 F---RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSV 170
F R ++R + LT YV +++R+ + Y V
Sbjct: 144 FGFARALRARP--ASPLTD-------YVATRWYRAPELLVGDTNYGKPV 183
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 15/169 (8%)
Query: 28 LSQINHRNVVKILGCCL------ETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
L +H N+V+++ C ET+V L V+E + + L Y+ + LP E
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTL-VFEHV-DQDLRTYLDKVPPPGLPA--ETIK 111
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQ 141
+ + R L +LH+ I H D+K NIL+ Q K++DF +R T
Sbjct: 112 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL--ARIYSCQMALTP 166
Query: 142 VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR 190
V VT Y P+ S + D++S + E+ KP+ + E ++
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSL--YQYIHEQTDDQLPIT 76
+Q ++E+ IL + + ++ G + EF+ GSL Y+ I E
Sbjct: 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG----- 98
Query: 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT 136
RI V V + L+YL S + I H D+K +N+L+ + Q K+ DF S + +
Sbjct: 99 -----RIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGV--STQLVNS 148
Query: 137 HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T V T Y+ P+ Q+ SDV+S + +EL
Sbjct: 149 IAKTYVG-TNAYMAPERISGEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 28/232 (12%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVP------LLVYEFIPNGSLYQYIHEQ 68
E ++Q IN + S +HRN+ G ++ P LV EF GS+ I
Sbjct: 46 EEEIKQEINMLKKYS--HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 103
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ L W I E+ R LS+LH I H DIK N+LL + + K+ DF
Sbjct: 104 KGNTLKEEWIAY--ICREILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGV- 157
Query: 129 KSRAIDRT--HLTTQVKVTFGYVDPKYFRSSQ-----FTEKSDVYSFSVVLVELNWTKPI 181
S +DRT T + + ++ P+ + + KSD++S + +E+ P
Sbjct: 158 -SAQLDRTVGRRNTFIGTPY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 214
Query: 182 HLVDVEENRSLAAYFSKEA----EKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
L D+ R+L A K+ F + CL N ++PT +++
Sbjct: 215 PLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 22 INEVVILSQINHRNVVKIL----GCCLETEVPLLVYEFIPN--GSLYQYIHEQTDDQLPI 75
+ E+ +L + H N+V++ G L++ LV E+ SL + P
Sbjct: 54 LREITLLLNLRHPNIVELKEVVVGKHLDS--IFLVMEYCEQDLASLLD------NMPTPF 105
Query: 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRA 132
+ + +++ R L YLH I H D+K +N+LL DK KI+DF RT+ A
Sbjct: 106 SESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162
Query: 133 IDRTHLTTQVKVTFGYVDPK-YFRSSQFTEKSDVYSFSVVLVELNWTKPI 181
+T +V VT Y P+ + +T D+++ +L EL KP+
Sbjct: 163 ---KPMTPKV-VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 17/156 (10%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPLLVYEFIP--NGSLYQYIHEQTDDQLPITWEMRL 81
E ++L +NH +V+++ + + +V +P + LY Y+ T P+ + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL---TKRSRPLPIDQAL 160
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF--RTFKSRAIDRTHLT 139
I ++ L YLH+ I H D+K+ NI + D Q I D F A L
Sbjct: 161 IIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217
Query: 140 TQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
V+ P+ ++ K+D++S +VL E+
Sbjct: 218 GTVETN----APEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 43/174 (24%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
I E+ +L ++ H N+V + ++ L++EF+ + L +Y+ D LP M
Sbjct: 47 IREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYL-----DSLPKGQYM-- 98
Query: 82 RITVEVSRVLSYLHSVASIPIY-------HLDIKSANILLVDKYQAKISDFRTFKSRAID 134
+ V SYL+ + ++ H D+K N+L+ +K K++DF ++ I
Sbjct: 99 ----DAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQ-FTEKSDVYSFSVVLVELNWTKPIHLVDVE 187
T +V VT Y P+ S ++ D++S + E+ KP+ D E
Sbjct: 155 VRVYTHEV-VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 39/119 (32%), Positives = 56/119 (47%), Gaps = 24/119 (20%)
Query: 14 HESNVE-QFINEVVILSQINHRNVVKILGCCLET-----EVPLLVYEFIPNGSLYQYIHE 67
HE V Q E+ IL +NH NVVK C + E+ +L+ EF+ GSL
Sbjct: 111 HEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSL------ 159
Query: 68 QTDDQLPITWEMRLRITVEVSR-VLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ I E L +V+R +LS + + I H DIK +N+L+ KI+DF
Sbjct: 160 ---EGTHIADEQFL---ADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212
|
Length = 353 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 34/164 (20%), Positives = 65/164 (39%), Gaps = 19/164 (11%)
Query: 23 NEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82
E++ Q+ H N++ + + +V + GS + + LP E+ +
Sbjct: 48 QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIA 104
Query: 83 -ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT--------FKSRAI 133
I +V L Y+HS I H +K+++ILL + +S R + R +
Sbjct: 105 FILKDVLNALDYIHSKGFI---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161
Query: 134 DRTHLTTQVKVTFGYVDPKYFRSS--QFTEKSDVYSFSVVLVEL 175
++ P+ + + + EKSD+YS + EL
Sbjct: 162 H--DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 43/180 (23%), Positives = 87/180 (48%), Gaps = 24/180 (13%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+LK S H + F ++SQ++H+++VK+ G C+ E ++V E++ G L ++
Sbjct: 34 VLKVLGSDHR-DSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFL 91
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-----DKYQ- 119
H + ++ + + W +L + +++ L YL + H ++ NIL+ + Y
Sbjct: 92 HREKNN-VSLHW--KLDVAKQLASALHYLEDKKLV---HGNVCGKNILVARYGLNEGYVP 145
Query: 120 -AKISDFRTFKSRAIDRTHLTTQVKVT-FGYVDPKYFR--SSQFTEKSDVYSFSVVLVEL 175
K+SD I T L+ + +V ++ P+ R + T +D +SF L+E+
Sbjct: 146 FIKLSD------PGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 27/187 (14%)
Query: 11 KSVHESNVEQ-----FINEVVILSQI---NHRNVVKILGCC----LETEVPL-LVYEFIP 57
K V E+ + E+ +L Q+ H N+V++L C + E+ L LV+E +
Sbjct: 30 KKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV- 88
Query: 58 NGSLYQYIHEQTDDQLP---ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL 114
+ L Y+ + LP I MR ++ R + +LHS I H D+K NIL+
Sbjct: 89 DQDLATYLSKCPKPGLPPETIKDLMR-----QLLRGVDFLHSHR---IVHRDLKPQNILV 140
Query: 115 VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
Q KI+DF +R T V VT Y P+ S + D++S + E
Sbjct: 141 TSDGQVKIADFGL--ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE 198
Query: 175 LNWTKPI 181
L +P+
Sbjct: 199 LFRRRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 5e-06
Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
I E +L + H N+V + E LV+E++ + L QY+ + P ++ L
Sbjct: 51 IREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL 109
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQ 141
++ R LSY+H I H D+K N+L+ D + K++DF +++++ +H +
Sbjct: 110 ---FQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSN 162
Query: 142 VKVTFGYVDPK-YFRSSQFTEKSDVYSFSVVLVEL 175
VT Y P S++++ D++ + VE+
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 45/173 (26%), Positives = 83/173 (47%), Gaps = 12/173 (6%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E +E ++ E+ IL+ +H N+VK+L ++ EF G++ + E + P
Sbjct: 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERP 99
Query: 75 ITWEMRLRITVEVS-RVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF--RTFKSR 131
+T E ++R+ + + L+YLH I H D+K+ NIL K++DF +R
Sbjct: 100 LT-EPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155
Query: 132 AIDR--THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIH 182
I R + + T + V + + + K+DV+S + L+E+ +P H
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH 208
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 45/183 (24%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 2 EELWLLKKSKSVHESNVE-QFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGS 60
E L LK+ + HE I EV +L + H N+V + + LV+E++ +
Sbjct: 31 ENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKD 89
Query: 61 LYQYIHEQTDDQLPITWEMRLRITV-EVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ 119
L QY+ DD I ++I + ++ R L+Y H + H D+K N+L+ ++ +
Sbjct: 90 LKQYM----DDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGE 142
Query: 120 AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-SSQFTEKSDVYSFSVVLVELNWT 178
K++DF +++++ + +V VT Y P SS+++ + D++ + E+
Sbjct: 143 LKLADFGLARAKSVPTKTYSNEV-VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201
Query: 179 KPI 181
+P+
Sbjct: 202 RPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 34/130 (26%), Positives = 59/130 (45%), Gaps = 16/130 (12%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LK+ + VH NE +L +++H ++++ + ++ E++P G L+ Y+
Sbjct: 42 LKQEQHVH--------NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR 93
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ L E+ L YLHS I + D+K NILL + K++DF
Sbjct: 94 NSGR----FSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDF- 145
Query: 127 TFKSRAIDRT 136
F + DRT
Sbjct: 146 GFAKKLRDRT 155
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 22/199 (11%)
Query: 3 ELWLLKKSKSVHESNVEQF----INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPN 58
EL LKK + +E E F I E+ IL Q+NHRN+V + + + L +F +
Sbjct: 33 ELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL---DFKKD 87
Query: 59 GSLYQYIHEQTDDQLPITWEMRL---------RITVEVSRVLSYLHSVASIPIYHLDIKS 109
+ + E D L E L ++ L+Y H + H DIK
Sbjct: 88 KGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFL---HRDIKC 144
Query: 110 ANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ-FTEKSDVYSF 168
+NILL +K Q K++DF + + + T +T Y P+ + + DV+S
Sbjct: 145 SNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 204
Query: 169 SVVLVELNWTKPIHLVDVE 187
+L EL KPI + E
Sbjct: 205 GCILGELFTKKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 38/121 (31%), Positives = 55/121 (45%), Gaps = 8/121 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
L+ S SV E +F+ E + H N+++ LG C E LLV EF P G L Y+
Sbjct: 30 LRVSASVQEQ--MKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLR 87
Query: 67 EQTDDQLPITWEMRL--RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+L +T + R+ E++ L +LH I H D+ N LL KI D
Sbjct: 88 SCRKAEL-MTPDPTTLQRMACEIALGLLHLHKNNFI---HSDLALRNCLLTADLTVKIGD 143
Query: 125 F 125
+
Sbjct: 144 Y 144
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 42/170 (24%), Positives = 79/170 (46%), Gaps = 10/170 (5%)
Query: 20 QFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79
Q I E+ +L + N +V G + E + GSL Q + + I ++
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQI 104
Query: 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT 139
++++ V + L+YL I H D+K +NIL+ + + K+ DF + ID +
Sbjct: 105 LGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDS--MA 159
Query: 140 TQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTK-PIHLVDVEE 188
T Y+ P+ + + ++ +SD++S + LVE+ + PI D +E
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 61/235 (25%), Positives = 96/235 (40%), Gaps = 20/235 (8%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLL-VYEFIPNGSLYQYI 65
LKK + + +VE + E +LS + L C +T+ L V E++ G L +I
Sbjct: 28 LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI 87
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
LP R T + ++ L + S I + D+K NILL KI+DF
Sbjct: 88 QSCHKFDLP-------RATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADF 140
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLV 184
K + T T Y+ P+ ++ D +SF V+L E L P H
Sbjct: 141 GMCKENMLGDAKTCTFCG-TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199
Query: 185 DVEE--------NRSLAAYFSKEAEKEEVITFAMVAKRCLNLNG--KKQPTMKEV 229
D EE N + ++EA+ V F +R L + G ++ P +E+
Sbjct: 200 DEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQ 141
+I++ V R L+YL I H D+K +NIL+ + + K+ DF + ID +
Sbjct: 103 KISIAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGV-SGQLIDS--MANS 157
Query: 142 VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T Y+ P+ + + +T +SD++S + LVE+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 46/175 (26%), Positives = 72/175 (41%), Gaps = 20/175 (11%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLL--VYEFIPNGSLYQY 64
L+ + EQ E +LSQ+ H N+V E E LL V F G LY
Sbjct: 35 LRNASRRERKAAEQ---EAQLLSQLKHPNIVAYRES-WEGEDGLLYIVMGFCEGGDLYHK 90
Query: 65 IHEQTDDQLP----ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
+ EQ LP + W V+++ L YLH I H D+K+ N+ L
Sbjct: 91 LKEQKGKLLPENQVVEW------FVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNII 141
Query: 121 KISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
K+ D + +T + + Y+ P+ F + + KSDV++ + E+
Sbjct: 142 KVGDLGIARVLENQCDMASTLIGTPY-YMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 48/165 (29%), Positives = 72/165 (43%), Gaps = 11/165 (6%)
Query: 26 VILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITV 85
V+L + H +V + TE V +F+ G L+ H Q + P E R R
Sbjct: 48 VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFP---EPRARFYA 102
Query: 86 -EVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKV 144
E++ L YLHS I I + D+K NILL + ++DF K I ++ TT
Sbjct: 103 AEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCG 158
Query: 145 TFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEE 188
T Y+ P+ R + D + VL E+ + P + DV E
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 9 KSKSVHESNVEQFINEVVILSQINH-RNVVKILGCCLETEVP------LLVYEFIPNGSL 61
K V E E+ E+ +L + +H RN+ G ++ P LV EF GS+
Sbjct: 47 KVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSV 106
Query: 62 YQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
+ + L W I E+ R L++LH+ I H DIK N+LL + + K
Sbjct: 107 TDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAHKVI---HRDIKGQNVLLTENAEVK 161
Query: 122 ISDFRTFKSRAIDRT--HLTTQVKVTFGYVDPKYFR-----SSQFTEKSDVYSFSVVLVE 174
+ DF S +DRT T + + ++ P+ + + +SD++S + +E
Sbjct: 162 LVDFGV--SAQLDRTVGRRNTFIGTPY-WMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
Query: 175 LNWTKPIHLVDVEENRSL 192
+ P L D+ R+L
Sbjct: 219 MAEGAP-PLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 6/155 (3%)
Query: 23 NEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82
+E+ L+ +H +VK + LL+ E+ G L + I ++ + LP
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ---EYE 170
Query: 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQV 142
+ + +++ L V S + H D+KSANI L+ K+ DF F + D L
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDF-GFSKQYSDSVSLDVAS 229
Query: 143 KV--TFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T Y+ P+ + ++++K+D++S V+L EL
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264
|
Length = 478 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 14/184 (7%)
Query: 2 EELWLLKKSKSVHESNVE-QFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNG 59
E L LK+ + HE I EV +L + H N+V L + TE L LV+E++ +
Sbjct: 30 ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT-LHDIIHTERCLTLVFEYLDS- 87
Query: 60 SLYQYIHEQTDDQLPITWEMRLRITV-EVSRVLSYLHSVASIPIYHLDIKSANILLVDKY 118
L QY+ D+ + ++I + ++ R LSY H I H D+K N+L+ +K
Sbjct: 88 DLKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKG 140
Query: 119 QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPK-YFRSSQFTEKSDVYSFSVVLVELNW 177
+ K++DF +++++ + +V VT Y P S++++ D++ +L E+
Sbjct: 141 ELKLADFGLARAKSVPTKTYSNEV-VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
Query: 178 TKPI 181
+P+
Sbjct: 200 GRPM 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 43/171 (25%), Positives = 71/171 (41%), Gaps = 11/171 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
LKK + + +VE + E +L+ + L C +T+ L V E++ G L
Sbjct: 28 LKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MF 85
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
H Q + E R R E+ L +LH I + D+K N+LL + KI+D
Sbjct: 86 HIQRSGRFD---EPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIAD 139
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
F K + T+ T Y+ P+ + D ++ V+L E+
Sbjct: 140 FGMCKEGILGGVT-TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 25/167 (14%)
Query: 20 QFINEVVILSQINHRNVVK---ILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD--QLP 74
Q NE++ L ++NH N++K IL T + Y+F LY +++++ D P
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
+ + R I ++ + Y+H I H DIK NI L + + DF T +
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 135 RTHLTTQVKVTFGYV------DPKYFRSSQFTEKSDVYSFSVVLVEL 175
R +G+V P+ + E +D++S ++L+++
Sbjct: 321 R------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
L K+K V VE +NE IL I H +V + G + LV E++P G L+ ++
Sbjct: 34 LSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL- 92
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDF 125
+ + P +V L YLHS I +Y D+K N+LL D KI+DF
Sbjct: 93 -RKSGRFPEPVARFY--AAQVVLALEYLHS-LDI-VYR-DLKPENLLL-DSDGYIKITDF 145
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
F R RT+ T Y+ P+ S + + D ++ +++ E+
Sbjct: 146 -GFAKRVKGRTYTLCG---TPEYLAPEIILSKGYGKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 33/138 (23%), Positives = 63/138 (45%), Gaps = 4/138 (2%)
Query: 39 ILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVA 98
+T V + + S E T+D P+ + LR + +V++ + +L S
Sbjct: 173 FSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN 232
Query: 99 SIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTT-QVKVTFGYVDPKYFRSS 157
I H D+ + N+LL D AKI DF + D ++ ++ ++ P+
Sbjct: 233 CI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDC 289
Query: 158 QFTEKSDVYSFSVVLVEL 175
+T +SDV+S+ ++L E+
Sbjct: 290 VYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 11/172 (6%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLET-EVPLLVYEFIPNGSLYQY 64
+LKK + + +VE + E ILS + + L CC +T + V EF+ G L
Sbjct: 27 VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL--M 84
Query: 65 IHEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKIS 123
H Q + E R R E++ L +LH I + D+K N+LL + K++
Sbjct: 85 FHIQKSRRFD---EARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLA 138
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
DF K I T+ T Y+ P+ + + D ++ V+L E+
Sbjct: 139 DFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 18/177 (10%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQY 64
LL K + + S+ F E I++ N VV++ C + + L +V E++P G L
Sbjct: 75 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDL--- 130
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKIS 123
++ ++ +P W T EV L +HS+ I H D+K N+LL DK+ K++
Sbjct: 131 VNLMSNYDVPEKWAKFY--TAEVVLALDAIHSMGLI---HRDVKPDNMLL-DKHGHLKLA 184
Query: 124 DFRT-FKSRAIDRTHLTTQVKVTFGYVDPKYFRSS----QFTEKSDVYSFSVVLVEL 175
DF T K T V T Y+ P+ +S + + D +S V L E+
Sbjct: 185 DFGTCMKMDETGMVRCDTAVG-TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 2 EELWLLKKSKSVHESNVEQFIN---EVVILSQINHRNVVKILGCCLETEVPLLVYEFIPN 58
E L +LK+ V E N + + E +LS+++H +VK LE + ++ E+
Sbjct: 28 ERLKVLKEI-PVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEG 86
Query: 59 GSLYQYIHE--QTDDQLP----ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANI 112
L + E T L W ++L + V Y+H I H D+K+ NI
Sbjct: 87 RDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH------YMHQRR---ILHRDLKAKNI 137
Query: 113 LLVDKYQAKISDFRTFKSRAI-DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVV 171
L KI DF SR + L T T Y+ P+ + + KSD++S +
Sbjct: 138 FL-KNNLLKIGDFGV--SRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCI 194
Query: 172 LVEL 175
L E+
Sbjct: 195 LYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 40/168 (23%), Positives = 78/168 (46%), Gaps = 18/168 (10%)
Query: 14 HESNVEQFINEVVILSQINHRNVVKILGCCL------ETEVPLLVYEFIPNGSLYQYIHE 67
++++ ++ E+V+L +NH+N++ +L E + LV E + + +L Q IH
Sbjct: 60 NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHM 118
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
+ D + R++ + ++L + + S I H D+K +NI++ KI DF
Sbjct: 119 ELDHE---------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 169
Query: 128 FKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+R + T VT Y P+ + E D++S ++ EL
Sbjct: 170 --ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 14/184 (7%)
Query: 2 EELWLLKKSKSVHESNVE-QFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNG 59
+ L LK+ + HE I EV +L + H N+V L + TE L LV+E++ +
Sbjct: 31 DNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT-LHDIIHTEKSLTLVFEYL-DK 88
Query: 60 SLYQYIHEQTDDQLPITWEMRLRITV-EVSRVLSYLHSVASIPIYHLDIKSANILLVDKY 118
L QY+ DD +++ + ++ R L+Y H + H D+K N+L+ ++
Sbjct: 89 DLKQYL----DDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERG 141
Query: 119 QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPK-YFRSSQFTEKSDVYSFSVVLVELNW 177
+ K++DF ++++I + +V VT Y P S+ ++ + D++ + E++
Sbjct: 142 ELKLADFGLARAKSIPTKTYSNEV-VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
Query: 178 TKPI 181
+P+
Sbjct: 201 GRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 55/228 (24%), Positives = 87/228 (38%), Gaps = 60/228 (26%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLV-YEFIPNGSLYQ 63
+LK+ + E + ++E+ IL I NH NVV +LG C + PL+V EF G+L
Sbjct: 44 MLKEGATASEH--KALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSN 101
Query: 64 YIHEQTDDQLPIT-----WEMRLRITVEVSRV---------------------------- 90
++ + + P R R VE SRV
Sbjct: 102 FLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161
Query: 91 ---------------LSYLHSVA-------SIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ Y VA S H D+ + NILL + KI DF
Sbjct: 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA 221
Query: 129 KSRAIDRTHLTT-QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ D ++ ++ ++ P+ +T +SDV+SF V+L E+
Sbjct: 222 RDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 6e-05
Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 42/173 (24%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPL-----------LVYEFIPNGSLYQYIHEQTDDQ 72
E+ +L + H N++ +L ++ +V E + L++ I
Sbjct: 49 EIKLLRHLRHENIIGLL------DILRPPSPEDFNDVYIVTELMET-DLHKVIK----SP 97
Query: 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFK 129
P+T + ++ R L YLHS + H D+K +NIL+ KI DF R
Sbjct: 98 QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154
Query: 130 SRAIDRTHLTTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVEL 175
++ LT YV +++R SS++T+ D++S + EL
Sbjct: 155 PDEDEKGFLT-------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 49/188 (26%), Positives = 76/188 (40%), Gaps = 32/188 (17%)
Query: 60 SLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ 119
SL ++ + D L I ++ +I V + + L YLHS S+ H D+K +N+L+ Q
Sbjct: 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQ 142
Query: 120 AKISDFRTFKSRAIDRTHLTTQVKVTFG-----YVDPKYF----RSSQFTEKSDVYSFSV 170
K+ DF +L V T Y+ P+ + KSDV+S +
Sbjct: 143 VKLCDFGI-------SGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGI 195
Query: 171 VLVEL--------NWTKPI-HLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGK 221
++EL +W P L V E S E E F +CL N K
Sbjct: 196 TMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ--LPAEKFSPEFQDF---VNKCLKKNYK 250
Query: 222 KQPTMKEV 229
++P E+
Sbjct: 251 ERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 11/172 (6%)
Query: 23 NEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
E IL+++NH +VK L +TE L L+ +F+ G L+ + ++ + T E
Sbjct: 47 MERDILAEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVK 101
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQ 141
E++ L +LHS+ I + D+K NILL ++ K++DF K +ID
Sbjct: 102 FYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYS 157
Query: 142 VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVDVEENRSL 192
T Y+ P+ T+ +D +SF V++ E L + P D +E ++
Sbjct: 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 30/88 (34%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 89 RVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGY 148
R L YLHS I H DIK N+L+ KI DF + D + TQ VT Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 149 VDPKYFRSSQ-FTEKSDVYSFSVVLVEL 175
P+ S+ +T D++S + EL
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAEL 198
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 11/169 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LKK + + V+ E IL +++H +V ++ + + EF+ G L+ H
Sbjct: 51 LKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFT--H 108
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ + P ++ E+ YLHS I + D+K N+LL +K K++DF
Sbjct: 109 LRKAGRFPN--DVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDF- 162
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
F + DRT T Y+ P+ +S + D ++ V+L E
Sbjct: 163 GFAKKVPDRTFTLCG---TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 38/170 (22%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 14 HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY-----IHEQ 68
++++ ++ E+V++ +NH+N++ +L F P SL ++ + E
Sbjct: 56 NQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMEL 103
Query: 69 TDDQLPITWEMRL---RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
D L +M L R++ + ++L + + S I H D+K +NI++ KI DF
Sbjct: 104 MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 163
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+R + + T VT Y P+ + E D++S ++ E+
Sbjct: 164 GL--ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 33/123 (26%), Positives = 53/123 (43%), Gaps = 19/123 (15%)
Query: 61 LYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
Y+Y++E +P E+ +I V + L+YL + I H D+K +NILL
Sbjct: 92 FYKYVYEVLKSVIP--EEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNI 147
Query: 121 KISDFRTFKSRAIDRTHLTTQVKVTFG-----YVDPKYFRSSQ---FTEKSDVYSFSVVL 172
K+ DF I L + T Y+ P+ S + +SDV+S + L
Sbjct: 148 KLCDF------GIS-GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITL 200
Query: 173 VEL 175
E+
Sbjct: 201 YEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 25/183 (13%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVP--------LLVYEFIPN--GSLYQYIHEQTDD 71
+ E+ IL + H NVV ++ C P LV+EF + L + +
Sbjct: 59 LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT- 117
Query: 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTF 128
L E++ ++ + L Y+H I H D+K+ANIL+ K++DF R F
Sbjct: 118 -LS---EIK-KVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAF 169
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSS-QFTEKSDVYSFSVVLVELNWTK-PIHLVDV 186
+ + T VT Y P+ + D++ ++ E+ WT+ PI +
Sbjct: 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM-WTRSPIMQGNT 228
Query: 187 EEN 189
E++
Sbjct: 229 EQH 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 38/170 (22%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 14 HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY-----IHEQ 68
++++ ++ E+V++ +NH+N++ +L F P SL ++ + E
Sbjct: 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMEL 110
Query: 69 TDDQLPITWEMRL---RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
D L +M L R++ + ++L + + S I H D+K +NI++ KI DF
Sbjct: 111 MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+R + + T VT Y P+ + E D++S ++ E+
Sbjct: 171 GL--ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPL-----LVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E+ IL H N++ I L +V + + + L+ IH DQ P+T E
Sbjct: 54 ELKILRHFKHDNIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHS---DQ-PLTEE 107
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDR 135
++ R L Y+HS + H D+K +N+L+ + + +I DF R S +
Sbjct: 108 HIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164
Query: 136 THLTTQVKVTFGYVDPK-YFRSSQFTEKSDVYSFSVVLVEL 175
+ T+ T Y P+ ++T D++S + E+
Sbjct: 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 10/184 (5%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLL-VYEFIPNGSLYQYI 65
LKK + + +VE + E +L+ + L C +T+ L V EF+ G L +I
Sbjct: 28 LKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI 87
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
++ L R T + ++ L + S I + D+K N++L KI+DF
Sbjct: 88 QDKGRFDL-------YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADF 140
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLV 184
K +T T Y+ P+ + ++T D +SF V+L E L P H
Sbjct: 141 GMCKENVFGDNRASTFCG-TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
Query: 185 DVEE 188
D +E
Sbjct: 200 DEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 20/103 (19%)
Query: 86 EVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVT 145
++ R L Y+HS + H D+K +NIL+ + KI DF + I +T
Sbjct: 116 QILRGLKYVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMT------ 163
Query: 146 FGYVDPKYFRSSQ-------FTEKSDVYSFSVVLVELNWTKPI 181
GYV +Y+R+ + + + D++S + E+ KP+
Sbjct: 164 -GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 37/161 (22%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
I E +L + H N+V + E V+E++ + L QY+ + P + +RL
Sbjct: 51 IREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHP--YNVRL 107
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQ 141
++ R L+Y+H I H D+K N+L+ + K++DF ++++I +++
Sbjct: 108 -FMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163
Query: 142 VKVTFGYVDPKYFR-SSQFTEKSDVYSFSVVLVELNWTKPI 181
V VT Y P ++ ++ D++ + +E+ +P
Sbjct: 164 V-VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 43/190 (22%), Positives = 69/190 (36%), Gaps = 52/190 (27%)
Query: 24 EVVILSQINHRNVVKILGCCLE-----TEVPLLVYEFIP------NGSLYQYIHEQTDDQ 72
E+ IL ++ H NVV ++ +E VY P +G L
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL----ENP---- 108
Query: 73 LPITWEMRLRITVEVSRV----------LSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
+ + S++ ++YLH I H DIK+ANIL+ ++ KI
Sbjct: 109 ---------SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKI 156
Query: 123 SDF----------RTFKSRAIDRTHLTTQVKVTFGYVDPKY-FRSSQFTEKSDVYSFSVV 171
+DF K T T + VT Y P+ ++T D++ V
Sbjct: 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCV 216
Query: 172 LVELNWTKPI 181
E+ +PI
Sbjct: 217 FAEMFTRRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 13/187 (6%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLL-VYEFIPNGSL-YQ 63
+LKK + + +V+ + E IL+ + L CC +T+ L V E++ G L +Q
Sbjct: 27 VLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQ 86
Query: 64 YIHEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
+ D E R R EV+ L +LH I + D+K NILL + K+
Sbjct: 87 IQRSRKFD------EPRSRFYAAEVTLALMFLHRHGVI---YRDLKLDNILLDAEGHCKL 137
Query: 123 SDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIH 182
+DF K I TT T Y+ P+ + ++ D ++ V++ E+ +P
Sbjct: 138 ADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF 196
Query: 183 LVDVEEN 189
D E++
Sbjct: 197 EADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 5e-04
Identities = 40/163 (24%), Positives = 78/163 (47%), Gaps = 24/163 (14%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80
I E+ +L ++NH N+VK+L + TE L LV+EF+ + L +++ D P++
Sbjct: 47 IREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFL-HQDLKKFM-----DASPLS---- 95
Query: 81 LRITVEVSRVLSYLHSVA-------SIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI 133
+ + + SYL + S + H D+K N+L+ + K++DF ++ +
Sbjct: 96 ---GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152
Query: 134 DRTHLTTQVKVTFGYVDPKYFRSSQF-TEKSDVYSFSVVLVEL 175
T +V VT Y P+ ++ + D++S + E+
Sbjct: 153 PVRTYTHEV-VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 31/105 (29%), Positives = 45/105 (42%), Gaps = 22/105 (20%)
Query: 82 RITVEVSRVLSYL---HSVASIPIYHLDIKSANILLVDKYQAKISDF----RTFKSRAID 134
++TV + + L YL H V H D+K +NILL K+ DF R S+A
Sbjct: 118 KMTVAIVKALHYLKEKHGVI-----HRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQFTEK----SDVYSFSVVLVEL 175
R+ Y+ P+ K +DV+S + LVEL
Sbjct: 173 RSAGCA------AYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 6e-04
Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 20/194 (10%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LK + S E N +F+ + + H N+++ LG C+E LLV+E+ G L Y+
Sbjct: 30 LKANASSKEQN--EFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLS 87
Query: 67 EQTDDQLPITWEMRL-RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
++ + + L R+ E++ ++++H + H D+ N L K+ D+
Sbjct: 88 QE-QWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL---HSDLALRNCFLTSDLTVKVGDY 143
Query: 126 RTFKSRAIDRTHLTTQVKVTFG--YVDPKYFRS-------SQFTEKSDVYSFSVVLVEL- 175
SR ++ T+ ++ P+ ++ T+ S+V++ V L EL
Sbjct: 144 GIGPSR-YKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
Query: 176 -NWTKPI-HLVDVE 187
N +P HL D E
Sbjct: 203 ENAAQPYSHLSDRE 216
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 8e-04
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 11/170 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LKK K + VE+ IL++++ R +V L +T+ L + I NG +Y
Sbjct: 31 LKKRKGYEGAMVEK-----RILAKVHSRFIVS-LAYAFQTKTDLCLVMTIMNGGDLRYHI 84
Query: 67 EQTDDQLPITWEMR-LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
D++ P E R T ++ L +LH I + D+K N+LL + +ISD
Sbjct: 85 YNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDL 141
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
D T T G++ P+ + ++ D ++ V L E+
Sbjct: 142 -GLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 16/176 (9%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQY 64
LL K + + S+ F E I++ N +V+ L + + L +V E++P G L
Sbjct: 75 LLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ-LHYAFQDDKYLYMVMEYMPGGDL--- 130
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
++ ++ +P W T EV L +HS+ I H D+K N+LL K++D
Sbjct: 131 VNLMSNYDIPEKWARFY--TAEVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLAD 185
Query: 125 FRT-FKSRAIDRTHLTTQVKVTFGYVDPKYFRS----SQFTEKSDVYSFSVVLVEL 175
F T K A T V T Y+ P+ +S + + D +S V L E+
Sbjct: 186 FGTCMKMDANGMVRCDTAVG-TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 43/174 (24%), Positives = 73/174 (41%), Gaps = 12/174 (6%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
LL K + + S+ F E I++ N VV++ + +V E++P G L +
Sbjct: 75 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL---V 131
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ ++ +P W T EV L +HS+ I H D+K N+LL K++DF
Sbjct: 132 NLMSNYDVPEKWARFY--TAEVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADF 186
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS----QFTEKSDVYSFSVVLVEL 175
T + T Y+ P+ +S + + D +S V L E+
Sbjct: 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.001
Identities = 43/161 (26%), Positives = 63/161 (39%), Gaps = 17/161 (10%)
Query: 32 NHRNVVKILGCCLETEVPL------LVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITV 85
NH N+ G ++ P LV E GS+ + + E I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 86 EVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKV- 144
E R L+YLH I H DIK NILL + K+ DF S +D T +
Sbjct: 121 ETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGV--SAQLDSTLGRRNTFIG 175
Query: 145 TFGYVDPKYFRSSQ-----FTEKSDVYSFSVVLVELNWTKP 180
T ++ P+ + + +SDV+S + +EL KP
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 4/103 (3%)
Query: 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI 133
+T E + + +V++ + +L S I H D+ + NILL + KI DF +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 134 DRTHLTT-QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
D ++ ++ ++ P+ +T +SDV+SF V+L E+
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.001
Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 31/173 (17%)
Query: 24 EVVILSQINHRNVVKILGC----CLET--EVPLLVYEFIPNGSLYQYIHEQ--TDDQLPI 75
E+ IL + H N++ IL E+ +V +V E + LY+ I Q ++D +
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQY 110
Query: 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR 135
++ R L Y+HS + H D+K +N+LL KI DF +R D
Sbjct: 111 -------FLYQILRGLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGL--ARIADP 158
Query: 136 THLTTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVELNWTKPI 181
H T YV +++R S +T+ D++S +L E+ +P+
Sbjct: 159 EHDHTGFLTE--YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 2 EELW---LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIP 57
+EL+ +LKK + + +VE + E +L+ + + L C +T L V E++
Sbjct: 25 DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84
Query: 58 NGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK 117
G L +I + + P + E+S L +LH I + D+K N++L +
Sbjct: 85 GGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSE 137
Query: 118 YQAKISDFRTFKSRAIDRTHLTTQVKV-TFGYVDPKYFRSSQFTEKSDVYSFSVVLVELN 176
KI+DF K +D +TT+ T Y+ P+ + + D +++ V+L E+
Sbjct: 138 GHIKIADFGMCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195
Query: 177 WTKP---------IHLVDVEENRSLAAYFSKEA 200
+P + +E N S SKEA
Sbjct: 196 AGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 32/165 (19%)
Query: 24 EVVILSQINHRNVVKILGC-----CLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76
E+V++ +NH+N++ +L LE +V LV E + + +L Q I D +
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV-YLVMELM-DANLCQVIQMDLDHE---- 118
Query: 77 WEMRLRITVEVSRVL---SYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKS 130
R++ + ++L +LHS I H D+K +NI++ KI DF RT
Sbjct: 119 -----RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--- 167
Query: 131 RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
A +T V VT Y P+ + E D++S ++ E+
Sbjct: 168 -AGTSFMMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 29/165 (17%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80
+NE IL ++N R VV L ET+ L LV + G L +I+ + E R
Sbjct: 48 LNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGR 103
Query: 81 -LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---------RTFKS 130
+ E+ L LH I + D+K NILL D +ISD +T K
Sbjct: 104 AVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160
Query: 131 RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
R T GY+ P+ ++ ++T D ++ +L E+
Sbjct: 161 RV-----------GTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 35/125 (28%), Positives = 56/125 (44%), Gaps = 10/125 (8%)
Query: 52 VYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSA 110
V +++ G L+ H Q + P E R R E++ L YLHS + I + D+K
Sbjct: 74 VLDYVNGGELF--FHLQRERSFP---EPRARFYAAEIASALGYLHS---LNIIYRDLKPE 125
Query: 111 NILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSV 170
NILL + ++DF K I+ + T+ T Y+ P+ R + D +
Sbjct: 126 NILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGA 184
Query: 171 VLVEL 175
VL E+
Sbjct: 185 VLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 31/192 (16%)
Query: 7 LKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCL-----ETEVPLLVYEFIPNG 59
+KK V H S+ + + E+ +L + H ++V+I L E + +V+E +
Sbjct: 30 IKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ES 88
Query: 60 SLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ 119
L+Q I D +T E ++ R L Y+H+ ++H D+K NIL +
Sbjct: 89 DLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCK 141
Query: 120 AKISDFRTFKSRAIDRTHLTTQVKVTF--GYVDPKYFRS--------SQFTEKSDVYSFS 169
KI DF + R F YV +++R+ S++T D++S
Sbjct: 142 LKICDF------GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 195
Query: 170 VVLVELNWTKPI 181
+ E+ KP+
Sbjct: 196 CIFAEVLTGKPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (90), Expect = 0.003
Identities = 55/252 (21%), Positives = 101/252 (40%), Gaps = 37/252 (14%)
Query: 5 WLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLY 62
W + + E Q + EV ++ ++ H+N+V+ + L + ++ EF G L
Sbjct: 43 WKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLS 102
Query: 63 QYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIP----IYHLDIKSANILLVDKY 118
+ I + I + IT ++ L+Y H++ P + H D+K NI L
Sbjct: 103 RNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162
Query: 119 Q-----------------AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF--RSSQF 159
+ AKI DF K+ I+ + T Y P+ + +
Sbjct: 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSY 220
Query: 160 TEKSDVYSFSVVLVELNWTK-PIHLVD-----VEENRSLAAYFSKEAEKEEVITFAMVAK 213
+KSD+++ ++ EL K P H + + E + K KE ++ K
Sbjct: 221 DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKE----LNILIK 276
Query: 214 RCLNLNGKKQPT 225
LNL+ K++P+
Sbjct: 277 NLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 37/165 (22%), Positives = 77/165 (46%), Gaps = 8/165 (4%)
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129
+D+L + E L + +V++ +S+L S I H D+ + NILL KI DF +
Sbjct: 206 EDELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLAR 262
Query: 130 SRAIDRTHLTT-QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL----NWTKPIHLV 184
D ++ ++ ++ P+ + +T +SDV+S+ ++L E+ + P V
Sbjct: 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322
Query: 185 DVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
D + + + + + + + K C + + K+PT K++
Sbjct: 323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQY 64
+LKK + + +VE + E +L+ + L C +T L V E++ G L
Sbjct: 32 ILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQ 91
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
I + + P + E++ L +LHS I + D+K N++L + KI+D
Sbjct: 92 IQQVGRFKEP----HAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD 144
Query: 125 FRTFKSRAIDRTHLTTQVKV-TFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
F K D +TT+ T Y+ P+ + + D ++F V+L E+
Sbjct: 145 FGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 290 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.64 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.81 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.29 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.29 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.24 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.24 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.15 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.13 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.08 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.97 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.71 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.69 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.67 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.67 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.63 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.48 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.47 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.17 | |
| PLN02236 | 344 | choline kinase | 97.1 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.05 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.04 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.73 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.61 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.38 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.37 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.29 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.2 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.16 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.09 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.85 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.83 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.78 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.73 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.8 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.61 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.5 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.41 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.33 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.26 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.11 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.96 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.63 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.4 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.97 | |
| KOG4720 | 391 | consensus Ethanolamine kinase [Lipid transport and | 91.83 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 90.13 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=341.39 Aligned_cols=227 Identities=22% Similarity=0.262 Sum_probs=194.3
Q ss_pred CceEEEEeec-ccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc-ceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSK-SVHESNVEQFINEVVILSQINHRNVVKILGCCLETEV-PLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~-~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
++.+|+|++. ..+....+++.+|+++++..+||+||.++|+|...+. +.|+||||.+|+|.++++..+ ++++..
T Consensus 104 ~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g----~i~E~~ 179 (364)
T KOG0581|consen 104 GKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG----RIPEPV 179 (364)
T ss_pred CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC----CCCHHH
Confidence 6789999995 4456678899999999999999999999999999994 999999999999999999764 689999
Q ss_pred HHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 80 RLRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.-.++.+|++||.|||+ ++ ||||||||+|||+...|.+||||||.++....+ ...++.||..|||||.+.+..
T Consensus 180 L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~ 253 (364)
T KOG0581|consen 180 LGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGES 253 (364)
T ss_pred HHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChhhhcCCc
Confidence 99999999999999996 77 999999999999999999999999997765433 667899999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchh----hhhhhHHHhh---hhhhH-HHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVE----ENRSLAAYFS---KEAEK-EEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~----~~~~~~~~~~---~~~~~-~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
|+.++||||||++++|+++|+-|+..... ....+..... ...+. .++++|+++|..||+.||.+|||+.|++
T Consensus 254 Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl 333 (364)
T KOG0581|consen 254 YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLL 333 (364)
T ss_pred CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 99999999999999999999877765421 1222222222 22233 4788999999999999999999999999
Q ss_pred HHHHhhHh
Q 044846 231 LELAGIRA 238 (290)
Q Consensus 231 ~~l~~~~~ 238 (290)
.|-+-.+.
T Consensus 334 ~Hpfi~~~ 341 (364)
T KOG0581|consen 334 QHPFIKKF 341 (364)
T ss_pred cCHHHhhc
Confidence 99765543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=340.35 Aligned_cols=228 Identities=21% Similarity=0.237 Sum_probs=189.4
Q ss_pred CceEEEEeecccCch-------hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVHES-------NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~-------~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||||++....-. ....+.+|+++|++|+|||||+++++|...+..|+||||+.||+|.+++-.+. .
T Consensus 197 gk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk----~ 272 (475)
T KOG0615|consen 197 GKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK----Y 272 (475)
T ss_pred CcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc----c
Confidence 678999998632211 12335799999999999999999999999999999999999999999998776 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC---CcEEEeccccccccccCCceeeccceecccccCc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK---YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
+.+...+.++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+... ......+..||+.|.||
T Consensus 273 l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g--~~sfm~TlCGTpsYvAP 347 (475)
T KOG0615|consen 273 LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG--EGSFMKTLCGTPSYVAP 347 (475)
T ss_pred cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhccc--cceehhhhcCCccccCh
Confidence 777888899999999999999999 9999999999999866 779999999988644 44556778999999999
Q ss_pred cccccCCC---CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH------hhhhhhHHHHHHHHHHHHHhhccCCCC
Q 044846 152 KYFRSSQF---TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY------FSKEAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 152 E~~~~~~~---~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
|++.+..+ ..++||||+||+||-+++|.+||............. +-...+...+.+..+||..||..||++
T Consensus 348 EVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~ 427 (475)
T KOG0615|consen 348 EVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPEN 427 (475)
T ss_pred hheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCccc
Confidence 99987653 347899999999999999999997554332111111 123556677889999999999999999
Q ss_pred CCCHHHHHHHHHhhHh
Q 044846 223 QPTMKEVTLELAGIRA 238 (290)
Q Consensus 223 Rps~~el~~~l~~~~~ 238 (290)
|||++|++.|.|--..
T Consensus 428 R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 428 RPSADEALNHPWFKDA 443 (475)
T ss_pred CcCHHHHhcChhhhcc
Confidence 9999999999775533
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=341.88 Aligned_cols=236 Identities=29% Similarity=0.423 Sum_probs=195.9
Q ss_pred Cce-EEEEeecccCch--hHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-cceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EEL-WLLKKSKSVHES--NVEQFINEVVILSQINHRNVVKILGCCLETE-VPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~-~avK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+. ||+|++...... ..+.|.+|+.+|.+|+|||||+++|+|.... ..+|||||+++|+|..++.... ...+++
T Consensus 64 g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~--~~~l~~ 141 (362)
T KOG0192|consen 64 GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKR--KRKLPL 141 (362)
T ss_pred CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcc--cCCCCH
Confidence 455 999999753322 2669999999999999999999999999987 7899999999999999998741 126999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-cEEEeccccccccccCCceeeccceecccccCccccc-
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR- 155 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 155 (290)
..++.++.|||.||.|||++++ ||||||||+|||++.++ ++||+|||+++...... ...+...||+.|||||++.
T Consensus 142 ~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~ 218 (362)
T KOG0192|consen 142 KVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRG 218 (362)
T ss_pred HHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcC
Confidence 9999999999999999999885 89999999999999997 99999999987655332 2223378999999999999
Q ss_pred -cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 156 -SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 156 -~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
...|+.|+||||||+++|||++|..||......+...... .+...+..++..+..||.+||+.||.+||++.+++.
T Consensus 219 ~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 219 EKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 5689999999999999999999998887555422222221 223334447888999999999999999999999999
Q ss_pred HHHhhHhhhCc
Q 044846 232 ELAGIRASIGA 242 (290)
Q Consensus 232 ~l~~~~~~~~~ 242 (290)
.|+.+......
T Consensus 299 ~l~~~~~~~~~ 309 (362)
T KOG0192|consen 299 RLESIMSHISS 309 (362)
T ss_pred HHHHHHHhhcc
Confidence 99988776543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=341.58 Aligned_cols=228 Identities=20% Similarity=0.251 Sum_probs=195.1
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.. .+....+.+.+||++.++|.|||||+++++|++.+++|||+|+|.+|+|..++++.. ++++.
T Consensus 43 ge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk----~ltEp 118 (592)
T KOG0575|consen 43 GEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK----PLTEP 118 (592)
T ss_pred CcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC----CCCcH
Confidence 78999999964 566778899999999999999999999999999999999999999999999999655 79999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.+++||+.||.|||+++ |||||||-.|++++++.++||+|||+|...... .....+..||+.|.|||++....
T Consensus 119 Eary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~Erk~TlCGTPNYIAPEVl~k~g 194 (592)
T KOG0575|consen 119 EARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-GERKKTLCGTPNYIAPEVLNKSG 194 (592)
T ss_pred HHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc-ccccceecCCCcccChhHhccCC
Confidence 99999999999999999999 999999999999999999999999998765422 23445688999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhh-hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENR-SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
.+..+||||+||++|-|+.|+|||....-... .-.....=..+...+.+.++||.++|+.||.+|||+++|+.+-.-..
T Consensus 195 HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 195 HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 99999999999999999999999976532211 11111111123356778999999999999999999999998865533
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=333.49 Aligned_cols=229 Identities=23% Similarity=0.348 Sum_probs=192.1
Q ss_pred eEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHH
Q 044846 4 LWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI 83 (290)
Q Consensus 4 ~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 83 (290)
.||+|.++.. .-..+.|.+|+++|++|+|+|||+++++|...+.++||||||+.|+|.++|+..... .+...+.+.+
T Consensus 232 ~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~--~l~~~~Ll~~ 308 (468)
T KOG0197|consen 232 KVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGG--LLNLPQLLDF 308 (468)
T ss_pred cccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCC--ccchHHHHHH
Confidence 6899999865 333567899999999999999999999999988999999999999999999973332 5788899999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCcc
Q 044846 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKS 163 (290)
Q Consensus 84 ~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 163 (290)
+.|||+||+||++++ +|||||.++||||+.+..+||+|||+++....+.........-++.|.|||.+..+.++.++
T Consensus 309 a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kS 385 (468)
T KOG0197|consen 309 AAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKS 385 (468)
T ss_pred HHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCccccc
Confidence 999999999999999 99999999999999999999999999984332222233334456789999999999999999
Q ss_pred cchhhHHHHHHHhcCCCCcccchhhhh---hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 164 DVYSFSVVLVELNWTKPIHLVDVEENR---SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 164 DiwS~G~il~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
||||||++|||+++-...++....... .+..-.+.+.+..++..+.++|..||..+|++|||++.+...++.+..
T Consensus 386 DVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 386 DVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 999999999999976555544433333 333334456777899999999999999999999999999888887754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=320.04 Aligned_cols=220 Identities=22% Similarity=0.292 Sum_probs=183.9
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
+..||||.+... ....++.+..|+++|+.|+|||||.+++++..++++|||||||.||+|..+++..+ .+++..
T Consensus 35 ~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~----~l~e~t 110 (429)
T KOG0595|consen 35 GTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG----RLPEAT 110 (429)
T ss_pred CceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC----CCCHHH
Confidence 568999999765 56678889999999999999999999999999999999999999999999999876 599999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC------CcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK------YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
++.++.||+.||++||+++ ||||||||+|||++.. -.+||+|||+|+... ......+..|++.|||||+
T Consensus 111 ~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~--~~~~a~tlcGSplYMAPEV 185 (429)
T KOG0595|consen 111 ARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ--PGSMAETLCGSPLYMAPEV 185 (429)
T ss_pred HHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC--chhHHHHhhCCccccCHHH
Confidence 9999999999999999999 9999999999999864 458999999987654 4455677899999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
+..++|+.|+|+||+|+|+|++++|++||......+- ..+.. ...+...+....+|+...+..+|.+|.++.
T Consensus 186 ~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL--~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~ 263 (429)
T KOG0595|consen 186 IMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL--LLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFE 263 (429)
T ss_pred HHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH--HHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchH
Confidence 9999999999999999999999999999964432222 11211 122233344566788888888888887766
Q ss_pred HHHHH
Q 044846 228 EVTLE 232 (290)
Q Consensus 228 el~~~ 232 (290)
+...+
T Consensus 264 ~~~~~ 268 (429)
T KOG0595|consen 264 DFFDH 268 (429)
T ss_pred Hhhhh
Confidence 65433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=333.50 Aligned_cols=224 Identities=21% Similarity=0.283 Sum_probs=194.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|++........+-+++|+.+|+..+|+|||++++.|...+.+|+|||||.||+|.+++.... +++.++.
T Consensus 298 ~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~-----~~E~qIA 372 (550)
T KOG0578|consen 298 KQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR-----MTEGQIA 372 (550)
T ss_pred CceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc-----ccHHHHH
Confidence 57799999987666667789999999999999999999999999999999999999999999998654 8999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++++++.||+|||.++ |+|||||.+|||++.+|.+||+|||+|........ .-.+.+||+.|||||+.....|++
T Consensus 373 ~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~ 448 (550)
T KOG0578|consen 373 AICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGP 448 (550)
T ss_pred HHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCCCCccchhhhhhcccCc
Confidence 99999999999999999 99999999999999999999999999876554443 335678999999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++||||||++++||+.|.||++.+......+..... ...+...+..|++|+.+||+.|+++|+++.|||+|-.
T Consensus 449 KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 449 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred cccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 999999999999999999999865433322222111 1234567788999999999999999999999998854
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=317.17 Aligned_cols=223 Identities=22% Similarity=0.240 Sum_probs=189.7
Q ss_pred CceEEEEeec---ccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSK---SVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~---~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++ .....+.+....|..+|.+++||+||+++-.|++.+.+|+|+||+.||+|+..|.+.+ .+++.
T Consensus 50 ~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg----~F~E~ 125 (357)
T KOG0598|consen 50 GKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG----RFSED 125 (357)
T ss_pred CceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC----Ccchh
Confidence 6789999885 3556678889999999999999999999999999999999999999999999999776 69999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.+|+.||.|||+++ ||||||||+|||++.+|+++|+|||+++..... ...+.++.||+.|||||++.+..
T Consensus 126 ~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~~t~tfcGT~eYmAPEil~~~g 201 (357)
T KOG0598|consen 126 RARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GDATRTFCGTPEYMAPEILLGKG 201 (357)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC-CCccccccCCccccChHHHhcCC
Confidence 99999999999999999999 999999999999999999999999999854322 23345589999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhh-hHHHhh-hhhhHHHHHHHHHHHHHhhccCCCCCC----CHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS-LAAYFS-KEAEKEEVITFAMVAKRCLNLNGKKQP----TMKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rp----s~~el~~~ 232 (290)
|+..+|.||+|+++|+|++|.+||......... ...... ...+...+.+.++++.+.|..||++|. .+.+|..|
T Consensus 202 y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 202 YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 999999999999999999999999765432221 111111 223334678899999999999999996 46777655
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=323.75 Aligned_cols=233 Identities=42% Similarity=0.633 Sum_probs=188.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-cceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE-VPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||++.....+...+|.+|+.++.+++|||+|+++|+|.+.+ ..+||+|||++|+|.++|...... +++|.++
T Consensus 99 ~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R 176 (361)
T KOG1187|consen 99 GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETR 176 (361)
T ss_pred CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHH
Confidence 3689999887655441445999999999999999999999999988 599999999999999999876543 6899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccccccccc-CCceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI-DRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
++|+.++|.||+|||....++|||||||++|||+|.++++||+|||+|+.... ........ .||.+|+|||++..+..
T Consensus 177 ~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~l 255 (361)
T KOG1187|consen 177 LKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKL 255 (361)
T ss_pred HHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeec-CCCCccCChhhhccCCc
Confidence 99999999999999998888899999999999999999999999999976553 22211111 89999999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccch-hhhhhhHHH-------------hh-----hhhhH-HHHHHHHHHHHHhhccC
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDV-EENRSLAAY-------------FS-----KEAEK-EEVITFAMVAKRCLNLN 219 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~-~~~~~~~~~-------------~~-----~~~~~-~~~~~~~~li~~cl~~d 219 (290)
+.++||||||+++.|+++|+++..... .....+..+ .. ..... .....+..+..+|++.+
T Consensus 256 t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~ 335 (361)
T KOG1187|consen 256 TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPD 335 (361)
T ss_pred CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcC
Confidence 999999999999999999996554221 111111111 01 11121 45666889999999999
Q ss_pred CCCCCCHHHHHHHHHhhH
Q 044846 220 GKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 220 p~~Rps~~el~~~l~~~~ 237 (290)
|..||+|.|+++.|+.+.
T Consensus 336 ~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 336 PKERPTMSQVVKELEGIL 353 (361)
T ss_pred CCcCcCHHHHHHHHHhhc
Confidence 999999999999886554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=307.98 Aligned_cols=230 Identities=21% Similarity=0.258 Sum_probs=190.7
Q ss_pred CceEEEEeec--ccCchhHHHHHHHHHHHHhcCCCceeeEEe-EEEeCCc-ceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSK--SVHESNVEQFINEVVILSQINHRNVVKILG-CCLETEV-PLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~--~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~-~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|..+|.|++. ..+....+.+..|+.+|++|+|||||++++ .|..++. ++||||+|.+|+|...++....+...+++
T Consensus 44 g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE 123 (375)
T KOG0591|consen 44 GKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPE 123 (375)
T ss_pred cchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCch
Confidence 5678999886 456777889999999999999999999998 5666555 89999999999999999988777778999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCC-CeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASI-PIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~-~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
..+++++.|++.||..+|.+-+. -|+||||||.||+++..|.+||+|||+++..... .....+.+||+.||+||.+.+
T Consensus 124 ~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~-~tfA~S~VGTPyYMSPE~i~~ 202 (375)
T KOG0591|consen 124 KTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK-TTFAHSLVGTPYYMSPERIHE 202 (375)
T ss_pred HHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch-hHHHHhhcCCCcccCHHHHhc
Confidence 99999999999999999983221 2999999999999999999999999998875533 334566899999999999999
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
..|+.++||||+||++|||+...+||..+.-. ......... .+...++..+..||..|+..||+.||+...++..
T Consensus 203 ~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~-~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 203 SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL-SLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred CCCCcchhHHHHHHHHHHHHhcCCCcccccHH-HHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 99999999999999999999999999876321 111111111 2235678899999999999999999985444444
Q ss_pred H
Q 044846 233 L 233 (290)
Q Consensus 233 l 233 (290)
+
T Consensus 282 i 282 (375)
T KOG0591|consen 282 I 282 (375)
T ss_pred H
Confidence 4
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=305.05 Aligned_cols=224 Identities=16% Similarity=0.241 Sum_probs=186.6
Q ss_pred CCceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 1 MEELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 1 ~~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
.|++||||++... +....+-.++|++.|++|.|+|+|.++.+|.....++||+|||.. ++.+.+....+ .++..
T Consensus 26 TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~---G~~~~ 101 (396)
T KOG0593|consen 26 TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPN---GVPSE 101 (396)
T ss_pred cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccC---CCCHH
Confidence 3889999998643 344455688999999999999999999999999999999999955 78788877665 58889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-C
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-S 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 157 (290)
.+..++.|++.|+.|+|+++ +|||||||+|||++.+|.+||||||.|+.... ....++.++.|.+|.|||.+.+ .
T Consensus 102 ~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVATRWYRaPELLvGDt 177 (396)
T KOG0593|consen 102 LVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVATRWYRAPELLVGDT 177 (396)
T ss_pred HHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-CcchhhhhhhhhhccChhhhcccC
Confidence 99999999999999999999 99999999999999999999999999886543 4455677888999999999987 6
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--------------------------------hhhhHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--------------------------------KEAEKEEV 205 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~ 205 (290)
+|+.++||||+||++.||++|.|.|....+-...+..... ....+..+
T Consensus 178 qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s 257 (396)
T KOG0593|consen 178 QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKIS 257 (396)
T ss_pred cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccch
Confidence 8999999999999999999999988766543332221111 00112234
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 206 ITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 206 ~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
....+|++.||..||.+|++-+|++.|
T Consensus 258 ~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 258 NVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHHHHHHhcCCccccccHHHHhcC
Confidence 468899999999999999999999866
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=313.13 Aligned_cols=227 Identities=22% Similarity=0.253 Sum_probs=188.1
Q ss_pred CCceEEEEeecccCc-hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 1 MEELWLLKKSKSVHE-SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 1 ~~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
+|+.||||++...+. .+.+.+++|+..|+.++||||++++.+|..+..+|+||.||.+|++.++++..-.. .+++..
T Consensus 50 ~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~--Gl~E~~ 127 (516)
T KOG0582|consen 50 TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPD--GLEEAS 127 (516)
T ss_pred cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccc--cccHHH
Confidence 478999999975333 33789999999999999999999999999999999999999999999999987554 489999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC--ceee-ccceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR--THLT-TQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~-~~~~g~~~y~aPE~~~~ 156 (290)
+..+.++++.||.|||.+| .||||||+.||||+.+|.+||+|||.+.....+. .... .++.|++.|||||++..
T Consensus 128 Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q 204 (516)
T KOG0582|consen 128 IATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ 204 (516)
T ss_pred HHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhh
Confidence 9999999999999999999 9999999999999999999999999765433221 1112 56789999999999654
Q ss_pred --CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------------hhhhHHHHHHHHHHHHHhhccCCCC
Q 044846 157 --SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------------KEAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 157 --~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
.+|+.|+||||||++..|+++|..||..-. ..+.+...+. ..........|+.+|..||+.||.+
T Consensus 205 ~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p-PmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~k 283 (516)
T KOG0582|consen 205 QLHGYDFKADIWSFGITACELAHGHAPFSKYP-PMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSK 283 (516)
T ss_pred cccCccchhhhhhhhHHHHHHhcCCCCcccCC-hHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCccc
Confidence 469999999999999999999999885332 2222222222 1223345668999999999999999
Q ss_pred CCCHHHHHHHH
Q 044846 223 QPTMKEVTLEL 233 (290)
Q Consensus 223 Rps~~el~~~l 233 (290)
|||+++++++-
T Consensus 284 RptAskLlkh~ 294 (516)
T KOG0582|consen 284 RPTASKLLKHA 294 (516)
T ss_pred CCCHHHHhccH
Confidence 99999998763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=329.06 Aligned_cols=222 Identities=24% Similarity=0.354 Sum_probs=187.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.|||||++..++ .+|+.|++|+||||+.|+|+|....-+|||||||+.|-|..+|+..+ .++.....
T Consensus 147 netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~----~itp~llv 215 (904)
T KOG4721|consen 147 NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR----PITPSLLV 215 (904)
T ss_pred CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC----ccCHHHHH
Confidence 67899999976443 46778999999999999999999999999999999999999999876 68888999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.|..+||.||.|||.+. |||||||.-||||+.+..+||+|||.++..... .....+.||+.|||||++.....++
T Consensus 216 ~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsE 290 (904)
T KOG4721|consen 216 DWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSE 290 (904)
T ss_pred HHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCccc
Confidence 99999999999999999 999999999999999999999999987643321 2234588999999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHH---HhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA---YFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
|+|||||||+||||+||.-|+..-......+.. .+.-+.+..++.-|.-||++||+..|..||||++++.||.....
T Consensus 291 KVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 291 KVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred ccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 999999999999999999877533322222211 12234456677889999999999999999999999999976554
Q ss_pred h
Q 044846 239 S 239 (290)
Q Consensus 239 ~ 239 (290)
.
T Consensus 371 e 371 (904)
T KOG4721|consen 371 E 371 (904)
T ss_pred H
Confidence 3
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=313.47 Aligned_cols=231 Identities=27% Similarity=0.307 Sum_probs=186.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--cceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE--VPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+..|||.+...+....+.+.+|+++|..|+|||||+++|...... .++|+|||+++|+|.+++.+.+. .+++..
T Consensus 42 g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~---~l~E~~ 118 (313)
T KOG0198|consen 42 GELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG---KLPEPL 118 (313)
T ss_pred CcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC---CCCHHH
Confidence 5788999987654444778999999999999999999999855544 68999999999999999998764 489999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEecccccccccc--CCceeeccceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAI--DRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
++.+.+||++||+|||+++ |+||||||+|||++. ++.+||+|||+++.... ..........||+.|||||++.+
T Consensus 119 v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 119 VRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred HHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC
Confidence 9999999999999999999 999999999999999 69999999998875542 12222345789999999999996
Q ss_pred C-CCCCcccchhhHHHHHHHhcCCCCcccchhhhh-hhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 157 S-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR-SLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 157 ~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
+ ....++||||+||++.||+||.+|+..-..... .+..... ...+...+.+..+++.+|+..||++||||++++.
T Consensus 196 g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 196 GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3 233589999999999999999888864211111 1111111 2233445678999999999999999999999999
Q ss_pred HHHhhHh
Q 044846 232 ELAGIRA 238 (290)
Q Consensus 232 ~l~~~~~ 238 (290)
|......
T Consensus 276 hpf~~~~ 282 (313)
T KOG0198|consen 276 HPFLKQN 282 (313)
T ss_pred Chhhhcc
Confidence 9765543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=313.95 Aligned_cols=225 Identities=23% Similarity=0.250 Sum_probs=187.3
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|++||+|+++... +.......+||.+|++|+||||+++.+..... ..+|+|+|||+. ||..++.... ..|++
T Consensus 142 gkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~---vkft~ 217 (560)
T KOG0600|consen 142 GKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPG---VKFTE 217 (560)
T ss_pred CcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCC---cccCh
Confidence 7899999997544 55577788999999999999999999998876 689999999965 9999998643 36999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
.+++.++.|++.||+|||+++ |+|||||.+|||||.+|.+||+|||+|+..........+..+.|.+|.|||.+.+.
T Consensus 218 ~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~ 294 (560)
T KOG0600|consen 218 PQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGA 294 (560)
T ss_pred HHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCC
Confidence 999999999999999999999 99999999999999999999999999997666665557778889999999999875
Q ss_pred -CCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhh----------------------------hhhhHHHHH
Q 044846 158 -QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFS----------------------------KEAEKEEVI 206 (290)
Q Consensus 158 -~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~----------------------------~~~~~~~~~ 206 (290)
.|+.++|+||.||||.||+.|+|++....+..+. +...-- .+.....+.
T Consensus 295 t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~ 374 (560)
T KOG0600|consen 295 TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPA 374 (560)
T ss_pred cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCH
Confidence 6999999999999999999999998765432221 111100 001112344
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
...+|+..+|..||.+|.||.+++..=
T Consensus 375 ~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 375 SALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred HHHHHHHHHhccCccccccHHHHhcCc
Confidence 677999999999999999999998653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=317.97 Aligned_cols=224 Identities=22% Similarity=0.247 Sum_probs=191.0
Q ss_pred CceEEEEeec---ccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSK---SVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~---~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
+++||+|++. ...+..++-+..|-.+|.+| .||.|++|+-.|++...+|.|+||+++|+|.++|+..+ .|++
T Consensus 98 ~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G----sfde 173 (604)
T KOG0592|consen 98 GKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG----SFDE 173 (604)
T ss_pred CceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhC----cchH
Confidence 6789999985 24455667788899999999 89999999999999999999999999999999999887 6999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce------------eeccceec
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH------------LTTQVKVT 145 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------------~~~~~~g~ 145 (290)
...+.++.+|+.||+|||++| ||||||||+|||++.+|+++|.|||.|+........ ....++||
T Consensus 174 ~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGT 250 (604)
T KOG0592|consen 174 TCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGT 250 (604)
T ss_pred HHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeee
Confidence 999999999999999999999 999999999999999999999999999865432211 11458999
Q ss_pred ccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 146 FGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 146 ~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
-.|.+||++.++..+..+|+|+||||+|+|+.|.|||....+.. ....... -..+...++...+||++.|..||.+|
T Consensus 251 AeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-iFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~R 329 (604)
T KOG0592|consen 251 AEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-IFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDR 329 (604)
T ss_pred ecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-HHHHHHHhcccCCCCCCHHHHHHHHHHHccCcccc
Confidence 99999999999999999999999999999999999997654431 1222111 12334456789999999999999999
Q ss_pred CCHHHHHHHH
Q 044846 224 PTMKEVTLEL 233 (290)
Q Consensus 224 ps~~el~~~l 233 (290)
+|..+|.+|.
T Consensus 330 lt~~qIk~Hp 339 (604)
T KOG0592|consen 330 LTSQQIKAHP 339 (604)
T ss_pred ccHHHHhhCc
Confidence 9999998885
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=315.82 Aligned_cols=224 Identities=22% Similarity=0.268 Sum_probs=185.1
Q ss_pred CceEEEEeecccCchh-HHHHHHHHHHHHhcC-CCceeeEEeEEEeCC-cceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVHESN-VEQFINEVVILSQIN-HRNVVKILGCCLETE-VPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~-~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++..-... .-.=++|++.|++|+ |||||++.+++.+.+ .+|+|||||. -+|+++++.++. .|+++
T Consensus 35 ~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R~r---~fse~ 110 (538)
T KOG0661|consen 35 GELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDRNR---LFSES 110 (538)
T ss_pred CceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhcCC---cCCHH
Confidence 6789999997543332 223467999999997 999999999999887 9999999995 599999998743 79999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc-cC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-SS 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~ 157 (290)
.++.|+.||++||+|+|.+| ++|||+||+|||+.....+||+|||+|+... ...-++.++.|.+|.|||++. ++
T Consensus 111 ~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~--SkpPYTeYVSTRWYRAPEvLLrs~ 185 (538)
T KOG0661|consen 111 DIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR--SKPPYTEYVSTRWYRAPEVLLRSG 185 (538)
T ss_pred HHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc--cCCCcchhhhcccccchHHhhhcc
Confidence 99999999999999999999 9999999999999999999999999987544 334456788899999999976 55
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------------------------------hhhhHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------------------------------KEAEKEEVI 206 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~ 206 (290)
.|+.++||||+|||++|++.-+|.|....+.++.+..... ...-...+.
T Consensus 186 ~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~ 265 (538)
T KOG0661|consen 186 YYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASS 265 (538)
T ss_pred ccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCH
Confidence 6899999999999999999999988765544333322211 111123567
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++.++|.+||.+||.+||||.|++++..
T Consensus 266 ~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 266 EAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 8999999999999999999999998853
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=287.52 Aligned_cols=227 Identities=20% Similarity=0.211 Sum_probs=185.7
Q ss_pred CceEEEEeecccCchh--HHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHESN--VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~--~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+||++..+..+ ....++|++.|+.++|+||+.++++|.....+.||+|||+. +|+.+++.... .++..+
T Consensus 27 ~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i---~l~pa~ 102 (318)
T KOG0659|consen 27 GKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNI---ILSPAD 102 (318)
T ss_pred CcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhccccc---ccCHHH
Confidence 7899999998654332 34678999999999999999999999999999999999965 99999987654 689999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-C
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-Q 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 158 (290)
++.|+.+++.|++|||.+. |+||||||.|+|++.+|.+||+|||+++......... +..+.|.+|.|||.+.+. .
T Consensus 103 iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-~~~V~TRWYRAPELLfGsr~ 178 (318)
T KOG0659|consen 103 IKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-THQVVTRWYRAPELLFGSRQ 178 (318)
T ss_pred HHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc-ccceeeeeccChHHhccchh
Confidence 9999999999999999999 9999999999999999999999999998765443333 333678999999998875 5
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----------------------------hhhhHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----------------------------KEAEKEEVITFA 209 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 209 (290)
|+..+||||.|||+.||+.+.|.+..+.+-++....... .......+.+..
T Consensus 179 Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~l 258 (318)
T KOG0659|consen 179 YGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDAL 258 (318)
T ss_pred cCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHH
Confidence 999999999999999999999887765443222111110 001112345678
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 210 MVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 210 ~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
+|+.++|..||.+|+|++|++++-...
T Consensus 259 dLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 259 DLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred HHHHhhhccCchhcccHHHHhcchhhh
Confidence 999999999999999999999875543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=313.35 Aligned_cols=227 Identities=19% Similarity=0.197 Sum_probs=188.5
Q ss_pred CceEEEEeeccc----Cc-hhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSV----HE-SNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~----~~-~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|.+... .. ...+.+.+|+.+++.++ ||||+++++++.....+++|||||.||+|++++.+.. ++
T Consensus 42 ~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g----~l 117 (370)
T KOG0583|consen 42 GEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKG----RL 117 (370)
T ss_pred CCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcC----CC
Confidence 578999976542 12 33556668999999998 9999999999999999999999999999999999844 68
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC-CcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
.+..+..+++|++.|++|||+++ |+||||||+|+|++.+ +.+||+|||++.... .......+..||+.|+|||++
T Consensus 118 ~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl 193 (370)
T KOG0583|consen 118 KEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVL 193 (370)
T ss_pred ChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHh
Confidence 89999999999999999999999 9999999999999999 999999999987653 334556678999999999999
Q ss_pred ccCC-CC-CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHH-HHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 155 RSSQ-FT-EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEE-VITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 155 ~~~~-~~-~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
.+.. |+ .++||||+|++||.|++|.-||........ ....... ..+... +.++..|+.+||..||.+|+|+.++
T Consensus 194 ~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i 272 (370)
T KOG0583|consen 194 SGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-YRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEI 272 (370)
T ss_pred CCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-HHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 9987 86 689999999999999999999976332211 1111121 112222 7889999999999999999999999
Q ss_pred HHHHHhhH
Q 044846 230 TLELAGIR 237 (290)
Q Consensus 230 ~~~l~~~~ 237 (290)
+++-+-..
T Consensus 273 ~~h~w~~~ 280 (370)
T KOG0583|consen 273 LEHPWFQK 280 (370)
T ss_pred hhChhhcc
Confidence 97766554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=328.40 Aligned_cols=234 Identities=23% Similarity=0.368 Sum_probs=193.9
Q ss_pred ceEEEEeecccCch-hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC----------
Q 044846 3 ELWLLKKSKSVHES-NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD---------- 71 (290)
Q Consensus 3 ~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------- 71 (290)
..||||.++..... ..++|.+|++.|..|+|||||+++|+|..++.+++|+|||..|||.+||+.....
T Consensus 517 ~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~ 596 (774)
T KOG1026|consen 517 QLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDT 596 (774)
T ss_pred eehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCC
Confidence 46999999876655 7889999999999999999999999999999999999999999999999775321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee-ccceecccccC
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT-TQVKVTFGYVD 150 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~a 150 (290)
..+++..+.+.++.|||.||.||-+++ ++||||..+||||.....+||+|||+++......-... .....+++||+
T Consensus 597 ~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMp 673 (774)
T KOG1026|consen 597 PPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMP 673 (774)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCC
Confidence 234888999999999999999999999 99999999999999999999999999875543322221 13345789999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHh-cCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELN-WTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
||.+..++|++++|||||||+|||++ .|..|+.. ...++.+..... -..+.+++.+++.||..||+.+|.+||++
T Consensus 674 pEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g-lSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF 752 (774)
T KOG1026|consen 674 PESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG-LSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSF 752 (774)
T ss_pred HHHhhcCcccchhhhhhhhhhhhhhhccccCcccc-cchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCH
Confidence 99999999999999999999999998 46655543 222222222211 34566788999999999999999999999
Q ss_pred HHHHHHHHhhHhhh
Q 044846 227 KEVTLELAGIRASI 240 (290)
Q Consensus 227 ~el~~~l~~~~~~~ 240 (290)
+||-..|+......
T Consensus 753 ~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 753 KEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHHHHHHhcC
Confidence 99999998776543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=310.94 Aligned_cols=251 Identities=18% Similarity=0.229 Sum_probs=200.3
Q ss_pred CCceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 1 MEELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 1 ~~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
.|+++|+|+++. ....+++.++.|-.+|...++|+||+++-.|++..++||||||++||++..+|.... .|++
T Consensus 165 Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~----~L~e 240 (550)
T KOG0605|consen 165 TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD----TLTE 240 (550)
T ss_pred CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC----cCch
Confidence 378999999974 456678889999999999999999999999999999999999999999999999876 6999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC-----------------------
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID----------------------- 134 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~----------------------- 134 (290)
..++.++.+++.|+.-+|+.| +|||||||+|+|||..|++||+|||+++.....
T Consensus 241 ~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (550)
T KOG0605|consen 241 DWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSD 317 (550)
T ss_pred HHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcc
Confidence 999999999999999999999 999999999999999999999999998532110
Q ss_pred Cc-----------------------eeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhh---
Q 044846 135 RT-----------------------HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE--- 188 (290)
Q Consensus 135 ~~-----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--- 188 (290)
.. ......+|||-|+|||++.+..|+..+|.||+|||+|||+.|.|||..+...
T Consensus 318 ~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~ 397 (550)
T KOG0605|consen 318 FPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETY 397 (550)
T ss_pred ccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 00 0112357899999999999999999999999999999999999999865432
Q ss_pred --hhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHHH----------HhhHhhhCccchhhhccccc
Q 044846 189 --NRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQP---TMKEVTLEL----------AGIRASIGASVLLQCEEINF 253 (290)
Q Consensus 189 --~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp---s~~el~~~l----------~~~~~~~~~~~~~~~~~~~~ 253 (290)
...+...+..+.....+.+..|||.+||. ||++|. .+.||.+|. .......-+.+....++..+
T Consensus 398 rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yF 476 (550)
T KOG0605|consen 398 RKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYF 476 (550)
T ss_pred HHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCCCccccccc
Confidence 11222223344445566889999999998 999996 488886653 33333333334444444455
Q ss_pred cccCCC
Q 044846 254 VDYDNA 259 (290)
Q Consensus 254 ~~~~~~ 259 (290)
.+++.+
T Consensus 477 ddF~e~ 482 (550)
T KOG0605|consen 477 DDFPEE 482 (550)
T ss_pred ccCccc
Confidence 555443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=302.10 Aligned_cols=224 Identities=19% Similarity=0.268 Sum_probs=182.8
Q ss_pred CceEEEEeecccCchh---HHHHHHHHHHHHhcCCCceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVHESN---VEQFINEVVILSQINHRNVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~---~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|+++...... .+.+.+|+.+|++++||||+++++++.. ....++||||+++|+|.+++.... .
T Consensus 43 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----~ 118 (283)
T PHA02988 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK----D 118 (283)
T ss_pred CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC----C
Confidence 6789999997543333 5778899999999999999999999877 347899999999999999998654 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
+++.....++.+++.||.|||+. + ++||||||+||+++.++.+||+|||+++..... .....++..|+|||+
T Consensus 119 ~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~ 191 (283)
T PHA02988 119 LSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFKNVNFMVYFSYKM 191 (283)
T ss_pred CChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc----cccccCcccccCHHH
Confidence 88889999999999999999984 6 889999999999999999999999997643221 123457788999999
Q ss_pred ccc--CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh----hhhhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 154 FRS--SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF----SKEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 154 ~~~--~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
+.+ ..++.++|||||||++|||++|..||...... ....... ....+...+..+.+++.+||+.||++|||++
T Consensus 192 ~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 270 (283)
T PHA02988 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK 270 (283)
T ss_pred hhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHH
Confidence 976 67899999999999999999999888644221 1111111 1112224667899999999999999999999
Q ss_pred HHHHHHHhhH
Q 044846 228 EVTLELAGIR 237 (290)
Q Consensus 228 el~~~l~~~~ 237 (290)
|++..|+.+.
T Consensus 271 ell~~l~~~~ 280 (283)
T PHA02988 271 EILYNLSLYK 280 (283)
T ss_pred HHHHHHHHHH
Confidence 9999998765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=289.31 Aligned_cols=210 Identities=22% Similarity=0.284 Sum_probs=185.5
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|..+|+|+++. .+..+++...+|..+|+.+.||+++++++.|.+..++|+||||++||.|+.++++.+ ++++.
T Consensus 69 g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~----rF~e~ 144 (355)
T KOG0616|consen 69 GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG----RFSEP 144 (355)
T ss_pred CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC----CCCch
Confidence 56789998863 556778889999999999999999999999999999999999999999999999876 69999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||+|||+++ |++|||||+|||+|.+|.+||.|||.|+... ..+.+..||+-|+|||++....
T Consensus 145 ~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----~rT~TlCGTPeYLAPEii~sk~ 217 (355)
T KOG0616|consen 145 HARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS----GRTWTLCGTPEYLAPEIIQSKG 217 (355)
T ss_pred hHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec----CcEEEecCCccccChHHhhcCC
Confidence 99999999999999999999 9999999999999999999999999987654 3356788999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
|+.++|.||||+++|||+.|.+||..+.. ...+...... ..+...+.++++|+.+.|+.|-.+|
T Consensus 218 ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 218 YNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 99999999999999999999999987655 3333333222 2445567889999999999999999
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=314.28 Aligned_cols=227 Identities=22% Similarity=0.239 Sum_probs=192.6
Q ss_pred CCceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 1 MEELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 1 ~~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
.|+.+|||++... .......+.+|+.+|+-|.||||+++++++++..++|+|+||++||.|++++.+.+ ++++
T Consensus 36 TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG----~l~e 111 (786)
T KOG0588|consen 36 TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG----PLPE 111 (786)
T ss_pred ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC----CCCC
Confidence 3889999998643 33345567899999999999999999999999999999999999999999999877 6899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+.+++.||+.|+.|||..+ |+||||||+|+|++..+++||+|||+|.... ...+..+..|+++|.|||++.+.
T Consensus 112 ~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklLeTSCGSPHYA~PEIV~G~ 186 (786)
T KOG0588|consen 112 REAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLLETSCGSPHYAAPEIVSGR 186 (786)
T ss_pred HHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--CCccccccCCCcccCCchhhcCC
Confidence 999999999999999999999 9999999999999999999999999975432 34566778999999999999999
Q ss_pred CCC-CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhh--hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 158 QFT-EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKE--AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 158 ~~~-~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.|. .++||||.|||||.|++|+-||..++.. ..+.....+. -+...+.++++|+.+||..||..|.|.+||++|.+
T Consensus 187 pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 187 PYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-VLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred CCCCCccccchhHHHHHHHHhCCCCCCCccHH-HHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 986 5899999999999999999999644322 2222222222 23456788999999999999999999999999976
Q ss_pred hhH
Q 044846 235 GIR 237 (290)
Q Consensus 235 ~~~ 237 (290)
-..
T Consensus 266 l~g 268 (786)
T KOG0588|consen 266 LSG 268 (786)
T ss_pred hhc
Confidence 443
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=284.93 Aligned_cols=229 Identities=21% Similarity=0.260 Sum_probs=191.5
Q ss_pred CceEEEEeecccC--------chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCC
Q 044846 2 EELWLLKKSKSVH--------ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQ 72 (290)
Q Consensus 2 ~~~~avK~~~~~~--------~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 72 (290)
|+.+|+|++.... ..-.+.-++|+.+|+++ .||+|+++.++++.+.++++|+|.|+.|.|++++.+.-
T Consensus 42 ~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V--- 118 (411)
T KOG0599|consen 42 GKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV--- 118 (411)
T ss_pred ccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe---
Confidence 5678888875321 11245667899999999 89999999999999999999999999999999998765
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcc
Q 044846 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPK 152 (290)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 152 (290)
.+++...+.+++|+.+|++|||.++ |+||||||+|||++++.++||+|||.+.... .........||++|+|||
T Consensus 119 -tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~--~GekLrelCGTPgYLAPE 192 (411)
T KOG0599|consen 119 -TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE--PGEKLRELCGTPGYLAPE 192 (411)
T ss_pred -eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC--CchhHHHhcCCCcccChh
Confidence 6899999999999999999999999 9999999999999999999999999976543 333445678999999999
Q ss_pred cccc------CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh-----hHHHhhhhhhHHHHHHHHHHHHHhhccCCC
Q 044846 153 YFRS------SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS-----LAAYFSKEAEKEEVITFAMVAKRCLNLNGK 221 (290)
Q Consensus 153 ~~~~------~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~cl~~dp~ 221 (290)
.+.. .+|+..+|+||+|+|+|-++.|.|||+........ -..-+..+.+.+.+.+.++||.+||+.||.
T Consensus 193 tikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~ 272 (411)
T KOG0599|consen 193 TIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPT 272 (411)
T ss_pred heeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCch
Confidence 9863 46888999999999999999999999865432111 011133566778888999999999999999
Q ss_pred CCCCHHHHHHHHHhhHhh
Q 044846 222 KQPTMKEVTLELAGIRAS 239 (290)
Q Consensus 222 ~Rps~~el~~~l~~~~~~ 239 (290)
+|.|+.|.+.|.......
T Consensus 273 ~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 273 KRITAKEALAHPFFIQIA 290 (411)
T ss_pred hcccHHHHhcChHHHHHH
Confidence 999999999997665543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=310.31 Aligned_cols=223 Identities=21% Similarity=0.253 Sum_probs=193.6
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
.+.||+|.+.. ..+.+.+.+.+|+++++.|+|||||.++++|++..++|+|.|||.| +|+.++.... .++++.
T Consensus 27 ~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~----~lpEe~ 101 (808)
T KOG0597|consen 27 IQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDG----KLPEEQ 101 (808)
T ss_pred eeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhcc----CCCHHH
Confidence 46799999864 3345677899999999999999999999999999999999999965 9999998766 599999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+..++.+++.||.|||+++ |+|||+||+|||++..|++|+||||+|+.... .....+...||+-|||||+..+..|
T Consensus 102 v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vltsikGtPlYmAPElv~e~py 177 (808)
T KOG0597|consen 102 VRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVLTSIKGTPLYMAPELVEEQPY 177 (808)
T ss_pred HHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-CceeeeeccCcccccCHHHHcCCCc
Confidence 9999999999999999999 99999999999999999999999999987654 3455677899999999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhh-HHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL-AAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+..+|+||+|||+||++.|.|||......+-.. ........+...+..|.++++..|..||.+|.|+.+++.|.
T Consensus 178 d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 178 DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 999999999999999999999998654332211 11122234557788999999999999999999999999884
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=305.47 Aligned_cols=233 Identities=23% Similarity=0.301 Sum_probs=181.9
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC-CcceEEEEeCCCCCHHHHHhhcCCC--------
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQI-NHRNVVKILGCCLET-EVPLLVYEFIPNGSLYQYIHEQTDD-------- 71 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~-------- 71 (290)
+.||+|+++... ....+.+.+|+.++..+ +||||++++++|... +.+++||||+++|+|.+++......
T Consensus 38 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~ 117 (338)
T cd05102 38 NTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKS 117 (338)
T ss_pred hhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccc
Confidence 568999987533 34466799999999999 899999999998764 4678999999999999999753210
Q ss_pred --------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 044846 72 --------------------------------------------------QLPITWEMRLRITVEVSRVLSYLHSVASIP 101 (290)
Q Consensus 72 --------------------------------------------------~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~ 101 (290)
..++++..+..++.||+.||.|||+++
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--- 194 (338)
T cd05102 118 PKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--- 194 (338)
T ss_pred hhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 124788889999999999999999999
Q ss_pred eEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccccccCCCCCcccchhhHHHHHHHhc-CC
Q 044846 102 IYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TK 179 (290)
Q Consensus 102 iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~ 179 (290)
|+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |.
T Consensus 195 ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~ 274 (338)
T cd05102 195 CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 274 (338)
T ss_pred EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998653322111 1123345678999999999999999999999999999986 77
Q ss_pred CCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 180 PIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
.||............... ...+...+..+.+|+.+||+.||.+|||+.|+++.|+.+..
T Consensus 275 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 275 SPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 776542221111111111 11123445679999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.90 Aligned_cols=236 Identities=21% Similarity=0.354 Sum_probs=195.9
Q ss_pred eEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC---CCCCCHHH
Q 044846 4 LWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD---QLPITWEM 79 (290)
Q Consensus 4 ~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~ 79 (290)
.||+|+++. .+.++...|++|..+|+.++|||||+++|++.+....+|++|||++|+|..||++.+.. ...++...
T Consensus 724 ~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~d 803 (1025)
T KOG1095|consen 724 QVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRD 803 (1025)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHH
Confidence 389999864 56777889999999999999999999999999999999999999999999999987221 22588999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee-ccceecccccCccccccCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT-TQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~ 158 (290)
.+.++.|||+|+.||++++ +|||||..+|||++....+||+|||+|+.......... ........|||||.+..+.
T Consensus 804 Ll~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i 880 (1025)
T KOG1095|consen 804 LLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI 880 (1025)
T ss_pred HHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcc
Confidence 9999999999999999999 99999999999999999999999999883221111111 1123457899999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
|+.|+|||||||++||+++....++......+....+.. -+.+..++..+.+||.+||+.+|++||++..|++.+..
T Consensus 881 FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 881 FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 999999999999999999766666656555554443333 34556678889999999999999999999999998877
Q ss_pred hHhhhCc
Q 044846 236 IRASIGA 242 (290)
Q Consensus 236 ~~~~~~~ 242 (290)
+......
T Consensus 961 i~~~~~~ 967 (1025)
T KOG1095|consen 961 ISNAALG 967 (1025)
T ss_pred hhhhhcc
Confidence 7665433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=301.81 Aligned_cols=223 Identities=17% Similarity=0.192 Sum_probs=183.8
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+.+|+.+++.++||||+++++++...+..|+||||+++|+|.+++.... .+++.
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~ 95 (323)
T cd05571 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSED 95 (323)
T ss_pred CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC----CCCHH
Confidence 678999998742 34456678899999999999999999999999999999999999999999997654 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..
T Consensus 96 ~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~ 171 (323)
T cd05571 96 RARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDND 171 (323)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceecCccccChhhhcCCC
Confidence 99999999999999999999 999999999999999999999999997643211 12223456899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~~ 231 (290)
++.++|||||||++|+|++|..||....... ...... ....+...+..+.+++.+||+.||++|| ++.++++
T Consensus 172 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCccccCcccchhhhhhhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 9999999999999999999999886433221 111111 1122234567799999999999999999 7999987
Q ss_pred HH
Q 044846 232 EL 233 (290)
Q Consensus 232 ~l 233 (290)
+-
T Consensus 251 h~ 252 (323)
T cd05571 251 HR 252 (323)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=316.60 Aligned_cols=237 Identities=20% Similarity=0.275 Sum_probs=193.4
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEE-e---C---CcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCL-E---T---EVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~-~---~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
..||+|++-..++...+.+.+|+.+|+.| .|+|||.|++... . . ...+|.||||+||.|-+++..+... .
T Consensus 63 ~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~ 140 (738)
T KOG1989|consen 63 KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT--R 140 (738)
T ss_pred ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhc--c
Confidence 67999999988999999999999999999 5999999999432 1 1 2467999999999999999876654 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee--------eccceecc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL--------TTQVKVTF 146 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--------~~~~~g~~ 146 (290)
|++..+++|+.|+++|+.+||...+ ||||||||.+|||++.+|+.||||||.+.......... ......|+
T Consensus 141 lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp 219 (738)
T KOG1989|consen 141 LTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTP 219 (738)
T ss_pred CChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCc
Confidence 9999999999999999999999874 59999999999999999999999999876443322110 01234688
Q ss_pred cccCccccc---cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 147 GYVDPKYFR---SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 147 ~y~aPE~~~---~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
.|+|||++. +...++|+|||+|||+||.|++...||..... ..++...+..+....++..+.+||..||+.||++|
T Consensus 220 ~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~R 298 (738)
T KOG1989|consen 220 QYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDER 298 (738)
T ss_pred cccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-eeEEeccccCCCCccHHHHHHHHHHHHhccCcccC
Confidence 999999875 56789999999999999999999988864422 22233333444446889999999999999999999
Q ss_pred CCHHHHHHHHHhhHhhhCcc
Q 044846 224 PTMKEVTLELAGIRASIGAS 243 (290)
Q Consensus 224 ps~~el~~~l~~~~~~~~~~ 243 (290)
|++.+++..+..+.......
T Consensus 299 PnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 299 PNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred CCHHHHHHHHHHHhcCCCCc
Confidence 99999999998887654433
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=304.89 Aligned_cols=224 Identities=21% Similarity=0.264 Sum_probs=183.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC-CC-----ceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN-HR-----NVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||+++.. .....+-..|+.+|..|+ |. |+|+++++|...+++|||+|.+ ..+|+++++.+... ++
T Consensus 211 ~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~--Gl 286 (586)
T KOG0667|consen 211 GEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFR--GL 286 (586)
T ss_pred CcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCC--CC
Confidence 789999999974 555667788999999996 43 9999999999999999999999 56999999998765 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC--cEEEeccccccccccCCceeeccceecccccCccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY--QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
+...++.++.||+.||.+||+.+ |||+||||+|||+...+ .+||+|||.+.... .... +...+..|.|||+
T Consensus 287 sl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~---q~vy-tYiQSRfYRAPEV 359 (586)
T KOG0667|consen 287 SLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFES---QRVY-TYIQSRFYRAPEV 359 (586)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccC---Ccce-eeeeccccccchh
Confidence 88999999999999999999999 99999999999997543 68999999876543 1222 5677889999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------------------------------------
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------------------------------------ 197 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------------------------------------ 197 (290)
+.+..|+.+.||||||||++||++|.|.|..+.+..........
T Consensus 360 ILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~ 439 (586)
T KOG0667|consen 360 ILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPR 439 (586)
T ss_pred hccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccc
Confidence 99999999999999999999999999888655332211100000
Q ss_pred -------------------hh---------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 198 -------------------KE---------AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 198 -------------------~~---------~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.+ ........|.+++.+||.+||.+|+|+.++++|.+--
T Consensus 440 ~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 440 GTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLT 506 (586)
T ss_pred cccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccc
Confidence 00 0012334689999999999999999999999997655
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=298.99 Aligned_cols=226 Identities=26% Similarity=0.312 Sum_probs=193.5
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc-ceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETEV-PLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.+|+|++.. .....++...+|+.+++++.|||||.+++.|..++. .+|||+||.||++.+.+..... ..++++
T Consensus 29 ~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~--~~f~E~ 106 (426)
T KOG0589|consen 29 DKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKG--VLFPEE 106 (426)
T ss_pred CceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhh--ccccHH
Confidence 35689999864 334455678899999999999999999999999888 9999999999999999988763 368999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..|+.|++.|+.|||+++ |.|||||+.||+++.++.+||.|||+|+...... ....+..||+.|++||.+.+..
T Consensus 107 ~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~p 182 (426)
T KOG0589|consen 107 RILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-SLASTVVGTPYYMCPEILSDIP 182 (426)
T ss_pred HHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch-hhhheecCCCcccCHHHhCCCC
Confidence 99999999999999999988 9999999999999999999999999998765433 3556789999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH--hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY--FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
|+.|+|||||||++|||++-++.|....-........ ...+.+..++.+++.+|..|+..+|..||++.+++.+.
T Consensus 183 Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 183 YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 9999999999999999999999886554332222221 12345567888999999999999999999999999773
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=281.97 Aligned_cols=229 Identities=19% Similarity=0.234 Sum_probs=190.6
Q ss_pred CceEEEEeec--ccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSK--SVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~--~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.+|+|.+. .....+.+.+.+|+.|.+.|+||||+++.+.+....+.|||+|+|.||+|..-+-..- .+++..
T Consensus 36 g~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~----~ySEa~ 111 (355)
T KOG0033|consen 36 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEAD 111 (355)
T ss_pred hHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHH----HHHHHH
Confidence 4556666653 3345578889999999999999999999999999999999999999999988776553 588899
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..+++||+++|.|+|.++ |||||+||+|+|+.. ..-+||+|||++.... ......+..||+.|||||++..
T Consensus 112 aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrk 186 (355)
T KOG0033|consen 112 ASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKK 186 (355)
T ss_pred HHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--CccccccccCCCcccCHHHhhc
Confidence 9999999999999999999 999999999999963 3458999999987654 4455667899999999999999
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH------hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY------FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
..|+.++|||+.|+|||-++.|++||..+... ..+... ...+.....+++.++|+++||..||.+|.|+.|.+
T Consensus 187 dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 187 DPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 99999999999999999999999999863221 111111 22445667788999999999999999999999999
Q ss_pred HHHHhhHhhh
Q 044846 231 LELAGIRASI 240 (290)
Q Consensus 231 ~~l~~~~~~~ 240 (290)
.|.+-...+.
T Consensus 266 ~HpWi~~r~~ 275 (355)
T KOG0033|consen 266 KHPWICNRER 275 (355)
T ss_pred CCchhcchHH
Confidence 8876555443
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=313.22 Aligned_cols=227 Identities=20% Similarity=0.200 Sum_probs=185.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|++...+......+.+|+.+++.++|||||+++++|...+..||||||+++|+|.+++........++++..+.
T Consensus 93 ~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~ 172 (478)
T PTZ00267 93 KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172 (478)
T ss_pred CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHH
Confidence 45688888766666666778899999999999999999999999999999999999999999987654444468899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccCccccccCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++
T Consensus 173 ~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 249 (478)
T PTZ00267 173 LLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249 (478)
T ss_pred HHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCC
Confidence 99999999999999999 99999999999999999999999999875432211 123445689999999999999999
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.++|||||||++|+|++|..|+...... ......... ..+...+..+.++|.+||+.||++|||+.+++.+
T Consensus 250 ~~~Dv~slG~~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 250 KKADMWSLGVILYELLTLHRPFKGPSQR-EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred cHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 9999999999999999999888543221 111111111 1223455679999999999999999999999754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=290.43 Aligned_cols=225 Identities=21% Similarity=0.248 Sum_probs=183.4
Q ss_pred CceEEEEeec--ccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe-----CCcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSK--SVHESNVEQFINEVVILSQINHRNVVKILGCCLE-----TEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~--~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+||+. ..+....++..+|+++|+.++|+||+.+++.+.. -+.+|+|+|+| +-+|...++.+. .
T Consensus 47 ~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~----~ 121 (359)
T KOG0660|consen 47 GEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ----D 121 (359)
T ss_pred CCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCc----c
Confidence 6789999997 4556678889999999999999999999999876 24679999999 669999998765 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC-CceeeccceecccccCccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID-RTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~ 153 (290)
++...+..++.|++.||+|+|+.+ |+||||||.|+|++.+..+||+|||+|+..... .....+..+.|.+|.|||+
T Consensus 122 L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPEl 198 (359)
T KOG0660|consen 122 LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPEL 198 (359)
T ss_pred ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHH
Confidence 899999999999999999999999 999999999999999999999999999876432 2223356788999999998
Q ss_pred ccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHH--------------------hh----------hhh
Q 044846 154 FRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAY--------------------FS----------KEA 200 (290)
Q Consensus 154 ~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~--------------------~~----------~~~ 200 (290)
+.. ..|+...||||.|||++||++|++.|.....-.+ .+... .. ...
T Consensus 199 ll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~ 278 (359)
T KOG0660|consen 199 LLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSI 278 (359)
T ss_pred HhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHH
Confidence 764 5799999999999999999999998875432111 11100 00 000
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.+...+...+|+.+||..||.+|+|++|+++|..
T Consensus 279 fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 279 FPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred cCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 1123456889999999999999999999998854
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=299.41 Aligned_cols=229 Identities=21% Similarity=0.240 Sum_probs=180.9
Q ss_pred CceEEEEeecccCc--------------hhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHE--------------SNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYI 65 (290)
Q Consensus 2 ~~~~avK~~~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l 65 (290)
|+.||+|++..... ...+.+.+|+.+|++|+|||||+++.+..+ .+.+|||+|||..|.+...-
T Consensus 122 ~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p 201 (576)
T KOG0585|consen 122 GKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP 201 (576)
T ss_pred CcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC
Confidence 67899999853111 124688999999999999999999999876 46899999999988875443
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC----ceeecc
Q 044846 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR----THLTTQ 141 (290)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~ 141 (290)
.. ...+++.+++++++++..||+|||.++ ||||||||+|+|++.+|++||+|||.+.....+. ......
T Consensus 202 ~d----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~ 274 (576)
T KOG0585|consen 202 PD----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSR 274 (576)
T ss_pred CC----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhh
Confidence 22 113889999999999999999999999 9999999999999999999999999876542221 112234
Q ss_pred ceecccccCccccccCC----CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH----hhhhhhHHHHHHHHHHHH
Q 044846 142 VKVTFGYVDPKYFRSSQ----FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY----FSKEAEKEEVITFAMVAK 213 (290)
Q Consensus 142 ~~g~~~y~aPE~~~~~~----~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~ 213 (290)
..||+.|+|||.+.++. .+.+.||||+||+||.|+.|.-||..+..... .... +..+........+++||.
T Consensus 275 tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l-~~KIvn~pL~fP~~pe~~e~~kDli~ 353 (576)
T KOG0585|consen 275 TVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL-FDKIVNDPLEFPENPEINEDLKDLIK 353 (576)
T ss_pred cCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH-HHHHhcCcccCCCcccccHHHHHHHH
Confidence 68999999999988733 35689999999999999999999986643321 1111 111222245677999999
Q ss_pred HhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 214 RCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 214 ~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++|..||++|.+..+|..|.+....
T Consensus 354 ~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 354 RLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhhcChhheeehhhheecceeccC
Confidence 9999999999999999999987765
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=303.82 Aligned_cols=222 Identities=23% Similarity=0.286 Sum_probs=189.0
Q ss_pred CceEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.||+|++.. ..+.+++...+|+.+|.+++++||.++|+.+..+..+|++||||.||++.+.++... .+++..+
T Consensus 38 ~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~----~~~E~~i 113 (467)
T KOG0201|consen 38 KKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN----ILDEFEI 113 (467)
T ss_pred cceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC----CCcccee
Confidence 67899999974 445668889999999999999999999999999999999999999999999998765 4577778
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++++++.||.|||..+ .+|||||+.|||+..+|.+||+|||.+.......... .++.||+.|||||++....|+
T Consensus 114 ~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~ 189 (467)
T KOG0201|consen 114 AVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQSGYD 189 (467)
T ss_pred eeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc-ccccccccccchhhhcccccc
Confidence 889999999999999999 9999999999999999999999999976554443333 779999999999999988999
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.++||||||++.+||++|.||+..-.. +..+..... ......++..|+++|..||+.||+.||||.+++++
T Consensus 190 ~KADIWSLGITaiEla~GePP~s~~hP-mrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 190 TKADIWSLGITAIELAKGEPPHSKLHP-MRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred chhhhhhhhHHHHHHhcCCCCCcccCc-ceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 999999999999999999998754332 222211111 12233667889999999999999999999999876
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=283.92 Aligned_cols=227 Identities=21% Similarity=0.218 Sum_probs=183.0
Q ss_pred CceEEEEeecccCchh--HHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVHESN--VEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~--~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
+++||+|+++...+.+ --.-++|+.+|.+++|||||.+..+.... +.+|+|||||+. +|..++..... +|..
T Consensus 101 ~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q---~F~~ 176 (419)
T KOG0663|consen 101 DEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQ---PFLP 176 (419)
T ss_pred ceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccC---CCch
Confidence 6899999998644322 33568999999999999999999888653 579999999965 99999987763 7999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
...+.++.|++.|++|||.+. |+|||||++|+|++..|.+||+|||+|+..... ....+..+.|.+|.|||.+.+.
T Consensus 177 ~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T~lVVTLWYRaPELLLG~ 252 (419)
T KOG0663|consen 177 GEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYTPLVVTLWYRAPELLLGA 252 (419)
T ss_pred HHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC-cccCcceEEEeeecCHHHhcCC
Confidence 999999999999999999999 999999999999999999999999999865433 3345667889999999999876
Q ss_pred -CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHhh---------------------hhhh----------HH
Q 044846 158 -QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYFS---------------------KEAE----------KE 203 (290)
Q Consensus 158 -~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~~---------------------~~~~----------~~ 203 (290)
.|++++||||+|||+.|++.++|.|....+..+.- ...+- ...+ ..
T Consensus 253 ~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~ 332 (419)
T KOG0663|consen 253 KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALS 332 (419)
T ss_pred cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccc
Confidence 59999999999999999999999887554332211 11110 0000 00
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 204 EVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 204 ~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.+..-++|+..+|.+||.+|.||.|.+++=+..
T Consensus 333 lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~ 365 (419)
T KOG0663|consen 333 LSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR 365 (419)
T ss_pred cchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence 235677999999999999999999999875543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=304.89 Aligned_cols=229 Identities=25% Similarity=0.361 Sum_probs=189.6
Q ss_pred EEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 5 WLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 5 ~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
||+|..+. .......+|++|+++|++++|||||+++|++.....++||||+|.||+|.++|+.... .++..++.
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~ 265 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKL 265 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHH
Confidence 89998874 4477788999999999999999999999999999999999999999999999998764 48899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.+.|.||+|||+++ +|||||..+|||++.++.+||+|||+++..... .........+..|+|||.+....|+.
T Consensus 266 ~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~ 341 (474)
T KOG0194|consen 266 RFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSF 341 (474)
T ss_pred HHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcce-eeccccccCcceecChhhhccCcccc
Confidence 99999999999999999 999999999999999999999999997654311 11111234578899999999999999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhh----HHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSL----AAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
++|||||||++||+.+ |..|+. ........ ....+...+...+.....++.+||..||++||||.++.+.++.+
T Consensus 342 kTDV~sfGV~~~Eif~~g~~Py~-g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 342 KTDVWSFGVLLWEIFENGAEPYP-GMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred ccchhheeeeEEeeeccCCCCCC-CCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 9999999999999987 455443 32222211 11222334445677788999999999999999999999999988
Q ss_pred HhhhC
Q 044846 237 RASIG 241 (290)
Q Consensus 237 ~~~~~ 241 (290)
.....
T Consensus 421 ~~~~~ 425 (474)
T KOG0194|consen 421 EKKKE 425 (474)
T ss_pred Hhccc
Confidence 76553
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=295.98 Aligned_cols=223 Identities=18% Similarity=0.193 Sum_probs=182.7
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+.+|+++++.++||||++++++|...+..|+||||+++|+|..++.... .+++.
T Consensus 20 ~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----~~~~~ 95 (323)
T cd05595 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEE 95 (323)
T ss_pred CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC----CCCHH
Confidence 678999998642 34456678899999999999999999999999999999999999999999887654 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..
T Consensus 96 ~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~ 171 (323)
T cd05595 96 RARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDND 171 (323)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCcCcCCcccccCCC
Confidence 99999999999999999999 9999999999999999999999999876432211 1223456899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~~ 231 (290)
++.++|||||||++|+|++|..|+........ ..... ....+...+..+.++|.+||+.||.+|| ++.++++
T Consensus 172 ~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 99999999999999999999988864332211 11111 1112234567789999999999999998 8899987
Q ss_pred HH
Q 044846 232 EL 233 (290)
Q Consensus 232 ~l 233 (290)
+-
T Consensus 251 h~ 252 (323)
T cd05595 251 HR 252 (323)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=286.93 Aligned_cols=228 Identities=18% Similarity=0.297 Sum_probs=182.1
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
+..||+|.++... ......+.+|+..+++++||||+++++++..++..++||||+++|+|.+++..... .+++..+
T Consensus 33 ~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~l~~~~~ 109 (266)
T cd05064 33 ELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQL 109 (266)
T ss_pred eeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCC---CCCHHHH
Confidence 4578999887543 34456799999999999999999999999999999999999999999999976432 5889999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
+.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+...............++..|+|||++.+..++
T Consensus 110 ~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (266)
T cd05064 110 MGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186 (266)
T ss_pred HHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCcc
Confidence 999999999999999999 99999999999999999999999998654322211111223345689999999999999
Q ss_pred CcccchhhHHHHHHHh-cCCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 161 EKSDVYSFSVVLVELN-WTKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.++|||||||++|+++ +|.+|+....... ..... .....+...+..+.+++.+||+.+|.+|||+.+|.+.|.++
T Consensus 187 ~~~Di~slG~~l~ell~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 187 SASDVWSFGIVMWEVMSYGERPYWDMSGQD-VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred chhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999976 5887775432221 11111 11122334567799999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=291.14 Aligned_cols=224 Identities=19% Similarity=0.212 Sum_probs=177.4
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++... ....+.+.+|+++++.++||||+++++++...+..++||||++++.+..+... .. .+++..
T Consensus 26 ~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~---~~~~~~ 101 (287)
T cd07848 26 KEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PN---GVPPEK 101 (287)
T ss_pred CcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc-CC---CCCHHH
Confidence 5679999986432 33456788999999999999999999999999999999999988666544432 22 588899
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...............|+..|+|||++.+..+
T Consensus 102 ~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 178 (287)
T cd07848 102 VRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178 (287)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCC
Confidence 9999999999999999999 9999999999999999999999999987543322222334568899999999998889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhH--HHh------------hh-------------------hhhHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA--AYF------------SK-------------------EAEKEEVI 206 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~--~~~------------~~-------------------~~~~~~~~ 206 (290)
+.++|+|||||++|+|++|.+||........... ... .. ......+.
T Consensus 179 ~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 258 (287)
T cd07848 179 GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSG 258 (287)
T ss_pred CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCH
Confidence 9999999999999999999988864322111100 000 00 00011345
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.+.+|+.+||+.||++|||++|+++|
T Consensus 259 ~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 259 VLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcC
Confidence 68999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=297.61 Aligned_cols=223 Identities=17% Similarity=0.200 Sum_probs=183.3
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+.+|+++++.++||||+++++++...+..++||||+++|+|..++.... .+++.
T Consensus 20 ~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----~l~~~ 95 (328)
T cd05593 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER----VFSED 95 (328)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC----CCCHH
Confidence 678999998642 34456788999999999999999999999999999999999999999999987654 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........|++.|+|||++.+..
T Consensus 96 ~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~ 171 (328)
T cd05593 96 RTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCGTPEYLAPEVLEDND 171 (328)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccCCcCccChhhhcCCC
Confidence 99999999999999999999 999999999999999999999999997643221 12223456899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~~ 231 (290)
++.++|||||||++|+|++|..||........ ..... ....+...+.++.+++.+||+.||++|+ ++.++++
T Consensus 172 ~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCccCCccccchHHHHHhhCCCCCCCCCHHHH-HHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 99999999999999999999998864322211 11111 1112233456789999999999999997 8999987
Q ss_pred HH
Q 044846 232 EL 233 (290)
Q Consensus 232 ~l 233 (290)
+.
T Consensus 251 h~ 252 (328)
T cd05593 251 HS 252 (328)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=295.47 Aligned_cols=224 Identities=20% Similarity=0.203 Sum_probs=183.3
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++. ........+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... .+++.
T Consensus 18 ~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~ 93 (312)
T cd05585 18 QRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG----RFDLS 93 (312)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC----CCCHH
Confidence 57799999864 234556778899999999999999999999999999999999999999999997654 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..... ........||+.|+|||++.+..
T Consensus 94 ~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~ 169 (312)
T cd05585 94 RARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLGHG 169 (312)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccccCCcccCCHHHHcCCC
Confidence 99999999999999999999 999999999999999999999999997643221 22234466899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQPT---MKEVTLEL 233 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps---~~el~~~l 233 (290)
++.++|||||||++|+|++|.+||...... ......... ..+...+..+.+++.+||+.||.+||+ +.|++.+.
T Consensus 170 ~~~~~DvwslGvil~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 170 YTKAVDWWTLGVLLYEMLTGLPPFYDENVN-EMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred CCCccceechhHHHHHHHhCCCCcCCCCHH-HHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 999999999999999999999988644322 111111111 122345567899999999999999975 67777764
Q ss_pred H
Q 044846 234 A 234 (290)
Q Consensus 234 ~ 234 (290)
+
T Consensus 249 ~ 249 (312)
T cd05585 249 F 249 (312)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=297.70 Aligned_cols=221 Identities=20% Similarity=0.212 Sum_probs=181.7
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++.... .+++.
T Consensus 43 ~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~ 118 (329)
T PTZ00263 43 GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG----RFPND 118 (329)
T ss_pred CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC----CCCHH
Confidence 578999998642 23446678999999999999999999999999999999999999999999998654 57888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... .....|++.|+|||++.+..
T Consensus 119 ~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~ 191 (329)
T PTZ00263 119 VAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQSKG 191 (329)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC----cceecCChhhcCHHHHcCCC
Confidence 99999999999999999999 999999999999999999999999997654321 12356889999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQPT-----MKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~el~~ 231 (290)
++.++|||||||++|+|++|..||....... ........ ..+...+..+.+||.+||+.||.+||+ +.+++.
T Consensus 192 ~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCcceeechHHHHHHHHcCCCCCCCCCHHH-HHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9999999999999999999999886443221 11111111 112224567889999999999999997 688887
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
|.+
T Consensus 271 hp~ 273 (329)
T PTZ00263 271 HPY 273 (329)
T ss_pred CCc
Confidence 754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.58 Aligned_cols=229 Identities=21% Similarity=0.343 Sum_probs=193.6
Q ss_pred eEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHH
Q 044846 4 LWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI 83 (290)
Q Consensus 4 ~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 83 (290)
.||||.++. +.-.+++|++|+.+|+.|.|||+|+++|+|.....+|||+|||..|+|.++|++.... .++.-..+.+
T Consensus 294 TvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyM 370 (1157)
T KOG4278|consen 294 TVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYM 370 (1157)
T ss_pred eeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchh--hcchhHHHHH
Confidence 478888885 5667899999999999999999999999999999999999999999999999987643 4666778889
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCcc
Q 044846 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKS 163 (290)
Q Consensus 84 ~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 163 (290)
+.||..||+||..++ +|||||..+|||+..+..+|++|||+++.+..+....+....-.+.|.|||.+..+.++.|+
T Consensus 371 AtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKS 447 (1157)
T KOG4278|consen 371 ATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKS 447 (1157)
T ss_pred HHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccch
Confidence 999999999999999 99999999999999999999999999987765554444445557789999999999999999
Q ss_pred cchhhHHHHHHHhcCCCCcccchhhhh---hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 164 DVYSFSVVLVELNWTKPIHLVDVEENR---SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 164 DiwS~G~il~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
|||+||++|||+.|-.-.++...+.-. .+..-++...+..|++.+.+||..||++.|.+||+++|+-+.++.+-.
T Consensus 448 DVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 448 DVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred hhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 999999999999864433333333222 223334455666788999999999999999999999999999988764
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=307.10 Aligned_cols=223 Identities=22% Similarity=0.300 Sum_probs=190.8
Q ss_pred eEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC--CHHHHH
Q 044846 4 LWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI--TWEMRL 81 (290)
Q Consensus 4 ~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~--~~~~~~ 81 (290)
..|+|.+...+..+.+-+..|+.+-++|+|.|||+|+|++..++++-|.||-++||+|.++++..-+ ++ .+.++.
T Consensus 602 rIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWG---PlKDNEstm~ 678 (1226)
T KOG4279|consen 602 RIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWG---PLKDNESTMN 678 (1226)
T ss_pred EEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccC---CCccchhHHH
Confidence 3688888887888888899999999999999999999999999999999999999999999987543 56 678888
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec-cCCcEEEeccccccccccCCceeeccceecccccCccccccC--C
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS--Q 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~ 158 (290)
.+..||++||.|||++. |+|||||-+|+|+. -.|.+||+|||.++-. .+-+.++.++.||..|||||++..+ +
T Consensus 679 fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRL-AginP~TETFTGTLQYMAPEvIDqG~RG 754 (1226)
T KOG4279|consen 679 FYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDQGPRG 754 (1226)
T ss_pred HHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhh-ccCCccccccccchhhhChHhhccCCcC
Confidence 99999999999999999 99999999999997 6789999999988643 3445677889999999999999865 4
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHH----HhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA----YFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
|+.++|||||||++.||.||+|||..-...+..... ....+-+...+.+.+++|.+|+.+||.+||++.+++...
T Consensus 755 YG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 755 YGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred CCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 899999999999999999999998654333322221 122445567788899999999999999999999998663
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=289.25 Aligned_cols=226 Identities=19% Similarity=0.163 Sum_probs=182.2
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.... ......+.+|+.+++.++|+||+++++++...+..++||||+++|+|..++...... .+++.
T Consensus 25 ~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~--~~~~~ 102 (285)
T cd05631 25 GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFDEQ 102 (285)
T ss_pred CceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCC--CCCHH
Confidence 6789999886422 233456789999999999999999999999999999999999999999888654322 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...... .......|+..|+|||++.+..
T Consensus 103 ~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~ 177 (285)
T cd05631 103 RAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVRGRVGTVGYMAPEVINNEK 177 (285)
T ss_pred HHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--CeecCCCCCCCccCHhhhcCCC
Confidence 99999999999999999999 999999999999999999999999997653221 1223456899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhh--hhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEEN--RSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPT-----MKE 228 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~e 228 (290)
++.++|||||||++|+|++|..||....... ........ .......+..+.+|+.+||+.||.+||+ +++
T Consensus 178 ~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~ 257 (285)
T cd05631 178 YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAG 257 (285)
T ss_pred CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHH
Confidence 9999999999999999999999886533211 11111111 1122345667999999999999999997 788
Q ss_pred HHHHHH
Q 044846 229 VTLELA 234 (290)
Q Consensus 229 l~~~l~ 234 (290)
++++.+
T Consensus 258 ~~~h~~ 263 (285)
T cd05631 258 VKQHPI 263 (285)
T ss_pred HhcCHh
Confidence 887653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=300.10 Aligned_cols=230 Identities=23% Similarity=0.365 Sum_probs=182.5
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC----------
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD---------- 70 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------- 70 (290)
+.||+|+++.. .....+.+.+|+++++.+ +||||++++++|...+..++|||||++|+|.+++.....
T Consensus 69 ~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~ 148 (374)
T cd05106 69 LRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALP 148 (374)
T ss_pred ceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhcccccccc
Confidence 46999999753 344466789999999999 899999999999999999999999999999999865321
Q ss_pred --------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 044846 71 --------------------------------------------------------DQLPITWEMRLRITVEVSRVLSYL 94 (290)
Q Consensus 71 --------------------------------------------------------~~~~~~~~~~~~~~~~i~~~l~yl 94 (290)
...++++..++.++.||+.||.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL 228 (374)
T cd05106 149 EISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL 228 (374)
T ss_pred ccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHH
Confidence 112478888999999999999999
Q ss_pred hhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccccccCCCCCcccchhhHHHHH
Q 044846 95 HSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLV 173 (290)
Q Consensus 95 H~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~ 173 (290)
|+++ |+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|
T Consensus 229 H~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ 305 (374)
T cd05106 229 ASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 305 (374)
T ss_pred HHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHH
Confidence 9999 999999999999999999999999998654322211 112233456799999999889999999999999999
Q ss_pred HHhc-CCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 174 ELNW-TKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 174 ~l~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
+|++ |..||........ ...... ...+...+.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus 306 ellt~G~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 306 EIFSLGKSPYPGILVNSK-FYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHhCCCCCCccccccHH-HHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9996 8887754332211 111111 111122357899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=281.77 Aligned_cols=227 Identities=21% Similarity=0.276 Sum_probs=184.3
Q ss_pred CceEEEEeecccCch--hHHHHHHHHHHHHhcCCCc-eeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCC
Q 044846 2 EELWLLKKSKSVHES--NVEQFINEVVILSQINHRN-VVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQ 72 (290)
Q Consensus 2 ~~~~avK~~~~~~~~--~~~~~~~E~~~l~~l~Hpn-iv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~ 72 (290)
|+.||+|+++....+ --....+|+.+|+.|+|+| ||.+++++.+.+ .+++|+||+ .-+|.+++.......
T Consensus 36 g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~ 114 (323)
T KOG0594|consen 36 GKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKP 114 (323)
T ss_pred CCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccc
Confidence 688999999865442 3345789999999999999 999999999877 789999999 559999998876422
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcc
Q 044846 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPK 152 (290)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 152 (290)
..++...++.+++||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+...... ...+...+|.+|.|||
T Consensus 115 ~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~-~~yt~evvTlWYRaPE 190 (323)
T KOG0594|consen 115 QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM-RTYTPEVVTLWYRAPE 190 (323)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCc-ccccccEEEeeccCHH
Confidence 35777889999999999999999999 9999999999999999999999999998654332 2356678899999999
Q ss_pred ccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----------------------h---h-----h
Q 044846 153 YFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----------------------K---E-----A 200 (290)
Q Consensus 153 ~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----------------------~---~-----~ 200 (290)
++.+. .|+..+||||+|||++||+++.+.|....+.......... . . .
T Consensus 191 vLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~ 270 (323)
T KOG0594|consen 191 VLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSI 270 (323)
T ss_pred HhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHh
Confidence 99987 6999999999999999999999988766543222111110 0 0 0
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.+....+..+++.+||+.+|.+|.|+..++.|-
T Consensus 271 ~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 271 LPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred ccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 011124688999999999999999999999873
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=287.07 Aligned_cols=226 Identities=19% Similarity=0.226 Sum_probs=185.7
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
+..+|+|++... ..+...+...|.+||+.++||.++++|..|+.+.+.|++||||+||+|..+++..... .++++
T Consensus 102 ~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~--~fse~ 179 (459)
T KOG0610|consen 102 NCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGK--RFSES 179 (459)
T ss_pred CceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCC--ccchh
Confidence 467899999643 3444556778999999999999999999999999999999999999999999887655 69999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccccccccc-------------------------
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI------------------------- 133 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~------------------------- 133 (290)
.++.++.+|+.||+|||-.| ||+|||||+||||..+|++.|+||.++.....
T Consensus 180 ~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s 256 (459)
T KOG0610|consen 180 AARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPS 256 (459)
T ss_pred hHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCccccccccc
Confidence 99999999999999999999 99999999999999999999999976532100
Q ss_pred ---------CC---------------------ceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcc
Q 044846 134 ---------DR---------------------THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHL 183 (290)
Q Consensus 134 ---------~~---------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~ 183 (290)
.. ......++||--|+|||++.+...+.++|.|+||+++|||+.|..||-
T Consensus 257 ~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFK 336 (459)
T KOG0610|consen 257 CFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFK 336 (459)
T ss_pred ccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcC
Confidence 00 011234678889999999999999999999999999999999999997
Q ss_pred cchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCC----HHHHHHHH
Q 044846 184 VDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPT----MKEVTLEL 233 (290)
Q Consensus 184 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps----~~el~~~l 233 (290)
....... +...+.. +.....+..++|||++.|..||.+|.. |+||-+|-
T Consensus 337 G~~~~~T-l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 337 GSNNKET-LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP 393 (459)
T ss_pred CCCchhh-HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence 5543322 2222221 222355678999999999999999998 88998773
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=294.13 Aligned_cols=224 Identities=18% Similarity=0.212 Sum_probs=181.9
Q ss_pred CceEEEEeeccc----CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV----HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|.++.. .......+..|+.+++.++||||++++++|..++..|+||||+++|+|.+++.... .+.+
T Consensus 24 ~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~ 99 (323)
T cd05584 24 GKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IFME 99 (323)
T ss_pred CCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC----CCCH
Confidence 577999998642 22344567889999999999999999999999999999999999999999997654 5788
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+.
T Consensus 100 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 175 (323)
T cd05584 100 DTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMRS 175 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-CcccccCCCccccChhhccCC
Confidence 888899999999999999999 9999999999999999999999999976432211 222345689999999999988
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVT 230 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~ 230 (290)
.++.++|||||||++|+|++|.+||....... ........ ..+...+..+.++|.+||+.||++|| ++.+++
T Consensus 176 ~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~ 254 (323)
T cd05584 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-TIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ 254 (323)
T ss_pred CCCCcceecccHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh
Confidence 89999999999999999999999886543221 11111111 11223456789999999999999999 889888
Q ss_pred HHHH
Q 044846 231 LELA 234 (290)
Q Consensus 231 ~~l~ 234 (290)
.+.+
T Consensus 255 ~h~~ 258 (323)
T cd05584 255 SHPF 258 (323)
T ss_pred cCCC
Confidence 7643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=299.92 Aligned_cols=226 Identities=17% Similarity=0.214 Sum_probs=180.3
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+++++.++||||+++++++.+.+.+++||||+++|+|.+++.... .+++.
T Consensus 26 ~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~e~ 101 (381)
T cd05626 26 HALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME----VFPEV 101 (381)
T ss_pred CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC----CCCHH
Confidence 578999998642 34456678999999999999999999999999999999999999999999998654 58888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-----------------------
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR----------------------- 135 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----------------------- 135 (290)
.+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++......
T Consensus 102 ~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (381)
T cd05626 102 LARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178 (381)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccc
Confidence 99999999999999999999 9999999999999999999999999875321000
Q ss_pred -----------------------ceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh
Q 044846 136 -----------------------THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL 192 (290)
Q Consensus 136 -----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~ 192 (290)
........||+.|+|||++.+..++.++|||||||++|||++|.+||..........
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~ 258 (381)
T cd05626 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQL 258 (381)
T ss_pred cccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHH
Confidence 001123568999999999998899999999999999999999999986544322211
Q ss_pred HHH-----hhhhhhHHHHHHHHHHHHHh--hccCCCCCCCHHHHHHHHH
Q 044846 193 AAY-----FSKEAEKEEVITFAMVAKRC--LNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 193 ~~~-----~~~~~~~~~~~~~~~li~~c--l~~dp~~Rps~~el~~~l~ 234 (290)
... ...+.....+.++.+||.+| +..++..||++.+++.|-.
T Consensus 259 ~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 259 KVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred HHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 111 11111223467889999984 4556666999999998854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=282.69 Aligned_cols=228 Identities=21% Similarity=0.312 Sum_probs=183.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|+.+.. ......+.+|+++++.++||||+++++++...+.++++|||+++++|.+++...... .+++..++
T Consensus 31 ~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~l~~~~~~ 107 (263)
T cd05052 31 SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVNAVVLL 107 (263)
T ss_pred CceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCC--CCCHHHHH
Confidence 567899988753 344677999999999999999999999999999999999999999999999764432 57889999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++...............++..|+|||.+.+..++.
T Consensus 108 ~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 184 (263)
T cd05052 108 YMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184 (263)
T ss_pred HHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCc
Confidence 99999999999999999 999999999999999999999999997654332222222233456799999999889999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
++|||||||++|+|++ |.+|+..... ........ ....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 185 ~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 185 KSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 9999999999999997 7776643221 11111111 1122233457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=293.61 Aligned_cols=227 Identities=21% Similarity=0.258 Sum_probs=182.5
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|..||+|.++.. .....+.+.+|++++++++||||+++++++...+..++||||+++|+|.+++.... .+++..+
T Consensus 30 ~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~ 105 (331)
T cd06649 30 GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK----RIPEEIL 105 (331)
T ss_pred CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC----CCCHHHH
Confidence 567889988753 33446679999999999999999999999999999999999999999999998654 5888999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.|++.||.|||+.+. |+||||||+|||++.++.+||+|||++..... .......|+..|+|||++.+..++
T Consensus 106 ~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~ 180 (331)
T cd06649 106 GKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHYS 180 (331)
T ss_pred HHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCcccccccc---cccccCCCCcCcCCHhHhcCCCCC
Confidence 9999999999999998532 99999999999999999999999999764321 122345688999999999998999
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhh-hh-H------------------------------------------HHh
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENR-SL-A------------------------------------------AYF 196 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~-~~-~------------------------------------------~~~ 196 (290)
.++|||||||++|+|++|..|+........ .. . ...
T Consensus 181 ~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T cd06649 181 VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYI 260 (331)
T ss_pred chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHH
Confidence 999999999999999999988753221100 00 0 000
Q ss_pred hh-----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 197 SK-----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 197 ~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
.. ......+.++.+||.+||+.||++|||+.|++++.+-..
T Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 261 VNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred HhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 00 001124567899999999999999999999999876543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=288.46 Aligned_cols=228 Identities=19% Similarity=0.341 Sum_probs=176.7
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC------------
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD------------ 70 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------ 70 (290)
.||+|.++.. .......|.+|++++.+++||||+++++++...+..++||||+++|+|.+++.....
T Consensus 48 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (304)
T cd05096 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127 (304)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccc
Confidence 6899998754 344566799999999999999999999999999999999999999999999865321
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecc
Q 044846 71 ---DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTF 146 (290)
Q Consensus 71 ---~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~ 146 (290)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......++.
T Consensus 128 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~ 204 (304)
T cd05096 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPI 204 (304)
T ss_pred cccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCc
Confidence 1124677889999999999999999999 99999999999999999999999999865432211 1122344577
Q ss_pred cccCccccccCCCCCcccchhhHHHHHHHhcC--CCCcccchhhh--hhhHHHhh-------hhhhHHHHHHHHHHHHHh
Q 044846 147 GYVDPKYFRSSQFTEKSDVYSFSVVLVELNWT--KPIHLVDVEEN--RSLAAYFS-------KEAEKEEVITFAMVAKRC 215 (290)
Q Consensus 147 ~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~--~~~~~~~~~~~--~~~~~~~~-------~~~~~~~~~~~~~li~~c 215 (290)
.|+|||++.+..++.++||||||+++|+|+++ ..|+....... ........ ...+..++..+.+|+.+|
T Consensus 205 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 284 (304)
T cd05096 205 RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQC 284 (304)
T ss_pred cccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHH
Confidence 89999999888899999999999999999864 33333211111 11111100 011123456789999999
Q ss_pred hccCCCCCCCHHHHHHHHH
Q 044846 216 LNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 216 l~~dp~~Rps~~el~~~l~ 234 (290)
|+.||++|||+.+|.+.|+
T Consensus 285 l~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 285 WSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred ccCCchhCcCHHHHHHHHh
Confidence 9999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=297.89 Aligned_cols=229 Identities=23% Similarity=0.333 Sum_probs=180.4
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC----------
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD---------- 70 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------- 70 (290)
..||||+++.. .....+.+.+|++++..+ +||||++++++|...+..++|||||++|+|.+++.....
T Consensus 66 ~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~ 145 (375)
T cd05104 66 MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDH 145 (375)
T ss_pred eeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccch
Confidence 46899998743 344567789999999999 899999999999999999999999999999999975321
Q ss_pred -------------------------------------------------------------CCCCCCHHHHHHHHHHHHH
Q 044846 71 -------------------------------------------------------------DQLPITWEMRLRITVEVSR 89 (290)
Q Consensus 71 -------------------------------------------------------------~~~~~~~~~~~~~~~~i~~ 89 (290)
....+++..++.++.||+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 225 (375)
T cd05104 146 AEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAK 225 (375)
T ss_pred hhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHH
Confidence 1124788889999999999
Q ss_pred HHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccccccCCCCCcccchhh
Q 044846 90 VLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSF 168 (290)
Q Consensus 90 ~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~ 168 (290)
||.|||+++ |+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||
T Consensus 226 ~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~sl 302 (375)
T cd05104 226 GMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 302 (375)
T ss_pred HHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHH
Confidence 999999999 999999999999999999999999998654322211 1122334567999999999999999999999
Q ss_pred HHHHHHHhc-CCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 169 SVVLVELNW-TKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 169 G~il~~l~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
||++|+|++ |..|+........ ...... ...+...+.++.+|+.+||+.||++|||+.|+++.|+.
T Consensus 303 G~~l~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 303 GILLWEIFSLGSSPYPGMPVDSK-FYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHHHhcCCCCCCCCCchHH-HHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 999999987 6666543221111 111111 11122335679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=293.37 Aligned_cols=222 Identities=19% Similarity=0.238 Sum_probs=182.6
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++|+|.+++.... .+++.
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~ 101 (291)
T cd05612 26 EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG----RFSNS 101 (291)
T ss_pred CCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC----CCCHH
Confidence 6789999986422 2345678899999999999999999999999999999999999999999998654 58889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....|++.|+|||++.+..
T Consensus 102 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~ 174 (291)
T cd05612 102 TGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKG 174 (291)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----cccccCChhhcCHHHHcCCC
Confidence 99999999999999999999 999999999999999999999999997654321 12356889999999999988
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPT-----MKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~el~~ 231 (290)
++.++|||||||++|+|++|..|+....... ....... ...+...+..+.+||.+||+.||.+||+ +.+++.
T Consensus 175 ~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFG-IYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 9999999999999999999999886543221 1111111 1122234567899999999999999995 889887
Q ss_pred HHHh
Q 044846 232 ELAG 235 (290)
Q Consensus 232 ~l~~ 235 (290)
+.+.
T Consensus 254 h~~~ 257 (291)
T cd05612 254 HRWF 257 (291)
T ss_pred Cccc
Confidence 7654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.09 Aligned_cols=226 Identities=17% Similarity=0.173 Sum_probs=180.5
Q ss_pred CceEEEEeeccc----CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSV----HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~----~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||+|+++.. .....+.+..|+++++.+ +||||+++++++...+..++||||+++|+|.+++.... .++
T Consensus 28 ~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~ 103 (332)
T cd05614 28 GKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD----NFS 103 (332)
T ss_pred CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC----CCC
Confidence 577999988632 233456788999999999 69999999999999999999999999999999997654 588
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............||..|+|||++.+
T Consensus 104 ~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 180 (332)
T cd05614 104 EDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180 (332)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcC
Confidence 9999999999999999999999 9999999999999999999999999986543322223334678999999999986
Q ss_pred C-CCCCcccchhhHHHHHHHhcCCCCcccchh--hhhhhHH-Hh--hhhhhHHHHHHHHHHHHHhhccCCCCCC-----C
Q 044846 157 S-QFTEKSDVYSFSVVLVELNWTKPIHLVDVE--ENRSLAA-YF--SKEAEKEEVITFAMVAKRCLNLNGKKQP-----T 225 (290)
Q Consensus 157 ~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~--~~~~~~~-~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s 225 (290)
. .++.++|||||||++|+|++|..||..... ....... .. ....+...+..+.+++.+||+.||++|| +
T Consensus 181 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 260 (332)
T cd05614 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQG 260 (332)
T ss_pred CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCC
Confidence 5 478899999999999999999998853221 1111111 11 1112223456789999999999999999 7
Q ss_pred HHHHHHHHH
Q 044846 226 MKEVTLELA 234 (290)
Q Consensus 226 ~~el~~~l~ 234 (290)
+.+++++.+
T Consensus 261 ~~~~l~h~~ 269 (332)
T cd05614 261 ASEIKEHPF 269 (332)
T ss_pred HHHHHcCCC
Confidence 778887743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=287.27 Aligned_cols=226 Identities=19% Similarity=0.257 Sum_probs=191.6
Q ss_pred CceEEEEeec---ccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSK---SVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~---~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|++||+|.++ ..++++.-.+++|++||..|+||||+.++.+|++.+.+.|||||..+|+|++++.+.+ .+++.
T Consensus 78 gR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~----~LsEr 153 (668)
T KOG0611|consen 78 GREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG----SLSER 153 (668)
T ss_pred CcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc----cccHH
Confidence 7899999885 4556677789999999999999999999999999999999999999999999999877 69999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.+++||..|+.|||.++ ++|||||.+|||+|.++++||+|||++.... .....+++.|++-|.+||++.+..
T Consensus 154 EaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~--~~kfLqTFCGSPLYASPEIvNG~P 228 (668)
T KOG0611|consen 154 EARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA--DKKFLQTFCGSPLYASPEIVNGTP 228 (668)
T ss_pred HHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc--cccHHHHhcCCcccCCccccCCCC
Confidence 99999999999999999999 9999999999999999999999999975432 335567899999999999999998
Q ss_pred CC-CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhh-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 159 FT-EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEA-EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 159 ~~-~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
|. +.+|.||+|++||-|+.|.-||... +-...+...-.+.+ .+..+.+...||+-||..+|++|.|..+|..|.|--
T Consensus 229 Y~GPEVDsWsLGvLLYtLVyGtMPFDG~-Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 229 YKGPEVDSWSLGVLLYTLVYGTMPFDGR-DHKRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred CCCCccchhhHHHHHHHHhhcccccCCc-hHHHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 86 4699999999999999999877432 22222333323222 233455677899999999999999999999887644
Q ss_pred H
Q 044846 237 R 237 (290)
Q Consensus 237 ~ 237 (290)
.
T Consensus 308 w 308 (668)
T KOG0611|consen 308 W 308 (668)
T ss_pred c
Confidence 3
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=284.92 Aligned_cols=233 Identities=20% Similarity=0.304 Sum_probs=187.1
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC---------CCC
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD---------DQL 73 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~ 73 (290)
..+|+|.++.......+.+.+|++++++++||||+++++++...+..++||||+++++|.+++..... ...
T Consensus 36 ~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~ 115 (288)
T cd05093 36 ILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPA 115 (288)
T ss_pred eEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCC
Confidence 35888888776666777899999999999999999999999999999999999999999999975431 122
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCcc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPK 152 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE 152 (290)
.+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||+++........ ......++..|+|||
T Consensus 116 ~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 192 (288)
T cd05093 116 ELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192 (288)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHH
Confidence 4889999999999999999999999 999999999999999999999999997644322111 112334567899999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
++.+..++.++|+|||||++|+|++ |.+|+...... ......... ......+..+.+|+.+||+.||.+|||+.+
T Consensus 193 ~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 271 (288)
T cd05093 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKE 271 (288)
T ss_pred HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9998889999999999999999998 77766433221 111111111 112234567999999999999999999999
Q ss_pred HHHHHHhhHhh
Q 044846 229 VTLELAGIRAS 239 (290)
Q Consensus 229 l~~~l~~~~~~ 239 (290)
+...|+.+...
T Consensus 272 v~~~l~~~~~~ 282 (288)
T cd05093 272 IHSLLQNLAKA 282 (288)
T ss_pred HHHHHHHHHHh
Confidence 99999888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=296.20 Aligned_cols=220 Identities=18% Similarity=0.206 Sum_probs=181.9
Q ss_pred ceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 3 ELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 3 ~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
..||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... .+++..
T Consensus 57 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~----~~~~~~ 132 (340)
T PTZ00426 57 PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK----RFPNDV 132 (340)
T ss_pred eEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHH
Confidence 47899988532 34456678899999999999999999999999999999999999999999998654 588999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ......||+.|+|||++.+..+
T Consensus 133 ~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~ 205 (340)
T PTZ00426 133 GCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT----RTYTLCGTPEYIAPEILLNVGH 205 (340)
T ss_pred HHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC----CcceecCChhhcCHHHHhCCCC
Confidence 9999999999999999999 99999999999999999999999999865432 1234568999999999998889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVTLE 232 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~~~ 232 (290)
+.++|||||||++|+|++|.+||...... ......... ..+...+..+.++|.+||+.||.+|+ ++.+++++
T Consensus 206 ~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 206 GKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999999999999999999988654322 111111111 12233456788999999999999995 89999887
Q ss_pred HH
Q 044846 233 LA 234 (290)
Q Consensus 233 l~ 234 (290)
.+
T Consensus 285 p~ 286 (340)
T PTZ00426 285 PW 286 (340)
T ss_pred CC
Confidence 54
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=298.50 Aligned_cols=219 Identities=25% Similarity=0.295 Sum_probs=184.1
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
+++||+||+.-.. ....+.+++|+..|++|+|||+|.|.|+|......||||||| -|+-.+++..... ++-+.
T Consensus 51 ~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkK---plqEv 126 (948)
T KOG0577|consen 51 SEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKK---PLQEV 126 (948)
T ss_pred cceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhc---cchHH
Confidence 5789999997433 334667899999999999999999999999999999999999 5688888876654 57777
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR--- 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--- 155 (290)
.+..|..+.+.||+|||+.+ .||||||..|||+++.|.+||+|||.+... ...++++||+.|||||++.
T Consensus 127 EIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~-----~PAnsFvGTPywMAPEVILAMD 198 (948)
T KOG0577|consen 127 EIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM-----APANSFVGTPYWMAPEVILAMD 198 (948)
T ss_pred HHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc-----CchhcccCCccccchhHheecc
Confidence 88899999999999999999 999999999999999999999999987543 2345689999999999986
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
.+.|+-++||||+|++..|+...+||.+..+..-. +...... .....++..|.+++..||+.-|.+|||.++++.
T Consensus 199 EGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 199 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ccccCCccceeeccchhhhhhhcCCCccCchHHHH-HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 46799999999999999999999998875544333 2222222 234578889999999999999999999999977
Q ss_pred HH
Q 044846 232 EL 233 (290)
Q Consensus 232 ~l 233 (290)
|-
T Consensus 278 H~ 279 (948)
T KOG0577|consen 278 HR 279 (948)
T ss_pred cc
Confidence 64
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=292.44 Aligned_cols=222 Identities=21% Similarity=0.226 Sum_probs=177.5
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHH---hcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILS---QINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~---~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|+++.. .....+.+.+|++++. .++||||+++++++...+..|+||||+++|+|...+... .+
T Consensus 24 ~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-----~l 98 (324)
T cd05589 24 GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-----VF 98 (324)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC-----CC
Confidence 678999998642 2344567778877664 567999999999999999999999999999999888643 48
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..... ........|++.|+|||++.
T Consensus 99 ~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g~~~y~aPE~~~ 174 (324)
T cd05589 99 SEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRTSTFCGTPEFLAPEVLT 174 (324)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CCcccccccCccccCHhHhc
Confidence 99999999999999999999999 999999999999999999999999987643221 12233466899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKE 228 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~e 228 (290)
+..++.++|||||||++|+|++|..||........ ...... ...+...+..+.++|.+||+.||.+|| ++.+
T Consensus 175 ~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 253 (324)
T cd05589 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-FDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAED 253 (324)
T ss_pred CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 99999999999999999999999998864432211 111111 112233466789999999999999999 5777
Q ss_pred HHHHH
Q 044846 229 VTLEL 233 (290)
Q Consensus 229 l~~~l 233 (290)
++++.
T Consensus 254 l~~~~ 258 (324)
T cd05589 254 VKKQP 258 (324)
T ss_pred HhhCC
Confidence 77654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=293.66 Aligned_cols=222 Identities=18% Similarity=0.227 Sum_probs=183.4
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+.+|++++..++||||+++++++...+..|+||||+++|+|.+++.... .+++.
T Consensus 26 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~ 101 (333)
T cd05600 26 GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG----VLSED 101 (333)
T ss_pred CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC----CCCHH
Confidence 678999998642 23456678899999999999999999999999999999999999999999997654 58889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..... ......|++.|+|||++.+..
T Consensus 102 ~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~ 174 (333)
T cd05600 102 HARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKG 174 (333)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccCCcccCccccChhHhcCCC
Confidence 99999999999999999999 99999999999999999999999999764332 233456899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHH---hhhhh----hHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAY---FSKEA----EKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~---~~~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
++.++|||||||++|+|++|.+||........ .+... ...+. ....+.++.+++.+||..+|.+||++.++
T Consensus 175 ~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~l 254 (333)
T cd05600 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDI 254 (333)
T ss_pred CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHH
Confidence 99999999999999999999998864332211 11110 01110 11346789999999999999999999999
Q ss_pred HHHHH
Q 044846 230 TLELA 234 (290)
Q Consensus 230 ~~~l~ 234 (290)
+.+.+
T Consensus 255 l~h~~ 259 (333)
T cd05600 255 KNHPF 259 (333)
T ss_pred HhCcc
Confidence 98843
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=294.78 Aligned_cols=223 Identities=17% Similarity=0.188 Sum_probs=181.9
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+.+|+++++.++||||+++++++...+..++||||+++|+|..++.... .+++.
T Consensus 20 ~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----~l~~~ 95 (325)
T cd05594 20 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSED 95 (325)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC----CCCHH
Confidence 578999998642 33456678899999999999999999999999999999999999999999887654 58899
Q ss_pred HHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 79 MRLRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
.+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+.
T Consensus 96 ~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 171 (325)
T cd05594 96 RARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDN 171 (325)
T ss_pred HHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccccCCcccCCHHHHccC
Confidence 999999999999999997 67 9999999999999999999999999976432211 122345689999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVT 230 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~ 230 (290)
.++.++|||||||++|+|++|..||........ ..... ....+...+.++.+++.+||+.||++|+ ++.+++
T Consensus 172 ~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 250 (325)
T cd05594 172 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIM 250 (325)
T ss_pred CCCCccccccccceeeeeccCCCCCCCCCHHHH-HHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence 999999999999999999999998864432211 11111 1112233566789999999999999997 899998
Q ss_pred HHH
Q 044846 231 LEL 233 (290)
Q Consensus 231 ~~l 233 (290)
++.
T Consensus 251 ~h~ 253 (325)
T cd05594 251 QHK 253 (325)
T ss_pred cCC
Confidence 774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=285.34 Aligned_cols=226 Identities=29% Similarity=0.476 Sum_probs=175.4
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
+..|+||.++.. ..+..+.+.+|++.+++++||||++++|++...+..++|+|||++|+|.+++...... .+++..+
T Consensus 28 ~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~--~~~~~~~ 105 (259)
T PF07714_consen 28 NQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKE--PLSEQQR 105 (259)
T ss_dssp EEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTT--TSBHHHH
T ss_pred CEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc
Confidence 356899999653 3445889999999999999999999999999888899999999999999999987222 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.||+.||.|||+++ ++|+||+++||+++.++.+||+|||++....... ............|+|||.+.+..+
T Consensus 106 ~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 182 (259)
T PF07714_consen 106 LSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEY 182 (259)
T ss_dssp HHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEE
T ss_pred cccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999 9999999999999999999999999976552221 122233456778999999999889
Q ss_pred CCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.++||||||+++||+++ |..++... .......... ....+..++..+.++|.+||+.||++|||+.++++.|
T Consensus 183 ~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 183 TKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccccccccccccccccccccc-ccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999 45554332 2222111111 1222334567799999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=284.04 Aligned_cols=232 Identities=19% Similarity=0.296 Sum_probs=187.0
Q ss_pred eEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC------------C
Q 044846 4 LWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD------------D 71 (290)
Q Consensus 4 ~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~ 71 (290)
.+++|.++.......+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++..... .
T Consensus 37 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~ 116 (291)
T cd05094 37 LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116 (291)
T ss_pred eeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccC
Confidence 4788888776666677899999999999999999999999999999999999999999999976431 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccC
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVD 150 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~a 150 (290)
...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++........ .......++..|+|
T Consensus 117 ~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~a 193 (291)
T cd05094 117 KGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 193 (291)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecC
Confidence 124788999999999999999999999 99999999999999999999999999764332211 11233446778999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
||++.+..++.++||||||+++|+|++ |.+|+....... ....... .......+..+.+++.+||+.||++|||+
T Consensus 194 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 272 (291)
T cd05094 194 PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNI 272 (291)
T ss_pred hHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCH
Confidence 999999999999999999999999998 887764432211 1111111 11223346679999999999999999999
Q ss_pred HHHHHHHHhhHhh
Q 044846 227 KEVTLELAGIRAS 239 (290)
Q Consensus 227 ~el~~~l~~~~~~ 239 (290)
.++++.|+.+...
T Consensus 273 ~~v~~~l~~~~~~ 285 (291)
T cd05094 273 KEIYKILHALGKA 285 (291)
T ss_pred HHHHHHHHHHHhh
Confidence 9999999988553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=296.20 Aligned_cols=220 Identities=20% Similarity=0.224 Sum_probs=174.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|+.. .+.+.+|+++++.|+||||++++++|......++|+|++ +++|..++.... .+++..++
T Consensus 117 ~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~l~~~~~~ 185 (391)
T PHA03212 117 CEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKR----NIAICDIL 185 (391)
T ss_pred CCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcC----CCCHHHHH
Confidence 5678888653 235679999999999999999999999999999999999 579999987654 58889999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...............||+.|+|||++.+..++.
T Consensus 186 ~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 262 (391)
T PHA03212 186 AIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGP 262 (391)
T ss_pred HHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCc
Confidence 99999999999999999 999999999999999999999999998643222222234467899999999999989999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchh------hhhhh----------------------HHHh----h--------h---
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVE------ENRSL----------------------AAYF----S--------K--- 198 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~------~~~~~----------------------~~~~----~--------~--- 198 (290)
++|||||||++|+|++|..+++.... ....+ .... . .
T Consensus 263 ~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (391)
T PHA03212 263 AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLW 342 (391)
T ss_pred HHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 99999999999999999876643210 00000 0000 0 0
Q ss_pred hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 199 EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 199 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
......+.++.+||.+||+.||++|||+.|++++-+.
T Consensus 343 ~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 343 TNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred HHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 0011234578899999999999999999999987653
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=285.30 Aligned_cols=228 Identities=18% Similarity=0.157 Sum_probs=181.9
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.... ....+.+..|+++++.++||||+++.+++...+..++||||+++|+|..++.........+++.
T Consensus 18 ~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~ 97 (280)
T cd05608 18 GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEP 97 (280)
T ss_pred CcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHH
Confidence 5789999986422 2344677889999999999999999999999999999999999999998886543333468999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++....... .......|++.|+|||++.+..
T Consensus 98 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~ 173 (280)
T cd05608 98 RACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAGTPGFMAPELLQGEE 173 (280)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccccCCCcCccCHHHhcCCC
Confidence 99999999999999999999 9999999999999999999999999976433221 1223456889999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhh--hhhhH-HHhh--hhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSLA-AYFS--KEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKE 228 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~~-~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~e 228 (290)
++.++|+|||||++|+|++|..||...... ..... .... ...+...+..+.+++.+||+.||++|| ++++
T Consensus 174 ~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 253 (280)
T cd05608 174 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDG 253 (280)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence 999999999999999999999888643221 11111 1111 111234567799999999999999999 6777
Q ss_pred HHHHH
Q 044846 229 VTLEL 233 (290)
Q Consensus 229 l~~~l 233 (290)
++.+-
T Consensus 254 ~l~h~ 258 (280)
T cd05608 254 LRTHP 258 (280)
T ss_pred HhcCh
Confidence 87664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=302.57 Aligned_cols=221 Identities=22% Similarity=0.265 Sum_probs=187.7
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
++.+|||.++. ...++++....|.+++... +||.+++++.+|++.+++|.||||+.||++.-+.+.. .|++
T Consensus 393 ~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~-----~F~e 467 (694)
T KOG0694|consen 393 NEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTD-----VFSE 467 (694)
T ss_pred CcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEecc-----cccH
Confidence 67899998874 4577899999999999988 6999999999999999999999999999954443322 5999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..|+..|+.||.|||+++ ||+||||-+|||+|.+|++||+|||+++...... ..++++.||+-|||||++.+.
T Consensus 468 ~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g-~~TsTfCGTpey~aPEil~e~ 543 (694)
T KOG0694|consen 468 PRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG-DRTSTFCGTPEFLAPEVLTEQ 543 (694)
T ss_pred HHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCC-CccccccCChhhcChhhhccC
Confidence 999999999999999999999 9999999999999999999999999998755333 366789999999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTM-----KEVT 230 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~el~ 230 (290)
.|+..+|.|||||+||||+.|.+||..+.+. ........ ..++...+.+..++++++|..+|++|..+ .+|.
T Consensus 544 ~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~ 622 (694)
T KOG0694|consen 544 SYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIK 622 (694)
T ss_pred cccchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhh
Confidence 9999999999999999999999999755433 22222222 23455677889999999999999999754 5665
Q ss_pred HH
Q 044846 231 LE 232 (290)
Q Consensus 231 ~~ 232 (290)
.|
T Consensus 623 ~h 624 (694)
T KOG0694|consen 623 KH 624 (694)
T ss_pred hC
Confidence 55
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=287.97 Aligned_cols=222 Identities=18% Similarity=0.221 Sum_probs=178.3
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++|+|..++.... .+++
T Consensus 20 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~----~~~~ 95 (316)
T cd05592 20 NEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG----RFDE 95 (316)
T ss_pred CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC----CCCH
Confidence 567999998642 234456677788888765 89999999999999999999999999999999997654 5888
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+.
T Consensus 96 ~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 171 (316)
T cd05592 96 ARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQ 171 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCC
Confidence 999999999999999999999 9999999999999999999999999986433222 233446689999999999998
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQPTMK-EVTLE 232 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-el~~~ 232 (290)
.++.++|||||||++|+|++|..||....... ...... ....+...+.++.+++.+||+.||.+||++. +++++
T Consensus 172 ~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-LFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 99999999999999999999999886443221 111111 1112233456788999999999999999864 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=292.93 Aligned_cols=224 Identities=17% Similarity=0.218 Sum_probs=181.6
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++..... .+++.
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~l~~~ 102 (330)
T cd05601 26 GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED---QFDED 102 (330)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcC---CCCHH
Confidence 678999998742 233456788999999999999999999999999999999999999999999987532 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR--- 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--- 155 (290)
.+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...............||+.|+|||++.
T Consensus 103 ~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 179 (330)
T cd05601 103 MAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179 (330)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhcccc
Confidence 99999999999999999999 999999999999999999999999998654433322333456889999999987
Q ss_pred ---cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 156 ---SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 156 ---~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
...++.++|||||||++|+|++|..||........ ...... .+.....+..+.+|+.+||. ||.+|||+
T Consensus 180 ~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~ 257 (330)
T cd05601 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-YNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGY 257 (330)
T ss_pred ccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCH
Confidence 45678899999999999999999998864432211 111111 11122346778999999997 99999999
Q ss_pred HHHHHHH
Q 044846 227 KEVTLEL 233 (290)
Q Consensus 227 ~el~~~l 233 (290)
.+++.+.
T Consensus 258 ~~l~~h~ 264 (330)
T cd05601 258 EGLCCHP 264 (330)
T ss_pred HHHhCCC
Confidence 9999774
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=271.26 Aligned_cols=234 Identities=23% Similarity=0.291 Sum_probs=191.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----cceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE-----VPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
++.||+|++.+.+.++.+..++|++..++++|||+++++++...+. ..||+++|...|+|.+.+.........++
T Consensus 46 ~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~s 125 (302)
T KOG2345|consen 46 GHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVS 125 (302)
T ss_pred ccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccC
Confidence 5789999999988888999999999999999999999998876544 48999999999999999988766655799
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee--------eccceecccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL--------TTQVKVTFGY 148 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--------~~~~~g~~~y 148 (290)
+.+++.|+.+|+.||++||+..+ ++.||||||.|||+++.+.+++.|||.+......-... ......|..|
T Consensus 126 E~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~py 204 (302)
T KOG2345|consen 126 EAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPY 204 (302)
T ss_pred HHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcc
Confidence 99999999999999999999875 59999999999999999999999999877654322111 1123457789
Q ss_pred cCcccccc---CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHH-----HhhhhhhHHHHHHHHHHHHHhhccCC
Q 044846 149 VDPKYFRS---SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA-----YFSKEAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 149 ~aPE~~~~---~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~cl~~dp 220 (290)
.|||.+.- ...++++|||||||+||.|+.|..||.........++. ....+.....+..+.++|+.||+.||
T Consensus 205 RAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP 284 (302)
T KOG2345|consen 205 RAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDP 284 (302)
T ss_pred cCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCc
Confidence 99999864 34678999999999999999999988654432222211 11223333477889999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 044846 221 KKQPTMKEVTLELAGI 236 (290)
Q Consensus 221 ~~Rps~~el~~~l~~~ 236 (290)
.+||++.+++.++..+
T Consensus 285 ~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 285 NQRPTIPELLSKLDDL 300 (302)
T ss_pred ccCCCHHHHHHHHHhh
Confidence 9999999999888754
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=278.86 Aligned_cols=228 Identities=18% Similarity=0.292 Sum_probs=182.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|++... ....+.+.+|+.+++.++|+||+++++.+...+..+++|||+++|+|.+++...... .+++..++
T Consensus 30 ~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~ 106 (261)
T cd05072 30 STKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGG--KVLLPKLI 106 (261)
T ss_pred CceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCC--CCCHHHHH
Confidence 356888987653 334678999999999999999999999999999999999999999999999764322 57888999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...............++..|+|||++.+..++.
T Consensus 107 ~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 183 (261)
T cd05072 107 DFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 183 (261)
T ss_pred HHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCCh
Confidence 99999999999999998 999999999999999999999999998754332222223344567899999998888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
++|+||||+++|+|++ |..|+........ ........+.....+..+.+++.+||+.+|++|||++++.+.|+.
T Consensus 184 ~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 184 KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred hhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999997 7777643322211 111111111222345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=288.41 Aligned_cols=222 Identities=17% Similarity=0.250 Sum_probs=176.3
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVV-ILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~-~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|++... .......+..|.. +++.++||||+++++.+...+..++||||+++|+|..++.... .+++
T Consensus 20 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~ 95 (323)
T cd05575 20 GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER----SFPE 95 (323)
T ss_pred CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC----CCCH
Confidence 678999998642 2333455666665 4577899999999999999999999999999999999997654 5888
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... .........|++.|+|||++.+.
T Consensus 96 ~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~ 171 (323)
T cd05575 96 PRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTSTFCGTPEYLAPEVLRKQ 171 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCccccccCChhhcChhhhcCC
Confidence 999999999999999999999 99999999999999999999999999764321 12223345689999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHH----HHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMK----EVTL 231 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~----el~~ 231 (290)
.++.++|||||||++|+|++|.+||....... ....... .......+..+.+++.+||+.||.+||++. +++.
T Consensus 172 ~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~ 250 (323)
T cd05575 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-MYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKN 250 (323)
T ss_pred CCCccccccccchhhhhhhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHc
Confidence 99999999999999999999999886432211 1111111 111223467799999999999999999974 6655
Q ss_pred H
Q 044846 232 E 232 (290)
Q Consensus 232 ~ 232 (290)
+
T Consensus 251 ~ 251 (323)
T cd05575 251 H 251 (323)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=294.03 Aligned_cols=224 Identities=20% Similarity=0.247 Sum_probs=181.2
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+.+|+.++..++||||+++++++...+..|+|||||++|+|.+++.... .+++.
T Consensus 26 ~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----~l~~~ 101 (364)
T cd05599 26 GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEE 101 (364)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC----CCCHH
Confidence 678999999743 23445678899999999999999999999999999999999999999999998654 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce---------------------
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--------------------- 137 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--------------------- 137 (290)
.+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++........
T Consensus 102 ~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (364)
T cd05599 102 ETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178 (364)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccccc
Confidence 99999999999999999999 999999999999999999999999987643211100
Q ss_pred ----------------eeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh-----
Q 044846 138 ----------------LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF----- 196 (290)
Q Consensus 138 ----------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~----- 196 (290)
......||+.|+|||++....++.++|||||||++|+|++|.+||........ .....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~-~~~i~~~~~~ 257 (364)
T cd05599 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET-YRKIINWKET 257 (364)
T ss_pred ccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH-HHHHHcCCCc
Confidence 11124589999999999999999999999999999999999998865432211 11111
Q ss_pred -hhhhhHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHHHH
Q 044846 197 -SKEAEKEEVITFAMVAKRCLNLNGKKQPT---MKEVTLELA 234 (290)
Q Consensus 197 -~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~el~~~l~ 234 (290)
..+.....+..+.++|.+|+. +|.+|++ +.+++.+.+
T Consensus 258 ~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 258 LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 111112345678999999996 9999998 999988743
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=290.30 Aligned_cols=225 Identities=24% Similarity=0.303 Sum_probs=175.0
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----cceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETE-----VPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|+++.. .......+.+|+++++.++||||+++++++.... ..|+||||| +++|.+++.... .
T Consensus 25 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~ 99 (338)
T cd07859 25 GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAND----D 99 (338)
T ss_pred CCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcc----c
Confidence 578999998642 2344567889999999999999999999886432 479999999 579999987654 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC--ceeeccceecccccCcc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR--THLTTQVKVTFGYVDPK 152 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~g~~~y~aPE 152 (290)
+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ........|+..|+|||
T Consensus 100 ~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE 176 (338)
T cd07859 100 LTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHH
Confidence 889999999999999999999999 9999999999999999999999999987533211 11223456889999999
Q ss_pred cccc--CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHH--------------------h---hh----h--
Q 044846 153 YFRS--SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAY--------------------F---SK----E-- 199 (290)
Q Consensus 153 ~~~~--~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~--------------------~---~~----~-- 199 (290)
++.+ ..++.++|||||||++|+|++|+++|........ ..... . .. .
T Consensus 177 ~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 256 (338)
T cd07859 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFS 256 (338)
T ss_pred HHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchH
Confidence 9876 5788999999999999999999988854321100 00000 0 00 0
Q ss_pred -hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 200 -AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 200 -~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.....+..+.+++.+||+.||++|||+.|++++-+
T Consensus 257 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 257 QKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred HhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 00112345789999999999999999999998854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=284.03 Aligned_cols=224 Identities=20% Similarity=0.265 Sum_probs=176.2
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+. |+|.+++..... .+++..+
T Consensus 30 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~ 105 (288)
T cd07871 30 ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGN---LMSMHNV 105 (288)
T ss_pred CCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcCC---CCCHHHH
Confidence 5789999987433 3334567899999999999999999999999999999999996 599999875442 4788899
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-CCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-SQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~ 159 (290)
..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......++..|+|||++.+ ..+
T Consensus 106 ~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 181 (288)
T cd07871 106 KIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSTEY 181 (288)
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccccCceecccccChHHhcCCccc
Confidence 999999999999999999 9999999999999999999999999986543221 12234567889999999875 568
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHhh---------------------hh--------hhHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYFS---------------------KE--------AEKEEVITF 208 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~~---------------------~~--------~~~~~~~~~ 208 (290)
+.++||||+||++|+|++|.++|.......... ..... .. .....+.++
T Consensus 182 ~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (288)
T cd07871 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDG 261 (288)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHH
Confidence 899999999999999999998886433211110 00000 00 001124568
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 209 AMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 209 ~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.+|+.+||+.||.+|||++|++.|-
T Consensus 262 ~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 262 IDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred HHHHHHhcCcCcccCCCHHHHhcCC
Confidence 8999999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=286.09 Aligned_cols=225 Identities=21% Similarity=0.253 Sum_probs=176.1
Q ss_pred CceEEEEeecccCc-hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHE-SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|+++.... .....+.+|+.+++.++||||+++++++......++||||+ .++|.+++..... .++...+
T Consensus 30 ~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~ 105 (303)
T cd07869 30 GKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPG---GLHPENV 105 (303)
T ss_pred CCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC-CcCHHHHHHhCCC---CCCHHHH
Confidence 67899999875332 23446788999999999999999999999999999999999 5689888875432 5788899
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-CCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-SQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~ 159 (290)
..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....... .......+++.|+|||++.+ ..+
T Consensus 106 ~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 181 (303)
T cd07869 106 KLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEY 181 (303)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCC
Confidence 999999999999999999 9999999999999999999999999976432211 12233567889999999865 457
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---h------------------------hh--h-----HHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---K------------------------EA--E-----KEEV 205 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~------------------------~~--~-----~~~~ 205 (290)
+.++||||+||++|+|++|.+||.........+..... . .. . ...+
T Consensus 182 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (303)
T cd07869 182 STCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYV 261 (303)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCC
Confidence 88999999999999999999988643222111111100 0 00 0 0112
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 206 ITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 206 ~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
..+.+|+.+||+.||++|||+.|+++|-+
T Consensus 262 ~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 262 NHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred hHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 46789999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=281.43 Aligned_cols=230 Identities=19% Similarity=0.301 Sum_probs=183.0
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC----------
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD---------- 71 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------- 71 (290)
+.||+|.++... ......+.+|+++++.++||||+++++++...+..+++|||+++|+|.+++......
T Consensus 36 ~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 115 (283)
T cd05048 36 TSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115 (283)
T ss_pred eeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccc
Confidence 468899886433 344567899999999999999999999999999999999999999999999764211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccc
Q 044846 72 --QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGY 148 (290)
Q Consensus 72 --~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y 148 (290)
...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+++....... .......++..|
T Consensus 116 ~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y 192 (283)
T cd05048 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRW 192 (283)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccc
Confidence 125788889999999999999999999 99999999999999999999999999764322211 112234457789
Q ss_pred cCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 149 VDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 149 ~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
+|||.+.+..++.++|||||||++|||++ |..|+........ .+........+...+.++.+|+.+||+.||.+||+
T Consensus 193 ~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~ 272 (283)
T cd05048 193 MPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPR 272 (283)
T ss_pred cCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcC
Confidence 99999988889999999999999999996 8777654322111 11111111223456678999999999999999999
Q ss_pred HHHHHHHHHh
Q 044846 226 MKEVTLELAG 235 (290)
Q Consensus 226 ~~el~~~l~~ 235 (290)
+.|++++|+.
T Consensus 273 ~~~i~~~l~~ 282 (283)
T cd05048 273 FKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHhc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=278.80 Aligned_cols=219 Identities=18% Similarity=0.284 Sum_probs=171.8
Q ss_pred eEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHH
Q 044846 4 LWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI 83 (290)
Q Consensus 4 ~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 83 (290)
.||+|.+..........+..|+.+++.++||||+++++++......++||||+++|+|..++..... .+++..++.+
T Consensus 34 ~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~i 110 (262)
T cd05077 34 KVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKV 110 (262)
T ss_pred eEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC---CCCHHHHHHH
Confidence 4788887765566667889999999999999999999999999999999999999999998875432 5889999999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc-------EEEeccccccccccCCceeeccceecccccCccccc-
Q 044846 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ-------AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR- 155 (290)
Q Consensus 84 ~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~-------~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 155 (290)
+.||+.||+|||+++ |+||||||+|||++.++. ++++|||++..... .....++..|+|||++.
T Consensus 111 ~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~ 182 (262)
T cd05077 111 AKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS-----RQECVERIPWIAPECVED 182 (262)
T ss_pred HHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC-----cccccccccccChhhhcC
Confidence 999999999999999 999999999999987664 89999998653321 12345677899999987
Q ss_pred cCCCCCcccchhhHHHHHHHh-cCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELN-WTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+..++.++|||||||++|+|+ +|..|+........................++.+||.+||+.||++||++.+|++++
T Consensus 183 ~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 183 SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 456888999999999999997 465554332211111000000011112345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=280.80 Aligned_cols=228 Identities=22% Similarity=0.342 Sum_probs=183.1
Q ss_pred ceEEEEeecccCch-hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC----------C
Q 044846 3 ELWLLKKSKSVHES-NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD----------D 71 (290)
Q Consensus 3 ~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------~ 71 (290)
+.||+|+++..... ..+.+.+|+++++.++||||+++++++......++||||+++|+|.+++..... .
T Consensus 36 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 115 (280)
T cd05049 36 ELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115 (280)
T ss_pred ceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccc
Confidence 57899998764444 567899999999999999999999999999999999999999999999976431 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccC
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVD 150 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~a 150 (290)
...+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.+||+|||++........ .......+++.|+|
T Consensus 116 ~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~a 192 (280)
T cd05049 116 MGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMP 192 (280)
T ss_pred cccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecC
Confidence 234788899999999999999999999 99999999999999999999999998764322111 11223345678999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
||++.+..++.++||||||+++|+|++ |..|+....... ....... ...+...+..+.+++.+||+.||++||++
T Consensus 193 PE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 271 (280)
T cd05049 193 PESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINI 271 (280)
T ss_pred hhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence 999999999999999999999999997 888765432221 1111111 11223456779999999999999999999
Q ss_pred HHHHHHHH
Q 044846 227 KEVTLELA 234 (290)
Q Consensus 227 ~el~~~l~ 234 (290)
.|+++.|+
T Consensus 272 ~eil~~l~ 279 (280)
T cd05049 272 KDIHERLQ 279 (280)
T ss_pred HHHHHHhh
Confidence 99998885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=277.34 Aligned_cols=223 Identities=22% Similarity=0.324 Sum_probs=177.6
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
..+|+|.++... ...+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... .+++..+..
T Consensus 29 ~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~ 104 (256)
T cd05114 29 IKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG---KLSKDMLLS 104 (256)
T ss_pred ceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc---CCCHHHHHH
Confidence 468888876432 3356788999999999999999999999999999999999999999999975432 478899999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
++.|++.||.|||+++ ++||||||+||+++.++.+||+|||.++..............++..|+|||++.+..++.+
T Consensus 105 ~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (256)
T cd05114 105 MCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181 (256)
T ss_pred HHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchh
Confidence 9999999999999999 9999999999999999999999999876543222222222344567999999998889999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+|+||||+++|++++ |.+|+...... ........ ...+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 182 ~Di~s~G~~l~el~~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 182 SDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred hhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999998 77766433221 11111111 111223456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=291.60 Aligned_cols=218 Identities=19% Similarity=0.191 Sum_probs=177.5
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++... ......+.+|++++++++||||+++++++...+..|+||||+++|+|.+++.... .+++..
T Consensus 24 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~ 99 (318)
T cd05582 24 GQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEED 99 (318)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHH
Confidence 5789999987422 2345567889999999999999999999999999999999999999999997644 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......|++.|+|||++.+..+
T Consensus 100 ~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~ 175 (318)
T cd05582 100 VKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGH 175 (318)
T ss_pred HHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcCCCC
Confidence 9999999999999999999 9999999999999999999999999976533221 22334568999999999998889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
+.++|||||||++|+|++|..|+....... ....... ...+...+..+.+|+.+||+.||++||++.+
T Consensus 176 ~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 176 TQSADWWSFGVLMFEMLTGSLPFQGKDRKE-TMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCccceeccceEeeeeccCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 999999999999999999998886433221 1111111 1112234567899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=277.79 Aligned_cols=232 Identities=20% Similarity=0.232 Sum_probs=186.6
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++. .+......+.+|+++++.++||||+++++++...+..++++||+++|+|.+++.........++..
T Consensus 27 ~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~ 106 (267)
T cd08228 27 RKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPER 106 (267)
T ss_pred CCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHH
Confidence 57789998753 234445678999999999999999999999999999999999999999999986543333357888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .......++..|+|||.+.+..
T Consensus 107 ~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~ 182 (267)
T cd08228 107 TVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred HHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchh-HHHhcCCCCccccChhhhccCC
Confidence 99999999999999999999 9999999999999999999999999876543211 1122345778899999998888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
++.++|+||||+++|+|++|..|+............... .......+..+.+++.+||..+|++|||+.++++.+
T Consensus 183 ~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 999999999999999999999887644322222222111 111224456799999999999999999999999999
Q ss_pred HhhH
Q 044846 234 AGIR 237 (290)
Q Consensus 234 ~~~~ 237 (290)
+.+.
T Consensus 263 ~~~~ 266 (267)
T cd08228 263 KQMH 266 (267)
T ss_pred HHhc
Confidence 8763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=286.49 Aligned_cols=222 Identities=18% Similarity=0.205 Sum_probs=178.7
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+..|..++..+ +||||+++++++...+..|+||||+++|+|..++.... .+++
T Consensus 20 ~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~----~~~~ 95 (316)
T cd05620 20 GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG----RFDL 95 (316)
T ss_pred CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC----CCCH
Confidence 678999998742 234456677888888865 89999999999999999999999999999999987654 5888
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||+++..... ........|+..|+|||++.+.
T Consensus 96 ~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 171 (316)
T cd05620 96 YRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFCGTPDYIAPEILQGL 171 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccCCCcCccCHHHHcCC
Confidence 999999999999999999999 999999999999999999999999987643211 1223446689999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCCCH-HHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQPTM-KEVTLE 232 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-~el~~~ 232 (290)
.++.++|||||||++|+|++|..||........ ..... ....+...+.++.+++.+||+.||++||++ ++++.|
T Consensus 172 ~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-FESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 999999999999999999999998864432211 11111 111122345678999999999999999997 466655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=296.32 Aligned_cols=225 Identities=18% Similarity=0.243 Sum_probs=179.3
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++... .......+.+|+++++.++||||+++++.+...+.+|+|||||++|+|.+++.... .+++.
T Consensus 26 ~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~----~~~~~ 101 (376)
T cd05598 26 NALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG----IFEED 101 (376)
T ss_pred CCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC----CCCHH
Confidence 678999998642 23345678899999999999999999999999999999999999999999997654 57888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-----------------------
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR----------------------- 135 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----------------------- 135 (290)
.+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (376)
T cd05598 102 LARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178 (376)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccccc
Confidence 89999999999999999999 9999999999999999999999999874221000
Q ss_pred -------------------ceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH-
Q 044846 136 -------------------THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY- 195 (290)
Q Consensus 136 -------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~- 195 (290)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 258 (376)
T cd05598 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVIN 258 (376)
T ss_pred ccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhc
Confidence 000123468999999999999999999999999999999999999886543322111110
Q ss_pred ----hhhhhhHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHHHH
Q 044846 196 ----FSKEAEKEEVITFAMVAKRCLNLNGKKQP---TMKEVTLELA 234 (290)
Q Consensus 196 ----~~~~~~~~~~~~~~~li~~cl~~dp~~Rp---s~~el~~~l~ 234 (290)
.........+..+.++|.+|+ .+|.+|+ |+.+++.+.+
T Consensus 259 ~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 259 WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 001111234567888999976 5999999 8999998843
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=287.64 Aligned_cols=224 Identities=20% Similarity=0.262 Sum_probs=178.9
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.+|+|.++.. .......+.+|+++++.++||||++++++|...+..++||||+++|+|.+++.... .+++..+
T Consensus 30 ~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~ 105 (333)
T cd06650 30 GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQIL 105 (333)
T ss_pred CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC----CCCHHHH
Confidence 567888887653 33446679999999999999999999999999999999999999999999997654 5788899
Q ss_pred HHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++..... .......|+..|+|||++.+..+
T Consensus 106 ~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~ 179 (333)
T cd06650 106 GKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 179 (333)
T ss_pred HHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh---hccccCCCCccccCHHHhcCCCC
Confidence 99999999999999974 6 99999999999999999999999998764321 12233567889999999998889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhH------------------------------------------HHhh
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA------------------------------------------AYFS 197 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~------------------------------------------~~~~ 197 (290)
+.++|+|||||++|++++|..|+........... ....
T Consensus 180 ~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (333)
T cd06650 180 SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIV 259 (333)
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHh
Confidence 9999999999999999999887653321111000 0000
Q ss_pred hhh-----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 198 KEA-----EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 198 ~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
... ....+.++.+|+.+||+.||++|||+.|++.+-.-
T Consensus 260 ~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 260 NEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred cCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 000 00124568999999999999999999999987553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=289.58 Aligned_cols=225 Identities=18% Similarity=0.249 Sum_probs=180.2
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+..|..++..+ +||||++++++|...+..|+|||||++|+|..++.... .+++
T Consensus 20 ~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~----~l~~ 95 (329)
T cd05588 20 RRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR----KLPE 95 (329)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC----CCCH
Confidence 578999998742 334456788999999998 79999999999999999999999999999999887654 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..... ........||..|+|||++.+.
T Consensus 96 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 171 (329)
T cd05588 96 EHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRGE 171 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccccCCccccCHHHHcCC
Confidence 999999999999999999999 999999999999999999999999997642211 1223346789999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchh-------hhh-hhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCC--
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVE-------ENR-SLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPT-- 225 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~-------~~~-~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps-- 225 (290)
.++.++|+|||||++|+|++|..||..... ... ....... ...+...+..+.+++.+||+.||.+|+|
T Consensus 172 ~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 251 (329)
T cd05588 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCH 251 (329)
T ss_pred CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 999999999999999999999998842110 000 0111111 1112234567899999999999999997
Q ss_pred ----HHHHHHHHH
Q 044846 226 ----MKEVTLELA 234 (290)
Q Consensus 226 ----~~el~~~l~ 234 (290)
+.+++.|-+
T Consensus 252 ~~~~~~~i~~hp~ 264 (329)
T cd05588 252 PQTGFRDIKSHPF 264 (329)
T ss_pred CCCCHHHHhcCCC
Confidence 678877643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=288.85 Aligned_cols=223 Identities=19% Similarity=0.244 Sum_probs=182.0
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+..|.+++..+ +||||+++++++...+..|+||||+++|+|...+.... .+++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----~~~~ 95 (321)
T cd05591 20 DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR----KFDE 95 (321)
T ss_pred CCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC----CCCH
Confidence 578999998642 344566788899999876 89999999999999999999999999999999987654 5888
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...... ........|++.|+|||++.+.
T Consensus 96 ~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 171 (321)
T cd05591 96 PRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPDYIAPEILQEL 171 (321)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC-CccccccccCccccCHHHHcCC
Confidence 999999999999999999999 999999999999999999999999997643221 1223345689999999999998
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCC-------CHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQP-------TMKE 228 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp-------s~~e 228 (290)
.++.++|||||||++|+|++|..||....... ........ ..+...+.++.+++.+||+.||++|| ++.+
T Consensus 172 ~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~ 250 (321)
T cd05591 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDA 250 (321)
T ss_pred CCCCccceechhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHH
Confidence 99999999999999999999999886543222 12211111 11222456789999999999999999 8888
Q ss_pred HHHHH
Q 044846 229 VTLEL 233 (290)
Q Consensus 229 l~~~l 233 (290)
++++.
T Consensus 251 ~~~hp 255 (321)
T cd05591 251 IKQHP 255 (321)
T ss_pred HhcCC
Confidence 88774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=291.91 Aligned_cols=224 Identities=19% Similarity=0.241 Sum_probs=184.2
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+..|++++..++||||+++++++...+..++||||+++|+|.+++.... .+++.
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~ 101 (350)
T cd05573 26 GQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD----VFPEE 101 (350)
T ss_pred CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcC----CCCHH
Confidence 678999998642 23456678899999999999999999999999999999999999999999998763 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-----------------------
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR----------------------- 135 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----------------------- 135 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (350)
T cd05573 102 TARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178 (350)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccccc
Confidence 99999999999999999999 9999999999999999999999999986543222
Q ss_pred -----ceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHH
Q 044846 136 -----THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEE 204 (290)
Q Consensus 136 -----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 204 (290)
........||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... .+.....
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~p~~~~~ 257 (350)
T cd05573 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET-YNKIINWKESLRFPPDPPV 257 (350)
T ss_pred ccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH-HHHHhccCCcccCCCCCCC
Confidence 1122345689999999999999999999999999999999999998865432211 111111 1111124
Q ss_pred HHHHHHHHHHhhccCCCCCCC-HHHHHHHHH
Q 044846 205 VITFAMVAKRCLNLNGKKQPT-MKEVTLELA 234 (290)
Q Consensus 205 ~~~~~~li~~cl~~dp~~Rps-~~el~~~l~ 234 (290)
+..+.++|.+||. ||.+||+ +.+++.+.+
T Consensus 258 ~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 258 SPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 6789999999997 9999999 999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=286.60 Aligned_cols=225 Identities=16% Similarity=0.238 Sum_probs=189.9
Q ss_pred CCceEEEEeecccCchh--HHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 1 MEELWLLKKSKSVHESN--VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 1 ~~~~~avK~~~~~~~~~--~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
.|++||||++...+-+. ...+.+|+++|+-++|||||++|.+..+...+|||+|+-.+|+|++||-.... .+.+.
T Consensus 42 TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~---Gl~E~ 118 (864)
T KOG4717|consen 42 TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEE---GLNED 118 (864)
T ss_pred ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhc---cccHH
Confidence 38899999997655444 44688999999999999999999999999999999999999999999977654 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec-cCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
.+.+++.||+.|+.|||+.+ ++||||||+|+.+. .-|-+||.|||.+.... .....++..|+..|.|||++.+.
T Consensus 119 La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--PG~kL~TsCGSLAYSAPEILLGD 193 (864)
T KOG4717|consen 119 LAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--PGKKLTTSCGSLAYSAPEILLGD 193 (864)
T ss_pred HHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC--CcchhhcccchhhccCchhhhcC
Confidence 99999999999999999999 99999999998775 67889999999975443 33445678899999999999999
Q ss_pred CCCC-cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 158 QFTE-KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 158 ~~~~-~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.|+. ++||||+|+|||-|+.|.+||....+.......+.-. ..+...+.++++||..||..||.+|.|.++|..+-
T Consensus 194 sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 194 SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred ccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 9986 6999999999999999999998665544332221111 23456778899999999999999999999997553
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=293.13 Aligned_cols=224 Identities=16% Similarity=0.219 Sum_probs=178.4
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++... .....+.+.+|+++++.++||||++++++|...+..|+||||+++|+|.+++.... .+++.
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~ 101 (377)
T cd05629 26 GKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD----TFSED 101 (377)
T ss_pred CCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC----CCCHH
Confidence 678999988542 23446678899999999999999999999999999999999999999999997654 58889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc----------------------
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT---------------------- 136 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---------------------- 136 (290)
.++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 102 ~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (377)
T cd05629 102 VTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178 (377)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999 99999999999999999999999999852110000
Q ss_pred ------------------------eeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh
Q 044846 137 ------------------------HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL 192 (290)
Q Consensus 137 ------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~ 192 (290)
.......||+.|+|||++.+..++.++|||||||++|||++|.+||....... ..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~ 257 (377)
T cd05629 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE-TY 257 (377)
T ss_pred cccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH-HH
Confidence 00012468999999999999999999999999999999999999886443221 11
Q ss_pred HHHhh------hhhhHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHHHH
Q 044846 193 AAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQ---PTMKEVTLELA 234 (290)
Q Consensus 193 ~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~R---ps~~el~~~l~ 234 (290)
..... -+.....+.++.+||.+||. +|.+| +|+.|++.+.+
T Consensus 258 ~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 258 RKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPF 307 (377)
T ss_pred HHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence 11111 01111345678999999997 77775 59999998854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=293.88 Aligned_cols=224 Identities=19% Similarity=0.219 Sum_probs=180.9
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++...+..|+||||+++|+|.+++... .+++.
T Consensus 68 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~ 142 (370)
T cd05596 68 KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEK 142 (370)
T ss_pred CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc-----CCCHH
Confidence 578999998632 2344556789999999999999999999999999999999999999999998753 37888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS- 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 157 (290)
.+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...............||+.|+|||++.+.
T Consensus 143 ~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 219 (370)
T cd05596 143 WARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219 (370)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCC
Confidence 88999999999999999999 99999999999999999999999999865432222223446789999999998754
Q ss_pred ---CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh------hhhHHHHHHHHHHHHHhhccCCCC--CCCH
Q 044846 158 ---QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK------EAEKEEVITFAMVAKRCLNLNGKK--QPTM 226 (290)
Q Consensus 158 ---~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~--Rps~ 226 (290)
.++.++|||||||++|+|++|.+||...... ......... +.....+..+.+||.+||+.+|.+ |+|+
T Consensus 220 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~ 298 (370)
T cd05596 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGV 298 (370)
T ss_pred CCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCH
Confidence 3788999999999999999999988654322 111111111 111234678999999999999988 9999
Q ss_pred HHHHHHHH
Q 044846 227 KEVTLELA 234 (290)
Q Consensus 227 ~el~~~l~ 234 (290)
.+++.+.+
T Consensus 299 ~ell~h~~ 306 (370)
T cd05596 299 DEIKSHPF 306 (370)
T ss_pred HHHhcCcc
Confidence 99998854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=289.04 Aligned_cols=223 Identities=20% Similarity=0.238 Sum_probs=181.0
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+..|..++..+ +||||+++++++...+..|+||||+++|+|..++.... .+++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~----~l~~ 95 (320)
T cd05590 20 GRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDE 95 (320)
T ss_pred CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC----CCCH
Confidence 578999998642 344566788899999887 79999999999999999999999999999999987654 5889
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........|++.|+|||++.+.
T Consensus 96 ~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 171 (320)
T cd05590 96 ARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPEILQEM 171 (320)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccccccCccccCHHHHcCC
Confidence 999999999999999999999 999999999999999999999999997643221 1223345689999999999998
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCCCH------HHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQPTM------KEV 229 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~------~el 229 (290)
.++.++|||||||++|+|++|..||....... ........ ..+...+.++.+++.+||+.||.+||++ .++
T Consensus 172 ~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~ 250 (320)
T cd05590 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAI 250 (320)
T ss_pred CCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHH
Confidence 99999999999999999999999886443221 11111111 1122345678999999999999999998 666
Q ss_pred HHHH
Q 044846 230 TLEL 233 (290)
Q Consensus 230 ~~~l 233 (290)
+.|.
T Consensus 251 ~~h~ 254 (320)
T cd05590 251 LRHP 254 (320)
T ss_pred HcCC
Confidence 6653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=282.45 Aligned_cols=221 Identities=24% Similarity=0.252 Sum_probs=175.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----cceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE-----VPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
++.||+|++-...+- --+|+++|+.++|||||+++-+|.... ...+|||||+. +|..+++.....+..++
T Consensus 49 ~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp 123 (364)
T KOG0658|consen 49 EEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMP 123 (364)
T ss_pred CceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCc
Confidence 578999998643321 127999999999999999998886532 34689999976 99999997654555788
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC-CcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
...++-+..||.+||.|||+.+ |+||||||+|+|+|.+ |.+||||||.|+....+... .++..|..|.|||.+.
T Consensus 124 ~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn--iSYicSRyYRaPELif 198 (364)
T KOG0658|consen 124 LLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN--ISYICSRYYRAPELIF 198 (364)
T ss_pred eeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc--eeEEEeccccCHHHHc
Confidence 8889999999999999999999 9999999999999976 99999999998865543322 4566788999999988
Q ss_pred cC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHhh----------------------------hhhhHHH
Q 044846 156 SS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYFS----------------------------KEAEKEE 204 (290)
Q Consensus 156 ~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~~----------------------------~~~~~~~ 204 (290)
+. .|+.+.||||.||++.||+.|++.|..+....+ .+...+- .......
T Consensus 199 ga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~ 278 (364)
T KOG0658|consen 199 GATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRL 278 (364)
T ss_pred CccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCC
Confidence 65 699999999999999999999999876533211 1111111 0011223
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 205 VITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 205 ~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+++..+|+.++|..+|.+|.++.|++.+
T Consensus 279 ~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 279 PPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 5678899999999999999999999877
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=275.10 Aligned_cols=227 Identities=19% Similarity=0.292 Sum_probs=178.3
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|..... .......+.+|+++++.++||||+++++++...+..++||||+++++|.+++..... .+++..+
T Consensus 20 ~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~ 96 (252)
T cd05084 20 NTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP---RLKVKEL 96 (252)
T ss_pred CceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCC---CCCHHHH
Confidence 567899987643 344566799999999999999999999999999999999999999999999975432 5789999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee-ccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT-TQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~ 159 (290)
+.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........... .....+..|+|||.+.+..+
T Consensus 97 ~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 173 (252)
T cd05084 97 IQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173 (252)
T ss_pred HHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCC
Confidence 999999999999999999 99999999999999999999999999764332111110 11123456999999998889
Q ss_pred CCcccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.++|+||||+++|++++ |.+|+........ ..........+...+..+.+++.+||+.||++|||+.++++.|.
T Consensus 174 ~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999997 6665543222111 11111111223344667899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.92 Aligned_cols=223 Identities=23% Similarity=0.254 Sum_probs=192.0
Q ss_pred CceEEEEeecccCc---hhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVHE---SNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~~---~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.+|+|.++.... ...+.+.+|+++|++|. |||||.++++|.+....++|||+|.||+|++.+... .+++
T Consensus 60 g~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE 134 (382)
T KOG0032|consen 60 GKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSE 134 (382)
T ss_pred CceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCH
Confidence 67899999964333 24568999999999997 999999999999999999999999999999999876 2899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC----CcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK----YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
..+..++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||++..... ........||+.|+|||+
T Consensus 135 ~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEv 209 (382)
T KOG0032|consen 135 RDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEV 209 (382)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchh
Confidence 999999999999999999999 9999999999999743 4799999999876544 445567889999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH-----hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY-----FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
+....|+..+||||+|+++|.|+.|.+||............. +..+.....+....++|.+|+..||.+|+|+.+
T Consensus 210 l~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~ 289 (382)
T KOG0032|consen 210 LGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQ 289 (382)
T ss_pred hcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHH
Confidence 999999999999999999999999999998765433322111 234455667888999999999999999999999
Q ss_pred HHHHHH
Q 044846 229 VTLELA 234 (290)
Q Consensus 229 l~~~l~ 234 (290)
+++|.|
T Consensus 290 ~L~HpW 295 (382)
T KOG0032|consen 290 ALQHPW 295 (382)
T ss_pred HhcCcc
Confidence 999876
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.57 Aligned_cols=227 Identities=19% Similarity=0.289 Sum_probs=185.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.+|+|.++.........+..|+.+++.++||||+++++++...+..++||||+++|+|.+++...... .+++..+.
T Consensus 30 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~ 107 (261)
T cd05148 30 RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ--VLPVASLI 107 (261)
T ss_pred CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCC--CCCHHHHH
Confidence 4668999988766666778999999999999999999999999999999999999999999999865432 57899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+....... .......++..|++||++....++.
T Consensus 108 ~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~ 183 (261)
T cd05148 108 DMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFST 183 (261)
T ss_pred HHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc-ccccCCCCceEecCHHHHccCCCCc
Confidence 99999999999999999 9999999999999999999999999876443211 1122334567899999998888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
++||||||+++|++++ |..|+.... ......... ....+...+..+.++|.+||+.||++|||+.++++.|+.
T Consensus 184 ~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 184 KSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 9999999999999997 666664322 111111111 112233456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=276.04 Aligned_cols=224 Identities=21% Similarity=0.296 Sum_probs=177.7
Q ss_pred eEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHH
Q 044846 4 LWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI 83 (290)
Q Consensus 4 ~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 83 (290)
.+|+|.++.... ..+.+.+|+.+++.++||||+++++++...+..+++|||+.+|+|.+++..... .+++..++.+
T Consensus 30 ~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~---~~~~~~~~~~ 105 (256)
T cd05113 30 DVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK---RFQPSQLLEM 105 (256)
T ss_pred cEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC---CCCHHHHHHH
Confidence 488998875332 346789999999999999999999999999999999999999999999976432 5889999999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCcc
Q 044846 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKS 163 (290)
Q Consensus 84 ~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 163 (290)
+.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.++..............++..|++||++.+..++.++
T Consensus 106 ~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~ 182 (256)
T cd05113 106 CKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182 (256)
T ss_pred HHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchh
Confidence 999999999999999 99999999999999999999999998764432221112223456779999999888899999
Q ss_pred cchhhHHHHHHHhc-CCCCcccchhhh--hhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 164 DVYSFSVVLVELNW-TKPIHLVDVEEN--RSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 164 DiwS~G~il~~l~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
||||||+++|+|++ |..|+....... ...............+..+.+++.+||+.||.+|||+.+++..|+
T Consensus 183 Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 183 DVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 99999999999997 777664322211 111111111112234567999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=292.08 Aligned_cols=231 Identities=20% Similarity=0.286 Sum_probs=181.7
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-----------
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD----------- 70 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------- 70 (290)
.||+|+++.. .....+.+.+|+++++.+. ||||++++++|...+..|||||||++|+|.+++.....
T Consensus 69 ~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 148 (400)
T cd05105 69 KVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPK 148 (400)
T ss_pred EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccccccc
Confidence 5899999743 3445678999999999995 99999999999999999999999999999999865321
Q ss_pred --------------------------------------------------------------------------------
Q 044846 71 -------------------------------------------------------------------------------- 70 (290)
Q Consensus 71 -------------------------------------------------------------------------------- 70 (290)
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 228 (400)
T cd05105 149 KDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSD 228 (400)
T ss_pred ccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHh
Confidence
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccc
Q 044846 71 -DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGY 148 (290)
Q Consensus 71 -~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y 148 (290)
....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ ......++..|
T Consensus 229 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y 305 (400)
T cd05105 229 DGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW 305 (400)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcce
Confidence 0124778888999999999999999999 999999999999999999999999998654322211 12233456789
Q ss_pred cCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHH---HhhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 149 VDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAA---YFSKEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 149 ~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
+|||++.+..++.++|||||||++|+|++ |..|+............ ......+...+..+.+++.+||+.||++||
T Consensus 306 ~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 385 (400)
T cd05105 306 MAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385 (400)
T ss_pred EChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCc
Confidence 99999998899999999999999999986 76666433221111111 111122234566799999999999999999
Q ss_pred CHHHHHHHHHhhH
Q 044846 225 TMKEVTLELAGIR 237 (290)
Q Consensus 225 s~~el~~~l~~~~ 237 (290)
|+.+|.+.|+.+.
T Consensus 386 t~~~l~~~l~~l~ 398 (400)
T cd05105 386 SFLHLSDIVESLL 398 (400)
T ss_pred CHHHHHHHHHHHc
Confidence 9999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=288.44 Aligned_cols=224 Identities=20% Similarity=0.262 Sum_probs=178.8
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+..|+.++..+ +||||+++++++...+..++||||+++|+|..++.... .+++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~----~l~~ 95 (329)
T cd05618 20 ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPE 95 (329)
T ss_pred CCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC----CCCH
Confidence 567999998742 344566788899999887 89999999999999999999999999999999887654 5889
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..... ........||..|+|||++.+.
T Consensus 96 ~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 171 (329)
T cd05618 96 EHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGE 171 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccccccCCccccCHHHHcCC
Confidence 999999999999999999999 999999999999999999999999997643211 1222346689999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchh-------hhh-hhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCC--
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVE-------ENR-SLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPT-- 225 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~-------~~~-~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps-- 225 (290)
.++.++|||||||++|+|++|..||..... ... ....... ...+...+..+.+++.+||+.||.+||+
T Consensus 172 ~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~ 251 (329)
T cd05618 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCH 251 (329)
T ss_pred CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCC
Confidence 999999999999999999999998742100 000 0111111 1122334567889999999999999998
Q ss_pred ----HHHHHHHH
Q 044846 226 ----MKEVTLEL 233 (290)
Q Consensus 226 ----~~el~~~l 233 (290)
+.+++.|.
T Consensus 252 ~~~~~~~i~~hp 263 (329)
T cd05618 252 PQTGFADIQGHP 263 (329)
T ss_pred CCCCHHHHhcCC
Confidence 46777663
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=294.59 Aligned_cols=224 Identities=17% Similarity=0.229 Sum_probs=178.6
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.||+|++... .....+.+.+|+.+++.++||||+++++.|...+.+|+|||||++|+|.+++.+.. .+++.
T Consensus 26 ~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~e~ 101 (382)
T cd05625 26 KALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFPED 101 (382)
T ss_pred CCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHH
Confidence 567999998642 23456678899999999999999999999999999999999999999999997654 57889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC------------------------
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID------------------------ 134 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~------------------------ 134 (290)
.+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (382)
T cd05625 102 LARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178 (382)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccccc
Confidence 99999999999999999999 999999999999999999999999986422100
Q ss_pred ----------------------CceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh
Q 044846 135 ----------------------RTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL 192 (290)
Q Consensus 135 ----------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~ 192 (290)
.........||+.|+|||++.+..++.++|||||||++|||++|.+||..........
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 258 (382)
T cd05625 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQM 258 (382)
T ss_pred ccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0001123468999999999999999999999999999999999999987543222111
Q ss_pred HHH-----hhhhhhHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHHH
Q 044846 193 AAY-----FSKEAEKEEVITFAMVAKRCLNLNGKKQPT---MKEVTLEL 233 (290)
Q Consensus 193 ~~~-----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~el~~~l 233 (290)
... ...+.....+.++.++|.+|+ .||.+|++ +.+++.|-
T Consensus 259 ~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 306 (382)
T cd05625 259 KVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHP 306 (382)
T ss_pred HHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCC
Confidence 111 011112234667888898876 59999987 88888774
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=287.46 Aligned_cols=217 Identities=17% Similarity=0.232 Sum_probs=172.5
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVV-ILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~-~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|++... .......+..|.. +++.++||||+++++++...+..|+||||+++|+|...+.... .+++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~ 95 (321)
T cd05603 20 GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER----CFLE 95 (321)
T ss_pred CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC----CCCH
Confidence 578999998632 2233445666665 5778899999999999999999999999999999998887643 5788
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.... .........|++.|+|||++.+.
T Consensus 96 ~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~ 171 (321)
T cd05603 96 PRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE-PEETTSTFCGTPEYLAPEVLRKE 171 (321)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC-CCCccccccCCcccCCHHHhcCC
Confidence 889999999999999999999 99999999999999999999999999764321 11223345689999999999988
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
.++.++|||||||++|+|++|.+||....... ....... ...+...+..+.+++.+||+.||.+||++.
T Consensus 172 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-MYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCcCcccccchhhhhhhcCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 89999999999999999999999886543221 1111111 111223456788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=285.34 Aligned_cols=222 Identities=20% Similarity=0.202 Sum_probs=178.4
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++|+|.+++.... .+++
T Consensus 20 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~ 95 (316)
T cd05619 20 NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH----KFDL 95 (316)
T ss_pred CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCH
Confidence 578999998742 234456677888888865 99999999999999999999999999999999997643 5888
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......||..|+|||++.+.
T Consensus 96 ~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 171 (316)
T cd05619 96 PRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLGQ 171 (316)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-CceeeecCCccccCHHHHcCC
Confidence 999999999999999999999 9999999999999999999999999976432211 122345688999999999998
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH--hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY--FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMK-EVTLE 232 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-el~~~ 232 (290)
.++.++|||||||++|+|++|..|+...... ...... .....+...+..+.+++.+||+.||++||++. +++.+
T Consensus 172 ~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-ELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 9999999999999999999999987543321 111111 11112223456788999999999999999986 67654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=276.92 Aligned_cols=228 Identities=24% Similarity=0.346 Sum_probs=179.0
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.||+|.++... ......+.+|+++++.++||||+++++++... ...+++|||+++|+|.+++... .+++.
T Consensus 33 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~l~~~ 107 (283)
T cd05080 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-----KLNLA 107 (283)
T ss_pred CceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-----CCCHH
Confidence 4578999987543 23466788999999999999999999988653 4578999999999999999753 48999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce--eeccceecccccCcccccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--LTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~ 156 (290)
.+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+++........ ......++..|+|||++.+
T Consensus 108 ~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 184 (283)
T cd05080 108 QLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc
Confidence 99999999999999999999 999999999999999999999999997654322111 1122334567999999988
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh-------------HHH----hhhhhhHHHHHHHHHHHHHhhccC
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL-------------AAY----FSKEAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~-------------~~~----~~~~~~~~~~~~~~~li~~cl~~d 219 (290)
..++.++||||||+++|+|++|..|+.......... ... .....+...+..+.+++.+||+.|
T Consensus 185 ~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 264 (283)
T cd05080 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETE 264 (283)
T ss_pred cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 889999999999999999999987764322110000 000 000111223568999999999999
Q ss_pred CCCCCCHHHHHHHHHhhH
Q 044846 220 GKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 220 p~~Rps~~el~~~l~~~~ 237 (290)
|++|||+++++..|+.+.
T Consensus 265 p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 265 AKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhCCCHHHHHHHHHHhh
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=279.17 Aligned_cols=225 Identities=17% Similarity=0.176 Sum_probs=177.8
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.... ......+..|+++++.++||||+++.+++......++||||+++|+|..++..... ..+++.
T Consensus 18 ~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~--~~~~~~ 95 (277)
T cd05607 18 GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEME 95 (277)
T ss_pred CcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccc--cCCCHH
Confidence 6789999886321 22344566799999999999999999999999999999999999999998865432 247888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...... .......|+..|+|||++.+..
T Consensus 96 ~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 170 (277)
T cd05607 96 RVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAGTNGYMAPEILKEEP 170 (277)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccCCCCCccCHHHHccCC
Confidence 99999999999999999999 999999999999999999999999987654322 1223356788999999999888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhh--hhhh-HHHhhhh---hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSL-AAYFSKE---AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~-~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++.++|+||+||++|+|++|..|+...... .... ....... .....+.++.+|+.+||+.||++||++.|+++.
T Consensus 171 ~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 999999999999999999999887542211 1111 1111111 112346678999999999999999999776544
Q ss_pred H
Q 044846 233 L 233 (290)
Q Consensus 233 l 233 (290)
+
T Consensus 251 ~ 251 (277)
T cd05607 251 P 251 (277)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=276.29 Aligned_cols=231 Identities=21% Similarity=0.238 Sum_probs=187.1
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.+|+|++.. .+....+.+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++.........+++.
T Consensus 27 ~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~ 106 (267)
T cd08229 27 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEK 106 (267)
T ss_pred CceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHH
Confidence 56789998754 234456688999999999999999999999999999999999999999999997544333468899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .......++..|+|||++.+..
T Consensus 107 ~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~ 182 (267)
T cd08229 107 TVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCC-cccccccCCcCccCHHHhcCCC
Confidence 99999999999999999999 9999999999999999999999999876543222 1122345788899999999888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
++.++|+||||+++|+|++|..|+............... .......+..+.+++.+||+.||++|||+.+|++.+
T Consensus 183 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 999999999999999999999887543322112111111 111224567899999999999999999999999988
Q ss_pred Hhh
Q 044846 234 AGI 236 (290)
Q Consensus 234 ~~~ 236 (290)
+++
T Consensus 263 ~~~ 265 (267)
T cd08229 263 KRM 265 (267)
T ss_pred hhh
Confidence 765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=278.64 Aligned_cols=228 Identities=21% Similarity=0.324 Sum_probs=182.7
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-----------C
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD-----------D 71 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~ 71 (290)
..+|+|.++.......+.+.+|+++++.++|+||+++++++...+..+++|||+++|+|.+++..... .
T Consensus 36 ~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~ 115 (280)
T cd05092 36 MLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA 115 (280)
T ss_pred eEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCC
Confidence 46788888876677778899999999999999999999999999999999999999999999976431 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccC
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVD 150 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~a 150 (290)
...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......... ......+++.|+|
T Consensus 116 ~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 192 (280)
T cd05092 116 PGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 192 (280)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccC
Confidence 124788999999999999999999999 999999999999999999999999987643322111 1122334678999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
||++.+..++.++|||||||++|+|++ |.+|+...... ........ ...+...+..+.+++.+||+.||++||++
T Consensus 193 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~ 271 (280)
T cd05092 193 PESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-EAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVI 271 (280)
T ss_pred HHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999999999999999999999999997 77766433221 11111111 11122345678999999999999999999
Q ss_pred HHHHHHHH
Q 044846 227 KEVTLELA 234 (290)
Q Consensus 227 ~el~~~l~ 234 (290)
.+|+..|+
T Consensus 272 ~~l~~~l~ 279 (280)
T cd05092 272 KDIHSRLQ 279 (280)
T ss_pred HHHHHHHh
Confidence 99998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=274.19 Aligned_cols=226 Identities=23% Similarity=0.295 Sum_probs=179.7
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
++.+|+|+++... ....+.+.+|+.+++.++||||+++++++. .+..++||||+++|+|.+++.... .+++..
T Consensus 22 ~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~ 96 (257)
T cd05116 22 EKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK----HVTEKN 96 (257)
T ss_pred ceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC----CCCHHH
Confidence 4678999886433 345678999999999999999999999875 456789999999999999997644 588999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee--ccceecccccCccccccC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT--TQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~ 157 (290)
+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++........... ....++..|+|||.+...
T Consensus 97 ~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05116 97 ITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173 (257)
T ss_pred HHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccC
Confidence 9999999999999999999 99999999999999999999999999875443322211 122335789999999888
Q ss_pred CCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.++.++|+|||||++||+++ |.+|+...... ........ ...+...+.++.++|.+||+.||++||++++|.+.|
T Consensus 174 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 88999999999999999997 88777543221 11111111 112234567899999999999999999999999998
Q ss_pred Hhh
Q 044846 234 AGI 236 (290)
Q Consensus 234 ~~~ 236 (290)
++.
T Consensus 253 ~~~ 255 (257)
T cd05116 253 RNY 255 (257)
T ss_pred hcc
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=277.41 Aligned_cols=228 Identities=19% Similarity=0.316 Sum_probs=178.1
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC------CCCC
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD------QLPI 75 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~ 75 (290)
+.||+|+++.. .......+.+|+.+++.++||||+++++++......++||||+++|+|.+++...... ...+
T Consensus 37 ~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 116 (277)
T cd05062 37 TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116 (277)
T ss_pred eEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCC
Confidence 46899988643 2345667899999999999999999999999999999999999999999999764321 1235
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee-eccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~ 154 (290)
++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++......... .....++..|+|||++
T Consensus 117 ~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05062 117 SLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 193 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHh
Confidence 77888999999999999999998 9999999999999999999999999876433221111 1123346789999999
Q ss_pred ccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.+..++.++|||||||++|+|++ |..|+..... ......... ...+...+..+.+++.+||+.||++|||+.|++
T Consensus 194 ~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 272 (277)
T cd05062 194 KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272 (277)
T ss_pred hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 98889999999999999999998 5665543322 111111111 111223456799999999999999999999999
Q ss_pred HHHH
Q 044846 231 LELA 234 (290)
Q Consensus 231 ~~l~ 234 (290)
.+|+
T Consensus 273 ~~l~ 276 (277)
T cd05062 273 SSIK 276 (277)
T ss_pred HHhh
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=274.57 Aligned_cols=232 Identities=21% Similarity=0.262 Sum_probs=187.9
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|.++. .+....+.+.+|++++++++|+||+++++++...+..++||||+++|+|.+++.........+++.
T Consensus 27 ~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 106 (267)
T cd08224 27 GRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPER 106 (267)
T ss_pred CCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHH
Confidence 67899998753 334446789999999999999999999999999999999999999999999997654444468899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .......++..|+|||.+.+..
T Consensus 107 ~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~ 182 (267)
T cd08224 107 TIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred HHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCC-cccceecCCccccCHHHhccCC
Confidence 99999999999999999999 9999999999999999999999999876433221 1123345778899999999888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhh-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEA-EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
++.++|+||||+++|++++|..|+............... ... ....+..+.++|.+||..+|++|||+.+|++.|
T Consensus 183 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 999999999999999999999887544322111111111 111 224556799999999999999999999999999
Q ss_pred HhhH
Q 044846 234 AGIR 237 (290)
Q Consensus 234 ~~~~ 237 (290)
+.+.
T Consensus 263 ~~~~ 266 (267)
T cd08224 263 KEMH 266 (267)
T ss_pred HHhc
Confidence 8763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.12 Aligned_cols=223 Identities=20% Similarity=0.229 Sum_probs=181.6
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
++.||+|+++.. .......+..|.++++.+ +||||+++++++...+..|+||||+++|+|..++.... .+++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~l~~ 95 (318)
T cd05570 20 DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG----RFDE 95 (318)
T ss_pred CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC----CCCH
Confidence 568999998742 344566788899999988 79999999999999999999999999999999987654 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......|+..|+|||++.+.
T Consensus 96 ~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~ 171 (318)
T cd05570 96 PRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQ 171 (318)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-CcccceecCccccCHHHhcCC
Confidence 999999999999999999999 9999999999999999999999999876432211 122335688999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTM-----KEVT 230 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~el~ 230 (290)
.++.++|||||||++|+|++|..||....... ....... ...+...+..+.+||.+||+.||.+|||+ .+++
T Consensus 172 ~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll 250 (318)
T cd05570 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-LFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIK 250 (318)
T ss_pred CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHh
Confidence 99999999999999999999999885433221 1111111 11222345678999999999999999999 8887
Q ss_pred HHH
Q 044846 231 LEL 233 (290)
Q Consensus 231 ~~l 233 (290)
.+-
T Consensus 251 ~~~ 253 (318)
T cd05570 251 GHP 253 (318)
T ss_pred cCC
Confidence 663
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=294.00 Aligned_cols=222 Identities=22% Similarity=0.303 Sum_probs=187.8
Q ss_pred EEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHH
Q 044846 5 WLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRIT 84 (290)
Q Consensus 5 ~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 84 (290)
.|-|++...+..+.+.|+-|++||..++||+||++++.|+..+.+||+.|||.||-+..++-.... .+++.++..++
T Consensus 60 AAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r---~LtE~QIqvvc 136 (1187)
T KOG0579|consen 60 AAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR---VLTEDQIQVVC 136 (1187)
T ss_pred hhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhcc---ccchHHHHHHH
Confidence 456777777788899999999999999999999999999999999999999999999999987764 69999999999
Q ss_pred HHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc-----cCCC
Q 044846 85 VEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-----SSQF 159 (290)
Q Consensus 85 ~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~ 159 (290)
.|++.||.|||+++ |||||||..|||++-+|.++|+|||.+...... ...-.++.||++|||||+.. ...|
T Consensus 137 ~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRDsFIGTPYWMAPEVvmCET~KD~PY 212 (1187)
T KOG0579|consen 137 YQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRDSFIGTPYWMAPEVVMCETFKDQPY 212 (1187)
T ss_pred HHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-HhhhccccCCcccccchheeeccccCCCc
Confidence 99999999999999 999999999999999999999999986432211 12234689999999999865 4679
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhh-----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKE-----AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.++||||||++|.||..+.||.. +......+....... .+..++..|.+++.+||..||..||++++|++|.+
T Consensus 213 DykaDiWSlGITLIEMAqiEPPHh-elnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 213 DYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred hhhhhHHhhhhHHHHHhccCCCcc-ccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 999999999999999999988764 333333333333322 34578889999999999999999999999998754
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=277.37 Aligned_cols=219 Identities=17% Similarity=0.273 Sum_probs=171.5
Q ss_pred eEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHH
Q 044846 4 LWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI 83 (290)
Q Consensus 4 ~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 83 (290)
.||+|++..........+.+|+.+++.++||||+++++++......++||||+++|+|..++..... .+++..+..+
T Consensus 46 ~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i 122 (274)
T cd05076 46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITV 122 (274)
T ss_pred eEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHH
Confidence 4888888765555567889999999999999999999999999999999999999999999875432 5788999999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-------cEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-------QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 84 ~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+.||+.||+|||+++ |+||||||+||+++..+ .+|++|||++..... .....++..|+|||.+.+
T Consensus 123 ~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~-----~~~~~~~~~~~aPe~~~~ 194 (274)
T cd05076 123 AQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS-----REERVERIPWIAPECVPG 194 (274)
T ss_pred HHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCcccccccc-----ccccccCCcccCchhhcC
Confidence 999999999999998 99999999999997643 379999998643221 112346778999998875
Q ss_pred -CCCCCcccchhhHHHHHHHh-cCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 157 -SQFTEKSDVYSFSVVLVELN-WTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 157 -~~~~~~~DiwS~G~il~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
..++.++||||||+++|+++ +|..|+..................+......+.++|.+||+.+|++|||+.++++.|
T Consensus 195 ~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 195 GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 56889999999999999985 677666433221111100000111112335689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=279.94 Aligned_cols=223 Identities=22% Similarity=0.309 Sum_probs=172.9
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhc---CCCceeeEEeEEEe-----CCcceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQI---NHRNVVKILGCCLE-----TEVPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l---~Hpniv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||+|+++... ......+.+|+.+++.+ +||||+++++++.. ...+++||||+. ++|.+++......
T Consensus 27 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~ 105 (290)
T cd07862 27 GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP 105 (290)
T ss_pred CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCC
Confidence 4678999886432 23345667788887766 69999999999863 346899999995 6999999765432
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .......|+..|+||
T Consensus 106 --~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aP 178 (290)
T cd07862 106 --GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAP 178 (290)
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC--cccccccccccccCh
Confidence 4788999999999999999999999 999999999999999999999999997654322 223345688999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHhhh--------------------------hhhHH
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYFSK--------------------------EAEKE 203 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~~~--------------------------~~~~~ 203 (290)
|++.+..++.++|||||||++|+|++|.++|........ ........ .....
T Consensus 179 E~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T cd07862 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 258 (290)
T ss_pred HHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccC
Confidence 999888899999999999999999999998864432111 11000000 00012
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 204 EVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 204 ~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.+..+.+|+.+||+.||++|||+.|++++
T Consensus 259 ~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 259 IDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 34567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=264.99 Aligned_cols=226 Identities=19% Similarity=0.200 Sum_probs=191.2
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
+-.||+|++.. .......++.+|+++-..|+||||++++++|.+....||++||.++|+|+..|...... .+++.
T Consensus 47 ~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~--~f~e~ 124 (281)
T KOG0580|consen 47 LFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMK--RFDEQ 124 (281)
T ss_pred CcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccc--ccccc
Confidence 34689999853 22334567899999999999999999999999999999999999999999999965543 58889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
....++.|+|.||.|+|.++ +|||||||+|+|++..+.+|++|||-+.... ...-.+..||.-|++||+..+..
T Consensus 125 ~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~ 198 (281)
T KOG0580|consen 125 RAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRG 198 (281)
T ss_pred chhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC---CCCceeeecccccCCHhhcCCCC
Confidence 99999999999999999999 9999999999999999999999999865433 23334578999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
++..+|+|++|++.||++.|.+||.... ....+..... -..+...+...+++|.+|+..+|.+|.+..|++++.+-.
T Consensus 199 hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 199 HDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred ccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 9999999999999999999999997554 3232322222 223456677899999999999999999999999998754
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=278.63 Aligned_cols=229 Identities=26% Similarity=0.373 Sum_probs=179.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++.......+.+.+|+++++.++||||+++++++.. ....++||||+++|+|.+++..... .+++..
T Consensus 33 ~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~l~~~~ 109 (284)
T cd05081 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE---RLDHRK 109 (284)
T ss_pred CcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCc---CCCHHH
Confidence 56799999987777777889999999999999999999998754 3468899999999999999976432 478999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee--eccceecccccCccccccC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL--TTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~ 157 (290)
+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......... .....++..|+|||++.+.
T Consensus 110 ~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 186 (284)
T cd05081 110 LLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186 (284)
T ss_pred HHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC
Confidence 9999999999999999999 9999999999999999999999999987543322211 1112234569999999988
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhh--------------hhHHHhh----hhhhHHHHHHHHHHHHHhhccC
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--------------SLAAYFS----KEAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--------------~~~~~~~----~~~~~~~~~~~~~li~~cl~~d 219 (290)
.++.++||||||+++|||+++..++........ .+..... .......+..+.+|+.+||..+
T Consensus 187 ~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 266 (284)
T cd05081 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNND 266 (284)
T ss_pred CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCC
Confidence 899999999999999999987654322111000 0000000 0111223467999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 044846 220 GKKQPTMKEVTLELAGI 236 (290)
Q Consensus 220 p~~Rps~~el~~~l~~~ 236 (290)
|++|||+.|+++.|+.+
T Consensus 267 p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 267 PSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhCCCHHHHHHHHHhc
Confidence 99999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=272.87 Aligned_cols=226 Identities=18% Similarity=0.271 Sum_probs=181.0
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
+.||+|.++... ...+.+.+|++++++++||||+++++++...+..+++|||+++++|.+++..... ..+++..+..
T Consensus 31 ~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~ 107 (261)
T cd05068 31 TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLID 107 (261)
T ss_pred eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCC--CCCCHHHHHH
Confidence 568999887533 3456789999999999999999999999999999999999999999999976542 2588999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+++...............+..|+|||++.+..++.+
T Consensus 108 ~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 184 (261)
T cd05068 108 MAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184 (261)
T ss_pred HHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCch
Confidence 9999999999999999 9999999999999999999999999976543221111122223457999999998899999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+|+||||+++|++++ |..|+...... ........ ...+...+..+.+++.+||+.||++||++.++...|+.
T Consensus 185 ~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 185 SDVWSFGILLTEIVTYGRMPYPGMTNA-EVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 999999999999998 77766433221 11111111 11223456779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=274.12 Aligned_cols=223 Identities=22% Similarity=0.326 Sum_probs=177.2
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
+.+|+|+++.... ....+.+|+++++.++||||+++++++...+..++||||+++++|.+++..... .+++..+..
T Consensus 29 ~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~ 104 (256)
T cd05059 29 IDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLD 104 (256)
T ss_pred ccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc---CCCHHHHHH
Confidence 4688998764332 345688999999999999999999999999999999999999999999976442 588999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..............++..|+|||.+.+..++.+
T Consensus 105 i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~ 181 (256)
T cd05059 105 MCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181 (256)
T ss_pred HHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCch
Confidence 9999999999999999 9999999999999999999999999876543221111122233457999999998899999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+|+||||+++|++++ |..|+...... ....... ....+...+..+.+++.+||..+|++|||+.|+++.|
T Consensus 182 ~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 182 SDVWSFGVLMWEVFSEGKMPYERFSNS-EVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 999999999999998 66666432221 1111111 1122234567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=273.29 Aligned_cols=226 Identities=22% Similarity=0.303 Sum_probs=177.9
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..||+|+.+... ....+.+.+|+.++++++||||+++++++. ....++||||+++|+|.+++..... .+++..++
T Consensus 23 ~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~ 98 (257)
T cd05115 23 IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKD---EITVSNVV 98 (257)
T ss_pred eeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCC---CCCHHHHH
Confidence 358899887543 334567999999999999999999999885 4568999999999999999975432 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee--ccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT--TQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........... ....++..|+|||++....+
T Consensus 99 ~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05115 99 ELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175 (257)
T ss_pred HHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCC
Confidence 99999999999999999 99999999999999999999999999764332222111 11223567999999988889
Q ss_pred CCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 160 TEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+.++||||||+++|++++ |..|+....... ....... ...+...+.++.+++.+||..||++||++.++.+.|+.
T Consensus 176 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 999999999999999985 777765332211 1111111 11223446789999999999999999999999998875
Q ss_pred h
Q 044846 236 I 236 (290)
Q Consensus 236 ~ 236 (290)
.
T Consensus 255 ~ 255 (257)
T cd05115 255 Y 255 (257)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=290.07 Aligned_cols=225 Identities=19% Similarity=0.215 Sum_probs=179.1
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++. ......+.+.+|+.+++.++||||+++++++...+..|+|||||++|+|.+++... .+++.
T Consensus 68 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~ 142 (370)
T cd05621 68 QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DVPEK 142 (370)
T ss_pred CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHH
Confidence 56799998853 22334556889999999999999999999999999999999999999999999753 37888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...............||+.|+|||++.+..
T Consensus 143 ~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 219 (370)
T cd05621 143 WAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219 (370)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccC
Confidence 99999999999999999999 999999999999999999999999998754322222234567899999999987643
Q ss_pred ----CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCC--CCCH
Q 044846 159 ----FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKK--QPTM 226 (290)
Q Consensus 159 ----~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~--Rps~ 226 (290)
++.++|+||+||++|+|++|.+||....... ....... .+.....+..+.+++.+||..++.+ |+|+
T Consensus 220 ~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~ 298 (370)
T cd05621 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGV 298 (370)
T ss_pred CCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCH
Confidence 7789999999999999999999986543221 1111111 1111234667889999999855543 8899
Q ss_pred HHHHHHHHh
Q 044846 227 KEVTLELAG 235 (290)
Q Consensus 227 ~el~~~l~~ 235 (290)
.|+++|.+.
T Consensus 299 ~e~l~hp~~ 307 (370)
T cd05621 299 EEIKQHPFF 307 (370)
T ss_pred HHHhcCccc
Confidence 999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=289.53 Aligned_cols=223 Identities=22% Similarity=0.239 Sum_probs=174.6
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|++.... ......+.+|+++++.++|+||+++++++...+.+++||||+.+|+|.... ..++..+
T Consensus 99 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~ 170 (353)
T PLN00034 99 GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFL 170 (353)
T ss_pred CCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc--------cCCHHHH
Confidence 5789999986433 344567899999999999999999999999999999999999999986432 3556778
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc----
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS---- 156 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---- 156 (290)
..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......|+..|+|||++..
T Consensus 171 ~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 246 (353)
T PLN00034 171 ADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCNSSVGTIAYMSPERINTDLNH 246 (353)
T ss_pred HHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccccccccCccccCcccccccccc
Confidence 889999999999999999 9999999999999999999999999976543221 11234568999999998753
Q ss_pred -CCCCCcccchhhHHHHHHHhcCCCCcccchhhh-hhhHH-H---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 157 -SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEEN-RSLAA-Y---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 157 -~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~-~~~~~-~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
...+.++|||||||++|+|++|+.+|....... ..... . .........+.++.+||.+||+.||++|||+.|++
T Consensus 247 ~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell 326 (353)
T PLN00034 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLL 326 (353)
T ss_pred CcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 224568999999999999999998886322111 11110 0 01112234567799999999999999999999999
Q ss_pred HHHHhh
Q 044846 231 LELAGI 236 (290)
Q Consensus 231 ~~l~~~ 236 (290)
++-+-.
T Consensus 327 ~hp~~~ 332 (353)
T PLN00034 327 QHPFIL 332 (353)
T ss_pred cCcccc
Confidence 886533
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=273.51 Aligned_cols=230 Identities=19% Similarity=0.289 Sum_probs=180.3
Q ss_pred ceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc------ceEEEEeCCCCCHHHHHhhcCC--CC
Q 044846 3 ELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEV------PLLVYEFIPNGSLYQYIHEQTD--DQ 72 (290)
Q Consensus 3 ~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~--~~ 72 (290)
+.||+|+++.. .......+.+|++.++.++||||+++++++..... .++++||+++|+|..++..... ..
T Consensus 28 ~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~ 107 (273)
T cd05035 28 LKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP 107 (273)
T ss_pred ceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCc
Confidence 56999998743 34456789999999999999999999998866543 7999999999999999865432 22
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee-eccceecccccCc
Q 044846 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFGYVDP 151 (290)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aP 151 (290)
..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......... .....++..|+||
T Consensus 108 ~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 184 (273)
T cd05035 108 EKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 184 (273)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCH
Confidence 35888999999999999999999999 9999999999999999999999999987543322111 1112345679999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
|++.+..++.++|||||||++|||++ |.+|+... ........... ...+...+..+.+++.+||+.||++|||+.
T Consensus 185 e~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 263 (273)
T cd05035 185 ESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFT 263 (273)
T ss_pred hhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99988889999999999999999998 66665432 22222211111 112234567899999999999999999999
Q ss_pred HHHHHHHhh
Q 044846 228 EVTLELAGI 236 (290)
Q Consensus 228 el~~~l~~~ 236 (290)
|+++.|+.+
T Consensus 264 e~~~~l~~~ 272 (273)
T cd05035 264 KLREVLENI 272 (273)
T ss_pred HHHHHHHhh
Confidence 999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=284.29 Aligned_cols=234 Identities=23% Similarity=0.312 Sum_probs=181.9
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhc-CCCceeeEEeEEEe-CCcceEEEEeCCCCCHHHHHhhcCCC-------
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQI-NHRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYIHEQTDD------- 71 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~------- 71 (290)
++.||+|+++... ....+.+.+|++++.++ +||||++++++|.. ...++++|||+++|+|.+++......
T Consensus 37 ~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~ 116 (337)
T cd05054 37 CRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNK 116 (337)
T ss_pred cceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccc
Confidence 3679999987533 33456788999999999 89999999998865 45788999999999999999653211
Q ss_pred --------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 044846 72 --------------------------------------------------QLPITWEMRLRITVEVSRVLSYLHSVASIP 101 (290)
Q Consensus 72 --------------------------------------------------~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~ 101 (290)
..++++..+..++.||+.||.|||+++
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--- 193 (337)
T cd05054 117 STRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--- 193 (337)
T ss_pred cccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 125788999999999999999999999
Q ss_pred eEeccCCCCceEeccCCcEEEeccccccccccCCcee-eccceecccccCccccccCCCCCcccchhhHHHHHHHhc-CC
Q 044846 102 IYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TK 179 (290)
Q Consensus 102 iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~ 179 (290)
|+||||||+||+++.++.++|+|||++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 194 ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~ 273 (337)
T cd05054 194 CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 273 (337)
T ss_pred eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999987543222111 123445678999999999999999999999999999997 87
Q ss_pred CCcccchhhhh---hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 180 PIHLVDVEENR---SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 180 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
.|+........ ..........+.....++.+++.+||+.+|++||++.|++++|+.+..
T Consensus 274 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 274 SPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 77643211111 111111111122345678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=272.91 Aligned_cols=227 Identities=19% Similarity=0.296 Sum_probs=181.9
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..||+|+++.. .......|.+|+.+++.++||||+++++++...+..+++|||+++|+|.+++..... .+++..+.
T Consensus 33 ~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~ 109 (266)
T cd05033 33 IDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLV 109 (266)
T ss_pred ceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC---CCCHHHHH
Confidence 36889988643 344466799999999999999999999999999999999999999999999976543 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee-eccceecccccCccccccCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.......... .....++..|+|||.+.+..++
T Consensus 110 ~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 186 (266)
T cd05033 110 GMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186 (266)
T ss_pred HHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCc
Confidence 99999999999999999 9999999999999999999999999987654222111 1123345679999999988999
Q ss_pred CcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 161 EKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.++|+||||+++|++++ |..|+...... ....... ..+.+...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 187 ~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 187 SASDVWSFGIVMWEVMSYGERPYWDMSNQ-DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred cccchHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999886 77766432211 1111111 1122234466789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=282.30 Aligned_cols=230 Identities=20% Similarity=0.325 Sum_probs=181.4
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.||+|+++.. .....+.+.+|+.+++.++||||+++++++... ..++++||+++|+|.+++..... .+++..++.
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~ 113 (316)
T cd05108 38 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD---NIGSQYLLN 113 (316)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccc---cCCHHHHHH
Confidence 3899998743 344567899999999999999999999999765 57899999999999999986542 478888999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee-ccceecccccCccccccCCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT-TQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......... ....++..|+|||++.+..++.
T Consensus 114 ~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 190 (316)
T cd05108 114 WCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTH 190 (316)
T ss_pred HHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCc
Confidence 9999999999999999 99999999999999999999999999875443222211 2233456799999999999999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhh-hh-HHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENR-SL-AAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++||||||+++|++++ |..|+........ .. ........+..++.++.+++.+||..||.+|||+.+++..+..+..
T Consensus 191 ~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 191 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 9999999999999986 7777643322111 11 1001111222345678999999999999999999999999887765
Q ss_pred hh
Q 044846 239 SI 240 (290)
Q Consensus 239 ~~ 240 (290)
..
T Consensus 271 ~~ 272 (316)
T cd05108 271 DP 272 (316)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=278.88 Aligned_cols=228 Identities=21% Similarity=0.314 Sum_probs=181.7
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
..+|+|+++... ....+.+.+|+++++++ +||||+++++++...+..+++|||+++|+|.+++...... .+++.++
T Consensus 66 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~--~l~~~~~ 143 (302)
T cd05055 66 MKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES--FLTLEDL 143 (302)
T ss_pred eEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCC--CCCHHHH
Confidence 368889887543 44466789999999999 8999999999999999999999999999999999764321 3789999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.|++.||.|||+++ |+|+||||+||+++.++.++++|||+++........ ......++..|+|||++.+..+
T Consensus 144 ~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 220 (302)
T cd05055 144 LSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY 220 (302)
T ss_pred HHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCC
Confidence 999999999999999999 999999999999999999999999998754322211 1222345678999999998889
Q ss_pred CCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.++|||||||++|++++ |.+|+....... ....... ...+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 221 ~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~ 299 (302)
T cd05055 221 TFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299 (302)
T ss_pred CcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 999999999999999997 777764332211 1111111 1112233567999999999999999999999999987
Q ss_pred hh
Q 044846 235 GI 236 (290)
Q Consensus 235 ~~ 236 (290)
.+
T Consensus 300 ~~ 301 (302)
T cd05055 300 KQ 301 (302)
T ss_pred hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=273.85 Aligned_cols=225 Identities=22% Similarity=0.262 Sum_probs=180.6
Q ss_pred CceEEEEeecccC-----chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVH-----ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|+||+++++|.+++.... .++
T Consensus 27 ~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~----~~~ 102 (263)
T cd06625 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG----ALT 102 (263)
T ss_pred CcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC----CCC
Confidence 5789999876432 2234678899999999999999999999999999999999999999999998654 578
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee--ccceecccccCcccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT--TQVKVTFGYVDPKYF 154 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~ 154 (290)
...+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++.......... ....++..|+|||++
T Consensus 103 ~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 179 (263)
T cd06625 103 ETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179 (263)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCccee
Confidence 8899999999999999999999 99999999999999999999999999764322111111 234567889999999
Q ss_pred ccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
.+..++.++||||||+++|++++|++|+............. .....+...+..+.+++.+||..+|++|||+.+++.
T Consensus 180 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred ccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 99889999999999999999999998875432221111110 011122345667899999999999999999999987
Q ss_pred HH
Q 044846 232 EL 233 (290)
Q Consensus 232 ~l 233 (290)
+.
T Consensus 260 ~~ 261 (263)
T cd06625 260 HF 261 (263)
T ss_pred CC
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=289.59 Aligned_cols=223 Identities=19% Similarity=0.245 Sum_probs=177.1
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+..|+.++..++||||+++++.+.+....|+|||||++|+|.+++.... .+++.
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~l~~~ 101 (363)
T cd05628 26 GHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD----TLTEE 101 (363)
T ss_pred CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC----CCCHH
Confidence 678999998642 23345678889999999999999999999999999999999999999999998654 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-----------------------
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR----------------------- 135 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----------------------- 135 (290)
.+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (363)
T cd05628 102 ETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178 (363)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccccccc
Confidence 99999999999999999999 9999999999999999999999999986432110
Q ss_pred -----------ceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------h
Q 044846 136 -----------THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------K 198 (290)
Q Consensus 136 -----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~ 198 (290)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||....... ....... .
T Consensus 179 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~ 257 (363)
T cd05628 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE-TYKKVMNWKETLIF 257 (363)
T ss_pred ccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCcCcccC
Confidence 001123568999999999999999999999999999999999999986443221 1111111 1
Q ss_pred hhhHHHHHHHHHHHHHhhccCCC---CCCCHHHHHHHH
Q 044846 199 EAEKEEVITFAMVAKRCLNLNGK---KQPTMKEVTLEL 233 (290)
Q Consensus 199 ~~~~~~~~~~~~li~~cl~~dp~---~Rps~~el~~~l 233 (290)
+.....+.++.++|.+++. +|. .||+++|+++|-
T Consensus 258 p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp 294 (363)
T cd05628 258 PPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNP 294 (363)
T ss_pred CCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCC
Confidence 1112245678888888654 444 468999999883
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=279.21 Aligned_cols=226 Identities=19% Similarity=0.172 Sum_probs=181.3
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.... ......+.+|+.+++.++||||+++++.+...+..++||||+++|+|.+++..... ..+++.
T Consensus 25 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~ 102 (285)
T cd05605 25 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN--PGFDEE 102 (285)
T ss_pred CceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCc--CCCCHH
Confidence 5789999986422 22345678899999999999999999999999999999999999999998875432 258899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ......|+..|+|||++.+..
T Consensus 103 ~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 177 (285)
T cd05605 103 RAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGRVGTVGYMAPEVVKNER 177 (285)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--ccccccCCCCccCcHHhcCCC
Confidence 99999999999999999999 9999999999999999999999999976533221 223346788999999999888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKE 228 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~e 228 (290)
++.++||||+||++|++++|..||........ ...... ....+...+..+.+|+.+||+.||.+|| ++++
T Consensus 178 ~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 257 (285)
T cd05605 178 YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEE 257 (285)
T ss_pred CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHH
Confidence 99999999999999999999998864322111 111111 1112234567789999999999999999 8889
Q ss_pred HHHHHH
Q 044846 229 VTLELA 234 (290)
Q Consensus 229 l~~~l~ 234 (290)
++.+.+
T Consensus 258 l~~~~~ 263 (285)
T cd05605 258 VKAHPF 263 (285)
T ss_pred HhcCcC
Confidence 887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=274.83 Aligned_cols=223 Identities=23% Similarity=0.262 Sum_probs=179.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+++++|.+++.... .+++..++
T Consensus 34 ~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~ 109 (267)
T cd06645 34 GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIA 109 (267)
T ss_pred CcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC----CCCHHHHH
Confidence 57899999886666666778899999999999999999999999999999999999999999987654 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---cCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR---SSQ 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~ 158 (290)
.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...... ........|+..|+|||++. ...
T Consensus 110 ~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 185 (267)
T cd06645 110 YVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGG 185 (267)
T ss_pred HHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccccccccCcccccChhhhccccCCC
Confidence 99999999999999999 999999999999999999999999987543221 11223456788999999974 445
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hh---hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KE---AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++.++|+|||||++|+|++|.+|+............... .. .....+..+.+++.+||+.||++|||+++++++
T Consensus 186 ~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 788999999999999999999887543322111111000 00 011234568899999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.90 Aligned_cols=232 Identities=18% Similarity=0.292 Sum_probs=198.8
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..||+|.+|... +.++..|+.|+.||.+++||||++|.|+.......+||.|||++|+|..||+.+.. .|+..+..
T Consensus 658 ~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG---qftviQLV 734 (996)
T KOG0196|consen 658 ITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG---QFTVIQLV 734 (996)
T ss_pred eeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHH
Confidence 469999999755 55677899999999999999999999999999999999999999999999998764 48899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeecccee--cccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKV--TFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~~~ 159 (290)
.++++|+.||+||-+.+ ++||||..+|||++.+-.||++|||+++....+....+++..| +++|.|||.+...++
T Consensus 735 gMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKF 811 (996)
T KOG0196|consen 735 GMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKF 811 (996)
T ss_pred HHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhccc
Confidence 99999999999999999 9999999999999999999999999998665444333444433 578999999999999
Q ss_pred CCcccchhhHHHHHHHh-cCCCCcccchhh--hhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 160 TEKSDVYSFSVVLVELN-WTKPIHLVDVEE--NRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
+.++||||||+++||.+ .|..|+.....+ ...+..-++-+.+.+++..+..|+..||++|-.+||.+.+|+..|.++
T Consensus 812 TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 812 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 99999999999999965 777777644322 222333345566778899999999999999999999999999999988
Q ss_pred Hhhh
Q 044846 237 RASI 240 (290)
Q Consensus 237 ~~~~ 240 (290)
-+..
T Consensus 892 IrnP 895 (996)
T KOG0196|consen 892 IRNP 895 (996)
T ss_pred hcCc
Confidence 7643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=291.90 Aligned_cols=228 Identities=21% Similarity=0.344 Sum_probs=188.7
Q ss_pred eEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 4 LWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 4 ~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
.||||++.... .+..+.|.+|+..+++-+|.||+-+.|+|...+. .||+-+|+|.+|+.+++.... .|+..+.+
T Consensus 416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~i 491 (678)
T KOG0193|consen 416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQET---KFDMNTTI 491 (678)
T ss_pred ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhh---hhhHHHHH
Confidence 48999997533 4468899999999999999999999999999887 899999999999999987653 69999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccccccccc-CCceeeccceecccccCcccccc---C
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI-DRTHLTTQVKVTFGYVDPKYFRS---S 157 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~---~ 157 (290)
.|++||++|+.|||.++ |||||||..||++.++++|||.|||++....- ..........|...|||||+++- .
T Consensus 492 dIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~n 568 (678)
T KOG0193|consen 492 DIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDN 568 (678)
T ss_pred HHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccC
Confidence 99999999999999999 99999999999999999999999999865332 12222344567788999999874 4
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.|++.+||||||+++|||++|.-|+......+. +...-++ ....++..++++|+..||..++++||.+.+|+
T Consensus 569 PfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-ifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il 647 (678)
T KOG0193|consen 569 PFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-IFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLL 647 (678)
T ss_pred CCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-EEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHH
Confidence 589999999999999999999988873333322 2222111 22335667899999999999999999999999
Q ss_pred HHHHhhHhh
Q 044846 231 LELAGIRAS 239 (290)
Q Consensus 231 ~~l~~~~~~ 239 (290)
..|+.+..+
T Consensus 648 ~~l~~l~~~ 656 (678)
T KOG0193|consen 648 SKLEELLPS 656 (678)
T ss_pred HHHHHhhhc
Confidence 988888764
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=276.49 Aligned_cols=224 Identities=24% Similarity=0.273 Sum_probs=179.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+++.........+.+|+.++++++||||+++++++...+..++||||+++++|.+++.... .+++..+.
T Consensus 34 ~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~ 109 (267)
T cd06646 34 GELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIA 109 (267)
T ss_pred CeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHH
Confidence 56789999876555666778899999999999999999999999999999999999999999987543 58889999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---cCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR---SSQ 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~ 158 (290)
.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ........++..|+|||.+. ...
T Consensus 110 ~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~ 185 (267)
T cd06646 110 YVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT-IAKRKSFIGTPYWMAPEVAAVEKNGG 185 (267)
T ss_pred HHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc-ccccCccccCccccCHhHcccccCCC
Confidence 99999999999999998 999999999999999999999999997643221 11123345788899999874 345
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHH---Hhhh---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA---YFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++.++|+|||||++|+|++|.+|+............ .... ......+..+.+++.+||+.||++|||+++++++
T Consensus 186 ~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 778999999999999999999877533211111100 0000 0112345678999999999999999999999876
Q ss_pred H
Q 044846 233 L 233 (290)
Q Consensus 233 l 233 (290)
+
T Consensus 266 l 266 (267)
T cd06646 266 L 266 (267)
T ss_pred C
Confidence 5
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=275.87 Aligned_cols=219 Identities=20% Similarity=0.345 Sum_probs=174.1
Q ss_pred eEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHH
Q 044846 4 LWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI 83 (290)
Q Consensus 4 ~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 83 (290)
.+|+|..........+.+..|+.+++.++||||+++++++......++||||+.+|+|.+++..... .+++..++.+
T Consensus 29 ~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~ 105 (258)
T cd05078 29 EVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN---LINISWKLEV 105 (258)
T ss_pred hhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC---CCCHHHHHHH
Confidence 3677777655555667889999999999999999999999999999999999999999999986543 4788999999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc--------EEEeccccccccccCCceeeccceecccccCccccc
Q 044846 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ--------AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 84 ~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
+.||+.||+|||+++ |+||||||+||+++.++. ++++|||++..... .....++..|+|||++.
T Consensus 106 ~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~ 177 (258)
T cd05078 106 AKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-----KEILLERIPWVPPECIE 177 (258)
T ss_pred HHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccccCC-----chhccccCCccCchhcc
Confidence 999999999999999 999999999999987765 69999998654321 12345778899999998
Q ss_pred cC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh-hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 156 SS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF-SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 156 ~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+. .++.++||||||+++|++++|..++.............. ....+.....++.+++.+||+.||++|||++++++.|
T Consensus 178 ~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 74 578899999999999999998654443322222111111 1111222346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=275.88 Aligned_cols=229 Identities=18% Similarity=0.302 Sum_probs=179.6
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-----------
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD----------- 70 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------- 70 (290)
+.+|+|.++... ......+.+|+++++.++||||+++++++...+..|+||||+++|+|.+++.....
T Consensus 35 ~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 114 (283)
T cd05090 35 QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114 (283)
T ss_pred ceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccc
Confidence 568899887433 34456788999999999999999999999999999999999999999999864321
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceeccc
Q 044846 71 --DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFG 147 (290)
Q Consensus 71 --~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~ 147 (290)
....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....... .......++..
T Consensus 115 ~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 191 (283)
T cd05090 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191 (283)
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccce
Confidence 1124788889999999999999999999 99999999999999999999999999865432211 11223345677
Q ss_pred ccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhh--hhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 148 YVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEEN--RSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 148 y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
|+|||++.+..++.++|+||||+++|+|++ |.+|+....... ...........+...+..+.+++.+||+.||.+||
T Consensus 192 y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 271 (283)
T cd05090 192 WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271 (283)
T ss_pred ecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCc
Confidence 999999988889999999999999999997 777664322111 11111111112233456789999999999999999
Q ss_pred CHHHHHHHHH
Q 044846 225 TMKEVTLELA 234 (290)
Q Consensus 225 s~~el~~~l~ 234 (290)
++.++.++|.
T Consensus 272 ~~~~i~~~l~ 281 (283)
T cd05090 272 RFKDIHTRLR 281 (283)
T ss_pred CHHHHHHHhh
Confidence 9999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=277.03 Aligned_cols=230 Identities=20% Similarity=0.301 Sum_probs=180.9
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcC-----------
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT----------- 69 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------- 69 (290)
..+|+|.++.. .......+.+|+++++.+ +||||+++++++...+..+++|||+++|+|..++....
T Consensus 43 ~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 122 (293)
T cd05053 43 STVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP 122 (293)
T ss_pred eeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccc
Confidence 46888988643 334556789999999999 89999999999999999999999999999999997532
Q ss_pred -CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee-eccceeccc
Q 044846 70 -DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFG 147 (290)
Q Consensus 70 -~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~ 147 (290)
.....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......... .....++..
T Consensus 123 ~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~ 199 (293)
T cd05053 123 RPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVK 199 (293)
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCcc
Confidence 12235889999999999999999999999 9999999999999999999999999987543221111 122234567
Q ss_pred ccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 148 YVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 148 y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
|+|||++.+..++.++|||||||++|++++ |..++...... ........ ...+...+..+.+|+.+||..||++|
T Consensus 200 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 278 (293)
T cd05053 200 WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQR 278 (293)
T ss_pred ccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 999999988889999999999999999986 66665432211 11111111 11222345678999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 044846 224 PTMKEVTLELAGI 236 (290)
Q Consensus 224 ps~~el~~~l~~~ 236 (290)
||+.++++.|+.+
T Consensus 279 ps~~eil~~l~~~ 291 (293)
T cd05053 279 PTFKQLVEDLDRM 291 (293)
T ss_pred cCHHHHHHHHHHh
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=272.10 Aligned_cols=229 Identities=24% Similarity=0.352 Sum_probs=177.8
Q ss_pred ceEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEE-eCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 3 ELWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCL-ETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 3 ~~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
..+|+|++.. ......+.+.+|+.+++.++||||+++++++. .++..+++|||+.+|+|.+++..... ..++..+
T Consensus 24 ~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~ 100 (262)
T cd05058 24 IHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH---NPTVKDL 100 (262)
T ss_pred EEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCC---CCCHHHH
Confidence 4688998854 33455778999999999999999999999776 45568999999999999999976432 3567778
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc---eeeccceecccccCccccccC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT---HLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........ .......++..|+|||.+.+.
T Consensus 101 ~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (262)
T cd05058 101 IGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177 (262)
T ss_pred HHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccC
Confidence 889999999999999998 99999999999999999999999999764322111 111223456689999999888
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.++.++|||||||++|||++|..++................ ..+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 178 ~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~ 257 (262)
T cd05058 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257 (262)
T ss_pred ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 89999999999999999998654443332222222211111 112223567899999999999999999999999998
Q ss_pred hhH
Q 044846 235 GIR 237 (290)
Q Consensus 235 ~~~ 237 (290)
.+.
T Consensus 258 ~~~ 260 (262)
T cd05058 258 QIF 260 (262)
T ss_pred HHh
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=270.12 Aligned_cols=227 Identities=20% Similarity=0.323 Sum_probs=179.3
Q ss_pred CceEEEEeecccCc-hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHE-SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.+|+|+++.... .....+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... .+++..+
T Consensus 19 ~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~ 95 (250)
T cd05085 19 KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD---ELKTKQL 95 (250)
T ss_pred CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC---CCCHHHH
Confidence 45689998875433 3345788999999999999999999999999999999999999999999875432 4789999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.|++.||.|+|+++ ++||||||+||+++.++.+||+|||++...............++..|+|||++.+..++
T Consensus 96 ~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 172 (250)
T cd05085 96 VKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172 (250)
T ss_pred HHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCC
Confidence 999999999999999999 99999999999999999999999998764332221111223345679999999988899
Q ss_pred CcccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 161 EKSDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.++||||||+++|++++ |..|+........ ..........+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 173 ~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 173 SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 99999999999999997 7776643322211 11111111112234578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=274.40 Aligned_cols=226 Identities=22% Similarity=0.247 Sum_probs=181.9
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
+..+++|.+........+.+.+|+++++.++||||+++++.+...+..++|+||+++|+|..++..... ++++..+.
T Consensus 30 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---~l~~~~~~ 106 (282)
T cd06643 30 GVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTEPQIR 106 (282)
T ss_pred CeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCC---CCCHHHHH
Confidence 456888888766667778899999999999999999999999999999999999999999998865332 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc-----c
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-----S 156 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~ 156 (290)
.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..... .........++..|+|||++. +
T Consensus 107 ~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~ 182 (282)
T cd06643 107 VVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSKD 182 (282)
T ss_pred HHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc-cccccccccccccccCHhhccccCCCC
Confidence 99999999999999999 99999999999999999999999998754321 112223456788999999984 3
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
..++.++|+|||||++|+|++|.+|+............... ...+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 183 ~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 45778999999999999999999887543322111111100 11223356789999999999999999999999877
Q ss_pred HH
Q 044846 233 LA 234 (290)
Q Consensus 233 l~ 234 (290)
..
T Consensus 263 ~~ 264 (282)
T cd06643 263 PF 264 (282)
T ss_pred CC
Confidence 65
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=283.86 Aligned_cols=224 Identities=18% Similarity=0.243 Sum_probs=179.1
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
++.||+|+++.. .....+.+.+|+.++.++ +||||+.+++++...+..|+||||+++|+|..++.... .+++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~l~~ 95 (327)
T cd05617 20 DQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR----KLPE 95 (327)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCH
Confidence 567999998742 234566788999999998 79999999999999999999999999999999887654 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+.
T Consensus 96 ~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 171 (327)
T cd05617 96 EHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGE 171 (327)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceecccCCcccCCHHHHCCC
Confidence 999999999999999999999 999999999999999999999999997642211 1222346689999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchh-----hh-hhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCH---
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVE-----EN-RSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTM--- 226 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~-----~~-~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~--- 226 (290)
.++.++|||||||++|+|++|..||..... .. ........ ...+...+..+.+++.+||+.||.+|+++
T Consensus 172 ~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 251 (327)
T cd05617 172 EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQ 251 (327)
T ss_pred CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCC
Confidence 999999999999999999999998843211 01 11111111 11222345678899999999999999984
Q ss_pred ---HHHHHHH
Q 044846 227 ---KEVTLEL 233 (290)
Q Consensus 227 ---~el~~~l 233 (290)
.+++.|-
T Consensus 252 ~~~~~i~~h~ 261 (327)
T cd05617 252 TGFSDIKSHT 261 (327)
T ss_pred CCHHHHHcCC
Confidence 5776663
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=281.36 Aligned_cols=228 Identities=17% Similarity=0.189 Sum_probs=176.1
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++... ....+.+.+|+++++.++||||++++++|..++..++||||+++|+|.+++...... .+++..
T Consensus 25 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~--~l~~~~ 102 (327)
T cd08227 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMSELA 102 (327)
T ss_pred CcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccC--CCCHHH
Confidence 6789999987532 334556778999999999999999999999999999999999999999999764322 488899
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc------eeeccceecccccCccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT------HLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~ 153 (290)
++.++.|++.||.|||+++ |+||||||+||+++.++.++++||+.......... .......++..|+|||+
T Consensus 103 ~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 179 (327)
T cd08227 103 IAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEV 179 (327)
T ss_pred HHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHH
Confidence 9999999999999999999 99999999999999999999999975432211000 01112345677999999
Q ss_pred ccc--CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----------------------------------
Q 044846 154 FRS--SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---------------------------------- 197 (290)
Q Consensus 154 ~~~--~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---------------------------------- 197 (290)
+.+ ..++.++|||||||++|+|++|..||...............
T Consensus 180 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T cd08227 180 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTT 259 (327)
T ss_pred hhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccc
Confidence 876 45889999999999999999999987532211110000000
Q ss_pred -------------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 198 -------------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 198 -------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.......+..+.+|+.+||+.||++|||++|++++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 260 VSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0011123457889999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=275.21 Aligned_cols=222 Identities=21% Similarity=0.277 Sum_probs=190.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+++|+|++.- ..+.+++.+|+.+|++++.|++|+|||.+.....+|||||||.-|++.+.++..+. ++++..+.
T Consensus 58 G~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K---~L~E~EIs 132 (502)
T KOG0574|consen 58 GHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRK---PLSEQEIS 132 (502)
T ss_pred CcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcC---CccHHHHH
Confidence 78999999975 66788999999999999999999999999999999999999999999999987654 69999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.+++..+.||+|||... =||||||..|||+.-+|..||+|||.+-....... ..+++.||+.|||||++..-.|+.
T Consensus 133 ~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVI~EIGY~~ 208 (502)
T KOG0574|consen 133 AVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIEEIGYDT 208 (502)
T ss_pred HHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCccccCcccccHHHHHHhccch
Confidence 99999999999999988 88999999999999999999999998754432222 235688999999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
++||||+|++..||..|+||+..-.. ...+...... ..+..++.+|.+++++||..+|++|-|+.++++|-
T Consensus 209 ~ADIWSLGITaIEMAEG~PPYsDIHP-MRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 209 KADIWSLGITAIEMAEGRPPYSDIHP-MRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hhhHhhhcchhhhhhcCCCCcccccc-cceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 99999999999999999998754332 2222222221 23456888999999999999999999999998874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.75 Aligned_cols=229 Identities=19% Similarity=0.304 Sum_probs=186.2
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
.+||||+++... ...+..|.+|+++|.+|+|||||.++|+|..++.+++++|||++|+|.+|+.....+ ....+...
T Consensus 563 lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheap--t~~t~~~v 640 (807)
T KOG1094|consen 563 LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELP--TAETAPGV 640 (807)
T ss_pred eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCc--ccccchhH
Confidence 579999998654 444689999999999999999999999999999999999999999999999876432 23455667
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee-ccceecccccCccccccCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT-TQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~ 160 (290)
.++.||+.||+||.+.+ ++||||.++|||++.++++||+|||+++....+..... .....+++|||+|.+..++++
T Consensus 641 si~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFt 717 (807)
T KOG1094|consen 641 SICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFT 717 (807)
T ss_pred HHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcccc
Confidence 79999999999999999 99999999999999999999999999887665444433 345567899999999999999
Q ss_pred CcccchhhHHHHHHHhc--CCCCcccchh--hhhhhHHHhhh-------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 161 EKSDVYSFSVVLVELNW--TKPIHLVDVE--ENRSLAAYFSK-------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~--~~~~~~~~~~--~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
.++|+|+||+++||++. ...|+..-.+ ..++....+.. ..+..++..+.++|.+||..|-.+|||++++
T Consensus 718 taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 718 TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 99999999999999863 3334432111 11222222221 2344567788999999999999999999999
Q ss_pred HHHHHhh
Q 044846 230 TLELAGI 236 (290)
Q Consensus 230 ~~~l~~~ 236 (290)
...|...
T Consensus 798 h~~lq~~ 804 (807)
T KOG1094|consen 798 HLFLQED 804 (807)
T ss_pred HHHHHHh
Confidence 9888653
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.19 Aligned_cols=224 Identities=21% Similarity=0.294 Sum_probs=183.6
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.|++|.+.. ......+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++..... ..+++..
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~ 102 (256)
T cd08529 25 KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQ 102 (256)
T ss_pred CcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcC--CCCCHHH
Confidence 57789998763 3455677899999999999999999999999999999999999999999999987532 2588899
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++...... .......++..|+|||++.+..+
T Consensus 103 ~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd08529 103 VWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NFANTIVGTPYYLSPELCEDKPY 178 (256)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc-chhhccccCccccCHHHhcCCCC
Confidence 9999999999999999998 9999999999999999999999999876543221 12233457888999999999889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+.++|+||||+++++|++|..|+....... ........ ......+..+.+++.+||+.+|++||++.+++++
T Consensus 179 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 179 NEKSDVWALGVVLYECCTGKHPFDANNQGA-LILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 999999999999999999998876443221 11111111 1222456779999999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.70 Aligned_cols=224 Identities=25% Similarity=0.377 Sum_probs=181.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+++.... ..+++.+|+.+++.++|+||+++++++...+..++||||+++++|.+++...... .+++..+.
T Consensus 29 ~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~ 105 (256)
T cd05039 29 GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRA--VITLAQQL 105 (256)
T ss_pred CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCC--CCCHHHHH
Confidence 57899999986544 5778999999999999999999999999999999999999999999999765432 47899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.++...... .....+..|+|||++....++.
T Consensus 106 ~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~ 178 (256)
T cd05039 106 GFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAPEALREKKFST 178 (256)
T ss_pred HHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----ccCCCcccccCchhhcCCcCCc
Confidence 99999999999999999 9999999999999999999999999976542211 1233456799999998888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
++|+||||+++|++++ |..|+........ ..........+...+..+.+++.+||..+|++|||+.++++.|+.
T Consensus 179 ~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 9999999999999986 7776643321111 011000111122345779999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=283.62 Aligned_cols=217 Identities=19% Similarity=0.259 Sum_probs=173.7
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHH-HHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVI-LSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~-l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|++... .......+..|... ++.++||||+++++.+...+..++||||+++|+|..++.... .+++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~ 95 (325)
T cd05604 20 GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER----SFPE 95 (325)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC----CCCH
Confidence 678999998642 23445566667654 667899999999999999999999999999999999887654 5889
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........|+..|+|||++.+.
T Consensus 96 ~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 171 (325)
T cd05604 96 PRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEVIRKQ 171 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcccccCChhhCCHHHHcCC
Confidence 999999999999999999999 999999999999999999999999997643211 1223345689999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
.++.++|||||||++|+|++|.+||...... ......... ......+..+.+++.+||+.||.+||++.
T Consensus 172 ~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-EMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CCCCcCccccccceehhhhcCCCCCCCCCHH-HHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 9999999999999999999999988644322 111111111 11123456788999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.22 Aligned_cols=229 Identities=18% Similarity=0.276 Sum_probs=180.4
Q ss_pred ceEEEEeecccCc-hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-----------
Q 044846 3 ELWLLKKSKSVHE-SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD----------- 70 (290)
Q Consensus 3 ~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------- 70 (290)
+.||+|+++.... ...+.+..|+.++..++||||+++++++......++++||+++++|.+++.....
T Consensus 36 ~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~ 115 (283)
T cd05091 36 QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115 (283)
T ss_pred eEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCcccccccccc
Confidence 5689999875433 3356788999999999999999999999999999999999999999999853210
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccc
Q 044846 71 -DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGY 148 (290)
Q Consensus 71 -~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y 148 (290)
....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....... .......+++.|
T Consensus 116 ~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y 192 (283)
T cd05091 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRW 192 (283)
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccc
Confidence 1124788889999999999999999999 99999999999999999999999999765432211 112233456789
Q ss_pred cCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 149 VDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 149 ~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
+|||++.+..++.++|||||||++|||++ |.+++.... ........... ..+..++..+.+|+.+||+.+|.+||
T Consensus 193 ~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 271 (283)
T cd05091 193 MSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRP 271 (283)
T ss_pred cCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCC
Confidence 99999988889999999999999999997 665554322 22222221111 12234566789999999999999999
Q ss_pred CHHHHHHHHHh
Q 044846 225 TMKEVTLELAG 235 (290)
Q Consensus 225 s~~el~~~l~~ 235 (290)
++++|+..|+.
T Consensus 272 ~~~~i~~~l~~ 282 (283)
T cd05091 272 RFKDIHSRLRT 282 (283)
T ss_pred CHHHHHHHhhC
Confidence 99999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=282.83 Aligned_cols=222 Identities=20% Similarity=0.241 Sum_probs=178.1
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINH-RNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
++.||+|+++.. .....+.+..|++++..++| ++|+++++++...+..|+||||+++|+|..++.... .+++
T Consensus 25 ~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~----~~~~ 100 (324)
T cd05587 25 DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----KFKE 100 (324)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC----CCCH
Confidence 567999998642 34456778899999999965 568889999999999999999999999999997654 5888
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+.
T Consensus 101 ~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 176 (324)
T cd05587 101 PHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQ 176 (324)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-CceeeecCCccccChhhhcCC
Confidence 999999999999999999999 9999999999999999999999999976432211 222345689999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTM-----KEVT 230 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~el~ 230 (290)
.++.++||||+||++|+|++|..||...... ........ ...+...+..+.+++.+||+.||.+|++. .+++
T Consensus 177 ~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~ 255 (324)
T cd05587 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIR 255 (324)
T ss_pred CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 9999999999999999999999988643322 11111111 11223346678899999999999999986 5666
Q ss_pred HH
Q 044846 231 LE 232 (290)
Q Consensus 231 ~~ 232 (290)
++
T Consensus 256 ~h 257 (324)
T cd05587 256 EH 257 (324)
T ss_pred cC
Confidence 55
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.32 Aligned_cols=224 Identities=21% Similarity=0.271 Sum_probs=183.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|++........+.+.+|+.+++.++||||+++++.|......++||||+++++|.+++... .+++..+.
T Consensus 45 ~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~ 119 (296)
T cd06654 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIA 119 (296)
T ss_pred CcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc-----CCCHHHHH
Confidence 5679999988766666778999999999999999999999999999999999999999999998643 47888999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.
T Consensus 120 ~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 195 (296)
T cd06654 120 AVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGP 195 (296)
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-cccCcccCCccccCHHHHcCCCCCc
Confidence 99999999999999999 9999999999999999999999999876433221 1122346788999999999888999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++|+|||||++|+|++|.+||................ ..+...+..+.+++.+||..||++|||+.+++.+-.
T Consensus 196 ~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred cchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 9999999999999999999886543322211111111 112334567889999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=269.68 Aligned_cols=224 Identities=23% Similarity=0.276 Sum_probs=183.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.+++|++........+.+.+|+++++.++||||+++++++...+..|++|||+++++|.+++..... .+++..+.
T Consensus 28 ~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~---~l~~~~~~ 104 (262)
T cd06613 28 GELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG---PLSELQIA 104 (262)
T ss_pred CCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhcc---CCCHHHHH
Confidence 467899999876666788899999999999999999999999999999999999999999999876532 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC---C
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS---Q 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~ 158 (290)
.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...... ........++..|+|||.+.+. .
T Consensus 105 ~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~ 180 (262)
T cd06613 105 YVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IAKRKSFIGTPYWMAPEVAAVERKGG 180 (262)
T ss_pred HHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh-hhccccccCCccccCchhhcccccCC
Confidence 99999999999999999 999999999999999999999999987643321 1122334677889999998776 7
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++.++|+||||+++|+|++|.+|+............... .......+.++.+++.+||..||..|||+.+++.+
T Consensus 181 ~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 181 YDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 888999999999999999999887643322221111111 11223456779999999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=286.84 Aligned_cols=230 Identities=18% Similarity=0.280 Sum_probs=180.7
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC----------
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD---------- 70 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------- 70 (290)
+.||+|+++... ....+.+.+|+++|..+. ||||++++++|...+..++|||||++|+|.+++.....
T Consensus 68 ~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~ 147 (401)
T cd05107 68 MKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKN 147 (401)
T ss_pred eEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccc
Confidence 469999997543 334567899999999996 99999999999999999999999999999999975421
Q ss_pred --------------------------------------------------------------------------------
Q 044846 71 -------------------------------------------------------------------------------- 70 (290)
Q Consensus 71 -------------------------------------------------------------------------------- 70 (290)
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (401)
T cd05107 148 RDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRD 227 (401)
T ss_pred cccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchh
Confidence
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceec
Q 044846 71 ----DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVT 145 (290)
Q Consensus 71 ----~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~ 145 (290)
....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++....... .......++
T Consensus 228 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 304 (401)
T cd05107 228 TLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304 (401)
T ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCC
Confidence 1124677788899999999999999998 99999999999999999999999999864322111 111223467
Q ss_pred ccccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCC
Q 044846 146 FGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 146 ~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp 220 (290)
..|+|||++.+..++.++||||||+++|||++ |..|+..... ......... ...+...+..+.+|+.+||..+|
T Consensus 305 ~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P 383 (401)
T cd05107 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKF 383 (401)
T ss_pred CceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 78999999998889999999999999999997 6655532211 111111111 11222345789999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 044846 221 KKQPTMKEVTLELAGI 236 (290)
Q Consensus 221 ~~Rps~~el~~~l~~~ 236 (290)
.+||++++|+..|+.+
T Consensus 384 ~~RPs~~ell~~L~~~ 399 (401)
T cd05107 384 EIRPDFSQLVHLVGDL 399 (401)
T ss_pred hHCcCHHHHHHHHHHH
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=287.88 Aligned_cols=225 Identities=21% Similarity=0.253 Sum_probs=177.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----cceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETE-----VPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|++... +....+.+.+|+++++.++||||+++++++...+ ..|+||||+. ++|.+++.... .
T Consensus 25 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~ 99 (372)
T cd07853 25 GKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ----P 99 (372)
T ss_pred CCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC----C
Confidence 678999998643 3344567899999999999999999999998776 7899999995 68988886543 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...............++..|+|||++
T Consensus 100 l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~ 176 (372)
T cd07853 100 LSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176 (372)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHH
Confidence 899999999999999999999999 99999999999999999999999999875443333333345678899999998
Q ss_pred ccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHH-------------------h-hh----h-------h
Q 044846 155 RSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAY-------------------F-SK----E-------A 200 (290)
Q Consensus 155 ~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~-------------------~-~~----~-------~ 200 (290)
.+. .++.++||||+||++|+|++|+++|......... +... . .. . .
T Consensus 177 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (372)
T cd07853 177 MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTL 256 (372)
T ss_pred cCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhccc
Confidence 874 4788999999999999999999888543221110 0000 0 00 0 0
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
....+.++.+||.+||+.||++|||+.|++.+.+
T Consensus 257 ~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 257 SSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred CCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0112456889999999999999999999998865
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=269.95 Aligned_cols=225 Identities=23% Similarity=0.322 Sum_probs=179.3
Q ss_pred ceEEEEeecccCc-hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSVHE-SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..+|+|.++.... ...+.+.+|+++++.++||||+++++++. .+..++||||+++|+|.+++.... .+++..+.
T Consensus 24 ~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~ 98 (257)
T cd05060 24 VEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR----EIPVSDLK 98 (257)
T ss_pred ceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC----CCCHHHHH
Confidence 5688998875443 35667999999999999999999999876 456799999999999999998654 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeec--cceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTT--QVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........... ...++..|+|||.+.+..+
T Consensus 99 ~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05060 99 ELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175 (257)
T ss_pred HHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCC
Confidence 99999999999999999 999999999999999999999999998754332222211 1223457999999998899
Q ss_pred CCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 160 TEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+.++||||||+++|++++ |.+|+...... ....... ....+...+..+.++|.+||..||++|||+.++++.|+.
T Consensus 176 ~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~ 254 (257)
T cd05060 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254 (257)
T ss_pred CccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 999999999999999997 77776433221 1111111 112223345678999999999999999999999999986
Q ss_pred h
Q 044846 236 I 236 (290)
Q Consensus 236 ~ 236 (290)
+
T Consensus 255 ~ 255 (257)
T cd05060 255 D 255 (257)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=269.85 Aligned_cols=226 Identities=21% Similarity=0.296 Sum_probs=178.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
+..+|+|+++.... ..+.+.+|+.++++++||||+++++++. ....+++|||+++++|.+++...... .+++..++
T Consensus 30 ~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~ 105 (260)
T cd05070 30 NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGR--ALKLPNLV 105 (260)
T ss_pred CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCC--CCCHHHHH
Confidence 34688888875333 3467899999999999999999999875 45689999999999999999764322 47899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...............++..|+|||++.+..++.
T Consensus 106 ~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 182 (260)
T cd05070 106 DMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182 (260)
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcc
Confidence 99999999999999999 999999999999999999999999998654322212222233456799999998888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
++|+||||+++|++++ |.+|+..... ........ ....+...+..+.+++.+||..||++|||++++.+.|+.
T Consensus 183 ~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 183 KSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred hhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999998 7776643221 11111111 111233455679999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=296.64 Aligned_cols=227 Identities=22% Similarity=0.214 Sum_probs=182.7
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--------cceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETE--------VPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||+|++... .......+.+|+.++..++|+||+++++.+.... .+++||||+++|+|.+++......
T Consensus 57 g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~ 136 (496)
T PTZ00283 57 GEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT 136 (496)
T ss_pred CCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhcc
Confidence 678999998643 3455677889999999999999999988776432 367999999999999999765444
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceecccccC
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFGYVD 150 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~a 150 (290)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ........||+.|+|
T Consensus 137 ~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~a 213 (496)
T PTZ00283 137 NRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213 (496)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeC
Confidence 446889999999999999999999999 9999999999999999999999999986543221 122234678999999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
||++.+..++.++|||||||++|+|++|..||...... ........ ...+...+..+.+++.+||+.||.+||++.
T Consensus 214 PE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ 292 (496)
T PTZ00283 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSS 292 (496)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHH
Confidence 99999999999999999999999999999888543221 11111111 122334567899999999999999999999
Q ss_pred HHHHH
Q 044846 228 EVTLE 232 (290)
Q Consensus 228 el~~~ 232 (290)
+++.+
T Consensus 293 ell~~ 297 (496)
T PTZ00283 293 KLLNM 297 (496)
T ss_pred HHHhC
Confidence 99876
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=272.92 Aligned_cols=229 Identities=19% Similarity=0.280 Sum_probs=178.5
Q ss_pred eEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.+++|++.... .....++..|+..++.++||||+++++++. ....++++||+++|+|.+++..... .+++..+..
T Consensus 38 ~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~---~~~~~~~~~ 113 (279)
T cd05111 38 PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRD---SLDPQRLLN 113 (279)
T ss_pred EEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhccc---CCCHHHHHH
Confidence 36777775432 334567888999999999999999999875 4567899999999999999976442 588999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccccccCCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++........ ......++..|++||++.+..++.
T Consensus 114 i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 190 (279)
T cd05111 114 WCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190 (279)
T ss_pred HHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCc
Confidence 9999999999999999 999999999999999999999999998654322211 223345677899999999888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhh-hh-hHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEEN-RS-LAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++||||||+++||+++ |..|+....... .. +........+..+...+.+++.+||..||++|||+.|+++.|..+..
T Consensus 191 ~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 191 QSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999997 877765332211 11 11101111122245578899999999999999999999999988765
Q ss_pred h
Q 044846 239 S 239 (290)
Q Consensus 239 ~ 239 (290)
.
T Consensus 271 ~ 271 (279)
T cd05111 271 D 271 (279)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=287.02 Aligned_cols=224 Identities=19% Similarity=0.229 Sum_probs=177.9
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.||+|++.. ......+.+.+|+.+++.++||||+++++.+...+..++||||+++|+|.+++... .++..
T Consensus 68 ~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~ 142 (371)
T cd05622 68 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEK 142 (371)
T ss_pred CcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHH
Confidence 56789998853 23344556889999999999999999999999999999999999999999998753 37888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...............||+.|+|||++.+..
T Consensus 143 ~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 219 (371)
T cd05622 143 WARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219 (371)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccC
Confidence 88999999999999999999 999999999999999999999999998654332222234567899999999987543
Q ss_pred ----CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCC--CCCH
Q 044846 159 ----FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKK--QPTM 226 (290)
Q Consensus 159 ----~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~--Rps~ 226 (290)
++.++|||||||++|+|++|.+||....... ....... .+.....+..+.++|.+||..++.+ |+++
T Consensus 220 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~ 298 (371)
T cd05622 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGV 298 (371)
T ss_pred CCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCH
Confidence 7889999999999999999999886543221 1111111 1111235677899999999844433 7799
Q ss_pred HHHHHHHH
Q 044846 227 KEVTLELA 234 (290)
Q Consensus 227 ~el~~~l~ 234 (290)
.+++.+.+
T Consensus 299 ~ei~~h~~ 306 (371)
T cd05622 299 EEIKRHLF 306 (371)
T ss_pred HHHhcCcc
Confidence 99998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=283.16 Aligned_cols=219 Identities=17% Similarity=0.230 Sum_probs=173.3
Q ss_pred CceEEEEeecccC---chhHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVV-ILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~-~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++|+|..++.... .+++
T Consensus 20 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~ 95 (325)
T cd05602 20 EKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLE 95 (325)
T ss_pred CCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC----CCCH
Confidence 4679999986421 223344555554 4677899999999999999999999999999999999997654 5788
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... .........|++.|+|||++.+.
T Consensus 96 ~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~-~~~~~~~~~gt~~y~aPE~~~~~ 171 (325)
T cd05602 96 PRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTSTFCGTPEYLAPEVLHKQ 171 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc-CCCCcccccCCccccCHHHHcCC
Confidence 888899999999999999999 99999999999999999999999999764321 12223345689999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
.++.++|||||||++|+|++|.+||....... .+..... .......+..+.+++.+||+.||.+||++.+.
T Consensus 172 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCCccccccccHHHHHHhcCCCCCCCCCHHH-HHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 99999999999999999999999886443221 1111111 11122456678999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=285.28 Aligned_cols=223 Identities=18% Similarity=0.168 Sum_probs=175.4
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc---CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI---NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l---~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|++... .......+..|..++..+ +||||+++++.+...+..|+||||+++|+|..++.... .+
T Consensus 18 ~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~ 93 (330)
T cd05586 18 RRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG----RF 93 (330)
T ss_pred CCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC----CC
Confidence 678999998532 223445566777777765 69999999999999999999999999999999987654 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++..... ........||..|+|||++.
T Consensus 94 ~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~ 169 (330)
T cd05586 94 SEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTFCGTTEYLAPEVLL 169 (330)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccCccCCccccCHHHHc
Confidence 89999999999999999999999 999999999999999999999999997643221 12233466899999999987
Q ss_pred cC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCC----CHH
Q 044846 156 SS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQP----TMK 227 (290)
Q Consensus 156 ~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rp----s~~ 227 (290)
+. .++.++|||||||++|+|++|..||........ ...... .......+..+.+++.+||+.||.+|| ++.
T Consensus 170 ~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 248 (330)
T cd05586 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-YRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAV 248 (330)
T ss_pred CCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHH
Confidence 65 478999999999999999999998865432211 111111 011112456788999999999999998 577
Q ss_pred HHHHHH
Q 044846 228 EVTLEL 233 (290)
Q Consensus 228 el~~~l 233 (290)
+++++.
T Consensus 249 ~ll~h~ 254 (330)
T cd05586 249 ELKEHP 254 (330)
T ss_pred HHhcCc
Confidence 777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=277.81 Aligned_cols=232 Identities=19% Similarity=0.313 Sum_probs=182.2
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-----------
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD----------- 70 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------- 70 (290)
.||+|..+.. .....+.+.+|+++++++ +||||++++++|...+..++++||+++|+|.+++.....
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 125 (334)
T cd05100 46 TVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125 (334)
T ss_pred eEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCccccccccccc
Confidence 5788887643 344567899999999999 899999999999999999999999999999999976431
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccc
Q 044846 71 -DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGY 148 (290)
Q Consensus 71 -~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y 148 (290)
....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++........ ......++..|
T Consensus 126 ~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y 202 (334)
T cd05100 126 LPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKW 202 (334)
T ss_pred CccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceE
Confidence 1124778889999999999999999999 999999999999999999999999997654322111 11223345679
Q ss_pred cCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 149 VDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 149 ~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
+|||++.+..++.++||||||+++|+|++ |..++.... .......... ...+...+..+.+++.+||+.+|++||
T Consensus 203 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 281 (334)
T cd05100 203 MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRP 281 (334)
T ss_pred cCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCc
Confidence 99999999999999999999999999997 666554322 1111111111 112233456789999999999999999
Q ss_pred CHHHHHHHHHhhHhh
Q 044846 225 TMKEVTLELAGIRAS 239 (290)
Q Consensus 225 s~~el~~~l~~~~~~ 239 (290)
|+.|+++.|+.+...
T Consensus 282 s~~ell~~l~~~~~~ 296 (334)
T cd05100 282 TFKQLVEDLDRVLTV 296 (334)
T ss_pred CHHHHHHHHHHHhhh
Confidence 999999999888653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.34 Aligned_cols=227 Identities=19% Similarity=0.166 Sum_probs=181.8
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.... ......+.+|+.+++.++|+||+.+++.+...+..++||||+++|+|.+++...... .+++.
T Consensus 25 ~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~--~l~~~ 102 (285)
T cd05630 25 GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA--GFEEG 102 (285)
T ss_pred CceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhccc--CCCHH
Confidence 5789999886432 223456788999999999999999999999999999999999999999998654332 58889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ......|+..|+|||++.+..
T Consensus 103 ~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~ 177 (285)
T cd05630 103 RAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNER 177 (285)
T ss_pred HHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--cccCCCCCccccChHHHcCCC
Confidence 99999999999999999999 9999999999999999999999999875432221 122346889999999999989
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhh--hhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEEN--RSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPT-----MKE 228 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~e 228 (290)
++.++|+||||+++|+|++|..||....... ...... .........+..+.+|+.+||+.||++||| +.|
T Consensus 178 ~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~ 257 (285)
T cd05630 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGARE 257 (285)
T ss_pred CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHH
Confidence 9999999999999999999999886432110 111111 111122334567899999999999999999 889
Q ss_pred HHHHHHh
Q 044846 229 VTLELAG 235 (290)
Q Consensus 229 l~~~l~~ 235 (290)
++.+.+-
T Consensus 258 ~~~h~~~ 264 (285)
T cd05630 258 VKEHPLF 264 (285)
T ss_pred HHcChhh
Confidence 9887553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=270.67 Aligned_cols=226 Identities=20% Similarity=0.319 Sum_probs=180.6
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.+|+|+++.. .....+.+.+|+++++.++||||+++.+++...+..++||||+++++|.+++..... .+++..+..
T Consensus 35 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~ 111 (268)
T cd05063 35 AVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVG 111 (268)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCC---CCCHHHHHH
Confidence 6888988754 344567899999999999999999999999999999999999999999999976432 588999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeec--cceecccccCccccccCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTT--QVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~ 160 (290)
++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++............ ....+..|+|||++.+..++
T Consensus 112 ~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 188 (268)
T cd05063 112 MLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188 (268)
T ss_pred HHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcC
Confidence 9999999999999999 999999999999999999999999987654322211111 12234579999999988899
Q ss_pred CcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 161 EKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.++|+|||||++|++++ |..|+....... ..... ...+.....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 189 ~~~Dv~slG~il~ell~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 189 SASDVWSFGIVMWEVMSFGERPYWDMSNHE-VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred hHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999886 887775432211 11111 11112223456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=273.92 Aligned_cols=228 Identities=21% Similarity=0.331 Sum_probs=178.8
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC-------CCC
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD-------QLP 74 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~ 74 (290)
..||+|++.... ....+.+.+|++++++++||||+++++++...+..+++|||+++++|.+++...... ...
T Consensus 47 ~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 126 (296)
T cd05051 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126 (296)
T ss_pred eeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCC
Confidence 458999987533 345778999999999999999999999999999999999999999999999765421 124
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccCccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~ 153 (290)
+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++....... .......++..|+|||+
T Consensus 127 ~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 203 (296)
T cd05051 127 LSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWES 203 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHH
Confidence 789999999999999999999999 99999999999999999999999999764332211 11223445678999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhc--CCCCcccchhhhhhhHHHhh----------hhhhHHHHHHHHHHHHHhhccCCC
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNW--TKPIHLVDVEENRSLAAYFS----------KEAEKEEVITFAMVAKRCLNLNGK 221 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~--~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~dp~ 221 (290)
+.+..++.++|||||||++|++++ +..|+.... ....+..... .......+.++.+++.+||+.||+
T Consensus 204 ~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 282 (296)
T cd05051 204 VLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEE 282 (296)
T ss_pred hhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChh
Confidence 988889999999999999999986 444443211 1111111100 011122346799999999999999
Q ss_pred CCCCHHHHHHHHH
Q 044846 222 KQPTMKEVTLELA 234 (290)
Q Consensus 222 ~Rps~~el~~~l~ 234 (290)
+|||+.|+++.|+
T Consensus 283 ~Rpt~~el~~~L~ 295 (296)
T cd05051 283 DRPTFREIHLFLQ 295 (296)
T ss_pred cCCCHHHHHHHhc
Confidence 9999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=273.18 Aligned_cols=228 Identities=21% Similarity=0.318 Sum_probs=180.5
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC------CCCC
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD------QLPI 75 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~ 75 (290)
+.||+|...... ......+.+|+.+++.++||||+++++++......++||||+++|+|.+++...... ...+
T Consensus 37 ~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 116 (277)
T cd05032 37 TRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116 (277)
T ss_pred eeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCC
Confidence 568999986433 345667899999999999999999999999999999999999999999999764321 1136
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~ 154 (290)
++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....... .......++..|+|||.+
T Consensus 117 ~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05032 117 TLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHH
Confidence 78889999999999999999999 99999999999999999999999999765432211 112233456789999999
Q ss_pred ccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.+..++.++|||||||++|++++ |.+|+...... ........ ...+...+..+.+++.+||+.+|++|||+.+++
T Consensus 194 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 272 (277)
T cd05032 194 KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272 (277)
T ss_pred hcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 88889999999999999999997 77766432211 11111111 112233467789999999999999999999999
Q ss_pred HHHH
Q 044846 231 LELA 234 (290)
Q Consensus 231 ~~l~ 234 (290)
..|+
T Consensus 273 ~~l~ 276 (277)
T cd05032 273 SSLK 276 (277)
T ss_pred HHhc
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=273.36 Aligned_cols=225 Identities=23% Similarity=0.288 Sum_probs=181.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|.+........+.+.+|+++++.++||||+++++.+...+..++||||+++++|..++.+... .+++..+.
T Consensus 37 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~l~~~~~~ 113 (292)
T cd06644 37 GALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQ 113 (292)
T ss_pred CceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcC---CCCHHHHH
Confidence 578999999877777788899999999999999999999999999999999999999999988865432 48899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc-----c
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-----S 156 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~ 156 (290)
.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ........++..|+|||++. .
T Consensus 114 ~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 189 (292)
T cd06644 114 VICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKD 189 (292)
T ss_pred HHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-ccccceecCCccccCceeeccccccC
Confidence 99999999999999998 999999999999999999999999987542211 11223345778899999985 3
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhh-----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKE-----AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
..++.++|+|||||++|+|++|.+|+...... .......... .+...+.++.+++.+||+.||++||++.++++
T Consensus 190 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 44678999999999999999999887543321 1111111111 12234567899999999999999999999987
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
+..
T Consensus 269 ~~~ 271 (292)
T cd06644 269 HPF 271 (292)
T ss_pred Ccc
Confidence 643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=271.37 Aligned_cols=229 Identities=24% Similarity=0.350 Sum_probs=179.3
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.||+|.++... ......+.+|+++++.++||||+++.+++... ...++||||+++++|.+++..... .+++.
T Consensus 33 ~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~ 109 (284)
T cd05079 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN---KINLK 109 (284)
T ss_pred cceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccC---CCCHH
Confidence 5679999987443 44456799999999999999999999998775 568999999999999999976432 47899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce--eeccceecccccCcccccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--LTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~ 156 (290)
.+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......... ......++..|+|||++.+
T Consensus 110 ~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 186 (284)
T cd05079 110 QQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186 (284)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhcc
Confidence 99999999999999999999 999999999999999999999999997654332221 1123456677999999988
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhh----------hh---hHHHh----hhhhhHHHHHHHHHHHHHhhccC
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEEN----------RS---LAAYF----SKEAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~----------~~---~~~~~----~~~~~~~~~~~~~~li~~cl~~d 219 (290)
..++.++||||||+++|+++++..+........ .. ..... ........+..+.+|+.+||+.|
T Consensus 187 ~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 266 (284)
T cd05079 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQ 266 (284)
T ss_pred CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCC
Confidence 889999999999999999998765432211100 00 00000 01112234567999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 044846 220 GKKQPTMKEVTLELAGI 236 (290)
Q Consensus 220 p~~Rps~~el~~~l~~~ 236 (290)
|++|||+.++++.++.+
T Consensus 267 p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 267 PSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccCcCHHHHHHHHHhh
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=270.36 Aligned_cols=228 Identities=20% Similarity=0.313 Sum_probs=178.3
Q ss_pred eEEEEeecc-cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-----------
Q 044846 4 LWLLKKSKS-VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD----------- 70 (290)
Q Consensus 4 ~~avK~~~~-~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------- 70 (290)
.+++|..+. ......+.+.+|++++.++ +||||+++++++...+..+++|||+++|+|.+++.....
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 103 (270)
T cd05047 24 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 103 (270)
T ss_pred EEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 357777764 3345567899999999999 899999999999999999999999999999999976431
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceeccccc
Q 044846 71 -DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYV 149 (290)
Q Consensus 71 -~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 149 (290)
....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .......+..|+
T Consensus 104 ~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~ 178 (270)
T cd05047 104 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWM 178 (270)
T ss_pred CCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchhh--hccCCCCccccC
Confidence 1124788999999999999999999998 9999999999999999999999999875322111 111122355799
Q ss_pred CccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 150 DPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 150 aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
|||++.+..++.++|+||||+++|+|++ |..||...... ....... ........+..+.+++.+||..||.+|||
T Consensus 179 apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 257 (270)
T cd05047 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS 257 (270)
T ss_pred ChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCC
Confidence 9999988889999999999999999996 77776432211 1111111 11122234567899999999999999999
Q ss_pred HHHHHHHHHhhH
Q 044846 226 MKEVTLELAGIR 237 (290)
Q Consensus 226 ~~el~~~l~~~~ 237 (290)
+.+++..|..+.
T Consensus 258 ~~~il~~l~~~~ 269 (270)
T cd05047 258 FAQILVSLNRML 269 (270)
T ss_pred HHHHHHHHHHhh
Confidence 999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=281.12 Aligned_cols=222 Identities=19% Similarity=0.231 Sum_probs=178.4
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
++.||+|+++.. .....+.+..|..++..+ .|++|+++++++...+..++||||+++|+|..++.... .+++
T Consensus 25 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~----~~~~ 100 (323)
T cd05616 25 DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG----RFKE 100 (323)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC----CCCH
Confidence 567999998642 233455677888888888 68999999999999999999999999999999987654 5888
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+.
T Consensus 101 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 176 (323)
T cd05616 101 PHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQ 176 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcCC
Confidence 999999999999999999999 9999999999999999999999999976432211 122345689999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTM-----KEVT 230 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~el~ 230 (290)
.++.++|||||||++|+|++|..||...... ........ ...+...+.++.+++.+||+.||.+|++. .+++
T Consensus 177 ~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~ 255 (323)
T cd05616 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 255 (323)
T ss_pred CCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHh
Confidence 9999999999999999999999988644322 11111111 11233456778999999999999999984 5665
Q ss_pred HH
Q 044846 231 LE 232 (290)
Q Consensus 231 ~~ 232 (290)
++
T Consensus 256 ~h 257 (323)
T cd05616 256 EH 257 (323)
T ss_pred cC
Confidence 44
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=270.50 Aligned_cols=229 Identities=21% Similarity=0.319 Sum_probs=177.4
Q ss_pred eEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CcceEEEEeCCCCCHHHHHhhcC--CCCC
Q 044846 4 LWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLET------EVPLLVYEFIPNGSLYQYIHEQT--DDQL 73 (290)
Q Consensus 4 ~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~--~~~~ 73 (290)
.+|+|.++.. .....+.+.+|+++++.++||||+++++.+... ...+++|||+++|+|.+++.... ....
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 107 (272)
T cd05075 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107 (272)
T ss_pred eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence 4888887642 355577899999999999999999999987532 25689999999999999885432 1223
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee-eccceecccccCcc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFGYVDPK 152 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE 152 (290)
.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......... .....+++.|++||
T Consensus 108 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 184 (272)
T cd05075 108 YLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184 (272)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHH
Confidence 5789999999999999999999998 9999999999999999999999999987543222111 12234566799999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
++.+..++.++||||||+++|++++ |.+|+..... .......... ......+..+.++|.+||+.||++|||+.+
T Consensus 185 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 263 (272)
T cd05075 185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFET 263 (272)
T ss_pred HccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 9999999999999999999999998 6666643222 1111111111 112234567899999999999999999999
Q ss_pred HHHHHHhh
Q 044846 229 VTLELAGI 236 (290)
Q Consensus 229 l~~~l~~~ 236 (290)
++++|+.+
T Consensus 264 l~~~l~~~ 271 (272)
T cd05075 264 LRCELEKA 271 (272)
T ss_pred HHHHHHhh
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=270.02 Aligned_cols=226 Identities=20% Similarity=0.301 Sum_probs=180.3
Q ss_pred eEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.+|+|.++... ....+.+.+|+.+++.++||||+++++++..++..++||||+++|+|.+++..... .+++..+..
T Consensus 34 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~ 110 (267)
T cd05066 34 PVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVG 110 (267)
T ss_pred EEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCC---CCCHHHHHH
Confidence 58888886432 33466899999999999999999999999999999999999999999999976542 478899999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeec--cceecccccCccccccCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTT--QVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~ 160 (290)
++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++............ ...++..|++||++.+..++
T Consensus 111 i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~ 187 (267)
T cd05066 111 MLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187 (267)
T ss_pred HHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccC
Confidence 9999999999999999 999999999999999999999999998754432222211 12235679999999988899
Q ss_pred CcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 161 EKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.++|+||||+++|++++ |..|+....... ...... ..+.....+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 188 ~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 188 SASDVWSYGIVMWEVMSYGERPYWEMSNQD-VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred chhhhHHHHHHHHHHhcCCCCCcccCCHHH-HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 99999999999999775 887765432211 111111 1111223456789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=274.30 Aligned_cols=232 Identities=22% Similarity=0.337 Sum_probs=182.0
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-----------
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD----------- 70 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------- 70 (290)
+.+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++++||+.+|+|.+++.....
T Consensus 31 ~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (290)
T cd05045 31 TTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110 (290)
T ss_pred eeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccc
Confidence 357778776432 34567899999999999999999999999999999999999999999999875321
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eec
Q 044846 71 ---------DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTT 140 (290)
Q Consensus 71 ---------~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~ 140 (290)
....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++........ ...
T Consensus 111 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 187 (290)
T cd05045 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187 (290)
T ss_pred cccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhccc
Confidence 1125788999999999999999999999 999999999999999999999999997643222111 112
Q ss_pred cceecccccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhh
Q 044846 141 QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCL 216 (290)
Q Consensus 141 ~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl 216 (290)
...++..|+|||++.+..++.++||||||+++|+|++ |..|+...... ...... .....+...+.++.+++.+||
T Consensus 188 ~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl 266 (290)
T cd05045 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-RLFNLLKTGYRMERPENCSEEMYNLMLTCW 266 (290)
T ss_pred CCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHhCCCCCCCCCCCCHHHHHHHHHHc
Confidence 2344668999999988889999999999999999997 77766432211 111111 111122334567999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhHh
Q 044846 217 NLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 217 ~~dp~~Rps~~el~~~l~~~~~ 238 (290)
+.||++||++.++++.|+.+..
T Consensus 267 ~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 267 KQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred cCCcccCCCHHHHHHHHHHHHh
Confidence 9999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.69 Aligned_cols=225 Identities=22% Similarity=0.260 Sum_probs=182.1
Q ss_pred CceEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.+|+|.++. ......+.+.+|+.+++.++||||+++++.+...+..+++|||+++|+|.+++...... .++...+
T Consensus 25 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~ 102 (255)
T cd08219 25 DQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGK--LFPEDTI 102 (255)
T ss_pred CceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCC--CCCHHHH
Confidence 56789998864 23445678889999999999999999999999999999999999999999998764332 5788999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
+.++.|++.||.|||+++ |+|+||||+||+++.++.++++|||.+...... ........++..|+|||++.+..++
T Consensus 103 ~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~ 178 (255)
T cd08219 103 LQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GAYACTYVGTPYYVPPEIWENMPYN 178 (255)
T ss_pred HHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc-ccccccccCCccccCHHHHccCCcC
Confidence 999999999999999999 999999999999999999999999987644321 1222345678889999999988899
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH--hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY--FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.++|+||||+++|+|++|.+|+............. .....+...+..+.+++.+||+.||++|||+.+++..
T Consensus 179 ~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred chhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 99999999999999999999886443222111110 0111223455678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=271.64 Aligned_cols=230 Identities=22% Similarity=0.318 Sum_probs=181.0
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.||+|+++.. .......+.+|+.+++.+.||||+++++++.. ...++++||+++|+|.+++..... .+++..++.
T Consensus 38 ~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~ 113 (279)
T cd05109 38 PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKD---RIGSQDLLN 113 (279)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccC---CCCHHHHHH
Confidence 4799988643 34456678999999999999999999999875 457899999999999999976432 588999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee-eccceecccccCccccccCCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......... .....++..|++||.+.+..++.
T Consensus 114 ~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (279)
T cd05109 114 WCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH 190 (279)
T ss_pred HHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCc
Confidence 9999999999999999 9999999999999999999999999987554322221 12233466799999999889999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhh--hhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEEN--RSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++|||||||++||+++ |.+|+....... ..+........+...+..+.+++.+||+.||++||++.+++..|+.+..
T Consensus 191 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 191 QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 9999999999999987 777664322111 1111111112223456678999999999999999999999999887765
Q ss_pred hh
Q 044846 239 SI 240 (290)
Q Consensus 239 ~~ 240 (290)
..
T Consensus 271 ~~ 272 (279)
T cd05109 271 DP 272 (279)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=266.80 Aligned_cols=227 Identities=21% Similarity=0.345 Sum_probs=179.9
Q ss_pred CceEEEEeecccCch-hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHES-NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|+.+..... ....+.+|++++++++||||+++++++...+..++||||+++++|.+++..... .+++..+
T Consensus 19 ~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~---~~~~~~~ 95 (251)
T cd05041 19 NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKL 95 (251)
T ss_pred CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC---CCCHHHH
Confidence 577999988754433 567899999999999999999999999999999999999999999999976432 5788899
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee-ccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT-TQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.+++.||.|||+++ ++||||||+||+++.++.++|+|||.+........... ....++..|+|||.+.++.+
T Consensus 96 ~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 172 (251)
T cd05041 96 LQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172 (251)
T ss_pred HHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCC
Confidence 999999999999999999 99999999999999999999999998764332111111 11233566999999988889
Q ss_pred CCcccchhhHHHHHHHhc-CCCCcccchhhh--hhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNW-TKPIHLVDVEEN--RSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.++|+||||+++|++++ |..|+....... ...........+...+..+.+++.+||..+|++|||+.|+++.|.
T Consensus 173 ~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999998 666554322111 111111111122344568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=274.60 Aligned_cols=231 Identities=20% Similarity=0.315 Sum_probs=182.1
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC----------
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD---------- 71 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------- 71 (290)
.||+|+.+.. .....+.+.+|+.+++.+ +||||+++++++......+++|||+++|+|.+++......
T Consensus 49 ~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 128 (304)
T cd05101 49 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128 (304)
T ss_pred eEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccccc
Confidence 5888888643 345567899999999999 8999999999999999999999999999999999764321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccc
Q 044846 72 --QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGY 148 (290)
Q Consensus 72 --~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y 148 (290)
...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++........ ......++..|
T Consensus 129 ~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y 205 (304)
T cd05101 129 VPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKW 205 (304)
T ss_pred CCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCcee
Confidence 124778889999999999999999999 999999999999999999999999998754322211 12223456789
Q ss_pred cCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 149 VDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 149 ~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
+|||++.+..++.++||||||+++|++++ |..++.... .......... ...+...+..+.+++.+||+.+|++||
T Consensus 206 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 284 (304)
T cd05101 206 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRP 284 (304)
T ss_pred eCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCC
Confidence 99999988889999999999999999997 555553221 1111111111 112234567799999999999999999
Q ss_pred CHHHHHHHHHhhHh
Q 044846 225 TMKEVTLELAGIRA 238 (290)
Q Consensus 225 s~~el~~~l~~~~~ 238 (290)
|+.|+++.|..+..
T Consensus 285 s~~e~l~~l~~~~~ 298 (304)
T cd05101 285 TFKQLVEDLDRILT 298 (304)
T ss_pred CHHHHHHHHHHHHH
Confidence 99999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=270.71 Aligned_cols=224 Identities=22% Similarity=0.322 Sum_probs=180.1
Q ss_pred CceEEEEeecccCch---------hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCC
Q 044846 2 EELWLLKKSKSVHES---------NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQ 72 (290)
Q Consensus 2 ~~~~avK~~~~~~~~---------~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 72 (290)
++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+..+++|||+++++|.+++....
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--- 101 (267)
T cd06628 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--- 101 (267)
T ss_pred CcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc---
Confidence 467899987643221 23568899999999999999999999999999999999999999999997654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-----eeccceeccc
Q 044846 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-----LTTQVKVTFG 147 (290)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~g~~~ 147 (290)
.+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||.++........ ......|+..
T Consensus 102 -~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (267)
T cd06628 102 -AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177 (267)
T ss_pred -CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcC
Confidence 5888899999999999999999999 999999999999999999999999987654321111 1122457788
Q ss_pred ccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhH--HHhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 148 YVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA--AYFSKEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 148 y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
|+|||.+.+..++.++|+||||+++|+|++|..|+........... .......+...+..+.++|.+||+.||.+||+
T Consensus 178 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 257 (267)
T cd06628 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPT 257 (267)
T ss_pred ccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcC
Confidence 9999999988899999999999999999999988864322211111 11112223345677899999999999999999
Q ss_pred HHHHHHH
Q 044846 226 MKEVTLE 232 (290)
Q Consensus 226 ~~el~~~ 232 (290)
+.+++++
T Consensus 258 ~~~il~~ 264 (267)
T cd06628 258 AAELLKH 264 (267)
T ss_pred HHHHhhC
Confidence 9999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=268.67 Aligned_cols=222 Identities=23% Similarity=0.373 Sum_probs=176.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEE-eCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCL-ETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|..+.. ...+.+.+|+.+++.++|+|++++++++. ..+..+++|||+++|+|.+++...... .+++..+
T Consensus 29 ~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~ 104 (256)
T cd05082 29 GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCL 104 (256)
T ss_pred CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCC--CCCHHHH
Confidence 567888988643 33567899999999999999999999764 456789999999999999999865432 4788999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...... ....++..|+|||++.+..++
T Consensus 105 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~ 177 (256)
T cd05082 105 LKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFS 177 (256)
T ss_pred HHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC----CCCccceeecCHHHHccCCCC
Confidence 999999999999999999 9999999999999999999999999876433211 223345679999999988899
Q ss_pred CcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 161 EKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.++|||||||++|+|++ |..|+...... ...... .........+..+.+++.+||+.||++|||+.+++++|+.
T Consensus 178 ~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 99999999999999996 77766432211 111111 1111122345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=280.07 Aligned_cols=226 Identities=14% Similarity=0.203 Sum_probs=177.4
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.. ......+.+.+|+.++..++|+||+++++++...+..|+||||+++|+|.+++..... .+++.
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~ 102 (331)
T cd05597 26 GQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED---RLPED 102 (331)
T ss_pred CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcC---CCCHH
Confidence 57899999863 2334456788999999999999999999999999999999999999999999976432 58889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc--
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-- 156 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 156 (290)
.+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...............||+.|+|||++..
T Consensus 103 ~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 179 (331)
T cd05597 103 MARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179 (331)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhcc
Confidence 99999999999999999999 9999999999999999999999999976543322222233568999999999863
Q ss_pred ---CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------hhhhHHHHHHHHHHHHHhhccCCCC--CC
Q 044846 157 ---SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------KEAEKEEVITFAMVAKRCLNLNGKK--QP 224 (290)
Q Consensus 157 ---~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~--Rp 224 (290)
..++.++|||||||++|+|++|..||........ ...... .......+..+.+++.+||..++++ |+
T Consensus 180 ~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~ 258 (331)
T cd05597 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRN 258 (331)
T ss_pred ccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCC
Confidence 4578899999999999999999998864322111 111111 0111224667899999988654443 78
Q ss_pred CHHHHHHHHH
Q 044846 225 TMKEVTLELA 234 (290)
Q Consensus 225 s~~el~~~l~ 234 (290)
++.+++.+.+
T Consensus 259 ~~~~~l~hp~ 268 (331)
T cd05597 259 GLQDFKDHPF 268 (331)
T ss_pred CHHHHhcCCC
Confidence 9999998854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=267.72 Aligned_cols=226 Identities=19% Similarity=0.277 Sum_probs=177.5
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
..||+|+++.... ..+.+.+|+++++.++||||+++++.+. ....++||||+++|+|.+++..... ..+++..+..
T Consensus 31 ~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~ 106 (262)
T cd05071 31 TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVD 106 (262)
T ss_pred ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccc--cCCCHHHHHH
Confidence 3588998875332 3457899999999999999999999875 4568999999999999999976432 2478899999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+...............++..|++||+..+..++.+
T Consensus 107 ~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 183 (262)
T cd05071 107 MAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183 (262)
T ss_pred HHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCch
Confidence 9999999999999999 9999999999999999999999999876443222222223345677999999988889999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
+|+||||+++|++++ |.+|+...... ........ .......+..+.+++.+||+.||++||++.++++.|+..
T Consensus 184 ~DvwslG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 184 SDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCChH-HHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 999999999999998 66555433221 11111111 112334567789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=287.05 Aligned_cols=224 Identities=18% Similarity=0.245 Sum_probs=179.1
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+..|+.++..++||||+++++.+...+..|+|||||++|+|.+++.... .+++.
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~l~~~ 101 (360)
T cd05627 26 GHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD----TLSEE 101 (360)
T ss_pred CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC----CCCHH
Confidence 678999998642 34456678899999999999999999999999999999999999999999997654 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-----------------------
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR----------------------- 135 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----------------------- 135 (290)
.+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++......
T Consensus 102 ~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (360)
T cd05627 102 ATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178 (360)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccccc
Confidence 99999999999999999999 9999999999999999999999999876432110
Q ss_pred -----------ceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------h
Q 044846 136 -----------THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------K 198 (290)
Q Consensus 136 -----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~ 198 (290)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||........ ...... .
T Consensus 179 ~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~-~~~i~~~~~~~~~ 257 (360)
T cd05627 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET-YRKVMNWKETLVF 257 (360)
T ss_pred ccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHH-HHHHHcCCCceec
Confidence 0011235689999999999999999999999999999999999998865433221 111111 0
Q ss_pred hhhHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHHHH
Q 044846 199 EAEKEEVITFAMVAKRCLNLNGKKQPT---MKEVTLELA 234 (290)
Q Consensus 199 ~~~~~~~~~~~~li~~cl~~dp~~Rps---~~el~~~l~ 234 (290)
+.....+.++.++|.+++. ||.+|++ +.+++.|-+
T Consensus 258 p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 258 PPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred CCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 1111245678899999874 9999985 788887743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=281.70 Aligned_cols=222 Identities=21% Similarity=0.249 Sum_probs=173.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||+|+++.. .......+.+|+.+++.++||||+++++++.... ..|+||||+. ++|...+..
T Consensus 46 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------ 118 (359)
T cd07876 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM------ 118 (359)
T ss_pred CceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhc------
Confidence 678999998642 3445667889999999999999999999987543 4699999995 577776642
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.... ........||..|+|||+
T Consensus 119 ~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~t~~y~aPE~ 193 (359)
T cd07876 119 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFMMTPYVVTRYYRAPEV 193 (359)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccccc--CccCCCCcccCCCCCchh
Confidence 3778888999999999999999999 99999999999999999999999999764322 122334567889999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh---------------------hHHHhhh--------------
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS---------------------LAAYFSK-------------- 198 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~---------------------~~~~~~~-------------- 198 (290)
+.+..++.++|||||||++|+|++|..||......... ...+...
T Consensus 194 ~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (359)
T cd07876 194 ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFP 273 (359)
T ss_pred ccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcc
Confidence 99999999999999999999999999988643211100 0000000
Q ss_pred --------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 199 --------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 199 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
......+..+.+||.+||+.||++|||+.|++.+.+-
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 274 DWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred ccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0000123467899999999999999999999988654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=268.79 Aligned_cols=227 Identities=20% Similarity=0.282 Sum_probs=170.4
Q ss_pred eEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.+++|..+... ....+.+.+|+.+++.++||||+++++.|......++||||+++|+|.+++.........++...+..
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 103 (268)
T cd05086 24 RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR 103 (268)
T ss_pred eEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHH
Confidence 35566665432 34567899999999999999999999999999999999999999999999986543323466777889
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceecccccCcccccc-----
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFGYVDPKYFRS----- 156 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~----- 156 (290)
++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++....... ........++..|+|||++..
T Consensus 104 ~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (268)
T cd05086 104 MACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL 180 (268)
T ss_pred HHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcc
Confidence 9999999999999999 9999999999999999999999999875422111 111223456788999998753
Q ss_pred --CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--------hhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 157 --SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--------EAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 157 --~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
..++.++||||||+++|+|+++..++.........+...... .........+.+++..|| .+|++||++
T Consensus 181 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~ 259 (268)
T cd05086 181 ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATA 259 (268)
T ss_pred ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCH
Confidence 235778999999999999986544333222222111111111 111224567888999999 789999999
Q ss_pred HHHHHHHH
Q 044846 227 KEVTLELA 234 (290)
Q Consensus 227 ~el~~~l~ 234 (290)
+++++.|.
T Consensus 260 ~~i~~~l~ 267 (268)
T cd05086 260 EEVHRLLT 267 (268)
T ss_pred HHHHHHhc
Confidence 99988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=276.11 Aligned_cols=225 Identities=21% Similarity=0.238 Sum_probs=179.8
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.+|+|.++.. ......++.+|+++++.++||||++++++|...+..++||||+++++|.+++.... .+++..+
T Consensus 26 ~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~----~~~~~~~ 101 (308)
T cd06615 26 GLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPENIL 101 (308)
T ss_pred CeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC----CCCHHHH
Confidence 466888887643 33445678999999999999999999999999999999999999999999998653 5888999
Q ss_pred HHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.|++.||.|||+ .+ ++||||||+||+++.++.++|+|||++..... .......++..|+|||++.+..+
T Consensus 102 ~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~ 175 (308)
T cd06615 102 GKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 175 (308)
T ss_pred HHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccc---cccccCCCCcCccChhHhcCCCC
Confidence 9999999999999997 46 99999999999999999999999998754321 12234567889999999988889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhh-HHHh----------------------------------hh----hh
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL-AAYF----------------------------------SK----EA 200 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~-~~~~----------------------------------~~----~~ 200 (290)
+.++|+||||+++|++++|..|+.......... .... .. ..
T Consensus 176 ~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (308)
T cd06615 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP 255 (308)
T ss_pred CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc
Confidence 999999999999999999998764322111000 0000 00 00
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
....+.++.+++.+||..||++|||+.+++.+.+-.
T Consensus 256 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 256 SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 011345689999999999999999999999887654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=274.86 Aligned_cols=225 Identities=20% Similarity=0.272 Sum_probs=184.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|..++... .+++..+.
T Consensus 44 ~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~ 118 (296)
T cd06655 44 GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-----CMDEAQIA 118 (296)
T ss_pred CcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc-----CCCHHHHH
Confidence 5789999987655666778899999999999999999999999999999999999999999998653 48899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.
T Consensus 119 ~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 194 (296)
T cd06655 119 AVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGP 194 (296)
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCCcCCCccccCcchhcCCCCCc
Confidence 99999999999999999 99999999999999999999999998764332211 122345778899999999888999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
++|+|||||++|++++|.+||............... ...+...+..+.++|.+||..||++|||+.+++.+-+.
T Consensus 195 ~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 999999999999999999988654332221111101 11223345678899999999999999999999977544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=275.13 Aligned_cols=233 Identities=18% Similarity=0.310 Sum_probs=181.7
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-----------
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD----------- 70 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------- 70 (290)
.+|+|.++.. .......+.+|+++++.+ +||||+++++++...+..+++|||+++|+|.+++.....
T Consensus 46 ~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ 125 (314)
T cd05099 46 TVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125 (314)
T ss_pred EEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccC
Confidence 5888887743 334566789999999999 699999999999999999999999999999999976431
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccc
Q 044846 71 -DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGY 148 (290)
Q Consensus 71 -~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y 148 (290)
....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++........ ......++..|
T Consensus 126 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y 202 (314)
T cd05099 126 VPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKW 202 (314)
T ss_pred CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccc
Confidence 1124788899999999999999999999 999999999999999999999999998654321111 11112234579
Q ss_pred cCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 149 VDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 149 ~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
+|||++.+..++.++||||||+++|++++ |..|+.... .......... ...+...+.++.+++.+||+.||++||
T Consensus 203 ~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 281 (314)
T cd05099 203 MAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRP 281 (314)
T ss_pred cCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 99999988889999999999999999998 666554321 1111111111 111223456788999999999999999
Q ss_pred CHHHHHHHHHhhHhhh
Q 044846 225 TMKEVTLELAGIRASI 240 (290)
Q Consensus 225 s~~el~~~l~~~~~~~ 240 (290)
|+.++++.|+.+....
T Consensus 282 s~~~ll~~l~~~~~~~ 297 (314)
T cd05099 282 TFKQLVEALDKVLAAV 297 (314)
T ss_pred CHHHHHHHHHHHHHHh
Confidence 9999999999887644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=273.05 Aligned_cols=228 Identities=19% Similarity=0.349 Sum_probs=177.4
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC-------CCCC
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD-------QLPI 75 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~ 75 (290)
.||+|+++.. .....+.+.+|+++++.++||||+++++++...+..+++|||+++|+|.+++...... ...+
T Consensus 48 ~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (296)
T cd05095 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127 (296)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccccccccccc
Confidence 5889988753 3445678999999999999999999999999999999999999999999999764321 1246
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~ 154 (290)
++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++........ ......++..|++||+.
T Consensus 128 ~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 204 (296)
T cd05095 128 SYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI 204 (296)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH
Confidence 78889999999999999999999 999999999999999999999999997643322111 11223345779999998
Q ss_pred ccCCCCCcccchhhHHHHHHHhc--CCCCcccchhhhh--hhHHHhh-------hhhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNW--TKPIHLVDVEENR--SLAAYFS-------KEAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~--~~~~~~~~~~~~~--~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
.++.++.++|+|||||++|||++ +..|+........ ....... .+.+..++..+.+|+.+||+.||++|
T Consensus 205 ~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 284 (296)
T cd05095 205 LLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKER 284 (296)
T ss_pred hcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 88889999999999999999997 4455532211110 0100000 01122345678999999999999999
Q ss_pred CCHHHHHHHHH
Q 044846 224 PTMKEVTLELA 234 (290)
Q Consensus 224 ps~~el~~~l~ 234 (290)
||+.++.+.|+
T Consensus 285 p~~~~i~~~l~ 295 (296)
T cd05095 285 PSFQEIHATLL 295 (296)
T ss_pred CCHHHHHHHHh
Confidence 99999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=275.64 Aligned_cols=230 Identities=20% Similarity=0.311 Sum_probs=179.6
Q ss_pred EEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC------------
Q 044846 5 WLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD------------ 70 (290)
Q Consensus 5 ~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------ 70 (290)
+|+|+.+.. .......+.+|++++.++ +||||+++++++...+..|+||||+++|+|.+++.....
T Consensus 37 ~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 116 (303)
T cd05088 37 AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 116 (303)
T ss_pred EEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhccccccccccccccc
Confidence 567766542 344566788999999999 899999999999999999999999999999999976431
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccC
Q 044846 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVD 150 (290)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 150 (290)
....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...... .......++..|+|
T Consensus 117 ~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~a 191 (303)
T cd05088 117 TASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMA 191 (303)
T ss_pred ccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchh--hhcccCCCcccccC
Confidence 1125788999999999999999999999 999999999999999999999999987532211 11111223567999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
||++.+..++.++|||||||++|++++ |.+|+...... ....... ....+...+..+.+|+.+||+.+|++||++
T Consensus 192 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 270 (303)
T cd05088 192 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF 270 (303)
T ss_pred HHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999988889999999999999999997 77776533221 1111111 111122345678999999999999999999
Q ss_pred HHHHHHHHhhHhhh
Q 044846 227 KEVTLELAGIRASI 240 (290)
Q Consensus 227 ~el~~~l~~~~~~~ 240 (290)
++++..|+.+....
T Consensus 271 ~~il~~l~~~~~~~ 284 (303)
T cd05088 271 AQILVSLNRMLEER 284 (303)
T ss_pred HHHHHHHHHHHHhh
Confidence 99999998776543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=274.56 Aligned_cols=233 Identities=21% Similarity=0.320 Sum_probs=182.8
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC---------
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD--------- 71 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------- 71 (290)
..+|+|.++.. .......+..|+++++.+ +||||+++++++...+..|+||||+++|+|.+++......
T Consensus 51 ~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 130 (307)
T cd05098 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130 (307)
T ss_pred ceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 35888988753 244566788999999999 8999999999999999999999999999999999764321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceeccc
Q 044846 72 ---QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFG 147 (290)
Q Consensus 72 ---~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~ 147 (290)
...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......... ......++..
T Consensus 131 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~ 207 (307)
T cd05098 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 207 (307)
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccc
Confidence 124788999999999999999999998 999999999999999999999999997644321111 1111223467
Q ss_pred ccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 148 YVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 148 y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
|+|||++.+..++.++|+|||||++|+|++ |.+|+..... ....... .....+...+.++.+++.+||..+|++|
T Consensus 208 y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 286 (307)
T cd05098 208 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 286 (307)
T ss_pred eeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhC
Confidence 999999998889999999999999999997 6666543221 1111111 1112223446789999999999999999
Q ss_pred CCHHHHHHHHHhhHhh
Q 044846 224 PTMKEVTLELAGIRAS 239 (290)
Q Consensus 224 ps~~el~~~l~~~~~~ 239 (290)
||+.++++.|+.+...
T Consensus 287 ps~~evl~~l~~~~~~ 302 (307)
T cd05098 287 PTFKQLVEDLDRILAL 302 (307)
T ss_pred cCHHHHHHHHHHHHHH
Confidence 9999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=266.81 Aligned_cols=225 Identities=24% Similarity=0.307 Sum_probs=183.7
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.+++|++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|.+++..... ..+++..
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~--~~~~~~~ 102 (256)
T cd08221 25 DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEM 102 (256)
T ss_pred CcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccc--cCCCHHH
Confidence 577899987643 355567889999999999999999999999999999999999999999999986532 2588999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........ ......++..|+|||++.+..+
T Consensus 103 ~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~ 178 (256)
T cd08221 103 VLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKY 178 (256)
T ss_pred HHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cccccCCCccccCHhhcCCCCC
Confidence 9999999999999999999 99999999999999999999999998765433221 2234567889999999988888
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.++|+||||+++|+|++|..++....... ........ ......+..+.+++.+||..+|.+|||+.++++++
T Consensus 179 ~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 179 NFKSDIWALGCVLYELLTLKRTFDATNPLN-LVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCcchhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 999999999999999999998875432221 11111111 11233466799999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=274.80 Aligned_cols=228 Identities=17% Similarity=0.213 Sum_probs=181.4
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++.. .....+.+.+|+++++.++||||+++++++...+..+++|||+++|+|.+++...... .+++..
T Consensus 25 ~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~--~~~~~~ 102 (314)
T cd08216 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPE--GLPELA 102 (314)
T ss_pred CCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhccc--CCCHHH
Confidence 678999998753 4556778999999999999999999999999999999999999999999999865332 478889
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc------eeeccceecccccCccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT------HLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~ 153 (290)
+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+........ .......++..|+|||+
T Consensus 103 ~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 179 (314)
T cd08216 103 IAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179 (314)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHH
Confidence 9999999999999999999 99999999999999999999999998754321111 11123456778999999
Q ss_pred cccC--CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH-----------------------------------h
Q 044846 154 FRSS--QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY-----------------------------------F 196 (290)
Q Consensus 154 ~~~~--~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~-----------------------------------~ 196 (290)
+... .++.++|+|||||++|+|++|..||............. .
T Consensus 180 ~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (314)
T cd08216 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSV 259 (314)
T ss_pred hcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhh
Confidence 8763 58889999999999999999999886432211111000 0
Q ss_pred hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 197 SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 197 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
........+..+.+++.+||+.||++|||+.+++++..
T Consensus 260 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 260 DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 01112233567889999999999999999999998855
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=270.39 Aligned_cols=232 Identities=22% Similarity=0.331 Sum_probs=184.3
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCcceEEEEeCCCCCHHHHHhhcCCC----CCCC
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYIHEQTDD----QLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~ 75 (290)
++.|++|+++.. .....+.+.+|+.+++.++||||+++++++.. ....++++||+++|+|.+++...... ...+
T Consensus 35 ~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l 114 (280)
T cd05043 35 EEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114 (280)
T ss_pred eeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCC
Confidence 466888888643 34557778999999999999999999998766 56789999999999999999765322 1358
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee-eccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~ 154 (290)
++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++......... .....++..|+|||++
T Consensus 115 ~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 115 STQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191 (280)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence 89999999999999999999999 9999999999999999999999999987543222221 1223456779999999
Q ss_pred ccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
.+..++.++||||||+++|++++ |.+|+...... . +...... ......+..+.+++.+||..||++|||+.++
T Consensus 192 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 269 (280)
T cd05043 192 VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-E-MAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQL 269 (280)
T ss_pred hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-H-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 98889999999999999999998 87776533221 1 1111111 1122345679999999999999999999999
Q ss_pred HHHHHhhHh
Q 044846 230 TLELAGIRA 238 (290)
Q Consensus 230 ~~~l~~~~~ 238 (290)
+..|+.+..
T Consensus 270 ~~~l~~~~~ 278 (280)
T cd05043 270 VQCLTDFHA 278 (280)
T ss_pred HHHHHHHHh
Confidence 999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=268.85 Aligned_cols=226 Identities=19% Similarity=0.329 Sum_probs=179.5
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.||+|.++.. .......|..|+.+++.++||||+++++++..++..++||||+++|+|.+++..... .+++..++.
T Consensus 34 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~ 110 (269)
T cd05065 34 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVG 110 (269)
T ss_pred eEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCC---CCCHHHHHH
Confidence 5899998754 355577899999999999999999999999999999999999999999999976532 478999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce--eeccce--ecccccCccccccCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--LTTQVK--VTFGYVDPKYFRSSQ 158 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~--g~~~y~aPE~~~~~~ 158 (290)
++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......... ...... .+..|+|||++.+..
T Consensus 111 i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (269)
T cd05065 111 MLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187 (269)
T ss_pred HHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc
Confidence 9999999999999999 999999999999999999999999987643322111 111111 235799999999889
Q ss_pred CCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++.++|||||||++||+++ |..|+....... ..... ...+.+...+..+.+++.+||+.+|++||++.+++..|+
T Consensus 188 ~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 188 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-HHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999875 777765332211 11111 111122334567899999999999999999999998887
Q ss_pred hh
Q 044846 235 GI 236 (290)
Q Consensus 235 ~~ 236 (290)
.+
T Consensus 267 ~~ 268 (269)
T cd05065 267 KM 268 (269)
T ss_pred hh
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=269.79 Aligned_cols=228 Identities=21% Similarity=0.276 Sum_probs=176.9
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC---CCCCCCHH
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD---DQLPITWE 78 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~ 78 (290)
..||+|...... ......+.+|+.+++.++|+||+++++++...+..++||||+++|+|.+++..... ....+++.
T Consensus 37 ~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~ 116 (277)
T cd05036 37 LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116 (277)
T ss_pred eeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHH
Confidence 457888776433 33456799999999999999999999999999999999999999999999976532 11258899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC---cEEEeccccccccccCCcee-eccceecccccCcccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY---QAKISDFRTFKSRAIDRTHL-TTQVKVTFGYVDPKYF 154 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~ 154 (290)
.++.++.||+.||.|||+++ ++||||||+||+++.++ .+||+|||+++......... ......+..|+|||++
T Consensus 117 ~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05036 117 DLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF 193 (277)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHH
Confidence 99999999999999999999 99999999999998654 58999999976542111111 1122335679999999
Q ss_pred ccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.+..++.++|||||||++|+|++ |..||....... ...... ....+...+..+.+++.+||+.||++|||+.+++
T Consensus 194 ~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl 272 (277)
T cd05036 194 LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272 (277)
T ss_pred hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 98899999999999999999986 777664332221 111111 1112233456789999999999999999999999
Q ss_pred HHHH
Q 044846 231 LELA 234 (290)
Q Consensus 231 ~~l~ 234 (290)
++|.
T Consensus 273 ~~l~ 276 (277)
T cd05036 273 ERIQ 276 (277)
T ss_pred HHhh
Confidence 9885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=266.82 Aligned_cols=225 Identities=21% Similarity=0.283 Sum_probs=177.2
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
..+|+|++.... ...+.+.+|+++++.++|||++++++++. .+..+++|||+++|+|.+++..... ..+++..+..
T Consensus 31 ~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~ 106 (260)
T cd05069 31 TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDG--KYLKLPQLVD 106 (260)
T ss_pred ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCC--CCCCHHHHHH
Confidence 357888876433 33567889999999999999999998875 4568999999999999999976432 2478899999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...............++..|+|||...+..++.+
T Consensus 107 ~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~ 183 (260)
T cd05069 107 MAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183 (260)
T ss_pred HHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChH
Confidence 9999999999999999 9999999999999999999999999986543222222223345678999999988889999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+|+||||+++|++++ |..|+...... ........ ...+...+..+.+++.+||..||++||+++++++.|+.
T Consensus 184 ~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 184 SDVWSFGILLTELVTKGRVPYPGMVNR-EVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 999999999999998 77666443222 11111111 11223456779999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=272.73 Aligned_cols=232 Identities=19% Similarity=0.306 Sum_probs=181.7
Q ss_pred EEEEeecc-cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC------------
Q 044846 5 WLLKKSKS-VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD------------ 70 (290)
Q Consensus 5 ~avK~~~~-~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------ 70 (290)
+++|.++. ......+.+.+|++++.++ +||||+++++++...+..++++||+++|+|.+++.....
T Consensus 32 ~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 111 (297)
T cd05089 32 AAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111 (297)
T ss_pred eEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccC
Confidence 57777764 3344567799999999999 799999999999999999999999999999999976431
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccC
Q 044846 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVD 150 (290)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 150 (290)
....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ........+..|+|
T Consensus 112 ~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~a 186 (297)
T cd05089 112 TASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVY--VKKTMGRLPVRWMA 186 (297)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCccccce--eccCCCCcCccccC
Confidence 1124788899999999999999999999 999999999999999999999999987532211 11111223456999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
||++.+..++.++|||||||++|+|++ |..||....... ....... ...+...+..+.+|+.+||+.||.+|||+
T Consensus 187 PE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 265 (297)
T cd05089 187 IESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPF 265 (297)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999988889999999999999999996 877775432211 1111111 11223356779999999999999999999
Q ss_pred HHHHHHHHhhHhhhCc
Q 044846 227 KEVTLELAGIRASIGA 242 (290)
Q Consensus 227 ~el~~~l~~~~~~~~~ 242 (290)
+++++.|+.+......
T Consensus 266 ~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 266 AQISVQLSRMLEARKA 281 (297)
T ss_pred HHHHHHHHHHHHhhcc
Confidence 9999999888765533
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=268.80 Aligned_cols=217 Identities=20% Similarity=0.352 Sum_probs=170.6
Q ss_pred eEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHH
Q 044846 4 LWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI 83 (290)
Q Consensus 4 ~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 83 (290)
.+++|..+..... ...+.+|+.+++.++||||+++++++.. ...++||||+++|+|.+++..... .+++..+..+
T Consensus 32 ~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~ 106 (259)
T cd05037 32 SVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN---NVSLHWKLDV 106 (259)
T ss_pred eeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc---CCCHHHHHHH
Confidence 4677776644333 6789999999999999999999999988 778999999999999999987543 4888999999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-------cEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-------QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 84 ~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+.||+.||+|||+++ |+||||||+||+++.++ .+||+|||++..... .....++..|+|||++.+
T Consensus 107 ~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~ 178 (259)
T cd05037 107 AKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRN 178 (259)
T ss_pred HHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcC
Confidence 999999999999999 99999999999999887 799999999765332 122345677999999987
Q ss_pred C--CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 157 S--QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 157 ~--~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
. .++.++|+||||+++|+++++..++............+.. ...+......+.+++.+||+.+|.+|||+.++++.|
T Consensus 179 ~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 6 7889999999999999999854333322211111111111 111111236789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.83 Aligned_cols=223 Identities=19% Similarity=0.232 Sum_probs=170.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--------CcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLET--------EVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||+|++.... ....+|+.+|+.++||||+++++++... ..+++||||++ ++|.+++........
T Consensus 91 ~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~ 165 (440)
T PTZ00036 91 SEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNH 165 (440)
T ss_pred CCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCC
Confidence 5789999885422 2234799999999999999999887542 24679999996 588888765433334
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-cEEEeccccccccccCCceeeccceecccccCcc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPK 152 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 152 (290)
.+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||
T Consensus 166 ~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~--~~~~~~~t~~y~aPE 240 (440)
T PTZ00036 166 ALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVSYICSRFYRAPE 240 (440)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCC--CcccCCCCcCccCHH
Confidence 6889999999999999999999999 99999999999999665 69999999987543221 223456788999999
Q ss_pred ccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHhh----------------------------hhhh
Q 044846 153 YFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYFS----------------------------KEAE 201 (290)
Q Consensus 153 ~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~~----------------------------~~~~ 201 (290)
++.+. .++.++|||||||++|+|++|.+||.......... ..... ...+
T Consensus 241 ~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p 320 (440)
T PTZ00036 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFP 320 (440)
T ss_pred HhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhc
Confidence 98764 68999999999999999999999886543211110 00000 0001
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 202 KEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 202 ~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
...+.++.+||.+||+.||.+|||+.|++.|.+
T Consensus 321 ~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 321 KGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 112457899999999999999999999998855
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=268.57 Aligned_cols=227 Identities=22% Similarity=0.302 Sum_probs=180.9
Q ss_pred eEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.||+|...... ....+.+.+|+.+++.++||||+++++++.. +..++||||+++|+|.+++..... .+++..++.
T Consensus 36 ~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~ 111 (270)
T cd05056 36 AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKY---SLDLASLIL 111 (270)
T ss_pred ceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCC---CCCHHHHHH
Confidence 47888876544 5567789999999999999999999998875 567899999999999999976432 488999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++..............++..|+|||.+....++.+
T Consensus 112 ~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 188 (270)
T cd05056 112 YSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188 (270)
T ss_pred HHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCch
Confidence 9999999999999999 9999999999999999999999999876543322222222334567999999988889999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
+||||||+++|++++ |..||........ ..... ....+...+..+.+++.+||..+|++|||+.+++..|+.+..
T Consensus 189 ~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 189 SDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999885 8877754332211 11111 111223445689999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=266.89 Aligned_cols=224 Identities=23% Similarity=0.319 Sum_probs=181.7
Q ss_pred eEEEEeecccCc-hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSVHE-SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.||+|.++.... ...+.+.+|++++++++||||+++++.+.. ...++||||+++|+|.+++..... ..+++..+..
T Consensus 25 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~ 101 (257)
T cd05040 25 PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCD 101 (257)
T ss_pred EEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHH
Confidence 589999886555 667789999999999999999999999988 889999999999999999987542 2588999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee--eccceecccccCccccccCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL--TTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++......... .....++..|+|||++.+..++
T Consensus 102 ~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~ 178 (257)
T cd05040 102 YAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178 (257)
T ss_pred HHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcC
Confidence 9999999999999999 9999999999999999999999999987544322111 1234567789999999988999
Q ss_pred CcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh----hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 161 EKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF----SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.++|||||||++|+|++ |..|+....... ...... ....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 179 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 179 HASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 99999999999999997 888774322211 111111 11112234567999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=267.82 Aligned_cols=228 Identities=22% Similarity=0.268 Sum_probs=172.8
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-CCCCCCHHHH
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD-DQLPITWEMR 80 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~ 80 (290)
..+|+|+++... ......+.+|+.+++.++||||+++++++......++||||+++|+|.+++..... .....++..+
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 102 (269)
T cd05087 23 AQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL 102 (269)
T ss_pred eEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHH
Confidence 457888886543 33445788999999999999999999999999999999999999999999976432 1224567788
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee-eccceecccccCccccccC--
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFGYVDPKYFRSS-- 157 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~-- 157 (290)
..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++......... .....++..|+|||++.+.
T Consensus 103 ~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 179 (269)
T cd05087 103 QRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179 (269)
T ss_pred HHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccc
Confidence 889999999999999999 9999999999999999999999999976433221111 1234467789999998642
Q ss_pred -----CCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh-------hhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 158 -----QFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS-------KEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 158 -----~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
.++.++|+||||+++|+|++ |..|+............... .......+..+.+++.+|| .+|++||
T Consensus 180 ~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp 258 (269)
T cd05087 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRP 258 (269)
T ss_pred cccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCC
Confidence 35789999999999999985 88776433222211110000 0111123456889999999 6899999
Q ss_pred CHHHHHHHHH
Q 044846 225 TMKEVTLELA 234 (290)
Q Consensus 225 s~~el~~~l~ 234 (290)
|++||+..|.
T Consensus 259 t~~~l~~~l~ 268 (269)
T cd05087 259 SAEEVHLLLS 268 (269)
T ss_pred CHHHHHHHhc
Confidence 9999997764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=270.98 Aligned_cols=225 Identities=22% Similarity=0.271 Sum_probs=183.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.+|+|..+.......+.+.+|+++++.++||||+++++.+......++||||+++++|.+++..... .+++..+.
T Consensus 30 ~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~l~~~~~~ 106 (280)
T cd06611 30 GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER---GLTEPQIR 106 (280)
T ss_pred CcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcC---CCCHHHHH
Confidence 567999999877777788899999999999999999999999999999999999999999999876432 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc-----c
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-----S 156 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~ 156 (290)
.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... .......++..|++||++. .
T Consensus 107 ~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~ 182 (280)
T cd06611 107 YVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QKRDTFIGTPYWMAPEVVACETFKD 182 (280)
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-cccceeecchhhcCHHHHhhcccCC
Confidence 99999999999999999 9999999999999999999999999865432221 1223356788899999975 3
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
..++.++|+||||+++|+|++|.+|+...... ......... ..+...+..+.+++.+||+.||.+||++.++++
T Consensus 183 ~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 183 NPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 44677999999999999999999887543221 111111111 112234567999999999999999999999998
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
+-+
T Consensus 262 ~~~ 264 (280)
T cd06611 262 HPF 264 (280)
T ss_pred Chh
Confidence 754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=275.36 Aligned_cols=225 Identities=19% Similarity=0.287 Sum_probs=168.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCC-----CCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTD-----DQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~ 74 (290)
++.||+|+++... ....+.+|+++++.++||||+++++++.. ....|++|||+ +++|..++..... ....
T Consensus 28 ~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~ 104 (317)
T cd07868 28 DRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQ 104 (317)
T ss_pred CceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCccc
Confidence 3568999886532 23457799999999999999999999864 45689999999 5689988864321 1225
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe----ccCCcEEEeccccccccccCCc--eeeccceecccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL----VDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGY 148 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~----~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y 148 (290)
+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++....... .......+|+.|
T Consensus 105 l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y 181 (317)
T cd07868 105 LPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccc
Confidence 888999999999999999999999 9999999999999 4567899999999865432211 122345678999
Q ss_pred cCccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhh--------hhhHHHhh---------------hhh----
Q 044846 149 VDPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEEN--------RSLAAYFS---------------KEA---- 200 (290)
Q Consensus 149 ~aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~--------~~~~~~~~---------------~~~---- 200 (290)
+|||++.+. .++.++||||+||++|+|++|.++|....... ..+..... ...
T Consensus 182 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (317)
T cd07868 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTL 261 (317)
T ss_pred cCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhh
Confidence 999998774 58889999999999999999998875322100 00000000 000
Q ss_pred ---------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 201 ---------------------EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 201 ---------------------~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
....+..+.+||.+||+.||.+|||++|+++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 262 MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred hhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00012357799999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=267.00 Aligned_cols=226 Identities=18% Similarity=0.294 Sum_probs=179.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|.+..... ....+.+|+.+++.++||||+++++++. .+..+++|||+++|+|.+++..... ..+++..+.
T Consensus 30 ~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~ 105 (260)
T cd05067 30 HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEG--IKLTINKLI 105 (260)
T ss_pred CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHH
Confidence 46799998875433 3567899999999999999999998874 5678999999999999999876443 258889999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...............++..|+|||++....++.
T Consensus 106 ~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~ 182 (260)
T cd05067 106 DMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182 (260)
T ss_pred HHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCc
Confidence 99999999999999999 999999999999999999999999997654322222222334567899999998888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
++||||||+++|++++ |.+|+...... ...... .........+..+.+++.+||+.+|++|||+++++..|+.
T Consensus 183 ~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 183 KSDVWSFGILLTEIVTYGRIPYPGMTNP-EVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ccchHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 9999999999999998 88777533221 111111 1111222345679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=267.10 Aligned_cols=222 Identities=22% Similarity=0.254 Sum_probs=181.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.+|+|.++.... .+.+.+|+++++.++||||+++++.+......|+++||+++++|.+++..... .+++..+.
T Consensus 28 ~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~---~l~~~~~~ 102 (256)
T cd06612 28 GQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIA 102 (256)
T ss_pred CcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCcc---CCCHHHHH
Confidence 46789998875322 67899999999999999999999999999999999999999999999975432 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.
T Consensus 103 ~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~ 178 (256)
T cd06612 103 AILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYNN 178 (256)
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-cccccccCCccccCHHHHhcCCCCc
Confidence 99999999999999999 9999999999999999999999999976543222 1223345778899999999889999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++||||||+++|+|++|.+|+............... .......+..+.+++.+||+.||++|||+.|++.+
T Consensus 179 ~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 999999999999999999887543322211111100 01122345678999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=278.71 Aligned_cols=216 Identities=20% Similarity=0.243 Sum_probs=175.0
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+..|..++..+. |++|+++++++...+..|+||||+++|+|..++.... .+++
T Consensus 25 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~----~l~~ 100 (323)
T cd05615 25 DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG----KFKE 100 (323)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC----CCCH
Confidence 678999998642 2344567888999999885 6788899999999999999999999999999997654 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+.
T Consensus 101 ~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 176 (323)
T cd05615 101 PQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQ 176 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-ccccCccCCccccCHHHHcCC
Confidence 999999999999999999999 9999999999999999999999999976432211 122345689999999999988
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
.++.++|+|||||++|+|++|.+|+...... ........ ...+...+..+.+++.+||+.||.+|++.
T Consensus 177 ~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 8999999999999999999999988644322 11111111 11223456678999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=276.51 Aligned_cols=225 Identities=15% Similarity=0.217 Sum_probs=177.0
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.||+|.+.. ........+..|+.++..++|+||+++++++...+..|+||||+++|+|.+++..... .+++.
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~---~l~~~ 102 (331)
T cd05624 26 ERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED---RLPED 102 (331)
T ss_pred CCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcC---CCCHH
Confidence 56789998864 2233455688899999999999999999999999999999999999999999986432 58889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc--
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-- 156 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 156 (290)
.+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..............|++.|+|||++.+
T Consensus 103 ~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 179 (331)
T cd05624 103 MARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179 (331)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccc
Confidence 99999999999999999999 9999999999999999999999999986543322222234568999999999875
Q ss_pred ---CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-------hhhHHHHHHHHHHHHHhhccCCCC--CC
Q 044846 157 ---SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-------EAEKEEVITFAMVAKRCLNLNGKK--QP 224 (290)
Q Consensus 157 ---~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~--Rp 224 (290)
..++.++|||||||++|+|++|..||....... ........ ......+..+.+++.+||..++++ |+
T Consensus 180 ~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~ 258 (331)
T cd05624 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQN 258 (331)
T ss_pred cCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCC
Confidence 457889999999999999999999886443221 11111111 011123567999999999876554 46
Q ss_pred CHHHHHHHH
Q 044846 225 TMKEVTLEL 233 (290)
Q Consensus 225 s~~el~~~l 233 (290)
++++++.+.
T Consensus 259 ~~~~~~~h~ 267 (331)
T cd05624 259 GIEDFKKHA 267 (331)
T ss_pred CHHHHhcCC
Confidence 889998774
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=268.54 Aligned_cols=228 Identities=20% Similarity=0.324 Sum_probs=180.1
Q ss_pred ceEEEEeecccCch-hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC-----CCCCC
Q 044846 3 ELWLLKKSKSVHES-NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD-----QLPIT 76 (290)
Q Consensus 3 ~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~ 76 (290)
+.+++|........ ..+.+.+|++++++++||||+++++++...+..++||||+++|+|.+++...... ...++
T Consensus 36 ~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~ 115 (275)
T cd05046 36 TLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115 (275)
T ss_pred ceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCC
Confidence 45888887654433 5678999999999999999999999999989999999999999999999765422 12588
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||++...............++..|++||.+.+
T Consensus 116 ~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 192 (275)
T cd05046 116 TKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE 192 (275)
T ss_pred HHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhcc
Confidence 9999999999999999999999 9999999999999999999999999876433222222233456778999999988
Q ss_pred CCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
..++.++||||||+++|++++ |..++..... ...+..... .......+..+.+++.+||+.||++|||+.|++.
T Consensus 193 ~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCccccch-HHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 888999999999999999997 5555532211 111111110 1112234567899999999999999999999998
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
.|.
T Consensus 272 ~l~ 274 (275)
T cd05046 272 ALG 274 (275)
T ss_pred Hhc
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=265.81 Aligned_cols=224 Identities=20% Similarity=0.271 Sum_probs=180.2
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.||+|++... .....+.+.+|++++++++|||++++.+.+.. ....+++|||+++++|.+++...... .+++.
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~--~l~~~ 102 (257)
T cd08223 25 GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK--LLPEN 102 (257)
T ss_pred CcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCC--CCCHH
Confidence 467999998643 33456678999999999999999999998864 44679999999999999999864322 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
++..++.+++.|+.|||+.+ ++||||||+||+++.++.++|+|||++....... .......+++.|+|||++.+..
T Consensus 103 ~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 178 (257)
T cd08223 103 QVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTLIGTPYYMSPELFSNKP 178 (257)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-CccccccCCcCccChhHhcCCC
Confidence 99999999999999999999 9999999999999999999999999976543221 2223455788899999999998
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++.++|+||||++++++++|..++........ ...... ...+...+..+.+++.+||+.||++|||+.+++.+
T Consensus 179 ~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 179 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 99999999999999999999987754322211 111111 12233456789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.65 Aligned_cols=228 Identities=20% Similarity=0.347 Sum_probs=176.5
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC--------CCCC
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD--------DQLP 74 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~ 74 (290)
.||+|+++.. .....+.|.+|++++++++||||+++++++...+..++||||+++++|.+++..... ....
T Consensus 46 ~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 125 (295)
T cd05097 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125 (295)
T ss_pred EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCc
Confidence 4889988653 344566799999999999999999999999999999999999999999999965321 1123
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccCccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~ 153 (290)
+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .......++..|+|||+
T Consensus 126 ~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 202 (295)
T cd05097 126 VSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES 202 (295)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhh
Confidence 678889999999999999999999 99999999999999999999999999765432211 11122345678999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhc--CCCCcccchhhh--hhhHHHhh-------hhhhHHHHHHHHHHHHHhhccCCCC
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNW--TKPIHLVDVEEN--RSLAAYFS-------KEAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~--~~~~~~~~~~~~--~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
+.+..++.++|+||||+++|+|++ +..++....... ........ .......+..+.+|+.+||+.||++
T Consensus 203 ~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 282 (295)
T cd05097 203 ILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKD 282 (295)
T ss_pred hccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchh
Confidence 998889999999999999999987 344443221111 11111000 0112224567999999999999999
Q ss_pred CCCHHHHHHHHH
Q 044846 223 QPTMKEVTLELA 234 (290)
Q Consensus 223 Rps~~el~~~l~ 234 (290)
|||++++++.|+
T Consensus 283 RPs~~~i~~~l~ 294 (295)
T cd05097 283 RPTFNKIHHFLR 294 (295)
T ss_pred CcCHHHHHHHHh
Confidence 999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=270.88 Aligned_cols=221 Identities=21% Similarity=0.247 Sum_probs=177.6
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.||+|.+... .....+.+.+|++++++++||||+++++.+...+..++||||+++|+|..+. .+++..+
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~ 97 (279)
T cd06619 26 RRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR--------KIPEHVL 97 (279)
T ss_pred CcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh--------cCCHHHH
Confidence 567999988643 3344567999999999999999999999999999999999999999996542 3678888
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..... .......++..|+|||++.+..++
T Consensus 98 ~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~ 171 (279)
T cd06619 98 GRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---SIAKTYVGTNAYMAPERISGEQYG 171 (279)
T ss_pred HHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc---ccccCCCCChhhcCceeecCCCCC
Confidence 999999999999999999 99999999999999999999999999764321 122345678899999999998999
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhh-----hhHHHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENR-----SLAAYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.++|+||||+++|+|++|..|+........ ....... .......+.++.+++.+||+.||++||+++|++
T Consensus 172 ~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil 251 (279)
T cd06619 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251 (279)
T ss_pred CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 999999999999999999988753221110 1111000 001122456789999999999999999999999
Q ss_pred HHHHhh
Q 044846 231 LELAGI 236 (290)
Q Consensus 231 ~~l~~~ 236 (290)
++.+-.
T Consensus 252 ~~~~~~ 257 (279)
T cd06619 252 DHPFIV 257 (279)
T ss_pred cCcccc
Confidence 886543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=275.08 Aligned_cols=228 Identities=21% Similarity=0.264 Sum_probs=185.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|.+........+.+.+|+.+++.++||||+++++++...+..++++||+++++|..++... .+++..+.
T Consensus 46 ~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-----~~~~~~~~ 120 (297)
T cd06659 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-----RLNEEQIA 120 (297)
T ss_pred CCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc-----CCCHHHHH
Confidence 6789999987655566778899999999999999999999999999999999999999999988652 47889999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .......++..|+|||++.+..++.
T Consensus 121 ~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 196 (297)
T cd06659 121 TVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRTPYGT 196 (297)
T ss_pred HHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceecCccccCHHHHccCCCCc
Confidence 99999999999999999 9999999999999999999999999875433221 1223356788999999999888999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
++|+|||||++|+|++|++|+........ ....... ......+..+.+++.+||+.+|++||++.+++++-...
T Consensus 197 ~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 99999999999999999998764332211 1111110 11122345688999999999999999999999986555
Q ss_pred Hhh
Q 044846 237 RAS 239 (290)
Q Consensus 237 ~~~ 239 (290)
...
T Consensus 276 ~~~ 278 (297)
T cd06659 276 QTG 278 (297)
T ss_pred cCC
Confidence 443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=265.47 Aligned_cols=229 Identities=24% Similarity=0.334 Sum_probs=184.3
Q ss_pred CceEEEEeecccCch-hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC-----CCCC
Q 044846 2 EELWLLKKSKSVHES-NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD-----QLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~ 75 (290)
+..||+|.++..... ..+.+.+|++.++.++|+||+++++++......+++|||+++++|.+++...... ...+
T Consensus 23 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 102 (262)
T cd00192 23 TTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL 102 (262)
T ss_pred CceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccC
Confidence 567899998764433 3778999999999999999999999999999999999999999999999876211 1268
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~ 154 (290)
++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||.+........ .......++..|+|||.+
T Consensus 103 ~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 179 (262)
T cd00192 103 SLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179 (262)
T ss_pred CHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHh
Confidence 99999999999999999999999 99999999999999999999999999865443221 122334567889999999
Q ss_pred ccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
....++.++||||+|+++|+|++ |..|+.... ......... ....+...+..+.+++.+||..||++|||+.|++
T Consensus 180 ~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~ 258 (262)
T cd00192 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELV 258 (262)
T ss_pred ccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHH
Confidence 98889999999999999999998 466664432 111111111 1122234467899999999999999999999999
Q ss_pred HHHH
Q 044846 231 LELA 234 (290)
Q Consensus 231 ~~l~ 234 (290)
.+|+
T Consensus 259 ~~l~ 262 (262)
T cd00192 259 ERLE 262 (262)
T ss_pred HhhC
Confidence 8873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=269.92 Aligned_cols=225 Identities=20% Similarity=0.289 Sum_probs=175.6
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++.. .......+.+|+.+++.++||||+++++++..++..++||||+. ++|.+++...... ..+++..
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~-~~~~~~~ 102 (285)
T cd07861 25 GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKG-QYMDAEL 102 (285)
T ss_pred CcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCC-CcCCHHH
Confidence 577999998643 23345678899999999999999999999999999999999996 6899988754321 2588999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-C
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-Q 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 158 (290)
+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....... .......++..|+|||++.+. .
T Consensus 103 ~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 178 (285)
T cd07861 103 VKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPR 178 (285)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCCCC
Confidence 9999999999999999999 9999999999999999999999999976433221 122234567889999988654 4
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH--h-----------------h-----------hhhhHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY--F-----------------S-----------KEAEKEEVITF 208 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~--~-----------------~-----------~~~~~~~~~~~ 208 (290)
++.++|+|||||++|+|++|.+++............. . . .......+.++
T Consensus 179 ~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (285)
T cd07861 179 YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDG 258 (285)
T ss_pred cCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHH
Confidence 7889999999999999999998886432211111000 0 0 00011134567
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHH
Q 044846 209 AMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 209 ~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.++|.+||+.||.+|||+.+++.+
T Consensus 259 ~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 259 LDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHHHHhcCChhhCCCHHHHhcC
Confidence 899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=270.55 Aligned_cols=229 Identities=19% Similarity=0.308 Sum_probs=178.8
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC----------
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD---------- 70 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------- 70 (290)
++.||+|+++... ......+.+|+.++++++||||+++++++......+++|||+++|+|.+++.....
T Consensus 35 ~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 114 (288)
T cd05050 35 FTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114 (288)
T ss_pred ceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccc
Confidence 3578899886533 34456799999999999999999999999999999999999999999999975321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeecc
Q 044846 71 --------DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQ 141 (290)
Q Consensus 71 --------~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 141 (290)
....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++........ .....
T Consensus 115 ~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 191 (288)
T cd05050 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191 (288)
T ss_pred cccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCC
Confidence 1124778889999999999999999999 99999999999999999999999998764322211 11122
Q ss_pred ceecccccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhc
Q 044846 142 VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLN 217 (290)
Q Consensus 142 ~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~ 217 (290)
...+..|+|||++.+..++.++|||||||++|+|++ |..|+...... ......... ..+...+..+.+++.+||+
T Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 270 (288)
T cd05050 192 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-EVIYYVRDGNVLSCPDNCPLELYNLMRLCWS 270 (288)
T ss_pred CccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 334567999999998899999999999999999986 66665432211 111111111 1122345679999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 044846 218 LNGKKQPTMKEVTLELA 234 (290)
Q Consensus 218 ~dp~~Rps~~el~~~l~ 234 (290)
.||.+|||+.|+++.|+
T Consensus 271 ~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 271 KLPSDRPSFASINRILQ 287 (288)
T ss_pred cCcccCCCHHHHHHHhh
Confidence 99999999999998886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=274.10 Aligned_cols=227 Identities=19% Similarity=0.284 Sum_probs=176.8
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+. ++|.+++..... .+++..+
T Consensus 31 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~ 106 (309)
T cd07872 31 ENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGN---IMSMHNV 106 (309)
T ss_pred CCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCC---CCCHHHH
Confidence 5679999987433 2334467899999999999999999999999999999999996 589988876432 4788899
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-CCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-SQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~ 159 (290)
..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......++..|+|||++.+ ..+
T Consensus 107 ~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 182 (309)
T cd07872 107 KIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSSEY 182 (309)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-cccccccccccccCCHHHhCCCCC
Confidence 999999999999999999 9999999999999999999999999976432221 12223456889999999865 458
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHhh---------------------h--------hhhHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYFS---------------------K--------EAEKEEVITF 208 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~~---------------------~--------~~~~~~~~~~ 208 (290)
+.++|||||||++|+|++|.++|........ ....... . ......+.++
T Consensus 183 ~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T cd07872 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEG 262 (309)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHH
Confidence 8899999999999999999988864322111 0000000 0 0001134568
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 209 AMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 209 ~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.+||.+||+.||.+|||+.|++.+.+-.
T Consensus 263 ~~li~~~L~~dp~~R~t~~e~l~h~~~~ 290 (309)
T cd07872 263 IELLTKFLQYESKKRISAEEAMKHAYFR 290 (309)
T ss_pred HHHHHHhccCChhhCCCHHHHhcChhhh
Confidence 8999999999999999999999876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=274.47 Aligned_cols=225 Identities=14% Similarity=0.209 Sum_probs=177.1
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.+|+|++.. ........+..|+.++..++|+||+++++++...+..|+||||+++|+|.+++.+... .+++.
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~l~~~ 102 (332)
T cd05623 26 DKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED---RLPED 102 (332)
T ss_pred CCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcC---CCCHH
Confidence 46789998853 2233445688899999999999999999999999999999999999999999986432 58888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR--- 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--- 155 (290)
.+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...............||+.|+|||++.
T Consensus 103 ~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 179 (332)
T cd05623 103 MARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179 (332)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccc
Confidence 99999999999999999999 999999999999999999999999997654332222333456899999999986
Q ss_pred --cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-------hhhHHHHHHHHHHHHHhhccCCCC--CC
Q 044846 156 --SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-------EAEKEEVITFAMVAKRCLNLNGKK--QP 224 (290)
Q Consensus 156 --~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~--Rp 224 (290)
...++.++|||||||++|+|++|+.||....... ........ ......+..+.+|+.+|+..++.+ |+
T Consensus 180 ~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~ 258 (332)
T cd05623 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQN 258 (332)
T ss_pred cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-HHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCC
Confidence 3457889999999999999999999886443211 11111111 111234677899999998665544 68
Q ss_pred CHHHHHHHH
Q 044846 225 TMKEVTLEL 233 (290)
Q Consensus 225 s~~el~~~l 233 (290)
++.++++|-
T Consensus 259 ~~~~~~~h~ 267 (332)
T cd05623 259 GIEDFKQHP 267 (332)
T ss_pred CHHHHhCCC
Confidence 999999884
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=267.60 Aligned_cols=224 Identities=21% Similarity=0.304 Sum_probs=179.4
Q ss_pred CceEEEEeecccC------chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVH------ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~------~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.+|+|+++... ....+.+.+|+++++.++|+||+++++++...+..++++||+++++|.+++.+.. .+
T Consensus 24 ~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~ 99 (265)
T cd06631 24 GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG----PL 99 (265)
T ss_pred CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC----CC
Confidence 5678999876422 2234568899999999999999999999999999999999999999999997654 57
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC-----CceeeccceecccccC
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID-----RTHLTTQVKVTFGYVD 150 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~g~~~y~a 150 (290)
++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++...... .........++..|+|
T Consensus 100 ~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (265)
T cd06631 100 PEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176 (265)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccC
Confidence 88899999999999999999999 999999999999999999999999987643211 1111223457888999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh----hhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF----SKEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
||++.+..++.++|+||||+++|++++|..|+.............. ....+...+..+.++|.+||+.+|++||++
T Consensus 177 pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 256 (265)
T cd06631 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSA 256 (265)
T ss_pred hhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCH
Confidence 9999988899999999999999999999988854322211111100 011223355678999999999999999999
Q ss_pred HHHHHH
Q 044846 227 KEVTLE 232 (290)
Q Consensus 227 ~el~~~ 232 (290)
.+++.+
T Consensus 257 ~~~l~~ 262 (265)
T cd06631 257 LQLLRH 262 (265)
T ss_pred HHHhcC
Confidence 999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=267.86 Aligned_cols=228 Identities=21% Similarity=0.313 Sum_probs=178.6
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC---CCCCCCHH
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD---DQLPITWE 78 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~ 78 (290)
+.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++..... ....+++.
T Consensus 27 ~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 106 (269)
T cd05044 27 IRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLK 106 (269)
T ss_pred eeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHH
Confidence 457888775432 34567899999999999999999999999999999999999999999999976422 12247889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-----cEEEeccccccccccCCce-eeccceecccccCcc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-----QAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPK 152 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-----~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE 152 (290)
.++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++++|||+++........ ......++..|+|||
T Consensus 107 ~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 183 (269)
T cd05044 107 ELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPE 183 (269)
T ss_pred HHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHH
Confidence 99999999999999999998 99999999999999877 8999999987643321111 112233467899999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
++.+..++.++||||||+++|+|++ |..|+....... ....... .......+..+.++|.+||..+|.+||++.+
T Consensus 184 ~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 262 (269)
T cd05044 184 SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDR 262 (269)
T ss_pred HHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-HHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHH
Confidence 9999999999999999999999997 877764332221 1111111 1122345677899999999999999999999
Q ss_pred HHHHHH
Q 044846 229 VTLELA 234 (290)
Q Consensus 229 l~~~l~ 234 (290)
+++.|+
T Consensus 263 i~~~l~ 268 (269)
T cd05044 263 IQEILQ 268 (269)
T ss_pred HHHHHh
Confidence 998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=269.54 Aligned_cols=229 Identities=25% Similarity=0.343 Sum_probs=182.0
Q ss_pred CceEEEEeecccCch-hHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVHES-NVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.+|+|+++..... ..+.|.+|+++++.++||||+++++++.. ....+++|||+++++|.+++..... .+++.
T Consensus 33 ~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~ 109 (284)
T cd05038 33 GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLK 109 (284)
T ss_pred ceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc---ccCHH
Confidence 567999998754443 56789999999999999999999999887 5678999999999999999976543 48899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee--eccceecccccCcccccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL--TTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~ 156 (290)
.+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......... .....++..|++||.+.+
T Consensus 110 ~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 186 (284)
T cd05038 110 RLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186 (284)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc
Confidence 99999999999999999999 9999999999999999999999999876543221111 112334556999999988
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhh-------------hhhHHHhh----hhhhHHHHHHHHHHHHHhhccC
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEEN-------------RSLAAYFS----KEAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~-------------~~~~~~~~----~~~~~~~~~~~~~li~~cl~~d 219 (290)
..++.++|+||||+++++|++|..++....... ........ ...+..++..+.+++.+||+.+
T Consensus 187 ~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 266 (284)
T cd05038 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAE 266 (284)
T ss_pred CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccC
Confidence 889999999999999999999987764332111 00111100 1112234567999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 044846 220 GKKQPTMKEVTLELAGI 236 (290)
Q Consensus 220 p~~Rps~~el~~~l~~~ 236 (290)
|++|||+.|+++.|+.+
T Consensus 267 p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 267 PQDRPSFADLILIVDRL 283 (284)
T ss_pred hhhCCCHHHHHHHHhhc
Confidence 99999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=283.74 Aligned_cols=210 Identities=20% Similarity=0.280 Sum_probs=178.5
Q ss_pred chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc--ceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 044846 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEV--PLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLS 92 (290)
Q Consensus 15 ~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ 92 (290)
....++|..|+.+|+.|+|||||++++++.+... +-+|+|++..|+|..|+++.+ .++...++.|++||+.||.
T Consensus 82 ~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~ 157 (632)
T KOG0584|consen 82 PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLV 157 (632)
T ss_pred hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhh
Confidence 4456889999999999999999999999987654 779999999999999999887 5888999999999999999
Q ss_pred HHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCcccchhhHHH
Q 044846 93 YLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVV 171 (290)
Q Consensus 93 ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~i 171 (290)
|||++.+ ||||||||.+||+|+. .|.+||+|+|+|+..... ....+.|||-|||||+.. ..|++.+||||||+.
T Consensus 158 yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMC 232 (632)
T KOG0584|consen 158 YLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMC 232 (632)
T ss_pred hhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhcc---ccceeccCccccChHHHh-hhcchhhhhhhhhHH
Confidence 9999874 5999999999999985 589999999998865532 233478999999999987 779999999999999
Q ss_pred HHHHhcCCCCcccchhhhhhhHHHhhhhhh----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 172 LVELNWTKPIHLVDVEENRSLAAYFSKEAE----KEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 172 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.||+|+..|+.........+.....+..+ ....++++++|.+||.. ...|||+.|++++-.
T Consensus 233 mLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~F 298 (632)
T KOG0584|consen 233 MLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPF 298 (632)
T ss_pred HHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChh
Confidence 999999998876555555555555544332 23357899999999999 999999999997743
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=274.41 Aligned_cols=223 Identities=21% Similarity=0.270 Sum_probs=182.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++........+.+.+|+.+++.++||||+++++.+...+..++||||+++++|.+++... .+++..+.
T Consensus 47 ~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~ 121 (292)
T cd06658 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIA 121 (292)
T ss_pred CCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC-----CCCHHHHH
Confidence 5789999987656666778999999999999999999999999999999999999999999988642 47889999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++....... .......++..|+|||++.+..++.
T Consensus 122 ~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 197 (292)
T cd06658 122 TVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGT 197 (292)
T ss_pred HHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCceeecCccccCHHHHccCCCCc
Confidence 99999999999999999 9999999999999999999999999876432211 1223356788999999998888999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhh--hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSK--EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++|+||||+++|++++|..|+........ .... ... ......+..+.+++.+||..||.+|||+.+++++-.
T Consensus 198 ~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 99999999999999999988764332211 1111 001 111134557889999999999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=270.30 Aligned_cols=225 Identities=19% Similarity=0.150 Sum_probs=180.0
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.... ......+.+|+++++.++|+||+.+.+.+..++..+++|||+++|+|.+++...... .+++.
T Consensus 25 ~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~ 102 (285)
T cd05632 25 GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFEEE 102 (285)
T ss_pred CcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCC--CCCHH
Confidence 5689999886432 233456788999999999999999999999999999999999999999988754322 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .......|+..|+|||++.+..
T Consensus 103 ~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~g~~~~~aPE~~~~~~ 177 (285)
T cd05632 103 RALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYMAPEVLNNQR 177 (285)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC--CcccCCCCCcCccChHHhcCCC
Confidence 99999999999999999999 999999999999999999999999987543221 1223456889999999999889
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPT-----MKE 228 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~e 228 (290)
++.++|+||||+++|++++|..||........ ....... .......+..+.+|+.+||+.||++||+ +.+
T Consensus 178 ~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 257 (285)
T cd05632 178 YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGE 257 (285)
T ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHH
Confidence 99999999999999999999998864332211 1111111 1122234567899999999999999999 677
Q ss_pred HHHHH
Q 044846 229 VTLEL 233 (290)
Q Consensus 229 l~~~l 233 (290)
++.+-
T Consensus 258 l~~~~ 262 (285)
T cd05632 258 VKRHP 262 (285)
T ss_pred HHcCh
Confidence 77663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=266.86 Aligned_cols=226 Identities=23% Similarity=0.292 Sum_probs=170.3
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC-CCCCCHHHH
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD-QLPITWEMR 80 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~ 80 (290)
..+|+|.+.... ......+.+|+++++.++||||+++++.+...+..++||||+++|+|.+++...... ....++...
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 102 (269)
T cd05042 23 ARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL 102 (269)
T ss_pred eEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHH
Confidence 357788765433 334567889999999999999999999999999999999999999999999775421 123467788
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCcccccc---
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRS--- 156 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~--- 156 (290)
..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......... ......++..|+|||++..
T Consensus 103 ~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 179 (269)
T cd05042 103 QRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179 (269)
T ss_pred HHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccc
Confidence 899999999999999999 999999999999999999999999987543221111 1122345667999998753
Q ss_pred ----CCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh--------hhhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 157 ----SQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS--------KEAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 157 ----~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
..++.++|||||||++|+|++ |..|+..... ......... .......+..+.+++..|| .||++|
T Consensus 180 ~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~R 257 (269)
T cd05042 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETR 257 (269)
T ss_pred cccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccc
Confidence 346789999999999999998 5555433222 111111111 1112234566788999999 599999
Q ss_pred CCHHHHHHHH
Q 044846 224 PTMKEVTLEL 233 (290)
Q Consensus 224 ps~~el~~~l 233 (290)
||+++|++.|
T Consensus 258 pt~~~v~~~l 267 (269)
T cd05042 258 PTAEEVHELL 267 (269)
T ss_pred cCHHHHHHHh
Confidence 9999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=269.24 Aligned_cols=230 Identities=20% Similarity=0.302 Sum_probs=178.0
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC------CCCC
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD------QLPI 75 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~ 75 (290)
..||+|.++... ......+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++...... ....
T Consensus 37 ~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 116 (288)
T cd05061 37 TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116 (288)
T ss_pred eEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCC
Confidence 368999876433 334556889999999999999999999999999999999999999999999764311 1245
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~ 154 (290)
+...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+++........ ......++..|+|||.+
T Consensus 117 ~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~ 193 (288)
T cd05061 117 TLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (288)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHh
Confidence 67788899999999999999999 999999999999999999999999987643321111 11122346679999999
Q ss_pred ccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.+..++.++|+|||||++|++++ +..|+.... ........... ..+...+..+.+++.+||+.||++|||+.+++
T Consensus 194 ~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 272 (288)
T cd05061 194 KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272 (288)
T ss_pred ccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 98889999999999999999997 565554322 11211111111 11223356799999999999999999999999
Q ss_pred HHHHhh
Q 044846 231 LELAGI 236 (290)
Q Consensus 231 ~~l~~~ 236 (290)
+.|+..
T Consensus 273 ~~l~~~ 278 (288)
T cd05061 273 NLLKDD 278 (288)
T ss_pred HHHHhh
Confidence 888765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=273.84 Aligned_cols=224 Identities=21% Similarity=0.267 Sum_probs=183.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.+. .+++..+.
T Consensus 44 ~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~ 118 (297)
T cd06656 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIA 118 (297)
T ss_pred CCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC-----CCCHHHHH
Confidence 5789999998666666778899999999999999999999999999999999999999999998653 47888999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.
T Consensus 119 ~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 194 (297)
T cd06656 119 AVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGP 194 (297)
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc-cCcCcccCCccccCHHHHcCCCCCc
Confidence 99999999999999999 9999999999999999999999999876533221 1123346788899999999888999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++|+||||+++|++++|.+||............... ...+...+..+.+++.+||+.||++||++.+++++-+
T Consensus 195 ~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 999999999999999999988644322111111000 0122334566889999999999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.47 Aligned_cols=224 Identities=23% Similarity=0.301 Sum_probs=179.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC--CHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI--TWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~--~~~~ 79 (290)
++.||+|.+........+.+.+|+++++.++|+||+++++++...+..++|+||+++++|.+++..... .+ +...
T Consensus 33 ~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~ 109 (268)
T cd06624 33 QVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG---PLKDNEQT 109 (268)
T ss_pred CcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcc---cCCCcHHH
Confidence 456899988876677778899999999999999999999999999999999999999999999986432 34 7788
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
+..++.|++.||.|||+++ |+||||||+||+++. ++.++|+|||.+....... .......++..|+|||++....
T Consensus 110 ~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~ 185 (268)
T cd06624 110 IIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEVIDKGP 185 (268)
T ss_pred HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCC-CccccCCCCccccChhhhcccc
Confidence 8899999999999999999 999999999999976 6789999999875432211 1222345788999999986643
Q ss_pred --CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH----hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 159 --FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY----FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 159 --~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++.++|+||||+++|++++|.+|+............. .....+.....++.+++.+||+.+|.+|||+.|++.+
T Consensus 186 ~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 186 RGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 7889999999999999999998875432211111111 0111223445678999999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.70 Aligned_cols=226 Identities=19% Similarity=0.287 Sum_probs=178.0
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
..+|+|.++.. ....+.+.+|+++++.++|+||+++.+.+.. ...+++|||+++|+|.+++...... .+++..+..
T Consensus 31 ~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~ 106 (260)
T cd05073 31 TKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGS--KQPLPKLID 106 (260)
T ss_pred ccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCcc--ccCHHHHHH
Confidence 45788877643 3346678999999999999999999999887 7789999999999999999764322 578888999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+...............++..|+|||++....++.+
T Consensus 107 ~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 183 (260)
T cd05073 107 FSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183 (260)
T ss_pred HHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCcc
Confidence 9999999999999998 9999999999999999999999999876543222222223345677999999998889999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhhh--hHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENRS--LAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+|+||||+++|++++ |..|+......... .............+..+.+++.+||+.+|++||++.+++..|+.
T Consensus 184 ~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 184 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999998 77766533221111 11111111223345679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=283.87 Aligned_cols=222 Identities=18% Similarity=0.235 Sum_probs=175.0
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
+.||+|.+... ..+.+|+++++.|+||||+++++++......++|||++ +++|.+++.... .+++..++.
T Consensus 120 ~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~----~l~~~~~~~ 189 (392)
T PHA03207 120 KKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSG----PLPLEQAIT 189 (392)
T ss_pred eeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHhcC----CCCHHHHHH
Confidence 56777877542 23458999999999999999999999999999999999 569999985433 589999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccCccccccCCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++........ .......||..|+|||++.+..++.
T Consensus 190 i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 266 (392)
T PHA03207 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA 266 (392)
T ss_pred HHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCc
Confidence 9999999999999999 99999999999999999999999999865432221 2223467899999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhh-----hhhhHHHhh--------------------------hhhh-------HH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEE-----NRSLAAYFS--------------------------KEAE-------KE 203 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~-----~~~~~~~~~--------------------------~~~~-------~~ 203 (290)
++|||||||++|+|++|..||...... ......... .... ..
T Consensus 267 ~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (392)
T PHA03207 267 KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYG 346 (392)
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccC
Confidence 999999999999999999887543211 000000000 0000 01
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 204 EVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 204 ~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
.+.++.++|.+||..||++|||+.|++.+.+...
T Consensus 347 ~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 347 MHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 2346788999999999999999999998866543
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=266.54 Aligned_cols=228 Identities=22% Similarity=0.265 Sum_probs=184.4
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.||+|.++... ....+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++... ++++..+
T Consensus 29 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-----~l~~~~~ 103 (277)
T cd06640 29 QQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-----PFDEFQI 103 (277)
T ss_pred CEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC-----CCCHHHH
Confidence 5679999887433 455678999999999999999999999999999999999999999999998643 4788889
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++
T Consensus 104 ~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~ 179 (277)
T cd06640 104 ATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIQQSAYD 179 (277)
T ss_pred HHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccccccCcccccCHhHhccCCCc
Confidence 999999999999999998 9999999999999999999999999976543222 122234567889999999888899
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhHH--HhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA--YFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
.++|+||||+++|+|++|.+|+............ ..........+..+.+++.+||+.+|++||++.+++.+......
T Consensus 180 ~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 180 SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999887543322111110 01112223456779999999999999999999999988655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=286.52 Aligned_cols=220 Identities=16% Similarity=0.237 Sum_probs=170.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|... ...+.+|+++|++|+|||||++++++...+..++|||++ .++|..++..... .+++..++
T Consensus 194 ~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~l~~~~~~ 263 (461)
T PHA03211 194 PQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLR---PLGLAQVT 263 (461)
T ss_pred CCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCC---CCCHHHHH
Confidence 4567888543 234568999999999999999999999999999999999 5799999876432 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccCccccccCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......||..|+|||++.+..++
T Consensus 264 ~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ 340 (461)
T PHA03211 264 AVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340 (461)
T ss_pred HHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCC
Confidence 99999999999999999 99999999999999999999999999865432211 122345689999999999999999
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhh------hhhhHHHhhh----------------------------------hh
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEE------NRSLAAYFSK----------------------------------EA 200 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~------~~~~~~~~~~----------------------------------~~ 200 (290)
.++|||||||++|||+++..+++..... ...+...... ..
T Consensus 341 ~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 420 (461)
T PHA03211 341 PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPA 420 (461)
T ss_pred chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcc
Confidence 9999999999999998776543321100 0000000000 00
Q ss_pred h---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 201 E---KEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 201 ~---~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
. ...+..+.+||.+||+.||.+|||+.|++++-+
T Consensus 421 ~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 421 WTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred hhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 0 012346889999999999999999999998743
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.19 Aligned_cols=234 Identities=22% Similarity=0.279 Sum_probs=178.9
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC-CcceEEEEeCCCCCHHHHHhhcCCC-------
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQI-NHRNVVKILGCCLET-EVPLLVYEFIPNGSLYQYIHEQTDD------- 71 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~------- 71 (290)
++.||||+++... ....+.+.+|+.++..+ +||||+++++++... ...+++||||++|+|.+++......
T Consensus 37 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~ 116 (343)
T cd05103 37 CRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTK 116 (343)
T ss_pred ceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCcccccccc
Confidence 4679999997533 34566789999999999 789999999988654 5678999999999999999753210
Q ss_pred --------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHh
Q 044846 72 --------------------------------------------------------QLPITWEMRLRITVEVSRVLSYLH 95 (290)
Q Consensus 72 --------------------------------------------------------~~~~~~~~~~~~~~~i~~~l~ylH 95 (290)
...+++..+..++.|++.||.|||
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 196 (343)
T cd05103 117 DARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA 196 (343)
T ss_pred ccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH
Confidence 013678888999999999999999
Q ss_pred hCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccccccCCCCCcccchhhHHHHHH
Q 044846 96 SVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174 (290)
Q Consensus 96 ~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~ 174 (290)
+++ |+||||||+||+++.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|+
T Consensus 197 ~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 273 (343)
T cd05103 197 SRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 273 (343)
T ss_pred hCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHH
Confidence 999 999999999999999999999999997653221111 1122335667999999988889999999999999999
Q ss_pred Hhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 175 LNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 175 l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
+++ |..|+............. .....+...+..+.+++.+||+.||++|||+.||+++|+.+.+
T Consensus 274 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 274 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 985 776664322111111111 0111112234578999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=283.42 Aligned_cols=228 Identities=21% Similarity=0.324 Sum_probs=190.9
Q ss_pred EEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHH
Q 044846 5 WLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI 83 (290)
Q Consensus 5 ~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 83 (290)
||||.-|. ......+.|+.|+.+|+.++|||||+++|+|... ..|||||+++-|.|..+++.+.+ .++......+
T Consensus 421 VAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly 496 (974)
T KOG4257|consen 421 VAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKD---SLPLRTLTLY 496 (974)
T ss_pred eeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccc---cchHHHHHHH
Confidence 78887765 4456688999999999999999999999999775 57999999999999999998775 5888899999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCcc
Q 044846 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKS 163 (290)
Q Consensus 84 ~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 163 (290)
+.||+.+|.|||+++ ++||||..+|||+....-+||+|||+++....+..-..+....++.|||||.+.-.+++.++
T Consensus 497 ~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtAS 573 (974)
T KOG4257|consen 497 CYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTAS 573 (974)
T ss_pred HHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchh
Confidence 999999999999999 99999999999999999999999999876554433333445567889999999999999999
Q ss_pred cchhhHHHHHHHh-cCCCCcccchhh--hhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 044846 164 DVYSFSVVLVELN-WTKPIHLVDVEE--NRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239 (290)
Q Consensus 164 DiwS~G~il~~l~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~ 239 (290)
|||-||+.+||++ .|..||+.-... ...+....+.+.++++++.+..|+.+||.+||.+||.+.++...|..+...
T Consensus 574 DVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 574 DVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred hHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 9999999999986 666666532211 111222233456778899999999999999999999999999998887753
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.82 Aligned_cols=224 Identities=22% Similarity=0.268 Sum_probs=176.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC------CcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLET------EVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
++.||+|+..... .....+.+|+.++..+ +||||+++++.|... ...|++|||+++|+|.+++...... .
T Consensus 31 ~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~--~ 107 (272)
T cd06637 31 GQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN--T 107 (272)
T ss_pred CcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCC--C
Confidence 5678999886543 3456788999999998 799999999998753 4578999999999999999864322 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...... ........|+..|+|||++
T Consensus 108 l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~g~~~y~aPE~~ 183 (272)
T cd06637 108 LKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFIGTPYWMAPEVI 183 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccc-cccCCcccccccccCHhHh
Confidence 889999999999999999999999 999999999999999999999999997643221 1223345688899999998
Q ss_pred c-----cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 155 R-----SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 155 ~-----~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
. +..++.++|+|||||++|+|++|..|+............... .......+..+.+|+.+||..||.+|||+
T Consensus 184 ~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 263 (272)
T cd06637 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTT 263 (272)
T ss_pred ccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCH
Confidence 6 335788999999999999999999887533222111111100 11122345679999999999999999999
Q ss_pred HHHHHH
Q 044846 227 KEVTLE 232 (290)
Q Consensus 227 ~el~~~ 232 (290)
.+++++
T Consensus 264 ~~il~~ 269 (272)
T cd06637 264 EQLMKH 269 (272)
T ss_pred HHHhhC
Confidence 999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=265.22 Aligned_cols=226 Identities=20% Similarity=0.293 Sum_probs=179.8
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
+.+|+|.+.... ...+.+.+|+.+++.++||||+++++++......+++|||+++++|.+++...... .+++..+..
T Consensus 31 ~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~--~~~~~~~~~ 107 (261)
T cd05034 31 TKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK--KLRLPQLVD 107 (261)
T ss_pred ceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccC--CCCHHHHHH
Confidence 458889887533 34567899999999999999999999999988999999999999999999765422 588999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||.+...............++..|+|||.+.+..++.+
T Consensus 108 ~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 184 (261)
T cd05034 108 MAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184 (261)
T ss_pred HHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCch
Confidence 9999999999999999 9999999999999999999999999876543211111112234567999999998889999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+|+||||+++|++++ |..|+..... ......... ...+...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 185 ~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 185 SDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 999999999999997 7777643322 121222111 11222335679999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.79 Aligned_cols=224 Identities=25% Similarity=0.360 Sum_probs=181.2
Q ss_pred CceEEEEeecccCchhHH--HHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHESNVE--QFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~--~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++......... ...+|+.+++.++||||+++++++......++|||++.+++|.+++.... .+++..
T Consensus 24 ~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~----~~~~~~ 99 (260)
T PF00069_consen 24 GQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK----PLSEEE 99 (260)
T ss_dssp TEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS----SBBHHH
T ss_pred CeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccccccccccc----cccccc
Confidence 467999999865544333 34569999999999999999999999999999999999889999998444 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc-cCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-SSQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~ 158 (290)
+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+... ...........++..|+|||++. +..
T Consensus 100 ~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (260)
T PF00069_consen 100 ILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFNPFVGTPEYMAPEVLQQGKK 175 (260)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBSSSSSSGGGSCHHHHTTTSS
T ss_pred ccccccccccccccccccc---cccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc
Confidence 9999999999999999999 999999999999999999999999997643 12223334566788999999998 788
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccch--hhhhhhHHHhhhhhhHH------HHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDV--EENRSLAAYFSKEAEKE------EVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~------~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
++.++|+||+|+++++|++|..|+.... ................. ....+.+++.+||+.||++|||+.+++
T Consensus 176 ~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~ 255 (260)
T PF00069_consen 176 YTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELL 255 (260)
T ss_dssp BSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHH
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHh
Confidence 8999999999999999999998886541 12222221111111111 137899999999999999999999998
Q ss_pred HHH
Q 044846 231 LEL 233 (290)
Q Consensus 231 ~~l 233 (290)
++.
T Consensus 256 ~~~ 258 (260)
T PF00069_consen 256 KHP 258 (260)
T ss_dssp TSG
T ss_pred cCC
Confidence 753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=266.92 Aligned_cols=224 Identities=23% Similarity=0.246 Sum_probs=183.2
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|.+.... ......+.+|+++++.++||||+++.+++......++|+||+++++|.+++... ++++..+
T Consensus 26 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~ 100 (274)
T cd06609 26 NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYI 100 (274)
T ss_pred CeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-----CCCHHHH
Confidence 6789999986543 445677889999999999999999999999999999999999999999998754 5889999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++...... .......++..|+|||++.+..++
T Consensus 101 ~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~ 176 (274)
T cd06609 101 AFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSGYD 176 (274)
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-cccccccCCccccChhhhccCCCC
Confidence 999999999999999999 9999999999999999999999999976544321 222345677889999999988899
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKE-EVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.++||||||+++|++++|.+|+....... ....... ...... .+..+.+++.+||..||++|||+++++.+-.-
T Consensus 177 ~~sDv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 177 EKADIWSLGITAIELAKGEPPLSDLHPMR-VLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred chhhHHHHHHHHHHHHhCCCCcccCchHH-HHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 99999999999999999998875432211 1111111 111111 56679999999999999999999999887543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=263.40 Aligned_cols=224 Identities=22% Similarity=0.342 Sum_probs=177.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.+|+|+++.... ....+..|++++++++||||+++++++......++||||+++++|.+++..... .+++..+.
T Consensus 28 ~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~ 103 (256)
T cd05112 28 KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG---KFSQETLL 103 (256)
T ss_pred CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc---CCCHHHHH
Confidence 45688898864332 345788999999999999999999999999999999999999999999976432 47889999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++...............++..|+|||++.+..++.
T Consensus 104 ~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~ 180 (256)
T cd05112 104 GMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180 (256)
T ss_pred HHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcCh
Confidence 99999999999999999 999999999999999999999999987644322111112233456899999999888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
++|+||||+++|++++ |..|+...... ....... ....+...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 181 ~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 181 KSDVWSFGVLMWEVFSEGKTPYENRSNS-EVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCcCCHH-HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 9999999999999997 77766433211 1111111 1111222456799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=271.55 Aligned_cols=224 Identities=19% Similarity=0.249 Sum_probs=174.8
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++++||+. ++|.+++..... .+++..
T Consensus 25 g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~ 100 (284)
T cd07839 25 HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNG---DIDPEI 100 (284)
T ss_pred CcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCC---CCCHHH
Confidence 6789999886432 2234567889999999999999999999999999999999995 689888875432 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC-
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ- 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~- 158 (290)
++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++....... .......++..|+|||++.+..
T Consensus 101 ~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 176 (284)
T cd07839 101 VKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKL 176 (284)
T ss_pred HHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcCCCccccCCcChHHHhCCcc
Confidence 9999999999999999999 9999999999999999999999999976433221 1122345678899999987654
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------------------------------hhhhHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------------------------------KEAEKEEVIT 207 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 207 (290)
++.++|||||||++|+|++|..|+.........+..... .......+.+
T Consensus 177 ~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (284)
T cd07839 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNST 256 (284)
T ss_pred cCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHH
Confidence 788999999999999999988776543222111111000 0001123467
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 208 FAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 208 ~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.+++.+||+.||.+|||+++++.+.
T Consensus 257 ~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 257 GRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred HHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 88999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=277.83 Aligned_cols=221 Identities=20% Similarity=0.248 Sum_probs=172.7
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
++.||+|++... .......+.+|+.+++.++||||+++++++.... ..++||||+. ++|...+..
T Consensus 42 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------ 114 (355)
T cd07874 42 DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------ 114 (355)
T ss_pred CceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh------
Confidence 577999998743 3344567889999999999999999999986543 4699999995 577777653
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........|+..|+|||+
T Consensus 115 ~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~t~~y~aPE~ 189 (355)
T cd07874 115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 189 (355)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCC--ccccCCccccCCccCHHH
Confidence 3778889999999999999999999 99999999999999999999999999864322 222334568899999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh---------------------HHHhhh--------------
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL---------------------AAYFSK-------------- 198 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~---------------------~~~~~~-------------- 198 (290)
+.+..++.++|||||||++|+|++|..+|.......... ..+...
T Consensus 190 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (355)
T cd07874 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269 (355)
T ss_pred HcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcc
Confidence 999999999999999999999999998875432111000 000000
Q ss_pred --------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 199 --------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 199 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.........+.+||.+||+.||++|||+.|++++.+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred ccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 000011345789999999999999999999998854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=271.65 Aligned_cols=225 Identities=20% Similarity=0.310 Sum_probs=168.3
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcC-----CCCCCC
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQT-----DDQLPI 75 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~ 75 (290)
+.||+|+++... ....+.+|+++++.++||||+++++++.. ....++||||+. ++|.+++.... .....+
T Consensus 29 ~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l 105 (317)
T cd07867 29 KEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQL 105 (317)
T ss_pred ceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccC
Confidence 568999886532 23457899999999999999999999854 457899999995 58888875321 112257
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe----ccCCcEEEeccccccccccCCc--eeeccceeccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL----VDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYV 149 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~----~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~ 149 (290)
++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||+++....... .......+|..|+
T Consensus 106 ~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~ 182 (317)
T cd07867 106 PRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182 (317)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceeccccc
Confidence 88899999999999999999999 9999999999999 4567899999999875432221 1123456789999
Q ss_pred CccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhh--------hhHHHhh-----------------------
Q 044846 150 DPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--------SLAAYFS----------------------- 197 (290)
Q Consensus 150 aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--------~~~~~~~----------------------- 197 (290)
|||++.+. .++.++|||||||++|+|++|.++|........ .......
T Consensus 183 aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (317)
T cd07867 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQ 262 (317)
T ss_pred CcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhh
Confidence 99998764 578899999999999999999988753221100 0000000
Q ss_pred h-----------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 198 K-----------------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 198 ~-----------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
. .........+.+|+.+||+.||.+|||+.|++++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 263 KDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred hhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 0 00001123577899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=268.66 Aligned_cols=224 Identities=23% Similarity=0.281 Sum_probs=181.0
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|.++... ....+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++... .+++..+
T Consensus 29 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~ 103 (277)
T cd06642 29 KEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-----PLEETYI 103 (277)
T ss_pred CeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC-----CCCHHHH
Confidence 5679999887433 445667899999999999999999999999999999999999999999998642 4788999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++
T Consensus 104 ~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 179 (277)
T cd06642 104 ATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYD 179 (277)
T ss_pred HHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-hhhhcccCcccccCHHHhCcCCCc
Confidence 999999999999999998 9999999999999999999999999876543221 112234577889999999988899
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.++|+||||+++|++++|..|+........ ...... .......+..+.+++.+||+.+|++|||+.+++.+..-
T Consensus 180 ~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06642 180 FKADIWSLGITAIELAKGEPPNSDLHPMRV-LFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256 (277)
T ss_pred hhhhHHHHHHHHHHHHhCCCCCcccchhhH-HhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence 999999999999999999988753322111 111100 11112345678999999999999999999999987553
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=277.83 Aligned_cols=220 Identities=19% Similarity=0.244 Sum_probs=172.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLET------EVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
++.||+|++... .....+.+.+|+.+++.++||||+++++++... ...|+||||+. ++|...+..
T Consensus 49 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------ 121 (364)
T cd07875 49 ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ 121 (364)
T ss_pred CcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh------
Confidence 567999998642 344566788999999999999999999987643 35699999995 578887753
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.... ........++..|+|||+
T Consensus 122 ~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~~~~~~~~~t~~y~aPE~ 196 (364)
T cd07875 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196 (364)
T ss_pred cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCC--CCcccCCcccCCcCCHHH
Confidence 3778889999999999999999999 99999999999999999999999999864322 222234568899999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----------------------h-------------
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----------------------K------------- 198 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----------------------~------------- 198 (290)
+.+..++.++|||||||++|+|++|..||........ +..... .
T Consensus 197 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (364)
T cd07875 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLF 275 (364)
T ss_pred HhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhC
Confidence 9999999999999999999999999988754321110 000000 0
Q ss_pred ---------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 199 ---------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 199 ---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.........+.+||.+||+.||.+|||+.|+++|.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 276 PDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred ccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 000011245789999999999999999999998854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=268.22 Aligned_cols=223 Identities=22% Similarity=0.303 Sum_probs=170.9
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhc---CCCceeeEEeEEEeC-----CcceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQI---NHRNVVKILGCCLET-----EVPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l---~Hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||+|.++... ......+.+|+++++.+ +||||+++++++... ...+++|||+. ++|.+++......
T Consensus 25 ~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~ 103 (288)
T cd07863 25 GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPP 103 (288)
T ss_pred CcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCC
Confidence 5779999886432 22234566788777765 799999999988642 45799999996 5999998765432
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... .......++..|+||
T Consensus 104 --~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aP 176 (288)
T cd07863 104 --GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAP 176 (288)
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCc--ccCCCccccccccCc
Confidence 4889999999999999999999999 999999999999999999999999997644321 122335678899999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHhh--------------------------hhhhHH
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYFS--------------------------KEAEKE 203 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~~--------------------------~~~~~~ 203 (290)
|++.+..++.++||||+||++|+|++|.++|........ ....... ......
T Consensus 177 E~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (288)
T cd07863 177 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPE 256 (288)
T ss_pred hHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcC
Confidence 999988999999999999999999999988754322111 0000000 000012
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 204 EVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 204 ~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.+..+.+++.+||+.||++|||+.|++.+
T Consensus 257 ~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 257 IEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 34567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=297.16 Aligned_cols=235 Identities=17% Similarity=0.202 Sum_probs=183.0
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC-------
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD------- 71 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------- 71 (290)
|+.||+|+++.. .....+++.+|+++++.++||||+++++++..++..+++|||++||+|.+++......
T Consensus 27 g~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~ 106 (932)
T PRK13184 27 SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL 106 (932)
T ss_pred CcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhh
Confidence 678999998642 2334567999999999999999999999999999999999999999999999753211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc---------------
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT--------------- 136 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--------------- 136 (290)
...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||+++.......
T Consensus 107 ~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s 183 (932)
T PRK13184 107 AEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183 (932)
T ss_pred hcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccccccccc
Confidence 123566778899999999999999999 99999999999999999999999999875421100
Q ss_pred --eeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhh----hhHHHHHHHHH
Q 044846 137 --HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKE----AEKEEVITFAM 210 (290)
Q Consensus 137 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 210 (290)
.......||+.|+|||++.+..++.++|||||||++|+|++|..|+................+ .....+..+.+
T Consensus 184 ~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~ 263 (932)
T PRK13184 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQ 263 (932)
T ss_pred ccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHH
Confidence 011224689999999999999999999999999999999999998865332221111111111 11234566889
Q ss_pred HHHHhhccCCCCCCC-HHHHHHHHHhhHhh
Q 044846 211 VAKRCLNLNGKKQPT-MKEVTLELAGIRAS 239 (290)
Q Consensus 211 li~~cl~~dp~~Rps-~~el~~~l~~~~~~ 239 (290)
++.+||+.||++||+ ++++++.|+.....
T Consensus 264 LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 264 IAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999965 77777777776543
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=265.09 Aligned_cols=228 Identities=22% Similarity=0.328 Sum_probs=181.4
Q ss_pred eEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.+|+|..+... ......+.+|+.+++.++||||+++++++.. ...++||||+++|+|.+++..... .+++..+..
T Consensus 38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~ 113 (279)
T cd05057 38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD---NIGSQYLLN 113 (279)
T ss_pred EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccC---CCCHHHHHH
Confidence 57888876543 3456789999999999999999999999987 788999999999999999986543 488999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee-ccceecccccCccccccCCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT-TQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......... ....++..|+|||.+....++.
T Consensus 114 ~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (279)
T cd05057 114 WCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190 (279)
T ss_pred HHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCc
Confidence 9999999999999998 99999999999999999999999999865432222111 1122356799999998888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
++|+||||+++|++++ |..|+....... ....... ...+...+..+.+++.+||..||+.||++.++++.|..+.
T Consensus 191 ~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred hhhHHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 9999999999999997 887765432211 1111111 1122234567889999999999999999999999999876
Q ss_pred hh
Q 044846 238 AS 239 (290)
Q Consensus 238 ~~ 239 (290)
..
T Consensus 270 ~~ 271 (279)
T cd05057 270 RD 271 (279)
T ss_pred hC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=268.16 Aligned_cols=227 Identities=23% Similarity=0.276 Sum_probs=182.5
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+++|+|..++.... .+++..+
T Consensus 30 ~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~ 105 (284)
T cd06620 30 GTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG----PIPVEIL 105 (284)
T ss_pred CcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc----CCCHHHH
Confidence 5678999876433 4456789999999999999999999999999999999999999999999987644 5889999
Q ss_pred HHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.+++.||.|||+ .+ ++||||||+||+++.++.++|+|||++...... ......|+..|+|||++.+..+
T Consensus 106 ~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~ 179 (284)
T cd06620 106 GKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKY 179 (284)
T ss_pred HHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh---ccCccccCcccCCHHHHccCCC
Confidence 9999999999999997 46 999999999999999999999999987543211 1223567889999999988889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhh----------hhhhHHHhhh---h-hhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEE----------NRSLAAYFSK---E-AEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~----------~~~~~~~~~~---~-~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
+.++|+|||||++|++++|..|+...... .......... . .....+..+.+|+.+||+.||++|||
T Consensus 180 ~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt 259 (284)
T cd06620 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT 259 (284)
T ss_pred CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcC
Confidence 99999999999999999999988643321 0011111110 0 11124567899999999999999999
Q ss_pred HHHHHHHHHhhHh
Q 044846 226 MKEVTLELAGIRA 238 (290)
Q Consensus 226 ~~el~~~l~~~~~ 238 (290)
+.|++++...+..
T Consensus 260 ~~e~~~~~~~~~~ 272 (284)
T cd06620 260 PQQLCAMPPFIQA 272 (284)
T ss_pred HHHHhcCcccccc
Confidence 9999988665543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=262.87 Aligned_cols=225 Identities=24% Similarity=0.361 Sum_probs=179.9
Q ss_pred ceEEEEeecccCch-hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSVHES-NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
+.||+|+++..... ..+.+..|+..++.++|+||+++++++...+..+++|||+++++|.+++...... .+++..+.
T Consensus 29 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~--~~~~~~~~ 106 (258)
T smart00219 29 VEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPK--ELSLSDLL 106 (258)
T ss_pred ceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhc--cCCHHHHH
Confidence 67999999754433 6778999999999999999999999999999999999999999999999865421 28899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...............++..|+|||.+.+..++.
T Consensus 107 ~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~ 183 (258)
T smart00219 107 SFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTS 183 (258)
T ss_pred HHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCc
Confidence 99999999999999999 999999999999999999999999997654432211111223677899999998888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
++|+||+|+++++|++ |.+|+.... ......... ........+..+.+++.+||..||++|||+.|+++.|
T Consensus 184 ~~Di~slG~i~~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 184 KSDVWSFGVLLWEIFTLGESPYPGMS-NEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred chhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999987 666554321 111111111 1112223567799999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=266.51 Aligned_cols=224 Identities=21% Similarity=0.232 Sum_probs=178.7
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||+ +++|.+++..... .+++..
T Consensus 25 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~---~~~~~~ 100 (286)
T cd07832 25 GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEER---PLPEAQ 100 (286)
T ss_pred CceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCC---CCCHHH
Confidence 5789999987543 344567999999999999999999999999999999999999 9999999976542 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC-
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ- 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~- 158 (290)
++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||.+...............++..|+|||++.+..
T Consensus 101 ~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 177 (286)
T cd07832 101 VKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177 (286)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeecccc
Confidence 9999999999999999999 999999999999999999999999987654433222233456788999999987544
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--------------------------------hhhhHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--------------------------------KEAEKEEVI 206 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~ 206 (290)
++.++||||+|+++++|++|.+++...... ..+..... .......+.
T Consensus 178 ~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (286)
T cd07832 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASP 256 (286)
T ss_pred CCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccH
Confidence 688999999999999999997766433221 11100000 000012346
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.+.+++.+||+.||++|||+++++.+.
T Consensus 257 ~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 257 EALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred HHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=300.09 Aligned_cols=229 Identities=22% Similarity=0.296 Sum_probs=177.0
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
++.+|+|.+.. ........+..|+.+++.|+|||||+++++|.. ...+||||||+++|+|.++|.........+++
T Consensus 38 g~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E 117 (1021)
T PTZ00266 38 QEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117 (1021)
T ss_pred CeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCH
Confidence 45788888764 234456789999999999999999999999865 35689999999999999999764332236899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCC----CCeEeccCCCCceEecc-----------------CCcEEEeccccccccccCCc
Q 044846 78 EMRLRITVEVSRVLSYLHSVAS----IPIYHLDIKSANILLVD-----------------KYQAKISDFRTFKSRAIDRT 136 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~----~~iiHrdlkp~Nil~~~-----------------~~~~kl~dfg~~~~~~~~~~ 136 (290)
..++.|+.||+.||.|||..+. .+||||||||+|||++. .+.+||+|||++......
T Consensus 118 ~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-- 195 (1021)
T PTZ00266 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-- 195 (1021)
T ss_pred HHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc--
Confidence 9999999999999999998542 23999999999999964 234899999997654321
Q ss_pred eeeccceecccccCcccccc--CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhh--hhHHHHHHHHHHH
Q 044846 137 HLTTQVKVTFGYVDPKYFRS--SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKE--AEKEEVITFAMVA 212 (290)
Q Consensus 137 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li 212 (290)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+....... .....+..+.+||
T Consensus 196 s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI 275 (1021)
T PTZ00266 196 SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILI 275 (1021)
T ss_pred ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHH
Confidence 22234568999999999864 4588899999999999999999998864332222222111111 1122456799999
Q ss_pred HHhhccCCCCCCCHHHHHHH
Q 044846 213 KRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 213 ~~cl~~dp~~Rps~~el~~~ 232 (290)
.+||+.+|.+||++.|++.+
T Consensus 276 ~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 276 KNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHhcCChhHCcCHHHHhcc
Confidence 99999999999999999865
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.14 Aligned_cols=222 Identities=18% Similarity=0.215 Sum_probs=172.3
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLET------EVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
++.||+|+++... ....+.+.+|+++++.++||||+++++++... ...++++|++ +++|..++...
T Consensus 40 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~----- 113 (343)
T cd07878 40 RQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ----- 113 (343)
T ss_pred CCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC-----
Confidence 5679999986432 23456688999999999999999999988643 3468999998 78999887642
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..... .....|+..|+|||+
T Consensus 114 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~ 186 (343)
T cd07878 114 KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEI 186 (343)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC----cCCccccccccCchH
Confidence 4889999999999999999999999 999999999999999999999999997654321 234567889999999
Q ss_pred ccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHh-----------hhhh-----------h-------
Q 044846 154 FRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYF-----------SKEA-----------E------- 201 (290)
Q Consensus 154 ~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~-----------~~~~-----------~------- 201 (290)
+.+ ..++.++|||||||++|+|++|..+|........ ...... .... +
T Consensus 187 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (343)
T cd07878 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKI 266 (343)
T ss_pred hcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHh
Confidence 877 4688899999999999999999988754321110 000000 0000 0
Q ss_pred -HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 202 -KEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 202 -~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
....+.+.+|+.+||+.||.+|||+.|++.+-+-.
T Consensus 267 ~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 267 FRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 01123467999999999999999999999886543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=261.94 Aligned_cols=220 Identities=21% Similarity=0.369 Sum_probs=175.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+.+... ..+.+.+|+.+++.++||||+++++++... ..+++|||+++|+|.+++...... .+++..+.
T Consensus 29 ~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~--~~~~~~~~ 103 (254)
T cd05083 29 GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRA--LVSVIQLL 103 (254)
T ss_pred CCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcC--CCCHHHHH
Confidence 5678999987532 346789999999999999999999998664 479999999999999999765422 47888999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ......+..|+|||++.+..++.
T Consensus 104 ~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~ 176 (254)
T cd05083 104 QFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVKWTAPEALKHKKFSS 176 (254)
T ss_pred HHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----CCCCCCCceecCHHHhccCCcCc
Confidence 99999999999999998 999999999999999999999999987643211 11223356799999998888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++|+||||+++|+|++ |.+|+...... ...... .........+..+.+++.+||+.+|++||++.++++.|+
T Consensus 177 ~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 177 KSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 9999999999999986 77776433221 111111 111122334567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=266.86 Aligned_cols=222 Identities=20% Similarity=0.265 Sum_probs=181.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.+|+|+++.......+.+.+|+.+++.++||||+++++++...+..++++||+++++|.+++... .+++..+.
T Consensus 44 ~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~ 118 (285)
T cd06648 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIA 118 (285)
T ss_pred CCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC-----CCCHHHHH
Confidence 5679999987666666777899999999999999999999999999999999999999999998762 47889999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||.+....... .......|+..|+|||++.+..++.
T Consensus 119 ~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 194 (285)
T cd06648 119 TVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPEVISRLPYGT 194 (285)
T ss_pred HHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccccccCCccccCHHHhcCCCCCC
Confidence 99999999999999999 9999999999999999999999999865433221 1222345788999999998888999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
++|+||||+++|+|++|..|+........ ....... ......+..+.+++.+||+.||++|||+.+++++-
T Consensus 195 ~~Dv~slGv~l~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQA-MKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred cccHHHHHHHHHHHHhCCCCCcCCCHHHH-HHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 99999999999999999988754322111 1111111 01112456799999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=262.55 Aligned_cols=224 Identities=21% Similarity=0.270 Sum_probs=181.7
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|+||+++++|.+++...... .+++..
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~ 102 (256)
T cd08218 25 GKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGV--LFPEDQ 102 (256)
T ss_pred CCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCC--CCCHHH
Confidence 577999988642 3445668899999999999999999999999999999999999999999999764322 478889
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .......|+..|+|||++.+..+
T Consensus 103 ~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~ 178 (256)
T cd08218 103 ILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-ELARTCIGTPYYLSPEICENRPY 178 (256)
T ss_pred HHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hhhhhccCCccccCHHHhCCCCC
Confidence 9999999999999999999 9999999999999999999999999876433221 11123457788999999998889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+.++|+||||++++++++|..++........ ...... ...+...+..+.++|.+||+.+|.+||++.+++++
T Consensus 179 ~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 179 NNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-VLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCccchhHHHHHHHHHHcCCCCccCCCHHHH-HHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 9999999999999999999988764432211 111111 11223446679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=267.67 Aligned_cols=229 Identities=21% Similarity=0.250 Sum_probs=181.8
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|.++.. .......+.+|+.++++++||||+++++.+...+..++||||+++++|..++..... ...+++..+
T Consensus 26 ~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~ 104 (286)
T cd06622 26 GVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVA-TEGIPEDVL 104 (286)
T ss_pred CcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccc-cCCCCHHHH
Confidence 678999988643 344567899999999999999999999999999999999999999999999876421 225899999
Q ss_pred HHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC-
Q 044846 81 LRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ- 158 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~- 158 (290)
..++.|++.||.|||+ .+ |+||||||+||+++.++.++|+|||++..... .......++..|+|||++.+..
T Consensus 105 ~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~ 178 (286)
T cd06622 105 RRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---SLAKTNIGCQSYMAPERIKSGGP 178 (286)
T ss_pred HHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC---CccccCCCccCccCcchhcCCCC
Confidence 9999999999999996 47 99999999999999999999999998764321 1223345778899999986543
Q ss_pred -----CCCcccchhhHHHHHHHhcCCCCcccchhhh--hhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 159 -----FTEKSDVYSFSVVLVELNWTKPIHLVDVEEN--RSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 159 -----~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
++.++|+|||||++|++++|+.|+....... ........ ...+...+.++.++|.+||+.+|++||++.+
T Consensus 179 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (286)
T cd06622 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQ 258 (286)
T ss_pred CccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHH
Confidence 5789999999999999999998875432211 11111111 1223346678999999999999999999999
Q ss_pred HHHHHHhhH
Q 044846 229 VTLELAGIR 237 (290)
Q Consensus 229 l~~~l~~~~ 237 (290)
++.+.+...
T Consensus 259 l~~~~~~~~ 267 (286)
T cd06622 259 LLEHPWLVK 267 (286)
T ss_pred HhcChhhhh
Confidence 998765443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=270.60 Aligned_cols=230 Identities=17% Similarity=0.218 Sum_probs=178.1
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+..... ....+.+.+|+.+++.++||||++++++|...+..++|+||+.+++|.+++.+.... .+++..
T Consensus 25 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~--~~~~~~ 102 (328)
T cd08226 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPE--GMSEAL 102 (328)
T ss_pred CcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhccc--CCCHHH
Confidence 6889999986432 334577889999999999999999999999999999999999999999999875432 488889
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee------eccceecccccCccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL------TTQVKVTFGYVDPKY 153 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~g~~~y~aPE~ 153 (290)
+..++.|++.||.|||+++ ++||||||+||+++.++.++++||+.+.......... .....++..|+|||+
T Consensus 103 ~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 179 (328)
T cd08226 103 IGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179 (328)
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhh
Confidence 9999999999999999999 9999999999999999999999997543221110000 011234567999999
Q ss_pred cccC--CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH------------------------------------
Q 044846 154 FRSS--QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY------------------------------------ 195 (290)
Q Consensus 154 ~~~~--~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~------------------------------------ 195 (290)
+.+. .++.++|||||||++|+|++|.+|+.............
T Consensus 180 ~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (328)
T cd08226 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVV 259 (328)
T ss_pred hcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchh
Confidence 8764 47889999999999999999998875432211111000
Q ss_pred ------------hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 196 ------------FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 196 ------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.........+..+.+|+.+||+.||++|||+.|++++.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 260 AAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred ccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 00111233566789999999999999999999999885543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=267.21 Aligned_cols=226 Identities=22% Similarity=0.213 Sum_probs=175.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEE-----eCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCL-----ETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.+|+|+.+... .....+.+|+.+++.+ +||||+++++++. .++..++||||+++|+|.+++.........+
T Consensus 43 ~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 121 (286)
T cd06638 43 GSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121 (286)
T ss_pred CceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccc
Confidence 5678899876432 2245678899999999 7999999999884 3456899999999999999886543333368
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++...... .......|+..|+|||++.
T Consensus 122 ~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 122 EEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred cHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCC-CccccccCCCcccChhhhc
Confidence 88899999999999999999998 9999999999999999999999999976543221 1223346888999999975
Q ss_pred c-----CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhh-----hhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 156 S-----SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKE-----AEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 156 ~-----~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
. ..++.++|||||||++|+|++|..|+........ +....... .+...+..+.+++.+||+.||++|||
T Consensus 198 ~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 276 (286)
T cd06638 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT 276 (286)
T ss_pred hhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-HhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC
Confidence 3 4478899999999999999999988754332111 11111110 11223457999999999999999999
Q ss_pred HHHHHHHH
Q 044846 226 MKEVTLEL 233 (290)
Q Consensus 226 ~~el~~~l 233 (290)
+.|+++++
T Consensus 277 ~~ell~~~ 284 (286)
T cd06638 277 VSDLLQHV 284 (286)
T ss_pred HHHHhhcc
Confidence 99999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=266.32 Aligned_cols=223 Identities=17% Similarity=0.212 Sum_probs=175.1
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||++++.|..++.... .+++..
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~ 101 (286)
T cd07847 26 GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR----GVPEHL 101 (286)
T ss_pred CcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC----CCCHHH
Confidence 5789999886432 2334568899999999999999999999999999999999999888877765433 488999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-CC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-SQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~ 158 (290)
++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ......++..|+|||++.+ ..
T Consensus 102 ~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~ 177 (286)
T cd07847 102 IKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQ 177 (286)
T ss_pred HHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCC
Confidence 9999999999999999999 99999999999999999999999999765432211 1223456788999999876 45
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhH--HHhh---------------------h---------hhhHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA--AYFS---------------------K---------EAEKEEVI 206 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~--~~~~---------------------~---------~~~~~~~~ 206 (290)
++.++|+||||+++|+|++|.+||........... .... . ......+.
T Consensus 178 ~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (286)
T cd07847 178 YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISS 257 (286)
T ss_pred cCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCH
Confidence 78899999999999999999988764332211110 0000 0 00012245
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.+.+|+.+||+.||++|||+.|++.+
T Consensus 258 ~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 258 PALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HHHHHHHHHhcCCccccCCHHHHhcC
Confidence 68899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=271.47 Aligned_cols=225 Identities=19% Similarity=0.260 Sum_probs=180.3
Q ss_pred CceEEEEeecccCc---hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVHE---SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|.+..... ...+.+..|+++++.++||||+++++.+......++||||+.+++|.+++..... ..+++.
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~ 103 (316)
T cd05574 26 GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG--KCLSEE 103 (316)
T ss_pred CcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCC--CccCHH
Confidence 57899999865332 3566789999999999999999999999999999999999999999999875432 258899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce---------------------
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--------------------- 137 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--------------------- 137 (290)
.+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 104 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (316)
T cd05574 104 VARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180 (316)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhh
Confidence 99999999999999999999 999999999999999999999999987643221110
Q ss_pred -------eeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHH
Q 044846 138 -------LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVI 206 (290)
Q Consensus 138 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 206 (290)
......|+..|+|||++.+..++.++||||||+++|+|++|..|+...... ......... ......+.
T Consensus 181 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 259 (316)
T cd05574 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD-ETFSNILKKEVTFPGSPPVSS 259 (316)
T ss_pred hcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH-HHHHHHhcCCccCCCccccCH
Confidence 111245788899999999888999999999999999999999987543322 111111111 11112467
Q ss_pred HHHHHHHHhhccCCCCCCC----HHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPT----MKEVTLE 232 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps----~~el~~~ 232 (290)
.+.+++.+||..||++||| +.+++.+
T Consensus 260 ~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 260 SARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 7999999999999999999 7777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=274.62 Aligned_cols=218 Identities=20% Similarity=0.302 Sum_probs=167.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|+.... ....|+.+++.++||||+++++++...+..++|||++ .++|.+++..... .+++..++
T Consensus 91 ~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~ 160 (357)
T PHA03209 91 PDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSR---PLPIDQAL 160 (357)
T ss_pred CceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhccC---CCCHHHHH
Confidence 456888875422 2356999999999999999999999999999999999 5699999876432 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... .......||..|+|||++.+..++.
T Consensus 161 ~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 235 (357)
T PHA03209 161 IIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGLAGTVETNAPEVLARDKYNS 235 (357)
T ss_pred HHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--cccccccccccccCCeecCCCCCCc
Confidence 99999999999999999 999999999999999999999999997643221 2223456899999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhh---------hhhhHHHhh-----h-h---------------------------
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEE---------NRSLAAYFS-----K-E--------------------------- 199 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~---------~~~~~~~~~-----~-~--------------------------- 199 (290)
++|||||||++|+|+++..+++..... ...+..... . .
T Consensus 236 ~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (357)
T PHA03209 236 KADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRY 315 (357)
T ss_pred hhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCccccc
Confidence 999999999999998754443221100 000000000 0 0
Q ss_pred ---hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 200 ---AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 200 ---~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.....+.++.+||.+||+.||.+|||+.|++.|-+
T Consensus 316 ~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 316 PCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred HHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 00011334567999999999999999999998743
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=262.10 Aligned_cols=222 Identities=21% Similarity=0.248 Sum_probs=180.0
Q ss_pred CceEEEEeecccC-----chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVH-----ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.|++|.+.... .+..+.+.+|+++++.++||||+++++++......++++||+++++|.+++.... .++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~ 100 (258)
T cd06632 25 GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG----SFP 100 (258)
T ss_pred CcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC----CCC
Confidence 5679999876433 3356789999999999999999999999999999999999999999999997654 578
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....... ......++..|++||.+..
T Consensus 101 ~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~ 175 (258)
T cd06632 101 EPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQ 175 (258)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc--cccccCCCcceeCHHHhcC
Confidence 8999999999999999999999 9999999999999999999999999876533222 2234567888999999887
Q ss_pred CC-CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 157 SQ-FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 157 ~~-~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.. ++.++|+||||+++|++++|.+|+.............. ....+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 176 ~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 76 88999999999999999999988754332211111111 111122345678999999999999999999999865
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=263.31 Aligned_cols=228 Identities=22% Similarity=0.328 Sum_probs=180.3
Q ss_pred CceEEEEeecc----------cCchhHHHHHHHHHHHHh-cCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC
Q 044846 2 EELWLLKKSKS----------VHESNVEQFINEVVILSQ-INHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD 70 (290)
Q Consensus 2 ~~~~avK~~~~----------~~~~~~~~~~~E~~~l~~-l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 70 (290)
++.+|+|.+.. .......++.+|+.++.+ ++||||+++++++...+..+++|||+++++|.+++.....
T Consensus 26 ~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~ 105 (269)
T cd08528 26 QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKE 105 (269)
T ss_pred CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHh
Confidence 46788998753 223345668889998876 6999999999999999999999999999999999865433
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceeccccc
Q 044846 71 DQLPITWEMRLRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYV 149 (290)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 149 (290)
....+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||.+....... ......++..|+
T Consensus 106 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~ 180 (269)
T cd08528 106 KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYS 180 (269)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc--ccccccCcccCc
Confidence 33368899999999999999999996 66 9999999999999999999999999976533221 233456788899
Q ss_pred CccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 150 DPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 150 aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
+||++.+..++.++|+||||+++|++++|.+|+............. .........+..+.++|.+||+.||++||++
T Consensus 181 ~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~ 260 (269)
T cd08528 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDI 260 (269)
T ss_pred ChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCH
Confidence 9999998889999999999999999999998875433221111100 0011112345679999999999999999999
Q ss_pred HHHHHHHH
Q 044846 227 KEVTLELA 234 (290)
Q Consensus 227 ~el~~~l~ 234 (290)
.|+..+++
T Consensus 261 ~e~~~~~~ 268 (269)
T cd08528 261 IQVSAMIS 268 (269)
T ss_pred HHHHHHhc
Confidence 99998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=262.80 Aligned_cols=223 Identities=21% Similarity=0.257 Sum_probs=174.9
Q ss_pred CceEEEEeecccC-----chhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVH-----ESNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.. .+..++++||+++++|.+++.... .
T Consensus 27 ~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~----~ 102 (266)
T cd06651 27 GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG----A 102 (266)
T ss_pred CcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC----C
Confidence 5679999876422 2345678899999999999999999999876 357789999999999999997654 4
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC--ceeeccceecccccCcc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR--THLTTQVKVTFGYVDPK 152 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~g~~~y~aPE 152 (290)
+++...+.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ........++..|+|||
T Consensus 103 l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (266)
T cd06651 103 LTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179 (266)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHH
Confidence 788899999999999999999998 9999999999999999999999999876432111 11112245788899999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
++.+..++.++|+|||||++|++++|.+|+........ ...... ...+......+.+++ +||..+|++||+++|
T Consensus 180 ~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~e 257 (266)
T cd06651 180 VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-IFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEE 257 (266)
T ss_pred HhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-HHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHH
Confidence 99988899999999999999999999998754322211 111111 111233456677888 788899999999999
Q ss_pred HHHHH
Q 044846 229 VTLEL 233 (290)
Q Consensus 229 l~~~l 233 (290)
++.+-
T Consensus 258 il~hp 262 (266)
T cd06651 258 LLRHP 262 (266)
T ss_pred HhcCc
Confidence 98763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=269.02 Aligned_cols=230 Identities=23% Similarity=0.342 Sum_probs=178.0
Q ss_pred eEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.||+|.+.... ......+.+|+.+++.++||||+++++++... ..++++||+++|+|.+++..... .+++..+..
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~---~~~~~~~~~ 113 (303)
T cd05110 38 PVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKD---NIGSQLLLN 113 (303)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhccc---CCCHHHHHH
Confidence 46888776433 33345788999999999999999999998754 46799999999999999976532 478889999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccccccCCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+..++.
T Consensus 114 ~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (303)
T cd05110 114 WCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 190 (303)
T ss_pred HHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCCh
Confidence 9999999999999999 999999999999999999999999998754322211 112234567899999999888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhh-hhhhHH-HhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEE-NRSLAA-YFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++||||||+++|++++ |..|+...... ...+.. ......+...+..+.+++.+||..+|++||++.++++.|..+..
T Consensus 191 ~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 191 QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999986 66666432211 111111 11111122345678999999999999999999999999988755
Q ss_pred hh
Q 044846 239 SI 240 (290)
Q Consensus 239 ~~ 240 (290)
..
T Consensus 271 ~~ 272 (303)
T cd05110 271 DP 272 (303)
T ss_pred ch
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=262.92 Aligned_cols=224 Identities=24% Similarity=0.364 Sum_probs=179.5
Q ss_pred CceEEEEeecccC------chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVH------ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~------~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|+++... ....+.+.+|++.++.++||||+++++++...+..++|+||+++++|.+++.+.. ++
T Consensus 25 ~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~ 100 (268)
T cd06630 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AF 100 (268)
T ss_pred CcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC----CC
Confidence 5679999886432 2235678999999999999999999999999999999999999999999998654 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-cEEEeccccccccccCCc---eeeccceecccccCc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDFRTFKSRAIDRT---HLTTQVKVTFGYVDP 151 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aP 151 (290)
++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .++|+|||.+........ .......++..|+||
T Consensus 101 ~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~P 177 (268)
T cd06630 101 KEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177 (268)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCH
Confidence 88999999999999999999999 99999999999998776 599999998765432211 111234578889999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhh--hhhhHHH----hhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSLAAY----FSKEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
|++.+..++.++|+||+|++++++++|..|+...... ....... .....+...+..+.+++.+||+.+|.+|||
T Consensus 178 E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 257 (268)
T cd06630 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP 257 (268)
T ss_pred hHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcC
Confidence 9998888999999999999999999999887533211 1111111 112223345678999999999999999999
Q ss_pred HHHHHHH
Q 044846 226 MKEVTLE 232 (290)
Q Consensus 226 ~~el~~~ 232 (290)
+.+++.+
T Consensus 258 ~~~ll~~ 264 (268)
T cd06630 258 SRELLKH 264 (268)
T ss_pred HHHHhcC
Confidence 9999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=268.10 Aligned_cols=224 Identities=21% Similarity=0.233 Sum_probs=176.8
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||||+++++|.+++.... .+++.
T Consensus 26 ~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~ 101 (305)
T cd05609 26 RQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG----ALPVD 101 (305)
T ss_pred CcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC----CCCHH
Confidence 4679999886433 3345678899999999999999999999999999999999999999999997654 58889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc--------------eeecccee
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT--------------HLTTQVKV 144 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~g 144 (290)
.+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++....... .......+
T Consensus 102 ~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (305)
T cd05609 102 MARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178 (305)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCcc
Confidence 99999999999999999998 99999999999999999999999998764211100 01112456
Q ss_pred cccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----hhhHHHHHHHHHHHHHhhccC
Q 044846 145 TFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----EAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 145 ~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~d 219 (290)
+..|+|||.+.+..++.++|+||||+++|++++|..|+...... ......... ......+..+.++|.+||+.|
T Consensus 179 ~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 257 (305)
T cd05609 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQN 257 (305)
T ss_pred CccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccC
Confidence 77899999998888999999999999999999999887643222 111111111 111134567899999999999
Q ss_pred CCCCCCH---HHHHHHH
Q 044846 220 GKKQPTM---KEVTLEL 233 (290)
Q Consensus 220 p~~Rps~---~el~~~l 233 (290)
|++||++ .+++++.
T Consensus 258 P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 258 PLERLGTGGAFEVKQHR 274 (305)
T ss_pred hhhccCccCHHHHHhCc
Confidence 9999985 5555553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=267.50 Aligned_cols=226 Identities=21% Similarity=0.300 Sum_probs=176.2
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++||||+. ++|.+++..... .+++..+
T Consensus 31 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~ 106 (301)
T cd07873 31 DNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN---SINMHNV 106 (301)
T ss_pred CcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCC---CCCHHHH
Confidence 5789999986433 3334567899999999999999999999999999999999996 699998876432 4788999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-CC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-QF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~ 159 (290)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .......++..|+|||++.+. .+
T Consensus 107 ~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~ 182 (301)
T cd07873 107 KLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVTLWYRPPDILLGSTDY 182 (301)
T ss_pred HHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-CcccccceeecccCcHHHhCCCCC
Confidence 999999999999999999 9999999999999999999999999976533221 112234567889999998654 47
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHh------------hh-----------------hhhHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYF------------SK-----------------EAEKEEVITF 208 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~------------~~-----------------~~~~~~~~~~ 208 (290)
+.++||||||+++|+|++|.++|.......... .... .. ......+..+
T Consensus 183 ~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (301)
T cd07873 183 STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDG 262 (301)
T ss_pred ccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHH
Confidence 889999999999999999998886432211100 0000 00 0001124567
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 209 AMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 209 ~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.+||.+||+.||.+|||+.|++.+-+.
T Consensus 263 ~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 263 AELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 899999999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=275.24 Aligned_cols=224 Identities=20% Similarity=0.240 Sum_probs=178.7
Q ss_pred ceEEEEeec--ccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 3 ELWLLKKSK--SVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 3 ~~~avK~~~--~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
+.||+|++. ..+.+..+.|.+|+..|.+| .|.+||+++++-..++++|+|||+- ..+|..+|+..... .+.-.
T Consensus 386 ~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~---~~~~~ 461 (677)
T KOG0596|consen 386 QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSI---DPDWF 461 (677)
T ss_pred cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCC---CchHH
Confidence 567777764 56677788999999999999 7999999999999999999999987 66999999887643 23226
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee-eccceecccccCccccccCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~ 158 (290)
++.+..|++.++.++|..| |||.||||.|.|+ -.|.+||+|||+|.....+.+.. ...-.||+.||+||.+....
T Consensus 462 lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~ 537 (677)
T KOG0596|consen 462 LKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMS 537 (677)
T ss_pred HHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcc
Confidence 7889999999999999999 9999999999988 45899999999998776555443 34567999999999986543
Q ss_pred -----------CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhh----hH-HHHHHHHHHHHHhhccCCCC
Q 044846 159 -----------FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEA----EK-EEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 159 -----------~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~li~~cl~~dp~~ 222 (290)
.+.++||||+|||||+|+.|++||..-......+........ +. ....++.++++.||..||++
T Consensus 538 s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkk 617 (677)
T KOG0596|consen 538 SSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKK 617 (677)
T ss_pred ccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCccc
Confidence 456899999999999999999998644333333333322211 10 11123889999999999999
Q ss_pred CCCHHHHHHHHH
Q 044846 223 QPTMKEVTLELA 234 (290)
Q Consensus 223 Rps~~el~~~l~ 234 (290)
|||..+|+++-.
T Consensus 618 R~si~eLLqhpF 629 (677)
T KOG0596|consen 618 RWSIPELLQHPF 629 (677)
T ss_pred CCCcHHHhcCcc
Confidence 999999998743
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=262.62 Aligned_cols=224 Identities=21% Similarity=0.197 Sum_probs=182.4
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.||+|++.... ....+.+.+|+++++.++||||+++++.+..++..++++||+++++|.+++.... .++..
T Consensus 18 ~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~ 93 (262)
T cd05572 18 NRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG----LFDEY 93 (262)
T ss_pred CcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC----CCCHH
Confidence 6789999986422 2345679999999999999999999999999999999999999999999998654 47889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......++..|++||.+.+..
T Consensus 94 ~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~ 168 (262)
T cd05572 94 TARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKG 168 (262)
T ss_pred HHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcCCC
Confidence 99999999999999999999 9999999999999999999999999976543322 223346788899999998888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchh-hhhhhHHHh----hhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVE-ENRSLAAYF----SKEAEKEEVITFAMVAKRCLNLNGKKQPT-----MKE 228 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~e 228 (290)
++.++|+||||+++|++++|..|+..... ......... ....+...+..+.++|.+||+.||++||+ +.|
T Consensus 169 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~ 248 (262)
T cd05572 169 YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKD 248 (262)
T ss_pred CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHH
Confidence 99999999999999999999998865442 111111111 11122233578999999999999999999 788
Q ss_pred HHHHHH
Q 044846 229 VTLELA 234 (290)
Q Consensus 229 l~~~l~ 234 (290)
++++-+
T Consensus 249 l~~~~~ 254 (262)
T cd05572 249 IKKHKW 254 (262)
T ss_pred HhcChh
Confidence 877644
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=267.00 Aligned_cols=220 Identities=21% Similarity=0.243 Sum_probs=180.8
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.+|+|+++.. .....+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++.... .++..
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~ 101 (290)
T cd05580 26 GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG----RFPEP 101 (290)
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC----CCCHH
Confidence 578999988642 23456778999999999999999999999999999999999999999999997754 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...... .....+++.|+|||.+.+..
T Consensus 102 ~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 174 (290)
T cd05580 102 VARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKG 174 (290)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CCCCCCCccccChhhhcCCC
Confidence 99999999999999999999 999999999999999999999999997654322 23346788999999998888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~~ 231 (290)
++.++|+||||+++|+|++|..|+...... ........ ...+...+..+.+++.+||+.||.+|+ +++|++.
T Consensus 175 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 889999999999999999999887543321 11111111 112223457789999999999999999 7788876
Q ss_pred HH
Q 044846 232 EL 233 (290)
Q Consensus 232 ~l 233 (290)
+.
T Consensus 254 ~~ 255 (290)
T cd05580 254 HP 255 (290)
T ss_pred Cc
Confidence 64
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=265.58 Aligned_cols=224 Identities=21% Similarity=0.240 Sum_probs=177.3
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++.. .....+.+.+|+++++.++|+||+++++++...+..+++|||++++.+..+..... .+++..
T Consensus 26 ~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~----~~~~~~ 101 (288)
T cd07833 26 GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG----GLPPDA 101 (288)
T ss_pred CcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCC----CCCHHH
Confidence 567999988642 34456789999999999999999999999999999999999998766665554332 488999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-C
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-Q 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 158 (290)
+..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++...............++..|+|||++.+. .
T Consensus 102 ~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 178 (288)
T cd07833 102 VRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178 (288)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCC
Confidence 9999999999999999999 99999999999999999999999999765543332233345677889999999888 7
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh---------------------------------hhhhhHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF---------------------------------SKEAEKEEV 205 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~ 205 (290)
++.++|+||||+++|++++|.+++.............. ....+...+
T Consensus 179 ~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (288)
T cd07833 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVS 258 (288)
T ss_pred cCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccc
Confidence 88999999999999999999987754322111100000 000111125
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 206 ITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 206 ~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.++.++|.+||..||++|||+++++++
T Consensus 259 ~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 259 SPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hHHHHHHHHHhccCchhcccHHHHhcC
Confidence 779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.20 Aligned_cols=223 Identities=21% Similarity=0.226 Sum_probs=175.9
Q ss_pred CceEEEEeecccC-----chhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVH-----ESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|++.... ....+.+.+|+++++.++||||+++++++... ..++++|||+++|+|.+++.... .
T Consensus 27 ~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~ 102 (265)
T cd06652 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG----A 102 (265)
T ss_pred CcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC----C
Confidence 5789999875321 23456788999999999999999999998763 46789999999999999997654 4
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc--eeeccceecccccCcc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYVDPK 152 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE 152 (290)
+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ .......++..|+|||
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (265)
T cd06652 103 LTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChh
Confidence 788889999999999999999999 99999999999999999999999998764321111 1112345788899999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
++.+..++.++|+||||+++|++++|++|+........ ...... ...+......+.+++.+||. +|++||+++|
T Consensus 180 ~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~ 257 (265)
T cd06652 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADE 257 (265)
T ss_pred hhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence 99888899999999999999999999998754322211 111111 11233455678899999994 9999999999
Q ss_pred HHHHH
Q 044846 229 VTLEL 233 (290)
Q Consensus 229 l~~~l 233 (290)
++++.
T Consensus 258 il~~~ 262 (265)
T cd06652 258 LLRHT 262 (265)
T ss_pred HhcCc
Confidence 98753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=262.90 Aligned_cols=225 Identities=23% Similarity=0.268 Sum_probs=176.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
++.+++|++..... ..+.+.+|+.+++.+ +|+||+++++++.... ..++||||+++++|.+++.........
T Consensus 31 ~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 109 (275)
T cd06608 31 GQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKR 109 (275)
T ss_pred CcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCC
Confidence 46789998875443 356789999999999 7999999999997654 489999999999999998764422236
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ........++..|+|||++
T Consensus 110 ~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~ 185 (275)
T cd06608 110 LKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST-LGRRNTFIGTPYWMAPEVI 185 (275)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccc-hhhhcCccccccccCHhHh
Confidence 889999999999999999999999 999999999999999999999999987543221 1222335578889999987
Q ss_pred cc-----CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----hhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 155 RS-----SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----EAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 155 ~~-----~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
.. ..++.++||||||+++|++++|.+|+....... ........ ......+..+.+++.+||..||++||
T Consensus 186 ~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 264 (275)
T cd06608 186 ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRP 264 (275)
T ss_pred cccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCc
Confidence 54 346778999999999999999999885432211 11111111 11223556789999999999999999
Q ss_pred CHHHHHHH
Q 044846 225 TMKEVTLE 232 (290)
Q Consensus 225 s~~el~~~ 232 (290)
|+.+++++
T Consensus 265 t~~~ll~~ 272 (275)
T cd06608 265 FMEELLEH 272 (275)
T ss_pred CHHHHhcC
Confidence 99999865
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=282.93 Aligned_cols=222 Identities=16% Similarity=0.199 Sum_probs=169.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCC------CceeeEEeEEEeC-CcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINH------RNVVKILGCCLET-EVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~H------pniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
++.||||+++... .....+..|+++++.++| +++++++++|... .+.|+|||++ +++|.+++.... .
T Consensus 154 ~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~----~ 227 (467)
T PTZ00284 154 KEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG----P 227 (467)
T ss_pred CeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC----C
Confidence 5679999997532 233456678888777754 4588899888764 5789999998 789999987654 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCC----------------cEEEeccccccccccCCce
Q 044846 75 ITWEMRLRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKY----------------QAKISDFRTFKSRAIDRTH 137 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~----------------~~kl~dfg~~~~~~~~~~~ 137 (290)
+++..+..++.||+.||.|||+ .+ ||||||||+|||++.++ .+||+|||.+.... .
T Consensus 228 l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~ 300 (467)
T PTZ00284 228 FSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER----H 300 (467)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc----c
Confidence 8899999999999999999997 48 99999999999998765 49999999865322 2
Q ss_pred eeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHH--------------------
Q 044846 138 LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAY-------------------- 195 (290)
Q Consensus 138 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~-------------------- 195 (290)
......||+.|+|||++.+..|+.++|||||||++|||++|++||........ .+...
T Consensus 301 ~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~ 380 (467)
T PTZ00284 301 SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLL 380 (467)
T ss_pred ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHH
Confidence 23346789999999999999999999999999999999999998854321110 00000
Q ss_pred hhh---------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 196 FSK---------------------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 196 ~~~---------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
... .........+.+||.+||..||.+|||++|+++|.+-.
T Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 381 YNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL 442 (467)
T ss_pred hhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccc
Confidence 000 00001134577999999999999999999999886643
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=259.31 Aligned_cols=223 Identities=23% Similarity=0.321 Sum_probs=179.4
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
++.+|+|.+... .......+.+|+++++.++||||+++++.+...+..++||||+++++|.+++...... .+++..
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~ 102 (256)
T cd08220 25 QKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS--LLDEDT 102 (256)
T ss_pred CcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhccc--CCCHHH
Confidence 567899988643 3445678999999999999999999999999999999999999999999999765422 478899
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC-CcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
+..++.+++.||.|||+++ ++|+||||+||+++.+ +.+||+|||.+...... .......++..|+|||.+.+..
T Consensus 103 ~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 177 (256)
T cd08220 103 ILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK--SKAYTVVGTPCYISPELCEGKP 177 (256)
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--ccccccccCCcccCchhccCCC
Confidence 9999999999999999999 9999999999999855 45799999987654322 1222345788899999999888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++.++|+||||+++|++++|..++........ ...... ...+...+..+.+++.+||+.||++|||+.|++.+
T Consensus 178 ~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 178 YNQKSDIWALGCVLYELASLKRAFEAANLPAL-VLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCcccchHHHHHHHHHHHhCCCCcccCchHHH-HHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 89999999999999999999888754322211 111111 11122356679999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.75 Aligned_cols=228 Identities=24% Similarity=0.253 Sum_probs=179.6
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.+|+|.+.... ......+.+|+++++.++||||++++++|... +.+++||||+++++|.+++.........++..
T Consensus 26 ~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 105 (287)
T cd06621 26 GMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK 105 (287)
T ss_pred CeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHH
Confidence 5678999887433 34566799999999999999999999998653 46899999999999999886543333468888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+..
T Consensus 106 ~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~ 179 (287)
T cd06621 106 VLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS---LAGTFTGTSFYMAPERIQGKP 179 (287)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc---ccccccCCccccCHHHhcCCC
Confidence 99999999999999999999 999999999999999999999999987543321 112345677899999999889
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchh---hhhhhHHHhhh---h-----h--hHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVE---ENRSLAAYFSK---E-----A--EKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~---~~~~~~~~~~~---~-----~--~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
++.++||||+|+++|+|++|..|+..... ........... . . ....+..+.+++.+||+.||.+|||
T Consensus 180 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 259 (287)
T cd06621 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259 (287)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC
Confidence 99999999999999999999988764411 00111111111 0 0 0124567899999999999999999
Q ss_pred HHHHHHHHHh
Q 044846 226 MKEVTLELAG 235 (290)
Q Consensus 226 ~~el~~~l~~ 235 (290)
+.|++.+.+-
T Consensus 260 ~~eil~~~~~ 269 (287)
T cd06621 260 PWDMLEHPWI 269 (287)
T ss_pred HHHHHhCccc
Confidence 9999987654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=263.55 Aligned_cols=224 Identities=22% Similarity=0.268 Sum_probs=181.5
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.+|+|.+.... ....+++.+|+++++.++||||+++++.+...+..++++||+++++|.+++.... ..++...+
T Consensus 26 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~ 102 (265)
T cd06605 26 GKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ---GRIPERIL 102 (265)
T ss_pred CcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc---CCCCHHHH
Confidence 5779999886543 3456779999999999999999999999999999999999999999999998653 26888999
Q ss_pred HHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||.+........ ....++..|+|||.+.+..+
T Consensus 103 ~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~ 176 (265)
T cd06605 103 GKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KTFVGTSSYMAPERIQGNDY 176 (265)
T ss_pred HHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---hcccCChhccCHHHHcCCCC
Confidence 9999999999999999 88 99999999999999999999999998754322111 12567788999999998899
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccch----hhhhhhHHHhhh---hhhH-HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDV----EENRSLAAYFSK---EAEK-EEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~----~~~~~~~~~~~~---~~~~-~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
+.++|+||||+++|++++|..|+.... ............ .... ..+..+.++|.+||..||++|||+.+++.
T Consensus 177 ~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 999999999999999999998875432 111111111111 1111 25667999999999999999999999987
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
+-+
T Consensus 257 ~~~ 259 (265)
T cd06605 257 HPF 259 (265)
T ss_pred Cch
Confidence 644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=260.64 Aligned_cols=224 Identities=22% Similarity=0.275 Sum_probs=180.2
Q ss_pred CceEEEEeecccCc--hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHE--SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
++.||+|.++.... ...+.+..|+.+++.++|+||+++++.+...+..++|+||+++++|.+++.... .+++..
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~ 100 (264)
T cd06626 25 GELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR----ILDEHV 100 (264)
T ss_pred CcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC----CCChHH
Confidence 56799999875444 367889999999999999999999999999999999999999999999998653 478888
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeec---cceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTT---QVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~---~~~g~~~y~aPE~~~~ 156 (290)
+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++............ ...++..|++||++.+
T Consensus 101 ~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 177 (264)
T cd06626 101 IRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177 (264)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccC
Confidence 9999999999999999999 999999999999999999999999987654432222211 3456788999999987
Q ss_pred CC---CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh---h--hhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 157 SQ---FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK---E--AEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 157 ~~---~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
.. ++.++||||||++++++++|..|+................ . .....+..+.+++.+||+.||++|||+.+
T Consensus 178 ~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 257 (264)
T cd06626 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASE 257 (264)
T ss_pred CCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 66 7889999999999999999998875332211111111111 1 11122567889999999999999999999
Q ss_pred HHHH
Q 044846 229 VTLE 232 (290)
Q Consensus 229 l~~~ 232 (290)
++.+
T Consensus 258 i~~~ 261 (264)
T cd06626 258 LLQH 261 (264)
T ss_pred HhcC
Confidence 8764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=261.92 Aligned_cols=223 Identities=21% Similarity=0.265 Sum_probs=177.4
Q ss_pred CceEEEEeecccCc----------hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSVHE----------SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~~~----------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.+|+|.++.... ...+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++....
T Consensus 26 ~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 103 (272)
T cd06629 26 GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-- 103 (272)
T ss_pred CceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc--
Confidence 57799998753211 123567889999999999999999999999999999999999999999998653
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccC
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVD 150 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~a 150 (290)
.+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++........ .......++..|+|
T Consensus 104 --~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~ 178 (272)
T cd06629 104 --RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178 (272)
T ss_pred --CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccC
Confidence 5888999999999999999999998 99999999999999999999999998765332111 12234557888999
Q ss_pred ccccccCC--CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--------hhhhHHHHHHHHHHHHHhhccCC
Q 044846 151 PKYFRSSQ--FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--------KEAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 151 PE~~~~~~--~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~dp 220 (290)
||.+.... ++.++|+||||+++|++++|..|+........ ...... .......+..+.+++.+||+.||
T Consensus 179 PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 257 (272)
T cd06629 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-MFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINP 257 (272)
T ss_pred HHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-HHHhhccccCCcCCccccccCCHHHHHHHHHHhcCCh
Confidence 99987654 78899999999999999999988753322211 111110 01112345689999999999999
Q ss_pred CCCCCHHHHHHH
Q 044846 221 KKQPTMKEVTLE 232 (290)
Q Consensus 221 ~~Rps~~el~~~ 232 (290)
++|||+.+++.+
T Consensus 258 ~~Rps~~~il~~ 269 (272)
T cd06629 258 DNRPTARELLQH 269 (272)
T ss_pred hhCCCHHHHhhC
Confidence 999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=264.05 Aligned_cols=224 Identities=20% Similarity=0.247 Sum_probs=175.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEe------CCcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLE------TEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
++.+|+|...... .....+..|+.+++++ +||||+++++++.. .+..+++|||+++|+|.+++...... .
T Consensus 41 ~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~--~ 117 (282)
T cd06636 41 GQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN--A 117 (282)
T ss_pred CcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCC--C
Confidence 5678999886543 3456788999999998 79999999999853 45779999999999999999865432 4
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... .......|+..|+|||++
T Consensus 118 ~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l 193 (282)
T cd06636 118 LKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVI 193 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhccc-cCCCcccccccccCHhhc
Confidence 788888999999999999999999 9999999999999999999999999876432211 122345678899999997
Q ss_pred c-----cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 155 R-----SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 155 ~-----~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
. ...++.++|+|||||++|+|++|.+|+............... .......+..+.++|.+||+.||.+|||+
T Consensus 194 ~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 273 (282)
T cd06636 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPST 273 (282)
T ss_pred CcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCH
Confidence 6 345788999999999999999999887543322211111101 11112356789999999999999999999
Q ss_pred HHHHHH
Q 044846 227 KEVTLE 232 (290)
Q Consensus 227 ~el~~~ 232 (290)
.|++++
T Consensus 274 ~ell~~ 279 (282)
T cd06636 274 EQLLKH 279 (282)
T ss_pred HHHhcC
Confidence 999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=264.35 Aligned_cols=224 Identities=24% Similarity=0.283 Sum_probs=178.3
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.... ....+.+.+|+++++.++||||+++.++|...+..++|+||+. |++.+++..... .+++.
T Consensus 40 ~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~---~l~~~ 115 (307)
T cd06607 40 NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKK---PLQEV 115 (307)
T ss_pred CcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHccc---CCCHH
Confidence 5789999886432 3345678999999999999999999999999999999999995 688887765432 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR--- 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--- 155 (290)
.+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...... ....++..|+|||++.
T Consensus 116 ~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~ 187 (307)
T cd06607 116 EIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMD 187 (307)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-----CCccCCccccCceeeeccC
Confidence 99999999999999999999 999999999999999999999999987543221 2345778899999874
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
...++.++||||||+++|+|++|.+|+............... ......++..+.+++.+||+.||++||++.+++.+
T Consensus 188 ~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 356888999999999999999999887643322211111000 11122356679999999999999999999999987
Q ss_pred HHhhH
Q 044846 233 LAGIR 237 (290)
Q Consensus 233 l~~~~ 237 (290)
.+...
T Consensus 268 ~~~~~ 272 (307)
T cd06607 268 RFVLR 272 (307)
T ss_pred hhhcc
Confidence 65443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=262.58 Aligned_cols=225 Identities=22% Similarity=0.206 Sum_probs=174.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC-----CcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLET-----EVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.+|+|.+.... .....+.+|+.+++.+ +|||++++++++... +..++||||+++|+|.+++.........+
T Consensus 47 ~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~ 125 (291)
T cd06639 47 GSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125 (291)
T ss_pred CCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCC
Confidence 5678899886532 2345677899999999 899999999998754 35799999999999999987543333368
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .......++..|+|||++.
T Consensus 126 ~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 201 (291)
T cd06639 126 DEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIA 201 (291)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhccccc-ccccCccCCccccChhhhc
Confidence 89999999999999999999998 9999999999999999999999999876433211 1122345788899999986
Q ss_pred cCC-----CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----hhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 156 SSQ-----FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----EAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 156 ~~~-----~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
... ++.++|+|||||++|+|++|.+|+........ +...... .........+.++|.+||+.||++||+
T Consensus 202 ~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 280 (291)
T cd06639 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS 280 (291)
T ss_pred CCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC
Confidence 432 67899999999999999999988764332211 1111111 112234457899999999999999999
Q ss_pred HHHHHHH
Q 044846 226 MKEVTLE 232 (290)
Q Consensus 226 ~~el~~~ 232 (290)
+.|++++
T Consensus 281 ~~~il~~ 287 (291)
T cd06639 281 VTHLLEH 287 (291)
T ss_pred HHHHhcC
Confidence 9999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=265.54 Aligned_cols=224 Identities=21% Similarity=0.276 Sum_probs=182.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|.+........+.+.+|+.+++.++||||+++++.+...+..|+|+||+++++|.+++.+. .+++..+.
T Consensus 44 ~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~ 118 (293)
T cd06647 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIA 118 (293)
T ss_pred CCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc-----CCCHHHHH
Confidence 4678999987655666778999999999999999999999999999999999999999999999753 37788899
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....... .......+++.|++||.+....++.
T Consensus 119 ~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~ 194 (293)
T cd06647 119 AVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGP 194 (293)
T ss_pred HHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc-cccccccCChhhcCchhhccCCCCc
Confidence 99999999999999999 9999999999999999999999999875433221 1223345778899999998888999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++|+||||+++|++++|.+||............... .......+..+.++|.+||+.+|++||++.+++.+-.
T Consensus 195 ~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 999999999999999999988643322111111000 0112223567889999999999999999999998843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=266.50 Aligned_cols=222 Identities=19% Similarity=0.266 Sum_probs=175.0
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|+||+++++|..+..... .+++..
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~ 101 (286)
T cd07846 26 GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN----GLDESR 101 (286)
T ss_pred CCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC----CCCHHH
Confidence 5779999875422 2245678899999999999999999999999999999999999988888766433 488999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-CC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-SQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~ 158 (290)
++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+ ..
T Consensus 102 ~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 177 (286)
T cd07846 102 VRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTK 177 (286)
T ss_pred HHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhccccc
Confidence 9999999999999999999 9999999999999999999999999976543322 22233557888999999875 34
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---------------------------------hhhhHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---------------------------------KEAEKEEV 205 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~ 205 (290)
++.++||||||+++|+|++|.+++........ ...... .......+
T Consensus 178 ~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (286)
T cd07846 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLS 256 (286)
T ss_pred cCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcC
Confidence 77899999999999999999987753321110 000000 00011235
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 206 ITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 206 ~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
..+.+++.+||+.||++||++.+++++
T Consensus 257 ~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 257 GLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 668999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=258.22 Aligned_cols=226 Identities=20% Similarity=0.219 Sum_probs=179.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC----CcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLET----EVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.+|+|++.. ....++|+++--.. .|||||.++++|.+. .-+.+|||.|+||+|+..+.+.+.. .|+
T Consensus 87 ~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~--afT 159 (400)
T KOG0604|consen 87 QEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQ--AFT 159 (400)
T ss_pred hhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccc--cch
Confidence 34455555542 33456888876555 799999999998753 3567999999999999999987654 799
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
+..+-.|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||.|+.... .....+..-|+.|.|||+
T Consensus 160 Erea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--~~~L~TPc~TPyYvaPev 234 (400)
T KOG0604|consen 160 EREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--PGDLMTPCFTPYYVAPEV 234 (400)
T ss_pred HHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCC--CccccCCcccccccCHHH
Confidence 9999999999999999999999 999999999999974 45789999999875332 222334555889999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--h-------HHHhhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--L-------AAYFSKEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
+...+|+..+|+||+|+++|-|+.|+|||+........ . ..-+..+.+...+...+++|+.+|..+|.+|.
T Consensus 235 lg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRl 314 (400)
T KOG0604|consen 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERL 314 (400)
T ss_pred hCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhe
Confidence 99999999999999999999999999999865431110 0 11123455667788899999999999999999
Q ss_pred CHHHHHHHHHhhHhh
Q 044846 225 TMKEVTLELAGIRAS 239 (290)
Q Consensus 225 s~~el~~~l~~~~~~ 239 (290)
|+.+++.+-+-....
T Consensus 315 TI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 315 TIEEVMDHPWINQYE 329 (400)
T ss_pred eHHHhhcCchhcccc
Confidence 999999987755443
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=259.41 Aligned_cols=226 Identities=23% Similarity=0.308 Sum_probs=181.3
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.+|+|.++. ......+.+..|+++++.++||||+++++.+.. ....+++|||+++++|.+++.........+++
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~ 104 (265)
T cd08217 25 GKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEE 104 (265)
T ss_pred CCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCH
Confidence 56789998864 234456778999999999999999999998764 45679999999999999999875443446899
Q ss_pred HHHHHHHHHHHHHHHHHh-----hCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcc
Q 044846 78 EMRLRITVEVSRVLSYLH-----SVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPK 152 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH-----~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 152 (290)
..++.++.|++.||.||| +.+ ++|+||||+||+++.++.+||+|||++........ ......++..|+|||
T Consensus 105 ~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~pE 180 (265)
T cd08217 105 EFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKTYVGTPYYMSPE 180 (265)
T ss_pred HHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCcc-cccccccCCCccChh
Confidence 999999999999999999 666 99999999999999999999999999765443221 123356788999999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
++.+..++.++|+||||+++++|++|..|+...... ........ ...+...+..+.+++.+||+.+|++|||+.+|
T Consensus 181 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~i 259 (265)
T cd08217 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259 (265)
T ss_pred hhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-HHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 999888999999999999999999999887644311 11111111 12233456789999999999999999999999
Q ss_pred HHH
Q 044846 230 TLE 232 (290)
Q Consensus 230 ~~~ 232 (290)
+++
T Consensus 260 l~~ 262 (265)
T cd08217 260 LQL 262 (265)
T ss_pred hhC
Confidence 876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=258.58 Aligned_cols=226 Identities=25% Similarity=0.293 Sum_probs=181.7
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|++++++|.+++...... ..+++..+
T Consensus 26 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~-~~~~~~~~ 104 (267)
T cd06610 26 NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPR-GGLDEAII 104 (267)
T ss_pred CcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhccc-CCCCHHHH
Confidence 4678999886432 335778999999999999999999999999999999999999999999999865321 25889999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce---eeccceecccccCccccccC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH---LTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......... ......++..|++||++...
T Consensus 105 ~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 105 ATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred HHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccc
Confidence 999999999999999999 999999999999999999999999987654432222 22334678899999998877
Q ss_pred -CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhh--------hhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 158 -QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKE--------AEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 158 -~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
.++.++|+||||+++|+|++|..|+...... .......... .....+..+.+++.+||..||++|||+.+
T Consensus 182 ~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06610 182 HGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260 (267)
T ss_pred cCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 7888999999999999999999987543221 1111111110 01234567899999999999999999999
Q ss_pred HHHH
Q 044846 229 VTLE 232 (290)
Q Consensus 229 l~~~ 232 (290)
++.+
T Consensus 261 ll~~ 264 (267)
T cd06610 261 LLKH 264 (267)
T ss_pred HhhC
Confidence 9875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=263.41 Aligned_cols=224 Identities=20% Similarity=0.278 Sum_probs=174.7
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+. ++|.+++...... .+++..
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~--~l~~~~ 101 (284)
T cd07860 25 GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLS--GIPLPL 101 (284)
T ss_pred CCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCC--CCCHHH
Confidence 6789999886432 3334678899999999999999999999999999999999995 6899988764332 588999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC-
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ- 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~- 158 (290)
+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++....... .......++..|+|||++.+..
T Consensus 102 ~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 177 (284)
T cd07860 102 IKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKY 177 (284)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-cccccccccccccCCeEEecCCC
Confidence 9999999999999999999 9999999999999999999999999876443221 1122334677899999887654
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH--hhh----------------------------hhhHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY--FSK----------------------------EAEKEEVITF 208 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~--~~~----------------------------~~~~~~~~~~ 208 (290)
++.++|+||||+++|+|++|+.++............. ... ......+..+
T Consensus 178 ~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (284)
T cd07860 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDG 257 (284)
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHH
Confidence 5788999999999999999998875443221111100 000 0001124567
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHH
Q 044846 209 AMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 209 ~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.++|.+||+.||.+|||+.+++++
T Consensus 258 ~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 258 RDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhcCCCcccCCCHHHHhcC
Confidence 899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=261.88 Aligned_cols=230 Identities=19% Similarity=0.238 Sum_probs=176.7
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHH-HHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVI-LSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~-l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++... ......+..|+.+ ++.++||||+++++++...+..+++|||++ |+|.+++.........+++..
T Consensus 26 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~ 104 (283)
T cd06617 26 GTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDI 104 (283)
T ss_pred CcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHH
Confidence 6789999987532 2334456667775 555699999999999999999999999995 699998876543344689999
Q ss_pred HHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc--
Q 044846 80 RLRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-- 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 156 (290)
++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++...... .......++..|+|||++.+
T Consensus 105 ~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 179 (283)
T cd06617 105 LGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTIDAGCKPYMAPERINPEL 179 (283)
T ss_pred HHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc--cccccccCCccccChhhcCCcc
Confidence 999999999999999987 7 999999999999999999999999997643211 11233457788999998865
Q ss_pred --CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 157 --SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 157 --~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
..++.++|+|||||++|+|++|..|+.........+...... ......+..+.++|.+||..+|.+||++.+++
T Consensus 180 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 259 (283)
T cd06617 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259 (283)
T ss_pred cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 446889999999999999999998875322211212111111 11123457799999999999999999999999
Q ss_pred HHHHhhH
Q 044846 231 LELAGIR 237 (290)
Q Consensus 231 ~~l~~~~ 237 (290)
.+-.-..
T Consensus 260 ~~~~~~~ 266 (283)
T cd06617 260 QHPFFEL 266 (283)
T ss_pred cCchhhh
Confidence 8754443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=263.57 Aligned_cols=224 Identities=21% Similarity=0.265 Sum_probs=181.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|.+++... .+++..+.
T Consensus 45 ~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~ 119 (292)
T cd06657 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIA 119 (292)
T ss_pred CeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC-----CCCHHHHH
Confidence 5679999987655666778999999999999999999999999999999999999999999987543 47889999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.+..++.
T Consensus 120 ~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~ 195 (292)
T cd06657 120 AVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGP 195 (292)
T ss_pred HHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccCccccCHHHhcCCCCCc
Confidence 99999999999999999 9999999999999999999999999865433211 1223355788899999998888899
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHhhhh--hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYFSKE--AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++|+||||+++|++++|.+|+........ ......... .....+..+.+++.+||+.||.+||++.+++.+-.
T Consensus 196 ~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence 99999999999999999988754322111 111111100 11223566889999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=258.23 Aligned_cols=224 Identities=23% Similarity=0.279 Sum_probs=184.1
Q ss_pred CceEEEEeecccCc-hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHE-SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|++..... ...+.+.+|+..+..++|+||+++++++...+..++||||+++++|.+++.... .+++..+
T Consensus 26 ~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~ 101 (264)
T cd06623 26 GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG----KIPEPVL 101 (264)
T ss_pred CcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC----CCCHHHH
Confidence 67899999876444 456789999999999999999999999999999999999999999999998653 6899999
Q ss_pred HHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..+
T Consensus 102 ~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~ 177 (264)
T cd06623 102 AYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFVGTVTYMSPERIQGESY 177 (264)
T ss_pred HHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC-cccceeecccccCHhhhCCCCC
Confidence 9999999999999999 99 99999999999999999999999998765432221 2224567888999999998889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccch--hhhhhhHHHhh---hhhhHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDV--EENRSLAAYFS---KEAEKE-EVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.++|+||||+++|++++|..|+.... ........... ...... .+..+.+++.+||+.+|++|||+.+++++-
T Consensus 178 ~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~ 257 (264)
T cd06623 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHP 257 (264)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCH
Confidence 999999999999999999998875442 11111111111 111222 567799999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=253.57 Aligned_cols=227 Identities=17% Similarity=0.261 Sum_probs=187.0
Q ss_pred CceEEEEeecc-cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS-VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~-~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|.+.|||.+.. .+.++.++++..+.++..- +.|+||+.+|+|..+...+|.||.| ...+..++++... ++++..
T Consensus 117 ~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~---piPE~i 192 (391)
T KOG0983|consen 117 GHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKG---PIPERI 192 (391)
T ss_pred ceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcC---CchHHh
Confidence 67899999965 4566788899999888776 6899999999999999999999999 5588888887654 688888
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc---
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS--- 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--- 156 (290)
+-++...+..||.||-+++. |||||+||+|||+|..|++|+||||++-. .-.+...+...|.+.|||||-+.-
T Consensus 193 lGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGr--lvdSkAhtrsAGC~~YMaPERidp~~~ 268 (391)
T KOG0983|consen 193 LGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGR--LVDSKAHTRSAGCAAYMAPERIDPPDK 268 (391)
T ss_pred hhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccce--eecccccccccCCccccCccccCCCCC
Confidence 88999999999999998764 99999999999999999999999999543 333344556678899999999864
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhh-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAE-----KEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
..|+.++||||||++++||+||..|+.........+...+...++ ...++.|.+++..||+.|+.+||...++++
T Consensus 269 ~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 269 PKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 468899999999999999999998887654444444444443221 236788999999999999999999999998
Q ss_pred HHHhh
Q 044846 232 ELAGI 236 (290)
Q Consensus 232 ~l~~~ 236 (290)
|-...
T Consensus 349 h~Fi~ 353 (391)
T KOG0983|consen 349 HPFIK 353 (391)
T ss_pred Cccee
Confidence 85433
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=260.98 Aligned_cols=223 Identities=22% Similarity=0.271 Sum_probs=179.2
Q ss_pred CceEEEEeecccCc---hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVHE---SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.+|+|.+..... ...+.+.+|+++++.++||||+++++.+......|+++||+++++|.+++.... .+++.
T Consensus 18 ~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~ 93 (265)
T cd05579 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG----SLDED 93 (265)
T ss_pred CCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC----CCCHH
Confidence 67899999864333 456788999999999999999999999999999999999999999999998654 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-------eeeccceecccccCc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-------HLTTQVKVTFGYVDP 151 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~g~~~y~aP 151 (290)
.+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .......++..|++|
T Consensus 94 ~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P 170 (265)
T cd05579 94 VARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170 (265)
T ss_pred HHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCH
Confidence 99999999999999999999 99999999999999999999999998765432211 122334567789999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHH--HHHHHHHHHHHhhccCCCCCCCH-
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKE--EVITFAMVAKRCLNLNGKKQPTM- 226 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~li~~cl~~dp~~Rps~- 226 (290)
|......++.++|+||||+++|++++|..++........ ...... ...+.. .+..+.+++.+||+.+|.+|||+
T Consensus 171 e~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 249 (265)
T cd05579 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-FQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAK 249 (265)
T ss_pred HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCc
Confidence 999888889999999999999999999988754432211 111111 111112 26778999999999999999999
Q ss_pred --HHHHHH
Q 044846 227 --KEVTLE 232 (290)
Q Consensus 227 --~el~~~ 232 (290)
.+++.+
T Consensus 250 ~~~~~l~~ 257 (265)
T cd05579 250 SIEEIKNH 257 (265)
T ss_pred cHHHHhcC
Confidence 555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=257.76 Aligned_cols=231 Identities=17% Similarity=0.304 Sum_probs=177.6
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcC--CC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQT--DD 71 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~--~~ 71 (290)
|+.||+|+++.. .....+++.+|+++++.++||||+++++++.... ..++++||+.+|+|..++.... ..
T Consensus 27 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 106 (273)
T cd05074 27 FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEE 106 (273)
T ss_pred ceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCC
Confidence 467999988643 3445677899999999999999999999886532 2478999999999998875432 12
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccC
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVD 150 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~a 150 (290)
...++...+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++........ ......++..|++
T Consensus 107 ~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (273)
T cd05074 107 PFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183 (273)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcC
Confidence 224788899999999999999999999 999999999999999999999999987654322211 1123345567999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
||.+....++.++|||||||++|++++ |.+++..... .......... ......+..+.+++.+||+.+|++|||+
T Consensus 184 pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~ 262 (273)
T cd05074 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSF 262 (273)
T ss_pred HhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999988889999999999999999998 6666643322 1111111111 1112345679999999999999999999
Q ss_pred HHHHHHHHhh
Q 044846 227 KEVTLELAGI 236 (290)
Q Consensus 227 ~el~~~l~~~ 236 (290)
.++++.|+.+
T Consensus 263 ~~~~~~l~~~ 272 (273)
T cd05074 263 QHLRDQLELI 272 (273)
T ss_pred HHHHHHHHhh
Confidence 9999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=254.09 Aligned_cols=223 Identities=26% Similarity=0.311 Sum_probs=182.9
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.+++|+.........+.+.+|++.++.++||||+++++++...+..++++||+++++|.+++.... ..+++..+.
T Consensus 25 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~ 101 (253)
T cd05122 25 GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN---QTLTESQIA 101 (253)
T ss_pred CcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC---CCCCHHHHH
Confidence 57799999987655677889999999999999999999999999999999999999999999997653 258999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .....++..|++||.+.+..++.
T Consensus 102 ~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~ 176 (253)
T cd05122 102 YVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDY 176 (253)
T ss_pred HHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--ccceecCCcccCHHHHcCCCCCc
Confidence 99999999999999998 99999999999999999999999998765443221 23456788899999998888899
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hh--hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KE--AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++|+||||++++++++|..|+............... .. .....+..+.+++.+||+.||++|||+.+++++
T Consensus 177 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999877544221111111101 11 111125679999999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=261.75 Aligned_cols=226 Identities=18% Similarity=0.150 Sum_probs=178.9
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|.+... .......+..|+++++.++||||+++++.+...+..|+||||+++++|.+++..... ..+++.
T Consensus 18 ~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~ 95 (277)
T cd05577 18 GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE--PGFPEA 95 (277)
T ss_pred CcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCc--CCCCHH
Confidence 678999988532 223355678899999999999999999999999999999999999999999976543 258899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..... ........++..|++||++.+..
T Consensus 96 ~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~ 170 (277)
T cd05577 96 RAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRAGTPGYMAPEVLQGEV 170 (277)
T ss_pred HHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccccCCCCcCCHHHhcCCC
Confidence 99999999999999999999 99999999999999999999999998764322 11222345677899999998888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchh--hhhhhHH-Hh--hhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVE--ENRSLAA-YF--SKEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKE 228 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~--~~~~~~~-~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~e 228 (290)
++.++|+||||+++|+|++|..|+..... ....+.. .. ....+...+..+.++|.+||+.||.+|| ++.+
T Consensus 171 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ 250 (277)
T cd05577 171 YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADE 250 (277)
T ss_pred CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHH
Confidence 99999999999999999999988754322 1111111 00 1112223467789999999999999999 6777
Q ss_pred HHHHHH
Q 044846 229 VTLELA 234 (290)
Q Consensus 229 l~~~l~ 234 (290)
++.+.+
T Consensus 251 ll~h~~ 256 (277)
T cd05577 251 VREHPL 256 (277)
T ss_pred HHhChh
Confidence 776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=261.30 Aligned_cols=221 Identities=23% Similarity=0.236 Sum_probs=180.5
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++... .....+.+.+|++++++++||||+++++.+...+..++|+||+.+++|..++.... .+++.
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~ 100 (258)
T cd05578 25 KKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV----KFSEE 100 (258)
T ss_pred CcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC----CcCHH
Confidence 678999988643 23457789999999999999999999999999999999999999999999997653 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||++.+..
T Consensus 101 ~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~ 175 (258)
T cd05578 101 QVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQG 175 (258)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcccC
Confidence 99999999999999999999 9999999999999999999999999876443221 223455778899999999888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhh-hhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCH--HHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEE-NRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTM--KEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~--~el~~ 231 (290)
++.++|+||||+++|++++|..|+...... ....... .....+...+..+.++|.+||+.||.+||++ .|++.
T Consensus 176 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 999999999999999999999887644321 1111111 1122233456789999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=258.86 Aligned_cols=228 Identities=23% Similarity=0.290 Sum_probs=183.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.+|+|+++.... ..+.+.+|++.++.++|+||+++++.+...+..++++||+++++|.+++.... ..+++..+.
T Consensus 44 ~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~ 119 (286)
T cd06614 44 GKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIA 119 (286)
T ss_pred CcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHH
Confidence 56789999876544 56778999999999999999999999999999999999999999999998764 258899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|++||++.+..++.
T Consensus 120 ~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~ 195 (286)
T cd06614 120 YVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNSVVGTPYWMAPEVIKRKDYGP 195 (286)
T ss_pred HHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch-hhhccccCCcccCCHhHhcCCCCCC
Confidence 99999999999999998 9999999999999999999999999865432211 1112344678899999998888999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
++|+||||+++|++++|..|+............... .......+..+.++|.+||+.+|.+|||+.+++.+..-..
T Consensus 196 ~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 999999999999999999887543322111111000 1111224567999999999999999999999997755443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=262.66 Aligned_cols=226 Identities=26% Similarity=0.315 Sum_probs=180.1
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.+|+|++... .......+.+|+++++.++|||++++++++...+..++||||+. |+|.+.+..... ++++.
T Consensus 50 ~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~---~l~~~ 125 (317)
T cd06635 50 NEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEV 125 (317)
T ss_pred CcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcC---CCCHH
Confidence 567999988643 23345678899999999999999999999999999999999996 588888765432 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR--- 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--- 155 (290)
.+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..... .....++..|+|||++.
T Consensus 126 ~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~ 197 (317)
T cd06635 126 EIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-----ANSFVGTPYWMAPEVILAMD 197 (317)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-----cccccCCccccChhhhhcCC
Confidence 99999999999999999999 99999999999999999999999998654321 22345778899999974
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
.+.++.++|+|||||++|+|++|.+|+........ ...... .......+..+.+++.+||+.+|.+||++.+++.
T Consensus 198 ~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 45688899999999999999999988764422211 111111 1112234567899999999999999999999999
Q ss_pred HHHhhHhhh
Q 044846 232 ELAGIRASI 240 (290)
Q Consensus 232 ~l~~~~~~~ 240 (290)
++.......
T Consensus 277 ~~~~~~~~~ 285 (317)
T cd06635 277 HMFVLRERP 285 (317)
T ss_pred ChhhhccCc
Confidence 877665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.15 Aligned_cols=227 Identities=22% Similarity=0.276 Sum_probs=174.9
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCC-CCC
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQ-LPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~ 75 (290)
|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...++||||+. ++|.+++....... ..+
T Consensus 27 ~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~ 105 (316)
T cd07842 27 GKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSI 105 (316)
T ss_pred CCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCc
Confidence 5789999987632 44456788999999999999999999999988 78999999995 58888876543322 268
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc----CCcEEEeccccccccccCCc--eeeccceeccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD----KYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYV 149 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~----~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~ 149 (290)
++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||++........ .......++..|+
T Consensus 106 ~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 182 (316)
T cd07842 106 PPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR 182 (316)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCcccccccc
Confidence 88999999999999999999999 999999999999999 99999999998775432221 1122345688899
Q ss_pred CccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhh-----------hhhHHHhh--------------------
Q 044846 150 DPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEEN-----------RSLAAYFS-------------------- 197 (290)
Q Consensus 150 aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~-----------~~~~~~~~-------------------- 197 (290)
|||++.+. .++.++||||||+++++|++|.+++....... ..+...+.
T Consensus 183 aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (316)
T cd07842 183 APELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLM 262 (316)
T ss_pred CHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhh
Confidence 99988764 57889999999999999999998875332211 00000000
Q ss_pred -----hh---------hhH--HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 198 -----KE---------AEK--EEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 198 -----~~---------~~~--~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.. ... ..+..+.+++.+||+.||++|||+.|++.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 263 KDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred hhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 000 233468899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=301.66 Aligned_cols=225 Identities=22% Similarity=0.201 Sum_probs=184.4
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+..|+|-++. ......+.+.+|..++..|+|||+|+++|+-...+..+|.||||.+|+|.+++...+ ..++..
T Consensus 1260 GellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gr----i~dE~v 1335 (1509)
T KOG4645|consen 1260 GELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGR----IEDEMV 1335 (1509)
T ss_pred cchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcc----hhhhhH
Confidence 67788998764 235556778899999999999999999999999999999999999999999998765 356667
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC---ceeeccceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR---THLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~ 156 (290)
...+..|++.|+.|||+.| |+||||||.||+++.+|.+|++|||.|....... ........||+.|||||++.+
T Consensus 1336 t~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~ 1412 (1509)
T KOG4645|consen 1336 TRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITG 1412 (1509)
T ss_pred HHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcc
Confidence 7778899999999999999 9999999999999999999999999987554332 122346789999999999976
Q ss_pred CC---CCCcccchhhHHHHHHHhcCCCCcccchhhhhh---hHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 157 SQ---FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS---LAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 157 ~~---~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.. -..++||||+||++.||+||+.||..-...... +...-.+..+...+.+-+++|.+||+.||.+|.++.||+
T Consensus 1413 t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1413 TKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred cccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 53 456899999999999999999988533222221 222222344555788899999999999999999999988
Q ss_pred HHH
Q 044846 231 LEL 233 (290)
Q Consensus 231 ~~l 233 (290)
++-
T Consensus 1493 e~~ 1495 (1509)
T KOG4645|consen 1493 EHA 1495 (1509)
T ss_pred Hhh
Confidence 763
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=262.49 Aligned_cols=224 Identities=22% Similarity=0.246 Sum_probs=175.6
Q ss_pred CceEEEEeecccCch-----hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVHES-----NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~~~-----~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||+|+++..... ....+..|+++++.++|+||+++++++...+..++||||+ +|+|.+++.... ..++
T Consensus 25 ~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~---~~~~ 100 (298)
T cd07841 25 GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS---IVLT 100 (298)
T ss_pred CcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC---CCCC
Confidence 578999998754322 3456778999999999999999999999999999999999 899999997643 2588
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 101 ~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 176 (298)
T cd07841 101 PADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-RKMTHQVVTRWYRAPELLFG 176 (298)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC-ccccccccceeeeCHHHHhC
Confidence 9999999999999999999999 9999999999999999999999999976543221 11222345778999998865
Q ss_pred -CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---h---------------------------hhhHHHH
Q 044846 157 -SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---K---------------------------EAEKEEV 205 (290)
Q Consensus 157 -~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~---------------------------~~~~~~~ 205 (290)
..++.++|+|||||++|++++|.+++........ +..... . ......+
T Consensus 177 ~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T cd07841 177 ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAAS 255 (298)
T ss_pred CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhccccc
Confidence 4578899999999999999999876643322111 100000 0 0001224
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 206 ITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 206 ~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
..+.++|.+||+.||++|||+.|++.+-+
T Consensus 256 ~~~~~li~~~l~~~P~~R~s~~e~l~~~~ 284 (298)
T cd07841 256 DDALDLLQRLLTLNPNKRITARQALEHPY 284 (298)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence 56889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=277.01 Aligned_cols=225 Identities=20% Similarity=0.327 Sum_probs=189.1
Q ss_pred eEEEEeecccCch-hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSVHES-NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.||||.++..... ....|++|+.+|.+|+|||++++||+..+ ....+|||+++.|+|.+.|+.... ..|.......
T Consensus 140 ~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~--~~llv~~Lcd 216 (1039)
T KOG0199|consen 140 NVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKK--AILLVSRLCD 216 (1039)
T ss_pred eEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccc--cceeHHHHHH
Confidence 3899999876655 78899999999999999999999999988 667899999999999999988332 2577788889
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee--ccceecccccCccccccCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT--TQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~ 160 (290)
++.|||.||.||..++ +|||||..+|+|+.....+||+|||+.+....+...+. ......+.|+|||.+....++
T Consensus 217 ya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS 293 (1039)
T KOG0199|consen 217 YAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFS 293 (1039)
T ss_pred HHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccc
Confidence 9999999999999999 99999999999999999999999999887766555443 334567789999999999999
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.++|+|+|||++|||+++..-++........+... ..-..+..++.++++++++||..+|.+||||..|.+.+-
T Consensus 294 haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 294 HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 99999999999999997665554444443333332 233456678999999999999999999999999986543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=260.97 Aligned_cols=223 Identities=19% Similarity=0.299 Sum_probs=172.5
Q ss_pred CceEEEEeecccCc-hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHE-SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+. ++|.+++..... .+++..+
T Consensus 30 ~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~ 105 (291)
T cd07844 30 GQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGG---GLSMHNV 105 (291)
T ss_pred CcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCC---CCCHHHH
Confidence 57899999864332 223457789999999999999999999999999999999996 599999876542 5788999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-CCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-SQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~ 159 (290)
+.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ......++..|+|||++.+ ..+
T Consensus 106 ~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~ 181 (291)
T cd07844 106 RLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEY 181 (291)
T ss_pred HHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-cccccccccccCCcHHhhcCccc
Confidence 999999999999999999 99999999999999999999999998764322111 1122345778999999875 457
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---------------------------hhhh-----HHH--H
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---------------------------KEAE-----KEE--V 205 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~-----~~~--~ 205 (290)
+.++||||+|+++|+|++|.+++.........+..... .... ... .
T Consensus 182 ~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (291)
T cd07844 182 STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRI 261 (291)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCc
Confidence 88999999999999999999887543311111110000 0000 011 1
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 206 ITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 206 ~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
..+.+++.+||+.||++|||+.+++.+
T Consensus 262 ~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 262 PHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhHHHHHHHHhccCcccccCHHHHhcC
Confidence 567899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=260.28 Aligned_cols=223 Identities=19% Similarity=0.239 Sum_probs=171.9
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|.++... ......+.+|+.+++.++|+||+++++++...+..++||||+. ++|.+++..... .+++..+
T Consensus 30 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~ 105 (291)
T cd07870 30 GQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPG---GLHPYNV 105 (291)
T ss_pred CcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCC---CCCHHHH
Confidence 5789999986433 2333467899999999999999999999999999999999994 788887765432 4677888
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-CC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-QF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~ 159 (290)
..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++...... .......++..|+|||++.+. .+
T Consensus 106 ~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 181 (291)
T cd07870 106 RLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYSSEVVTLWYRPPDVLLGATDY 181 (291)
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC-CCCCCccccccccCCceeecCCCC
Confidence 899999999999999999 9999999999999999999999999876433211 112234467889999998754 57
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------------------------h--hh-------hHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------------------------K--EA-------EKEEV 205 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------------------------~--~~-------~~~~~ 205 (290)
+.++|+||||+++|+|++|.+++.........+..... . .. .....
T Consensus 182 ~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (291)
T cd07870 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRP 261 (291)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCC
Confidence 88999999999999999999887543322111111000 0 00 00113
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 206 ITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 206 ~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
..+.+++.+|++.||.+|||+.|++.+
T Consensus 262 ~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 262 PKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 568899999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=257.75 Aligned_cols=224 Identities=23% Similarity=0.287 Sum_probs=180.5
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.||+|...... ....+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++... .+++..+
T Consensus 29 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~-----~~~~~~~ 103 (277)
T cd06641 29 QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQI 103 (277)
T ss_pred CcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC-----CCCHHHH
Confidence 5689999876432 344567889999999999999999999999999999999999999999998643 4788999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++....... .......++..|++||.+.+..++
T Consensus 104 ~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~ 179 (277)
T cd06641 104 ATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYD 179 (277)
T ss_pred HHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-hhhccccCCccccChhhhccCCCC
Confidence 999999999999999999 9999999999999999999999999876443211 122334577889999999888889
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.++|+|||||++|++++|..|+...... ......... ......+..+.+++.+||+.+|.+||++.+++.+-.-
T Consensus 180 ~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 256 (277)
T cd06641 180 SKADIWSLGITAIELAKGEPPHSELHPM-KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256 (277)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCccchH-HHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 9999999999999999999887533221 111111111 1122345678999999999999999999999987443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=259.23 Aligned_cols=223 Identities=21% Similarity=0.241 Sum_probs=173.4
Q ss_pred CceEEEEeecccCc--hhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVHE--SNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.+|+|+++.... .....+.+|+.++++++||||+++++++... +..++||||+. ++|.+++..... .+++
T Consensus 30 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~l~~ 105 (293)
T cd07843 30 GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQ---PFLQ 105 (293)
T ss_pred CcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccC---CCCH
Confidence 56799999874332 2334577899999999999999999999877 88999999996 599999876442 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .......++..|+|||.+.+.
T Consensus 106 ~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~ 181 (293)
T cd07843 106 SEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGA 181 (293)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cccccccccccccCchhhcCC
Confidence 999999999999999999999 9999999999999999999999999876543321 112234567889999998765
Q ss_pred C-CCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhh------------------------------hhhhHH-
Q 044846 158 Q-FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFS------------------------------KEAEKE- 203 (290)
Q Consensus 158 ~-~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~------------------------------~~~~~~- 203 (290)
. ++.++|+||||+++|+|++|.+++......... ...... ...+..
T Consensus 182 ~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (293)
T cd07843 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALS 261 (293)
T ss_pred ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccC
Confidence 4 688999999999999999999887543221110 000000 000000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 204 EVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 204 ~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.+..+.++|.+||+.||++|||+.|++.+
T Consensus 262 ~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 262 LSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred CChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 25568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=258.13 Aligned_cols=224 Identities=21% Similarity=0.240 Sum_probs=179.4
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQIN---HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~---Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|.++.. .....+.+.+|+++++.++ |||++++++++......++||||+++++|.+++... .+++
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~ 100 (277)
T cd06917 26 GRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-----PIAE 100 (277)
T ss_pred CcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc-----CCCH
Confidence 677999988643 3455677889999999996 999999999999999999999999999999998653 4889
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......|+..|+|||.+.++
T Consensus 101 ~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 176 (277)
T cd06917 101 KYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFVGTPYWMAPEVITEG 176 (277)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-cccccccCCcceeCHHHhccC
Confidence 999999999999999999999 9999999999999999999999999876544322 222334678889999998754
Q ss_pred -CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh---h-hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 158 -QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK---E-AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 158 -~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.++.++|+||||+++|+|++|.+|+......... ...... . .....+.++.+++.+||+.||++||++.+++.+
T Consensus 177 ~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-MLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-hccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 4688999999999999999999987543222111 110000 0 011245678999999999999999999999876
Q ss_pred HHh
Q 044846 233 LAG 235 (290)
Q Consensus 233 l~~ 235 (290)
-+.
T Consensus 256 ~~~ 258 (277)
T cd06917 256 KWI 258 (277)
T ss_pred hHh
Confidence 543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=257.67 Aligned_cols=226 Identities=17% Similarity=0.206 Sum_probs=185.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|..||||++.......+.++.+|++++.+. .|+||++++++|+++..+|||||.|.||+|...|.+.. .|++..+
T Consensus 103 ~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~----~F~E~EA 178 (463)
T KOG0607|consen 103 GKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK----HFNEREA 178 (463)
T ss_pred chhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh----hccHHHH
Confidence 678999999888888899999999999999 79999999999999999999999999999999998876 6999999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc---EEEeccccccccccC------CceeeccceecccccCc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ---AKISDFRTFKSRAID------RTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~---~kl~dfg~~~~~~~~------~~~~~~~~~g~~~y~aP 151 (290)
..++.+|+.||.|||.++ |.||||||+|||...... +|||||.+....... .+....+..|+-.||||
T Consensus 179 s~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAP 255 (463)
T KOG0607|consen 179 SRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAP 255 (463)
T ss_pred HHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcch
Confidence 999999999999999999 999999999999976544 799999765332111 11223446678889999
Q ss_pred cccc-----cCCCCCcccchhhHHHHHHHhcCCCCcccchhh-------------hhhhHHHh-------hhhhhHHHHH
Q 044846 152 KYFR-----SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE-------------NRSLAAYF-------SKEAEKEEVI 206 (290)
Q Consensus 152 E~~~-----~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~-------------~~~~~~~~-------~~~~~~~~~~ 206 (290)
|+.. ...|+.++|.||+|+|+|-|+.|++||...... +..+.... ....+...+.
T Consensus 256 EVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~ 335 (463)
T KOG0607|consen 256 EVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISS 335 (463)
T ss_pred hHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhH
Confidence 9864 235889999999999999999999998654221 11121111 1234455677
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+..++|...|..|+.+|.++.+++.+.+
T Consensus 336 eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 336 EAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 8999999999999999999999988653
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=256.59 Aligned_cols=225 Identities=21% Similarity=0.258 Sum_probs=178.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.+|+|.+... ...+.+.+.+|+++++.++|+||+++++.+...+..++|+||+++++|.+++..... ..+++..
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~ 102 (257)
T cd08225 25 SEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG--VLFSEDQ 102 (257)
T ss_pred CceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccC--CCCCHHH
Confidence 567899988643 234456788999999999999999999999999999999999999999999976443 2578999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-cEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||.+....... .......|++.|+|||++.+..
T Consensus 103 ~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~ 178 (257)
T cd08225 103 ILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-ELAYTCVGTPYYLSPEICQNRP 178 (257)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-ccccccCCCccccCHHHHcCCC
Confidence 9999999999999999999 99999999999999875 46999999876543221 1222345788899999998888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++.++|+||||++++++++|..|+.............. ........+..+.+++.+||..+|++|||+.+++.+
T Consensus 179 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 99999999999999999999988754322211111110 011122345679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=259.00 Aligned_cols=224 Identities=15% Similarity=0.149 Sum_probs=172.7
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHh---cCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQ---INHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~---l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.+|+|.+.... ......+.+|...++. .+||||+.+++.+...+..++||||+++|+|..++.... .+
T Consensus 19 ~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----~l 94 (279)
T cd05633 19 GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG----VF 94 (279)
T ss_pred CcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC----CC
Confidence 5789999885422 2223334555544443 479999999999999999999999999999999987654 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ......|+..|+|||.+.
T Consensus 95 ~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~ 168 (279)
T cd05633 95 SEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQ 168 (279)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccCcCCCcCccCHHHhc
Confidence 99999999999999999999999 999999999999999999999999987543211 112346788999999986
Q ss_pred c-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh-hhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCC-----C
Q 044846 156 S-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR-SLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQP-----T 225 (290)
Q Consensus 156 ~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s 225 (290)
. ..++.++|+|||||++|+|++|..||........ ..... .....+...+..+.++|.+||..||.+|| |
T Consensus 169 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 248 (279)
T cd05633 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRG 248 (279)
T ss_pred CCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCC
Confidence 4 5688999999999999999999998854322111 11111 11122234567899999999999999999 5
Q ss_pred HHHHHHHHHh
Q 044846 226 MKEVTLELAG 235 (290)
Q Consensus 226 ~~el~~~l~~ 235 (290)
+.+++++...
T Consensus 249 ~~~~~~h~~~ 258 (279)
T cd05633 249 AQEVKEHVFF 258 (279)
T ss_pred HHHHHhCccc
Confidence 9999887543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=252.97 Aligned_cols=226 Identities=26% Similarity=0.314 Sum_probs=184.3
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.+|+|++.... ....+.+.+|+++++.++|||++++.+.+...+..++|+|++++++|.+++.........+++..
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 104 (258)
T cd08215 25 GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQ 104 (258)
T ss_pred CcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHH
Confidence 5789999987543 35677899999999999999999999999999999999999999999999987542223689999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..+
T Consensus 105 ~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~ 180 (258)
T cd08215 105 ILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPY 180 (258)
T ss_pred HHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc-ceecceeeeecccChhHhccCCC
Confidence 9999999999999999998 9999999999999999999999999876543222 22334567888999999988889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+.++|+||+|++++++++|..++...... ........ ...+...+..+.+++.+||..+|++|||+.+++++
T Consensus 181 ~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 181 NYKSDIWSLGCVLYELCTLKHPFEGENLL-ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CccccHHHHHHHHHHHHcCCCCCCCCcHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999999887543211 11111111 11122345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=258.23 Aligned_cols=224 Identities=21% Similarity=0.289 Sum_probs=174.6
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++.... ......+.+|+++++.++|||++++++++...+..+++|||+ +++|.+++..... ..+++..
T Consensus 24 ~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~--~~~~~~~ 100 (283)
T cd07835 24 GEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPL--TGLDPPL 100 (283)
T ss_pred CCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCC--CCCCHHH
Confidence 6779999886433 233457889999999999999999999999999999999999 5699999876542 2588999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-C
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-Q 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 158 (290)
+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++........ ......++..|+|||++.+. .
T Consensus 101 ~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~ 176 (283)
T cd07835 101 IKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQ 176 (283)
T ss_pred HHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccCccccccCCCCCceeecCcc
Confidence 9999999999999999998 99999999999999999999999999764332211 11223457889999988764 4
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH-----------------------hh-------hhhhHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY-----------------------FS-------KEAEKEEVITF 208 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~-----------------------~~-------~~~~~~~~~~~ 208 (290)
++.++|+||||+++|+|++|.++|............. .. .......+..+
T Consensus 177 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (283)
T cd07835 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDG 256 (283)
T ss_pred cCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHH
Confidence 6889999999999999999998875432211110000 00 00011223568
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHH
Q 044846 209 AMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 209 ~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.++|.+||+.||.+|||+.|++++
T Consensus 257 ~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 257 LDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcC
Confidence 899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=255.14 Aligned_cols=219 Identities=19% Similarity=0.198 Sum_probs=171.9
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHh-cCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQ-INHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~-l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|.++... ......+..|..++.. ++||||+++++++...+..++|+||+++++|.+++.... .+++
T Consensus 21 ~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~ 96 (260)
T cd05611 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG----GLPE 96 (260)
T ss_pred CCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC----CCCH
Confidence 5789999986433 2223345566655544 489999999999999999999999999999999997654 5888
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..... .....++..|++||.+.+.
T Consensus 97 ~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~ 168 (260)
T cd05611 97 DWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGV 168 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhhhcCC
Confidence 999999999999999999999 99999999999999999999999998764322 2234577889999999888
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCH---HH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTM---KE 228 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~---~e 228 (290)
.++.++|+||||+++|++++|.+|+....... ....... .......+..+.+++.+||+.||++||++ .|
T Consensus 169 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 88999999999999999999998875433221 1111111 01111346779999999999999999966 46
Q ss_pred HHHHH
Q 044846 229 VTLEL 233 (290)
Q Consensus 229 l~~~l 233 (290)
++.+.
T Consensus 248 ~l~~~ 252 (260)
T cd05611 248 IKSHP 252 (260)
T ss_pred HHcCh
Confidence 55543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=280.35 Aligned_cols=215 Identities=18% Similarity=0.199 Sum_probs=165.2
Q ss_pred hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHh
Q 044846 17 NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD-QLPITWEMRLRITVEVSRVLSYLH 95 (290)
Q Consensus 17 ~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~ylH 95 (290)
....+.+|+.+|+.++||||+++++++...+..|+|+|++ +++|..++...... ........+..++.||+.||.|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 3556889999999999999999999999999999999999 56888887654311 112345667789999999999999
Q ss_pred hCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCcccchhhHHHHHHH
Q 044846 96 SVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175 (290)
Q Consensus 96 ~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l 175 (290)
+++ |+||||||+|||++.++.+||+|||+++..............|+..|+|||++.+..++.++|||||||++|||
T Consensus 285 ~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 285 DKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred hCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 999 99999999999999999999999999875543333333456789999999999999999999999999999999
Q ss_pred hcCCCCcccchh--hhhhhHHHhh---------------------h--------h-----hhHHHHHHHHHHHHHhhccC
Q 044846 176 NWTKPIHLVDVE--ENRSLAAYFS---------------------K--------E-----AEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 176 ~~~~~~~~~~~~--~~~~~~~~~~---------------------~--------~-----~~~~~~~~~~~li~~cl~~d 219 (290)
+++..++..... ....+..... . . .....+..+.++|.+||+.|
T Consensus 362 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 362 LSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred HHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence 988754432211 0000000000 0 0 00012235778899999999
Q ss_pred CCCCCCHHHHHHHHHh
Q 044846 220 GKKQPTMKEVTLELAG 235 (290)
Q Consensus 220 p~~Rps~~el~~~l~~ 235 (290)
|.+|||+.|++.+.+.
T Consensus 442 P~~Rpsa~elL~hp~f 457 (501)
T PHA03210 442 WHLRPGAAELLALPLF 457 (501)
T ss_pred cccCcCHHHHhhChhh
Confidence 9999999999987553
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=254.48 Aligned_cols=225 Identities=23% Similarity=0.293 Sum_probs=183.0
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.+|+|++... .......+.+|+++++.++||||+++.+++......++|+||+++++|.+++.........+++..
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~ 104 (256)
T cd08530 25 NQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQE 104 (256)
T ss_pred CCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHH
Confidence 567899988643 334566788999999999999999999999999999999999999999999977443333688999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...... ......++..|++||.+.+..+
T Consensus 105 ~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~ 178 (256)
T cd08530 105 IWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPY 178 (256)
T ss_pred HHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC---CcccccCCccccCHHHHCCCCC
Confidence 9999999999999999999 999999999999999999999999987654432 2223457788999999998889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhH--HHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA--AYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+.++|+||+|++++++++|..|+........... ...........+.++.+++.+||+.+|++|||+.+++.+
T Consensus 179 ~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 9999999999999999999988754332211111 001112233556779999999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=255.36 Aligned_cols=221 Identities=19% Similarity=0.255 Sum_probs=170.4
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQI-NHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++... ........+|+..+.++ +||||+++++++... +..++||||+. |+|.+++..... .+++
T Consensus 24 ~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~ 99 (282)
T cd07831 24 GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKR---PLPE 99 (282)
T ss_pred CcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccC---CCCH
Confidence 5779999886532 22233456899999998 599999999999987 88999999995 689988876432 5889
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS- 156 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 156 (290)
..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||++....... ......++..|+|||++..
T Consensus 100 ~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 173 (282)
T cd07831 100 KRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--PYTEYISTRWYRAPECLLTD 173 (282)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC--CcCCCCCCcccCChhHhhcC
Confidence 999999999999999999999 999999999999999 999999999976543221 1123456788999997654
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHh-----------h-----------------hhhhHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYF-----------S-----------------KEAEKEEVI 206 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~-----------~-----------------~~~~~~~~~ 206 (290)
..++.++|+|||||++|+|++|.+|+........ ...... . .......+.
T Consensus 174 ~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (282)
T cd07831 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASA 253 (282)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccH
Confidence 4578899999999999999999888754321110 000000 0 000112357
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.+.++|.+||+.||++|||+.+++.+
T Consensus 254 ~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 254 EGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHHHHHHhccCcccccCHHHHhhC
Confidence 89999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=258.31 Aligned_cols=226 Identities=19% Similarity=0.246 Sum_probs=172.9
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCc-----ceEEEEeCCCCCHHHHHhhcCCC-C
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEV-----PLLVYEFIPNGSLYQYIHEQTDD-Q 72 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~-~ 72 (290)
|+.||+|+.+... ......+.+|+.+++.+ +||||+++++++...+. .|+||||+++ +|.+++...... .
T Consensus 26 ~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~ 104 (295)
T cd07837 26 GKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPG 104 (295)
T ss_pred CcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCC
Confidence 6789999876432 23356788999999999 56999999999987665 7999999974 899988764322 2
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
..+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||++....... .......+++.|+||
T Consensus 105 ~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aP 180 (295)
T cd07837 105 RPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV-KSYTHEIVTLWYRAP 180 (295)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCc-cccCCcccccCCCCh
Confidence 36899999999999999999999999 999999999999998 8899999999876432211 112233467789999
Q ss_pred ccccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhH--HHhh---------------------------hhhh
Q 044846 152 KYFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA--AYFS---------------------------KEAE 201 (290)
Q Consensus 152 E~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~--~~~~---------------------------~~~~ 201 (290)
|++.+ ..++.++|+||||+++|+|++|.+++........... .... ....
T Consensus 181 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (295)
T cd07837 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAV 260 (295)
T ss_pred HHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhc
Confidence 98865 4578899999999999999999988764322211110 0000 0000
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 202 KEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 202 ~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
...+..+.++|.+||+.||.+|||+.|++.+
T Consensus 261 ~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 261 PDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1235668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=255.33 Aligned_cols=225 Identities=18% Similarity=0.262 Sum_probs=175.5
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|+++... ....+.+.+|+++++.++||||+++++++...+..++||||++ |+|.+++..... ...+++..+
T Consensus 25 ~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~ 102 (284)
T cd07836 25 GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGV-RGALDPNTV 102 (284)
T ss_pred CeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCC-CCCcCHHHH
Confidence 5779999987543 3345677899999999999999999999999999999999997 589998876542 225899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-CC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-QF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~ 159 (290)
..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .......++..|++||++.+. .+
T Consensus 103 ~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~ 178 (284)
T cd07836 103 KSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NTFSNEVVTLWYRAPDVLLGSRTY 178 (284)
T ss_pred HHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cccccccccccccChHHhcCCCCC
Confidence 999999999999999999 9999999999999999999999999876433221 112234567889999998664 46
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHh------------h----------------hhhhHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYF------------S----------------KEAEKEEVITFA 209 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~------------~----------------~~~~~~~~~~~~ 209 (290)
+.++|+||||+++|++++|.+++.......... .... . .......+..+.
T Consensus 179 ~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (284)
T cd07836 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGI 258 (284)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHH
Confidence 889999999999999999998875432211100 0000 0 000112345688
Q ss_pred HHHHHhhccCCCCCCCHHHHHHH
Q 044846 210 MVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 210 ~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+++.+||+.||.+||++.+++.+
T Consensus 259 ~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 259 DLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=260.17 Aligned_cols=227 Identities=22% Similarity=0.245 Sum_probs=174.6
Q ss_pred CceEEEEeecccCc--hhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVHE--SNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++||||+. ++|.+++..... .+++
T Consensus 32 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~l~~ 107 (309)
T cd07845 32 GEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPT---PFSE 107 (309)
T ss_pred CcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhccc---CCCH
Confidence 67899999864322 2234567899999999999999999998765 46899999995 589998876432 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS- 156 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 156 (290)
..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .......++..|+|||++.+
T Consensus 108 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 183 (309)
T cd07845 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVVTLWYRAPELLLGC 183 (309)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc-CCCCcccccccccChhhhcCC
Confidence 999999999999999999999 9999999999999999999999999976543221 11222345778999999865
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhh---------------------h-h-------hhHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFS---------------------K-E-------AEKEEV 205 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~---------------------~-~-------~~~~~~ 205 (290)
..++.++|+||+||++|+|++|.+++......... ...... . . .....+
T Consensus 184 ~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T cd07845 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLS 263 (309)
T ss_pred CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccC
Confidence 45788999999999999999999887643322110 000000 0 0 001135
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 206 ITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 206 ~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
..+.++|.+||+.||++|||+.+++.+.+..
T Consensus 264 ~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 264 EAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 6688999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=256.16 Aligned_cols=224 Identities=22% Similarity=0.256 Sum_probs=175.9
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.+|+|+++.. .....+.+.+|+++++.++|||++++++++... +..++|+||++ ++|.+++.... ..+++
T Consensus 24 ~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~ 99 (287)
T cd07840 24 GELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPE---VKFTE 99 (287)
T ss_pred CeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccC---CCCCH
Confidence 567999999764 244456788999999999999999999999988 88999999996 59999887653 25889
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS- 156 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 156 (290)
..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...............++..|+|||.+.+
T Consensus 100 ~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 176 (287)
T cd07840 100 SQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEcc
Confidence 999999999999999999999 9999999999999999999999999976544332222333456778999998765
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHhh------------------------------hhhhHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYFS------------------------------KEAEKEE 204 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~~------------------------------~~~~~~~ 204 (290)
..++.++||||||+++|+|++|.+++........ ....... .......
T Consensus 177 ~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T cd07840 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLI 256 (287)
T ss_pred ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccC
Confidence 4578899999999999999999988754332111 0000000 0000012
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 205 VITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 205 ~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+..+.+++.+||+.||.+||++.+++++
T Consensus 257 ~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 257 DPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 5678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=256.24 Aligned_cols=225 Identities=20% Similarity=0.267 Sum_probs=173.1
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++... ....+.+.+|+++++.++||||+++++++...+..++||||++ ++|.+++..... ..+++..
T Consensus 27 ~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~ 103 (294)
T PLN00009 27 NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPD--FAKNPRL 103 (294)
T ss_pred CcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCC--CCcCHHH
Confidence 6789999886432 2334678899999999999999999999999999999999995 689888865432 2467888
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCceeeccceecccccCccccccC-
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS- 157 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 157 (290)
+..++.||+.||.|||+++ ++||||+|+||+++. ++.+||+|||++....... .......++..|+|||++.+.
T Consensus 104 ~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~ 179 (294)
T PLN00009 104 IKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSR 179 (294)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc-cccccCceeecccCHHHHhCCC
Confidence 8899999999999999999 999999999999985 5679999999976433221 112234567889999988664
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--h------------------------hh----hhHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--S------------------------KE----AEKEEVIT 207 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~------------------------~~----~~~~~~~~ 207 (290)
.++.++|+||||+++|+|++|.+++.............. . .. .....+..
T Consensus 180 ~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (294)
T PLN00009 180 HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPA 259 (294)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChH
Confidence 478899999999999999999988754322211111000 0 00 01123456
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 208 FAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 208 ~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.+++.+||+.||++||++.+++++-
T Consensus 260 ~~~~i~~~l~~~P~~Rps~~~~l~~~ 285 (294)
T PLN00009 260 GVDLLSKMLRLDPSKRITARAALEHE 285 (294)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCc
Confidence 88999999999999999999999764
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=259.04 Aligned_cols=224 Identities=23% Similarity=0.279 Sum_probs=178.1
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.+|+|++.. ......+++.+|+++++.++|+|++++.+++......++||||+. |++.+++..... .+++.
T Consensus 40 ~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~l~~~ 115 (308)
T cd06634 40 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEV 115 (308)
T ss_pred CcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCC---CCCHH
Confidence 46789998863 223345678899999999999999999999999999999999995 688888765432 57889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR--- 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--- 155 (290)
.+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..... .....++..|+|||++.
T Consensus 116 ~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~ 187 (308)
T cd06634 116 EIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVILAMD 187 (308)
T ss_pred HHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-----cccccCCccccCHHHHhhcc
Confidence 99999999999999999998 99999999999999999999999998754321 12345778899999975
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
...++.++|||||||++|+|++|..|+.......... .... .......+..+.++|.+||+.+|++||++.+++.
T Consensus 188 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 3457889999999999999999998875432221111 1111 1112245667899999999999999999999998
Q ss_pred HHHhhHh
Q 044846 232 ELAGIRA 238 (290)
Q Consensus 232 ~l~~~~~ 238 (290)
+.+....
T Consensus 267 ~~~~~~~ 273 (308)
T cd06634 267 HRFVLRE 273 (308)
T ss_pred Ccccccc
Confidence 8766554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=252.21 Aligned_cols=224 Identities=21% Similarity=0.228 Sum_probs=177.4
Q ss_pred CceEEEEeeccc-----CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSV-----HESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|.+... .......+.+|+++++.++||||+++++++... +.+++++||+++++|.+++.... .
T Consensus 27 ~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~ 102 (264)
T cd06653 27 GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG----A 102 (264)
T ss_pred CCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC----C
Confidence 567999987421 234456889999999999999999999998764 45789999999999999997654 4
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC--ceeeccceecccccCcc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR--THLTTQVKVTFGYVDPK 152 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~g~~~y~aPE 152 (290)
+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++...... ........++..|+|||
T Consensus 103 l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (264)
T cd06653 103 LTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179 (264)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHh
Confidence 788889999999999999999999 9999999999999999999999999986532211 11112355788899999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
++.+..++.++|+|||||++|++++|.+|+............... ...+...+..+.+++.+||+ +|..||++.++
T Consensus 180 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~ 258 (264)
T cd06653 180 VISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFL 258 (264)
T ss_pred hhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHH
Confidence 999888999999999999999999999988644322222211111 12234456779999999999 57999999998
Q ss_pred HHHH
Q 044846 230 TLEL 233 (290)
Q Consensus 230 ~~~l 233 (290)
+.|.
T Consensus 259 ~~~~ 262 (264)
T cd06653 259 LRHP 262 (264)
T ss_pred hcCC
Confidence 8653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=258.21 Aligned_cols=227 Identities=21% Similarity=0.219 Sum_probs=174.8
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhc-CCCCCCCCHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ-TDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~ 78 (290)
|+.||+|++... .......+.+|+.++.++. ||||+++++++...+..+++|||+. +++.++.... ......+++.
T Consensus 29 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~ 107 (288)
T cd06616 29 GTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEE 107 (288)
T ss_pred CCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHH
Confidence 578999998643 2345667899999999995 9999999999999999999999995 5666654321 1111258899
Q ss_pred HHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 79 MRLRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
.+..++.+++.||+|||+. + ++||||||+||+++.++.++|+|||++...... .......|+..|+|||++.+.
T Consensus 108 ~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 108 ILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPERIDPS 182 (288)
T ss_pred HHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccC--CccccccCccCccCHHHhccc
Confidence 9999999999999999975 7 999999999999999999999999997643221 112234578889999998876
Q ss_pred ---CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-------hhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 158 ---QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-------EAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 158 ---~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
.++.++||||||+++|++++|+.|+................ ......+..+.+|+.+||+.||++|||+.
T Consensus 183 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 262 (288)
T cd06616 183 ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK 262 (288)
T ss_pred cccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence 68899999999999999999999875432211111111111 11123566799999999999999999999
Q ss_pred HHHHHHH
Q 044846 228 EVTLELA 234 (290)
Q Consensus 228 el~~~l~ 234 (290)
+++.+-.
T Consensus 263 ~i~~~~~ 269 (288)
T cd06616 263 ELLEHPF 269 (288)
T ss_pred HHhcChh
Confidence 9998744
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=281.15 Aligned_cols=232 Identities=21% Similarity=0.318 Sum_probs=188.6
Q ss_pred ceEEEEeecc-cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcC---CC------
Q 044846 3 ELWLLKKSKS-VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT---DD------ 71 (290)
Q Consensus 3 ~~~avK~~~~-~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~------ 71 (290)
..||||..+. ....+.+.+..|+++|+.+ .||||+.++|+|..++..++|+||+..|+|.++++..+ .-
T Consensus 329 ~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~ 408 (609)
T KOG0200|consen 329 VTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVF 408 (609)
T ss_pred EEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCC
Confidence 4689999974 3446788999999999999 79999999999999999999999999999999998876 00
Q ss_pred -C--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccce--ecc
Q 044846 72 -Q--LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVK--VTF 146 (290)
Q Consensus 72 -~--~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~--g~~ 146 (290)
. ..++....+.++.|||.|++||++.. +|||||..+|||+..+..+||+|||+++.............. .+.
T Consensus 409 ~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~ 485 (609)
T KOG0200|consen 409 PNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPV 485 (609)
T ss_pred ccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccce
Confidence 0 13888899999999999999999998 999999999999999999999999998754332222211111 356
Q ss_pred cccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh----hhhhhHHHHHHHHHHHHHhhccCCCC
Q 044846 147 GYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF----SKEAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 147 ~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
.|||||.+....|+.++||||||++|||+.+....+.........+..+. +...+..+..++.++|+.||+.+|++
T Consensus 486 kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~ 565 (609)
T KOG0200|consen 486 KWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPED 565 (609)
T ss_pred eecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCccc
Confidence 79999999999999999999999999999865555544432122222222 23456677889999999999999999
Q ss_pred CCCHHHHHHHHHhhH
Q 044846 223 QPTMKEVTLELAGIR 237 (290)
Q Consensus 223 Rps~~el~~~l~~~~ 237 (290)
||++.++.+.++...
T Consensus 566 RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 566 RPTFSECVEFFEKHL 580 (609)
T ss_pred CCCHHHHHHHHHHHH
Confidence 999999999998853
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=294.50 Aligned_cols=221 Identities=21% Similarity=0.382 Sum_probs=173.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+++...... ..|++.+++++|||||+++++|...+..++||||+++|+|.++++ .+++..+.
T Consensus 715 ~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~ 783 (968)
T PLN00113 715 GMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRR 783 (968)
T ss_pred CcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHH
Confidence 5679999887533221 356889999999999999999999999999999999999999996 37889999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||+|||.....+|+||||||+||+++.++..++. ||...... ......++..|+|||++.+..++.
T Consensus 784 ~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~ 857 (968)
T PLN00113 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-----TDTKCFISSAYVAPETRETKDITE 857 (968)
T ss_pred HHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----cCCCccccccccCcccccCCCCCc
Confidence 999999999999996544449999999999999998888775 55433211 112235788999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHH-------------hh------hhhhHHHHHHHHHHHHHhhccCCCC
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY-------------FS------KEAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~-------------~~------~~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
++|||||||++|||++|+.|+............+ .. .........++.+++.+||+.||++
T Consensus 858 ~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~ 937 (968)
T PLN00113 858 KSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTA 937 (968)
T ss_pred ccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchh
Confidence 9999999999999999998874322111111000 00 0112234556889999999999999
Q ss_pred CCCHHHHHHHHHhhHhh
Q 044846 223 QPTMKEVTLELAGIRAS 239 (290)
Q Consensus 223 Rps~~el~~~l~~~~~~ 239 (290)
|||++|+++.|+.+...
T Consensus 938 RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 938 RPCANDVLKTLESASRS 954 (968)
T ss_pred CcCHHHHHHHHHHhhcc
Confidence 99999999999887653
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=254.04 Aligned_cols=214 Identities=19% Similarity=0.225 Sum_probs=168.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.+|+|.......... |+.....+ +||||+++++.|...+..++||||+++|+|.+++.... .+++..+
T Consensus 41 ~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~ 111 (267)
T PHA03390 41 QKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEV 111 (267)
T ss_pred CcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHH
Confidence 46688888764322211 33333333 79999999999999999999999999999999998654 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-cEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|||++...... ....++..|+|||++.+..+
T Consensus 112 ~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 183 (267)
T PHA03390 112 KKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNY 183 (267)
T ss_pred HHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcCCCC
Confidence 999999999999999999 99999999999999988 9999999987644321 22457889999999998889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhh---hhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENR---SLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQPT-MKEVTLE 232 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps-~~el~~~ 232 (290)
+.++|+||||+++|+|++|..|+........ .+...... ......+..+.++|.+||+.||.+||+ +++++++
T Consensus 184 ~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 184 DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 9999999999999999999988863322211 11111111 122246678999999999999999996 6999865
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=250.26 Aligned_cols=223 Identities=21% Similarity=0.250 Sum_probs=181.9
Q ss_pred CceEEEEeecccCc--hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHE--SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.|++|....... ...+.+.+|++++++++|||++++++++...+..+++|||+++++|.+++.... .+++..
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~~ 100 (254)
T cd06627 25 GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG----PFPESL 100 (254)
T ss_pred CcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc----CCCHHH
Confidence 56799999876544 567789999999999999999999999999999999999999999999998653 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......... .....++..|+|||...+..+
T Consensus 101 ~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~ 176 (254)
T cd06627 101 VAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGA 176 (254)
T ss_pred HHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-ccccccchhhcCHhhhcCCCC
Confidence 9999999999999999999 999999999999999999999999987654432221 233567888999999988888
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH--hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY--FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+.++|+||+|++++++++|..|+............. .....+...+..+.+++.+||..+|++|||+.+++.+
T Consensus 177 ~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 899999999999999999998775433221111111 0111222345678999999999999999999999753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=263.35 Aligned_cols=221 Identities=19% Similarity=0.249 Sum_probs=172.3
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||+|++.. .+......+.+|+.+++.++||||++++++|.... ..|+||||+. ++|.+.+..
T Consensus 41 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------ 113 (353)
T cd07850 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------ 113 (353)
T ss_pred CCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh------
Confidence 67899998864 23445567889999999999999999999986543 4699999994 589888763
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..... ........++..|+|||+
T Consensus 114 ~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~ 188 (353)
T cd07850 114 DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 188 (353)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCC--CCCCCCCcccccccCHHH
Confidence 2778888999999999999999999 99999999999999999999999999764322 112233457888999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hh-------------------HHHhhh--------------
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SL-------------------AAYFSK-------------- 198 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~-------------------~~~~~~-------------- 198 (290)
+.+..++.++|||||||++|+|++|+.+|........ .. ......
T Consensus 189 ~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (353)
T cd07850 189 ILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFP 268 (353)
T ss_pred HhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCc
Confidence 9999999999999999999999999987753321100 00 000000
Q ss_pred ---------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 199 ---------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 199 ---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
......+..+.++|.+||+.||++|||+.|++.+-+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 269 DVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred ccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 000122445789999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=257.57 Aligned_cols=224 Identities=21% Similarity=0.261 Sum_probs=169.5
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc--------ceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEV--------PLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~--------~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||+|++.... ......+.+|++++++++||||+++++++...+. .++||||+. ++|.+++.....
T Consensus 37 ~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~- 114 (310)
T cd07865 37 KQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV- 114 (310)
T ss_pred CcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhccc-
Confidence 5789999886432 2234456789999999999999999999876543 499999995 589888865432
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc---eeeccceecccc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT---HLTTQVKVTFGY 148 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y 148 (290)
.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........ .......++..|
T Consensus 115 --~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y 189 (310)
T cd07865 115 --KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189 (310)
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccc
Confidence 5889999999999999999999999 99999999999999999999999998765432221 112234567889
Q ss_pred cCccccccCC-CCCcccchhhHHHHHHHhcCCCCcccchhhhhh-hHHHhh-----------------------hhh---
Q 044846 149 VDPKYFRSSQ-FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS-LAAYFS-----------------------KEA--- 200 (290)
Q Consensus 149 ~aPE~~~~~~-~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~-~~~~~~-----------------------~~~--- 200 (290)
+|||++.+.. ++.++|+||||+++|+|++|.+++......... ...... ...
T Consensus 190 ~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (310)
T cd07865 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRK 269 (310)
T ss_pred cCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchh
Confidence 9999887654 688999999999999999999877543221100 000000 000
Q ss_pred ------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 201 ------EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 201 ------~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.......+.++|.+||..||.+|||+++++++
T Consensus 270 ~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 270 VKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00113457799999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=264.62 Aligned_cols=227 Identities=18% Similarity=0.240 Sum_probs=175.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|++... .....+.+.+|+.+++.++||||+++++++.. ....++||||+. |+|.+++.... .+
T Consensus 30 ~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~ 104 (334)
T cd07855 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ----PL 104 (334)
T ss_pred CCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC----CC
Confidence 678999998643 23446678899999999999999999998864 346799999994 69999987543 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc---eeeccceecccccCcc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT---HLTTQVKVTFGYVDPK 152 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE 152 (290)
++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ .......++..|+|||
T Consensus 105 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 181 (334)
T cd07855 105 TEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181 (334)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChH
Confidence 99999999999999999999999 99999999999999999999999999765432211 1112346788899999
Q ss_pred cccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHH--------------------Hh---hh-------h
Q 044846 153 YFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAA--------------------YF---SK-------E 199 (290)
Q Consensus 153 ~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~--------------------~~---~~-------~ 199 (290)
.+.+ ..++.++||||||+++|+|++|.++|......... ... .. .. .
T Consensus 182 ~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (334)
T cd07855 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSK 261 (334)
T ss_pred HhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHH
Confidence 9865 45888999999999999999999988543211100 000 00 00 0
Q ss_pred hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 200 AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 200 ~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.....+..+.++|.+||+.||++|||+.+++.+.+.-
T Consensus 262 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 262 IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 0012356789999999999999999999999886544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=256.85 Aligned_cols=224 Identities=21% Similarity=0.212 Sum_probs=175.7
Q ss_pred CceEEEEeecccC----chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVH----ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||+|.++... ....+.+.+|+++++.+ +|+||+++++++..++..++||||+++++|.+++.... .++
T Consensus 28 g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~ 103 (290)
T cd05613 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE----RFK 103 (290)
T ss_pred CceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC----CCC
Confidence 5678999886422 23346788899999999 69999999999999999999999999999999998654 578
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...............|+..|+|||.+.+
T Consensus 104 ~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (290)
T cd05613 104 EQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccC
Confidence 8899999999999999999999 9999999999999999999999999876543222222234557888999999875
Q ss_pred C--CCCCcccchhhHHHHHHHhcCCCCcccchh--hhhhhHH-Hhh--hhhhHHHHHHHHHHHHHhhccCCCCCC-----
Q 044846 157 S--QFTEKSDVYSFSVVLVELNWTKPIHLVDVE--ENRSLAA-YFS--KEAEKEEVITFAMVAKRCLNLNGKKQP----- 224 (290)
Q Consensus 157 ~--~~~~~~DiwS~G~il~~l~~~~~~~~~~~~--~~~~~~~-~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp----- 224 (290)
. .++.++||||||+++|++++|..|+..... ....... ... ...+...+..+.+++.+||+.||++||
T Consensus 181 ~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~ 260 (290)
T cd05613 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPS 260 (290)
T ss_pred CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence 3 467899999999999999999988753211 1111111 111 112223456788999999999999997
Q ss_pred CHHHHHHH
Q 044846 225 TMKEVTLE 232 (290)
Q Consensus 225 s~~el~~~ 232 (290)
++.+++.+
T Consensus 261 ~~~~l~~~ 268 (290)
T cd05613 261 DADEIKKH 268 (290)
T ss_pred CHHHHHcC
Confidence 67777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=268.69 Aligned_cols=222 Identities=21% Similarity=0.242 Sum_probs=185.5
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|..||+|.++. .+....+.+.+|+++|..|+|||||+++.+......+|+||||+.+|.+++++.... ++.+..
T Consensus 81 ~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g----r~~e~~ 156 (596)
T KOG0586|consen 81 GTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG----RMKEKE 156 (596)
T ss_pred CceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc----cchhhh
Confidence 56799999864 334445679999999999999999999999999999999999999999999999876 466688
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+..++.|+..+++|||+++ |+|||||.+|+|++.++++||+|||++.... ......+..|++.|.|||++.+..|
T Consensus 157 ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~~lqt~cgsppyAaPEl~~g~~y 231 (596)
T KOG0586|consen 157 ARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD--YGLMLQTFCGSPPYAAPELFNGKKY 231 (596)
T ss_pred hhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec--ccccccccCCCCCccChHhhcCccc
Confidence 8899999999999999999 9999999999999999999999999976554 3455677889999999999999887
Q ss_pred C-CcccchhhHHHHHHHhcCCCCcccchhh---hhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 160 T-EKSDVYSFSVVLVELNWTKPIHLVDVEE---NRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 160 ~-~~~DiwS~G~il~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
. +.+|+||+|+++|-|+.|.-||....-. ...+...+ ..+...+.++.++|+++|..+|.+|++.+++..+-+
T Consensus 232 ~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 232 DGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred CCcceehhhhhhhheeeeecccccCCcccccccchheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 5 4799999999999999999888533211 11111111 122335667999999999999999999999987643
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=254.10 Aligned_cols=224 Identities=14% Similarity=0.136 Sum_probs=172.2
Q ss_pred CceEEEEeecccC---chhHHHHHHHHH---HHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVV---ILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~---~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|.+.... ......+..|.. .++..+||||+++++.+...+..++||||++||+|..++.... .+
T Consensus 19 ~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~----~l 94 (278)
T cd05606 19 GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VF 94 (278)
T ss_pred CCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC----CC
Confidence 5789999875422 122223444444 3444589999999999999999999999999999999887543 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ......|+..|+|||++.
T Consensus 95 ~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~ 168 (278)
T cd05606 95 SEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQ 168 (278)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCcCcCCCcCCcCcHHhc
Confidence 99999999999999999999999 999999999999999999999999987643221 122346788999999987
Q ss_pred cC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhh-hH-HH--hhhhhhHHHHHHHHHHHHHhhccCCCCCC-----C
Q 044846 156 SS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS-LA-AY--FSKEAEKEEVITFAMVAKRCLNLNGKKQP-----T 225 (290)
Q Consensus 156 ~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~-~~-~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s 225 (290)
++ .++.++|+||+|+++|+|++|..|+......... .. .. .....+...+..+.+++.+||..||.+|| +
T Consensus 169 ~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~ 248 (278)
T cd05606 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 248 (278)
T ss_pred CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCC
Confidence 54 6889999999999999999999887543211111 11 00 01112223467899999999999999999 9
Q ss_pred HHHHHHHHHh
Q 044846 226 MKEVTLELAG 235 (290)
Q Consensus 226 ~~el~~~l~~ 235 (290)
+.+++++.+.
T Consensus 249 ~~~ll~~~~~ 258 (278)
T cd05606 249 AQEVKEHPFF 258 (278)
T ss_pred HHHHHhCccc
Confidence 9999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=252.53 Aligned_cols=206 Identities=19% Similarity=0.173 Sum_probs=163.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+++... .+.+|...+....||||+++++++...+..+++|||+++|+|.+++.... .+++..+.
T Consensus 18 ~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~ 88 (237)
T cd05576 18 QQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL----NIPEECVK 88 (237)
T ss_pred CcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc----CCCHHHHH
Confidence 6789999987532 23345555666689999999999999999999999999999999997654 48899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.++++|||.+...... .....++..|+|||.+.+..++.
T Consensus 89 ~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~ 161 (237)
T cd05576 89 RWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGISEETE 161 (237)
T ss_pred HHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcccCCCCCCc
Confidence 99999999999999999 999999999999999999999999976443211 12234566799999998888999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
++|+||+|+++|++++|.+++........ .......+...+..+++++.+||+.||++||++
T Consensus 162 ~~DvwslG~il~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 162 ACDWWSLGAILFELLTGKTLVECHPSGIN---THTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred hhhHHHHHHHHHHHHHCcchhhcCchhcc---cccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 99999999999999999876542211100 000111122345678999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=257.04 Aligned_cols=221 Identities=25% Similarity=0.303 Sum_probs=175.3
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++... .....+.+.+|+++++.++|||++++++++...+..|+||||+. |++.+++..... ++++.
T Consensus 46 ~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~l~~~ 121 (313)
T cd06633 46 NEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK---PLQEV 121 (313)
T ss_pred CcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCC---CCCHH
Confidence 567999988642 23345678899999999999999999999999999999999995 688888865432 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR--- 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--- 155 (290)
.+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.... ......++..|+|||++.
T Consensus 122 ~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~~~~~~~~~~y~aPE~~~~~~ 193 (313)
T cd06633 122 EIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMAPEVILAMD 193 (313)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC-----CCCCccccccccChhhccccC
Confidence 99999999999999999999 9999999999999999999999999865321 123456788899999974
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
...++.++|+||||+++|+|++|.+|+.............. ........+..+.+++.+||+.+|.+||++.+++.+
T Consensus 194 ~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 194 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 45678899999999999999999988764432211111110 111122344568999999999999999999999977
Q ss_pred HH
Q 044846 233 LA 234 (290)
Q Consensus 233 l~ 234 (290)
-.
T Consensus 274 ~~ 275 (313)
T cd06633 274 DF 275 (313)
T ss_pred cc
Confidence 43
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=253.94 Aligned_cols=223 Identities=21% Similarity=0.275 Sum_probs=176.9
Q ss_pred CceEEEEeecccCc--hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHE--SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.+++|+++.... .....+.+|+++++.++|+||+++++++..++..++|+||++ ++|..++..... .+++..
T Consensus 24 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~~---~~~~~~ 99 (283)
T cd05118 24 GEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQR---GLPESL 99 (283)
T ss_pred CcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhcc---cCCHHH
Confidence 56789998865332 345678899999999999999999999999999999999996 599988876432 588999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-C
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-Q 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 158 (290)
+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .
T Consensus 100 ~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~ 175 (283)
T cd05118 100 IKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKG 175 (283)
T ss_pred HHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCC
Confidence 9999999999999999999 9999999999999999999999999876543322 122234567789999998876 7
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHH--Hh------------h-----------------hhhhHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA--YF------------S-----------------KEAEKEEVIT 207 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~--~~------------~-----------------~~~~~~~~~~ 207 (290)
++.++|+||||+++|++++|.+++............ .. . .......+..
T Consensus 176 ~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (283)
T cd05118 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQ 255 (283)
T ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHH
Confidence 889999999999999999999877543221110000 00 0 0011234567
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 208 FAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 208 ~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+.++|.+||+.||.+||++.+++.+
T Consensus 256 ~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 256 ALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HHHHHHHHhccCcccCcCHHHHhhC
Confidence 8999999999999999999999865
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=262.43 Aligned_cols=224 Identities=22% Similarity=0.278 Sum_probs=178.3
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----cceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETE-----VPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|++.... ....+.+.+|+.+++.++||||+++.+++.... ..|++|||+. ++|.+++.... .
T Consensus 25 ~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~ 99 (330)
T cd07834 25 GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ----P 99 (330)
T ss_pred CcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC----C
Confidence 5789999987533 445678999999999999999999999998765 7899999996 58999987644 6
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc--eeeccceecccccCcc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYVDPK 152 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE 152 (290)
+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........ .......++..|+|||
T Consensus 100 l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 176 (330)
T cd07834 100 LTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCce
Confidence 899999999999999999999999 99999999999999999999999999875443321 1223345788899999
Q ss_pred ccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhh------------------------------hh
Q 044846 153 YFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFS------------------------------KE 199 (290)
Q Consensus 153 ~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~------------------------------~~ 199 (290)
++.+. .++.++|+||||+++|+|++|.++|......... ...... ..
T Consensus 177 ~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
T cd07834 177 LLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSK 256 (330)
T ss_pred eeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHH
Confidence 99887 7889999999999999999999988544321110 000000 00
Q ss_pred hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 200 AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 200 ~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.....+..+.++|.+||+.||++|||+.+++.+.
T Consensus 257 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 257 LFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 0011345688999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=254.44 Aligned_cols=235 Identities=20% Similarity=0.253 Sum_probs=180.3
Q ss_pred ceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCcceEEEEeCCCCCHHHHHhhcCCCC-CCCCHH
Q 044846 3 ELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYIHEQTDDQ-LPITWE 78 (290)
Q Consensus 3 ~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~ 78 (290)
..+|+|+++..+ ........+|+.+++.|+||||+.+..+|.. +..+|+++||.+. +|...|+-.+... ..++..
T Consensus 54 k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~ 132 (438)
T KOG0666|consen 54 KEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRS 132 (438)
T ss_pred hhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHH
Confidence 367888887532 2234567899999999999999999999987 7789999999965 9999997654321 246778
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC----CcEEEeccccccccccCCcee--eccceecccccCcc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK----YQAKISDFRTFKSRAIDRTHL--TTQVKVTFGYVDPK 152 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~----~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE 152 (290)
..+.++.||+.|+.|||++- |+||||||.|||+..+ |.+||+|||+++....--... ...++.|++|.|||
T Consensus 133 mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE 209 (438)
T KOG0666|consen 133 MVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE 209 (438)
T ss_pred HHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence 88999999999999999999 9999999999999887 999999999988654332222 24577899999999
Q ss_pred ccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhh--------hhHHHhh------------------------h-
Q 044846 153 YFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--------SLAAYFS------------------------K- 198 (290)
Q Consensus 153 ~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--------~~~~~~~------------------------~- 198 (290)
.+.+. .|+.+.||||.|||+.||++..|.|....+... .+...+. .
T Consensus 210 LLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f 289 (438)
T KOG0666|consen 210 LLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDF 289 (438)
T ss_pred HhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHh
Confidence 99876 489999999999999999999988764322100 0000000 0
Q ss_pred --hhhHH------------HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhhC
Q 044846 199 --EAEKE------------EVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRASIG 241 (290)
Q Consensus 199 --~~~~~------------~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~~~ 241 (290)
....+ -++...+|+.++|+.||.+|.|+.+.+++.......+.
T Consensus 290 ~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 290 RRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred HHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 00000 12236789999999999999999999999876665443
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=261.00 Aligned_cols=226 Identities=20% Similarity=0.226 Sum_probs=174.7
Q ss_pred CceEEEEeecccCchh--------------HHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhh
Q 044846 2 EELWLLKKSKSVHESN--------------VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHE 67 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~--------------~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 67 (290)
|+.||+|+++...... ...+.+|+++++.++||||+++++++...+..++||||+. |+|.+++..
T Consensus 34 ~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~ 112 (335)
T PTZ00024 34 GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR 112 (335)
T ss_pred CCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh
Confidence 5789999986432221 1257899999999999999999999999999999999995 699999876
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC------------
Q 044846 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR------------ 135 (290)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~------------ 135 (290)
.. .+++.....++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 113 ~~----~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 185 (335)
T PTZ00024 113 KI----RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185 (335)
T ss_pred cC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeeccccccccccccccccc
Confidence 43 5888999999999999999999999 9999999999999999999999999876433100
Q ss_pred -ceeeccceecccccCccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhhh-------------
Q 044846 136 -THLTTQVKVTFGYVDPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFSK------------- 198 (290)
Q Consensus 136 -~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~~------------- 198 (290)
........++..|+|||++.+. .++.++|+|||||++|+|++|.+++......... .......
T Consensus 186 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 265 (335)
T PTZ00024 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLP 265 (335)
T ss_pred ccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcc
Confidence 1111223457789999998764 4688999999999999999999887644322110 0000000
Q ss_pred --------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 199 --------------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 199 --------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
......+..+.+++.+||+.||++|||++|++.+.+-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 266 LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred cccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 0001224568899999999999999999999977554
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=262.44 Aligned_cols=224 Identities=18% Similarity=0.149 Sum_probs=185.5
Q ss_pred CceEEEEeec---ccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSK---SVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~---~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|++||.|++. ..........++|.++|.+++.+.||.+--.|.+.+.+|+||..|.||+|.-+|.+.++. .|++.
T Consensus 210 GKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~--gF~e~ 287 (591)
T KOG0986|consen 210 GKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNP--GFDEQ 287 (591)
T ss_pred hhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCC--CCchH
Confidence 5667777763 223444556789999999999999999999999999999999999999999999887754 69999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.+|+.||++||..+ |+.|||||+|||+|++|+++|+|+|+|..... .......+||.+|||||++.+..
T Consensus 288 ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~--g~~~~~rvGT~GYMAPEvl~ne~ 362 (591)
T KOG0986|consen 288 RARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE--GKPIRGRVGTVGYMAPEVLQNEV 362 (591)
T ss_pred HHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC--CCccccccCcccccCHHHHcCCc
Confidence 99999999999999999999 99999999999999999999999999865442 23344568999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhh--hhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPT-----MKE 228 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~e 228 (290)
|+...|.||+||++|||+.|..||....+. .+.+... .....+...+++.++|....|+.||.+|.. +++
T Consensus 363 Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~e 442 (591)
T KOG0986|consen 363 YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQE 442 (591)
T ss_pred ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcch
Confidence 999999999999999999999998643221 1112221 123355677888999999999999999974 567
Q ss_pred HHHH
Q 044846 229 VTLE 232 (290)
Q Consensus 229 l~~~ 232 (290)
+.+|
T Consensus 443 vk~H 446 (591)
T KOG0986|consen 443 VKEH 446 (591)
T ss_pred hhhC
Confidence 7666
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=256.38 Aligned_cols=225 Identities=19% Similarity=0.181 Sum_probs=175.7
Q ss_pred CceEEEEeecccC----chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVH----ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
++.||+|.++... ....+.+.+|++++.++ +||||+++++.+......++||||+++|+|.+++.... .++
T Consensus 28 ~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~ 103 (288)
T cd05583 28 GKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE----HFT 103 (288)
T ss_pred CcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC----CcC
Confidence 4568899886421 23355688999999999 69999999999999999999999999999999987643 588
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...............++..|+|||.+.+
T Consensus 104 ~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (288)
T cd05583 104 ESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcC
Confidence 8899999999999999999998 9999999999999999999999999876543332222333457889999999876
Q ss_pred CC--CCCcccchhhHHHHHHHhcCCCCcccchhh--hhhhHH-Hhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 157 SQ--FTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSLAA-YFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 157 ~~--~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~~~-~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
.. .+.++|+||||+++|+|++|..|+...... ...... ... ...+...+..+.+++.+||+.||++|||+.++
T Consensus 181 ~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~ 260 (288)
T cd05583 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGA 260 (288)
T ss_pred CCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchH
Confidence 55 678999999999999999999887432111 111111 111 11222345678999999999999999997766
Q ss_pred HHHH
Q 044846 230 TLEL 233 (290)
Q Consensus 230 ~~~l 233 (290)
.+.|
T Consensus 261 ~~~l 264 (288)
T cd05583 261 DEIK 264 (288)
T ss_pred HHHh
Confidence 5444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=256.17 Aligned_cols=222 Identities=19% Similarity=0.264 Sum_probs=177.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC-C-C----ceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN-H-R----NVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-H-p----niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
++.||||+++.+.+- ++..+-|+++|++|. + | -+|.+.++|...++.|||+|.+ |-+++++++++... ++
T Consensus 114 ~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~--~f 189 (415)
T KOG0671|consen 114 KEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYI--PF 189 (415)
T ss_pred CceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCcc--cc
Confidence 467999999976544 666778999999993 2 3 4788889999999999999999 77999999987654 68
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc--------------------CCcEEEeccccccccccCC
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD--------------------KYQAKISDFRTFKSRAIDR 135 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~--------------------~~~~kl~dfg~~~~~~~~~ 135 (290)
+..+++.++.|++++++|||+.+ ++|-||||+|||+.. ...++|+|||.|+.....
T Consensus 190 pi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~- 265 (415)
T KOG0671|consen 190 PIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH- 265 (415)
T ss_pred chHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-
Confidence 88999999999999999999999 999999999999953 123799999997654322
Q ss_pred ceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh-hhHHHhh-----------------
Q 044846 136 THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR-SLAAYFS----------------- 197 (290)
Q Consensus 136 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~-~~~~~~~----------------- 197 (290)
....+.|..|.|||++.+-+++.++||||+||||+|+.+|...|+.....+. .......
T Consensus 266 ---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf 342 (415)
T KOG0671|consen 266 ---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYF 342 (415)
T ss_pred ---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhh
Confidence 2557789999999999999999999999999999999999988875432111 0000000
Q ss_pred -----------------------------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 198 -----------------------------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 198 -----------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
..........+.+|+++||..||.+|+|+.|++.|..
T Consensus 343 ~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 343 RRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPF 408 (415)
T ss_pred hcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHH
Confidence 0011123446899999999999999999999998754
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=248.19 Aligned_cols=225 Identities=25% Similarity=0.296 Sum_probs=184.0
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.|++|+..... ....+.+.+|+..+++++||||+++++.+... +..++++||+++++|.+++.... .+++
T Consensus 25 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~ 100 (260)
T cd06606 25 GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG----KLPE 100 (260)
T ss_pred CcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC----CCCH
Confidence 5679999887544 35678899999999999999999999999988 88999999999999999998754 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCcccccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~ 156 (290)
..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......... ......++..|++||.+.+
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 177 (260)
T cd06606 101 PVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcC
Confidence 999999999999999999998 999999999999999999999999987654433221 1233567788999999988
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh----hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF----SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
..++.++|+||||++++++++|..|+.............. ....+...+..+.+++.+||+.||++||++.+++.+
T Consensus 178 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 8899999999999999999999988754432211111111 111223346789999999999999999999999876
Q ss_pred H
Q 044846 233 L 233 (290)
Q Consensus 233 l 233 (290)
.
T Consensus 258 ~ 258 (260)
T cd06606 258 P 258 (260)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=262.32 Aligned_cols=223 Identities=22% Similarity=0.291 Sum_probs=171.5
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----CcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLET-----EVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|+++.. .......+.+|+.+++.++||||+++++++... ...++++||+. ++|.+++... .+
T Consensus 30 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~l 103 (336)
T cd07849 30 GVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQ-----HL 103 (336)
T ss_pred CCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhcC-----CC
Confidence 678999998643 233456788999999999999999999887654 35799999995 5898887643 48
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce--eeccceecccccCccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--LTTQVKVTFGYVDPKY 153 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~ 153 (290)
++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ......|+..|+|||.
T Consensus 104 ~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 180 (336)
T cd07849 104 SNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180 (336)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHH
Confidence 89999999999999999999999 999999999999999999999999987654322111 1223467888999998
Q ss_pred ccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHhh------------------------h---h---h
Q 044846 154 FRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYFS------------------------K---E---A 200 (290)
Q Consensus 154 ~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~~------------------------~---~---~ 200 (290)
+.+ ..++.++||||||+++|+|++|++++........ ....... . . .
T Consensus 181 ~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (336)
T cd07849 181 MLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKL 260 (336)
T ss_pred hhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHH
Confidence 754 4688899999999999999999988753321100 0000000 0 0 0
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
....+..+.+++.+||+.||++|||+.|++++-
T Consensus 261 ~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 261 FPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred hcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 012245688999999999999999999999883
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=261.75 Aligned_cols=223 Identities=22% Similarity=0.294 Sum_probs=173.7
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----CcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLET-----EVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|+++.. .......+.+|+.+++.++||||+++++++... ...++|+||+ +++|.+++.... .
T Consensus 30 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~ 104 (337)
T cd07858 30 NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQ----T 104 (337)
T ss_pred CCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcCC----C
Confidence 678999998642 333456778999999999999999999988654 3479999999 479999987644 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....... .......++..|+|||.+
T Consensus 105 l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 180 (337)
T cd07858 105 LSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELL 180 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHH
Confidence 899999999999999999999999 9999999999999999999999999976543221 222334578889999988
Q ss_pred cc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--------------h--------HHHhh----------hhhh
Q 044846 155 RS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--------------L--------AAYFS----------KEAE 201 (290)
Q Consensus 155 ~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--------------~--------~~~~~----------~~~~ 201 (290)
.. ..++.++|+|||||++|+|++|.++|......... + ..+.. ....
T Consensus 181 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (337)
T cd07858 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLF 260 (337)
T ss_pred hcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHc
Confidence 65 46888999999999999999999887533211000 0 00000 0001
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 202 KEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 202 ~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
...+..+.++|.+||+.||++|||+.+++.+.
T Consensus 261 ~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 261 PHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred ccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 12456688999999999999999999999883
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=259.25 Aligned_cols=223 Identities=23% Similarity=0.285 Sum_probs=172.3
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQI-NHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.+|+|++.. ........+.+|+.+++++ +||||++++++|... ...++||||+. ++|..++... .++
T Consensus 32 ~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~ 105 (337)
T cd07852 32 KEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-----ILE 105 (337)
T ss_pred CeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-----CCC
Confidence 56799998853 2344556788899999999 999999999998653 36799999996 6999988753 478
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc----eeeccceecccccCcc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT----HLTTQVKVTFGYVDPK 152 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~g~~~y~aPE 152 (290)
+..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ .......|+..|+|||
T Consensus 106 ~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 182 (337)
T cd07852 106 DVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCce
Confidence 8888999999999999999999 99999999999999999999999998875443221 1223456788999999
Q ss_pred cccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhH--HH--------------------h---h-------hh
Q 044846 153 YFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA--AY--------------------F---S-------KE 199 (290)
Q Consensus 153 ~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~--~~--------------------~---~-------~~ 199 (290)
++.+ ..++.++|+||||+++|+|++|.+++........... .. . . ..
T Consensus 183 ~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (337)
T cd07852 183 ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE 262 (337)
T ss_pred eeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhh
Confidence 8765 4578899999999999999999988753221110000 00 0 0 00
Q ss_pred hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 200 AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 200 ~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.....+..+.++|.+||+.||++|||+.+++.+-
T Consensus 263 ~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 263 LLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred hccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 0011345688999999999999999999999773
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=254.53 Aligned_cols=224 Identities=25% Similarity=0.284 Sum_probs=172.0
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----------cceEEEEeCCCCCHHHHHhhcC
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETE----------VPLLVYEFIPNGSLYQYIHEQT 69 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~----------~~~lv~e~~~~g~L~~~l~~~~ 69 (290)
|+.||+|+++... ......+.+|+++++.++||||+++++++.... ..++|+||+++ ++..++....
T Consensus 32 ~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~ 110 (302)
T cd07864 32 GELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL 110 (302)
T ss_pred CcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC
Confidence 5789999987533 233456788999999999999999999987654 78999999965 7888876542
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceeccccc
Q 044846 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYV 149 (290)
Q Consensus 70 ~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 149 (290)
..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...............++..|+
T Consensus 111 ---~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~ 184 (302)
T cd07864 111 ---VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184 (302)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCcc
Confidence 25889999999999999999999999 999999999999999999999999987654332222222334577899
Q ss_pred CccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhhh----------------------------
Q 044846 150 DPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFSK---------------------------- 198 (290)
Q Consensus 150 aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~~---------------------------- 198 (290)
|||++.+. .++.++|||||||++++|++|++++......... +......
T Consensus 185 ~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (302)
T cd07864 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRL 264 (302)
T ss_pred ChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccch
Confidence 99988653 4688999999999999999999887543221110 0000000
Q ss_pred -hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 199 -EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 199 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
......+..+.+++.+||+.||.+|||+.+++.+
T Consensus 265 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 265 REEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0001135678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=249.07 Aligned_cols=222 Identities=25% Similarity=0.331 Sum_probs=172.7
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhc---CCCceeeEEeEEEeCCc-----ceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQI---NHRNVVKILGCCLETEV-----PLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l---~Hpniv~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||+|+++... ......+.+|+.+++++ +||||+++++++...+. .+++|||+. ++|.+++......
T Consensus 24 ~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~ 102 (287)
T cd07838 24 GRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKP 102 (287)
T ss_pred CCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCC
Confidence 6789999987422 22344567788877766 59999999999988776 899999996 5899988764422
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
.+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... .......++..|+||
T Consensus 103 --~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~P 175 (287)
T cd07838 103 --GLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTSVVVTLWYRAP 175 (287)
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCC--cccccccccccccCh
Confidence 5889999999999999999999999 999999999999999999999999987654322 112233467889999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----------------------------hhhhH
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----------------------------KEAEK 202 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~ 202 (290)
|++.+..++.++|+|||||++|+|++|.+++........ ...... .....
T Consensus 176 E~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T cd07838 176 EVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ-LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVP 254 (287)
T ss_pred HHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH-HHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhh
Confidence 999988899999999999999999999887754332111 110000 00011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 203 EEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 203 ~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
..+..+.+++.+||+.||.+||++.+++.+
T Consensus 255 ~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 255 EICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 234667899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=269.43 Aligned_cols=217 Identities=18% Similarity=0.194 Sum_probs=176.5
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
+..++|++... .....+|+.++... +||||+++.+.+.+..+.|+|||.+.||.+.+.+..... +. ..+.
T Consensus 348 ~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~----~~-~e~~ 418 (612)
T KOG0603|consen 348 QEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE----FC-SEAS 418 (612)
T ss_pred cchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch----hH-HHHH
Confidence 34566666543 12234677777766 899999999999999999999999999988888876542 33 6777
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe-ccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILL-VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
.|+++|+.++.|||++| ++||||||+|||+ +..++++|+|||.++..... ..+..-|..|.|||++....|+
T Consensus 419 ~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt 491 (612)
T KOG0603|consen 419 QWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYT 491 (612)
T ss_pred HHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCC
Confidence 89999999999999999 9999999999999 58999999999997654433 2233456789999999999999
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+++|+||||++||+|++|..++......................+...++|+.+||+.||.+||++.++..+-+.
T Consensus 492 ~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 492 EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 999999999999999999999876554433333333344446677889999999999999999999999988776
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=281.09 Aligned_cols=224 Identities=19% Similarity=0.242 Sum_probs=187.9
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
+++||+|++.. .+..+..-|+.|-.+|..-+.+-|+.+.-.|.+.+++|+|||||+||+|..++.... ++++.
T Consensus 100 ~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~ 175 (1317)
T KOG0612|consen 100 EKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD----RLPED 175 (1317)
T ss_pred ccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC----CChHH
Confidence 67888888864 455566778899999999899999999999999999999999999999999998765 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc--
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-- 156 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 156 (290)
.+++|+.+|+.||.-||+.| +|||||||+|||+|.+|++||+|||.|-....+..-.....+|||-|.+||++..
T Consensus 176 ~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~ 252 (1317)
T KOG0612|consen 176 WARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQG 252 (1317)
T ss_pred HHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhc
Confidence 99999999999999999999 9999999999999999999999999987666555556677899999999999863
Q ss_pred ---CCCCCcccchhhHHHHHHHhcCCCCcccchh--hhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCC---
Q 044846 157 ---SQFTEKSDVYSFSVVLVELNWTKPIHLVDVE--ENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPT--- 225 (290)
Q Consensus 157 ---~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps--- 225 (290)
+.|+.-+|.||+||++|||+.|..||+.+.- ....+..+ +.-+.....+.+.++||.+.+ .+|+.|..
T Consensus 253 ~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrng 331 (1317)
T KOG0612|consen 253 DGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNG 331 (1317)
T ss_pred CCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhccccc
Confidence 4688999999999999999999999986532 11111111 122223446778999998866 78888988
Q ss_pred HHHHHHHH
Q 044846 226 MKEVTLEL 233 (290)
Q Consensus 226 ~~el~~~l 233 (290)
++++..|.
T Consensus 332 iedik~Hp 339 (1317)
T KOG0612|consen 332 IEDIKNHP 339 (1317)
T ss_pred HHHHHhCc
Confidence 99998775
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=252.92 Aligned_cols=223 Identities=22% Similarity=0.290 Sum_probs=180.3
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+... ......+.+.+|+++++.++ ||||+++++++...+..++|||++++++|.+++.... .+++
T Consensus 26 ~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~ 101 (280)
T cd05581 26 NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDE 101 (280)
T ss_pred CCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC----CCCH
Confidence 57789998864 22344567889999999997 9999999999999999999999999999999998754 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-------------------ee
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-------------------HL 138 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-------------------~~ 138 (290)
..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 102 ~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (280)
T cd05581 102 KCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccc
Confidence 999999999999999999999 99999999999999999999999998765432221 11
Q ss_pred eccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhh
Q 044846 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCL 216 (290)
Q Consensus 139 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl 216 (290)
.....++..|++||++....++.++|+||||++++++++|..|+...... ....... ....+...+..+.+++.+||
T Consensus 179 ~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l 257 (280)
T cd05581 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LTFQKILKLEYSFPPNFPPDAKDLIEKLL 257 (280)
T ss_pred cccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhcCCCCCCccCHHHHHHHHHHh
Confidence 22345678899999998888899999999999999999999887644321 1111111 11122334567899999999
Q ss_pred ccCCCCCCCH----HHHHHH
Q 044846 217 NLNGKKQPTM----KEVTLE 232 (290)
Q Consensus 217 ~~dp~~Rps~----~el~~~ 232 (290)
+.||.+|||+ .+++.+
T Consensus 258 ~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 258 VLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred cCCHhhCCCcccCHHHHhcC
Confidence 9999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=252.61 Aligned_cols=224 Identities=19% Similarity=0.280 Sum_probs=173.9
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|.++... ......+..|+.++..+ +||||+++++++......+++|||+ +++|.+++..... .+++..
T Consensus 40 ~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~---~l~~~~ 115 (296)
T cd06618 40 GHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQG---PIPEDI 115 (296)
T ss_pred CeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcC---CCCHHH
Confidence 6789999987533 33455677788877777 5999999999999999999999998 5588888766432 588999
Q ss_pred HHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 80 RLRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
+..++.|++.||.|||+ .+ |+||||+|+||+++.++.+||+|||++...... .......++..|+|||++.+..
T Consensus 116 ~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 190 (296)
T cd06618 116 LGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS--KAKTRSAGCAAYMAPERIDPPD 190 (296)
T ss_pred HHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC--CcccCCCCCccccCHhhcCCCC
Confidence 99999999999999997 47 999999999999999999999999987543221 1112234677899999987554
Q ss_pred ----CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhh-----hhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 159 ----FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKE-----AEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 159 ----~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
++.++|+||||+++|+|++|+.|+.........+....... .....+.++.+++.+||+.||++||++.++
T Consensus 191 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i 270 (296)
T cd06618 191 PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270 (296)
T ss_pred CccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 78899999999999999999998854322222221111111 111245678999999999999999999999
Q ss_pred HHHHH
Q 044846 230 TLELA 234 (290)
Q Consensus 230 ~~~l~ 234 (290)
+.+.+
T Consensus 271 l~~~~ 275 (296)
T cd06618 271 LQHPF 275 (296)
T ss_pred hcChh
Confidence 98765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=259.68 Aligned_cols=224 Identities=19% Similarity=0.252 Sum_probs=171.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--------------CcceEEEEeCCCCCHHHHHhh
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLET--------------EVPLLVYEFIPNGSLYQYIHE 67 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--------------~~~~lv~e~~~~g~L~~~l~~ 67 (290)
|+.||+|++...+....+.+.+|+++++.++||||+++++++... ...++||||+. ++|.+++..
T Consensus 30 ~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~ 108 (342)
T cd07854 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ 108 (342)
T ss_pred CcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc
Confidence 678999999876667778899999999999999999999776543 35789999996 699888864
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCc--eeecccee
Q 044846 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRT--HLTTQVKV 144 (290)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~--~~~~~~~g 144 (290)
. .+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++........ .......+
T Consensus 109 ~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 180 (342)
T cd07854 109 G-----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180 (342)
T ss_pred C-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccc
Confidence 3 4888999999999999999999999 999999999999984 55789999998764321111 11122346
Q ss_pred cccccCcccccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHH---------------------Hhh-----
Q 044846 145 TFGYVDPKYFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA---------------------YFS----- 197 (290)
Q Consensus 145 ~~~y~aPE~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~---------------------~~~----- 197 (290)
+..|+|||++.. ..++.++|||||||++|+|++|..||............ ...
T Consensus 181 ~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (342)
T cd07854 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGE 260 (342)
T ss_pred cccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccc
Confidence 778999998754 45788999999999999999999888543221110000 000
Q ss_pred h-----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 198 K-----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 198 ~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
. ......+.++.+++.+||+.||++|||+.+++.+-+
T Consensus 261 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~ 302 (342)
T cd07854 261 PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302 (342)
T ss_pred cCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence 0 000123456889999999999999999999997743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=252.60 Aligned_cols=229 Identities=22% Similarity=0.280 Sum_probs=177.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc--CCCceeeEEeEEEeCC----cceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI--NHRNVVKILGCCLETE----VPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l--~Hpniv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||++...++ +.|.+|.++++++ +|+||+.|++.-..++ ++|||++|-+.|+|++||.++ .+
T Consensus 234 Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-----tv 305 (513)
T KOG2052|consen 234 GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN-----TV 305 (513)
T ss_pred CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc-----cC
Confidence 78899999976444 4688999999974 9999999998877654 679999999999999999875 48
Q ss_pred CHHHHHHHHHHHHHHHHHHhh-----CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee---eccceeccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHS-----VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL---TTQVKVTFG 147 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~-----~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~g~~~ 147 (290)
+.+..++++..+|.||++||. +|.+.|.|||||..||||..++.+-|+|+|+|.......... .+..+||.+
T Consensus 306 ~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKR 385 (513)
T KOG2052|consen 306 TTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKR 385 (513)
T ss_pred CHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceee
Confidence 999999999999999999993 456669999999999999999999999999986544332222 356789999
Q ss_pred ccCccccccCC------CCCcccchhhHHHHHHHhcC----------CCCcccchhhhhhhHHHhh--------hh----
Q 044846 148 YVDPKYFRSSQ------FTEKSDVYSFSVVLVELNWT----------KPIHLVDVEENRSLAAYFS--------KE---- 199 (290)
Q Consensus 148 y~aPE~~~~~~------~~~~~DiwS~G~il~~l~~~----------~~~~~~~~~~~~~~~~~~~--------~~---- 199 (290)
|||||++...- .-..+||||||.++||++.. .+|+..-.........+.. ..
T Consensus 386 YMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr 465 (513)
T KOG2052|consen 386 YMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR 465 (513)
T ss_pred ccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcc
Confidence 99999987542 12369999999999998632 1333322222222222211 11
Q ss_pred -hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 200 -AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 200 -~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
........+..+|+.||..+|..|.|+-.+.+.|.++..
T Consensus 466 W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 466 WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 122344568899999999999999999999988887764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=246.15 Aligned_cols=222 Identities=24% Similarity=0.268 Sum_probs=179.2
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.+|+|.++... ....+.+..|+++++.++||||+++++.+..++..+++|||+++++|.+++.... .+++.
T Consensus 18 ~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~l~~~ 93 (250)
T cd05123 18 GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG----RFSEE 93 (250)
T ss_pred CcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC----CCCHH
Confidence 6788999886432 2356688999999999999999999999999999999999999999999998654 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|++||...+..
T Consensus 94 ~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~ 169 (250)
T cd05123 94 RARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKG 169 (250)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCCCC
Confidence 99999999999999999998 9999999999999999999999999876543221 1233456778899999998888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCCCH---HHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQPTM---KEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~---~el~~~ 232 (290)
.+.++|+||||+++|++++|..|+..... ........ ....+...+..+.+++.+||..||++||++ .+++.+
T Consensus 170 ~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 88999999999999999999988754332 11111111 111222335678999999999999999999 566543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=248.03 Aligned_cols=223 Identities=19% Similarity=0.199 Sum_probs=188.8
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++. ..++++..-+.|-++|+..+||.+..+.-.|+..+.+|.||||..||.|+-+|.+.. .+++.
T Consensus 193 ~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer----~FsE~ 268 (516)
T KOG0690|consen 193 GKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER----VFSED 268 (516)
T ss_pred CceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhh----cccch
Confidence 67899998873 557778888999999999999999999999999999999999999999999998765 68999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
..+.+..+|+.||.|||+++ |+.||||.+|.|+|.+|++||+|||+++... .......++.||+.|+|||++....
T Consensus 269 RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~t~kTFCGTPEYLAPEVleDnD 344 (516)
T KOG0690|consen 269 RTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGDTTKTFCGTPEYLAPEVLEDND 344 (516)
T ss_pred hhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-cccceeccccCChhhcCchhhcccc
Confidence 99999999999999999999 9999999999999999999999999998543 2233445689999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhh-hhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEE-NRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPT-----MKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~el~~~ 232 (290)
|+.++|.|.+|+++|||+.|+.||...... .-.+........+...+++...|+...|..||.+|.. +.||.++
T Consensus 345 YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 345 YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 999999999999999999999988754322 1112222223345566788999999999999999963 5666655
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=249.96 Aligned_cols=230 Identities=24% Similarity=0.312 Sum_probs=177.4
Q ss_pred CCceEEEEeecccCchhHHHHHHHHHHHHhc--CCCceeeEEeEEEeCC----cceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 1 MEELWLLKKSKSVHESNVEQFINEVVILSQI--NHRNVVKILGCCLETE----VPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 1 ~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l--~Hpniv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
+++.||||++. .++.+.|..|-.|+... .|+||++|++.-.... .+|||+||.+.|+|.++|+.+.
T Consensus 232 ~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt----- 303 (534)
T KOG3653|consen 232 DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT----- 303 (534)
T ss_pred cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc-----
Confidence 47899999997 55677899999999875 8999999998876655 7899999999999999999864
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCC------CCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee-eccceeccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVA------SIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFG 147 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~------~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~ 147 (290)
++|....+++..++.||+|||+.. .++|+|||||.+||||..|+++.|+|||+|.......... ...-+||.+
T Consensus 304 isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~R 383 (534)
T KOG3653|consen 304 ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRR 383 (534)
T ss_pred ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhh
Confidence 899999999999999999999643 3579999999999999999999999999987655333222 233679999
Q ss_pred ccCccccccCC-CC-----CcccchhhHHHHHHHhcCCCCcc------------cchhhhh---hhHHH-----hhhhhh
Q 044846 148 YVDPKYFRSSQ-FT-----EKSDVYSFSVVLVELNWTKPIHL------------VDVEENR---SLAAY-----FSKEAE 201 (290)
Q Consensus 148 y~aPE~~~~~~-~~-----~~~DiwS~G~il~~l~~~~~~~~------------~~~~~~~---~~~~~-----~~~~~~ 201 (290)
|||||++.+.- +. .+.||||+|.+|||++.+...+. ....... ..... .+...+
T Consensus 384 YMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p 463 (534)
T KOG3653|consen 384 YMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIP 463 (534)
T ss_pred hcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCCh
Confidence 99999987642 22 36999999999999985543321 1111111 11111 111111
Q ss_pred -----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 202 -----KEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 202 -----~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
......+.+.+..||+.||+.|.|+.-+.+++..+..
T Consensus 464 ~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 464 DAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred hhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1234458899999999999999999999999887754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=267.67 Aligned_cols=224 Identities=21% Similarity=0.245 Sum_probs=185.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEe-----CCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLE-----TEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+..|+|+...... .-++...|..+++.+ +|||++.++|+|.. ++++|||||||.+|++.++++.... .++
T Consensus 44 ~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g--~rl 120 (953)
T KOG0587|consen 44 GQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKG--NRL 120 (953)
T ss_pred CceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcc--cch
Confidence 56788888765433 334566788899988 89999999999975 4689999999999999999998873 379
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
.|..+..|++.++.|+.+||.+. +||||+|-.|||++.++.+||+|||.+...... .....+..||+.|||||++.
T Consensus 121 ~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT-~grRnT~iGtP~WMAPEVia 196 (953)
T KOG0587|consen 121 KEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIA 196 (953)
T ss_pred hhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecc-cccccCcCCCcccccceeee
Confidence 99999999999999999999999 999999999999999999999999997655433 33456788999999999987
Q ss_pred cC-----CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhh-----hhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 156 SS-----QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKE-----AEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 156 ~~-----~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
.. .|+..+|+||+|++..||..|.||+..... ...+....+.+ .+..++.+|-++|..||..|.++||+
T Consensus 197 c~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-mraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~ 275 (953)
T KOG0587|consen 197 CDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS 275 (953)
T ss_pred cccCCCCCcccccchhhccceeehhcCCCCCccCcch-hhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc
Confidence 54 377799999999999999999988764433 33333332222 35678899999999999999999999
Q ss_pred HHHHHHHH
Q 044846 226 MKEVTLEL 233 (290)
Q Consensus 226 ~~el~~~l 233 (290)
..++++|-
T Consensus 276 ~~~ll~hp 283 (953)
T KOG0587|consen 276 TEELLKHP 283 (953)
T ss_pred hhhhccCC
Confidence 99998774
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=247.69 Aligned_cols=223 Identities=24% Similarity=0.300 Sum_probs=176.9
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.+|+|+..... ....+.+..|+.+++.++|+||+++++++...+..++|+||+. ++|.+++.... ..+++..
T Consensus 24 ~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~---~~~~~~~ 99 (282)
T cd07829 24 GEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP---GPLSPNL 99 (282)
T ss_pred CcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc---cCCCHHH
Confidence 6789999987542 4445678899999999999999999999999999999999996 69999998753 2588999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-C
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-Q 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 158 (290)
+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .
T Consensus 100 ~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~ 175 (282)
T cd07829 100 IKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKH 175 (282)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcC
Confidence 9999999999999999999 99999999999999999999999998765433221 12233456779999998776 7
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHhh----------------------------hhhhHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYFS----------------------------KEAEKEEVITF 208 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~~----------------------------~~~~~~~~~~~ 208 (290)
++.++|+||||++++++++|.+++.......... ..... .......+..+
T Consensus 176 ~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (282)
T cd07829 176 YSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEG 255 (282)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHH
Confidence 8889999999999999999988775433211100 00000 00011124578
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHH
Q 044846 209 AMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 209 ~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.+++.+||+.||++||++.+++.+
T Consensus 256 ~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 256 IDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHHHHhhccCcccCCCHHHHhhC
Confidence 999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=247.44 Aligned_cols=223 Identities=22% Similarity=0.300 Sum_probs=172.7
Q ss_pred CceEEEEeecccCc-hhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHE-SNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
++.||+|++..... .......+|+..++.++ ||||+++++++...+..++||||+ +|+|.+++..... ..+++..
T Consensus 24 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~ 100 (283)
T cd07830 24 GELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG--KPFSESV 100 (283)
T ss_pred CcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhccc--ccCCHHH
Confidence 56799998864322 23334567999999998 999999999999999999999999 8899999876542 2578999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-CC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-SQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~ 158 (290)
+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++...... .......++..|+|||++.. ..
T Consensus 101 ~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~ 175 (283)
T cd07830 101 IRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPYTDYVSTRWYRAPEILLRSTS 175 (283)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC--CCcCCCCCcccccCceeeecCcC
Confidence 9999999999999999999 999999999999999999999999987643321 12233457788999998754 45
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHhh-----------------------------hhhhHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYFS-----------------------------KEAEKEEVIT 207 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~~-----------------------------~~~~~~~~~~ 207 (290)
++.++|+||||++++++++|.+++.......... ..... ..........
T Consensus 176 ~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (283)
T cd07830 176 YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPE 255 (283)
T ss_pred cCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHH
Confidence 7889999999999999999998774332111100 00000 0000111356
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 208 FAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 208 ~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+.+++.+||+.||++|||+.|++.+
T Consensus 256 ~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 256 AIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHHHHHhcccCcccCCCHHHHhhC
Confidence 8899999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=252.16 Aligned_cols=225 Identities=22% Similarity=0.239 Sum_probs=170.9
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC----CcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQI-NHRNVVKILGCCLET----EVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
++.||+|+++.. .....+.+.+|+.+++.+ +||||+++++.+... ...++++||+ +++|.+++.... .
T Consensus 27 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~ 101 (332)
T cd07857 27 EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQ----P 101 (332)
T ss_pred CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhcCC----C
Confidence 567999988642 223356788999999999 699999999876432 4578999998 469999987543 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc---eeeccceecccccCc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT---HLTTQVKVTFGYVDP 151 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aP 151 (290)
+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++....... .......|+..|+||
T Consensus 102 ~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aP 178 (332)
T cd07857 102 LTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCc
Confidence 889999999999999999999999 99999999999999999999999999865332111 112335678899999
Q ss_pred ccccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--------------hhHHHhh---------------hh--
Q 044846 152 KYFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--------------SLAAYFS---------------KE-- 199 (290)
Q Consensus 152 E~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--------------~~~~~~~---------------~~-- 199 (290)
|++.+ ..++.++|+||+|+++|++++|.+++........ .+..... ..
T Consensus 179 E~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (332)
T cd07857 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE 258 (332)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchH
Confidence 98765 4688999999999999999999988754321100 0000000 00
Q ss_pred -hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 200 -AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 200 -~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.....+..+.+++.+||+.||++|||+.+++.+-+
T Consensus 259 ~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 259 SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 00012457889999999999999999999987754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=223.56 Aligned_cols=224 Identities=19% Similarity=0.265 Sum_probs=178.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
++.||+|.++.. ++..-...++|+.+++.|.|.|||++++....++.+-+|+||| .-+|.++....+. .++.+.
T Consensus 27 ~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng---~~d~~~ 102 (292)
T KOG0662|consen 27 HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNG---DLDPEI 102 (292)
T ss_pred cceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcCC---cCCHHH
Confidence 578999998743 3334557889999999999999999999999999999999999 5699999987654 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC-
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ- 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~- 158 (290)
++.++.|++.||.|+|+++ +.||||||+|.|+..+|.+|++|||+++..... ..+......|.+|.+|.++.+..
T Consensus 103 ~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip-vrcysaevvtlwyrppdvlfgakl 178 (292)
T KOG0662|consen 103 VRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKL 178 (292)
T ss_pred HHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc-eEeeeceeeeeeccCcceeeeeeh
Confidence 9999999999999999999 999999999999999999999999999876543 34455667799999999988765
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------------------------------hhhhHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------------------------------KEAEKEEVIT 207 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 207 (290)
|++..|+||-|||+.|+.....|.+...+-...+...+. ...-+.....
T Consensus 179 y~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~ 258 (292)
T KOG0662|consen 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNST 258 (292)
T ss_pred hccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcch
Confidence 888999999999999998544433333333222322221 0000112224
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 208 FAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 208 ~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
-++|+++.|..+|.+|.++++.+++.
T Consensus 259 grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 259 GRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred hHHHHHHHhccCcccccCHHHHhcCc
Confidence 67999999999999999999888664
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=250.33 Aligned_cols=224 Identities=21% Similarity=0.224 Sum_probs=168.3
Q ss_pred CceEEEEeecccCc--hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--------cceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSVHE--SNVEQFINEVVILSQINHRNVVKILGCCLETE--------VPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.+|+|++..... .....+.+|+++++.++||||+++++++.... .+++|+||+. ++|...+....
T Consensus 33 ~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~-- 109 (311)
T cd07866 33 GRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS-- 109 (311)
T ss_pred CcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccc--
Confidence 56789998854322 22346778999999999999999999875533 4699999995 57887776532
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc----------eeecc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT----------HLTTQ 141 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~----------~~~~~ 141 (290)
..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........ .....
T Consensus 110 -~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (311)
T cd07866 110 -VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185 (311)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCccccccccc
Confidence 25899999999999999999999999 99999999999999999999999998764332111 11123
Q ss_pred ceecccccCccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHhh---------------------
Q 044846 142 VKVTFGYVDPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYFS--------------------- 197 (290)
Q Consensus 142 ~~g~~~y~aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~~--------------------- 197 (290)
..++..|+|||.+.+. .++.++||||||+++|+|++|++++........ .......
T Consensus 186 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (311)
T cd07866 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHS 265 (311)
T ss_pred ceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhccccccccc
Confidence 4567889999987654 578899999999999999999988753322111 0000000
Q ss_pred ---h-----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 198 ---K-----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 198 ---~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
. .........+.+++.+||+.||.+|||+.|++.+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 266 FTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 0001122568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=245.34 Aligned_cols=210 Identities=19% Similarity=0.226 Sum_probs=169.2
Q ss_pred hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 044846 17 NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHS 96 (290)
Q Consensus 17 ~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~ 96 (290)
....+..|+.+++.++||||+++++++......++|+||+++++|.+++.........+++..++.++.|++.||.|||+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 124 (260)
T cd08222 45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124 (260)
T ss_pred hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 44567789999999999999999999999999999999999999999987643333468999999999999999999999
Q ss_pred CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCcccchhhHHHHHHHh
Q 044846 97 VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELN 176 (290)
Q Consensus 97 ~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~ 176 (290)
.+ ++|+||||+||+++. +.++|+|||.++..... ........++..|+|||.+.+..++.++|+||||+++|+++
T Consensus 125 ~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 125 RR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS-CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred cC---ccccCCChhheEeec-CCEeecccCceeecCCC-cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99 999999999999975 56999999987654321 12223455788899999998888899999999999999999
Q ss_pred cCCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 177 WTKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+|..++...... ....... ....+...+.++.++|.+||+.||++||++.+++++
T Consensus 200 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 200 CLAHAFEGQNFL-SVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred hCCCCCCCccHH-HHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 999887533221 1111111 111233556789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=250.93 Aligned_cols=219 Identities=18% Similarity=0.253 Sum_probs=170.3
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.. ......+.+.+|+++++.++||||+++.++|.. .+..++++||+ +++|..+++.. .++..
T Consensus 35 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~~~~ 108 (328)
T cd07856 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR-----PLEKQ 108 (328)
T ss_pred CCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC-----CCCHH
Confidence 57799998753 223345678899999999999999999999876 56789999999 67999888643 47788
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-C
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-S 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 157 (290)
.+..++.|+++||.|||+++ |+||||+|+||+++.++.++|+|||++..... ......++..|+|||.+.+ .
T Consensus 109 ~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 181 (328)
T cd07856 109 FIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYRAPEIMLTWQ 181 (328)
T ss_pred HHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC----CcCCCcccccccCceeeeccC
Confidence 88899999999999999999 99999999999999999999999998764321 1123456778999998766 5
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHH-----------------------hh--hhhh-----HHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAY-----------------------FS--KEAE-----KEEV 205 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~-----------------------~~--~~~~-----~~~~ 205 (290)
.++.++|+||||+++|++++|.+++........ .+... .. ...+ ...+
T Consensus 182 ~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (328)
T cd07856 182 KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNAD 261 (328)
T ss_pred CcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCC
Confidence 688999999999999999999988753321100 00000 00 0000 1124
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 206 ITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 206 ~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
..+.++|.+||+.+|++|||+.+++.+-
T Consensus 262 ~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 262 PSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 6789999999999999999999998774
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=262.84 Aligned_cols=230 Identities=21% Similarity=0.268 Sum_probs=178.8
Q ss_pred CCceEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 1 MEELWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLET------EVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 1 ~~~~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
.|+.||||..+. .....++.+.+|+++|++|+|||||+++++-... ....+|||||.||||+.++.+-.+. .
T Consensus 37 tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~-~ 115 (732)
T KOG4250|consen 37 TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENA-Y 115 (732)
T ss_pred cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccc-c
Confidence 378999999874 4456688899999999999999999999886543 3568999999999999999875543 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec--cCCc--EEEeccccccccccCCceeeccceeccccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV--DKYQ--AKISDFRTFKSRAIDRTHLTTQVKVTFGYV 149 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~--~~~~--~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 149 (290)
.+++...+.++.+++.||.|||+++ |+||||||.||++- .+|+ .||+|||.|+....+ .....++||..|+
T Consensus 116 GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~--s~~~S~vGT~~YL 190 (732)
T KOG4250|consen 116 GLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN--SLFTSLVGTEEYL 190 (732)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCC--CeeeeecCchhhc
Confidence 7999999999999999999999999 99999999999985 3343 699999998865533 3667799999999
Q ss_pred Ccccccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh----hhHHHhh----------------------hhh--
Q 044846 150 DPKYFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR----SLAAYFS----------------------KEA-- 200 (290)
Q Consensus 150 aPE~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~----~~~~~~~----------------------~~~-- 200 (290)
+||++.. ..|+..+|.|||||++|+++||..||........ .+..... -+.
T Consensus 191 hPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~ 270 (732)
T KOG4250|consen 191 HPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPN 270 (732)
T ss_pred ChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcc
Confidence 9999984 7788899999999999999999998865432211 1111100 001
Q ss_pred --hHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHhh
Q 044846 201 --EKEEVITFAMVAKRCLNLNGKKQP--TMKEVTLELAGI 236 (290)
Q Consensus 201 --~~~~~~~~~~li~~cl~~dp~~Rp--s~~el~~~l~~~ 236 (290)
.......+-.++..+|..+|++|- .+.+....+..+
T Consensus 271 ~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 271 HLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred cccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 112233466788999999999998 555555444443
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=252.89 Aligned_cols=220 Identities=18% Similarity=0.195 Sum_probs=170.2
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLET------EVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||+|+++... ....+.+.+|+.++++++||||+++++++... ...+++++++ +++|.+++...
T Consensus 42 ~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----- 115 (345)
T cd07877 42 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----- 115 (345)
T ss_pred CeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC-----
Confidence 5789999987532 23356788999999999999999999988643 3467888887 78998887643
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..... ......++..|+|||.
T Consensus 116 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~ 188 (345)
T cd07877 116 KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEI 188 (345)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccccc----cccccccCCCccCHHH
Confidence 4888999999999999999999999 99999999999999999999999999764321 1223457888999999
Q ss_pred ccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHhh-----------hh---------------h----
Q 044846 154 FRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYFS-----------KE---------------A---- 200 (290)
Q Consensus 154 ~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~~-----------~~---------------~---- 200 (290)
+.+ ..++.++|+|||||++|+|++|.+++........ ....... .. .
T Consensus 189 ~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (345)
T cd07877 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 268 (345)
T ss_pred HhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhh
Confidence 866 4678899999999999999999988753321110 0000000 00 0
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
....+..+.++|.+||+.||.+|||+.+++.+-.
T Consensus 269 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 269 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 0012456789999999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=254.56 Aligned_cols=216 Identities=19% Similarity=0.249 Sum_probs=167.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||+|+++.. .......+.+|+++++.++||||+++++++.... ..++|+||+. ++|..+...
T Consensus 40 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------ 112 (342)
T cd07879 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMGH------ 112 (342)
T ss_pred CcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHcC------
Confidence 678999998642 2333456889999999999999999999987543 3589999995 477766521
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++..... .....++..|+|||+
T Consensus 113 ~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~ 185 (342)
T cd07879 113 PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEV 185 (342)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----CCCceeeecccChhh
Confidence 4788899999999999999999999 999999999999999999999999997643221 123456788999999
Q ss_pred ccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----------------------------hhh---
Q 044846 154 FRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----------------------------KEA--- 200 (290)
Q Consensus 154 ~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~--- 200 (290)
+.+ ..++.++|+|||||++|+|++|+.+|........ +..... ...
T Consensus 186 ~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (342)
T cd07879 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFST 264 (342)
T ss_pred hcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHH
Confidence 876 4588899999999999999999998864322111 100000 000
Q ss_pred -hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 201 -EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 201 -~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
....+..+.++|.+||+.||++||++.+++.+
T Consensus 265 ~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 265 LFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01123467899999999999999999999977
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=254.04 Aligned_cols=219 Identities=19% Similarity=0.230 Sum_probs=170.5
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||+|++... .......+.+|+.+++.++||||+++++++.... ..++||||+ +++|.+++...
T Consensus 40 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----- 113 (343)
T cd07880 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE----- 113 (343)
T ss_pred CcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC-----
Confidence 577999988532 2333456889999999999999999999987654 358999999 77999888642
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....++..|+|||+
T Consensus 114 ~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~ 186 (343)
T cd07880 114 KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEV 186 (343)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC----ccccccCCcccCHHH
Confidence 4889999999999999999999999 999999999999999999999999987643221 123456788999999
Q ss_pred ccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--------------h-------------------h
Q 044846 154 FRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--------------K-------------------E 199 (290)
Q Consensus 154 ~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--------------~-------------------~ 199 (290)
+.+ ..++.++|+||||+++|++++|.+|+........ ...... . .
T Consensus 187 ~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (343)
T cd07880 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRS 265 (343)
T ss_pred HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHH
Confidence 876 4578899999999999999999988754322111 000000 0 0
Q ss_pred hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 200 AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 200 ~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.....+..+.++|.+||+.||.+|||+.+++.+-.
T Consensus 266 ~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 266 LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300 (343)
T ss_pred hccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 00122445889999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=246.45 Aligned_cols=202 Identities=15% Similarity=0.113 Sum_probs=153.9
Q ss_pred HHHHHHhcCCCceeeEEeEEEeCC----cceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 044846 24 EVVILSQINHRNVVKILGCCLETE----VPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVAS 99 (290)
Q Consensus 24 E~~~l~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~ 99 (290)
+...+..++|+||+++++++.... ..++++|++ ..++.+.+.... ..++..+..++.|++.||.|||+++
T Consensus 73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~- 146 (294)
T PHA02882 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEHG- 146 (294)
T ss_pred HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 334456678999999999876543 347888888 457777776543 3567888999999999999999999
Q ss_pred CCeEeccCCCCceEeccCCcEEEeccccccccccCCce------eeccceecccccCccccccCCCCCcccchhhHHHHH
Q 044846 100 IPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH------LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLV 173 (290)
Q Consensus 100 ~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~ 173 (290)
|+||||||+|||++.++.++|+|||+++........ ......||+.|+|||+..+..++.++|||||||++|
T Consensus 147 --iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~ 224 (294)
T PHA02882 147 --ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCML 224 (294)
T ss_pred --eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 999999999999999999999999998754322111 112346899999999999999999999999999999
Q ss_pred HHhcCCCCcccchhhhhh-------hHHHhh-h-hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 174 ELNWTKPIHLVDVEENRS-------LAAYFS-K-EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 174 ~l~~~~~~~~~~~~~~~~-------~~~~~~-~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+|++|..||......... ...... . ......+..+.+++..||..+|++||++.++.+.+
T Consensus 225 el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 225 KWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 999999988644211110 001001 0 11223456789999999999999999999998765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=256.64 Aligned_cols=219 Identities=20% Similarity=0.231 Sum_probs=172.3
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc------ceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEV------PLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
++.||+|++... .....+.+.+|+.+++.++||||+++.+++...+. .++|+||+ +++|.+++...
T Consensus 40 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----- 113 (343)
T cd07851 40 GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ----- 113 (343)
T ss_pred CcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcC-----
Confidence 567999988642 23345678889999999999999999988876554 89999999 77999998752
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....++..|+|||.
T Consensus 114 ~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~ 186 (343)
T cd07851 114 KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 186 (343)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCcccccccCHHH
Confidence 4899999999999999999999999 999999999999999999999999997654322 233456788999999
Q ss_pred cccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------------------------------h---h
Q 044846 154 FRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------------------------------K---E 199 (290)
Q Consensus 154 ~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------------------------------~---~ 199 (290)
+.+. .++.++||||||+++|++++|.+++....... .+..... . .
T Consensus 187 ~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (343)
T cd07851 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKE 265 (343)
T ss_pred HhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHH
Confidence 8653 57889999999999999999998875432211 1110000 0 0
Q ss_pred hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 200 AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 200 ~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.....+..+.+++.+||+.||++|||+.+|+.+-+
T Consensus 266 ~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~ 300 (343)
T cd07851 266 VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300 (343)
T ss_pred HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence 00112567889999999999999999999987743
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=257.54 Aligned_cols=223 Identities=19% Similarity=0.212 Sum_probs=185.4
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||||++.. ....+..++++|++||+.+.||.||.+.-.|++.+.+++|||.+ +|+..+.|-..... ++++..
T Consensus 589 GrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILSsEkg--RL~er~ 665 (888)
T KOG4236|consen 589 GRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILSSEKG--RLPERI 665 (888)
T ss_pred CceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHHhhcc--cchHHH
Confidence 78899999863 34555678999999999999999999999999999999999999 66777766543322 689999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
...++.||+.||.|||.++ |+|+||||+|||+.. .-++||||||.|+... .......++||+.|+|||++..
T Consensus 666 TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--EksFRrsVVGTPAYLaPEVLrn 740 (888)
T KOG4236|consen 666 TKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKSFRRSVVGTPAYLAPEVLRN 740 (888)
T ss_pred HHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc--hhhhhhhhcCCccccCHHHHhh
Confidence 9999999999999999999 999999999999964 3479999999987543 2333456889999999999999
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh---hHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS---LAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
..|+..-||||.|+|+|--+.|.-||..+.+.... ...++...++...+....+||...|+..=++|-|.+.-+.+
T Consensus 741 kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 741 KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 99999999999999999988898888765443332 23344555677778889999999999999999998876544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=246.45 Aligned_cols=227 Identities=21% Similarity=0.285 Sum_probs=184.6
Q ss_pred CceEEEEeecc-------cCchhHHHHHHHHHHHHhcCCCceeeEEeEEE-eCCcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKS-------VHESNVEQFINEVVILSQINHRNVVKILGCCL-ETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~-------~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
++.||+|+-.. .++..++...+|..|-+.|+||-||++|++|. +.+.+|-|+|||+|.+|.-+|+...
T Consensus 488 qRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk---- 563 (775)
T KOG1151|consen 488 QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK---- 563 (775)
T ss_pred hheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh----
Confidence 35688887431 22334667788999999999999999999996 4568999999999999999999876
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec---cCCcEEEeccccccccccCCc------eeecccee
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV---DKYQAKISDFRTFKSRAIDRT------HLTTQVKV 144 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~---~~~~~kl~dfg~~~~~~~~~~------~~~~~~~g 144 (290)
.+++..++.|+.||+.||.||.+..+ ||||-||||.|||+. ..|.+||.|||+++.+..+.. .++....|
T Consensus 564 lmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAG 642 (775)
T KOG1151|consen 564 LMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAG 642 (775)
T ss_pred hhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCc
Confidence 68999999999999999999998764 599999999999995 457899999999987654322 23456789
Q ss_pred cccccCccccccC----CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------hhhhHHHHHHHHHHHH
Q 044846 145 TFGYVDPKYFRSS----QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------KEAEKEEVITFAMVAK 213 (290)
Q Consensus 145 ~~~y~aPE~~~~~----~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~ 213 (290)
|++|++||++.-+ ..+.++||||+|+|+|+++.|+.||..+...+..+..... -+..+..+.+..++|+
T Consensus 643 TYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIR 722 (775)
T KOG1151|consen 643 TYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIR 722 (775)
T ss_pred eeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHH
Confidence 9999999998754 4788999999999999999999999887766665544322 1223345677889999
Q ss_pred HhhccCCCCCCCHHHHHHHH
Q 044846 214 RCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 214 ~cl~~dp~~Rps~~el~~~l 233 (290)
+||++.-++|....++..+.
T Consensus 723 RCLaYRKeDR~DV~qLA~dp 742 (775)
T KOG1151|consen 723 RCLAYRKEDRIDVQQLACDP 742 (775)
T ss_pred HHHHhhhhhhhhHHHHccCc
Confidence 99999999998888776443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=238.69 Aligned_cols=222 Identities=23% Similarity=0.276 Sum_probs=181.8
Q ss_pred CceEEEEeecccCchh-HHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESN-VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~-~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.+|+|+........ .+.+.+|++.++.++|+||+++++++......++++||+++++|.+++.... .++...+
T Consensus 14 ~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~----~~~~~~~ 89 (244)
T smart00220 14 GKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG----RLSEDEA 89 (244)
T ss_pred CcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc----CCCHHHH
Confidence 5789999997655544 7889999999999999999999999999999999999999999999997654 3788999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+..++
T Consensus 90 ~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~ 164 (244)
T smart00220 90 RFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYG 164 (244)
T ss_pred HHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCC
Confidence 999999999999999998 9999999999999999999999999876543221 22345567889999999888899
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhh--HH---HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAE--KE---EVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.++|+||||++++++++|..++................... .. .+..+.+++.+||..+|++||++.+++++
T Consensus 165 ~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 165 KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 99999999999999999988775422222222111111111 11 55679999999999999999999999864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=237.62 Aligned_cols=233 Identities=18% Similarity=0.226 Sum_probs=180.6
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--------CcceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLET--------EVPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||+|++-. .++..-...++|+++|+.|.|+|++.++..|... ..+|+||.+|+. +|..++.+..
T Consensus 42 ~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~-- 118 (376)
T KOG0669|consen 42 GKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRK-- 118 (376)
T ss_pred cchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCcc--
Confidence 56788887643 2333455678999999999999999998887542 358999999965 9999997653
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc---eeeccceecccc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT---HLTTQVKVTFGY 148 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y 148 (290)
.+++...+..++.++..||.|+|... |+|||+|+.|+||+.+|.+||+|||+++....... ..++..+.|.+|
T Consensus 119 -vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwY 194 (376)
T KOG0669|consen 119 -VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWY 194 (376)
T ss_pred -ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeec
Confidence 36999999999999999999999999 99999999999999999999999999875443222 234556679999
Q ss_pred cCccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhH-HHhh----------------------hh-----
Q 044846 149 VDPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA-AYFS----------------------KE----- 199 (290)
Q Consensus 149 ~aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~-~~~~----------------------~~----- 199 (290)
++||.+.+. .|+++.|||.-|||+.+|.++.+.+....+.+.... ..+- .+
T Consensus 195 rppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~ 274 (376)
T KOG0669|consen 195 RPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQ 274 (376)
T ss_pred CCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcch
Confidence 999998875 599999999999999999999998865543322111 1000 00
Q ss_pred --------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhhC
Q 044846 200 --------AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRASIG 241 (290)
Q Consensus 200 --------~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~~~ 241 (290)
.+..-..+..+|+.++|..||.+|+++++++.|-..-++...
T Consensus 275 ~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 275 KRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred hhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 000112357799999999999999999999988766555443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=273.64 Aligned_cols=174 Identities=24% Similarity=0.276 Sum_probs=132.5
Q ss_pred eEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccccc
Q 044846 50 LLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 50 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
||-||||+.-.+..++.++...+ .....++++++|++||+|+|+++ ||||||||.||+++.++.+||+|||+++
T Consensus 672 YIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 672 YIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccch
Confidence 68899998877777776654211 35678899999999999999999 9999999999999999999999999998
Q ss_pred ccc-----------------cCCceeeccceecccccCccccccCC---CCCcccchhhHHHHHHHhcCCCCcccchhhh
Q 044846 130 SRA-----------------IDRTHLTTQVKVTFGYVDPKYFRSSQ---FTEKSDVYSFSVVLVELNWTKPIHLVDVEEN 189 (290)
Q Consensus 130 ~~~-----------------~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~ 189 (290)
... .......++..||.-|+|||++.+.. |+.|+||||+|+|++||+.- |....+..
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa 822 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSMERA 822 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchHHHH
Confidence 621 01111235678999999999998654 99999999999999999754 43334333
Q ss_pred hhhHHHhhh---hh---hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 190 RSLAAYFSK---EA---EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 190 ~~~~~~~~~---~~---~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
..+...-.. .. ..+..+.-+.+|..+++.||.+||||.|++..
T Consensus 823 ~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 823 SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 333322221 11 23344556789999999999999999999743
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=255.67 Aligned_cols=221 Identities=17% Similarity=0.244 Sum_probs=176.6
Q ss_pred eEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 4 LWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 4 ~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
+||+|.++. ....++..+..|-.||..-+.+-||+|+-.|.+++.+|.||+|++||++..+|-+.+ -|++..+
T Consensus 656 lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg----IFeE~LA 731 (1034)
T KOG0608|consen 656 LYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFEEDLA 731 (1034)
T ss_pred HHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc----cCHHHHH
Confidence 355555543 224456667789999999999999999999999999999999999999999998876 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc------------------------
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT------------------------ 136 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~------------------------ 136 (290)
+.++.++.+|+++.|+.| +|||||||+|||||.+|++||.|||+|........
T Consensus 732 RFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~ 808 (1034)
T KOG0608|consen 732 RFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADI 808 (1034)
T ss_pred HHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccc
Confidence 999999999999999999 99999999999999999999999999864311000
Q ss_pred -----------------eeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhh-----hhhhHH
Q 044846 137 -----------------HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE-----NRSLAA 194 (290)
Q Consensus 137 -----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~-----~~~~~~ 194 (290)
...-..+||..|+|||++....|+..+|.||.|+|||||+.|.+||..+... ..++..
T Consensus 809 ~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 809 SKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred cccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh
Confidence 0012357899999999999999999999999999999999999999866432 223444
Q ss_pred HhhhhhhHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 044846 195 YFSKEAEKEEVITFAMVAKRCLNLNGKKQPT---MKEVTLE 232 (290)
Q Consensus 195 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~el~~~ 232 (290)
.+......+.+.++.++|.+.+ .++++|.. ++||..|
T Consensus 889 ~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaH 928 (1034)
T KOG0608|consen 889 FLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAH 928 (1034)
T ss_pred ccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcC
Confidence 4455566667778888887755 56677753 4556544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=253.38 Aligned_cols=220 Identities=17% Similarity=0.152 Sum_probs=188.8
Q ss_pred EEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 044846 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVE 86 (290)
Q Consensus 7 vK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (290)
+||...++..+.+.+..|-.+|...+.|.||++|..|.++.+.|++||-|-||.|+..++..+ .|+..+.+.++..
T Consensus 453 lkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg----~Fdd~tarF~~ac 528 (732)
T KOG0614|consen 453 LKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRG----SFDDYTARFYVAC 528 (732)
T ss_pred HhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcC----CcccchhhhhHHH
Confidence 344446788888899999999999999999999999999999999999999999999999876 6999999999999
Q ss_pred HHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCcccch
Q 044846 87 VSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVY 166 (290)
Q Consensus 87 i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 166 (290)
+++|++|||.++ ||.|||||+|++++.+|-+||.|||.|+... ....+.++.||+.|.|||++.+...+.++|.|
T Consensus 529 v~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--~g~KTwTFcGTpEYVAPEIILnKGHD~avDyW 603 (732)
T KOG0614|consen 529 VLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYW 603 (732)
T ss_pred HHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc--cCCceeeecCCcccccchhhhccCcchhhHHH
Confidence 999999999999 9999999999999999999999999987544 34556789999999999999999999999999
Q ss_pred hhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHhh
Q 044846 167 SFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPT-----MKEVTLELAGI 236 (290)
Q Consensus 167 S~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~el~~~l~~~ 236 (290)
|+|+++|||++|.|||..... ...+...+. ...+........+||++.+..+|.+|.. ..+|.+|-+..
T Consensus 604 aLGIli~ELL~G~pPFs~~dp-mktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 604 ALGILIYELLTGSPPFSGVDP-MKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred HHHHHHHHHHcCCCCCCCCch-HHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 999999999999999875432 232322222 3344555667889999999999999975 67888776543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=267.97 Aligned_cols=222 Identities=20% Similarity=0.187 Sum_probs=171.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||.+-. +..+-..+|+..|+.- +|||||++++.-.+..+.||..|.|. -+|.+++...............
T Consensus 533 ~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~ 608 (903)
T KOG1027|consen 533 GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDP 608 (903)
T ss_pred CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccH
Confidence 67889988853 2233456999999998 79999999999999999999999995 5999999874111101111334
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---C--CcEEEeccccccccccCCcee--eccceecccccCccc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---K--YQAKISDFRTFKSRAIDRTHL--TTQVKVTFGYVDPKY 153 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~--~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~ 153 (290)
+..+.|++.||++||+.+ ||||||||+||||+. + .+++|+|||+++....+.... ..+..||.+|+|||+
T Consensus 609 ~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~ 685 (903)
T KOG1027|consen 609 ISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQ 685 (903)
T ss_pred HHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHH
Confidence 678899999999999999 999999999999986 3 467999999998766554433 456789999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcC-CCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWT-KPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
+....-+.++||+|+||++|+.++| ..||......+.++..... -.....+ +..+||.+|+++||..||+|.+
T Consensus 686 L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~ 763 (903)
T KOG1027|consen 686 LREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATD 763 (903)
T ss_pred HhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHH
Confidence 9998888899999999999998876 5556544444333222111 1111112 7889999999999999999999
Q ss_pred HHHH
Q 044846 229 VTLE 232 (290)
Q Consensus 229 l~~~ 232 (290)
|+.|
T Consensus 764 VL~H 767 (903)
T KOG1027|consen 764 VLNH 767 (903)
T ss_pred HhCC
Confidence 9866
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=266.39 Aligned_cols=121 Identities=26% Similarity=0.332 Sum_probs=109.0
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+..|+.++..++||||+++++++...+..||||||+.+++|.+++.... .+++.
T Consensus 29 ~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~----~l~~~ 104 (669)
T cd05610 29 SKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG----YFDEE 104 (669)
T ss_pred CcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC----CCCHH
Confidence 678999998643 23445678899999999999999999999999999999999999999999997654 57888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
.++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 105 MAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=238.29 Aligned_cols=228 Identities=20% Similarity=0.186 Sum_probs=178.9
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcC-CCCCCCCHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT-DDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~ 78 (290)
|++.|||+++.. ...+.++++.|.....+= +.||||+++|.+-..+.-||.||+| ..+|..+.+.-- -....++++
T Consensus 89 g~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~ 167 (361)
T KOG1006|consen 89 GKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPEN 167 (361)
T ss_pred CcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHh
Confidence 788999999854 457788999999866655 8999999999999999999999999 568877664321 111257788
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS- 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 157 (290)
..-.+..-.+.||.||-..-. |||||+||+|||++..|.+||||||++-... .+-..+...|...|||||-+...
T Consensus 168 Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv--~SiAkT~daGCrpYmAPERi~p~~ 243 (361)
T KOG1006|consen 168 ILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV--DSIAKTVDAGCRPYMAPERIDPSD 243 (361)
T ss_pred hhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH--HHHHhhhccCCccccChhccCCcc
Confidence 888888888999999986432 9999999999999999999999999964322 22233456788899999998743
Q ss_pred -CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhh--------hHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 158 -QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEA--------EKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 158 -~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
.|+.++|+||+|++|||++||.-|...-......+.....+.. ....+..+..+|..||..|-+.||...+
T Consensus 244 ~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~ 323 (361)
T KOG1006|consen 244 KGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDD 323 (361)
T ss_pred CCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhh
Confidence 5889999999999999999999887655444444444433322 2335677999999999999999999999
Q ss_pred HHHHHH
Q 044846 229 VTLELA 234 (290)
Q Consensus 229 l~~~l~ 234 (290)
+.++-.
T Consensus 324 Lk~~~f 329 (361)
T KOG1006|consen 324 LKKFPF 329 (361)
T ss_pred hhcCch
Confidence 987643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=236.51 Aligned_cols=221 Identities=20% Similarity=0.256 Sum_probs=174.6
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
++.||+|++.. ......++..+|..++..+.|+||++++.+|.-.. .+|+|||+| .++|..++..
T Consensus 41 ~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~------ 113 (369)
T KOG0665|consen 41 GRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM------ 113 (369)
T ss_pred cCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH------
Confidence 67899998743 33344566778999999999999999999997543 569999999 5699999883
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.++-+++..+..|+++|++|||+.+ |+||||||+||++..+..+||.|||+++..... ...+.+..+..|.|||+
T Consensus 114 elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapev 188 (369)
T KOG0665|consen 114 ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEV 188 (369)
T ss_pred hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchh
Confidence 3566888999999999999999999 999999999999999999999999998765433 34566778899999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchh--hhh-------------------hhHHHhh---------------
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVE--ENR-------------------SLAAYFS--------------- 197 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~--~~~-------------------~~~~~~~--------------- 197 (290)
+.+..|.+.+||||+||++.||++|+-.|..... +-. ....+..
T Consensus 189 il~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fp 268 (369)
T KOG0665|consen 189 ILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFP 268 (369)
T ss_pred eeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCC
Confidence 9999999999999999999999988876653211 000 0000000
Q ss_pred -------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 198 -------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 198 -------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
...+.......++++.+||-.||++|.|+++++.|..
T Consensus 269 D~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 269 DSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred cccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 0011122345789999999999999999999998853
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=259.40 Aligned_cols=232 Identities=23% Similarity=0.327 Sum_probs=191.4
Q ss_pred eEEEEeec-ccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSK-SVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~-~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
+||+|++. ....+..++++.|+-+|..|+|||+++++++|..+. +.||++|++.|+|.++++..+. .+-....+.
T Consensus 727 pVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~---~igsq~lLn 802 (1177)
T KOG1025|consen 727 PVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRD---NIGSQDLLN 802 (1177)
T ss_pred eeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhc---cccHHHHHH
Confidence 58999885 455666789999999999999999999999998876 7899999999999999998765 477788899
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeec-cceecccccCccccccCCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTT-QVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~ 161 (290)
|..||++||.|||+++ ++||||..+|+||.....+|+.|||+++........... ..+..+.|||-|.+....|+.
T Consensus 803 w~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~th 879 (1177)
T KOG1025|consen 803 WCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTH 879 (1177)
T ss_pred HHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCc
Confidence 9999999999999999 999999999999999999999999999876655444332 334567899999999999999
Q ss_pred cccchhhHHHHHHHhc-CCCCccc-chhhhhhh-HHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLV-DVEENRSL-AAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++|||||||++||++| |..|+.. ..++...+ ..-.+-..++.++.++..++.+||..|+..||+|+++...+..+..
T Consensus 880 qSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 880 QSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred hhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 9999999999999874 4444432 22222222 2222344566788899999999999999999999999999888776
Q ss_pred hhCc
Q 044846 239 SIGA 242 (290)
Q Consensus 239 ~~~~ 242 (290)
....
T Consensus 960 dpqr 963 (1177)
T KOG1025|consen 960 DPQR 963 (1177)
T ss_pred Ccce
Confidence 5443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=239.86 Aligned_cols=215 Identities=22% Similarity=0.265 Sum_probs=179.8
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
.+.||||+++. ...++++--+.|-++|.-. +-|.++++..+|++.+.+|.||||+.||+|.-.+++.+ .+.+
T Consensus 374 dELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G----kFKE 449 (683)
T KOG0696|consen 374 DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----KFKE 449 (683)
T ss_pred chhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhc----ccCC
Confidence 46789998874 2345566667788888877 68899999999999999999999999999999998776 5888
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.+|+-||-|||+++ ||.||||.+||+++.+|++||+|||+++...... ..+.++.||+.|+|||++..+
T Consensus 450 p~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~-~TTkTFCGTPdYiAPEIi~Yq 525 (683)
T KOG0696|consen 450 PVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG-VTTKTFCGTPDYIAPEIIAYQ 525 (683)
T ss_pred chhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCC-cceeeecCCCcccccceEEec
Confidence 899999999999999999999 9999999999999999999999999987543222 234568899999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
.|+..+|.||||++||||+.|.+||..+.+. ........ -.++...+.+..++.+..|...|.+|..
T Consensus 526 PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 526 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ccccchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 9999999999999999999999988654332 22222222 2345667778889999999999999964
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=214.10 Aligned_cols=188 Identities=20% Similarity=0.254 Sum_probs=152.0
Q ss_pred CceEEEEeecc-cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS-VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~-~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|...|+|.++. .+.+..++.++|+.+...- ..|.+|.++|........||.||.| .-+|..+-++-......+++..
T Consensus 71 g~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~v 149 (282)
T KOG0984|consen 71 GTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDV 149 (282)
T ss_pred CeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHH
Confidence 67899999974 4556677889999876655 8999999999999999999999999 5599888877555555789999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc---
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS--- 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--- 156 (290)
+-+++..+..||.|||++-. +||||+||+|||++.+|++|+||||++-... .+-..+...|...|||||.+..
T Consensus 150 lGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~--dSiAkt~daGCkpYmaPEri~~e~n 225 (282)
T KOG0984|consen 150 LGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLV--DSIAKTMDAGCKPYMAPERINPELN 225 (282)
T ss_pred hhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeeh--hhhHHHHhcCCCccCChhhcCcccC
Confidence 99999999999999998643 9999999999999999999999999954322 2222233567788999998753
Q ss_pred -CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHH
Q 044846 157 -SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA 194 (290)
Q Consensus 157 -~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~ 194 (290)
..|+.++||||+|+++.||.+++.|+.........+..
T Consensus 226 ~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 226 QKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred cccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 36899999999999999999998777554444444443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=239.31 Aligned_cols=223 Identities=17% Similarity=0.171 Sum_probs=177.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC------CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN------HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~------Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|..||||+++.. +--.+.-++|+++|++|+ --|+++|+..|...+++|||+|.+ ..+|.++|+..+.. ..|
T Consensus 457 ~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL 533 (752)
T KOG0670|consen 457 GQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGL 533 (752)
T ss_pred CCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc-cce
Confidence 568999999864 333566789999999994 228999999999999999999999 56999999987643 468
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC-CcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
....+..|+.|+..||..|-..+ |+|.||||+||||... ..+||||||.|-... . ...+.+..+..|.|||++
T Consensus 534 ~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~--e-neitPYLVSRFYRaPEIi 607 (752)
T KOG0670|consen 534 HIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFAS--E-NEITPYLVSRFYRAPEII 607 (752)
T ss_pred eehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccc--c-ccccHHHHHHhccCccee
Confidence 88899999999999999999999 9999999999999865 457999999864332 1 122345567789999999
Q ss_pred ccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh-hhHHHhh------------------------------------
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR-SLAAYFS------------------------------------ 197 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~-~~~~~~~------------------------------------ 197 (290)
.+-.|+...|+||.||+||||++|+-.|......+. .+..-+.
T Consensus 608 LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~ 687 (752)
T KOG0670|consen 608 LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTERE 687 (752)
T ss_pred ecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccce
Confidence 999999999999999999999999977754322111 1100000
Q ss_pred ------------------------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 198 ------------------------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 198 ------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
..........|.+|+.+||..||++|.|..+++.|.
T Consensus 688 ~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 688 KRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred eEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 111233456799999999999999999999998875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=214.96 Aligned_cols=219 Identities=17% Similarity=0.214 Sum_probs=171.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.+++|.++.+... .+.+|+++|+.| .||||+++++...+. ....|++||+.+.+...+.. .++.-
T Consensus 63 ~eK~ViKiLKPVkkk---KIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-------tl~d~ 132 (338)
T KOG0668|consen 63 NEKCVIKILKPVKKK---KIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-------TLTDY 132 (338)
T ss_pred CceEEEeeechHHHH---HHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh-------hhchh
Confidence 567899999876555 566999999999 499999999998764 45679999998877766654 46677
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
.++.++.+++.||.|||+.| |+|||+||.|++++. ...++|+|+|+|..... ....+....+..|..||.+..-
T Consensus 133 dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp--~~eYnVRVASRyfKGPELLVdy 207 (338)
T KOG0668|consen 133 DIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELLVDY 207 (338)
T ss_pred hHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC--CceeeeeeehhhcCCchheeec
Confidence 88999999999999999999 999999999999995 45699999999875432 2234445667789999998754
Q ss_pred -CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---------------------------------------
Q 044846 158 -QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--------------------------------------- 197 (290)
Q Consensus 158 -~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--------------------------------------- 197 (290)
.|+..-|+|||||+++.|++.+.||+...+....+.....
T Consensus 208 ~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~ 287 (338)
T KOG0668|consen 208 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFIN 287 (338)
T ss_pred hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCC
Confidence 5888999999999999999999998866443222221111
Q ss_pred hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 198 KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 198 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.+.....+++..+|+.+.|..|-.+|+|+.|.+.|...
T Consensus 288 ~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF 325 (338)
T KOG0668|consen 288 SENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF 325 (338)
T ss_pred ccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence 00011123578899999999999999999999988543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=263.72 Aligned_cols=200 Identities=16% Similarity=0.108 Sum_probs=144.4
Q ss_pred HHhcCC-CceeeEEeEE-------EeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 044846 28 LSQINH-RNVVKILGCC-------LETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVAS 99 (290)
Q Consensus 28 l~~l~H-pniv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~ 99 (290)
.+.++| +||++++++| .....++.++|++ +++|.+++.... ..+++..++.++.||+.||.|||+++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g- 100 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG- 100 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 345567 6888888887 3334678889988 679999997532 25899999999999999999999999
Q ss_pred CCeEeccCCCCceEeccC-------------------CcEEEeccccccccccCC---------------ceeeccceec
Q 044846 100 IPIYHLDIKSANILLVDK-------------------YQAKISDFRTFKSRAIDR---------------THLTTQVKVT 145 (290)
Q Consensus 100 ~~iiHrdlkp~Nil~~~~-------------------~~~kl~dfg~~~~~~~~~---------------~~~~~~~~g~ 145 (290)
|+||||||+|||++.. +.+|++|||+++...... ........||
T Consensus 101 --IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 101 --IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred --eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 9999999999999654 445666666654311000 0001123578
Q ss_pred ccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 146 FGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 146 ~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
+.|+|||++.+..|+.++|||||||+||||+++.+++.........+.................+++.+||+.||.+||+
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence 88999999999999999999999999999999887654322222222111111111223445678899999999999999
Q ss_pred HHHHHHHHH
Q 044846 226 MKEVTLELA 234 (290)
Q Consensus 226 ~~el~~~l~ 234 (290)
+.|++++.+
T Consensus 259 ~~eil~h~~ 267 (793)
T PLN00181 259 MSELLQSEF 267 (793)
T ss_pred hHHHhhchh
Confidence 999987643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=225.55 Aligned_cols=232 Identities=18% Similarity=0.272 Sum_probs=186.3
Q ss_pred EEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCcceEEEEeCCCCCHHHHHhhcC----CCCCCCCHHHH
Q 044846 7 LKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYIHEQT----DDQLPITWEMR 80 (290)
Q Consensus 7 vK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~ 80 (290)
+|.++. .+.-++..++.|.-.+..+.|||+..+.+++.. ....++++.++..|+|..|+...+ ...+.++..+.
T Consensus 319 vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~ql 398 (563)
T KOG1024|consen 319 VKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQL 398 (563)
T ss_pred HHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHH
Confidence 444442 334457788999999999999999999999865 567889999999999999998322 12235667788
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee-ccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT-TQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.|++.|++|||+.+ +||.||..+||+|++.-++||+|-.+++......-+.. .....+..||+||.+.+..|
T Consensus 399 V~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y 475 (563)
T KOG1024|consen 399 VLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY 475 (563)
T ss_pred HHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh
Confidence 899999999999999999 99999999999999999999999988776544333332 23345678999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhh---HHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL---AAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
+.++|+||||+++|||++....+..+.+..+.. ....+...+.+++.++..++..||..+|++||+++|++..|.++
T Consensus 476 ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 476 SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 999999999999999987665555555443322 22334456778999999999999999999999999999999888
Q ss_pred HhhhC
Q 044846 237 RASIG 241 (290)
Q Consensus 237 ~~~~~ 241 (290)
...+.
T Consensus 556 ~~qlt 560 (563)
T KOG1024|consen 556 HTQLT 560 (563)
T ss_pred HHHHh
Confidence 76653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=243.91 Aligned_cols=228 Identities=16% Similarity=0.181 Sum_probs=147.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeE------EEeCCcceEEEEeCCCCCHHHHHhhcCCC----
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGC------CLETEVPLLVYEFIPNGSLYQYIHEQTDD---- 71 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---- 71 (290)
++.||+|++..... .+.+..| .+....+.+++.+... .......+||+||+.+++|.+++......
T Consensus 161 ~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~ 236 (566)
T PLN03225 161 EGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVE 236 (566)
T ss_pred CcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHH
Confidence 57899998764322 2222222 1222222333332222 23456789999999999999998754311
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCcee
Q 044846 72 ------------QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRTHL 138 (290)
Q Consensus 72 ------------~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~ 138 (290)
........+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.........
T Consensus 237 ~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~ 313 (566)
T PLN03225 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI 313 (566)
T ss_pred HHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccC
Confidence 001123345679999999999999999 999999999999985 5799999999987544333333
Q ss_pred eccceecccccCccccccC----------------------CCCCcccchhhHHHHHHHhcCCCCcccchhhhhh-----
Q 044846 139 TTQVKVTFGYVDPKYFRSS----------------------QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS----- 191 (290)
Q Consensus 139 ~~~~~g~~~y~aPE~~~~~----------------------~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~----- 191 (290)
.....+++.|+|||.+... .++.++|||||||++|||+++..+..........
T Consensus 314 ~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~ 393 (566)
T PLN03225 314 PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRN 393 (566)
T ss_pred CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhc
Confidence 4456788999999965422 2344679999999999999765433221111000
Q ss_pred ------hHHHhhhhhhH----------HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 192 ------LAAYFSKEAEK----------EEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 192 ------~~~~~~~~~~~----------~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
+.......... .......+||.+||+.||++|||+.|+++|.+-.
T Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~ 454 (566)
T PLN03225 394 DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454 (566)
T ss_pred CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcC
Confidence 00000000000 0112345899999999999999999999986543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=225.11 Aligned_cols=225 Identities=20% Similarity=0.252 Sum_probs=176.4
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----cceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETE-----VPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+||+.... -...+++.+|++.|..++|.|++..++...-.. .+|+++|+| ..+|.+.+..-. .
T Consensus 78 grrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSPQ----~ 152 (449)
T KOG0664|consen 78 GKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSPQ----A 152 (449)
T ss_pred ccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccCC----C
Confidence 6789999987533 334668999999999999999999988876543 468899999 458988887544 6
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
++...++-++.||+.||+|||+.+ |.||||||.|.|++.+..+||||||+++....+.....+....|..|.|||++
T Consensus 153 Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiL 229 (449)
T KOG0664|consen 153 LTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELL 229 (449)
T ss_pred CCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHh
Confidence 888899999999999999999999 99999999999999999999999999998776666666667788999999999
Q ss_pred ccC-CCCCcccchhhHHHHHHHhcCCCCcccchh--hhhhhHHHhh--------------------hh------------
Q 044846 155 RSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVE--ENRSLAAYFS--------------------KE------------ 199 (290)
Q Consensus 155 ~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~--~~~~~~~~~~--------------------~~------------ 199 (290)
.+. .|+.++||||.|||+.|++..+-.|..... +...+...+- ..
T Consensus 230 MGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtl 309 (449)
T KOG0664|consen 230 MGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKI 309 (449)
T ss_pred hcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeee
Confidence 986 489999999999999999877766654321 1111111110 00
Q ss_pred -hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 200 -AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 200 -~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.......+..++..+++..||++|.+.++.+.++.
T Consensus 310 sS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 310 ASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred cCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00011224567888999999999999999887764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=235.64 Aligned_cols=231 Identities=16% Similarity=0.152 Sum_probs=159.3
Q ss_pred CceEEEEeecccCchhHHHHH--------------HHHHHHHhcCCCce-----eeEEeEEEe--------CCcceEEEE
Q 044846 2 EELWLLKKSKSVHESNVEQFI--------------NEVVILSQINHRNV-----VKILGCCLE--------TEVPLLVYE 54 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~--------------~E~~~l~~l~Hpni-----v~~~~~~~~--------~~~~~lv~e 54 (290)
++.||||+++.......+.|. .|+..+..++|.++ ++++++|.. .+..|||+|
T Consensus 186 ~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~E 265 (507)
T PLN03224 186 KRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWK 265 (507)
T ss_pred CceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEE
Confidence 357999998754443333443 46667777765544 677777653 356799999
Q ss_pred eCCCCCHHHHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe
Q 044846 55 FIPNGSLYQYIHEQTDD--------------------QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL 114 (290)
Q Consensus 55 ~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~ 114 (290)
|+++|+|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 266 y~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl 342 (507)
T PLN03224 266 FESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLV 342 (507)
T ss_pred cCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEE
Confidence 99999999998753210 112456778899999999999999999 9999999999999
Q ss_pred ccCCcEEEeccccccccccCCceeeccceecccccCccccccCC--------------------CC--CcccchhhHHHH
Q 044846 115 VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ--------------------FT--EKSDVYSFSVVL 172 (290)
Q Consensus 115 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--------------------~~--~~~DiwS~G~il 172 (290)
+.++.+||+|||++...............+++.|+|||.+.... |+ .+.||||+||++
T Consensus 343 ~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil 422 (507)
T PLN03224 343 TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLL 422 (507)
T ss_pred CCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHH
Confidence 99999999999998643322111112233478899999876432 11 247999999999
Q ss_pred HHHhcCCCCcccchh-hhhh----------hHHHhh----hhhhHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHHHH
Q 044846 173 VELNWTKPIHLVDVE-ENRS----------LAAYFS----KEAEKEEVITFAMVAKRCLNLNG---KKQPTMKEVTLELA 234 (290)
Q Consensus 173 ~~l~~~~~~~~~~~~-~~~~----------~~~~~~----~~~~~~~~~~~~~li~~cl~~dp---~~Rps~~el~~~l~ 234 (290)
++|+++...+..... .... +..... -......+....+|+.++|..+| .+|+|+.|++.|.+
T Consensus 423 ~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 423 MQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred HHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 999988753322111 0000 000000 01112345678999999999876 68999999998865
Q ss_pred h
Q 044846 235 G 235 (290)
Q Consensus 235 ~ 235 (290)
.
T Consensus 503 f 503 (507)
T PLN03224 503 F 503 (507)
T ss_pred c
Confidence 3
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=205.04 Aligned_cols=194 Identities=30% Similarity=0.443 Sum_probs=167.2
Q ss_pred CceEEEEeecccCch-hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHES-NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.+++|+....... ..+.+.+|++.++.+.|++|+++++++......++++|++.+++|.+++.... ..++...+
T Consensus 18 ~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~---~~~~~~~~ 94 (215)
T cd00180 18 GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEI 94 (215)
T ss_pred CcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc---CCCCHHHH
Confidence 678999998764433 45689999999999999999999999999999999999999899999998653 14788999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCceeeccceecccccCccccccC-C
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-Q 158 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 158 (290)
..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+...|++||.+... .
T Consensus 95 ~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~ 170 (215)
T cd00180 95 LRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGY 170 (215)
T ss_pred HHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCC
Confidence 999999999999999998 999999999999999 89999999998764432211 12234467789999999877 7
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++.+.|+|++|++++++ ..+.+++.+|++.||++||++.+++++
T Consensus 171 ~~~~~D~~~lg~~~~~l------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 171 YSEKSDIWSLGVILYEL------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred CCchhhhHHHHHHHHHH------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 88899999999999998 568899999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=240.28 Aligned_cols=222 Identities=23% Similarity=0.265 Sum_probs=185.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+..|+|+++.....++.-..+|+-+++..+|||||.|+|.+...+..||.||||.+|+|.+.-.... ++++.++.
T Consensus 40 ~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg----plselqia 115 (829)
T KOG0576|consen 40 GELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG----PLSELQIA 115 (829)
T ss_pred CchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc----cchhHHHH
Confidence 67789999998888888888999999999999999999999999999999999999999999887665 79999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---cCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR---SSQ 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~ 158 (290)
...++.+.||.|||+.+ =+|||||-.|||+++.|.+|++|||.+......-. ..-.+.||+.|||||+.. .+.
T Consensus 116 yvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~-KrksfiGtpywmapEvaaverkgg 191 (829)
T KOG0576|consen 116 YVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KRKSFIGTPYWMAPEVAAVERKGG 191 (829)
T ss_pred HHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh-hhhcccCCccccchhHHHHHhccc
Confidence 99999999999999999 78999999999999999999999998643322211 223478999999999864 467
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
|...+|||+.|++..|+....+|-+.-. .+..+...... .....++..|-+|++.||..+|++|||++.++.
T Consensus 192 ynqlcdiwa~gitAiel~eLqpplfdlh-pmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 192 YNQLCDIWALGITAIELGELQPPLFDLH-PMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccccccccccccchhhhhhcCCcccccc-hHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 8999999999999999987777655433 33333333221 123456778999999999999999999998865
Q ss_pred H
Q 044846 232 E 232 (290)
Q Consensus 232 ~ 232 (290)
|
T Consensus 271 h 271 (829)
T KOG0576|consen 271 H 271 (829)
T ss_pred c
Confidence 4
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=216.23 Aligned_cols=215 Identities=19% Similarity=0.272 Sum_probs=175.8
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
.+.||+|+++. .+.++++-+..|..+..+- +||.+|-+..+|++...++.|.||++||+|.-.+.+.+ .+++
T Consensus 275 ~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqr----klpe 350 (593)
T KOG0695|consen 275 DQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPE 350 (593)
T ss_pred ceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhh----cCcH
Confidence 36788888863 4556677788898888887 89999999999999999999999999999988887665 5999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
+.++.+..+|+.||.|||+.| ||.||||.+|+|++..|++||.|+|+++.. ......+.++.||+.|.|||++.+.
T Consensus 351 eharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~-l~~gd~tstfcgtpnyiapeilrge 426 (593)
T KOG0695|consen 351 EHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-LGPGDTTSTFCGTPNYIAPEILRGE 426 (593)
T ss_pred HHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC-CCCCcccccccCCCcccchhhhccc
Confidence 999999999999999999999 999999999999999999999999998753 3334456779999999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccch--h-----hhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDV--E-----ENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~--~-----~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
.|+..+|.|++|++++||+.|+.||..-- . +....+..+. ...+...+.....+++.-|+.||.+|.
T Consensus 427 eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 427 EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 99999999999999999999998875311 0 1111111111 112223345566789999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=200.69 Aligned_cols=160 Identities=21% Similarity=0.209 Sum_probs=126.2
Q ss_pred CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee
Q 044846 59 GSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138 (290)
Q Consensus 59 g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 138 (290)
|+|.+++..... ++++..++.++.|++.||.|||+.+ ||+|||++.++.+|+ ||.+......
T Consensus 1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 689999986432 5999999999999999999999875 999999999999999 9987653321
Q ss_pred eccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hh------hhHHHHH--H
Q 044846 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KE------AEKEEVI--T 207 (290)
Q Consensus 139 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~~~--~ 207 (290)
...|++.|+|||++.+..++.++|||||||++|||++|..|+............... .. ....... .
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARS 140 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhh
Confidence 125789999999999999999999999999999999999987544322221111111 11 1122222 6
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 208 FAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 208 ~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
+.+++.+||+.||.+||++.|+++++.....
T Consensus 141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 141 FADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 8999999999999999999999999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=212.61 Aligned_cols=109 Identities=26% Similarity=0.340 Sum_probs=92.5
Q ss_pred CCceEEEEeecccCchhHHHHHHHHHHHHhcC-----CC---ceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHhhc
Q 044846 1 MEELWLLKKSKSVHESNVEQFINEVVILSQIN-----HR---NVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIHEQ 68 (290)
Q Consensus 1 ~~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-----Hp---niv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~ 68 (290)
+.+.||+|+.+.. ....+..+.||++|++++ |+ .||+|++.|.. +.++|+|+|++ |-+|..+|+..
T Consensus 102 ~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s 179 (590)
T KOG1290|consen 102 NKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS 179 (590)
T ss_pred CCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh
Confidence 4578999999863 444667889999999982 33 79999999975 34889999999 77999999987
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec
Q 044846 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV 115 (290)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~ 115 (290)
... .++...++.|++||+.||.|||.... |||-||||+|||+.
T Consensus 180 ~Yr--Glpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 180 NYR--GLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLC 222 (590)
T ss_pred CCC--CCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeee
Confidence 765 57888999999999999999998764 99999999999995
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=216.09 Aligned_cols=170 Identities=19% Similarity=0.240 Sum_probs=142.9
Q ss_pred ceEEEEeecccCchhHH---------HHHHHHHHHHhcC---CCceeeEEeEEEeCCcceEEEEeC-CCCCHHHHHhhcC
Q 044846 3 ELWLLKKSKSVHESNVE---------QFINEVVILSQIN---HRNVVKILGCCLETEVPLLVYEFI-PNGSLYQYIHEQT 69 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~---------~~~~E~~~l~~l~---Hpniv~~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~ 69 (290)
..|++|.+... +--.+ .+-.|++||..|+ |+||++++++|++++++||+||-- +|.+|+++|....
T Consensus 587 ~eVViK~I~Ke-RIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp 665 (772)
T KOG1152|consen 587 YEVVIKMIFKE-RILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP 665 (772)
T ss_pred eEEEeeehhhh-hhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC
Confidence 46788877531 11111 2456999999997 999999999999999999999976 4679999998765
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceeccccc
Q 044846 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYV 149 (290)
Q Consensus 70 ~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 149 (290)
.+++..+..|+.||+.|+++||+.+ |||||||-+|+.++.+|-+||+|||.+.... +..-..+.||..|.
T Consensus 666 ----~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~k---sgpfd~f~gtv~~a 735 (772)
T KOG1152|consen 666 ----RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTK---SGPFDVFVGTVDYA 735 (772)
T ss_pred ----ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhc---CCCcceeeeecccc
Confidence 6899999999999999999999999 9999999999999999999999999864333 22334588999999
Q ss_pred CccccccCCCC-CcccchhhHHHHHHHhcCCCCcc
Q 044846 150 DPKYFRSSQFT-EKSDVYSFSVVLVELNWTKPIHL 183 (290)
Q Consensus 150 aPE~~~~~~~~-~~~DiwS~G~il~~l~~~~~~~~ 183 (290)
|||++.+..|- ..-|||++|++||-++....|++
T Consensus 736 apevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 736 APEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999998875 56999999999999988877764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=192.94 Aligned_cols=177 Identities=30% Similarity=0.418 Sum_probs=151.2
Q ss_pred CceEEEEeecccCch-hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHES-NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.+|+|........ ..+.+.+|++.++.++|+|++++++++......++++|++++++|.+++..... .+++..+
T Consensus 24 ~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~ 100 (225)
T smart00221 24 GELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGG---KLSEEEA 100 (225)
T ss_pred CcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhccc---CCCHHHH
Confidence 577999998765544 678899999999999999999999999998999999999999999999987542 1788899
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccc-ccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF-RSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~ 159 (290)
..++.+++.++.|||+.+ ++|+|++|.||+++.++.++|+|||.+...............++..|++||.+ ....+
T Consensus 101 ~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 177 (225)
T smart00221 101 RFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGY 177 (225)
T ss_pred HHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCC
Confidence 999999999999999998 99999999999999999999999998765443221122334567789999998 66677
Q ss_pred CCcccchhhHHHHHHHhcCCCCccc
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLV 184 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~ 184 (290)
+.++|+|+||++++++++|+.||..
T Consensus 178 ~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 178 GEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CchhhHHHHHHHHHHHHHCCCCccc
Confidence 8899999999999999999998854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=192.54 Aligned_cols=215 Identities=15% Similarity=0.224 Sum_probs=157.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeE-EEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGC-CLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
+..+|+|-+... ....+.|.+|.-.=-.| .|.||+.-|+. |+..+..+.++||++.|+|.+-+...+ +-+..
T Consensus 49 ~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G-----igE~~ 122 (378)
T KOG1345|consen 49 KTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG-----IGEAN 122 (378)
T ss_pred ceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc-----ccHHH
Confidence 345777777653 33366788888766667 58999987754 788888899999999999998876543 67788
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec--cCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV--DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
.+.++.|+++|+.|+|+++ ++|||||.+||||- +..++||||||........ ......+..|.+||.....
T Consensus 123 ~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~ 195 (378)
T KOG1345|consen 123 TKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTV 195 (378)
T ss_pred HHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCce----ehhhhhhcccCCcHHHhhc
Confidence 8999999999999999999 99999999999995 4568999999986533211 1112234568899876532
Q ss_pred -----CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhh------hhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 158 -----QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSK------EAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 158 -----~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
...+.+|+|.||++++.+++|++|++........+..+ ... ......++....+.++-|.++|++|
T Consensus 196 ~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 196 VNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 24567999999999999999999998544333333222 221 1223345667788899999999999
Q ss_pred CCHHHH
Q 044846 224 PTMKEV 229 (290)
Q Consensus 224 ps~~el 229 (290)
=-..++
T Consensus 276 cki~~~ 281 (378)
T KOG1345|consen 276 CKIWTA 281 (378)
T ss_pred chhHHH
Confidence 333333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=201.10 Aligned_cols=221 Identities=18% Similarity=0.215 Sum_probs=168.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.||+|.+...+ ...+...|++.|..+ .+.||+++.+++..+++..+|+||++.-...++... ++...+
T Consensus 64 ~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i 134 (418)
T KOG1167|consen 64 RRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEI 134 (418)
T ss_pred cceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHH
Confidence 4679999997643 344688999999999 799999999999999999999999999899888873 667889
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccC---------------C---------
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAID---------------R--------- 135 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~---------------~--------- 135 (290)
..+++.++.||.++|.+| ||||||||.|+|.+. .++-.|+|||++...... .
T Consensus 135 ~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~ 211 (418)
T KOG1167|consen 135 RWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQ 211 (418)
T ss_pred HHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccccc
Confidence 999999999999999999 999999999999985 467789999998610000 0
Q ss_pred -------------------ceeeccceecccccCcccccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH
Q 044846 136 -------------------THLTTQVKVTFGYVDPKYFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY 195 (290)
Q Consensus 136 -------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~ 195 (290)
........||++|.|||++.. +..++++||||.|+|+..++++.-||+-..+....+...
T Consensus 212 ~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei 291 (418)
T KOG1167|consen 212 SVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEI 291 (418)
T ss_pred ccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHH
Confidence 000112468999999999875 456789999999999999988777665332111100000
Q ss_pred hh------------------------------------hh---------h--------hHHHHHHHHHHHHHhhccCCCC
Q 044846 196 FS------------------------------------KE---------A--------EKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 196 ~~------------------------------------~~---------~--------~~~~~~~~~~li~~cl~~dp~~ 222 (290)
.. .. . ....+..+.+|+.+|++.||.+
T Consensus 292 ~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~k 371 (418)
T KOG1167|consen 292 ATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQK 371 (418)
T ss_pred HHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhh
Confidence 00 00 0 0011235789999999999999
Q ss_pred CCCHHHHHHHHH
Q 044846 223 QPTMKEVTLELA 234 (290)
Q Consensus 223 Rps~~el~~~l~ 234 (290)
|.|+++.++|..
T Consensus 372 RitAEeALkHpF 383 (418)
T KOG1167|consen 372 RITAEDALKHPF 383 (418)
T ss_pred cccHHHHhcCcC
Confidence 999999998853
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=205.64 Aligned_cols=207 Identities=19% Similarity=0.234 Sum_probs=163.2
Q ss_pred HHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 044846 21 FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASI 100 (290)
Q Consensus 21 ~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~ 100 (290)
+..|..+-..|.|||++..+..+.......-+||||++ +|+.++.... .++...+..++.|++.|+.|+|+.|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~G-- 440 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSMG-- 440 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhcC--
Confidence 55566677788999998887777666555555999999 9999998763 4777888899999999999999999
Q ss_pred CeEeccCCCCceEeccCCcEEEeccccccccccCCc---eeeccceecccccCccccccCCCCC-cccchhhHHHHHHHh
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT---HLTTQVKVTFGYVDPKYFRSSQFTE-KSDVYSFSVVLVELN 176 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~-~~DiwS~G~il~~l~ 176 (290)
|.|||+|++|+++...|.+||+|||.+........ .......|+..|+|||++.+..|.. ..||||.|+++..|.
T Consensus 441 -iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~ 519 (601)
T KOG0590|consen 441 -LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMI 519 (601)
T ss_pred -ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEe
Confidence 99999999999999999999999998765443222 3456678899999999999999987 599999999999999
Q ss_pred cCCCCcccchhhhhhhHH--Hh---h---h--hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 177 WTKPIHLVDVEENRSLAA--YF---S---K--EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~--~~---~---~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+|+.+|............ .. . . ......+...+.+|.+||+.||.+|.|+.+|++.-|-
T Consensus 520 ~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 520 LGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred cCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 998877654333222100 00 0 1 1122334568899999999999999999999876553
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=177.29 Aligned_cols=224 Identities=19% Similarity=0.290 Sum_probs=168.0
Q ss_pred eEEEEeec--ccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 4 LWLLKKSK--SVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 4 ~~avK~~~--~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
-++.|++. .......+.|..|...|+.+.||||..+++.|.....+.++..||+.|+|+.++.+..+- ..+-.++.
T Consensus 215 divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~v--vvd~sqav 292 (448)
T KOG0195|consen 215 DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSV--VVDHSQAV 292 (448)
T ss_pred chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccE--EEecchHH
Confidence 34556654 233444557888999999999999999999999999999999999999999999976542 56778999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC-
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT- 160 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~- 160 (290)
+++.+++.|++|||+..+. |-.-.|....+++|++.+.+|.-= -.+.. .......-.+.||+||.+....-+
T Consensus 293 ~faldiargmaflhslep~-ipr~~lns~hvmidedltarisma-d~kfs-----fqe~gr~y~pawmspealqrkped~ 365 (448)
T KOG0195|consen 293 RFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMA-DTKFS-----FQEVGRAYSPAWMSPEALQRKPEDL 365 (448)
T ss_pred HHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecc-cceee-----eeccccccCcccCCHHHHhcCchhc
Confidence 9999999999999998754 555568889999999988776521 11110 111122336789999999866433
Q ss_pred --CcccchhhHHHHHHHhcCCCCcccchhh---hhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 161 --EKSDVYSFSVVLVELNWTKPIHLVDVEE---NRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 161 --~~~DiwS~G~il~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.++|+|||.+++||+.|..-||..-... .......++...++..+.....|+.-|++.||.+||.++.++--|++
T Consensus 366 n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 366 NIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred chhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 4799999999999999988877532221 11112222333445566778899999999999999999999988876
Q ss_pred h
Q 044846 236 I 236 (290)
Q Consensus 236 ~ 236 (290)
+
T Consensus 446 m 446 (448)
T KOG0195|consen 446 M 446 (448)
T ss_pred h
Confidence 5
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-22 Score=171.22 Aligned_cols=225 Identities=26% Similarity=0.299 Sum_probs=173.3
Q ss_pred eEEEEeecccCch---hHHHHHHHHHHHHhcCCC-ceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 4 LWLLKKSKSVHES---NVEQFINEVVILSQINHR-NVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 4 ~~avK~~~~~~~~---~~~~~~~E~~~l~~l~Hp-niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
.+++|.+...... ....+.+|+.+++.+.|+ +|+++++.+......+++++++.++++.+++...... ..++...
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~ 102 (384)
T COG0515 24 LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESE 102 (384)
T ss_pred EEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHH
Confidence 5678887643332 477899999999999887 7999999997777789999999999999777765321 2478889
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-cEEEeccccccccccCCce-----eeccceecccccCccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDFRTFKSRAIDRTH-----LTTQVKVTFGYVDPKY 153 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~-----~~~~~~g~~~y~aPE~ 153 (290)
...++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|||.+......... ......|+..|++||.
T Consensus 103 ~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~ 179 (384)
T COG0515 103 ALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179 (384)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHH
Confidence 9999999999999999999 99999999999999988 7999999998643322221 2356778999999999
Q ss_pred ccc---CCCCCcccchhhHHHHHHHhcCCCCcccchh---hhhhhHHHhhhhh-----hHH------HHHHHHHHHHHhh
Q 044846 154 FRS---SQFTEKSDVYSFSVVLVELNWTKPIHLVDVE---ENRSLAAYFSKEA-----EKE------EVITFAMVAKRCL 216 (290)
Q Consensus 154 ~~~---~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~---~~~~~~~~~~~~~-----~~~------~~~~~~~li~~cl 216 (290)
+.+ ..+....|+||+|+++++++.+..|+..... ............. ... ....+.+++.+|+
T Consensus 180 ~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (384)
T COG0515 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLL 259 (384)
T ss_pred hcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHH
Confidence 987 5788899999999999999999887544432 1111111111110 011 1246889999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 044846 217 NLNGKKQPTMKEVTLE 232 (290)
Q Consensus 217 ~~dp~~Rps~~el~~~ 232 (290)
..+|..|.+..+....
T Consensus 260 ~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 260 AKDPKNRLSSSSDLSH 275 (384)
T ss_pred hcCchhcCCHHHHhhc
Confidence 9999999998877654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=177.64 Aligned_cols=206 Identities=21% Similarity=0.396 Sum_probs=156.8
Q ss_pred HHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-Eecc
Q 044846 28 LSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPI-YHLD 106 (290)
Q Consensus 28 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~i-iHrd 106 (290)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.... +.+++.-...++++|+.||.|||.-. | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 457899999999999999999999999999999999998733 36888888899999999999999865 4 9999
Q ss_pred CCCCceEeccCCcEEEeccccccccccC-CceeeccceecccccCccccccCC-------CCCcccchhhHHHHHHHhcC
Q 044846 107 IKSANILLVDKYQAKISDFRTFKSRAID-RTHLTTQVKVTFGYVDPKYFRSSQ-------FTEKSDVYSFSVVLVELNWT 178 (290)
Q Consensus 107 lkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwS~G~il~~l~~~ 178 (290)
|+..||+++..+.+||.|||+....... ............-|.|||.+.... .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999986544210 011111122344599999988642 35679999999999999998
Q ss_pred CCCcccchhhh--hhhHHHhhh-h--------h-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 044846 179 KPIHLVDVEEN--RSLAAYFSK-E--------A-EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239 (290)
Q Consensus 179 ~~~~~~~~~~~--~~~~~~~~~-~--------~-~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~ 239 (290)
..+|....... ..+...... . . .......+..++.+||..+|.+||+++++...++.+...
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 88876432211 111111111 0 0 112233688999999999999999999998888777653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-21 Score=167.37 Aligned_cols=232 Identities=17% Similarity=0.119 Sum_probs=173.9
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCC----CceeeEEeEE-EeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINH----RNVVKILGCC-LETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~H----pniv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
+.+|+|............+..|+.++..+.. +++..+++.. ....+.|+||+.+ |.+|.++..... ...++.
T Consensus 45 ~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~ 121 (322)
T KOG1164|consen 45 KEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSR 121 (322)
T ss_pred eeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCH
Confidence 3578888766444433367889999999863 5888899888 4777889999999 889999887665 236999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC-----CcEEEecccccc--ccccCCc-----ee--eccce
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-----YQAKISDFRTFK--SRAIDRT-----HL--TTQVK 143 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~-----~~~kl~dfg~~~--~~~~~~~-----~~--~~~~~ 143 (290)
.+...++.|++.+|+++|+.| ++||||||.|+++... ..+.|.|||+++ ....... .. .....
T Consensus 122 ~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~r 198 (322)
T KOG1164|consen 122 KTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFR 198 (322)
T ss_pred hHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCC
Confidence 999999999999999999999 9999999999999865 468999999998 3211111 11 13456
Q ss_pred ecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchh--hhhhhHHHhhhh----hhHHHHHHHHHHHHHhhc
Q 044846 144 VTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVE--ENRSLAAYFSKE----AEKEEVITFAMVAKRCLN 217 (290)
Q Consensus 144 g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~ 217 (290)
||..|.++++..+...+.+.|+||++.++.++..|..|+..... ............ .....+..+..+...+-.
T Consensus 199 GT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (322)
T KOG1164|consen 199 GTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDS 278 (322)
T ss_pred CccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhc
Confidence 99999999999999999999999999999999989866633221 111111111111 111234567777777777
Q ss_pred cCCCCCCCHHHHHHHHHhhHhhh
Q 044846 218 LNGKKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 218 ~dp~~Rps~~el~~~l~~~~~~~ 240 (290)
.+...+|....+...+.......
T Consensus 279 ~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 279 LDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred cCCcCCCCHHHHHHHHHHHHHhc
Confidence 99999999999988877766543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=172.49 Aligned_cols=138 Identities=17% Similarity=0.089 Sum_probs=104.0
Q ss_pred CceEEEEeeccc-----CchhHHHHHHHHHHHHhcCCCceee-EEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSV-----HESNVEQFINEVVILSQINHRNVVK-ILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~-~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||++... .....+.+.+|+++|+.|+|+|++. +++ .+..|||||||+|++|... . . .
T Consensus 44 ~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~--~-----~ 111 (365)
T PRK09188 44 GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-R--P-----H 111 (365)
T ss_pred CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-C--c-----c
Confidence 456799986532 2234567999999999999999985 443 2467999999999999632 1 1 1
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccC-CCCceEeccCCcEEEeccccccccccCCcee-------eccceeccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDI-KSANILLVDKYQAKISDFRTFKSRAIDRTHL-------TTQVKVTFG 147 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdl-kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-------~~~~~g~~~ 147 (290)
. ...++.+++.+|.|||+++ |+|||| ||+|||++.++.+||+|||+++......... .....++..
T Consensus 112 ~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~ 185 (365)
T PRK09188 112 G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKR 185 (365)
T ss_pred c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCc
Confidence 1 1457889999999999999 999999 9999999999999999999987543221110 134567788
Q ss_pred ccCccccccC
Q 044846 148 YVDPKYFRSS 157 (290)
Q Consensus 148 y~aPE~~~~~ 157 (290)
|+|||.+...
T Consensus 186 ~~~pe~~~~~ 195 (365)
T PRK09188 186 TYAPDALTPR 195 (365)
T ss_pred cCCcccCChh
Confidence 9999998654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=151.21 Aligned_cols=230 Identities=18% Similarity=0.126 Sum_probs=176.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINH-RNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|..+.. ....++.-|.++.+.|++ ..|..+..+.....+-.+||+++ |-+|.+++.-... .++..+.
T Consensus 40 ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R---~ftmkTv 113 (341)
T KOG1163|consen 40 GEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSR---RFTMKTV 113 (341)
T ss_pred CceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhh---hhhHHhH
Confidence 789999998752 334568899999999964 67888888888888999999999 8899998865433 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCcee------eccceecccccCc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRTHL------TTQVKVTFGYVDP 151 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~------~~~~~g~~~y~aP 151 (290)
+-++.|++.-++|+|.++ +|||||||+|.|..- ...+.++|||+++......+.. .....||.+|.+-
T Consensus 114 LMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASi 190 (341)
T KOG1163|consen 114 LMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASI 190 (341)
T ss_pred HHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhh
Confidence 999999999999999999 999999999999974 3457899999998644322221 2335688899987
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh-hh-----HHHhh---hhhhHHHHHHHHHHHHHhhccCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR-SL-----AAYFS---KEAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~-~~-----~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
....+...+.+.|+=|+|.+|.++..|.-||..-..... .. ..... .......+.+|...+..|-..--++
T Consensus 191 nAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E 270 (341)
T KOG1163|consen 191 NAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEE 270 (341)
T ss_pred hhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCC
Confidence 777777778889999999999888889888875332211 11 11111 1223345678999999999999999
Q ss_pred CCCHHHHHHHHHhhHhhh
Q 044846 223 QPTMKEVTLELAGIRASI 240 (290)
Q Consensus 223 Rps~~el~~~l~~~~~~~ 240 (290)
-|...-+.+.+..+...+
T Consensus 271 ~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 271 KPDYMYLRQLFRILFRTL 288 (341)
T ss_pred CCcHHHHHHHHHHHHhhc
Confidence 999888877776665544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-22 Score=178.19 Aligned_cols=208 Identities=20% Similarity=0.190 Sum_probs=166.0
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|..+|+|+.+... .........|..++..++ ||.+|++.-.|+.+...+++++|..||+|...+.... .+++.
T Consensus 22 ~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~----~f~~~ 97 (612)
T KOG0603|consen 22 GHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV----MFDEL 97 (612)
T ss_pred cchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC----chHHH
Confidence 4567777765311 112225567888999985 9999999999999999999999999999999988765 47788
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
....+...++.++..+|+.+ |+|||+|++||+++.+|++++.|||+++..-.... ..||.-|||||++. .
T Consensus 98 ~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~cgt~eymApEI~~--g 167 (612)
T KOG0603|consen 98 DVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----ACGTYEYRAPEIIN--G 167 (612)
T ss_pred HHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-----cccchhhhhhHhhh--c
Confidence 88889999999999999999 99999999999999999999999999875432221 16799999999998 5
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
....+|.||||++++||++|..+|..+. ..... ......+........+++.+++..+|.+|.-.
T Consensus 168 h~~a~D~ws~gvl~felltg~~pf~~~~-~~~Il--~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 168 HLSAADWWSFGVLAFELLTGTLPFGGDT-MKRIL--KAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCcccchhhhhhHHHHhhCCCCCchHH-HHHHh--hhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 5678999999999999999999987611 11111 11233455667778899999999999999754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.2e-22 Score=174.98 Aligned_cols=175 Identities=20% Similarity=0.297 Sum_probs=134.9
Q ss_pred cceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccc
Q 044846 48 VPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127 (290)
Q Consensus 48 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~ 127 (290)
++||.|++|...+|.+++....... ..++...+.++.|++.|+.| ++ .+|||+||.||....+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e-~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGE-ERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCccc-ccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997544322 46678889999999999999 67 89999999999999999999999999
Q ss_pred ccccccCC-----ceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhH
Q 044846 128 FKSRAIDR-----THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEK 202 (290)
Q Consensus 128 ~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (290)
........ ....+.-.||..||+||.+.+..|+.++||||+|+||+|++.-.............+.....++...
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFL 482 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHh
Confidence 76654333 1234557899999999999999999999999999999999874433332333333333222232333
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 203 EEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 203 ~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
...+.-..|+.+++.+.|.+||++.+.
T Consensus 483 ~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 483 QDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 444556789999999999999965544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=161.72 Aligned_cols=187 Identities=17% Similarity=0.157 Sum_probs=137.7
Q ss_pred CCCceeeEEeEEEeC---------------------------CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHH
Q 044846 32 NHRNVVKILGCCLET---------------------------EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRIT 84 (290)
Q Consensus 32 ~Hpniv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 84 (290)
.|||||++.++|.+. ..+|+||...+. +|..++..+. .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 699999999988643 235899998854 9999997653 5566777788
Q ss_pred HHHHHHHHHHhhCCCCCeEeccCCCCceEec--cCC--cEEEeccccccccccCCc--e---eeccceecccccCccccc
Q 044846 85 VEVSRVLSYLHSVASIPIYHLDIKSANILLV--DKY--QAKISDFRTFKSRAIDRT--H---LTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 85 ~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~--~~~--~~kl~dfg~~~~~~~~~~--~---~~~~~~g~~~y~aPE~~~ 155 (290)
.|+++|+.|||.++ |.|||+|.+|||+. +|+ .+.|+|||.+.......- . ......|.-..||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 99999999999995 332 478999998754332111 1 112345777899999976
Q ss_pred cCC------CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 156 SSQ------FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 156 ~~~------~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
... --.|+|.|+.|.+.||+++...||+..-+..-....+ .....+...++.+++|+...|+.||.+|++.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 432 1248999999999999999998887633322222222 2233344567789999999999999999985
Q ss_pred H
Q 044846 227 K 227 (290)
Q Consensus 227 ~ 227 (290)
.
T Consensus 505 ~ 505 (598)
T KOG4158|consen 505 N 505 (598)
T ss_pred c
Confidence 4
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-19 Score=149.14 Aligned_cols=230 Identities=14% Similarity=0.074 Sum_probs=178.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|.... .++..++..|-+.++.| ..+.|..++-+-..+.+-.||+|++ |-+|+++..-... .|+..++
T Consensus 53 ne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR---~FSvKTV 126 (449)
T KOG1165|consen 53 NEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGR---RFSVKTV 126 (449)
T ss_pred CceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcC---cccHHhH
Confidence 68899999875 55566788999999999 5789999887777788889999999 8899998875543 6999999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-----cEEEeccccccccccCCceee------ccceeccccc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-----QAKISDFRTFKSRAIDRTHLT------TQVKVTFGYV 149 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-----~~kl~dfg~~~~~~~~~~~~~------~~~~g~~~y~ 149 (290)
..++.|++.-++|+|++. +|.|||||+|.||...+ .+.++|||+|+......++.+ -...||.+||
T Consensus 127 ~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYM 203 (449)
T KOG1165|consen 127 AMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYM 203 (449)
T ss_pred HHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeee
Confidence 999999999999999999 99999999999998654 478999999986543333222 2356899999
Q ss_pred CccccccCCCCCcccchhhHHHHHHHhcCCCCcccchh-hhhhhHHH--------hhhhhhHHHHHHHHHHHHHhhccCC
Q 044846 150 DPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVE-ENRSLAAY--------FSKEAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 150 aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~-~~~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~dp 220 (290)
+-....+.+.+.+-|+=|+|-++.+.+.|..||..-.. ....-... .........+.+|..-+...=..+-
T Consensus 204 SINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F 283 (449)
T KOG1165|consen 204 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDF 283 (449)
T ss_pred EeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCc
Confidence 99999999999999999999999888899988864321 11111110 0122334456788888888888899
Q ss_pred CCCCCHHHHHHHHHhhHhhh
Q 044846 221 KKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 221 ~~Rps~~el~~~l~~~~~~~ 240 (290)
.+-|..+-+...+..+....
T Consensus 284 ~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 284 FETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred ccCCCHHHHHHHHHHHHHhc
Confidence 99999887776665555433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=178.49 Aligned_cols=216 Identities=21% Similarity=0.294 Sum_probs=152.2
Q ss_pred ceEEEEeecccC-c---hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 3 ELWLLKKSKSVH-E---SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 3 ~~~avK~~~~~~-~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
..|++|++-..+ . ....+-+.|++ ...++|||++.+..+.......|||-+|..+ +|++.+.-+. -+..-
T Consensus 47 G~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRP----FL~~i 120 (1431)
T KOG1240|consen 47 GLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRP----FLVLI 120 (1431)
T ss_pred ceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccch----HHHHH
Confidence 347889874333 3 33444444555 4445899999998888888888999999954 9999997654 25556
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceee-ccc----eecccccCcc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLT-TQV----KVTFGYVDPK 152 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~-~~~----~g~~~y~aPE 152 (290)
..+-|+.|++.||.-+|..+ |+|+|||.+|||++.=.=+.|+||...+...... .... +-+ ..-..|.|||
T Consensus 121 EKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPE 197 (1431)
T KOG1240|consen 121 EKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPE 197 (1431)
T ss_pred HHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChH
Confidence 66778899999999999999 9999999999999877678999997655332211 1111 111 1123599999
Q ss_pred ccccCC-----------CCCcccchhhHHHHHHHh-cCCCCcccchhhhhhhHHHhhh-h------hhHHHHHHHHHHHH
Q 044846 153 YFRSSQ-----------FTEKSDVYSFSVVLVELN-WTKPIHLVDVEENRSLAAYFSK-E------AEKEEVITFAMVAK 213 (290)
Q Consensus 153 ~~~~~~-----------~~~~~DiwS~G~il~~l~-~~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~li~ 213 (290)
-+.... .+++.||||+||+++|++ .|.|+|.-. + +..+... . ...-....++++|.
T Consensus 198 RFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--Q---L~aYr~~~~~~~e~~Le~Ied~~~Rnlil 272 (1431)
T KOG1240|consen 198 RFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--Q---LLAYRSGNADDPEQLLEKIEDVSLRNLIL 272 (1431)
T ss_pred hhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--H---HHhHhccCccCHHHHHHhCcCccHHHHHH
Confidence 875421 467899999999999987 456666322 1 1111111 1 11112346899999
Q ss_pred HhhccCCCCCCCHHHHHHH
Q 044846 214 RCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 214 ~cl~~dp~~Rps~~el~~~ 232 (290)
.|++.||.+|.|+++.++.
T Consensus 273 ~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 273 SMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHccCchhccCHHHHHHh
Confidence 9999999999999999876
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.1e-20 Score=151.83 Aligned_cols=145 Identities=12% Similarity=0.174 Sum_probs=107.4
Q ss_pred CceEEEEeecccCch---hHHH------HHHHHHHHHhcCCCceeeEEeEEEeC--------CcceEEEEeCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHES---NVEQ------FINEVVILSQINHRNVVKILGCCLET--------EVPLLVYEFIPNGSLYQY 64 (290)
Q Consensus 2 ~~~~avK~~~~~~~~---~~~~------~~~E~~~l~~l~Hpniv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~ 64 (290)
++.+|+|.++..... .... +.+|++.+.++.||+|....+++... +..+|+|||++|.+|.++
T Consensus 54 ~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~ 133 (232)
T PRK10359 54 YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDM 133 (232)
T ss_pred CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHh
Confidence 456899998643222 2222 67899999999999999998886643 357899999999999877
Q ss_pred HhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeecccee
Q 044846 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKV 144 (290)
Q Consensus 65 l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g 144 (290)
.. ++. ....+++.++..+|..+ ++|||+||+|++++.+| ++|+|||..........
T Consensus 134 ~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a-------- 189 (232)
T PRK10359 134 PE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA-------- 189 (232)
T ss_pred hh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhh--------
Confidence 32 332 24569999999999999 99999999999999988 99999997543211000
Q ss_pred cccccCccccccCCCCCcccchhhHHHHHHH
Q 044846 145 TFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175 (290)
Q Consensus 145 ~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l 175 (290)
...++....|+.++|+||||+++..+
T Consensus 190 -----~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 190 -----KDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred -----HHHHHHHhHhcccccccceeEeehHH
Confidence 00133344567799999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=146.13 Aligned_cols=99 Identities=17% Similarity=0.175 Sum_probs=77.5
Q ss_pred HHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCC
Q 044846 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYL-HSVASI 100 (290)
Q Consensus 22 ~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~yl-H~~~~~ 100 (290)
.+|++++..+.++++...... .. ...+|||||++++++........ .++...+..++.|++.+|.|+ |+.+
T Consensus 67 ~~E~~~l~~l~~~~v~~p~~~-~~-~~~~iVmE~i~g~~l~~~~~~~~----~~~~~~~~~i~~qi~~~L~~l~H~~g-- 138 (190)
T cd05147 67 EKEMRNLKRLVTAGIPCPEPI-LL-KSHVLVMEFIGDDGWAAPRLKDA----PLSESKARELYLQVIQIMRILYQDCR-- 138 (190)
T ss_pred HHHHHHHHHHHHCCCCCCcEE-Ee-cCCEEEEEEeCCCCCcchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 349999999987766332222 22 22389999998877765533222 588899999999999999999 6888
Q ss_pred CeEeccCCCCceEeccCCcEEEeccccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTFKS 130 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~ 130 (290)
|+||||||+|||++ ++.++|+|||++..
T Consensus 139 -iiHrDlkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 139 -LVHADLSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred -cccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence 99999999999998 57899999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-19 Score=143.56 Aligned_cols=113 Identities=13% Similarity=0.157 Sum_probs=90.9
Q ss_pred EEEEeecccCchhHHHHHHHHHHHHhc-----CCCceeeEEeEEEeCC---c-ceEEEEe--CCCCCHHHHHhhcCCCCC
Q 044846 5 WLLKKSKSVHESNVEQFINEVVILSQI-----NHRNVVKILGCCLETE---V-PLLVYEF--IPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 5 ~avK~~~~~~~~~~~~~~~E~~~l~~l-----~Hpniv~~~~~~~~~~---~-~~lv~e~--~~~g~L~~~l~~~~~~~~ 73 (290)
.++|++........+.+.+|+.+++.+ +||||++++|++.++. . +.+|+|| +.+|+|.+++++.
T Consensus 27 k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~----- 101 (210)
T PRK10345 27 RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC----- 101 (210)
T ss_pred eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-----
Confidence 468888765455667899999999999 5799999999999863 3 3478999 5579999999763
Q ss_pred CCCHHHHHHHHHHHHHHH-HHHhhCCCCCeEeccCCCCceEecc----CCcEEEecccc
Q 044846 74 PITWEMRLRITVEVSRVL-SYLHSVASIPIYHLDIKSANILLVD----KYQAKISDFRT 127 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l-~ylH~~~~~~iiHrdlkp~Nil~~~----~~~~kl~dfg~ 127 (290)
.+++. ..++.+++.++ +|||+++ |+||||||+|||++. .++++|+||+.
T Consensus 102 ~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 102 RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 25544 35678888888 9999999 999999999999974 34799999544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=140.62 Aligned_cols=151 Identities=17% Similarity=0.142 Sum_probs=109.4
Q ss_pred HHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 044846 20 QFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVA 98 (290)
Q Consensus 20 ~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~ 98 (290)
.+.+|+++|++| .|++|++++++ +..+++|||+.|.+|...+.. ....++.|++.+|.++|.+|
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G 111 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG 111 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc
Confidence 578999999999 45889999886 346899999999888654321 11346789999999999999
Q ss_pred CCCeEeccC-CCCceEeccCCcEEEeccccccccccCCce----e--------eccceecccccCccccccC-CCC-Ccc
Q 044846 99 SIPIYHLDI-KSANILLVDKYQAKISDFRTFKSRAIDRTH----L--------TTQVKVTFGYVDPKYFRSS-QFT-EKS 163 (290)
Q Consensus 99 ~~~iiHrdl-kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~~ 163 (290)
|+|||| ||+|||++.++.++|+|||++......... . ......++.+++|+...-. ..+ ...
T Consensus 112 ---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~ 188 (218)
T PRK12274 112 ---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRE 188 (218)
T ss_pred ---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHH
Confidence 999999 799999999999999999998743221100 0 0011234556666543221 223 345
Q ss_pred cchhhHHHHHHHhcCCCCcccchhh
Q 044846 164 DVYSFSVVLVELNWTKPIHLVDVEE 188 (290)
Q Consensus 164 DiwS~G~il~~l~~~~~~~~~~~~~ 188 (290)
+.++.|+-+|.++|+.-+...+.+.
T Consensus 189 ~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 189 LWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred HHHHhcchHHHHHhccCCccccCCC
Confidence 6679999999999999877765543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-18 Score=138.19 Aligned_cols=99 Identities=20% Similarity=0.154 Sum_probs=79.2
Q ss_pred HHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHH-HhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CC
Q 044846 21 FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY-IHEQTDDQLPITWEMRLRITVEVSRVLSYLHS-VA 98 (290)
Q Consensus 21 ~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~-~~ 98 (290)
+..|.+.+.++.|+++.....+... ..+|||||++|+++... +.. . .++......++.|++.++.++|+ .+
T Consensus 66 ~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~----~~~~~~~~~i~~~l~~~l~~lH~~~g 138 (190)
T cd05145 66 AEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-V----PLEEEEAEELYEQVVEQMRRLYQEAG 138 (190)
T ss_pred HHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh-c----cCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 3578999999999987443333322 24899999988755433 332 2 47778889999999999999999 88
Q ss_pred CCCeEeccCCCCceEeccCCcEEEeccccccc
Q 044846 99 SIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130 (290)
Q Consensus 99 ~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~ 130 (290)
|+||||||+||+++ ++.++|+|||++..
T Consensus 139 ---ivHrDlkP~NIll~-~~~~~liDFG~a~~ 166 (190)
T cd05145 139 ---LVHGDLSEYNILYH-DGKPYIIDVSQAVE 166 (190)
T ss_pred ---EecCCCChhhEEEE-CCCEEEEEccccee
Confidence 99999999999998 89999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.1e-18 Score=142.83 Aligned_cols=211 Identities=18% Similarity=0.246 Sum_probs=127.6
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCC-----------Ccee-----eEE---eEEEeCC--------cceE
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINH-----------RNVV-----KIL---GCCLETE--------VPLL 51 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~H-----------pniv-----~~~---~~~~~~~--------~~~l 51 (290)
|+.+|||+... ......+++.+|.-....+.+ ..++ ++- .++.... ..++
T Consensus 37 ~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~ 116 (288)
T PF14531_consen 37 GEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFL 116 (288)
T ss_dssp TEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEE
T ss_pred CceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhh
Confidence 67899998742 223457777777765555432 1111 111 1111111 2367
Q ss_pred EEEeCCCCCHHHHHhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccc
Q 044846 52 VYEFIPNGSLYQYIHE---QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 52 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
+|+-+ .++|.+++.. .......+....++.+..|++..+++||..| ++|+||||+|++++.+|.+.|+||+..
T Consensus 117 l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 117 LMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSL 192 (288)
T ss_dssp EEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred ccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHH
Confidence 88887 5699888654 2211112444556677789999999999999 999999999999999999999999864
Q ss_pred cccccCCceeeccceecccccCccccccC--------CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhh
Q 044846 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSS--------QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEA 200 (290)
Q Consensus 129 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (290)
.... . .... ...+..|.+||..... .++.+.|.|++|+++|.|+.+.-|+........... .+. .
T Consensus 193 ~r~g--~-~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-~f~-~- 265 (288)
T PF14531_consen 193 VRAG--T-RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-DFS-R- 265 (288)
T ss_dssp EETT--E-EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-GGT-T-
T ss_pred eecC--c-eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-cch-h-
Confidence 3221 1 1111 3344678999976442 467899999999999999999887764432211111 112 2
Q ss_pred hHHHHHHHHHHHHHhhccCCCCC
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~R 223 (290)
+.+.+..++.||..+|+.||.+|
T Consensus 266 C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 266 CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCcCHHHHHHHHHHccCCcccC
Confidence 22777889999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.1e-16 Score=126.95 Aligned_cols=116 Identities=22% Similarity=0.241 Sum_probs=95.9
Q ss_pred CceEEEEeecccCch--------hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSVHES--------NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~~~~--------~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|..+++|+....... ....+.+|++++..+.|++|+....++...+..+++|||++|++|.+++....
T Consensus 19 ~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~---- 94 (211)
T PRK14879 19 GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG---- 94 (211)
T ss_pred CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----
Confidence 567889976532211 13467889999999999988777777777788899999999999999986432
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
. ....++.+++.+|.++|+.+ ++|||++|.||+++ ++.++|+|||.+.
T Consensus 95 ---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 95 ---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred ---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCccc
Confidence 1 67789999999999999999 99999999999999 7889999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.5e-17 Score=155.23 Aligned_cols=134 Identities=21% Similarity=0.235 Sum_probs=105.2
Q ss_pred HHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce--------------eeccceecccccCcc
Q 044846 87 VSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--------------LTTQVKVTFGYVDPK 152 (290)
Q Consensus 87 i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--------------~~~~~~g~~~y~aPE 152 (290)
++.+++|||+.+ |+|||+||+|.+|..-|++|+.|||+++........ ....+.||+.|.|||
T Consensus 152 mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 152 MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 378999999999 999999999999999999999999998754322111 123467899999999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
++.-+.|+..+|+|++|+|+|+.+-|+.+|+.+..+. .+..... .+.......+.++++.+.|+.+|..|.
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 9999999999999999999999999998887663221 1111111 122334567899999999999999994
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=123.84 Aligned_cols=113 Identities=22% Similarity=0.238 Sum_probs=90.1
Q ss_pred CceEEEEeecccCc--------hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSVHE--------SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~~~--------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|..+++|+...... ....++.+|++++..+.|+++.....++...+..++||||++|++|.+++....
T Consensus 17 ~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~---- 92 (199)
T TIGR03724 17 GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN---- 92 (199)
T ss_pred CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH----
Confidence 56788898643211 123567789999999988876554445556677899999999999998875421
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
. .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++.
T Consensus 93 -~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 93 -D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred -H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 1 67899999999999999 99999999999999 8899999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.2e-16 Score=147.93 Aligned_cols=224 Identities=17% Similarity=0.162 Sum_probs=154.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN---HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~---Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|++||||+.+....-++- -=.+++.+|+ -+-|..+..+....+.-+||+||.+-|+|.+++.... .+++.
T Consensus 722 ~~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~----~m~e~ 794 (974)
T KOG1166|consen 722 GKLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNK----VMDEY 794 (974)
T ss_pred CcEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCC----CCCch
Confidence 688999998864443311 1112333333 1234555555566777889999999999999998444 58889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-------CCcEEEeccccccccccCCce-eeccceecccccC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-------KYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVD 150 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-------~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~a 150 (290)
....+..|++..++.||..+ |||+||||+|+|+.. ...++|+|||.+-.+..-... .-....+|-.|-.
T Consensus 795 lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C 871 (974)
T KOG1166|consen 795 LVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDC 871 (974)
T ss_pred hhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchh
Confidence 99999999999999999999 999999999999953 345899999987544332222 2234567788999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHH-HHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEE-VITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
+|+..+..|+..+|-|.+.-+++.|++|+-.-. .... .+.. ........ -.-+-++..++|+.|-..=|...+|
T Consensus 872 ~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-~~g~--~~~~--~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 872 IEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-KNGS--SWMV--KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred HHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh-cCCc--ceec--cccchhhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 999999999999999999999999998874321 0000 0000 00001111 1124456677777666666778888
Q ss_pred HHHHHhhHhhh
Q 044846 230 TLELAGIRASI 240 (290)
Q Consensus 230 ~~~l~~~~~~~ 240 (290)
...++......
T Consensus 947 r~~~~~~~~~~ 957 (974)
T KOG1166|consen 947 RTELEEVLAEH 957 (974)
T ss_pred HHHHHHHHHHH
Confidence 87777766543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=126.08 Aligned_cols=117 Identities=17% Similarity=0.067 Sum_probs=87.4
Q ss_pred CceEEEEeecccCch------------------------hHHHHHHHHHHHHhcCCC--ceeeEEeEEEeCCcceEEEEe
Q 044846 2 EELWLLKKSKSVHES------------------------NVEQFINEVVILSQINHR--NVVKILGCCLETEVPLLVYEF 55 (290)
Q Consensus 2 ~~~~avK~~~~~~~~------------------------~~~~~~~E~~~l~~l~Hp--niv~~~~~~~~~~~~~lv~e~ 55 (290)
|+.||+|+++..... ....+..|++++..+.+. .++++++. ...++||||
T Consensus 54 g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~ 129 (237)
T smart00090 54 GKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEF 129 (237)
T ss_pred CcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEE
Confidence 688999998743210 112356899999999653 33444432 235899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccccc
Q 044846 56 IPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 56 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
++|++|........ .++......++.|++.++.+||+.+. ++||||||+||+++ ++.++|+|||.+.
T Consensus 130 ~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli~-~~~i~LiDFg~a~ 196 (237)
T smart00090 130 IGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILVH-DGKVVIIDVSQSV 196 (237)
T ss_pred ecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEEE-CCCEEEEEChhhh
Confidence 98888766543222 35556678899999999999998873 99999999999999 8899999999865
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.1e-15 Score=139.31 Aligned_cols=97 Identities=21% Similarity=0.254 Sum_probs=85.9
Q ss_pred HHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 044846 18 VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSV 97 (290)
Q Consensus 18 ~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~ 97 (290)
.+++.+|+++++.++|++++....++......++||||++|++|.+++. ....++.+++.+|.|||+.
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~ 447 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA 447 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC
Confidence 4568899999999999999887777777778899999999999998875 2356889999999999999
Q ss_pred CCCCeEeccCCCCceEeccCCcEEEeccccccc
Q 044846 98 ASIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130 (290)
Q Consensus 98 ~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~ 130 (290)
+ ++||||||+|||+ .++.++|+|||+++.
T Consensus 448 g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 448 G---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred C---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9 9999999999999 678999999999753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.9e-15 Score=123.60 Aligned_cols=101 Identities=19% Similarity=0.283 Sum_probs=80.8
Q ss_pred HHHHHHHHHHHHhcCCCce--eeEEeEEEeC-Cc---ceEEEEeCCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 044846 18 VEQFINEVVILSQINHRNV--VKILGCCLET-EV---PLLVYEFIPN-GSLYQYIHEQTDDQLPITWEMRLRITVEVSRV 90 (290)
Q Consensus 18 ~~~~~~E~~~l~~l~Hpni--v~~~~~~~~~-~~---~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~ 90 (290)
..++.+|++++..|+|++| +..+++.... .. .++|||+++| .+|.+++... +++.. .+.+++.+
T Consensus 84 ~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~ 154 (239)
T PRK01723 84 RTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQL 154 (239)
T ss_pred hhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHH
Confidence 4568889999999988775 6666664432 22 3599999987 6999888642 34443 35689999
Q ss_pred HHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccc
Q 044846 91 LSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130 (290)
Q Consensus 91 l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~ 130 (290)
+.+||+.| |+||||||.|||++.++.++|+|||.+..
T Consensus 155 l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 155 IARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99999999 99999999999999989999999998654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-16 Score=132.54 Aligned_cols=201 Identities=20% Similarity=0.255 Sum_probs=140.4
Q ss_pred HHhcCCCceeeEEeEEEeCC-----cceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 044846 28 LSQINHRNVVKILGCCLETE-----VPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPI 102 (290)
Q Consensus 28 l~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~i 102 (290)
|-++.|.|||++..++.+.. ....+.|||..|++..+|++.......+......+|+.||+.||.|||+.. ++|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccc
Confidence 44567999999999887543 467899999999999999998777667888888999999999999999976 459
Q ss_pred EeccCCCCceEeccCCcEEEeccccc---cccccCCceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCC
Q 044846 103 YHLDIKSANILLVDKYQAKISDFRTF---KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTK 179 (290)
Q Consensus 103 iHrdlkp~Nil~~~~~~~kl~dfg~~---~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~ 179 (290)
+|+++..+.|++..+|-+|+.----. ...............+-++|.+||.-.....+.++|||+||+...+|.-+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999999999998888886521100 000000001111233457899999877677778999999999888886544
Q ss_pred CCcccc---hhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 180 PIHLVD---VEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 180 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
-..... ...+.......... ....-++++.+|++..|+.||+|++++-|.
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~l----en~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGL----ENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eccCCCcceeehhhhhhhheeec----cCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 322111 11111111111110 011234679999999999999999987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.6e-17 Score=152.10 Aligned_cols=227 Identities=19% Similarity=0.149 Sum_probs=170.7
Q ss_pred eEEEEeecccC--chhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHh-hcCCCCCCCCHHH
Q 044846 4 LWLLKKSKSVH--ESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH-EQTDDQLPITWEM 79 (290)
Q Consensus 4 ~~avK~~~~~~--~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~ 79 (290)
.+|+|.+.... .........|..+-..+. |+|++.+++.....+..+++++|..||++...+. ... ...+...
T Consensus 48 ~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~---~~~~~~~ 124 (601)
T KOG0590|consen 48 SSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDS---TGTSSSS 124 (601)
T ss_pred eeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCc---cCCCCcc
Confidence 35555554332 344455556888888885 9999999999999999999999999999998883 222 1355566
Q ss_pred HHHHHHHHHHHHHHHh-hCCCCCeEeccCCCCceEeccCC-cEEEecccccccccc--CCceeecccee-cccccCcccc
Q 044846 80 RLRITVEVSRVLSYLH-SVASIPIYHLDIKSANILLVDKY-QAKISDFRTFKSRAI--DRTHLTTQVKV-TFGYVDPKYF 154 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH-~~~~~~iiHrdlkp~Nil~~~~~-~~kl~dfg~~~~~~~--~~~~~~~~~~g-~~~y~aPE~~ 154 (290)
...++.|+..++.|+| ..+ +.|||+||+|.+++..+ .++++|||+|..... +.........| ++.|+|||..
T Consensus 125 ~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~ 201 (601)
T KOG0590|consen 125 ASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHL 201 (601)
T ss_pred hhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccc
Confidence 7789999999999999 888 99999999999999999 999999999876554 22233344566 8999999999
Q ss_pred ccCC-CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 155 RSSQ-FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 155 ~~~~-~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
.+.. .....|+||.|+++.-+++|..++............+.. ............+++.+++..+|..|.+.+
T Consensus 202 ~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~ 281 (601)
T KOG0590|consen 202 SGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIE 281 (601)
T ss_pred cchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccc
Confidence 8854 456799999999999999998877655443332222111 122333455677889999999999999999
Q ss_pred HHHHHHHhh
Q 044846 228 EVTLELAGI 236 (290)
Q Consensus 228 el~~~l~~~ 236 (290)
++...-+..
T Consensus 282 ~~~~d~~~~ 290 (601)
T KOG0590|consen 282 ELKLDNWLS 290 (601)
T ss_pred ccccccccc
Confidence 886554433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.1e-14 Score=117.43 Aligned_cols=95 Identities=22% Similarity=0.182 Sum_probs=76.0
Q ss_pred HHHHHHHHHHhcCCCc--eeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 044846 20 QFINEVVILSQINHRN--VVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSV 97 (290)
Q Consensus 20 ~~~~E~~~l~~l~Hpn--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~ 97 (290)
.+..|..++..+.|++ ++..++ ....++||||++|++|...... .....++.+++.++.++|..
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~ 144 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH 144 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC
Confidence 3667899999997774 444443 2456899999999988765321 23456888999999999999
Q ss_pred CCCCeEeccCCCCceEeccCCcEEEecccccccc
Q 044846 98 ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSR 131 (290)
Q Consensus 98 ~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~ 131 (290)
+ |+||||||+||+++.++.++|+|||++...
T Consensus 145 g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 145 G---IIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred C---CCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 8 999999999999999999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.6e-14 Score=108.93 Aligned_cols=114 Identities=25% Similarity=0.268 Sum_probs=93.5
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCC--CceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINH--RNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~H--pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
+.+++|....... ...+..|+..++.+.| .+++++++++...+..+++|||+.++.+..+ +....
T Consensus 22 ~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~ 88 (155)
T cd05120 22 EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----------SEEEK 88 (155)
T ss_pred CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----------CHHHH
Confidence 4678888765333 5678899999999965 5899999888888889999999988766543 33556
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccccc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
..++.+++.+++++|.....+++|+|++|.||+++..+.++++|||.+.
T Consensus 89 ~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 89 EDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred HHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 6788999999999998644449999999999999998999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.4e-12 Score=117.98 Aligned_cols=163 Identities=15% Similarity=0.124 Sum_probs=120.9
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
+.+|.|.+.+.......+...+-++.|+.|+||||++|++.+...+.+|||+|-+ ..|..++++.. .....
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-------~~~v~ 107 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-------KEEVC 107 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-------HHHHH
Confidence 4567777777655544556778889999999999999999999999999999998 37888888643 34455
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
-.+.||+.||.|||+.+. ++|++|.-+.|+++..|..||++|.++........ .......-..|..|+.+....+
T Consensus 108 ~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~~-- 182 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSEW-- 182 (690)
T ss_pred HHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcccc--
Confidence 567899999999986543 99999999999999999999999977533221111 0001111123556665443332
Q ss_pred cccchhhHHHHHHHhcC
Q 044846 162 KSDVYSFSVVLVELNWT 178 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~ 178 (290)
..|.|-|||++++++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 35999999999999887
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.6e-14 Score=125.93 Aligned_cols=223 Identities=19% Similarity=0.180 Sum_probs=157.8
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
+..+|+|+-+. ........=.+|+....++ .|+|.++....+..++..++-+|+| +.+|.++.....+ -++..
T Consensus 143 ~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~---~~p~~ 218 (524)
T KOG0601|consen 143 PHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCN---FLPDN 218 (524)
T ss_pred CcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccc---cCCch
Confidence 34677777443 2223333334677777777 6999999999999999999999999 6799888876543 36677
Q ss_pred HHHHHHHHHHH----HHHHHhhCCCCCeEeccCCCCceEeccC-CcEEEeccccccccccCCce----eeccceeccccc
Q 044846 79 MRLRITVEVSR----VLSYLHSVASIPIYHLDIKSANILLVDK-YQAKISDFRTFKSRAIDRTH----LTTQVKVTFGYV 149 (290)
Q Consensus 79 ~~~~~~~~i~~----~l~ylH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~----~~~~~~g~~~y~ 149 (290)
..+....+... |+..+|..+ ++|-|+||.||+...+ ..+++.|||+.......... ......|...|+
T Consensus 219 ~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~ 295 (524)
T KOG0601|consen 219 LLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYA 295 (524)
T ss_pred hhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEe
Confidence 77888888888 999999999 9999999999999999 88999999986543322211 111224667799
Q ss_pred CccccccCCCCCcccchhhHHHHHHHhcCCCCcccc--hhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 150 DPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVD--VEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 150 aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
+||... +-++...|++|+|.++.+...+...+... ....+.-..+...+.....+.++...+.++++.+|..|++++
T Consensus 296 ~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q 374 (524)
T KOG0601|consen 296 AKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQ 374 (524)
T ss_pred Chhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHH
Confidence 999875 44788999999999999877665444322 111111111122233333445566689999999999999988
Q ss_pred HHHHH
Q 044846 228 EVTLE 232 (290)
Q Consensus 228 el~~~ 232 (290)
.+..+
T Consensus 375 ~~~~l 379 (524)
T KOG0601|consen 375 ILTAL 379 (524)
T ss_pred HHhcc
Confidence 77543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.5e-12 Score=105.34 Aligned_cols=94 Identities=19% Similarity=0.194 Sum_probs=67.5
Q ss_pred HHHHHHHhcCCC--ceeeEEeEEEeCCcceEEEEeCCCCCHHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CC
Q 044846 23 NEVVILSQINHR--NVVKILGCCLETEVPLLVYEFIPNGSLYQ-YIHEQTDDQLPITWEMRLRITVEVSRVLSYLHS-VA 98 (290)
Q Consensus 23 ~E~~~l~~l~Hp--niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~-~~ 98 (290)
.|.+.+..+.+. .+.+.++. ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .+
T Consensus 66 ~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ 135 (187)
T cd05119 66 KEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG 135 (187)
T ss_pred HHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC
Confidence 566666666433 23444432 24689999998854321 121111 11 4567889999999999999 88
Q ss_pred CCCeEeccCCCCceEeccCCcEEEeccccccc
Q 044846 99 SIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130 (290)
Q Consensus 99 ~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~ 130 (290)
|+||||||+||+++ ++.++++|||.+..
T Consensus 136 ---ivH~Dl~p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 136 ---LVHGDLSEYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred ---cCcCCCChhhEEEE-CCcEEEEECccccc
Confidence 99999999999999 89999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.1e-13 Score=120.46 Aligned_cols=222 Identities=18% Similarity=0.192 Sum_probs=155.7
Q ss_pred CceEEEEeecccCchhH--HHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVHESNV--EQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~--~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
+..|++|.....-.... ..-+.|+-+...+ .|.+++.++..+...+..||-.|||.++++...+.-.. .+++.
T Consensus 291 ~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~----~~d~~ 366 (524)
T KOG0601|consen 291 DCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQ----MLDED 366 (524)
T ss_pred CceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHH----hcCcc
Confidence 34566666653222222 2235577777777 69999999989988888899999999998877763322 46777
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC-CcEEEeccccccccccCCceeeccceeccccc--Cccccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYV--DPKYFR 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~--aPE~~~ 155 (290)
..+.+..|++.++.++|++. ++|+|+||+||++..+ +..++.|||..+... .......+.-++. +++...
T Consensus 367 ~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~----~~~~~~~~~~r~~p~~~~~~e 439 (524)
T KOG0601|consen 367 PRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA----FSSGVFHHIDRLYPIAEILLE 439 (524)
T ss_pred hhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccc----eecccccccccccccchhhcc
Confidence 88899999999999999998 9999999999999986 677899999865321 1111222333344 455555
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
...+..++|++|||..+.+.+++.+............... -.........+..+.+.++..|+..||.+.++..+...
T Consensus 440 ~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~--~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 440 DYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGD--TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccccccccccccccccccccccCcccCcccccceeeeccc--ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 6678889999999999999988887654322211111110 11111222667788999999999999999988766554
Q ss_pred h
Q 044846 236 I 236 (290)
Q Consensus 236 ~ 236 (290)
.
T Consensus 518 ~ 518 (524)
T KOG0601|consen 518 Y 518 (524)
T ss_pred h
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.1e-13 Score=125.74 Aligned_cols=201 Identities=20% Similarity=0.205 Sum_probs=147.4
Q ss_pred HHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 044846 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVA 98 (290)
Q Consensus 19 ~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~ 98 (290)
+..+.+-.++-...+|.++...-.+......+|+++|..+++|...++... ..+.+-.+.+...+.++++|||...
T Consensus 849 ~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~ 924 (1205)
T KOG0606|consen 849 ESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL 924 (1205)
T ss_pred cccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch
Confidence 333444444444456777665555566778899999999999999998765 4566666777888999999999987
Q ss_pred CCCeEeccCCCCceEeccCCcEEEeccccccccc-c----C-----------C--------------ceeeccceecccc
Q 044846 99 SIPIYHLDIKSANILLVDKYQAKISDFRTFKSRA-I----D-----------R--------------THLTTQVKVTFGY 148 (290)
Q Consensus 99 ~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~-~----~-----------~--------------~~~~~~~~g~~~y 148 (290)
++|||++|.|.+...+++.++.|||...... . . . ........+|+.|
T Consensus 925 ---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~ 1001 (1205)
T KOG0606|consen 925 ---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDY 1001 (1205)
T ss_pred ---hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcc
Confidence 8999999999999999999999997332110 0 0 0 0011234678899
Q ss_pred cCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----hhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 149 VDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----EAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 149 ~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
.+||...+...+..+|.|++|+++++.++|.++|.....+.. ....... ..+...+....+++.+.+..+|.+|
T Consensus 1002 laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~-f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1002 LAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI-FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred cCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh-hhccccCCCCCCCCccccChhhhhhhhhhhccCchhc
Confidence 999999999999999999999999999999998865433221 2221111 1233455678899999999999999
Q ss_pred CCHH
Q 044846 224 PTMK 227 (290)
Q Consensus 224 ps~~ 227 (290)
..+.
T Consensus 1081 ~~a~ 1084 (1205)
T KOG0606|consen 1081 LGAK 1084 (1205)
T ss_pred cCcc
Confidence 8765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-10 Score=94.14 Aligned_cols=95 Identities=15% Similarity=0.150 Sum_probs=71.3
Q ss_pred HHHHHHHhcC--CCceeeEEeEEEeCCcceEEEEeCCCCCHHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCC
Q 044846 23 NEVVILSQIN--HRNVVKILGCCLETEVPLLVYEFIPNGSLYQ-YIHEQTDDQLPITWEMRLRITVEVSRVLSYL-HSVA 98 (290)
Q Consensus 23 ~E~~~l~~l~--Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~i~~~l~yl-H~~~ 98 (290)
+|.+.|+++. .-+++..+++ ...+|||||+.++.+.. .+++. .++......+..+++.+|..+ |..+
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~g 145 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKECN 145 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 7999999983 3466666654 45689999996543321 22221 244556667789999999998 8888
Q ss_pred CCCeEeccCCCCceEeccCCcEEEeccccccc
Q 044846 99 SIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130 (290)
Q Consensus 99 ~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~ 130 (290)
++|+||++.||++. ++.+.|+|||.+..
T Consensus 146 ---lVHGDLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 146 ---LVHADLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred ---eecCCCCHHHEEEE-CCcEEEEECCCcee
Confidence 99999999999996 57899999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.24 E-value=7e-11 Score=107.76 Aligned_cols=102 Identities=17% Similarity=0.202 Sum_probs=69.9
Q ss_pred HHHHHHHHHhcC----CCceeeEEeEEE-eCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHH-HHHHH
Q 044846 21 FINEVVILSQIN----HRNVVKILGCCL-ETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSR-VLSYL 94 (290)
Q Consensus 21 ~~~E~~~l~~l~----Hpniv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~-~l~yl 94 (290)
|.+|++.+..+. |.+-+.+-..+. .....+|||||++|++|.++...... ..+ ...++..++. .+..+
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHHHHHHHHHH
Confidence 455666666552 222233333332 23456899999999999887754321 122 2345555555 46788
Q ss_pred hhCCCCCeEeccCCCCceEeccCCcEEEecccccccc
Q 044846 95 HSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSR 131 (290)
Q Consensus 95 H~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~ 131 (290)
|..| ++|+|++|.||+++.+++++++|||++...
T Consensus 274 ~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 274 LRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9988 999999999999999999999999997543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.9e-11 Score=95.36 Aligned_cols=112 Identities=18% Similarity=0.132 Sum_probs=79.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCc-eeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRN-VVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.|++|....... ....+.+|+++++.+.+.+ +++++.+.. ...++|||+++|.++... . . ..
T Consensus 21 ~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~----~-----~---~~ 85 (170)
T cd05151 21 NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE----D-----F---SD 85 (170)
T ss_pred CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc----c-----c---cC
Confidence 46788888754322 2234678999999985444 345555433 345899999999877543 0 1 11
Q ss_pred HHHHHHHHHHHHHHhhCC--CCCeEeccCCCCceEeccCCcEEEecccccc
Q 044846 81 LRITVEVSRVLSYLHSVA--SIPIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~--~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
..++.+++.+|+.||..+ ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 235678999999999887 22259999999999998 6789999999754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.3e-09 Score=96.13 Aligned_cols=206 Identities=16% Similarity=0.192 Sum_probs=142.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCcceEEEEeCCC-CCHHHHHhhcCC------
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLE----TEVPLLVYEFIPN-GSLYQYIHEQTD------ 70 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~-g~L~~~l~~~~~------ 70 (290)
|..|++|++.............=++.++++.|+|+|++.++|.. +..+++|++|.++ ++|.++-.....
T Consensus 301 G~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n 380 (655)
T KOG3741|consen 301 GNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTN 380 (655)
T ss_pred CceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccc
Confidence 56788998843222222223345778999999999999999874 3467899999985 678877644321
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceec
Q 044846 71 -----DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVT 145 (290)
Q Consensus 71 -----~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~ 145 (290)
.+...++..+|.++.|+..||.++|+.| +.-+-|.+.+||++.+.+++|...|+......+.
T Consensus 381 ~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~---------- 447 (655)
T KOG3741|consen 381 SFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP---------- 447 (655)
T ss_pred cccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCC----------
Confidence 2234678899999999999999999999 8889999999999999999988777632221111
Q ss_pred ccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 146 FGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 146 ~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
. +.+.. -.+-|.=-||.++..|.+|..-.......+. .-........+.++++++......++++ -+
T Consensus 448 ---~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~----s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ks 514 (655)
T KOG3741|consen 448 ---T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQS----SHLTRITTTYSTDLRNVVEYLESLNFRE-KS 514 (655)
T ss_pred ---C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHH----HHHHHhhhhhhHHHHHHHHHHHhcCccc-cc
Confidence 0 11111 1245888999999999998653221111111 1112223456778889999999999987 58
Q ss_pred HHHHHHHH
Q 044846 226 MKEVTLEL 233 (290)
Q Consensus 226 ~~el~~~l 233 (290)
..+++.++
T Consensus 515 I~~llp~~ 522 (655)
T KOG3741|consen 515 IQDLLPMI 522 (655)
T ss_pred HHHHHHHH
Confidence 88887664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.9e-09 Score=90.68 Aligned_cols=123 Identities=14% Similarity=0.161 Sum_probs=87.5
Q ss_pred CceEEEEeecccCch-hHH----------HHHHHHHHHHhcCCC--ceeeEEeEEEe-----CCcceEEEEeCCCC-CHH
Q 044846 2 EELWLLKKSKSVHES-NVE----------QFINEVVILSQINHR--NVVKILGCCLE-----TEVPLLVYEFIPNG-SLY 62 (290)
Q Consensus 2 ~~~~avK~~~~~~~~-~~~----------~~~~E~~~l~~l~Hp--niv~~~~~~~~-----~~~~~lv~e~~~~g-~L~ 62 (290)
|+.|.||........ ..+ .+.+|...+..|..- .++..+++... ....+||+|++++- +|.
T Consensus 45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~ 124 (268)
T PRK15123 45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE 124 (268)
T ss_pred CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence 567888966432211 111 367898888877322 23444445433 23468999999775 799
Q ss_pred HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-------CCcEEEecccccc
Q 044846 63 QYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-------KYQAKISDFRTFK 129 (290)
Q Consensus 63 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-------~~~~kl~dfg~~~ 129 (290)
+++...... +.+......++.+++..+.-||..| |+|+|+++.|||++. ++.+.++||+.+.
T Consensus 125 ~~~~~~~~~--~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 125 DYCADWATN--PPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 998643211 3455677789999999999999999 999999999999985 4678999999754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.1e-10 Score=103.16 Aligned_cols=101 Identities=13% Similarity=0.115 Sum_probs=61.7
Q ss_pred HHHHHHHHHhcC----CCceeeEEeEEEe-CCcceEEEEeCCCCCHHHHH--hhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 044846 21 FINEVVILSQIN----HRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYI--HEQTDDQLPITWEMRLRITVEVSRVLSY 93 (290)
Q Consensus 21 ~~~E~~~l~~l~----Hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~~~~~~i~~~l~y 93 (290)
|.+|+..+.++. +.+.+.+-.++.+ ....+|||||+.|+.+.++- ...+.....+....+..++.|
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q------- 275 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ------- 275 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------
Confidence 444555555552 3333433333322 34567999999999998753 222111001222222233333
Q ss_pred HhhCCCCCeEeccCCCCceEeccCC----cEEEecccccccc
Q 044846 94 LHSVASIPIYHLDIKSANILLVDKY----QAKISDFRTFKSR 131 (290)
Q Consensus 94 lH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~dfg~~~~~ 131 (290)
+...| ++|+|+||.||+++.++ +++++|||+....
T Consensus 276 if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 34567 99999999999999888 9999999986543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.9e-09 Score=83.92 Aligned_cols=95 Identities=26% Similarity=0.334 Sum_probs=73.1
Q ss_pred HHHHHHHHHHHHhcCC--CceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 044846 18 VEQFINEVVILSQINH--RNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLH 95 (290)
Q Consensus 18 ~~~~~~E~~~l~~l~H--pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH 95 (290)
..+-.+|++++.++.- -+++.+++ .+.+...|+|||++|..|.+.+... ...++..+-.-+.-||
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~d--vD~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH 109 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYD--VDPDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLH 109 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEE--EcCCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHH
Confidence 4457789999998742 23344443 4455567999999888888888754 1346777888888999
Q ss_pred hCCCCCeEeccCCCCceEeccCCcEEEecccccc
Q 044846 96 SVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 96 ~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
..+ |+|+||.++||++...+ +.++|||++.
T Consensus 110 ~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 110 KAG---IVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred hcC---eecCCCccceEEEeCCc-EEEEECCccc
Confidence 999 99999999999997655 9999999965
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=5.1e-09 Score=82.31 Aligned_cols=107 Identities=19% Similarity=0.203 Sum_probs=79.1
Q ss_pred HHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 044846 18 VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPN-GSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHS 96 (290)
Q Consensus 18 ~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~ 96 (290)
..+..+|++.|.++.--.|.-=.=+|.+.+.-.|+|||++| -++.+++...... ..+......++..|-+.+.-||.
T Consensus 54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~ 131 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHD 131 (229)
T ss_pred HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhh
Confidence 45678899999987422221111235566667899999955 3899999876543 33444447889999999999999
Q ss_pred CCCCCeEeccCCCCceEeccCCc---EEEecccccc
Q 044846 97 VASIPIYHLDIKSANILLVDKYQ---AKISDFRTFK 129 (290)
Q Consensus 97 ~~~~~iiHrdlkp~Nil~~~~~~---~kl~dfg~~~ 129 (290)
++ |||+||..+||++..++. +.++|||++.
T Consensus 132 nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 132 ND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99 999999999999976553 5799999853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.5e-09 Score=86.99 Aligned_cols=123 Identities=19% Similarity=0.240 Sum_probs=90.0
Q ss_pred CceEEEEeecccCc-hhHHHHHHHHHHHHhcCC--CceeeEEeEEEeC---CcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHE-SNVEQFINEVVILSQINH--RNVVKILGCCLET---EVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~H--pniv~~~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.+++|....... .....+..|+++++.+.+ .++.+++.+.... +..++||||++|+++...+.. . .+
T Consensus 22 g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~----~~ 96 (223)
T cd05154 22 GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-P----EL 96 (223)
T ss_pred CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-C----CC
Confidence 36788998764322 235578899999999964 4467777776653 366899999999888765432 1 36
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCC-----------------------------------------------------CCCe
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVA-----------------------------------------------------SIPI 102 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~-----------------------------------------------------~~~i 102 (290)
+......++.+++.+|..||+.. ...+
T Consensus 97 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 176 (223)
T cd05154 97 SPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGL 176 (223)
T ss_pred CHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEE
Confidence 66777778888888888888421 1337
Q ss_pred EeccCCCCceEecc--CCcEEEecccccc
Q 044846 103 YHLDIKSANILLVD--KYQAKISDFRTFK 129 (290)
Q Consensus 103 iHrdlkp~Nil~~~--~~~~kl~dfg~~~ 129 (290)
+|+|+.+.||+++. ++.+.|+||+.+.
T Consensus 177 ~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 177 VHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred EECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 99999999999998 5668999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.8e-09 Score=99.73 Aligned_cols=149 Identities=17% Similarity=0.183 Sum_probs=102.3
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eee-------ccceecccccCc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLT-------TQVKVTFGYVDP 151 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~-------~~~~g~~~y~aP 151 (290)
...=+.+++.|+.|+|.... +||++|.|++|.++..+..||+.|+.+........ ... .-..-..-|.||
T Consensus 101 ~f~nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 33344567799999997543 99999999999999999999999987654332111 000 011123459999
Q ss_pred cccccCCCCCcccchhhHHHHHHHh-cCCCCcccchhhhh-----hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELN-WTKPIHLVDVEENR-----SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~-~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
|++.+...+.++|++|+|+++|-+. .|+..+........ ..............+.++.+-+.+++..++..||+
T Consensus 179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred hhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 9999988888999999999999887 55554433211100 00111112233455678899999999999999997
Q ss_pred HHHHH
Q 044846 226 MKEVT 230 (290)
Q Consensus 226 ~~el~ 230 (290)
+.++.
T Consensus 259 ~~~l~ 263 (700)
T KOG2137|consen 259 LDLLL 263 (700)
T ss_pred hhhhh
Confidence 77664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=7.9e-08 Score=79.05 Aligned_cols=105 Identities=17% Similarity=0.243 Sum_probs=81.2
Q ss_pred HHHHHHHHHHHHhcC--CCceeeEEeEEEeCC----cceEEEEeCCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 044846 18 VEQFINEVVILSQIN--HRNVVKILGCCLETE----VPLLVYEFIPNG-SLYQYIHEQTDDQLPITWEMRLRITVEVSRV 90 (290)
Q Consensus 18 ~~~~~~E~~~l~~l~--Hpniv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~ 90 (290)
..+..+|...+..|. .=.+++.+++..... ..+||+|++++- +|.+++..... .+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence 446778888877773 223455566655432 348999999874 79999886432 4556677899999999
Q ss_pred HHHHhhCCCCCeEeccCCCCceEeccCC---cEEEecccccc
Q 044846 91 LSYLHSVASIPIYHLDIKSANILLVDKY---QAKISDFRTFK 129 (290)
Q Consensus 91 l~ylH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~dfg~~~ 129 (290)
+.-||..| |+|+|+++.|||++.++ .+.++||+.++
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 99999999 99999999999999887 78999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.4e-08 Score=78.93 Aligned_cols=98 Identities=23% Similarity=0.203 Sum_probs=63.6
Q ss_pred HHHHHHHHHHHhcCCC--ceeeEEeEEEeCCcceEEEEeCC--CCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH-
Q 044846 19 EQFINEVVILSQINHR--NVVKILGCCLETEVPLLVYEFIP--NGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSY- 93 (290)
Q Consensus 19 ~~~~~E~~~l~~l~Hp--niv~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~y- 93 (290)
....+|.+.|..+..- ++++.+++. ...|||||+. |..+..+.... ++......++.+++..+..
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHH
Confidence 3567799999999644 566666442 4579999997 54454433322 1123345677788876655
Q ss_pred HhhCCCCCeEeccCCCCceEeccCCcEEEeccccccc
Q 044846 94 LHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130 (290)
Q Consensus 94 lH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~ 130 (290)
+|..| |+|+||.+.|||++.+ .+.++|||.+..
T Consensus 123 ~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 123 LHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp HHCTT---EEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred HHhcC---ceecCCChhhEEeecc-eEEEEecCccee
Confidence 57888 9999999999999877 899999997643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.2e-06 Score=77.26 Aligned_cols=191 Identities=12% Similarity=0.141 Sum_probs=126.0
Q ss_pred ceEEEEeCCCC-CHHHHHhhc-CC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecc
Q 044846 49 PLLVYEFIPNG-SLYQYIHEQ-TD-DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125 (290)
Q Consensus 49 ~~lv~e~~~~g-~L~~~l~~~-~~-~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~df 125 (290)
+-+.|..+++. .+..++.-. +. .-....|...++.++.++.+.+-||..| ..-+|+.++|+|+++++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 45677777653 233333221 11 1123678999999999999999999999 889999999999999999999974
Q ss_pred ccccccccCCceeeccceecccccCccccc-----cCCCCCcccchhhHHHHHHHhcC-CCCcccchh--------hh-h
Q 044846 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-----SSQFTEKSDVYSFSVVLVELNWT-KPIHLVDVE--------EN-R 190 (290)
Q Consensus 126 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwS~G~il~~l~~~-~~~~~~~~~--------~~-~ 190 (290)
..... +.........+|...|.+||.-. +-.-+...|.|.+|+++++++.| ..|+. ... .+ .
T Consensus 162 Dsfqi--~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys-GI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQI--NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS-GIPLISDAPNPLETD 238 (637)
T ss_pred cceee--ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC-cccccCCCCCcchhh
Confidence 32111 12233444567788899999755 23345679999999999999876 33332 111 00 0
Q ss_pred hhHHHh---h-----------hhhhHHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHHhhHhhhCccch
Q 044846 191 SLAAYF---S-----------KEAEKEEVITFAMVAKRCLNLN--GKKQPTMKEVTLELAGIRASIGASVL 245 (290)
Q Consensus 191 ~~~~~~---~-----------~~~~~~~~~~~~~li~~cl~~d--p~~Rps~~el~~~l~~~~~~~~~~~~ 245 (290)
.....+ . .....-.++++..|..+|+... +.-|||++.-+..|..+..++..+..
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v 309 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTV 309 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhh
Confidence 000000 0 1112233556778888888754 56799999888888888877765543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.1e-06 Score=68.26 Aligned_cols=109 Identities=19% Similarity=0.164 Sum_probs=81.7
Q ss_pred chhHHHHHHHHHHHHhcCC--CceeeEEeEEE-eC----CcceEEEEeCCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 044846 15 ESNVEQFINEVVILSQINH--RNVVKILGCCL-ET----EVPLLVYEFIPN-GSLYQYIHEQTDDQLPITWEMRLRITVE 86 (290)
Q Consensus 15 ~~~~~~~~~E~~~l~~l~H--pniv~~~~~~~-~~----~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~ 86 (290)
......|.+|...|+.|.. -.+++.. ++. .. ...+||+|-+.| -+|.+++.+..-. +.+......+..+
T Consensus 60 P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~ 136 (216)
T PRK09902 60 PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVS--PYSDEVRQAMLKA 136 (216)
T ss_pred CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcC--CcchHHHHHHHHH
Confidence 3467789999999999842 2344444 332 11 245799998853 5898888654321 4566777889999
Q ss_pred HHHHHHHHhhCCCCCeEeccCCCCceEeccCCc--EEEecccccc
Q 044846 87 VSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ--AKISDFRTFK 129 (290)
Q Consensus 87 i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~--~kl~dfg~~~ 129 (290)
++..+.-||+.+ +.|+|+-+.||+++.++. ++++||.-++
T Consensus 137 va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 137 VALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred HHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 999999999999 999999999999987777 8999996543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.1e-06 Score=67.13 Aligned_cols=102 Identities=25% Similarity=0.384 Sum_probs=79.2
Q ss_pred HHHHHHHHhcCC-CceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 044846 22 INEVVILSQINH-RNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASI 100 (290)
Q Consensus 22 ~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~ 100 (290)
..|.-+++.+.+ +++++++|+|.. +++.||...+++...... .......+|..+.+++.++++.+.+++..-..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888999965 699999999933 689999977666432100 00111367999999999999999999985444
Q ss_pred CeEeccCCCCceEeccCCcEEEeccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
.+.-+|++++|+.++.+|++|++|....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhc
Confidence 4899999999999999999999999754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.29 E-value=6.1e-06 Score=67.58 Aligned_cols=66 Identities=21% Similarity=0.291 Sum_probs=51.5
Q ss_pred CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccc
Q 044846 47 EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126 (290)
Q Consensus 47 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg 126 (290)
...+++|||++|..|.++.. ++. .+...+.+++.-+|+.| +.|+|..|.|++++.+ .++++||+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred eEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECc
Confidence 34569999999987765532 222 24456778899999999 9999999999999855 49999997
Q ss_pred cc
Q 044846 127 TF 128 (290)
Q Consensus 127 ~~ 128 (290)
..
T Consensus 180 ~k 181 (229)
T PF06176_consen 180 GK 181 (229)
T ss_pred cc
Confidence 64
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=6.1e-06 Score=69.17 Aligned_cols=94 Identities=19% Similarity=0.159 Sum_probs=66.2
Q ss_pred HHHHHHHHHHHHhcCCC--ceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 044846 18 VEQFINEVVILSQINHR--NVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLH 95 (290)
Q Consensus 18 ~~~~~~E~~~l~~l~Hp--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH 95 (290)
+....+|.++|+.|... .+++-++ .+...+||||+.|-.|...- ++.+..-.++..|++-+.-.-
T Consensus 153 Rl~A~rEf~~L~~L~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~ 219 (304)
T COG0478 153 RLAAEREFEALQRLYPEGVKVPKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAY 219 (304)
T ss_pred HHHHHHHHHHHHHhhhcCCCCCCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHH
Confidence 34567899999998433 4444333 35668999999886665432 122333445555666665555
Q ss_pred hCCCCCeEeccCCCCceEeccCCcEEEecccc
Q 044846 96 SVASIPIYHLDIKSANILLVDKYQAKISDFRT 127 (290)
Q Consensus 96 ~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~ 127 (290)
..| |||+|+.+-||+++.+|.+.++||-.
T Consensus 220 ~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ 248 (304)
T COG0478 220 RRG---IVHGDLSEFNILVTEDGDIVVIDWPQ 248 (304)
T ss_pred HcC---ccccCCchheEEEecCCCEEEEeCcc
Confidence 778 99999999999999999999999954
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.9e-06 Score=79.94 Aligned_cols=200 Identities=16% Similarity=0.143 Sum_probs=134.0
Q ss_pred HHHHHHHHHHHHhcCCCceeeEEeEEEeCC----cceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 044846 18 VEQFINEVVILSQINHRNVVKILGCCLETE----VPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSY 93 (290)
Q Consensus 18 ~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~y 93 (290)
......|...+..+.|+|++.++.+-.... ...+..|+|..-++...+..-. ..+..+.+.+..++.+||.|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHH
Confidence 444455777888889999999988865432 3346678898888988887665 57888999999999999999
Q ss_pred HhhCCCCCeEeccCCCC---ceEeccCCcEEEe--ccccccccccCCceeeccceecccccCccccccCCCCC--cccch
Q 044846 94 LHSVASIPIYHLDIKSA---NILLVDKYQAKIS--DFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE--KSDVY 166 (290)
Q Consensus 94 lH~~~~~~iiHrdlkp~---Nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Diw 166 (290)
+|+.. .-|.-+..+ +-..+..+...+. ||+..+..... ........+..+.++|......+.. ..|+|
T Consensus 302 ~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~--~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 302 LHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN--EKSFSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCc--ccchhhcCccccccccccccccchhhhhhHHH
Confidence 99985 545544444 3334455556655 77765433221 1112223344577888777666554 47999
Q ss_pred hhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 167 SFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 167 S~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.+|.....+..+............ .+.. .......+...+|+.-++++|+++.+++.+..
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~~~~----~l~~----~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAVPVS----LLDV----LSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred HHHHHHhhhhhcCcccccccchhh----hhcc----ccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 999999988777654432211111 0000 11115677889999999999999999987754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.2e-07 Score=81.67 Aligned_cols=197 Identities=17% Similarity=0.090 Sum_probs=124.8
Q ss_pred HHHHHHHHHHHhcCCCc-eeeEEeEEEeCCcceEEEEeCCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 044846 19 EQFINEVVILSQINHRN-VVKILGCCLETEVPLLVYEFIPNG-SLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHS 96 (290)
Q Consensus 19 ~~~~~E~~~l~~l~Hpn-iv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~ 96 (290)
....-+++.|.+++||| .+.+++.+......+++++++.+| +........ ...+..-+...+.+.-..+++|+|+
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~s---e~~~~~~~~~~~~r~et~~l~~l~~ 354 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVS---EIALEQYQFAYPLRKETRPLAELHS 354 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChh---hHhhhhhhhhhhhhhhccccccccc
Confidence 34556889999999999 777788888888999999999776 222111110 0122233344456666788999998
Q ss_pred CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCcccchhhHHHHHHHh
Q 044846 97 VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELN 176 (290)
Q Consensus 97 ~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~ 176 (290)
.- =+||| ||+... +..+..||+...... .........+++.|+|||+...+.+..+.|.|+.|.-..++.
T Consensus 355 ~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~--~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~a 424 (829)
T KOG0576|consen 355 SY---KVHRD----NILGSE-EEVKLLDFAVPPQLT--RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMA 424 (829)
T ss_pred cc---ccCcc----cccccc-cccccccccCCcccC--cccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcC
Confidence 64 46888 776654 678999998754332 222345577899999999999999999999999998777776
Q ss_pred cCCCCcccchhhhhhh-----HHHhhhhhhHHHHHHHH-HHHHHhhccCCCCCCCHHHHH
Q 044846 177 WTKPIHLVDVEENRSL-----AAYFSKEAEKEEVITFA-MVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 177 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-~li~~cl~~dp~~Rps~~el~ 230 (290)
-|-+|........... ...+.. ...+...+. ++...|+...|..|+.....+
T Consensus 425 p~~pPr~~P~~~~~~~g~~p~s~~L~~--~~aw~~~~~~~~~~~~~~g~P~~pkv~mgac 482 (829)
T KOG0576|consen 425 PGLPPRSSPPAVLPMIGNGPNSPMLTD--KSAWSPVFHRDFPAPCLNGLPPTPKVHMGAC 482 (829)
T ss_pred CCCCCCCCCccccCCCCCCCCccccch--hhhcCcccccCCcccccCCCCCCCcchhhHH
Confidence 6655432211000000 000000 011111122 356678888888888755543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.7e-05 Score=64.82 Aligned_cols=58 Identities=14% Similarity=0.050 Sum_probs=41.3
Q ss_pred eEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHH
Q 044846 4 LWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY 64 (290)
Q Consensus 4 ~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 64 (290)
.+++|...... ...+.+|+++++.+ ++--+.+++++....+..++|||+++|.+|...
T Consensus 24 ~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 24 GLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 45666665432 33567899999988 444566778777766778999999998777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.08 E-value=8.9e-05 Score=61.81 Aligned_cols=123 Identities=16% Similarity=0.171 Sum_probs=68.5
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCC--ceeeEEeEEEeCCcceEEEEeCCCCC-HHHHHh-------------
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHR--NVVKILGCCLETEVPLLVYEFIPNGS-LYQYIH------------- 66 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hp--niv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~------------- 66 (290)
..+++|...... ......+|.++++.+..- -+.+.+++....+...+|||+++|.+ +...+.
T Consensus 23 ~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~l 100 (226)
T TIGR02172 23 GKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIF 100 (226)
T ss_pred CCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHH
Confidence 445677765422 334567899999988432 24667777777777889999998753 211111
Q ss_pred -h-------cCCCCCCCCHHHHHHHHH----------HHHHH-HHHHhhC-CCCCeEeccCCCCceEeccCCcEEEeccc
Q 044846 67 -E-------QTDDQLPITWEMRLRITV----------EVSRV-LSYLHSV-ASIPIYHLDIKSANILLVDKYQAKISDFR 126 (290)
Q Consensus 67 -~-------~~~~~~~~~~~~~~~~~~----------~i~~~-l~ylH~~-~~~~iiHrdlkp~Nil~~~~~~~kl~dfg 126 (290)
+ .......+.. ....+.. .+... ..+|... ....++|+|+.|.||+++.++ +.++||+
T Consensus 101 a~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe 178 (226)
T TIGR02172 101 AEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLG 178 (226)
T ss_pred HHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEech
Confidence 0 0000001110 0000100 01111 1222211 122378999999999999887 9999998
Q ss_pred ccc
Q 044846 127 TFK 129 (290)
Q Consensus 127 ~~~ 129 (290)
.+.
T Consensus 179 ~a~ 181 (226)
T TIGR02172 179 DFG 181 (226)
T ss_pred hcC
Confidence 753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00018 Score=58.59 Aligned_cols=97 Identities=21% Similarity=0.200 Sum_probs=71.0
Q ss_pred hhHHHHHHHHHHHHhcC------CCceeeEEeEEEeCCcceEEEEeCCC------CCHHHHHhhcCCCCCCCCHHHHHHH
Q 044846 16 SNVEQFINEVVILSQIN------HRNVVKILGCCLETEVPLLVYEFIPN------GSLYQYIHEQTDDQLPITWEMRLRI 83 (290)
Q Consensus 16 ~~~~~~~~E~~~l~~l~------Hpniv~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~~ 83 (290)
...++..+|+.....+. +.+|.+++|+..++-..-+|+|.+.+ .+|.+++++.. ++. ...
T Consensus 53 ~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~-- 124 (199)
T PF10707_consen 53 SRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELR-- 124 (199)
T ss_pred chhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHH--
Confidence 34667788888777766 78999999999999888999998753 36888886543 544 222
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC----cEEEec
Q 044846 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY----QAKISD 124 (290)
Q Consensus 84 ~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~d 124 (290)
..+-+-..||-+++ |+.+|++|.||++.... .+.|+|
T Consensus 125 -~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 125 -QALDEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred -HHHHHHHHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 23334446777778 99999999999997432 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00043 Score=64.34 Aligned_cols=75 Identities=20% Similarity=0.219 Sum_probs=51.5
Q ss_pred CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH-HHHHhhCCCCCeEeccCCCCceEeccCCcEEEec
Q 044846 46 TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRV-LSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124 (290)
Q Consensus 46 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~-l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~d 124 (290)
...-.|+|||+.|-.+.++..-... .++... ++..++.+ +.-+-..| ++|.|..|-||++..+|++.+.|
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k~---ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lD 308 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKSA---GIDRKE---LAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLD 308 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHhc---CCCHHH---HHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEc
Confidence 4456799999999888888432221 244222 33322222 22233456 99999999999999999999999
Q ss_pred ccccc
Q 044846 125 FRTFK 129 (290)
Q Consensus 125 fg~~~ 129 (290)
||+..
T Consensus 309 fGi~g 313 (517)
T COG0661 309 FGIVG 313 (517)
T ss_pred Cccee
Confidence 99854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00044 Score=57.96 Aligned_cols=29 Identities=24% Similarity=0.407 Sum_probs=24.5
Q ss_pred CeEeccCCCCceEeccCCcEEEecccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
.++|+|+.+.|++++..+..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 38999999999999876656799998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00044 Score=57.29 Aligned_cols=59 Identities=25% Similarity=0.408 Sum_probs=40.0
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcC-C-CceeeEEeEEEe---CCcceEEEEeCCCCCHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQIN-H-RNVVKILGCCLE---TEVPLLVYEFIPNGSLYQ 63 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-H-pniv~~~~~~~~---~~~~~lv~e~~~~g~L~~ 63 (290)
+.+++|..... .....+.+|..+++.|. + .-+.+++..... ....+++|++++|..+..
T Consensus 21 ~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 21 GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 46778886653 45667889999999883 3 235666664433 335689999999887777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00052 Score=67.99 Aligned_cols=57 Identities=16% Similarity=0.334 Sum_probs=39.9
Q ss_pred eEEEEeecccC-chhHHHHHHHHHHHHhcC-CCce--eeEEeEEEeC---CcceEEEEeCCCCC
Q 044846 4 LWLLKKSKSVH-ESNVEQFINEVVILSQIN-HRNV--VKILGCCLET---EVPLLVYEFIPNGS 60 (290)
Q Consensus 4 ~~avK~~~~~~-~~~~~~~~~E~~~l~~l~-Hpni--v~~~~~~~~~---~~~~lv~e~~~~g~ 60 (290)
.+++|+..... ......+.+|.++|+.|. |+++ ++++.++.+. +..|+||||++|..
T Consensus 67 ~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 67 RYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred eEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 46677764322 123446889999999994 6665 7777777654 46789999998754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00047 Score=57.44 Aligned_cols=96 Identities=20% Similarity=0.185 Sum_probs=62.2
Q ss_pred HHHHHHHHhcC--CCceeeEEeEEEeCCcceEEEEeCCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-C
Q 044846 22 INEVVILSQIN--HRNVVKILGCCLETEVPLLVYEFIPNG-SLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHS-V 97 (290)
Q Consensus 22 ~~E~~~l~~l~--Hpniv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~-~ 97 (290)
.+|...|.++. +-.+++=+++ ..-.|||||+... .-...|+.- +++......+..++++++.-|-. .
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHhc
Confidence 44666676662 2222222222 1336999999532 111112211 23334566778888999988777 6
Q ss_pred CCCCeEeccCCCCceEeccCCcEEEeccccccc
Q 044846 98 ASIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130 (290)
Q Consensus 98 ~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~ 130 (290)
+ ++|+||..-|||+. ++.+.++|||.+..
T Consensus 187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred C---cccccchhhheEEE-CCeEEEEECccccc
Confidence 7 99999999999998 88999999987643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00066 Score=57.66 Aligned_cols=28 Identities=18% Similarity=0.339 Sum_probs=24.3
Q ss_pred CeEeccCCCCceEeccCCcEEEecccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
-++|+|+.|.||+++.++ +.++||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 389999999999999876 7899998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0011 Score=55.30 Aligned_cols=28 Identities=29% Similarity=0.375 Sum_probs=24.8
Q ss_pred CeEeccCCCCceEecc-CCcEEEeccccc
Q 044846 101 PIYHLDIKSANILLVD-KYQAKISDFRTF 128 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~-~~~~kl~dfg~~ 128 (290)
.++|+|+.+.|||++. ++.+.++||..+
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a 199 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYA 199 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence 3899999999999997 578999999764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.47 E-value=1.6e-05 Score=80.23 Aligned_cols=161 Identities=12% Similarity=-0.013 Sum_probs=115.8
Q ss_pred HHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 044846 21 FINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVA 98 (290)
Q Consensus 21 ~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~ 98 (290)
.+.|..-++...|+++.....-... +...|.+++|+.+|++++.+-++.....+++..-+.....+...+..-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3444445556689988876655443 33568999999999999999887766556655544444444466666666443
Q ss_pred --CCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCcccchhhHHHHHHHh
Q 044846 99 --SIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELN 176 (290)
Q Consensus 99 --~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~ 176 (290)
..-.+|++||+-|.++..+..+++.++|+.+...... .......+++.|+.++....-.++.++|+|+.|+.+|...
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2237899999999999999999999999977332221 1223355677899999988888898899999999999887
Q ss_pred cCCCCc
Q 044846 177 WTKPIH 182 (290)
Q Consensus 177 ~~~~~~ 182 (290)
.|.+++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 665544
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0072 Score=52.58 Aligned_cols=44 Identities=16% Similarity=0.099 Sum_probs=33.7
Q ss_pred HHHHHHHHHHHHhcC-C--CceeeEEeEEEe---CCcceEEEEeCCCCCH
Q 044846 18 VEQFINEVVILSQIN-H--RNVVKILGCCLE---TEVPLLVYEFIPNGSL 61 (290)
Q Consensus 18 ~~~~~~E~~~l~~l~-H--pniv~~~~~~~~---~~~~~lv~e~~~~g~L 61 (290)
...+..|.+.|+.|. + -.++++++++.. .+..+||||+++|+++
T Consensus 51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 347889999999883 3 367888887754 3668999999988654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0041 Score=55.30 Aligned_cols=122 Identities=18% Similarity=0.195 Sum_probs=67.3
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHH-------H---------
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY-------I--------- 65 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~-------l--------- 65 (290)
+.|++|.........+++ .+|..+++.+ ++.--.++++.+..+ .|.||+++.+|... +
T Consensus 66 ~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~ 140 (344)
T PLN02236 66 RKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLRE 140 (344)
T ss_pred CeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHH
Confidence 467777765433333333 6799999988 444445666666432 68999977665421 0
Q ss_pred -hhcC--CCCCCCCHHHHHHHHHHH-----------------HHHHHHH----hh-CCCCCeEeccCCCCceEecc-CCc
Q 044846 66 -HEQT--DDQLPITWEMRLRITVEV-----------------SRVLSYL----HS-VASIPIYHLDIKSANILLVD-KYQ 119 (290)
Q Consensus 66 -~~~~--~~~~~~~~~~~~~~~~~i-----------------~~~l~yl----H~-~~~~~iiHrdlkp~Nil~~~-~~~ 119 (290)
+... .......+..+..+..++ ...+..| .. ..+.-++|+|+++.||+++. ++.
T Consensus 141 lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~ 220 (344)
T PLN02236 141 FHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRA 220 (344)
T ss_pred HhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCc
Confidence 1100 000011123333333221 1111112 21 12234899999999999986 468
Q ss_pred EEEecccccc
Q 044846 120 AKISDFRTFK 129 (290)
Q Consensus 120 ~kl~dfg~~~ 129 (290)
+.++||..+.
T Consensus 221 ~~lID~Eya~ 230 (344)
T PLN02236 221 ITIIDYEYAS 230 (344)
T ss_pred EEEEeehhcc
Confidence 9999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0034 Score=54.59 Aligned_cols=30 Identities=27% Similarity=0.437 Sum_probs=25.9
Q ss_pred CCeEeccCCCCceEeccC----CcEEEecccccc
Q 044846 100 IPIYHLDIKSANILLVDK----YQAKISDFRTFK 129 (290)
Q Consensus 100 ~~iiHrdlkp~Nil~~~~----~~~kl~dfg~~~ 129 (290)
..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 348999999999999975 889999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.002 Score=59.88 Aligned_cols=77 Identities=16% Similarity=0.138 Sum_probs=49.8
Q ss_pred CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec----cCCcEEE
Q 044846 47 EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV----DKYQAKI 122 (290)
Q Consensus 47 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~----~~~~~kl 122 (290)
....|+||||.|..+.+.-.-... .++...+..-+.+...-+.+ ..| ++|+|-.|-||++. .++.+.+
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~~qIf--~~G---ffHaDPHPGNilv~~~~~~~~~ivl 346 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYLEQIF--KTG---FFHADPHPGNILVRPNPEGDEEIVL 346 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHHHHHH--hcC---CccCCCCCCcEEEecCCCCCccEEE
Confidence 345799999998766554322211 25544443333333322222 346 99999999999998 3678999
Q ss_pred ecccccccc
Q 044846 123 SDFRTFKSR 131 (290)
Q Consensus 123 ~dfg~~~~~ 131 (290)
-|||+....
T Consensus 347 lDhGl~~~i 355 (538)
T KOG1235|consen 347 LDHGLYAVI 355 (538)
T ss_pred Ecccccccc
Confidence 999996543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0033 Score=57.67 Aligned_cols=153 Identities=24% Similarity=0.309 Sum_probs=90.2
Q ss_pred HHHHHHHHHHHHhcCCCceeeEEeEEEe-CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 044846 18 VEQFINEVVILSQINHRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHS 96 (290)
Q Consensus 18 ~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~ 96 (290)
..+.+...+.++.+.|+|.-.++++... .....+|||++ +.+|++.+..+... ... ++ .
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~-----~~s----------~~----~ 85 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK-----DES----------LL----A 85 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc-----hhh----------hc----c
Confidence 4456778889999999999999888764 34578999999 67999998865411 111 00 1
Q ss_pred CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCcccchhhHHHHHHHh
Q 044846 97 VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELN 176 (290)
Q Consensus 97 ~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~ 176 (290)
++ +.|- |++ +.+| .+.. . | |- ...+|+||||+|.++.++.
T Consensus 86 ~~---~~~~-----~~~-------~~td-~~~t-------~----------~--~~-----~~~pKsdVwsl~~i~~el~ 125 (725)
T KOG1093|consen 86 HG---VLHL-----NII-------YITD-HFLT-------K----------Y--PS-----PIGPKSDVWSLGFIILELY 125 (725)
T ss_pred cc---ccee-----hhh-------hccc-cccc-------c----------C--CC-----CCCcchhhhhHHHHHHHHH
Confidence 22 3332 221 2222 0000 0 0 00 0114899999999999998
Q ss_pred cCCCCcccchhhh--hhhHHHhh-----------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 177 WTKPIHLVDVEEN--RSLAAYFS-----------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 177 ~~~~~~~~~~~~~--~~~~~~~~-----------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
-|...+....... ..+..+.. ......++..+.++...|+-..|..||...++.
T Consensus 126 L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 126 LGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 7765443221111 11111111 112234456688899999999999998766554
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.003 Score=51.96 Aligned_cols=27 Identities=30% Similarity=0.445 Sum_probs=19.6
Q ss_pred eEeccCCCCceEe-ccCCcEEEeccccc
Q 044846 102 IYHLDIKSANILL-VDKYQAKISDFRTF 128 (290)
Q Consensus 102 iiHrdlkp~Nil~-~~~~~~kl~dfg~~ 128 (290)
++|.|+.+.|||+ ..++.++++||..+
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya 172 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYA 172 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred EeeccCccccEEeccCCCeEEEecHHHH
Confidence 8999999999999 88899999999775
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.016 Score=50.10 Aligned_cols=123 Identities=15% Similarity=0.185 Sum_probs=67.0
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCC--ceeeEEeE------EEeCCcceEEEEeCCCCCHHH----HHhh---
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHR--NVVKILGC------CLETEVPLLVYEFIPNGSLYQ----YIHE--- 67 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hp--niv~~~~~------~~~~~~~~lv~e~~~~g~L~~----~l~~--- 67 (290)
..+++|+... ........|++++..|.+. .+++.+.. ....+..++|+++++|..+.. ....
T Consensus 38 ~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~ 114 (296)
T cd05153 38 GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGE 114 (296)
T ss_pred CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHH
Confidence 4567777654 2334566788888888322 24444331 233456789999998865421 1100
Q ss_pred -------cC-C--CC----CCCCHHHHH----------HHHHHHHHHHHHHhhC----CCCCeEeccCCCCceEeccCCc
Q 044846 68 -------QT-D--DQ----LPITWEMRL----------RITVEVSRVLSYLHSV----ASIPIYHLDIKSANILLVDKYQ 119 (290)
Q Consensus 68 -------~~-~--~~----~~~~~~~~~----------~~~~~i~~~l~ylH~~----~~~~iiHrdlkp~Nil~~~~~~ 119 (290)
.. . .. ....+.... .....+...+.++... -+..++|+|+.|.|++++.++.
T Consensus 115 ~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~ 194 (296)
T cd05153 115 ALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDEL 194 (296)
T ss_pred HHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCce
Confidence 00 0 00 001111110 0111223344444431 1233999999999999998777
Q ss_pred EEEeccccc
Q 044846 120 AKISDFRTF 128 (290)
Q Consensus 120 ~kl~dfg~~ 128 (290)
+.|+||+.+
T Consensus 195 ~~iIDfe~a 203 (296)
T cd05153 195 SGVIDFYFA 203 (296)
T ss_pred EEEeehhhh
Confidence 789999864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.017 Score=50.44 Aligned_cols=30 Identities=20% Similarity=0.192 Sum_probs=26.0
Q ss_pred CCeEeccCCCCceEeccCCcEEEecccccc
Q 044846 100 IPIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 100 ~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
..++|+|+.+.|++++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 449999999999999988777899998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.035 Score=48.53 Aligned_cols=32 Identities=13% Similarity=0.154 Sum_probs=28.0
Q ss_pred CCeEeccCCCCceEeccCCcEEEecccccccc
Q 044846 100 IPIYHLDIKSANILLVDKYQAKISDFRTFKSR 131 (290)
Q Consensus 100 ~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~ 131 (290)
..++|+|+.+.|++++..+.+-|.||+++...
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 35999999999999998888999999987643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.1 Score=45.70 Aligned_cols=29 Identities=21% Similarity=0.224 Sum_probs=24.7
Q ss_pred CeEeccCCCCceEeccCCcEEEecccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
.+||+|+.|.||+++.+...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 49999999999999866556899998754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.036 Score=47.67 Aligned_cols=30 Identities=20% Similarity=0.340 Sum_probs=24.6
Q ss_pred CeEeccCCCCceEeccCCc-EEEeccccccc
Q 044846 101 PIYHLDIKSANILLVDKYQ-AKISDFRTFKS 130 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~-~kl~dfg~~~~ 130 (290)
-++|+|+.+.|++++.+++ .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997555 46999987543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.03 Score=48.43 Aligned_cols=55 Identities=22% Similarity=0.279 Sum_probs=34.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCcceEEEEeCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN---HRNVVKILGCCLETEVPLLVYEFIPNG 59 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~---Hpniv~~~~~~~~~~~~~lv~e~~~~g 59 (290)
++.+.||.-. ......|..|.+-|+.|. --.+++.+++....+..+|||||++.+
T Consensus 40 ~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 40 GGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp S-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4556677766 333446788999999883 346778888888777889999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.039 Score=48.75 Aligned_cols=27 Identities=26% Similarity=0.290 Sum_probs=23.9
Q ss_pred eEeccCCCCceEecc-CCcEEEeccccc
Q 044846 102 IYHLDIKSANILLVD-KYQAKISDFRTF 128 (290)
Q Consensus 102 iiHrdlkp~Nil~~~-~~~~kl~dfg~~ 128 (290)
++|.|+-+.|||++. ++.++++||..|
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEccccc
Confidence 799999999999975 578999999875
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.056 Score=43.99 Aligned_cols=84 Identities=27% Similarity=0.440 Sum_probs=59.7
Q ss_pred HHHHHHHHHHHhcC---CCce--eeEEeEEEeCC------------------cceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 19 EQFINEVVILSQIN---HRNV--VKILGCCLETE------------------VPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 19 ~~~~~E~~~l~~l~---Hpni--v~~~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
.-|..|.+...+|+ +.++ |+.+|+..-.. ...||.||++... .+
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~ 165 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL 165 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc
Confidence 35788999888873 4456 88899975331 1247888776533 12
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~ 127 (290)
... -+.+|.+-+..+|..+ |+-+|+++.|.. .-+|+|||.
T Consensus 166 ~~~----~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~ 205 (207)
T PF13095_consen 166 QIR----DIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSS 205 (207)
T ss_pred chh----HHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEeccc
Confidence 222 2467778889999999 999999999973 358999985
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.3 Score=44.29 Aligned_cols=56 Identities=16% Similarity=0.101 Sum_probs=37.0
Q ss_pred ceEEEEeecc----cC---chhHHHHHHHHHHHHhc-C--CCceeeEEeEEEeCCcceEEEEeCCCCC
Q 044846 3 ELWLLKKSKS----VH---ESNVEQFINEVVILSQI-N--HRNVVKILGCCLETEVPLLVYEFIPNGS 60 (290)
Q Consensus 3 ~~~avK~~~~----~~---~~~~~~~~~E~~~l~~l-~--Hpniv~~~~~~~~~~~~~lv~e~~~~g~ 60 (290)
+.++||.-.. .. .-..+++..|.+.|+.+ . ..++++++.+. ....++|||++++..
T Consensus 52 ~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lVME~L~~~~ 117 (401)
T PRK09550 52 KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTVMEDLSDHK 117 (401)
T ss_pred eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEEEecCCCcc
Confidence 3688887531 11 12456778899999887 2 34677777663 355789999997643
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.039 Score=45.49 Aligned_cols=100 Identities=18% Similarity=0.109 Sum_probs=63.6
Q ss_pred EEEeecccCch-hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHH
Q 044846 6 LLKKSKSVHES-NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRIT 84 (290)
Q Consensus 6 avK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 84 (290)
.+||++...-. ...-|..+..+++++. .|+++..- .....-++.|.|-.... . ..-.+.
T Consensus 89 ~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~---~~N~i~ 148 (308)
T PF07387_consen 89 FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------N---FSNFIT 148 (308)
T ss_pred hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------c---hhHHHH
Confidence 35666654444 3445677888888774 47777622 33345689999943111 0 011111
Q ss_pred HHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEecccc
Q 044846 85 VEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127 (290)
Q Consensus 85 ~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~ 127 (290)
-=+..|.-.|+.++. .+|+|-.|+||+-|..|-+||.|=+.
T Consensus 149 -agi~~L~~fH~~~~~-~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 -AGIKDLMDFHSENQH-CLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -HhHHHHHHhhccCCC-eecCCCChhheeecCCCCEEecChhh
Confidence 113566777854433 89999999999999999999999764
|
The function of this family is unknown. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.13 Score=41.03 Aligned_cols=108 Identities=18% Similarity=0.141 Sum_probs=67.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCcee-eEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVV-KILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv-~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|..+|+|+-+. .+-+..+..|+++|..+.--++. +++.+ +..++.|||+.|..|.+.-... +..
T Consensus 45 ~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~L~~~~~~~-------~rk-- 109 (201)
T COG2112 45 GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRPLGKLEIGG-------DRK-- 109 (201)
T ss_pred CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcchhhhhhcc-------cHH--
Confidence 45688888765 34456788999999998654442 33333 2234669999887887664421 112
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCC-CceEeccCCcEEEecccccc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKS-ANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp-~Nil~~~~~~~kl~dfg~~~ 129 (290)
-...+++.---|-..| |-|..|.- ...++..++.+.|+||..|+
T Consensus 110 --~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 110 --HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred --HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 2234445433344456 88888864 44455556689999998765
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.066 Score=44.41 Aligned_cols=50 Identities=22% Similarity=0.341 Sum_probs=38.2
Q ss_pred cCchhHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCcceEEEEeCCCCCHH
Q 044846 13 VHESNVEQFINEVVILSQIN---HRNVVKILGCCLETEVPLLVYEFIPNGSLY 62 (290)
Q Consensus 13 ~~~~~~~~~~~E~~~l~~l~---Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~ 62 (290)
........|..|+.-|..|. .-++.+++.+-...++.|+||||++-|.+.
T Consensus 47 n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 47 NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 34555677889999888873 345777787888888999999999876554
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.052 Score=47.41 Aligned_cols=91 Identities=18% Similarity=0.210 Sum_probs=60.9
Q ss_pred HHHHHHHHHHhc-CCCc-eeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 044846 20 QFINEVVILSQI-NHRN-VVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSV 97 (290)
Q Consensus 20 ~~~~E~~~l~~l-~Hpn-iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~ 97 (290)
...+|...|+.| .|-. +++-+ +.+..++|||++.|-.|...-... +..+ +...+..-+--|-.+
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~-------d~~~---ly~~lm~~Iv~la~~ 221 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHVE-------DPPT---LYDDLMGLIVRLANH 221 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeecC-------ChHH---HHHHHHHHHHHHHHc
Confidence 456788999988 4432 22222 335668999999887776554321 1122 222333334445567
Q ss_pred CCCCeEeccCCCCceEeccCCcEEEecccc
Q 044846 98 ASIPIYHLDIKSANILLVDKYQAKISDFRT 127 (290)
Q Consensus 98 ~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~ 127 (290)
| +||+|..-=||++..++.++++||-.
T Consensus 222 G---lIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 222 G---LIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred C---ceecccchheeEEecCCCEEEeechH
Confidence 7 99999999999999999999999954
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.12 Score=45.77 Aligned_cols=73 Identities=18% Similarity=0.154 Sum_probs=52.6
Q ss_pred CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccc
Q 044846 47 EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126 (290)
Q Consensus 47 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg 126 (290)
.+.|++|++- |++|.. ++ .-.++++..++.+-+.-+.-+..+- ++=|||+.-.|||++ .|++-|+||-
T Consensus 299 ~y~yl~~kdh-gt~is~-ik-------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-IK-------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeee-ee-------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 4567888876 555532 22 1345777777777666665555543 378999999999999 9999999999
Q ss_pred ccccc
Q 044846 127 TFKSR 131 (290)
Q Consensus 127 ~~~~~ 131 (290)
+++..
T Consensus 367 lsRl~ 371 (488)
T COG5072 367 LSRLS 371 (488)
T ss_pred eeecc
Confidence 87743
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.06 Score=47.04 Aligned_cols=41 Identities=22% Similarity=0.293 Sum_probs=27.9
Q ss_pred HHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeccC
Q 044846 77 WEMRLRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVDK 117 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~~ 117 (290)
.+.++.++.||+.-.-.+-+. +-..++|-||||+|||+-+.
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 356777888887655444222 12239999999999999543
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.11 Score=45.67 Aligned_cols=55 Identities=20% Similarity=0.298 Sum_probs=34.0
Q ss_pred HHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeccCC------------------cEEEeccccccccc
Q 044846 78 EMRLRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVDKY------------------QAKISDFRTFKSRA 132 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~~~------------------~~kl~dfg~~~~~~ 132 (290)
+.++.+..|||.-.--+-+. +-..++|-||||+|||+-+.. .++|.||..++...
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 45666777776433113222 122399999999999995432 36777887766544
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.33 E-value=1.3 Score=40.22 Aligned_cols=60 Identities=13% Similarity=0.138 Sum_probs=36.8
Q ss_pred eEEEEeec----ccCc---hhHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCcceEEEEeCCC--CCHHHHH
Q 044846 4 LWLLKKSK----SVHE---SNVEQFINEVVILSQIN---HRNVVKILGCCLETEVPLLVYEFIPN--GSLYQYI 65 (290)
Q Consensus 4 ~~avK~~~----~~~~---~~~~~~~~E~~~l~~l~---Hpniv~~~~~~~~~~~~~lv~e~~~~--g~L~~~l 65 (290)
.++||.-. .... ....+-..|...|+.+. ..++++++.++. +..+++||++++ ..+.+-+
T Consensus 57 svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 57 SFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred cEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEeecCCcceehhhhh
Confidence 46777754 1111 13444556677777663 247888888776 446789999966 2454444
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.26 E-value=0.21 Score=44.49 Aligned_cols=96 Identities=17% Similarity=0.190 Sum_probs=63.7
Q ss_pred HHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHH--HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 044846 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLY--QYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVAS 99 (290)
Q Consensus 22 ~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~--~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~ 99 (290)
.+|++.|.+|....|.- -.-..- ....|||+|+. ++=+ ..|+.. .++...+..+-.+++.-|.-|...+.
T Consensus 214 EKE~RNLkRl~~aGIP~-PePIlL-k~hVLVM~FlG-rdgw~aPkLKd~-----~ls~~ka~~~Y~~~v~~MR~lY~~c~ 285 (520)
T KOG2270|consen 214 EKEMRNLKRLNNAGIPC-PEPILL-KNHVLVMEFLG-RDGWAAPKLKDA-----SLSTSKARELYQQCVRIMRRLYQKCR 285 (520)
T ss_pred HHHHHHHHHHHhcCCCC-CCceee-ecceEeeeecc-CCCCcCcccccc-----cCChHHHHHHHHHHHHHHHHHHHHhc
Confidence 34777777775443321 111111 12469999994 3332 223322 46777788888888888888876653
Q ss_pred CCeEeccCCCCceEeccCCcEEEeccccc
Q 044846 100 IPIYHLDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 100 ~~iiHrdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
++|.||.--|+|+ .+|.+.++|.+.+
T Consensus 286 --LVHADLSEfN~Ly-hdG~lyiIDVSQS 311 (520)
T KOG2270|consen 286 --LVHADLSEFNLLY-HDGKLYIIDVSQS 311 (520)
T ss_pred --eeccchhhhhheE-ECCEEEEEEcccc
Confidence 9999999999988 5688999998764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.11 E-value=0.87 Score=41.97 Aligned_cols=27 Identities=26% Similarity=0.385 Sum_probs=22.6
Q ss_pred CeEeccCCCCceEeccCCcEEEeccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
-++|.|+-+.|||.+.+ .++++||-.|
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYA 311 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYS 311 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeeccc
Confidence 48999999999987654 4999999764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.96 E-value=0.51 Score=42.63 Aligned_cols=37 Identities=14% Similarity=0.131 Sum_probs=26.9
Q ss_pred HHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHH
Q 044846 22 INEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLY 62 (290)
Q Consensus 22 ~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~ 62 (290)
.+|.++++.|. +.--.++++.+.. +++.||++|.+|.
T Consensus 100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTMG 137 (383)
T ss_pred HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccCC
Confidence 47899999994 4555666777643 5999999887654
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.63 E-value=0.1 Score=42.02 Aligned_cols=27 Identities=15% Similarity=0.290 Sum_probs=23.9
Q ss_pred eEeccCCCCceEeccCCcEEEecccccc
Q 044846 102 IYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 102 iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
.+|+|+.|.|++++.++ ++++||+.+.
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCccc
Confidence 69999999999998776 9999998754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.40 E-value=0.3 Score=42.48 Aligned_cols=27 Identities=33% Similarity=0.388 Sum_probs=23.7
Q ss_pred CeEeccCCCCceEeccCCcEEEeccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
.++|+|+.+.|++++. +.+.|+||+.+
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 4899999999999987 67899999864
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.97 E-value=0.3 Score=41.79 Aligned_cols=27 Identities=30% Similarity=0.342 Sum_probs=25.2
Q ss_pred eEeccCCCCceEeccCCcEEEeccccc
Q 044846 102 IYHLDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 102 iiHrdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
++|+|+.|.|++.+..+.++|+||..|
T Consensus 155 ~cH~Dl~~~N~l~t~~~~l~LIDWEyA 181 (269)
T COG0510 155 PCHNDLNPGNLLLTDKGGLFLIDWEYA 181 (269)
T ss_pred eecCCCCccceEEcCCCcEEEEecccC
Confidence 899999999999999899999999764
|
|
| >KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.83 E-value=0.79 Score=39.56 Aligned_cols=36 Identities=33% Similarity=0.445 Sum_probs=28.9
Q ss_pred HHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHH
Q 044846 23 NEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLY 62 (290)
Q Consensus 23 ~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~ 62 (290)
+|+...+.| .|-.-.++++-|..+ ||+||+.|.+|.
T Consensus 127 ~Ev~afk~L~a~G~ap~Ly~tF~NG----Lvyefi~g~tL~ 163 (391)
T KOG4720|consen 127 NEVIAFKLLAAYGFAPKLYGTFNNG----LVYEFIQGKTLE 163 (391)
T ss_pred HHHHHHHHHHHcCcChhhhheecCc----eEEeeecCcccC
Confidence 677777777 577888899888766 999999987775
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=90.13 E-value=0.28 Score=39.76 Aligned_cols=29 Identities=21% Similarity=0.267 Sum_probs=23.9
Q ss_pred CeEeccCCCCceEeccCC-----cEEEecccccc
Q 044846 101 PIYHLDIKSANILLVDKY-----QAKISDFRTFK 129 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~-----~~kl~dfg~~~ 129 (290)
.++|+|+.+.|+++..++ .+.++||..+.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 389999999999998543 58899998743
|
subfamily of choline kinases |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 290 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-28 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-28 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 8e-71
Identities = 81/247 (32%), Positives = 125/247 (50%), Gaps = 42/247 (17%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E+F E+ LS H ++V ++G C E +L+Y+++ NG+L ++++ + ++WE
Sbjct: 80 EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDR 135
RL I + +R L YLH+ I H D+KS NILL + + KI+DF + +D+
Sbjct: 140 QRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTE--LDQ 194
Query: 136 THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-------------------N 176
THL+T VK T GY+DP+YF + TEKSDVYSF VVL E+
Sbjct: 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 177 WTKPIH-------LVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
W H +VD +LA E + F A +CL L+ + +P+M +V
Sbjct: 255 WAVESHNNGQLEQIVD----PNLADKIR----PESLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 230 TLELAGI 236
+L
Sbjct: 307 LWKLEYA 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-68
Identities = 75/238 (31%), Positives = 118/238 (49%), Gaps = 36/238 (15%)
Query: 20 QFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79
QF EV ++S HRN++++ G C+ LLVY ++ NGS+ + E+ + Q P+ W
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT 139
R RI + +R L+YLH I H D+K+ANILL ++++A + DF K TH+T
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192
Query: 140 TQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL---------------------NWT 178
T V+ T G++ P+Y + + +EK+DV+ + V+L+EL +W
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 179 KPIH-------LVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
K + LVD L + EEV VA C + ++P M EV
Sbjct: 253 KGLLKEKKLEALVD----VDLQGNYK----DEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-67
Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 48/264 (18%)
Query: 8 KKSKSVHESNVEQ----FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQ 63
KK ++ + E+ F E+ ++++ H N+V++LG + + LVY ++PNGSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 64 YIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKIS 123
+ D P++W MR +I + +++LH I H DIKSANILL + + AKIS
Sbjct: 120 RLSC-LDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKIS 175
Query: 124 DF---RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL----- 175
DF R + +T +T+++ T Y+ P+ R + T KSD+YSF VVL+E+
Sbjct: 176 DFGLARASEKF--AQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLP 232
Query: 176 ------------NWTKPIH--------LVDVEENRSLAAYFSKEAEKEEVITFAMVAKRC 215
+ + I +D + + S E VA +C
Sbjct: 233 AVDEHREPQLLLDIKEEIEDEEKTIEDYID----KKMNDADSTSVEA-----MYSVASQC 283
Query: 216 LNLNGKKQPTMKEVTLELAGIRAS 239
L+ K+P +K+V L + AS
Sbjct: 284 LHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-45
Identities = 63/242 (26%), Positives = 110/242 (45%), Gaps = 22/242 (9%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
+ H V +F+ EV I+ ++ H N+V +G + +V E++ GSLY+ +H+
Sbjct: 69 MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ + RL + +V++ ++YLH+ + PI H ++KS N+L+ KY K+ DF
Sbjct: 129 -GAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL- 185
Query: 129 KSRAIDRTHLT-TQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL----------NW 177
SR T L+ T ++ P+ R EKSDVYSF V+L EL N
Sbjct: 186 -SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244
Query: 178 TKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237
+ + V + + L + + A + + C K+P+ + L +
Sbjct: 245 AQVVAAV-GFKCKRLE--IPRNLNPQ----VAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297
Query: 238 AS 239
S
Sbjct: 298 KS 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-45
Identities = 64/238 (26%), Positives = 113/238 (47%), Gaps = 18/238 (7%)
Query: 14 HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQTDDQ 72
ES + FI E+ LS++NH N+VK+ G CL P+ LV E+ GSLY +H +
Sbjct: 41 SESERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGA-EPL 96
Query: 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ-AKISDFRTFKSR 131
T + ++ S+ ++YLHS+ + H D+K N+LLV KI DF T +
Sbjct: 97 PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT--AC 154
Query: 132 AIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-NWTKPIHLVDVEENR 190
I TH+T + ++ P+ F S ++EK DV+S+ ++L E+ KP ++
Sbjct: 155 DIQ-THMTNNKG-SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPA 210
Query: 191 SLAAYFSKEAEKEEVIT-----FAMVAKRCLNLNGKKQPTMKEVTLELAGIRASIGAS 243
+ + +I + RC + + ++P+M+E+ + + +
Sbjct: 211 FRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-43
Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 16/178 (8%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+E E + + + H N++ + G CL+ LV EF G L + +
Sbjct: 38 ARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 97
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ------ 119
+ I ++ + V+++R ++YLH A +PI H D+KS+NIL++ K +
Sbjct: 98 SGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152
Query: 120 --AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
KI+DF +R RT + + ++ P+ R+S F++ SDV+S+ V+L EL
Sbjct: 153 KILKITDFGL--AREWHRTTKMSAAG-AYAWMAPEVIRASMFSKGSDVWSYGVLLWEL 207
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-43
Identities = 52/269 (19%), Positives = 95/269 (35%), Gaps = 52/269 (19%)
Query: 12 SVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVP----LLVYEFIPNGSLYQYIHE 67
+ + Q EV L + H N+++ +G L+ F GSL ++
Sbjct: 56 PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA 115
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASI-------PIYHLDIKSANILLVDKYQA 120
++W I ++R L+YLH I H DIKS N+LL + A
Sbjct: 116 NV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 121 KISDF---RTFKSRAIDRTHLTTQVKV-TFGYVDPKYFRSS-----QFTEKSDVYSFSVV 171
I+DF F++ ++ T +V T Y+ P+ + + D+Y+ +V
Sbjct: 171 CIADFGLALKFEA---GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227
Query: 172 LVELNWTKPIHLVDVEENR-----SLAAYFSKEAEKEEVI-------------------T 207
L EL V+E + + S E +E V+
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM 287
Query: 208 FAMVAKRCLNLNGKKQPTMKEVTLELAGI 236
+ C + + + + + V + +
Sbjct: 288 LCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-41
Identities = 48/174 (27%), Positives = 90/174 (51%), Gaps = 17/174 (9%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
+ ++ ++F EV I+S +NH N+VK+ G P +V EF+P G LY + ++
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDK 115
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-----YQAKIS 123
PI W ++LR+ ++++ + Y+ + + PI H D++S NI L AK++
Sbjct: 116 AH---PIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF--RSSQFTEKSDVYSFSVVLVEL 175
DF S+ + + + F ++ P+ +TEK+D YSF+++L +
Sbjct: 172 DFGL--SQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-41
Identities = 36/172 (20%), Positives = 73/172 (42%), Gaps = 14/172 (8%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLL--VYEFIPNGSLYQYIH 66
K + F E L +H NV+ +LG C P + ++P GSLY +H
Sbjct: 42 KVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH 101
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
E T+ + ++ ++++R +++LH+ I + S ++++ + A+IS
Sbjct: 102 EGTN--FVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMAD 158
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ---FTEKSDVYSFSVVLVEL 175
+ + +V P+ + +D++SF+V+L EL
Sbjct: 159 V------KFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWEL 204
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 51/261 (19%), Positives = 96/261 (36%), Gaps = 35/261 (13%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+K+ E F+ EV ++ + H NV+K +G + + + E+I G+L I
Sbjct: 40 MKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK 99
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF- 125
W R+ +++ ++YLH S+ I H D+ S N L+ + ++DF
Sbjct: 100 SMDS---QYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFG 153
Query: 126 --RTFKSRAIDRTHLTTQVKVTFGYVD----------PKYFRSSQFTEKSDVYSFSVVLV 173
R L + K P+ + EK DV+SF +VL
Sbjct: 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213
Query: 174 EL----------NWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQ 223
E+ ++V +F + RC +L+ +K+
Sbjct: 214 EIIGRVNADPDYLPRTMDFGLNVRGFLDR------YCPPNCPPSFFPITVRCCDLDPEKR 267
Query: 224 PTMKEVTLELAGIRASIGASV 244
P+ ++ L +R + +
Sbjct: 268 PSFVKLEHWLETLRMHLAGHL 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-37
Identities = 38/180 (21%), Positives = 69/180 (38%), Gaps = 20/180 (11%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
+ +E ++ F EV+ Q H NVV +G C+ ++ +LY + +
Sbjct: 64 DIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA 123
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ +I E+ + + YLH+ I H D+KS N+ D + I+DF F
Sbjct: 124 KI---VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNV-FYDNGKVVITDFGLF 176
Query: 129 KSRAI----DRTHLTTQVKVTFGYVDPKYFRSSQ---------FTEKSDVYSFSVVLVEL 175
+ R ++ P+ R F++ SDV++ + EL
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-36
Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 17/174 (9%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHE 67
+ ++ F NEV +L + H N++ +G T L +V ++ SLY ++H
Sbjct: 55 NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHA 112
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
+ + I + +R + YLH + I H D+KS NI L + KI DF
Sbjct: 113 SET---KFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166
Query: 128 FKSRAIDRTHL---TTQVKVTFGYVDP---KYFRSSQFTEKSDVYSFSVVLVEL 175
+ R Q+ + ++ P + S+ ++ +SDVY+F +VL EL
Sbjct: 167 --ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 36/185 (19%), Positives = 66/185 (35%), Gaps = 25/185 (13%)
Query: 11 KSVHESNVEQFINEVVI--LSQINHRNVVKILGCCLETEVP----LLVYEFIPNGSLYQY 64
K + + + E + + H N++ + + + L+ + GSLY Y
Sbjct: 37 KIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY 96
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHS-----VASIPIYHLDIKSANILLVDKYQ 119
+ T + LRI + ++ L++LH I H D+KS NIL+ Q
Sbjct: 97 LQLTT-----LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151
Query: 120 AKISDF---RTFKSRAIDRTHLTTQVKVTFGYVDP------KYFRSSQFTEKSDVYSFSV 170
I+D T Y+ P ++ D+++F +
Sbjct: 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211
Query: 171 VLVEL 175
VL E+
Sbjct: 212 VLWEV 216
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 51/283 (18%), Positives = 93/283 (32%), Gaps = 59/283 (20%)
Query: 11 KSVHESNVEQFINEVVI--LSQINHRNVVKILGCCLETEVP-----LLVYEFIPNGSLYQ 63
K +N + FINE I + + H N+ + + LLV E+ PNGSL +
Sbjct: 42 KVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK 101
Query: 64 YIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASI------PIYHLDIKSANILLVDK 117
Y+ T W R+ V+R L+YLH+ I H D+ S N+L+ +
Sbjct: 102 YLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156
Query: 118 YQAKISDF-------RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-------QFTEKS 163
ISDF R + + T Y+ P+ + ++
Sbjct: 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQV 216
Query: 164 DVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF-------SKEAEKEEVI---------- 206
D+Y+ ++ E+ A+ + E + V
Sbjct: 217 DMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE 276
Query: 207 ----------TFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239
+ + C + + + + T + +A +
Sbjct: 277 AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-31
Identities = 38/185 (20%), Positives = 67/185 (36%), Gaps = 25/185 (13%)
Query: 11 KSVHESNVEQFINE--VVILSQINHRNVVKILGCCLETEVP----LLVYEFIPNGSLYQY 64
K + + E + + H N++ + ++ L+ ++ NGSLY Y
Sbjct: 66 KVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDY 125
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHS-----VASIPIYHLDIKSANILLVDKYQ 119
+ T + + L++ L +LH+ I H D+KS NIL+
Sbjct: 126 LKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180
Query: 120 AKISDF---RTFKSRAIDRTHLTTQVKVTFGYVDP------KYFRSSQFTEKSDVYSFSV 170
I+D F S + T Y+ P Q +D+YSF +
Sbjct: 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240
Query: 171 VLVEL 175
+L E+
Sbjct: 241 ILWEV 245
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 34/185 (18%), Positives = 68/185 (36%), Gaps = 25/185 (13%)
Query: 11 KSVHESNVEQFINE--VVILSQINHRNVVKILGCCLETEVP----LLVYEFIPNGSLYQY 64
K + E + + H N++ + + LV ++ +GSL+ Y
Sbjct: 71 KIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY 130
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHS-----VASIPIYHLDIKSANILLVDKYQ 119
++ T +T E +++ + + L++LH I H D+KS NIL+
Sbjct: 131 LNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185
Query: 120 AKISDF---RTFKSRAIDRTHLTTQVKVTFGYVDP------KYFRSSQFTEKSDVYSFSV 170
I+D S T Y+ P + + +++D+Y+ +
Sbjct: 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245
Query: 171 VLVEL 175
V E+
Sbjct: 246 VFWEI 250
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 39/160 (24%), Positives = 80/160 (50%), Gaps = 5/160 (3%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75
VE+F+ E ++ +I H N+V++LG C ++ EF+ G+L Y+ + ++ +
Sbjct: 258 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEV 315
Query: 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR 135
+ + L + ++S + YL I H ++ + N L+ + + K++DF + D
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFI---HRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
Query: 136 THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
K + P+ ++F+ KSDV++F V+L E+
Sbjct: 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 38/172 (22%), Positives = 87/172 (50%), Gaps = 14/172 (8%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
L+++ S ++ ++E +++ +++ +V ++LG CL + V L+ + +P G L Y+
Sbjct: 52 LREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVR 108
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
E D + + L V++++ ++YL + H D+ + N+L+ KI+DF
Sbjct: 109 EH-KDNIGS--QYLLNWCVQIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFG 162
Query: 127 TFKSRAI---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
++ + ++ + KV ++ + +T +SDV+S+ V + EL
Sbjct: 163 L--AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 56/250 (22%), Positives = 95/250 (38%), Gaps = 38/250 (15%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
I E+ +L Q+NH NV+K +E +V E G L + I + I
Sbjct: 77 ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER 136
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDR 135
+ V++ L ++HS + H DIK AN+ + K+ D R F S
Sbjct: 137 TVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KT 190
Query: 136 THLTTQVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL 192
T + V G Y+ P+ + + KSD++S +L E+ + D SL
Sbjct: 191 TAAHSLV----GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246
Query: 193 AA-------------YFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239
++S+E + C+N + +K+P + V ++A +
Sbjct: 247 CKKIEQCDYPPLPSDHYSEE--------LRQLVNMCINPDPEKRPDVTYV-YDVAKRMHA 297
Query: 240 IGASVLLQCE 249
AS L
Sbjct: 298 CTASSLEHHH 307
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 21/176 (11%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+++ +F+ E IL Q +H N+V+++G C + + +V E + G ++
Sbjct: 147 CRETLPPDL--KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR 204
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ + + L++ + + + YL S I H D+ + N L+ +K KISDF
Sbjct: 205 TEGA---RLRVKTLLQMVGDAAAGMEYLESKCCI---HRDLAARNCLVTEKNVLKISDFG 258
Query: 127 TFKSRAIDRTHLTTQ-------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
SR VK T P+ +++ +SDV+SF ++L E
Sbjct: 259 M--SREEADGVYAASGGLRQVPVKWT----APEALNYGRYSSESDVWSFGILLWET 308
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-22
Identities = 51/230 (22%), Positives = 97/230 (42%), Gaps = 25/230 (10%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLL--VYEFIPNGSLYQYIHEQTDDQ 72
E+ + ++EV +L ++ H N+V+ ++ L V E+ G L I + T ++
Sbjct: 46 EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 73 LPITWEMRLRITVEVSRVLSYLHS--VASIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130
+ E LR+ +++ L H + H D+K AN+ L K K+ DF +
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL--A 163
Query: 131 RAIDRTHLTTQVKV-TFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL----------NWTK 179
R ++ + V T Y+ P+ + EKSD++S +L EL + +
Sbjct: 164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223
Query: 180 PIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
+ + R + +S E + R LNL +P+++E+
Sbjct: 224 LAGKIREGKFRRIPYRYSDE--------LNEIITRMLNLKDYHRPSVEEI 265
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 45/160 (28%), Positives = 87/160 (54%), Gaps = 14/160 (8%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQTDDQLPITW 77
+ F+ E +++Q+ H N+V++LG +E + L +V E++ GSL Y+ ++ + +
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGG 288
Query: 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH 137
+ L+ +++V + YL + H D+ + N+L+ + AK+SDF ++ T
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGL--TKEASSTQ 343
Query: 138 LTTQ--VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T + VK T P+ R +F+ KSDV+SF ++L E+
Sbjct: 344 DTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEI 379
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-22
Identities = 50/173 (28%), Positives = 90/173 (52%), Gaps = 12/173 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLL-VYEFIPNGSLYQYI 65
L + + E V QF+ E +I+ +H NV+ +LG CL +E L V ++ +G L +I
Sbjct: 61 LNRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+T + T + + ++V++ + YL S + H D+ + N +L +K+ K++DF
Sbjct: 119 RNETHN---PTVKDLIGFGLQVAKGMKYLASKKFV---HRDLAARNCMLDEKFTVKVADF 172
Query: 126 ---RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
R + H T K+ ++ + ++ +FT KSDV+SF V+L EL
Sbjct: 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 225
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-22
Identities = 36/164 (21%), Positives = 81/164 (49%), Gaps = 12/164 (7%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
++ ++E +++ +++ +V ++LG CL L+ + +P G L Y+ E D+
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN--- 113
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI- 133
I + L V++++ ++YL + H D+ + N+L+ KI+DF ++ +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGL--AKLLG 168
Query: 134 --DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
++ + KV ++ + +T +SDV+S+ V + EL
Sbjct: 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 7e-22
Identities = 38/170 (22%), Positives = 84/170 (49%), Gaps = 14/170 (8%)
Query: 11 KSVHESNVEQ--FINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHE 67
K++ + F+ E ++ ++ H +V++ +E P+ +V E++ GSL ++
Sbjct: 297 KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFL-- 352
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
+ + + + + +++ ++Y+ + + H D+++ANIL+ + K++DF
Sbjct: 353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGL 409
Query: 128 FKSRAIDRTHLTTQVKVTFGY--VDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+R I+ T + F P+ +FT KSDV+SF ++L EL
Sbjct: 410 --ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-22
Identities = 41/181 (22%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE-----VPLLVYEFIPNGSLYQ 63
K + + +E+F++E + +H NV+++LG C+E P+++ F+ G L+
Sbjct: 71 KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT 130
Query: 64 YI--HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
Y+ I + L+ V+++ + YL ++ H D+ + N +L D
Sbjct: 131 YLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVC 187
Query: 122 ISDFRTFKSRAIDRTHLTTQ-------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
++DF S+ I Q VK + +T KSDV++F V + E
Sbjct: 188 VADFGL--SKKIYSGDYYRQGRIAKMPVKWI----AIESLADRVYTSKSDVWAFGVTMWE 241
Query: 175 L 175
+
Sbjct: 242 I 242
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-22
Identities = 48/232 (20%), Positives = 99/232 (42%), Gaps = 36/232 (15%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPL----------------LVYEFIPNGSLY 62
E+ EV L++++H N+V GC + + EF G+L
Sbjct: 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 63 QYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
Q+I ++ ++L + L + ++++ + Y+HS + + D+K +NI LVD Q KI
Sbjct: 109 QWIEKRRGEKLDK--VLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKI 163
Query: 123 SDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP-- 180
DF ++ T+ K T Y+ P+ S + ++ D+Y+ ++L EL
Sbjct: 164 GDFGL--VTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
Query: 181 ---IHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
+ ++ F K+ + ++ ++ L+ + +P E+
Sbjct: 222 FETSKFFTDLRDGIISDIFDKKE--KTLL------QKLLSKKPEDRPNTSEI 265
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 38/182 (20%), Positives = 83/182 (45%), Gaps = 24/182 (13%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLY 62
K+ + S++E+F+ E + + +H +V K++G L + +P+++ F+ +G L+
Sbjct: 60 KADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLH 119
Query: 63 QYI--HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
++ ++ + + +R V+++ + YL +S H D+ + N +L +
Sbjct: 120 AFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTV 176
Query: 121 KISDFRTFKSRAIDRTHLTTQ-------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLV 173
++DF SR I Q VK + + +T SDV++F V +
Sbjct: 177 CVADFGL--SRKIYSGDYYRQGCASKLPVKWL----ALESLADNLYTVHSDVWAFGVTMW 230
Query: 174 EL 175
E+
Sbjct: 231 EI 232
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-21
Identities = 47/169 (27%), Positives = 89/169 (52%), Gaps = 15/169 (8%)
Query: 11 KSVHESNVEQ-FINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQ 68
K + Q F+ E +++Q+ H N+V++LG +E + L +V E++ GSL Y+ +
Sbjct: 50 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--R 107
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ + + + L+ +++V + YL + H D+ + N+L+ + AK+SDF
Sbjct: 108 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGL- 163
Query: 129 KSRAIDRTHLTTQ--VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
++ T T + VK T P+ R +F+ KSDV+SF ++L E+
Sbjct: 164 -TKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEI 207
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-21
Identities = 38/163 (23%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQTDDQLP 74
+ E F+ E ++ ++ H +V++ +E P+ +V E++ GSL ++ + +
Sbjct: 221 MSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFL--KGETGKY 276
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
+ + + +++ ++Y+ + + H D+++ANIL+ + K++DF +R I+
Sbjct: 277 LRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGL--ARLIE 331
Query: 135 RTHLTTQVKVTFGY--VDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T + F P+ +FT KSDV+SF ++L EL
Sbjct: 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 13/173 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LK ++ FI EV + ++HRN++++ G L + +V E P GSL +
Sbjct: 54 LKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLR 112
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ + R V+V+ + YL S I H D+ + N+LL + KI DF
Sbjct: 113 KH-QGHFLL--GTLSRYAVQVAEGMGYLESKRFI---HRDLAARNLLLATRDLVKIGDFG 166
Query: 127 TFKSRAI----DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
RA+ D + KV F + P+ ++ F+ SD + F V L E+
Sbjct: 167 L--MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-21
Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 20/167 (11%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLL-VYEFIPNGSLYQYIHEQTDDQLP 74
+ + F+ E ++ Q+ H+ +V++ T+ P+ + E++ NGSL ++ +T +
Sbjct: 50 MSPDAFLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFL--KTPSGIK 105
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
+T L + +++ ++++ I H D+++ANIL+ D KI+DF +R I+
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGL--ARLIE 160
Query: 135 RTHLTTQ------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T + +K T P+ FT KSDV+SF ++L E+
Sbjct: 161 DNEYTAREGAKFPIKWT----APEAINYGTFTIKSDVWSFGILLTEI 203
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-21
Identities = 49/173 (28%), Positives = 89/173 (51%), Gaps = 12/173 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLL-VYEFIPNGSLYQYI 65
L + V QF+ E +I+ +H NV+ +LG CL +E L V ++ +G L +I
Sbjct: 125 LNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+T + T + + ++V++ + +L S + H D+ + N +L +K+ K++DF
Sbjct: 183 RNETHN---PTVKDLIGFGLQVAKGMKFLASKKFV---HRDLAARNCMLDEKFTVKVADF 236
Query: 126 ---RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
R + D H T K+ ++ + ++ +FT KSDV+SF V+L EL
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-21
Identities = 46/189 (24%), Positives = 74/189 (39%), Gaps = 46/189 (24%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVP--LLVYEFIPNGSLYQY 64
LK + + E+ IL + H +++K GCC + LV E++P GSL Y
Sbjct: 68 LKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY 125
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ + I L ++ ++YLH+ I H D+ + N+LL + KI D
Sbjct: 126 LPRHS-----IGLAQLLLFAQQICEGMAYLHAQHYI---HRDLAARNVLLDNDRLVKIGD 177
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ------------------FTEKSDVY 166
F ++A+ +Y+R + F SDV+
Sbjct: 178 FGL--AKAV--------------PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVW 221
Query: 167 SFSVVLVEL 175
SF V L EL
Sbjct: 222 SFGVTLYEL 230
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-21
Identities = 34/172 (19%), Positives = 83/172 (48%), Gaps = 14/172 (8%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
++ + + + ++ + ++H ++V++LG C LV +++P GSL ++
Sbjct: 50 IEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVR 106
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ L ++ L V++++ + YL + H ++ + N+LL Q +++DF
Sbjct: 107 QH-RGALGP--QLLLNWGVQIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFG 160
Query: 127 TFKSRAI---DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ + D+ L ++ K ++ + ++T +SDV+S+ V + EL
Sbjct: 161 V--ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWEL 210
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-21
Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 42/188 (22%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLET-EVPL-LVYEFIPNGSLYQYI 65
KK + E ++ F E+ IL + H N+VK G C L L+ E++P GSL Y+
Sbjct: 45 KKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ + I L+ T ++ + + YL + I H D+ + NIL+ ++ + KI DF
Sbjct: 105 QKHKER---IDHIKLLQYTSQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDF 158
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ------------------FTEKSDVYS 167
++ + D ++F+ + F+ SDV+S
Sbjct: 159 GL--TKVLP--------------QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWS 202
Query: 168 FSVVLVEL 175
F VVL EL
Sbjct: 203 FGVVLYEL 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 8e-21
Identities = 41/174 (23%), Positives = 85/174 (48%), Gaps = 22/174 (12%)
Query: 11 KSVHESNVEQ--FINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHE 67
K++ ++ F+ E ++ + H +VK+ T+ P+ ++ EF+ GSL ++
Sbjct: 218 KTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFL-- 273
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
++D+ + + +++ ++++ I H D+++ANIL+ KI+DF
Sbjct: 274 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGL 330
Query: 128 FKSRAIDRTHLTTQ------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+R I+ T + +K T P+ FT KSDV+SF ++L+E+
Sbjct: 331 --ARVIEDNEYTAREGAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEI 378
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-21
Identities = 42/182 (23%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI- 65
+ ++ S+ E +F+NE ++ + N +VV++LG + + L++ E + G L Y+
Sbjct: 63 VNEAASMRE--RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
Query: 66 -----HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
P + +++ E++ ++YL + H D+ + N ++ + +
Sbjct: 121 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTV 177
Query: 121 KISDFRTFKSRAIDRTHLTTQ-------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLV 173
KI DF +R I T + V+ P+ + FT SDV+SF VVL
Sbjct: 178 KIGDFGM--TRDIYETDYYRKGGKGLLPVRWM----SPESLKDGVFTTYSDVWSFGVVLW 231
Query: 174 EL 175
E+
Sbjct: 232 EI 233
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-21
Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 42/188 (22%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLET-EVPL-LVYEFIPNGSLYQYI 65
KK + E ++ F E+ IL + H N+VK G C L L+ E++P GSL Y+
Sbjct: 76 KKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ + I L+ T ++ + + YL + I H D+ + NIL+ ++ + KI DF
Sbjct: 136 QKHKER---IDHIKLLQYTSQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDF 189
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ------------------FTEKSDVYS 167
++ + D +Y++ + F+ SDV+S
Sbjct: 190 GL--TKVLP--------------QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWS 233
Query: 168 FSVVLVEL 175
F VVL EL
Sbjct: 234 FGVVLYEL 241
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 43/175 (24%), Positives = 84/175 (48%), Gaps = 16/175 (9%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE-VPLLVYEFIPNGSLYQYI 65
L + VE F+ E +++ +NH NV+ ++G L E +P ++ ++ +G L Q+I
Sbjct: 57 LSRITE--MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ T + + ++V+R + YL + H D+ + N +L + + K++DF
Sbjct: 115 RSPQRN---PTVKDLISFGLQVARGMEYLAEQKFV---HRDLAARNCMLDESFTVKVADF 168
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYV-----DPKYFRSSQFTEKSDVYSFSVVLVEL 175
+R I + + + + ++ +FT KSDV+SF V+L EL
Sbjct: 169 GL--ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWEL 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-20
Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 11/172 (6%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+ E +++F EV SQ++H+N+V ++ E + LV E+I +L +YI
Sbjct: 43 AIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI 102
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
P++ + + T ++ + + H + I H DIK NIL+ KI DF
Sbjct: 103 ESHG----PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDF 155
Query: 126 RTFKSRAIDRTHLTTQVKV--TFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
++A+ T LT V T Y P+ + E +D+YS +VL E+
Sbjct: 156 GI--AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEM 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-20
Identities = 43/166 (25%), Positives = 83/166 (50%), Gaps = 17/166 (10%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75
VE+F+ E ++ +I H N+V++LG C ++ EF+ G+L Y+ + ++ +
Sbjct: 51 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEV 108
Query: 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR 135
+ + L + ++S + YL I H D+ + N L+ + + K++DF SR +
Sbjct: 109 SAVVLLYMATQISSAMEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGL--SRLMTG 163
Query: 136 THLTTQ------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T +K T P+ ++F+ KSDV++F V+L E+
Sbjct: 164 DTYTAHAGAKFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEI 205
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-20
Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 14/174 (8%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLET-EVPL-LVYEFIPNGSLYQYI 65
K+ + F E+ IL ++ +VK G L LV E++P+G L ++
Sbjct: 58 KQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL 117
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ L + ++ + + YL S + H D+ + NIL+ + KI+DF
Sbjct: 118 QRHRAR---LDASRLLLYSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADF 171
Query: 126 RTFKSRAIDRTH----LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
++ + + + + P+ + F+ +SDV+SF VVL EL
Sbjct: 172 GL--AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-20
Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 44/189 (23%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVP--LLVYEFIPNGSLYQY 64
LK +++ E+ IL + H N+VK G C E L+ EF+P+GSL +Y
Sbjct: 58 LKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY 115
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ + + I + +L+ V++ + + YL S + H D+ + N+L+ ++Q KI D
Sbjct: 116 LPKNKNK---INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGD 169
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ------------------FTEKSDVY 166
F ++AI D +Y+ F SDV+
Sbjct: 170 FGL--TKAI--------------ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVW 213
Query: 167 SFSVVLVEL 175
SF V L EL
Sbjct: 214 SFGVTLHEL 222
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-20
Identities = 44/178 (24%), Positives = 78/178 (43%), Gaps = 27/178 (15%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
KK + N E+F++E VI+ ++H ++VK++G E E ++ E P G L Y+
Sbjct: 48 CKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLE 104
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ + + ++++ + ++YL S+ + H DI NIL+ K+ DF
Sbjct: 105 RNKNS---LKVLTLVLYSLQICKAMAYLESINCV---HRDIAVRNILVASPECVKLGDFG 158
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDP---------KYFRSSQFTEKSDVYSFSVVLVEL 175
SR I+ P + R FT SDV+ F+V + E+
Sbjct: 159 L--SRYIEDEDYYKASVTRL----PIKWMSPESINFRR---FTTASDVWMFAVCMWEI 207
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-19
Identities = 38/166 (22%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75
+ ++F E + +++H +VK G C + +V E+I NG L Y+ +
Sbjct: 45 MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGL 101
Query: 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR 135
L + +V +++L S I H D+ + N L+ K+SDF +R +
Sbjct: 102 EPSQLLEMCYDVCEGMAFLESHQFI---HRDLAARNCLVDRDLCVKVSDFGM--TRYVLD 156
Query: 136 THLTTQ------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ VK + P+ F +++ KSDV++F +++ E+
Sbjct: 157 DQYVSSVGTKFPVKWS----APEVFHYFKYSSKSDVWAFGILMWEV 198
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-19
Identities = 45/227 (19%), Positives = 96/227 (42%), Gaps = 26/227 (11%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVP----LLVYEFIPNGSLYQYIHEQTD 70
+S ++F E +L + H N+V+ T +LV E + +G+L Y+
Sbjct: 66 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK- 124
Query: 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDFRTFK 129
+ ++ ++ + L +LH+ + PI H D+K NI + KI D
Sbjct: 125 ---VMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL-- 178
Query: 130 SRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEEN 189
+ R V T ++ P+ + ++ E DVY+F + ++E+ ++ + E
Sbjct: 179 -ATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS----EC 232
Query: 190 RSLAAYFSKEAEKEEVITFAMVA--------KRCLNLNGKKQPTMKE 228
++ A + + + +F VA + C+ N ++ ++K+
Sbjct: 233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 36/185 (19%), Positives = 73/185 (39%), Gaps = 36/185 (19%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHE 67
K H + E F ++S+++H+++V G C+ + +LV EF+ GSL Y+ +
Sbjct: 46 KVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK 105
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ-------- 119
+ + I W+ L + +++ + +L I H ++ + NILL+ +
Sbjct: 106 N-KNCINILWK--LEVAKQLAAAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPF 159
Query: 120 AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP---------KYFRSSQFTEKSDVYSFSV 170
K+SD S + + + + +D +SF
Sbjct: 160 IKLSDPGI--SITVLPKD---------ILQERIPWVPPECIENPK--NLNLATDKWSFGT 206
Query: 171 VLVEL 175
L E+
Sbjct: 207 TLWEI 211
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 10/159 (6%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E+ EV +L+ + H N+V+ E +V ++ G L++ I+ Q E
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ---E 124
Query: 79 MR-LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH 137
+ L V++ L ++H I H DIKS NI L ++ DF +R ++ T
Sbjct: 125 DQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGI--ARVLNSTV 179
Query: 138 LTTQVKV-TFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ + T Y+ P+ + + KSD+++ VL EL
Sbjct: 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 40/166 (24%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75
+ ++FI E ++ ++H +V++ G C + ++ E++ NG L Y+ E +
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQT 119
Query: 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR 135
L + +V + YL S + H D+ + N L+ D+ K+SDF SR +
Sbjct: 120 Q--QLLEMCKDVCEAMEYLESKQFL---HRDLAARNCLVNDQGVVKVSDFGL--SRYVLD 172
Query: 136 THLTTQ------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T+ V+ + P+ S+F+ KSD+++F V++ E+
Sbjct: 173 DEYTSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEI 214
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 45/180 (25%), Positives = 76/180 (42%), Gaps = 20/180 (11%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
L + S + F+ E +I+S+ NH+N+V+ +G L++ ++ E + G L ++
Sbjct: 68 LPEVCSEQD--ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 67 E---QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV---DKYQA 120
E + + L + +++ YL H DI + N LL A
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVA 182
Query: 121 KISDFRTFKSRAIDRTHLTTQVKVTFGYV-----DPKYFRSSQFTEKSDVYSFSVVLVEL 175
KI DF +R I R K + P+ F FT K+D +SF V+L E+
Sbjct: 183 KIGDFGM--ARDIYRASYYR--KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-19
Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 16 SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75
+ E FI E ++ +++H +V++ G CLE LV EF+ +G L Y+ Q
Sbjct: 45 MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAA 103
Query: 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR 135
E L + ++V ++YL I H D+ + N L+ + K+SDF +R +
Sbjct: 104 --ETLLGMCLDVCEGMAYLEEACVI---HRDLAARNCLVGENQVIKVSDFGM--TRFVLD 156
Query: 136 THLTTQ------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
T+ VK P+ F S+++ KSDV+SF V++ E+
Sbjct: 157 DQYTSSTGTKFPVKWA----SPEVFSFSRYSSKSDVWSFGVLMWEV 198
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-19
Identities = 43/185 (23%), Positives = 84/185 (45%), Gaps = 42/185 (22%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K+++ + ++ + E ++ Q+++ +V+++G C E +LV E G L +Y+ Q
Sbjct: 53 KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL--Q 109
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ + + + + +VS + YL + H D+ + N+LLV ++ AKISDF
Sbjct: 110 QNRHVKD--KNIIELVHQVSMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGL- 163
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ------------------FTEKSDVYSFSV 170
S+A+ D Y+++ F+ KSDV+SF V
Sbjct: 164 -SKAL--------------RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 208
Query: 171 VLVEL 175
++ E
Sbjct: 209 LMWEA 213
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-19
Identities = 36/181 (19%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 19 EQFINEVVILSQINHRNVVKILGCCLE---------TEVPLLVY---EFIPNGSLYQYIH 66
E+ + EV L+++ H +V+ LE + + +Y + +L +++
Sbjct: 48 EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN 107
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF- 125
+ + + L I ++++ + +LHS + H D+K +NI K+ DF
Sbjct: 108 GRCTIEER-ERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFG 163
Query: 126 -----------RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
+T + T QV T Y+ P+ + ++ K D++S ++L E
Sbjct: 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVG-TKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
Query: 175 L 175
L
Sbjct: 223 L 223
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-19
Identities = 47/184 (25%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY--- 64
K K ES + F E +L+ + H+++V+ G C E L+V+E++ +G L ++
Sbjct: 77 KALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRS 136
Query: 65 --------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD 116
+ P+ L + +V+ + YL A + H D+ + N L+
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQ 193
Query: 117 KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYV-----DPKYFRSSQFTEKSDVYSFSVV 171
KI DF SR I T + P+ +FT +SDV+SF VV
Sbjct: 194 GLVVKIGDFGM--SRDIYSTDYYR--VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249
Query: 172 LVEL 175
L E+
Sbjct: 250 LWEI 253
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-19
Identities = 41/184 (22%), Positives = 69/184 (37%), Gaps = 18/184 (9%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVP----LLVYEFIPNGSLY 62
LK+ + + E+ E + NH N+++++ CL L+ F G+L+
Sbjct: 59 LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 63 QYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
I D +T + L + + + R L +H+ H D+K NILL D+ Q +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVL 175
Query: 123 SDF--------RTFKSRAIDRTHLTTQVKVTFGYVDP---KYFRSSQFTEKSDVYSFSVV 171
D SR + T Y P E++DV+S V
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 172 LVEL 175
L +
Sbjct: 236 LYAM 239
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 8e-19
Identities = 41/165 (24%), Positives = 87/165 (52%), Gaps = 13/165 (7%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
+++ E+ + E I+ Q+++ +V+++G C + +LV E G L++++ + ++
Sbjct: 377 KADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--- 432
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI- 133
I + +VS + YL + H ++ + N+LLV+++ AKISDF S+A+
Sbjct: 433 IPVSNVAELLHQVSMGMKYLEEKNFV---HRNLAARNVLLVNRHYAKISDFGL--SKALG 487
Query: 134 -DRTHLTTQV--KVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
D ++ T + K + P+ +F+ +SDV+S+ V + E
Sbjct: 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 532
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-19
Identities = 43/197 (21%), Positives = 76/197 (38%), Gaps = 49/197 (24%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY- 64
LK + E E ++E+ I+S + H N+V +LG C L++ E+ G L +
Sbjct: 84 LKSTAHADE--KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
Query: 65 ---------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV 115
+ L + +V++ +++L AS H D+ + N+LL
Sbjct: 142 RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 198
Query: 116 DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ----------------- 158
+ + AKI DF +R I D Y
Sbjct: 199 NGHVAKIGDFGL--ARDI--------------MNDSNYIVKGNARLPVKWMAPESIFDCV 242
Query: 159 FTEKSDVYSFSVVLVEL 175
+T +SDV+S+ ++L E+
Sbjct: 243 YTVQSDVWSYGILLWEI 259
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-19
Identities = 38/167 (22%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
+S E+F+ E + + Q +H ++VK++G E ++ E G L ++ +
Sbjct: 57 DSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--- 112
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
+ + ++S L+YL S + H DI + N+L+ K+ DF SR ++
Sbjct: 113 LDLASLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGL--SRYME 167
Query: 135 RTHLTTQ------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ +K P+ +FT SDV+ F V + E+
Sbjct: 168 DSTYYKASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEI 210
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-19
Identities = 41/187 (21%), Positives = 78/187 (41%), Gaps = 28/187 (14%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY--- 64
K K + + F E +L+ + H ++VK G C + + ++V+E++ +G L ++
Sbjct: 51 KALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA 110
Query: 65 ---------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV 115
+ + + L I +++ + YL S + H D+ + N L+
Sbjct: 111 HGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFV---HRDLATRNCLVG 167
Query: 116 DKYQAKISDFRTFKSRAIDRTHLTTQ-------VKVTFGYVDPKYFRSSQFTEKSDVYSF 168
KI DF SR + T ++ P+ +FT +SDV+SF
Sbjct: 168 ANLLVKIGDFGM--SRDVYSTDYYRVGGHTMLPIRWM----PPESIMYRKFTTESDVWSF 221
Query: 169 SVVLVEL 175
V+L E+
Sbjct: 222 GVILWEI 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-19
Identities = 40/179 (22%), Positives = 81/179 (45%), Gaps = 41/179 (22%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
+++ E+ + E I+ Q+++ +V+++G C + +LV E G L++++ + ++
Sbjct: 51 KADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--- 106
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
I + +VS + YL + H D+ + N+LLV+++ AKISDF S+A+
Sbjct: 107 IPVSNVAELLHQVSMGMKYLEEKNFV---HRDLAARNVLLVNRHYAKISDFGL--SKAL- 160
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQ------------------FTEKSDVYSFSVVLVEL 175
D Y+ + F+ +SDV+S+ V + E
Sbjct: 161 -------------GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 58/206 (28%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY-- 64
LK++ S E + ++E +L Q+NH +V+K+ G C + LL+ E+ GSL +
Sbjct: 61 LKENASPSE--LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
Query: 65 ------------------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLD 106
D+ +T + ++S+ + YL A + + H D
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRD 175
Query: 107 IKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ-------- 158
+ + NIL+ + + KISDF SR + Y + Y + SQ
Sbjct: 176 LAARNILVAEGRKMKISDFGL--SRDV--------------YEEDSYVKRSQGRIPVKWM 219
Query: 159 ---------FTEKSDVYSFSVVLVEL 175
+T +SDV+SF V+L E+
Sbjct: 220 AIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
K S +S E+F+ E + + Q +H ++VK++G E V ++ E G L ++
Sbjct: 426 CKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ 482
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ L + + ++S L+YL S + H DI + N+L+ K+ DF
Sbjct: 483 VR-KFSLDL--ASLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFG 536
Query: 127 TFKSRAIDRTHLTTQV--KVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
SR ++ + K+ ++ P+ +FT SDV+ F V + E+
Sbjct: 537 L--SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 585
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-18
Identities = 53/254 (20%), Positives = 99/254 (38%), Gaps = 54/254 (21%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-------------LVYEFIPNGSL 61
E + ++EV++L+ +NH+ VV+ LE + + E+ NG+L
Sbjct: 43 EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL 102
Query: 62 YQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
Y IH + L + R+ ++ LSY+HS I H D+K NI + + K
Sbjct: 103 YDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156
Query: 122 ISDF--------------RTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-SSQFTEKSDVY 166
I DF ++ +LT+ + T YV + + + EK D+Y
Sbjct: 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG-TAMYVATEVLDGTGHYNEKIDMY 215
Query: 167 SFSVVLVELNWT-----------KPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRC 215
S ++ E+ + K + V +E K +K +I +
Sbjct: 216 SLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKK--II------RLL 267
Query: 216 LNLNGKKQPTMKEV 229
++ + K+P + +
Sbjct: 268 IDHDPNKRPGARTL 281
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 41/179 (22%), Positives = 73/179 (40%), Gaps = 40/179 (22%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E F++E I+ Q +H N++++ G + ++V E++ NGSL ++ D Q
Sbjct: 91 ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQF- 148
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
T + + V + YL + + H D+ + N+L+ K+SDF SR +
Sbjct: 149 -TIMQLVGMLRGVGAGMRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGL--SRVL- 201
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQ------------------FTEKSDVYSFSVVLVEL 175
DP ++ F+ SDV+SF VV+ E+
Sbjct: 202 -------------EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV 247
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 35/160 (21%), Positives = 57/160 (35%), Gaps = 11/160 (6%)
Query: 18 VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77
+ E ++ +VV I + I L + Q P+
Sbjct: 78 RTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAP 133
Query: 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH 137
+ I ++ L H+ H D+K NIL+ A + DF + A
Sbjct: 134 PRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGI--ASATTDEK 188
Query: 138 LT-TQVKV-TFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
LT V T Y+ P+ F S T ++D+Y+ + VL E
Sbjct: 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYEC 228
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 45/180 (25%), Positives = 76/180 (42%), Gaps = 20/180 (11%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
L + S + F+ E +I+S+ NH+N+V+ +G L++ ++ E + G L ++
Sbjct: 109 LPEVCSEQD--ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 166
Query: 67 E---QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV---DKYQA 120
E + + L + +++ YL H DI + N LL A
Sbjct: 167 ETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVA 223
Query: 121 KISDFRTFKSRAIDRTHLTTQVKVTFGYV-----DPKYFRSSQFTEKSDVYSFSVVLVEL 175
KI DF +R I R K + P+ F FT K+D +SF V+L E+
Sbjct: 224 KIGDFGM--ARDIYRAGYYR--KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 43/173 (24%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LK + E F+ E I+ Q +H N++++ G +++ ++V E++ NGSL ++
Sbjct: 81 LKVGYT--EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ D Q T + + ++ + YL + + H D+ + NIL+ K+SDF
Sbjct: 139 KH-DAQF--TVIQLVGMLRGIASGMKYLSDMGYV---HRDLAARNILINSNLVCKVSDFG 192
Query: 127 TFKSRAI----DRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
R + + + T K+ + P+ +FT SDV+S+ +VL E+
Sbjct: 193 L--GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-18
Identities = 41/177 (23%), Positives = 84/177 (47%), Gaps = 22/177 (12%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LK + E F+ E I+ Q +H N++++ G + + +++ E++ NG+L +++
Sbjct: 81 LKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF- 125
E+ D + + + + ++ + YL ++ + H D+ + NIL+ K+SDF
Sbjct: 139 EK-DGEF--SVLQLVGMLRGIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFG 192
Query: 126 --RTFKSRAIDRTHLTTQ-----VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
R + TT ++ T P+ +FT SDV+SF +V+ E+
Sbjct: 193 LSRVLED--DPEATYTTSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEV 243
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 40/199 (20%), Positives = 83/199 (41%), Gaps = 51/199 (25%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY- 64
LK + + + I+E+ ++ I H+N++ +LG C + ++ E+ G+L +Y
Sbjct: 109 LKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 166
Query: 65 -----------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANIL 113
+ + + ++ + + +V+R + YL AS H D+ + N+L
Sbjct: 167 QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVL 223
Query: 114 LVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ--------------- 158
+ + KI+DF +R I + Y +++
Sbjct: 224 VTEDNVMKIADFGL--ARDI--------------HHIDYYKKTTNGRLPVKWMAPEALFD 267
Query: 159 --FTEKSDVYSFSVVLVEL 175
+T +SDV+SF V+L E+
Sbjct: 268 RIYTHQSDVWSFGVLLWEI 286
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-18
Identities = 39/199 (19%), Positives = 82/199 (41%), Gaps = 51/199 (25%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY- 64
LK + + + ++E+ ++ I H+N++ +LG C + ++ E+ G+L +Y
Sbjct: 75 LKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 65 -----------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANIL 113
+ +T++ + T +++R + YL AS H D+ + N+L
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVL 189
Query: 114 LVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ--------------- 158
+ + KI+DF +R I Y +++
Sbjct: 190 VTENNVMKIADFGL--ARDI--------------NNIDYYKKTTNGRLPVKWMAPEALFD 233
Query: 159 --FTEKSDVYSFSVVLVEL 175
+T +SDV+SF V++ E+
Sbjct: 234 RVYTHQSDVWSFGVLMWEI 252
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 35/163 (21%), Positives = 67/163 (41%), Gaps = 21/163 (12%)
Query: 18 VEQFINEVVILSQINHRNVVKIL-----GCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQ 72
+ E L+++ H ++V+I V +V E++ SL + +
Sbjct: 123 QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----- 177
Query: 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRA 132
+ + +E+ LSYLHS+ + + D+K NI+L ++ Q K+ D
Sbjct: 178 -KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA--VSR 230
Query: 133 IDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
I+ + T G+ P+ R+ T +D+Y+ L L
Sbjct: 231 INSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL 269
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQY 64
LK+ + E ++E+ IL I +H NVV +LG C + PL ++ EF G+L Y
Sbjct: 65 LKEGATHSE--HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 122
Query: 65 ------------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANI 112
+ + + +T E + + +V++ + +L AS H D+ + NI
Sbjct: 123 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNI 179
Query: 113 LLVDKYQAKISDFRTFKSRAIDRTH---LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFS 169
LL +K KI DF +R I + ++ ++ P+ +T +SDV+SF
Sbjct: 180 LLSEKNVVKICDFGL--ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 170 VVLVEL 175
V+L E+
Sbjct: 238 VLLWEI 243
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 28/239 (11%), Positives = 74/239 (30%), Gaps = 19/239 (7%)
Query: 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLY 62
+ ++LK K + + L +K L +LV E G+L
Sbjct: 96 QKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155
Query: 63 QYIHE-QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA- 120
I+ + + + + + + + ++ +H I H DIK N +L + +
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212
Query: 121 ----------KISDF-RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFS 169
+ D ++ + + + T T G+ + + + + D + +
Sbjct: 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVA 272
Query: 170 VVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
+ + + + + + F + + + LN+ +
Sbjct: 273 ATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLD 328
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-17
Identities = 39/199 (19%), Positives = 82/199 (41%), Gaps = 51/199 (25%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY- 64
LK + + + ++E+ ++ I H+N++ +LG C + ++ E+ G+L +Y
Sbjct: 121 LKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
Query: 65 -----------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANIL 113
+ +T++ + T +++R + YL AS H D+ + N+L
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVL 235
Query: 114 LVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ--------------- 158
+ + KI+DF +R I Y +++
Sbjct: 236 VTENNVMKIADFGL--ARDI--------------NNIDYYKKTTNGRLPVKWMAPEALFD 279
Query: 159 --FTEKSDVYSFSVVLVEL 175
+T +SDV+SF V++ E+
Sbjct: 280 RVYTHQSDVWSFGVLMWEI 298
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 20/182 (10%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY- 64
+K+ S + + F E+ +L ++ +H N++ +LG C L E+ P+G+L +
Sbjct: 60 MKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117
Query: 65 -----------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANIL 113
++ + L +V+R + YL + H D+ + NIL
Sbjct: 118 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNIL 174
Query: 114 LVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLV 173
+ + Y AKI+DF SR + T ++ ++ + S +T SDV+S+ V+L
Sbjct: 175 VGENYVAKIADFGL--SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232
Query: 174 EL 175
E+
Sbjct: 233 EI 234
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 50/201 (24%), Positives = 79/201 (39%), Gaps = 53/201 (26%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY- 64
LK S + E E ++E+ +LS + NH N+V +LG C L++ E+ G L +
Sbjct: 61 LKPSAHLTE--REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
Query: 65 -------------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSAN 111
DD+L + E L + +V++ +++L AS H D+ + N
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARN 175
Query: 112 ILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ------------- 158
ILL KI DF +R I D Y
Sbjct: 176 ILLTHGRITKICDFGL--ARDI--------------KNDSNYVVKGNARLPVKWMAPESI 219
Query: 159 ----FTEKSDVYSFSVVLVEL 175
+T +SDV+S+ + L EL
Sbjct: 220 FNCVYTFESDVWSYGIFLWEL 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-17
Identities = 36/199 (18%), Positives = 76/199 (38%), Gaps = 52/199 (26%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY-- 64
LK E+F +E ++ +++ H NVV +LG + + +++ + +G L+++
Sbjct: 47 LKDKAEGPL--REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLV 104
Query: 65 ----------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL 114
+ + + + + +++ + YL S + H D+ + N+L+
Sbjct: 105 MRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVV---HKDLATRNVLV 161
Query: 115 VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ---------------- 158
DK KISD R + Y++
Sbjct: 162 YDKLNVKISDLGL--FREVYAAD---------------YYKLLGNSLLPIRWMAPEAIMY 204
Query: 159 --FTEKSDVYSFSVVLVEL 175
F+ SD++S+ VVL E+
Sbjct: 205 GKFSIDSDIWSYGVVLWEV 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-17
Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 17/166 (10%)
Query: 18 VEQFINEVVILSQINHRNVVKIL--GC--CLETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73
+F E + +NH +V + G +P +V E++ +L +H +
Sbjct: 56 YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---- 111
Query: 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI 133
P+T + + + + + L++ H I H D+K ANI++ K+ DF +RAI
Sbjct: 112 PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI--ARAI 166
Query: 134 DRTHLT-TQVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ + TQ G Y+ P+ R +SDVYS VL E+
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 42/176 (23%), Positives = 71/176 (40%), Gaps = 24/176 (13%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
L K++ Q EV I S + H N++++ G + L+ E+ P G++Y+ +
Sbjct: 42 LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYREL 100
Query: 66 HEQTDDQLPITWEMRL------RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ 119
+ + + E++ LSY HS + H DIK N+LL +
Sbjct: 101 QKLS----------KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGE 147
Query: 120 AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
KI+DF + A T Y+ P+ EK D++S V+ E
Sbjct: 148 LKIADF-GWSVHAPSSRRTDLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 44/206 (21%), Positives = 79/206 (38%), Gaps = 58/206 (28%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY- 64
LK+ E E ++E+ +++Q+ +H N+V +LG C + L++E+ G L Y
Sbjct: 83 LKEKADSSE--REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 140
Query: 65 ------------------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLD 106
E+ +D +T+E L +V++ + +L H D
Sbjct: 141 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRD 197
Query: 107 IKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ-------- 158
+ + N+L+ KI DF +R I D Y
Sbjct: 198 LAARNVLVTHGKVVKICDFGL--ARDI--------------MSDSNYVVRGNARLPVKWM 241
Query: 159 ---------FTEKSDVYSFSVVLVEL 175
+T KSDV+S+ ++L E+
Sbjct: 242 APESLFEGIYTIKSDVWSYGILLWEI 267
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 37/190 (19%), Positives = 74/190 (38%), Gaps = 27/190 (14%)
Query: 7 LKKSK--SVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQ 63
+K+SK + + + EV + + H +VV+ E + L+ E+ GSL
Sbjct: 41 IKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLAD 100
Query: 64 YIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKIS 123
I E + ++V R L Y+HS++ + H+DIK +NI + I
Sbjct: 101 AISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRT---SIP 154
Query: 124 DFRTFKSRAIDRTHLTTQVKV-TFGYV-----------DPKYF------RSSQFTEKSDV 165
+ + + D K+ G+V D ++ + K+D+
Sbjct: 155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADI 214
Query: 166 YSFSVVLVEL 175
++ ++ +V
Sbjct: 215 FALALTVVCA 224
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 41/207 (19%), Positives = 81/207 (39%), Gaps = 60/207 (28%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY-- 64
LK+ S F E ++++ ++ N+VK+LG C + L++E++ G L ++
Sbjct: 85 LKEEASADM--QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 142
Query: 65 ------------------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLD 106
+ P++ +L I +V+ ++YL + H D
Sbjct: 143 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRD 199
Query: 107 IKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS--------- 157
+ + N L+ + KI+DF SR I Y+++
Sbjct: 200 LATRNCLVGENMVVKIADFGL--SRNIYSAD---------------YYKADGNDAIPIRW 242
Query: 158 ---------QFTEKSDVYSFSVVLVEL 175
++T +SDV+++ VVL E+
Sbjct: 243 MPPESIFYNRYTTESDVWAYGVVLWEI 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-16
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 7/113 (6%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
+ E+ + + H+N+V+ LG E + E +P GSL + L
Sbjct: 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLK 118
Query: 75 ITWEMRLR-ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDF 125
E + T ++ L YLH I H DIK N+L+ KISDF
Sbjct: 119 DN-EQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDF 167
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-16
Identities = 37/171 (21%), Positives = 64/171 (37%), Gaps = 16/171 (9%)
Query: 11 KSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD 70
K V E+V + ++ +V + G E + E + GSL Q I +
Sbjct: 89 KKVRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQM 144
Query: 71 DQLPITWEMRLR-ITVEVSRVLSYLHSVASIPIYHLDIKSANILL-VDKYQAKISDFRTF 128
LP E R + L YLH+ + H D+K+ N+LL D +A + DF
Sbjct: 145 GCLP---EDRALYYLGQALEGLEYLHTRRIL---HGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 129 KSRAIDRTHLTTQVKVTF-G---YVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
D + G ++ P+ K D++S +++ +
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 34/176 (19%), Positives = 63/176 (35%), Gaps = 27/176 (15%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
V E+ + NH N+V + +V F+ GS I D +
Sbjct: 67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN 126
Query: 75 ITWEMRLR-ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAI 133
E+ + I V + L Y+H + + H +K+++IL+ + +S R+ + ++
Sbjct: 127 ---ELAIAYILQGVLKALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRS--NLSM 178
Query: 134 DRTHLTTQVKVTFGYVDPKYF--------------RSSQFTEKSDVYSFSVVLVEL 175
+ + PKY + KSD+YS + EL
Sbjct: 179 IS----HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 49/239 (20%), Positives = 90/239 (37%), Gaps = 31/239 (12%)
Query: 3 ELWLLKKSKSVH--ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNG 59
L+ +K+S S + + + EV ++ H V++ E + L E
Sbjct: 83 RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GP 141
Query: 60 SLYQYIHEQTDDQLPITWEMRLR-ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY 118
SL Q+ E LP E ++ + L++LHS + HLD+K ANI L +
Sbjct: 142 SLQQHC-EAWGASLP---EAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRG 194
Query: 119 QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL--N 176
+ K+ DF + + Y+ P+ + + +DV+S + ++E+ N
Sbjct: 195 RCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACN 251
Query: 177 WTKPIHLVDVEENRS------LAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
P ++ R A S E V+ L + K + T + +
Sbjct: 252 MELPHGGEGWQQLRQGYLPPEFTAGLSSEL--RSVL------VMMLEPDPKLRATAEAL 302
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 42/174 (24%), Positives = 66/174 (37%), Gaps = 20/174 (11%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
L KS+ E Q E+ I S + H N++++ + L+ EF P G LY+ +
Sbjct: 47 LFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN-YFHDRKRIYLMLEFAPRGELYKEL 105
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
Q + E++ L Y H + H DIK N+L+ K + KI+DF
Sbjct: 106 --QKHGRFD-EQRSA-TFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADF 158
Query: 126 RTFKSRAIDRTHLTTQVKVTF----GYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
R T Y+ P+ EK D++ V+ E
Sbjct: 159 GWSVHAPSLRRR-------TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 205
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 8/111 (7%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
E +E E+ +LSQ + V K G L+ ++ E++ GS + D+
Sbjct: 61 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ 120
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
I +R E+ + L YLHS I H DIK+AN+LL + + K++DF
Sbjct: 121 IATILR-----EILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADF 163
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-15
Identities = 35/246 (14%), Positives = 91/246 (36%), Gaps = 27/246 (10%)
Query: 1 MEELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGS 60
+ S ++ ++ + + +N V L + + +
Sbjct: 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKEN 147
Query: 61 LYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
L +++ + + + L I ++++ + +LHS + H D+K +NI
Sbjct: 148 LKDWMNRRCSLEDR-EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVV 203
Query: 121 KISDF---RTFKSRAIDRTHLTTQVKV--------TFGYVDPKYFRSSQFTEKSDVYSFS 169
K+ DF ++T LT T Y+ P+ + ++ K D++S
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263
Query: 170 VVLVELNWTKP-----IHLVDVEENRSLAAYFSKEAEKE-EVITFAMVAKRCLNLNGKKQ 223
++L EL ++ + ++ N F+++ +E ++ + L+ + ++
Sbjct: 264 LILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMV------QDMLSPSPTER 317
Query: 224 PTMKEV 229
P ++
Sbjct: 318 PEATDI 323
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-15
Identities = 43/248 (17%), Positives = 91/248 (36%), Gaps = 49/248 (19%)
Query: 11 KSVHESNVEQFINEVVILSQINHRN--VVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
+ ++ + NE+ L+++ + ++++ + + +V E N L ++ ++
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK 121
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
I R + + +H I H D+K AN L+VD K+ DF
Sbjct: 122 K----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGI- 172
Query: 129 KSRAID----RTHLTTQVKVTFGYVDP-----------KYFRSSQFTEKSDVYSFSVVLV 173
+ + +QV T Y+ P S+ + KSDV+S +L
Sbjct: 173 -ANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230
Query: 174 EL------------NWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGK 221
+ +K ++D K+ ++V+ K CL + K
Sbjct: 231 YMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL--QDVL------KCCLKRDPK 282
Query: 222 KQPTMKEV 229
++ ++ E+
Sbjct: 283 QRISIPEL 290
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-15
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 8/112 (7%)
Query: 14 HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73
+ E INE++++ + + N+V L L + +V E++ GSL + E D+
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG 116
Query: 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
I + E + L +LHS I H DIKS NILL K++DF
Sbjct: 117 QIA-----AVCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDF 160
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 17/176 (9%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE-------VPLLVYEFIPNGSLY 62
+ + N E++ E+ I+ ++NH NVV + +PLL E+ G L
Sbjct: 48 RQELSPKNRERWCLEIQIMKKLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLR 106
Query: 63 QYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA-- 120
+Y+++ ++ + + ++S L YLH I H D+K NI+L Q
Sbjct: 107 KYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLI 162
Query: 121 -KISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
KI D ++ +D+ L T+ T Y+ P+ ++T D +SF + E
Sbjct: 163 HKIIDLGY--AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFEC 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 8/112 (7%)
Query: 14 HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73
+ E NEVVI+ H NVV++ L E ++ EF+ G+L + + ++
Sbjct: 82 KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE 141
Query: 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
I + V + L+YLH+ I H DIKS +ILL + K+SDF
Sbjct: 142 QIA-----TVCEAVLQALAYLHAQGVI---HRDIKSDSILLTLDGRVKLSDF 185
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-15
Identities = 31/124 (25%), Positives = 55/124 (44%), Gaps = 16/124 (12%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+ K V++ NEV I Q+ H +++++ E + LV E NG + +Y+
Sbjct: 44 IDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYL 102
Query: 66 HEQ----TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
+ +++ E R ++ + YLHS I H D+ +N+LL K
Sbjct: 103 KNRVKPFSEN------EAR-HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIK 152
Query: 122 ISDF 125
I+DF
Sbjct: 153 IADF 156
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-15
Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
ES++++ I E+ I+ Q + +VVK G + +V E+ GS+ I +
Sbjct: 65 ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---T 121
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+T + I + L YLH + I H DIK+ NILL + AK++DF
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADF 169
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 19/177 (10%), Positives = 56/177 (31%), Gaps = 16/177 (9%)
Query: 14 HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIP-------NGSLYQYIH 66
++ + + + + K++ L+ ++ F + + +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ + RL++T++V R+L+ LH + H ++ +I+L + ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ-----FTEKSDVYSFSVVLVELNWT 178
+ + Q T D ++ + + + W
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI-WC 312
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 13/172 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+ K + +++ E + EV +L Q++H N++K+ + LV E G L+ I
Sbjct: 59 ISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KIS 123
+ + RI +V ++Y+H I H D+K N+LL K + +I
Sbjct: 119 SRK----RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII 171
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
DF S + + T Y+ P+ + + EK DV+S V+L L
Sbjct: 172 DFGL--STHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYIL 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-14
Identities = 29/123 (23%), Positives = 48/123 (39%), Gaps = 15/123 (12%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+ KS + E+ E+ I + H++VV G E + +V E SL +
Sbjct: 48 VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH 106
Query: 66 HEQ---TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
+ T+ E R ++ YLH + H D+K N+ L + + KI
Sbjct: 107 KRRKALTEP------EAR-YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKI 156
Query: 123 SDF 125
DF
Sbjct: 157 GDF 159
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 39/247 (15%), Positives = 85/247 (34%), Gaps = 47/247 (19%)
Query: 11 KSVHESNVEQFINEVVILSQINH--RNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
+ ++ + NE+ L+++ ++++ + + +V E N L ++ ++
Sbjct: 44 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK 102
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
I R + + +H I H D+K AN L+VD K+ DF
Sbjct: 103 K----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGI- 153
Query: 129 KSRAID----RTHLTTQ----------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
+ + +Q S+ + KSDV+S +L
Sbjct: 154 -ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212
Query: 175 L------------NWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKK 222
+ +K ++D K+ ++V+ K CL + K+
Sbjct: 213 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL--QDVL------KCCLKRDPKQ 264
Query: 223 QPTMKEV 229
+ ++ E+
Sbjct: 265 RISIPEL 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 29/123 (23%), Positives = 48/123 (39%), Gaps = 15/123 (12%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+ KS + E+ E+ I + H++VV G E + +V E SL +
Sbjct: 74 VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH 132
Query: 66 HEQ---TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
+ T+ E R ++ YLH + H D+K N+ L + + KI
Sbjct: 133 KRRKALTEP------EAR-YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKI 182
Query: 123 SDF 125
DF
Sbjct: 183 GDF 185
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-14
Identities = 38/180 (21%), Positives = 72/180 (40%), Gaps = 20/180 (11%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGC--CLETEVPLLVYEFIPNGSLYQYIHE 67
+ V+ + E +L ++NH+N+VK+ T +L+ EF P GSLY + E
Sbjct: 43 NNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE 102
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA----KIS 123
++ + L + +V +++L I H +IK NI+ V K++
Sbjct: 103 PSNAY-GLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFGYVDP--------KYFRSSQFTEKSDVYSFSVVLVEL 175
DF +R ++ + T Y+ P + ++ D++S V
Sbjct: 159 DFGA--ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 39/247 (15%), Positives = 85/247 (34%), Gaps = 47/247 (19%)
Query: 11 KSVHESNVEQFINEVVILSQINH--RNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
+ ++ + NE+ L+++ ++++ + + +V E N L ++ ++
Sbjct: 91 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK 149
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
I R + + +H I H D+K AN L+VD K+ DF
Sbjct: 150 K----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGI- 200
Query: 129 KSRAID----RTHLTTQ----------VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
+ + +Q S+ + KSDV+S +L
Sbjct: 201 -ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259
Query: 175 L------------NWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKK 222
+ +K ++D K+ ++V+ K CL + K+
Sbjct: 260 MTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL--QDVL------KCCLKRDPKQ 311
Query: 223 QPTMKEV 229
+ ++ E+
Sbjct: 312 RISIPEL 318
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-14
Identities = 30/116 (25%), Positives = 58/116 (50%), Gaps = 14/116 (12%)
Query: 14 HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ----T 69
E +E +I E+ IL+ +H +VK+LG ++ EF P G++ + E T
Sbjct: 56 SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT 115
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ Q+ + + ++ L++LHS I H D+K+ N+L+ + +++DF
Sbjct: 116 EPQIQV-------VCRQMLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADF 161
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 5e-14
Identities = 38/176 (21%), Positives = 71/176 (40%), Gaps = 18/176 (10%)
Query: 11 KSVHESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT 69
K + EV +L + + H NV++ + + + E +L +Y+ ++
Sbjct: 54 KRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKD 112
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-----YQAKISD 124
L + + + + L++LHS + I H D+K NIL+ +A ISD
Sbjct: 113 FAHLG---LEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISD 166
Query: 125 FRTFKSRAIDRTHLTTQVKV--TFGYVDPKYFRSSQF---TEKSDVYSFSVVLVEL 175
F K A+ R + + V T G++ P+ T D++S V +
Sbjct: 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-14
Identities = 28/134 (20%), Positives = 56/134 (41%), Gaps = 16/134 (11%)
Query: 1 MEELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNG 59
+ K +S + F NE+ I++ I + + G + + ++YE++ N
Sbjct: 70 KRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMEND 128
Query: 60 SLYQYIHEQTDDQLPITWEMRLRITVEVSRV--------LSYLHSVASIPIYHLDIKSAN 111
S+ ++ + I ++V + SY+H+ I H D+K +N
Sbjct: 129 SILKFDEYFF----VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSN 182
Query: 112 ILLVDKYQAKISDF 125
IL+ + K+SDF
Sbjct: 183 ILMDKNGRVKLSDF 196
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-13
Identities = 29/115 (25%), Positives = 52/115 (45%), Gaps = 7/115 (6%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
++++++ + E+ +SQ +H N+V + + LV + + GS+ I
Sbjct: 54 QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEH 113
Query: 75 ITWEMRLR----ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ + I EV L YLH I H D+K+ NILL + +I+DF
Sbjct: 114 KSGVLDESTIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADF 165
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 38/180 (21%), Positives = 72/180 (40%), Gaps = 20/180 (11%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGC--CLETEVPLLVYEFIPNGSLYQYIHE 67
+ V+ + E +L ++NH+N+VK+ T +L+ EF P GSLY + E
Sbjct: 43 NNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE 102
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV----DKYQAKIS 123
+ + L + +V +++L I H +IK NI+ V + K++
Sbjct: 103 P-SNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFGYVDP--------KYFRSSQFTEKSDVYSFSVVLVEL 175
DF +R ++ + T Y+ P + ++ D++S V
Sbjct: 159 DFGA--ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 3e-13
Identities = 25/264 (9%), Positives = 63/264 (23%), Gaps = 49/264 (18%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVP----------------- 49
S +E+ +++ + +
Sbjct: 95 FTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPG 154
Query: 50 ---------LLVYEFIP--NGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVA 98
LL+ L+ + + +T ++ R+ + L S
Sbjct: 155 QDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG 214
Query: 99 SIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS- 157
+ H N+ ++ + + D S V Y ++ +S
Sbjct: 215 ---LVHGHFTPDNLFIMPDGRLMLGDV----SALWKVGTRGPASSVPVTYAPREFLNAST 267
Query: 158 -QFTEKSDVYSFSVVLVELNWT-KPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVA--- 212
FT + + + + + W + + S + + F
Sbjct: 268 ATFTHALNAWQLGLSIYRV-WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP 326
Query: 213 -------KRCLNLNGKKQPTMKEV 229
R LN + +++ E
Sbjct: 327 DFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 14/172 (8%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
++K+ V S+ + + EV +L ++H N++K+ + LV E G L+ I
Sbjct: 70 IRKTS-VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KIS 123
+ I +V ++YLH I H D+K N+LL K + KI
Sbjct: 129 HRM----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIV 181
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
DF S + + T Y+ P+ R + EK DV+S V+L L
Sbjct: 182 DFGL--SAVFENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFIL 230
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-13
Identities = 32/111 (28%), Positives = 47/111 (42%), Gaps = 7/111 (6%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
+ I EV L ++ H N ++ GC L LV E+ GS + P
Sbjct: 95 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---P 150
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ +T + L+YLHS I H D+K+ NILL + K+ DF
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDF 198
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 25/186 (13%), Positives = 70/186 (37%), Gaps = 14/186 (7%)
Query: 1 MEELWLLKKSKSVHESNVE-QFINEVVILSQINHRNVVKILGCCLETEVPLLVYEF-IPN 58
+ L LL+ K+ ++ V +FI ++ + ++++ + V + +
Sbjct: 124 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 183
Query: 59 GSLYQ---YIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV 115
+L + + + RL++T++V R+L+ LH + H ++ +I+L
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLD 240
Query: 116 DKYQAKISDFRTFKSRAIDRTHLTTQ------VKVTFGYVDPKYFRSSQFTEKSDVYSFS 169
+ ++ F ++ ++ + R + T D ++
Sbjct: 241 QRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300
Query: 170 VVLVEL 175
+V+ +
Sbjct: 301 LVIYWI 306
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 37/125 (29%), Positives = 54/125 (43%), Gaps = 14/125 (11%)
Query: 9 KSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPL------LVYEFIPNGSL 61
K V E+ E+ +L + +HRN+ G ++ P LV EF GS+
Sbjct: 55 KVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV 114
Query: 62 YQYIHEQTDDQLPITWEMRLR-ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
I + L E + I E+ R LS+LH I H DIK N+LL + +
Sbjct: 115 TDLIKNTKGNTLK---EEWIAYICREILRGLSHLHQHKVI---HRDIKGQNVLLTENAEV 168
Query: 121 KISDF 125
K+ DF
Sbjct: 169 KLVDF 173
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 47/222 (21%), Positives = 88/222 (39%), Gaps = 9/222 (4%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
+ Q I E+ +L + N +V G + E + GSL Q + +
Sbjct: 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----R 127
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
I ++ ++++ V + L+YL I H D+K +NIL+ + + K+ DF S +
Sbjct: 128 IPEQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGV--SGQLI 183
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA 194
+ + V T Y+ P+ + + ++ +SD++S + LVE+ + + L
Sbjct: 184 DSMANSFVG-TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 195 YFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236
E + E R LN G + L I
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 13/168 (7%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHE 67
E E+ NE+ +L ++H N++K+ + + LV EF G L++ I
Sbjct: 80 SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN 139
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KISD 124
+ I ++ + YLH I H DIK NILL +K KI D
Sbjct: 140 RH----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD 192
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
F S + + T Y+ P+ + + EK DV+S V++
Sbjct: 193 FGL--SSFFSKDYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIM 237
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-12
Identities = 40/191 (20%), Positives = 77/191 (40%), Gaps = 24/191 (12%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVP-------LLVYEFIPN 58
LK+ S E I EV + ++ H N+V+ + L+ +
Sbjct: 58 LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117
Query: 59 GSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY 118
G L +++ ++ + + P++ + L+I + R + ++H PI H D+K N+LL ++
Sbjct: 118 GQLVEFL-KKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQG 175
Query: 119 QAKISDF--RTFKSRAIDRTHLTTQVKV---------TFGYVDPKYFRSSQ---FTEKSD 164
K+ DF T S D + + + T Y P+ EK D
Sbjct: 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235
Query: 165 VYSFSVVLVEL 175
+++ +L L
Sbjct: 236 IWALGCILYLL 246
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-12
Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 13/170 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+ K +S + +EQ E+ +L ++H N++KI E + +V E G L + I
Sbjct: 55 INKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERI 111
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK---YQAKI 122
++ + ++ L+Y HS + H D+K NIL D KI
Sbjct: 112 VSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKI 168
Query: 123 SDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
DF + +T T Y+ P+ F+ T K D++S VV+
Sbjct: 169 IDFGL--AELFKSDEHSTNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVM 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-12
Identities = 17/161 (10%), Positives = 44/161 (27%), Gaps = 37/161 (22%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74
+ +++ ++ + LS+I+ V ++L L+V E+I GSL +
Sbjct: 72 DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT------S 125
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID 134
+ +R ++ H + + + + ++
Sbjct: 126 PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP--------- 173
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ + D+ L L
Sbjct: 174 ------------ATMPDA-------NPQDDIRGIGASLYAL 195
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 16/170 (9%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+ K+ + + EV +L +++H N++K+ E +V E G L+ I
Sbjct: 55 INKAS-AKNKDTSTILREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEI 112
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KI 122
++ + RI +V ++Y+H I H D+K NILL K + KI
Sbjct: 113 IKRK----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI 165
Query: 123 SDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
DF S + T Y+ P+ R + + EK DV+S V+L
Sbjct: 166 IDFGL--STCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 31/168 (18%), Positives = 67/168 (39%), Gaps = 15/168 (8%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIH 66
+ + NE+ I++Q++H ++ + E + + L+ EF+ G L+ I
Sbjct: 85 NTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRI- 139
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA--KISD 124
+ ++ + + L ++H + I HLDIK NI+ K + KI D
Sbjct: 140 --AAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIID 194
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
F + ++ + T + P+ +D+++ V+
Sbjct: 195 FGL--ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 35/170 (20%), Positives = 68/170 (40%), Gaps = 11/170 (6%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIH 66
K S + E E I + H ++V++L ++ L +V+EF+ L I
Sbjct: 60 AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIV 118
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KIS 123
++ D + + ++ L Y H I H D+K +LL K + K+
Sbjct: 119 KRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLG 175
Query: 124 DFRTFKSRAIDRTHLTTQVKV-TFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
F + + + L +V T ++ P+ + + + DV+ V+L
Sbjct: 176 GFGV--AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 5e-11
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 18/170 (10%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+KKS + +S++E NE+ +L +I H N+V + E+ LV + + G L+ I
Sbjct: 42 IKKSPAFRDSSLE---NEIAVLKKIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRI 97
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KI 122
E+ T + + +V + YLH I H D+K N+L + + I
Sbjct: 98 LERG----VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMI 150
Query: 123 SDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
+DF S+ ++T T GYV P+ +++ D +S V+
Sbjct: 151 TDFGL--SKMEQNGIMSTACG-TPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-11
Identities = 39/172 (22%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+K + E+ NE+ +++Q++H N++++ E++ + LV E++ G L+ I
Sbjct: 122 IKTRGM---KDKEEVKNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRI 177
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA--KIS 123
D+ +T + ++ + ++H + I HLD+K NIL V++ KI
Sbjct: 178 ---IDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKII 231
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVL 172
DF +R ++KV FG ++ P+ + +D++S V+
Sbjct: 232 DFGL--ARRYKP---REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 6e-11
Identities = 35/171 (20%), Positives = 70/171 (40%), Gaps = 19/171 (11%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+ S+ E E+ +S + H +V + + +++YEF+ G L++ +
Sbjct: 190 VMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV- 245
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA--KISD 124
D+ ++ + + +V + L ++H HLD+K NI+ K K+ D
Sbjct: 246 --ADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLID 300
Query: 125 FRTFKSRAIDRTHLTTQVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVL 172
F + +D VKVT G + P+ +D++S V+
Sbjct: 301 FGL--TAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-11
Identities = 52/237 (21%), Positives = 93/237 (39%), Gaps = 42/237 (17%)
Query: 15 ESNVEQFINEV-VILSQINHRNVVKILGCCL-ETEVPLLVYEFIPNGSLYQYIHEQTDDQ 72
++ + ++ + + ++ V G E +V + E + + SL ++ + D
Sbjct: 46 SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV-WICMELM-DTSLDKFYKQVIDKG 103
Query: 73 LPITWEMRL-RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF----RT 127
I E L +I V + + L +LHS S+ I H D+K +N+L+ Q K+ DF
Sbjct: 104 QTIP-EDILGKIAVSIVKALEHLHSKLSV-I-HRDVKPSNVLINALGQVKMCDFGISGYL 160
Query: 128 FKSRAIDRTHLTTQVKVTFGYVDP----KYFRSSQFTEKSDVYSFSVVLVEL-------- 175
A Y+ P ++ KSD++S + ++EL
Sbjct: 161 VDDVA-----KDIDAG-CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
Query: 176 NWTKPI----HLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
+W P +V+ + A FS E F +CL N K++PT E
Sbjct: 215 SWGTPFQQLKQVVEEPSPQLPADKFSAE--------FVDFTSQCLKKNSKERPTYPE 263
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-11
Identities = 36/172 (20%), Positives = 65/172 (37%), Gaps = 16/172 (9%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+ E+ IL ++NH ++KI + E +V E + G L+ +
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV 231
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KIS 123
+ ++ + YLH I H D+K N+LL + + KI+
Sbjct: 232 GNK----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFGYVDP---KYFRSSQFTEKSDVYSFSVVL 172
DF S+ + T L + T Y+ P ++ + D +S V+L
Sbjct: 285 DFGH--SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 31/117 (26%), Positives = 55/117 (47%), Gaps = 13/117 (11%)
Query: 15 ESNVEQFINEV-VILSQINHRNVVKILGCCL-ETEVPLLVYEFIPNGSL---YQYIHEQT 69
E +Q + ++ V++ + +V+ G E + + E + + S Y+Y++
Sbjct: 61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMELM-STSFDKFYKYVYSVL 118
Query: 70 DDQLPITWEMRL-RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
DD +P E L +IT+ + L++L I H DIK +NILL K+ DF
Sbjct: 119 DDVIP---EEILGKITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDF 170
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 26/173 (15%)
Query: 15 ESNVEQFINEV-VILSQINHRNVVKILGCCL-ETEVPLLVYEFIPNGSLYQYIHEQTDDQ 72
+ ++ + ++ V+L + +V+ G + T+V + E + + +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKK--RMQGP 120
Query: 73 LPITWEMRL-RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF----RT 127
+P E L ++TV + + L YL + I H D+K +NILL ++ Q K+ DF R
Sbjct: 121 IP---ERILGKMTVAIVKALYYLKEKHGV-I-HRDVKPSNILLDERGQIKLCDFGISGRL 175
Query: 128 FKSRAIDRTHLTTQVKVTFGY-----VDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+A Y +DP + ++DV+S + LVEL
Sbjct: 176 VDDKAK-----DRSAG-CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 43/179 (24%), Positives = 79/179 (44%), Gaps = 29/179 (16%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+ K++ ++ +++++ EV I+ +NH N+VK+ +ETE L L+ E+ G ++ Y+
Sbjct: 48 IDKTQ-LNPTSLQKLFREVRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYL 105
Query: 66 HEQTDDQLPITWEMRLRITVEVSRV--------LSYLHSVASIPIYHLDIKSANILLVDK 117
R+ + +R + Y H I H D+K+ N+LL
Sbjct: 106 VAHG------------RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDAD 150
Query: 118 YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT-EKSDVYSFSVVLVEL 175
KI+DF F + L Y P+ F+ ++ + DV+S V+L L
Sbjct: 151 MNIKIADF-GFSNEFTVGGKLDAFCG-APPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-10
Identities = 39/171 (22%), Positives = 73/171 (42%), Gaps = 17/171 (9%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIH 66
+ S + E+ EV IL Q+ H NV+ + E + L+ E + G L+ ++
Sbjct: 49 QSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLA 107
Query: 67 EQTDDQLPITWEMRLRITV-EVSRVLSYLHSVASIPIYHLDIKSANILLVDK----YQAK 121
+ + L E + ++ ++YLH+ I H D+K NI+L+DK K
Sbjct: 108 Q--KESLS---EEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIK 159
Query: 122 ISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
+ DF + I+ + T +V P+ ++D++S V+
Sbjct: 160 LIDFGL--AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 6e-10
Identities = 32/166 (19%), Positives = 73/166 (43%), Gaps = 14/166 (8%)
Query: 11 KSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQT 69
K + + ++ E I ++ H N+V++ + E LV++ + G L++ I +
Sbjct: 42 KKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVARE 100
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KISDFR 126
+ ++ ++Y HS I H ++K N+LL K + K++DF
Sbjct: 101 ----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG 153
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
+ ++ + T GY+ P+ + +++ D+++ V+L
Sbjct: 154 L--AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 48/255 (18%), Positives = 92/255 (36%), Gaps = 42/255 (16%)
Query: 11 KSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI--H 66
K + + + E+ +L++ +H NV++ C T+ L + E N +L +
Sbjct: 45 KRMLIDFCDIALMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELC-NLNLQDLVESK 102
Query: 67 EQTDDQLPITWEMRLR-ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-------- 117
+D+ L + E + +++ +++LHS+ I H D+K NIL+
Sbjct: 103 NVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQ 159
Query: 118 -----YQAKISDF---RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF-------TEK 162
+ ISDF + S T G+ P+ S T
Sbjct: 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219
Query: 163 SDVYSFSVVLVELNWTKPIH----LVDVEENRSLAAYFSKEAEKEEVITFAMVAK----R 214
D++S V + +K H E N + E + + A +
Sbjct: 220 IDIFSMGCVFYYI-LSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQ 278
Query: 215 CLNLNGKKQPTMKEV 229
++ + K+PT +V
Sbjct: 279 MIDHDPLKRPTAMKV 293
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 8e-10
Identities = 39/208 (18%), Positives = 70/208 (33%), Gaps = 46/208 (22%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHE 67
K + ++ +VE+ EV ++ +++H N+ ++ + + LV E G L ++
Sbjct: 62 NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 68 QTDDQLPITWEMRL------------------------------------RITVEVSRVL 91
DD + I ++ L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 92 SYLHSVASIPIYHLDIKSANILLVDKYQA--KISDF---RTFKSRAIDRTHLTTQVKVTF 146
YLH+ I H DIK N L K+ DF + F + T T
Sbjct: 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 147 GYVDPKYFRSSQ--FTEKSDVYSFSVVL 172
+V P+ ++ + K D +S V+L
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 9e-10
Identities = 40/167 (23%), Positives = 72/167 (43%), Gaps = 17/167 (10%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQ 68
K+V + V E+ +L +++H N++K+ ET + LV E + G L+ I E+
Sbjct: 87 KKTVDKKIVR---TEIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEK 142
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KISDF 125
+ ++ ++YLH I H D+K N+L KI+DF
Sbjct: 143 G----YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADF 195
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
S+ ++ L V T GY P+ R + + D++S ++
Sbjct: 196 GL--SKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 9e-10
Identities = 34/170 (20%), Positives = 69/170 (40%), Gaps = 18/170 (10%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHE 67
K V ++ E+ IL+ HRN++ + E+ L +++EFI +++ I
Sbjct: 36 KFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-ESMEELVMIFEFISGLDIFERI-- 92
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA--KISDF 125
+ + +V L +LHS I H DI+ NI+ + + KI +F
Sbjct: 93 -NTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEF 148
Query: 126 RTFKSRAIDRTHLTTQVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVL 172
+R + ++ F Y P+ + + +D++S ++
Sbjct: 149 GQ--ARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 9e-10
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 13/165 (7%)
Query: 11 KSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD 70
S + + EV +L +++H N++K+ ++ +V E G L+ I ++
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK- 116
Query: 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KISDFRT 127
+ RI +V ++Y+H I H D+K NILL K + KI DF
Sbjct: 117 ---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170
Query: 128 FKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
S + T Y+ P+ R + + EK DV+S V+L
Sbjct: 171 --STCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-09
Identities = 33/170 (19%), Positives = 66/170 (38%), Gaps = 18/170 (10%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+ K +V++F E+ I+ ++H N++++ E + LV E G L++ +
Sbjct: 42 IPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERV 97
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KI 122
+ RI +V ++Y H + + H D+K N L + K+
Sbjct: 98 VHKR----VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKL 150
Query: 123 SDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
DF + + T YV P+ + + D +S V++
Sbjct: 151 IDFGL--AARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMM 197
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-09
Identities = 29/128 (22%), Positives = 49/128 (38%), Gaps = 25/128 (19%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
L + K V + E+ L H +++K+ + T +V E++ G L+ YI
Sbjct: 44 LNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYI 102
Query: 66 HEQTDDQLPITWEMRLRITVEVSRV--------LSYLHSVASIPIYHLDIKSANILLVDK 117
+ R+ +R + Y H + H D+K N+LL
Sbjct: 103 CKHG------------RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAH 147
Query: 118 YQAKISDF 125
AKI+DF
Sbjct: 148 MNAKIADF 155
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 39/173 (22%), Positives = 74/173 (42%), Gaps = 21/173 (12%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIH 66
+ S E+ EV IL Q+ H N++ + E + L+ E + G L+ ++
Sbjct: 49 QSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLA 107
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK----YQAKI 122
++ ++ E ++ ++YLH+ I H D+K NI+L+DK K+
Sbjct: 108 QKE----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 123 SDFRTFKSRAIDRTHLTTQVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVL 172
DF + I+ + K FG +V P+ ++D++S V+
Sbjct: 161 IDFGL--AHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 32/166 (19%), Positives = 73/166 (43%), Gaps = 14/166 (8%)
Query: 11 KSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQT 69
K + + ++ E I ++ H N+V++ + E LV++ + G L++ I +
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVARE 123
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KISDFR 126
+ ++ ++Y HS I H ++K N+LL K + K++DF
Sbjct: 124 ----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
+ ++ + T GY+ P+ + +++ D+++ V+L
Sbjct: 177 L--AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 43/174 (24%), Positives = 74/174 (42%), Gaps = 23/174 (13%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIH 66
+ S + E EV IL +I H NV+ + E + + L+ E + G L+ ++
Sbjct: 48 RTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLA 106
Query: 67 EQTDDQLPITWEMR----LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA-- 120
E + L E L+ + + YLHS+ I H D+K NI+L+D+
Sbjct: 107 E--KESLT---EEEATEFLKQILN---GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKP 155
Query: 121 --KISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
KI DF + ID + + T +V P+ ++D++S V+
Sbjct: 156 RIKIIDFGL--AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 38/178 (21%), Positives = 66/178 (37%), Gaps = 28/178 (15%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+ E+ IL ++NH ++KI + E +V E + G L+ +
Sbjct: 48 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV 106
Query: 67 EQTDDQLPITWEMRL------RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
RL ++ + YLH I H D+K N+LL + +
Sbjct: 107 GNK----------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 153
Query: 121 ---KISDFRTFKSRAIDRTHLTTQVKVTFGYVDP---KYFRSSQFTEKSDVYSFSVVL 172
KI+DF S+ + T L + T Y+ P ++ + D +S V+L
Sbjct: 154 CLIKITDFGH--SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-09
Identities = 43/180 (23%), Positives = 76/180 (42%), Gaps = 35/180 (19%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIH 66
+ S S + E+ EV IL +I H N++ + E + + L+ E + G L+ ++
Sbjct: 42 RLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLA 100
Query: 67 EQTDDQLPITWEMR----LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA-- 120
E + L E L+ ++ + YLHS I H D+K NI+L+DK
Sbjct: 101 E--KESLT---EDEATQFLKQILD---GVHYLHSKR---IAHFDLKPENIMLLDKNVPNP 149
Query: 121 --KISDF---RTFKSRAIDRTHLTTQVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVL 172
K+ DF ++ + K FG +V P+ ++D++S V+
Sbjct: 150 RIKLIDFGIAHKIEAG--------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 37/178 (20%), Positives = 70/178 (39%), Gaps = 28/178 (15%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHR-NVVKILGCCLETEVPL-LVYEFIPNGSLYQY 64
LKK + + + ++E+ +L V+ + E + L+ E+ G ++
Sbjct: 62 LKKRR-RGQDCRAEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSL 119
Query: 65 IHEQTDDQLPITWEMR----LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
+ + + E ++ +E + YLH I HLD+K NILL Y
Sbjct: 120 CLPELAEMVS---ENDVIRLIKQILEG---VYYLHQNN---IVHLDLKPQNILLSSIYPL 170
Query: 121 ---KISDFRTFKSRAIDRTHLTTQVKVTFG---YVDPKYFRSSQFTEKSDVYSFSVVL 172
KI DF SR I +++ G Y+ P+ T +D+++ ++
Sbjct: 171 GDIKIVDFGM--SRKIGH---ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-09
Identities = 32/125 (25%), Positives = 45/125 (36%), Gaps = 25/125 (20%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQ 68
E E+ I +NH NVVK G L E+ G L+ I
Sbjct: 41 DMKRAVDCPENIKKEICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI--- 96
Query: 69 TDDQLPITWEMRLRITVEVSRV--------LSYLHSVASIPIYHLDIKSANILLVDKYQA 120
E + + ++ + YLH + I H DIK N+LL ++
Sbjct: 97 ---------EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNL 144
Query: 121 KISDF 125
KISDF
Sbjct: 145 KISDF 149
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 43/172 (25%), Positives = 79/172 (45%), Gaps = 26/172 (15%)
Query: 24 EVVILSQINHRNVVKILGCCLET-----EVPL-LVYEFIPNGSLYQYIHEQTDDQLPITW 77
E+ I+ +++H N+V++ + EV L LV +++P ++Y+ + + +
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV 155
Query: 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL-VDKYQAKISDFRTFKSRAIDRT 136
++ R L+Y+HS I H DIK N+LL D K+ DF + ++ + R
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS--AKQLVRG 210
Query: 137 HLTTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVELNWTKPI 181
Y+ +Y+R ++ +T DV+S VL EL +PI
Sbjct: 211 EPNV------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 29/166 (17%), Positives = 67/166 (40%), Gaps = 13/166 (7%)
Query: 11 KSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQT 69
K + + ++ E I + H N+V++ E L+++ + G L++ I +
Sbjct: 47 KKLSARDHQKLEREARICRLLKHPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVARE 105
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KISDFR 126
+ ++ + + H + + H ++K N+LL K + K++DF
Sbjct: 106 ----YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG 158
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
++ T GY+ P+ R + + D+++ V+L
Sbjct: 159 LAIEVEGEQQAWFGFAG-TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 31/128 (24%), Positives = 51/128 (39%), Gaps = 25/128 (19%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
L + K V + E+ L H +++K+ + T + +V E++ G L+ YI
Sbjct: 49 LNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYI 107
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVL--------SYLHSVASIPIYHLDIKSANILLVDK 117
+ R+ + SR L Y H + H D+K N+LL
Sbjct: 108 CKNG------------RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAH 152
Query: 118 YQAKISDF 125
AKI+DF
Sbjct: 153 MNAKIADF 160
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 40/172 (23%), Positives = 74/172 (43%), Gaps = 26/172 (15%)
Query: 24 EVVILSQINHRNVVKILGCCLET-----EVPL-LVYEFIPNGSLYQYIHEQTDDQLPITW 77
E+ I+ + H NVV + EV L LV E++P ++Y+ + +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140
Query: 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL-VDKYQAKISDFRTFKSRAIDRT 136
+ ++ R L+Y+HS+ I H DIK N+LL K+ DF + ++ +
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGS--AKILIAG 195
Query: 137 HLTTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVELNWTKPI 181
Y+ +Y+R ++ +T D++S V+ EL +P+
Sbjct: 196 EPNV------SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-09
Identities = 32/125 (25%), Positives = 45/125 (36%), Gaps = 25/125 (20%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQ 68
E E+ I +NH NVVK G L E+ G L+ I
Sbjct: 41 DMKRAVDCPENIKKEICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI--- 96
Query: 69 TDDQLPITWEMRLRITVEVSRV--------LSYLHSVASIPIYHLDIKSANILLVDKYQA 120
E + + ++ + YLH + I H DIK N+LL ++
Sbjct: 97 ---------EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNL 144
Query: 121 KISDF 125
KISDF
Sbjct: 145 KISDF 149
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 7e-09
Identities = 37/121 (30%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
L+K + +NE IL ++N R VV L ET+ L LV + G L +I
Sbjct: 217 LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHI 275
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ P E R E+ L LH I + D+K NILL D +ISD
Sbjct: 276 YHMGQAGFP---EARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329
Query: 125 F 125
Sbjct: 330 L 330
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-09
Identities = 38/166 (22%), Positives = 67/166 (40%), Gaps = 12/166 (7%)
Query: 11 KSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT 69
K + + E+ L H N+VK+ + LV E + G L++ I ++
Sbjct: 42 KIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK 101
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KISDFR 126
+ I ++ +S++H V + H D+K N+L D+ KI DF
Sbjct: 102 ----HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFG 154
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
+ + D L T T Y P+ + + E D++S V+L
Sbjct: 155 FARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 30/122 (24%), Positives = 53/122 (43%), Gaps = 28/122 (22%)
Query: 15 ESNVEQFINEVVILSQINHRNVVK---ILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD 71
+EQ E+ IL +++H NVVK +L E + +V+E + G + + +
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLK--- 132
Query: 72 QLPITWEMRLRITVEVSRV--------LSYLHSVASIPIYHLDIKSANILLVDKYQAKIS 123
++ + +R + YLH I H DIK +N+L+ + KI+
Sbjct: 133 ----------PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIA 179
Query: 124 DF 125
DF
Sbjct: 180 DF 181
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 34/132 (25%), Positives = 53/132 (40%), Gaps = 29/132 (21%)
Query: 7 LKKSKSVHESNVEQFIN-EVVILSQINHRNVVKILG-CCLETEVPL-LVYEFIPNGS--L 61
LKK K N E + E+ +L ++ H+NV++++ E + + +V E+ G +
Sbjct: 38 LKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEM 97
Query: 62 YQYIHEQTDDQLPITWEMRLRITVEVSRV--------LSYLHSVASIPIYHLDIKSANIL 113
+ E+ R V + L YLHS I H DIK N+L
Sbjct: 98 LDSVPEK-------------RFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLL 141
Query: 114 LVDKYQAKISDF 125
L KIS
Sbjct: 142 LTTGGTLKISAL 153
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 19/141 (13%)
Query: 22 INEVVILSQINHRNVVKILGCCLE-TEVPL-LVYEFIPNGSLYQYIH-----EQTDDQLP 74
E+ +L ++ H NV+ + L + + L++++ + L+ I + +
Sbjct: 66 CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQ 124
Query: 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA----KISDF---RT 127
+ M + ++ + YLH+ + H D+K ANIL++ + KI+D R
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 128 FKSRAIDRTHLTTQVKVTFGY 148
F S L V VTF Y
Sbjct: 182 FNSPLKPLADLDPVV-VTFWY 201
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 34/166 (20%), Positives = 61/166 (36%), Gaps = 10/166 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+ K + V F E +L + R + + L + E L LV E+ G L +
Sbjct: 94 MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ-LHFAFQDENYLYLVMEYYVGGDLLTLL 152
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ +++P R E+ + +H + H DIK NILL +++D
Sbjct: 153 -SKFGERIP---AEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSV 170
F + D T + T Y+ P+ ++ + Y
Sbjct: 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPEC 251
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 41/180 (22%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQY 64
+ S E E E IL Q+ H +++ ++ E+ + LV++ + G L+ Y
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDY 190
Query: 65 IHEQTDDQLPITWEMRL------RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY 118
+ E+ L I + +S+LH+ I H D+K NILL D
Sbjct: 191 LTEKV----------ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM 237
Query: 119 QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP------KYFRSSQFTEKSDVYSFSVVL 172
Q ++SDF S ++ ++ T GY+ P + ++ D+++ V+L
Sbjct: 238 QIRLSDFGF--SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 32/121 (26%), Positives = 53/121 (43%), Gaps = 7/121 (5%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
L K + + + E IL++++ R +V L ET+ L LV + G + +I
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHI 276
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ +D E R T ++ L +LH I + D+K N+LL D +ISD
Sbjct: 277 YNVDEDNPGFQ-EPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISD 332
Query: 125 F 125
Sbjct: 333 L 333
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 29/121 (23%), Positives = 53/121 (43%), Gaps = 10/121 (8%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGS-LYQY 64
+ + + + + + E+ ILS++ H N++K+L E + LV E +G L+ +
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAF 120
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
I P I ++ + YL I H DIK NI++ + + K+ D
Sbjct: 121 IDRHPRLDEP---LAS-YIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID 173
Query: 125 F 125
F
Sbjct: 174 F 174
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 33/170 (19%), Positives = 73/170 (42%), Gaps = 25/170 (14%)
Query: 27 ILSQINHRNVVKIL------GCCLETEVPL-LVYEFIPNGSLYQYIHEQTDDQLPITWEM 79
L+ ++H N+V++ G ++ L +V E++P+ +L++ Q+ +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL-VDKYQAKISDFRTFKSRAIDRTHL 138
++ R + LH S+ + H DIK N+L+ K+ DF + ++ + +
Sbjct: 131 IKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGS--AKKLSPSEP 187
Query: 139 TTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVELNWTKPI 181
Y+ +Y+R + +T D++S + E+ +PI
Sbjct: 188 NV------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 6e-08
Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 64/231 (27%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLV-YEFIPNGSLYQY 64
LK+ + E ++E+ IL I +H NVV +LG C + PL+V EF G+L Y
Sbjct: 60 LKEGATHSE--HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 117
Query: 65 IHEQTDDQLP-----------------ITWEMRLRITVEVS------------RVLSYLH 95
+ + ++ +P I +++ R+ S + LS +
Sbjct: 118 LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
Query: 96 SVASIPIYHLDIKSANILLVDKYQ-AKISDF---RTFKSRAID-RTHLTTQ---VKVT-F 146
+ + D + L+ +Q AK +F R R + R L ++ VK+ F
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 237
Query: 147 G-----YVDPKYFRSSQ-----------------FTEKSDVYSFSVVLVEL 175
G Y DP Y R +T +SDV+SF V+L E+
Sbjct: 238 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-08
Identities = 36/165 (21%), Positives = 71/165 (43%), Gaps = 20/165 (12%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPL------LVYEFIPNGSLYQYIHEQTDDQLPITW 77
E+V++ +NH+N++ +L + +V E + +L Q I + D +
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHE----- 127
Query: 78 EMRLR-ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT 136
R+ + ++ + +LHS I H D+K +NI++ KI DF +R +
Sbjct: 128 --RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL--ARTAGTS 180
Query: 137 HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPI 181
+ T VT Y P+ + E D++S ++ E+ +
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVL 225
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 7e-08
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 18/175 (10%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
L+K + E+ V E ++S+++H VK L + + L + NG L +YI
Sbjct: 63 LEKRHIIKENKVPYVTRERDVMSRLDHPFFVK-LYFTFQDDEKLYFGLSYAKNGELLKYI 121
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ E R T E+ L YLH I H D+K NILL + +I+D
Sbjct: 122 --RKIGSFD---ETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 173
Query: 125 FRTFKSRAIDRTHLTTQVKVTF-G---YVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
F T K + + +F G YV P+ + SD+++ ++ +L
Sbjct: 174 FGTAKVLSPESKQARAN---SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 8e-08
Identities = 42/179 (23%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 8 KKSKSVHESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
S + E + EV IL +++ H N++++ ET LV++ + G L+ Y+
Sbjct: 57 SFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYL 115
Query: 66 HEQTDDQLPITWEMRL------RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ 119
E+ L +I + V+ LH + I H D+K NILL D
Sbjct: 116 TEKV----------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 162
Query: 120 AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP------KYFRSSQFTEKSDVYSFSVVL 172
K++DF S +D +V T Y+ P + ++ D++S V++
Sbjct: 163 IKLTDFGF--SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 34/121 (28%), Positives = 50/121 (41%), Gaps = 10/121 (8%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
LKK V + V + E +L H + L +T L V E+ G L +
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA-LKYSFQTHDRLCFVMEYANGGEL--FF 237
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
H + E R R E+ L YLHS ++ +Y D+K N++L KI+D
Sbjct: 238 HLSRERVFS---EDRARFYGAEIVSALDYLHSEKNV-VYR-DLKLENLMLDKDGHIKITD 292
Query: 125 F 125
F
Sbjct: 293 F 293
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 37/158 (23%), Positives = 64/158 (40%), Gaps = 16/158 (10%)
Query: 23 NEVVILSQI-NHRNVVKILGCCLETEVP----LLVYEFIPNGSLYQYIHEQTDDQLPITW 77
EV Q ++V IL L++ E + G L+ I E+ D T
Sbjct: 70 QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF--TE 127
Query: 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KISDFRTFKSRAID 134
I ++ + +LHS I H D+K N+L K + K++DF ++
Sbjct: 128 REAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF--AKETT 182
Query: 135 RTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
+ L T T YV P+ ++ + D++S V++
Sbjct: 183 QNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 27/121 (22%), Positives = 50/121 (41%), Gaps = 10/121 (8%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
L K + + + F E +L + + + L + + L LV ++ G L +
Sbjct: 107 LNKWEMLKRAETACFREERDVLVNGDSKWITT-LHYAFQDDNNLYLVMDYYVGGDLLTLL 165
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ +D+LP E R E+ + +H + H DIK NIL+ +++D
Sbjct: 166 -SKFEDRLP---EEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218
Query: 125 F 125
F
Sbjct: 219 F 219
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 29/128 (22%), Positives = 50/128 (39%), Gaps = 26/128 (20%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+ + + E+ L + H +++K+ + T + +V E+ G L+ YI
Sbjct: 42 ISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYI 99
Query: 66 HEQTDDQLPITWEMRLRITVEVSRV--------LSYLHSVASIPIYHLDIKSANILLVDK 117
E+ R+T + R + Y H I H D+K N+LL D
Sbjct: 100 VEKK------------RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDN 144
Query: 118 YQAKISDF 125
KI+DF
Sbjct: 145 LNVKIADF 152
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 35/121 (28%), Positives = 54/121 (44%), Gaps = 12/121 (9%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
L K + + S+ F E I++ N VV+ L + + L +V E++P G L +
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ-LFYAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+P E R T EV L +HS+ I H D+K N+LL K++D
Sbjct: 161 SNY---DVP---EKWARFYTAEVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLAD 211
Query: 125 F 125
F
Sbjct: 212 F 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-07
Identities = 46/182 (25%), Positives = 75/182 (41%), Gaps = 27/182 (14%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
++K S V EV +L Q HRNV++++ E + LV+E + GS+ +I
Sbjct: 46 IEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI 102
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KI 122
H++ + +V+ L +LH+ I H D+K NIL Q KI
Sbjct: 103 HKRR----HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKI 155
Query: 123 SDF---RTFK----SRAIDRTHLTTQVKVTFGYVDP-----KYFRSSQFTEKSDVYSFSV 170
DF K I L T + Y+ P +S + ++ D++S V
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPELLTPCG-SAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
Query: 171 VL 172
+L
Sbjct: 215 IL 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 6e-07
Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 9/112 (8%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
I E+ ++ ++ H N+V++ LV+EF+ N L +Y+ +T P E+ L
Sbjct: 51 IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL 109
Query: 82 --RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTF 128
++ + L++ H I H D+K N+L+ + Q K+ DF R F
Sbjct: 110 VKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 7e-07
Identities = 47/237 (19%), Positives = 90/237 (37%), Gaps = 40/237 (16%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHR--NVVKILGCCLETEVPL-LVYEFI-PNGSLYQ 63
+ S N + EVV+L +++ V+++L E L+ E P L+
Sbjct: 80 RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFD 138
Query: 64 YIHEQTDDQLPITWEMRL------RITVEVSRVLSYLHSVASIPIYHLDIKSANILL-VD 116
+I E+ L +V + + H+ + H DIK NIL+ ++
Sbjct: 139 FITERG----------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN 185
Query: 117 KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT-EKSDVYSFSVVL-VE 174
+ + K+ DF + + T T T Y P++ R ++ + V+S ++L
Sbjct: 186 RGELKLIDFGS--GALLKDTVYTDFDG-TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 242
Query: 175 LNWTKPIHLVD--VEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
+ P + + S E + +I + CL L +PT +E+
Sbjct: 243 VCGDIPFEHDEEIIRGQVFFRQRVSSECQH--LI------RWCLALRPSDRPTFEEI 291
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 7e-07
Identities = 38/171 (22%), Positives = 73/171 (42%), Gaps = 32/171 (18%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPL------LVYEFIPNGSLYQYIHEQTDDQLPITW 77
E+V++ +NH+N++ +L + LV E + +L Q I + D +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHE----- 164
Query: 78 EMRLR-ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT 136
R+ + ++ + +LHS I H D+K +NI++ KI DF +R +
Sbjct: 165 --RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL--ARTAGTS 217
Query: 137 HLTTQVKVTFGYVDPKYFR------SSQFTEKSDVYSFSVVLVELNWTKPI 181
+ T YV +Y+R + E D++S ++ E+ K +
Sbjct: 218 FMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 262
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 35/171 (20%), Positives = 72/171 (42%), Gaps = 32/171 (18%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPL------LVYEFIPNGSLYQYIHEQTDDQLPITW 77
E+ +L + H NV+ +L E LV F+ L + + + +
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE-----KLGE 127
Query: 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH 137
+ + ++ + L Y+H+ I H D+K N+ + + + KI DF +R D +
Sbjct: 128 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL--ARQAD-SE 181
Query: 138 LTTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVELNWTKPI 181
+T GYV +++R ++T+ D++S ++ E+ K +
Sbjct: 182 MT-------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 225
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-07
Identities = 40/170 (23%), Positives = 67/170 (39%), Gaps = 27/170 (15%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPL-----LVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E+ +L+ +H N++ + + E P LV E + L Q IH+Q ++ I+ +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ---RIVISPQ 134
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138
+ L LH + H D+ NILL D I DF +R
Sbjct: 135 HIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNL--AREDTADAN 189
Query: 139 TTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVELNWTKPI 181
T YV +++R FT+ D++S V+ E+ K +
Sbjct: 190 KT------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 13/154 (8%)
Query: 24 EVVILSQ-INHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82
E+ IL + H N++ + + + +V E + G L I Q +
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----FFSEREASA 120
Query: 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA----KISDFRTFKSRAIDRTHL 138
+ +++ + YLH+ + H D+K +NIL VD+ +I DF K + L
Sbjct: 121 VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
T T +V P+ + D++S V+L
Sbjct: 178 MTPCY-TANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 31/146 (21%), Positives = 56/146 (38%), Gaps = 20/146 (13%)
Query: 7 LKKSKSVHESNVEQFIN--EVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY 64
+KK + V + I E+ +L Q+ H N+V +L LV+E+ + ++
Sbjct: 33 IKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHE 91
Query: 65 IHEQTDDQLPITWEMRL--RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
+ D+ L IT + + +++ H H D+K NIL+ K+
Sbjct: 92 L-----DRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKL 143
Query: 123 SDF---RTFKSRAIDRTHLTTQVKVT 145
DF R + +V T
Sbjct: 144 CDFGFARLL---TGPSDYYDDEV-AT 165
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 31/173 (17%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPL-----LVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E+ IL + H N++ I + +V + + LY+ + Q ++ +
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ-----HLSND 128
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDR 135
++ R L Y+HS + H D+K +N+LL KI DF R
Sbjct: 129 HICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 136 THLTTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVELNWTKPI 181
LT YV +++R S +T+ D++S +L E+ +PI
Sbjct: 186 GFLT-------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 35/171 (20%), Positives = 67/171 (39%), Gaps = 32/171 (18%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPL------LVYEFIPNGSLYQYIHEQTDDQLPITW 77
E+ +L + H NV+ +L LV + L + Q +T
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ-----KLTD 131
Query: 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH 137
+ + ++ R L Y+HS I H D+K +N+ + + + KI DF +R
Sbjct: 132 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL--ARHTA-DE 185
Query: 138 LTTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVELNWTKPI 181
+T GYV +++R + + D++S ++ EL + +
Sbjct: 186 MT-------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 50/245 (20%), Positives = 95/245 (38%), Gaps = 49/245 (20%)
Query: 7 LKKSKSVHESNVEQFIN---EVVILSQIN----HRNVVKILGCCLETEVPL-LVYEF-IP 57
+ +++ + S + + EV +L ++ H V+++L ET+ LV E +P
Sbjct: 64 IPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLP 122
Query: 58 NGSLYQYIHEQTDDQLPITWEMRLRITVEVSRV--------LSYLHSVASIPIYHLDIKS 109
L+ YI E+ + SR + + HS + H DIK
Sbjct: 123 AQDLFDYITEKG------------PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKD 167
Query: 110 ANILL-VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT-EKSDVYS 167
NIL+ + + AK+ DF + + T T Y P++ Q+ + V+S
Sbjct: 168 ENILIDLRRGCAKLIDFGS--GALLHDEPYTDFDG-TRVYSPPEWISRHQYHALPATVWS 224
Query: 168 FSVVL-VELNWTKPIHLVD--VEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQP 224
++L + P +E A+ S + +I +RCL +P
Sbjct: 225 LGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCA--LI------RRCLAPKPSSRP 276
Query: 225 TMKEV 229
+++E+
Sbjct: 277 SLEEI 281
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 37/183 (20%), Positives = 73/183 (39%), Gaps = 41/183 (22%)
Query: 24 EVVILSQINHRNVVKIL------GCCLETEVPL--------LVYEFIPNGSLYQYIHEQT 69
E+ I+ +++H N+VK+ G L +V +V E++ L + +
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG- 115
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL-VDKYQAKISDF--- 125
P+ E ++ R L Y+HS + H D+K AN+ + + KI DF
Sbjct: 116 ----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLA 168
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVELNWT 178
R + HL+ + K++R + +T+ D+++ + E+
Sbjct: 169 RIMDPHYSHKGHLS-------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
Query: 179 KPI 181
K +
Sbjct: 222 KTL 224
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 31/130 (23%), Positives = 54/130 (41%), Gaps = 31/130 (23%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+++ ++ E NV++ E++ + H N+V+ + T L ++ E+ G LY+ I
Sbjct: 53 IERGAAIDE-NVQR---EIINHRSLRHPNIVR-FKEVILTPTHLAIIMEYASGGELYERI 107
Query: 66 HEQTDDQLPITWEMRLRITVEVSRV--------LSYLHSVASIPIYHLDIKSANILLVDK 117
R + + +R +SY HS+ I H D+K N LL
Sbjct: 108 CN------------AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGS 152
Query: 118 YQA--KISDF 125
KI DF
Sbjct: 153 PAPRLKICDF 162
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 8e-06
Identities = 30/130 (23%), Positives = 57/130 (43%), Gaps = 14/130 (10%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
I E+ +L +++H N+V ++ LV+EF+ L + + +++ +
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD---ENKTGLQDSQIK 122
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDRTHL 138
++ R +++ H I H D+K N+L+ K++DF R F I
Sbjct: 123 IYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF---GIPVRSY 176
Query: 139 TTQVKVTFGY 148
T +V VT Y
Sbjct: 177 THEV-VTLWY 185
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 27/124 (21%), Positives = 53/124 (42%), Gaps = 14/124 (11%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQIN---HRNVVKILGCCLETEVPL-LVYEFIPNGSLY 62
L K + + +NE ++LS ++ +V + T L + + + G L+
Sbjct: 222 LDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLH 280
Query: 63 QYIHEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
++ Q + E +R E+ L ++H+ + + D+K ANILL + +
Sbjct: 281 YHLS-----QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVR 332
Query: 122 ISDF 125
ISD
Sbjct: 333 ISDL 336
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 8e-06
Identities = 33/172 (19%), Positives = 72/172 (41%), Gaps = 35/172 (20%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPL------LVYEFIPNGSLYQYIHEQ-TDDQLPIT 76
E+++L + H NV+ +L LV F+ L + + + +++++
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY- 130
Query: 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT 136
+ ++ + L Y+HS + H D+K N+ + + + KI DF +R D
Sbjct: 131 ------LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL--ARHAD-A 178
Query: 137 HLTTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVELNWTKPI 181
+T GYV +++R + + D++S ++ E+ K +
Sbjct: 179 EMT-------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 35/191 (18%), Positives = 73/191 (38%), Gaps = 56/191 (29%)
Query: 19 EQFINEVVILSQIN-----------HRNVVKILGC-----------CLETEVPLLVYEFI 56
E +E+ +L ++N +++K+L + E +L
Sbjct: 60 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE--VL----- 112
Query: 57 PNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD 116
+L I + +P+ + ++ +I+ ++ L Y+H I I H DIK N+L+
Sbjct: 113 -GENLLALIKKYEHRGIPLIY-VK-QISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEI 167
Query: 117 ------KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS------SQFTEKSD 164
Q KI+D + H T + + +RS + + +D
Sbjct: 168 VDSPENLIQIKIAD---LGNACWYDEHYTN-------SIQTREYRSPEVLLGAPWGCGAD 217
Query: 165 VYSFSVVLVEL 175
++S + ++ EL
Sbjct: 218 IWSTACLIFEL 228
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 33/204 (16%), Positives = 77/204 (37%), Gaps = 58/204 (28%)
Query: 24 EVVILSQINHRNVVKILGC-------------------------------------CLET 46
E+ I+ ++H N++K++
Sbjct: 50 ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQ 109
Query: 47 EVPL-LVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHL 105
L ++ E++P+ +L++ + I + ++ R + ++HS+ I H
Sbjct: 110 NKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHR 165
Query: 106 DIKSANILL-VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-------SS 157
DIK N+L+ K+ DF + ++ + + + Y+ +++R ++
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGS--AKKLIPSEPSV------AYICSRFYRAPELMLGAT 217
Query: 158 QFTEKSDVYSFSVVLVELNWTKPI 181
++T D++S V EL KP+
Sbjct: 218 EYTPSIDLWSIGCVFGELILGKPL 241
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 9e-06
Identities = 31/138 (22%), Positives = 60/138 (43%), Gaps = 16/138 (11%)
Query: 7 LKKSKSVHESNVEQFIN--EVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY 64
+KK + + + I E+ +L Q+ H N+V +L C + + LV+EF+ + ++
Sbjct: 55 IKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDD 113
Query: 65 IHEQTDDQLPITWEMRL--RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
+ + P + ++ + ++ + + HS I H DIK NIL+ K+
Sbjct: 114 L-----ELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKL 165
Query: 123 SDF---RTFKSRAIDRTH 137
DF RT +
Sbjct: 166 CDFGFARTLAAPGEVYDD 183
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 9e-06
Identities = 32/132 (24%), Positives = 57/132 (43%), Gaps = 18/132 (13%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
I E+ IL ++ H N+VK+ + +LV+E + L + + D E
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL-----DVCEGGLESVT 101
Query: 82 --RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDRT 136
+++ ++Y H + H D+K N+L+ + + KI+DF R F I
Sbjct: 102 AKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAF---GIPVR 155
Query: 137 HLTTQVKVTFGY 148
T ++ VT Y
Sbjct: 156 KYTHEI-VTLWY 166
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 1e-05
Identities = 29/130 (22%), Positives = 57/130 (43%), Gaps = 14/130 (10%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
+ E+ +L ++ H+N+V++ + LV+EF L +Y + E+
Sbjct: 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD---SCNGDLDPEIVK 104
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDRTHL 138
++ + L + HS + H D+K N+L+ + K+++F R F I
Sbjct: 105 SFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF---GIPVRCY 158
Query: 139 TTQVKVTFGY 148
+ +V VT Y
Sbjct: 159 SAEV-VTLWY 167
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 1e-05
Identities = 32/127 (25%), Positives = 61/127 (48%), Gaps = 13/127 (10%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
I E+ +L ++NH N+VK+L LV+EF+ L +++ +P+ ++
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLP-LIKS 107
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDRTHL 138
++ + L++ HS + H D+K N+L+ + K++DF R F +
Sbjct: 108 -YLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTY 160
Query: 139 TTQVKVT 145
T +V VT
Sbjct: 161 THEV-VT 166
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 41/182 (22%), Positives = 71/182 (39%), Gaps = 42/182 (23%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPL-----LVYEFIPNGSLYQYIHEQ--TDD----- 71
E+ IL H N++ I ++ E + L++ I Q +DD
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYF 117
Query: 72 --QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---R 126
Q LR + LH +++ H D+K +N+L+ K+ DF R
Sbjct: 118 IYQT-------LR-------AVKVLHG-SNV--IHRDLKPSNLLINSNCDLKVCDFGLAR 160
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFR-------SSQFTEKSDVYSFSVVLVELNWTK 179
A D + T Q +V +++R S++++ DV+S +L EL +
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
Query: 180 PI 181
PI
Sbjct: 221 PI 222
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 12/133 (9%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
L K K V +E +NE IL +N +VK L + L +V E++ G ++ ++
Sbjct: 74 LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ + E R ++ YLHS+ + + D+K N+L+ + +++D
Sbjct: 133 --RRIGRFS---EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTD 184
Query: 125 FRTFKSRAIDRTH 137
F F R RT
Sbjct: 185 F-GFAKRVKGRTW 196
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 33/135 (24%), Positives = 54/135 (40%), Gaps = 18/135 (13%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPL--------LVYEFIPNGSLYQYIHEQTDDQL 73
+ E+ IL + H NVV ++ C P LV++F + L + +
Sbjct: 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV---LV 119
Query: 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKS 130
T R+ + L Y+H I H D+K+AN+L+ K++DF R F
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
Query: 131 RAIDRTHLTTQVKVT 145
+ + T VT
Sbjct: 177 AKNSQPNRYTNRVVT 191
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 3e-05
Identities = 32/121 (26%), Positives = 48/121 (39%), Gaps = 11/121 (9%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
L+K + + V + E +L H + L +T L V E+ G L+
Sbjct: 38 LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA-LKYAFQTHDRLCFVMEYANGGELFF-- 94
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
H + E R R E+ L YLHS + + DIK N++L KI+D
Sbjct: 95 HLSRERVFT---EERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITD 148
Query: 125 F 125
F
Sbjct: 149 F 149
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 4e-05
Identities = 33/130 (25%), Positives = 56/130 (43%), Gaps = 14/130 (10%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
I EV +L + H N+V + + LV+E++ L QY+ D I
Sbjct: 48 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD---DCGNIINMHNVK 103
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDRTHL 138
++ R L+Y H + H D+K N+L+ ++ + K++DF R +T
Sbjct: 104 LFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKT-Y 157
Query: 139 TTQVKVTFGY 148
+V VT Y
Sbjct: 158 DNEV-VTLWY 166
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 31/121 (25%), Positives = 51/121 (42%), Gaps = 11/121 (9%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
+ K K V + V E+ I+ + H +V L + E + +V + + G L
Sbjct: 48 MNKQKCVERNEVRNVFKELQIMQGLEHPFLVN-LWYSFQDEEDMFMVVDLLLGGDLRY-- 104
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
H Q + E +++ E+ L YL + I H D+K NILL + I+D
Sbjct: 105 HLQQNVHFK---EETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITD 158
Query: 125 F 125
F
Sbjct: 159 F 159
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 4e-05
Identities = 42/147 (28%), Positives = 67/147 (45%), Gaps = 19/147 (12%)
Query: 7 LKKSKSVHESNVEQFIN-----EVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSL 61
+KK K H S + IN E+ +L +++H N++ +L LV++F+ L
Sbjct: 40 IKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DL 98
Query: 62 YQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
I D+ L +T + + L YLH I H D+K N+LL + K
Sbjct: 99 EVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK 152
Query: 122 ISDF---RTFKSRAIDRTHLTTQVKVT 145
++DF ++F S +R T QV VT
Sbjct: 153 LADFGLAKSFGSP--NRA-YTHQV-VT 175
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 37/166 (22%), Positives = 67/166 (40%), Gaps = 17/166 (10%)
Query: 16 SNVEQFINEVVILSQI-NHRNVVKILGCCLETEVP-----LLVYEFIPNGSLYQYIHEQT 69
+ + EV + + ++V+I+ E L+V E + G L+ I ++
Sbjct: 96 QDCPKARREVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG 154
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KISDFR 126
D T I + + YLHS I I H D+K N+L K K++DF
Sbjct: 155 DQAF--TEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG 209
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172
++ + T T YV P+ ++ + D++S V++
Sbjct: 210 F--AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 6e-05
Identities = 27/115 (23%), Positives = 50/115 (43%), Gaps = 16/115 (13%)
Query: 22 INEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81
I EV +L ++ HRN++++ L++E+ N L +Y+ D ++ +
Sbjct: 81 IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM----DKNPDVSMRVIK 135
Query: 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILL-----VDKYQAKISDF---RTF 128
++ +++ HS H D+K N+LL + KI DF R F
Sbjct: 136 SFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 8e-05
Identities = 35/201 (17%), Positives = 62/201 (30%), Gaps = 38/201 (18%)
Query: 19 EQFINEVVILSQINHRNVVKI--LGC-CLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75
+ + N +++L + + L C L T V +F+ + + L
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL-- 298
Query: 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHL--DIKSANILLVDKYQAKISDFR----TFK 129
V S L L ++ + N + I D +K
Sbjct: 299 ----------TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK 348
Query: 130 SRAIDRTHLTTQVKVTFGYVDP----KYFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLV 184
D+ LTT ++ + ++P K F S F + +++L + W I
Sbjct: 349 HVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSVFPP--SAHIPTILLSLI-WFDVIK-S 402
Query: 185 DVEE------NRSLAAYFSKE 199
DV SL KE
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKE 423
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 1e-04
Identities = 46/191 (24%), Positives = 77/191 (40%), Gaps = 27/191 (14%)
Query: 7 LKKSKSVHESNVEQFIN-----EVVILSQIN---HRNVVKILGCCLETEVPL-----LVY 53
LK + + + EV +L ++ H NVV+++ C + LV+
Sbjct: 39 LKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVF 98
Query: 54 EFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANIL 113
E + L Y+ + LP E + + R L +LH+ I H D+K NIL
Sbjct: 99 EHVDQ-DLRTYLDKAPPPGLPA--ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL 152
Query: 114 LVDKYQAKISDF---RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSV 170
+ K++DF R + + LT V VT Y P+ S + D++S
Sbjct: 153 VTSGGTVKLADFGLARIY---SYQMA-LTPVV-VTLWYRAPEVLLQSTYATPVDMWSVGC 207
Query: 171 VLVELNWTKPI 181
+ E+ KP+
Sbjct: 208 IFAEMFRRKPL 218
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 2e-04
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 12/133 (9%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYI 65
LKK V VE +E ++LS + H +++ + + + ++ ++I G L+ +
Sbjct: 39 LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR-MWGTFQDAQQIFMIMDYIEGGELFSLL 97
Query: 66 HEQTDDQLPITWEMRLRI-TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ + P + EV L YLHS I IY D+K NILL KI+D
Sbjct: 98 --RKSQRFP---NPVAKFYAAEVCLALEYLHSK-DI-IYR-DLKPENILLDKNGHIKITD 149
Query: 125 FRTFKSRAIDRTH 137
F F D T+
Sbjct: 150 F-GFAKYVPDVTY 161
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 38/179 (21%), Positives = 67/179 (37%), Gaps = 46/179 (25%)
Query: 19 EQFINEVVILSQINHR------NVVKILGC-------CLETEVPLLVYEFIPNGSLYQYI 65
Q E+ IL + + NV+ +L C+ E LL +LY+ I
Sbjct: 138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE--LLSM------NLYELI 189
Query: 66 HEQTDDQLPITWEMRLR-ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD--KYQAKI 122
+ + +R + + L LH I H D+K NILL + K+
Sbjct: 190 KKNKFQGFSLP---LVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKV 243
Query: 123 SDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS------SQFTEKSDVYSFSVVLVEL 175
D F S + + T Y+ +++R+ +++ D++S +L EL
Sbjct: 244 ID---FGSSCYEHQRVYT-------YIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 19/162 (11%)
Query: 28 LSQINHRNVVKILGCCLETEVPL-----LVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82
L H NVV++ C + LV+E + L Y+ + + +P E
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKD 124
Query: 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDRTHLT 139
+ ++ R L +LHS + H D+K NIL+ Q K++DF R + + LT
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMA-LT 177
Query: 140 TQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPI 181
+ V VT Y P+ S + D++S + E+ KP+
Sbjct: 178 SVV-VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 5e-04
Identities = 27/123 (21%), Positives = 53/123 (43%), Gaps = 17/123 (13%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCL--ETEVPLLVYEFIPNGSLYQ 63
+K K V + ++ E+ IL + N++ + + P LV+E + N Q
Sbjct: 66 VKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122
Query: 64 YIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL-VDKYQAKI 122
TD +R + E+ + L Y HS+ I H D+K N+++ + + ++
Sbjct: 123 LYQTLTDYD------IRFYMY-EILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRL 172
Query: 123 SDF 125
D+
Sbjct: 173 IDW 175
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 6e-04
Identities = 34/128 (26%), Positives = 52/128 (40%), Gaps = 34/128 (26%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQI--------NHRNVVKILGC-----------CLETE 47
+K KS E E ++E+ +L + N VV++L C+
Sbjct: 67 MKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM--- 122
Query: 48 VPLLVYEFIPNG-SLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLD 106
V+E G L ++I + LP+ +I +V + L YLH+ I H D
Sbjct: 123 ----VFE--VLGHHLLKWIIKSNYQGLPL--PCVKKIIQQVLQGLDYLHTKCRII--HTD 172
Query: 107 IKSANILL 114
IK NILL
Sbjct: 173 IKPENILL 180
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 7e-04
Identities = 28/119 (23%), Positives = 48/119 (40%), Gaps = 15/119 (12%)
Query: 16 SNVEQFINEVVILSQI-NHRNVVKILGCCLETEVP-----LLVYEFIPNGSLYQYIHEQT 69
+ + EV + + ++V+I+ E L+V E + G L+ I ++
Sbjct: 52 QDCPKARREVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG 110
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA---KISDF 125
D T I + + YLHS+ I H D+K N+L K K++DF
Sbjct: 111 DQAF--TEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 164
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 36/178 (20%), Positives = 68/178 (38%), Gaps = 42/178 (23%)
Query: 19 EQFINEVVILSQINHR------NVVKILGC-------CLETEVPLLVYEFIPNGSLYQYI 65
Q EV +L +N +V + CL E +L + +LY +
Sbjct: 95 NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--ML------SYNLYDLL 146
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD--KYQAKIS 123
T+ + ++ + + ++ L +L + + I H D+K NILL + + KI
Sbjct: 147 -RNTNFR-GVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIV 203
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS------SQFTEKSDVYSFSVVLVEL 175
D F S + Y+ +++RS + D++S +LVE+
Sbjct: 204 D---FGSSCQLGQRIYQ-------YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEM 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 32/149 (21%), Positives = 55/149 (36%), Gaps = 19/149 (12%)
Query: 24 EVVILSQINHRNVVKILGCCLETEVPL-----LVYEFIPNGSLYQYIHEQTDDQLPITWE 78
E+ IL+++NH +VVK+L + +V +V E + + +T
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPV----YLTEL 156
Query: 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF---RTFKSRAIDR 135
+ + + Y+HS A I H D+K AN L+ K+ DF RT
Sbjct: 157 HIKTLLYNLLVGVKYVHS-AGI--LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 136 THLTTQVKVTFGYVDPKYFRSS---QFTE 161
+ L + + + Q T
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 290 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.48 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.1 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.07 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.98 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.54 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.4 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.32 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.28 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.21 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.15 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.93 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.49 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.25 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.13 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.04 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.83 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 88.45 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.36 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.06 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=387.10 Aligned_cols=234 Identities=19% Similarity=0.305 Sum_probs=197.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcC---------CCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT---------DDQ 72 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~ 72 (290)
|+.||||+++.......++|.+|+++|++|+|||||+++|+|.+.+.++||||||++|+|.++|.... ...
T Consensus 43 ~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~ 122 (299)
T 4asz_A 43 KILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPP 122 (299)
T ss_dssp CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CC
T ss_pred CEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCC
Confidence 46799999988777788899999999999999999999999999999999999999999999997642 223
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCc
Q 044846 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDP 151 (290)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aP 151 (290)
..+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+........ ......||+.||||
T Consensus 123 ~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP 199 (299)
T 4asz_A 123 TELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 199 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCH
Confidence 36999999999999999999999999 999999999999999999999999998754433222 23346789999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
|++.+..|+.++|||||||++|||++ |.+||...... ........ ...+..++.++.+||.+||+.||++|||++
T Consensus 200 E~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ 278 (299)
T 4asz_A 200 ESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIK 278 (299)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999999999999999999998 78877543322 22222111 223445677899999999999999999999
Q ss_pred HHHHHHHhhHhh
Q 044846 228 EVTLELAGIRAS 239 (290)
Q Consensus 228 el~~~l~~~~~~ 239 (290)
||...|+.+...
T Consensus 279 ~i~~~L~~~~~~ 290 (299)
T 4asz_A 279 GIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHhc
Confidence 999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-56 Score=388.08 Aligned_cols=234 Identities=21% Similarity=0.346 Sum_probs=190.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC----------
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD---------- 71 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------- 71 (290)
|+.||||+++..+....++|.+|+++|++|+|||||+++|+|.+.+.+|||||||++|+|.++++.....
T Consensus 71 ~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~ 150 (329)
T 4aoj_A 71 KMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150 (329)
T ss_dssp CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC----------
T ss_pred CeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccc
Confidence 4679999999877888889999999999999999999999999999999999999999999999764321
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceeccccc
Q 044846 72 -QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFGYV 149 (290)
Q Consensus 72 -~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~ 149 (290)
..++++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++...... ........||+.||
T Consensus 151 ~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ym 227 (329)
T 4aoj_A 151 APGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 227 (329)
T ss_dssp -CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGC
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCccccccccc
Confidence 236899999999999999999999999 9999999999999999999999999987543322 22234567899999
Q ss_pred CccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 150 DPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 150 aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
|||++.+..|+.++|||||||++|||++ |..||...... ..+.... ....+..++.++.+||.+||+.||++|||
T Consensus 228 APE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs 306 (329)
T 4aoj_A 228 PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHS 306 (329)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-HHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCC
T ss_pred ChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcC
Confidence 9999999999999999999999999998 78877543322 1121111 12234456788999999999999999999
Q ss_pred HHHHHHHHHhhHhh
Q 044846 226 MKEVTLELAGIRAS 239 (290)
Q Consensus 226 ~~el~~~l~~~~~~ 239 (290)
+.||+++|+.+.+.
T Consensus 307 ~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 307 IKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHhhC
Confidence 99999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-56 Score=388.49 Aligned_cols=226 Identities=20% Similarity=0.263 Sum_probs=190.8
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||||+++. ......+.+.+|+++|+.|+|||||+++++|.+.+.+|||||||+||+|.+++...... .+++..
T Consensus 49 ~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~--~~~e~~ 126 (350)
T 4b9d_A 49 GRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV--LFQEDQ 126 (350)
T ss_dssp CCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTC--CCCHHH
T ss_pred CCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCC--CCCHHH
Confidence 78899999864 34556788999999999999999999999999999999999999999999999765432 578999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
++.++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+..... .....+..||+.|||||++.+..|
T Consensus 127 ~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GT~~YmAPE~l~~~~y 202 (350)
T 4b9d_A 127 ILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELARACIGTPYYLSPEICENKPY 202 (350)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-HHHHHHHHSCCTTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-cccccccCCCccccCHHHHCCCCC
Confidence 9999999999999999999 999999999999999999999999998754321 122345679999999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.++|||||||++|||++|.+||........ +...... ..+...+.++.+||.+||+.||++|||++|+++|-+
T Consensus 203 ~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 203 NNKSDIWALGCVLYELCTLKHAFEAGSMKNL-VLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 9999999999999999999999975433221 2222111 223345678999999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=386.10 Aligned_cols=225 Identities=21% Similarity=0.250 Sum_probs=192.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||||+++..+....+.+.+|+++|+.|+|||||+++++|.+.+.+|||||||+||+|.+++... .+++..+.
T Consensus 99 g~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-----~l~e~~~~ 173 (346)
T 4fih_A 99 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIA 173 (346)
T ss_dssp CCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS-----CCCHHHHH
T ss_pred CCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHH
Confidence 7899999997666666778899999999999999999999999999999999999999999999763 48999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+..... .....+..||+.|||||++.+..|+.
T Consensus 174 ~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GTp~YmAPEvl~~~~y~~ 249 (346)
T 4fih_A 174 AVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPELISRLPYGP 249 (346)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC-CCcccccccCcCcCCHHHHCCCCCCc
Confidence 99999999999999999 999999999999999999999999998754322 22345678999999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
++|||||||++|||++|.+||........ +..... .......+.++.+||.+||+.||++|||++|+++|-+-.
T Consensus 250 ~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~ 328 (346)
T 4fih_A 250 EVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 328 (346)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence 99999999999999999999875432221 111111 112234567899999999999999999999999886543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-55 Score=376.56 Aligned_cols=231 Identities=22% Similarity=0.280 Sum_probs=185.1
Q ss_pred ceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 3 ELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 3 ~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
..||||+++.. ..+..+.|.+|+++|++|+|||||++++++.. +.++||||||+||+|.+++..... ++++..+
T Consensus 59 ~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~---~l~~~~~ 134 (307)
T 3omv_A 59 GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQET---KFQMFQL 134 (307)
T ss_dssp SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCC---CCCHHHH
T ss_pred CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCC---CCCHHHH
Confidence 45899998743 34567889999999999999999999998864 568999999999999999976543 5999999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC-CceeeccceecccccCcccccc---
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID-RTHLTTQVKVTFGYVDPKYFRS--- 156 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~--- 156 (290)
..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+..... .........||+.|||||++.+
T Consensus 135 ~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~ 211 (307)
T 3omv_A 135 IDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211 (307)
T ss_dssp HHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSS
T ss_pred HHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCC
Confidence 999999999999999999 999999999999999999999999998754322 2223345689999999999864
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
..|+.++|||||||++|||++|.+||............... ...+..++..+.+||.+||+.||++|||+.||
T Consensus 212 ~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 291 (307)
T 3omv_A 212 NPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQI 291 (307)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHH
T ss_pred CCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 35899999999999999999999998643322211111111 11223456789999999999999999999999
Q ss_pred HHHHHhhHhhh
Q 044846 230 TLELAGIRASI 240 (290)
Q Consensus 230 ~~~l~~~~~~~ 240 (290)
+.+|+.++..+
T Consensus 292 ~~~Le~l~~~l 302 (307)
T 3omv_A 292 LSSIELLQHSL 302 (307)
T ss_dssp HHHHHHHHTTC
T ss_pred HHHHHHHhccC
Confidence 99999887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-55 Score=379.27 Aligned_cols=231 Identities=18% Similarity=0.272 Sum_probs=190.2
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC---------
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD--------- 71 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------- 71 (290)
++.||||+++.. .....++|.+|+.+|++|+|||||+++|+|...+.++||||||++|+|.++|......
T Consensus 56 ~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~ 135 (308)
T 4gt4_A 56 TQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 135 (308)
T ss_dssp CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----
T ss_pred CeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccc
Confidence 467999999743 3445678999999999999999999999999999999999999999999999754211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceeccc
Q 044846 72 ---QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFG 147 (290)
Q Consensus 72 ---~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~ 147 (290)
...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++...... ........||+.
T Consensus 136 ~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ 212 (308)
T 4gt4_A 136 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 212 (308)
T ss_dssp CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGG
T ss_pred cccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCc
Confidence 135899999999999999999999999 9999999999999999999999999987654322 223345678999
Q ss_pred ccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 148 YVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 148 y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
|||||++.+..|+.++|||||||++|||++ |.+||...... ........ .+.+..++..+.+||.+||+.||++|
T Consensus 213 ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~R 291 (308)
T 4gt4_A 213 WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 291 (308)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred ccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHC
Confidence 999999999999999999999999999997 77777543222 21221111 22344567789999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 044846 224 PTMKEVTLELAGI 236 (290)
Q Consensus 224 ps~~el~~~l~~~ 236 (290)
|||.||+++|+..
T Consensus 292 Ps~~ei~~~L~a~ 304 (308)
T 4gt4_A 292 PRFKDIHSRLRAW 304 (308)
T ss_dssp CCHHHHHHHHHTS
T ss_pred cCHHHHHHHHHhc
Confidence 9999999999754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-54 Score=370.23 Aligned_cols=224 Identities=18% Similarity=0.281 Sum_probs=184.0
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|++.. ......+.|.+|+++|++|+|||||+++++|.. .+.+|||||||+||+|.+++.+.. .+
T Consensus 51 ~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~----~l 126 (290)
T 3fpq_A 51 TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VM 126 (290)
T ss_dssp CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS----SC
T ss_pred CeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC----CC
Confidence 67899999853 345567789999999999999999999999975 346899999999999999998765 68
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
++..+..++.||+.||.|||+++. +||||||||+|||++. ++.+||+|||+|+.... ....+..||+.|||||++
T Consensus 127 ~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~---~~~~~~~GTp~YmAPE~~ 202 (290)
T 3fpq_A 127 KIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMY 202 (290)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---TSBEESCSSCCCCCGGGG
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCC---CccCCcccCccccCHHHc
Confidence 999999999999999999999864 3999999999999984 79999999999875332 233457899999999998
Q ss_pred ccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.+ .|+.++|||||||++|||++|.+||................ ..+...++++.+||.+||+.||++|||++|++
T Consensus 203 ~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 203 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp GT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 65 69999999999999999999999986433322222222111 12223456799999999999999999999999
Q ss_pred HHHH
Q 044846 231 LELA 234 (290)
Q Consensus 231 ~~l~ 234 (290)
+|.+
T Consensus 282 ~Hp~ 285 (290)
T 3fpq_A 282 NHAF 285 (290)
T ss_dssp TSGG
T ss_pred cCcc
Confidence 8754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=377.97 Aligned_cols=226 Identities=17% Similarity=0.120 Sum_probs=187.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||||+++.... ..+|+.+|+.|+|||||+++++|.+.+.+|||||||+||+|.++++... .+++..+.
T Consensus 83 g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~ 153 (336)
T 4g3f_A 83 GFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG----CLPEDRAL 153 (336)
T ss_dssp CCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS----SCCHHHHH
T ss_pred CCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC----CCCHHHHH
Confidence 78899999975322 2479999999999999999999999999999999999999999998765 69999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-cEEEeccccccccccCCce----eeccceecccccCcccccc
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDFRTFKSRAIDRTH----LTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~ 156 (290)
.++.||+.||.|||+++ ||||||||+|||++.+| ++||+|||+|+........ ......||+.|||||++.+
T Consensus 154 ~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~ 230 (336)
T 4g3f_A 154 YYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230 (336)
T ss_dssp HHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC
Confidence 99999999999999999 99999999999999988 6999999998764432111 1234679999999999999
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
..|+.++|||||||++|||++|.+||........ ...... ...+...+..+.+||.+||+.||.+|||+.|+++
T Consensus 231 ~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 9999999999999999999999999864332211 111111 1123346678999999999999999999999999
Q ss_pred HHHhhHhhh
Q 044846 232 ELAGIRASI 240 (290)
Q Consensus 232 ~l~~~~~~~ 240 (290)
+|.......
T Consensus 310 ~l~~~l~~~ 318 (336)
T 4g3f_A 310 KVGKALQEV 318 (336)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHhhh
Confidence 998876654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=387.70 Aligned_cols=225 Identities=21% Similarity=0.250 Sum_probs=192.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||||++...+....+.+.+|+.+|+.|+|||||+++++|.+.+.+|||||||+||+|.++++.. .+++..+.
T Consensus 176 g~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~-----~l~e~~~~ 250 (423)
T 4fie_A 176 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIA 250 (423)
T ss_dssp CCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS-----CCCHHHHH
T ss_pred CCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc-----CCCHHHHH
Confidence 7889999998766666778999999999999999999999999999999999999999999999754 48999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+..... .....+..||+.|||||++.+..|+.
T Consensus 251 ~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GTp~YmAPEvl~~~~y~~ 326 (423)
T 4fie_A 251 AVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPELISRLPYGP 326 (423)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CCCBCCCEECTTTCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC-CccccccccCcCcCCHHHHCCCCCCc
Confidence 99999999999999999 999999999999999999999999998754322 22345678999999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
++|||||||++|||++|.+||........ +..... .......+.++.+||.+||+.||++|||+.|+++|-+-.
T Consensus 327 ~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~ 405 (423)
T 4fie_A 327 EVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 405 (423)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence 99999999999999999999865432221 111111 112234567899999999999999999999999886543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=374.63 Aligned_cols=223 Identities=21% Similarity=0.261 Sum_probs=189.6
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.. .+....+.+.+|+++|+.|+|||||+++++|.+.+.+|||||||+||+|.+++.+.. .+++.
T Consensus 57 ~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~----~l~e~ 132 (311)
T 4aw0_A 57 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDET 132 (311)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS----SCCHH
T ss_pred CCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC----CCCHH
Confidence 78899999963 234557789999999999999999999999999999999999999999999998765 69999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC-CceeeccceecccccCccccccC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID-RTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..... ......+..||+.|||||++.+.
T Consensus 133 ~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~ 209 (311)
T 4aw0_A 133 CTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS
T ss_pred HHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCC
Confidence 99999999999999999999 999999999999999999999999999865432 23344567899999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.|+.++||||+||++|+|++|.+||....... ........ ..+...+.++.+||.+||+.||++|||++|++.+
T Consensus 210 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 99999999999999999999999997543321 11111111 2233456789999999999999999999997544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=373.90 Aligned_cols=233 Identities=23% Similarity=0.285 Sum_probs=190.8
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCC-CceeeEEeEEEeC-CcceEEEEeCCCCCHHHHHhhcCC---------
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINH-RNVVKILGCCLET-EVPLLVYEFIPNGSLYQYIHEQTD--------- 70 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~--------- 70 (290)
+.||||+++... ....+.|.+|+++|.+++| ||||+++|+|... +.++||||||++|+|.++|+....
T Consensus 95 k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~ 174 (353)
T 4ase_A 95 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 174 (353)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC----
T ss_pred eEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccc
Confidence 579999997543 4456789999999999965 9999999999764 578999999999999999976432
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecc
Q 044846 71 ---DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTF 146 (290)
Q Consensus 71 ---~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~ 146 (290)
....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+....... .......||+
T Consensus 175 ~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~ 251 (353)
T 4ase_A 175 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251 (353)
T ss_dssp ---CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred hhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccc
Confidence 1235899999999999999999999999 99999999999999999999999999986543322 2345577899
Q ss_pred cccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhh---hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCC
Q 044846 147 GYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENR---SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 147 ~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
.|||||++.+..|+.++|||||||++|||++ |.+||........ .+........+..++.++.+||.+||+.||++
T Consensus 252 ~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~ 331 (353)
T 4ase_A 252 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 331 (353)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhH
Confidence 9999999999999999999999999999997 7887754322111 11111122334456778999999999999999
Q ss_pred CCCHHHHHHHHHhhHh
Q 044846 223 QPTMKEVTLELAGIRA 238 (290)
Q Consensus 223 Rps~~el~~~l~~~~~ 238 (290)
|||+.||+++|+.+.+
T Consensus 332 RPt~~eil~~L~~llq 347 (353)
T 4ase_A 332 RPTFSELVEHLGNLLQ 347 (353)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999999988765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-53 Score=358.65 Aligned_cols=223 Identities=17% Similarity=0.186 Sum_probs=177.4
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. +....+.+.+|+++|+.++|||||++++++.+.+.+||||||| +|+|.+++.... .+++.
T Consensus 38 ~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~----~l~e~ 112 (275)
T 3hyh_A 38 GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD----KMSEQ 112 (275)
T ss_dssp CCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC----SCCHH
T ss_pred CCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC----CCCHH
Confidence 788999998632 3344678999999999999999999999999999999999999 789999998754 69999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+.... .....+..||+.|||||++.+..
T Consensus 113 ~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~~GT~~Y~APE~~~~~~ 187 (275)
T 3hyh_A 113 EARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPEVISGKL 187 (275)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----------------CTTSCHHHHSSSS
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC--CCccCCeeECcccCChhhhcCCC
Confidence 99999999999999999999 99999999999999999999999999875332 22334578999999999999887
Q ss_pred C-CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 159 F-TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 159 ~-~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
| +.++||||+||++|+|++|.+||...... ........ ...+...+.++.+||.+||+.||++|||++|+++|-+-
T Consensus 188 y~~~~~DiwSlGvily~lltg~~PF~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 188 YAGPEVDVWSCGVILYVMLCRRLPFDDESIP-VLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred CCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 6 57999999999999999999998654322 11111111 11223456789999999999999999999999988653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=368.02 Aligned_cols=224 Identities=19% Similarity=0.189 Sum_probs=180.0
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++.. ......++.+|+++|++|+|||||+++++|.+.+.+|||||||+||+|.+++.+.. .+++..
T Consensus 52 ~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~----~l~e~~ 127 (304)
T 3ubd_A 52 RQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEED 127 (304)
T ss_dssp TCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC----CCCHHH
T ss_pred CEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC----CCCHHH
Confidence 578999998642 23334568899999999999999999999999999999999999999999998765 699999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+..... .....+..||+.|||||++.+..|
T Consensus 128 ~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~y 203 (304)
T 3ubd_A 128 VKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAYSFCGTVEYMAPEVVNRRGH 203 (304)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC------CCCCSCCCCGGGCCHHHHHTSCC
T ss_pred HHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC-CccccccccCcccCCHHHhccCCC
Confidence 9999999999999999999 999999999999999999999999998753322 223345789999999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTM-----KEVTLE 232 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~el~~~ 232 (290)
+.++||||+||++|||++|.+||....... ....... ...+...+.++.+||.+||+.||++|||+ +|+++|
T Consensus 204 ~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 999999999999999999999997543322 1221111 12233456789999999999999999985 677766
Q ss_pred HH
Q 044846 233 LA 234 (290)
Q Consensus 233 l~ 234 (290)
-+
T Consensus 283 p~ 284 (304)
T 3ubd_A 283 SF 284 (304)
T ss_dssp GG
T ss_pred cc
Confidence 43
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=359.31 Aligned_cols=225 Identities=18% Similarity=0.273 Sum_probs=173.0
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------------cceEEEEeCCCCCHHHHHhhc
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETE------------VPLLVYEFIPNGSLYQYIHEQ 68 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------------~~~lv~e~~~~g~L~~~l~~~ 68 (290)
|+.||||+++... ....+.+.+|+++|++|+|||||+++++|...+ .+|||||||++|+|.+++...
T Consensus 30 ~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~ 109 (299)
T 4g31_A 30 DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR 109 (299)
T ss_dssp CCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTC
T ss_pred CCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhc
Confidence 7889999997543 445678999999999999999999999997654 369999999999999999865
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-----------e
Q 044846 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-----------H 137 (290)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----------~ 137 (290)
... ...++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....... .
T Consensus 110 ~~~-~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~ 185 (299)
T 4g31_A 110 CTI-EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185 (299)
T ss_dssp CSG-GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------
T ss_pred CCC-ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCcccccccccccccc
Confidence 421 13456778899999999999999999 99999999999999999999999999876433211 1
Q ss_pred eeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHH
Q 044846 138 LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKR 214 (290)
Q Consensus 138 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~ 214 (290)
..++..||+.|||||++.+..|+.++|||||||++|||++ ||....+....+..... .+.....++...+||.+
T Consensus 186 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~ 262 (299)
T 4g31_A 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD 262 (299)
T ss_dssp ------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHH
T ss_pred ccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 1234679999999999999999999999999999999996 34333222222222211 12223445667899999
Q ss_pred hhccCCCCCCCHHHHHHHH
Q 044846 215 CLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 215 cl~~dp~~Rps~~el~~~l 233 (290)
||+.||++|||+.|++++-
T Consensus 263 ~L~~dP~~Rps~~eil~h~ 281 (299)
T 4g31_A 263 MLSPSPMERPEAINIIENA 281 (299)
T ss_dssp HTCSSGGGSCCHHHHHTSG
T ss_pred HcCCChhHCcCHHHHhcCH
Confidence 9999999999999998763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=360.23 Aligned_cols=230 Identities=19% Similarity=0.254 Sum_probs=175.3
Q ss_pred CceEEEEeecccCchhHHHHHH--HHHHHHhcCCCceeeEEeEEEeCC----cceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFIN--EVVILSQINHRNVVKILGCCLETE----VPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~--E~~~l~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||+++... .+.+.. |+..+..++|||||+++++|...+ .+|||||||++|+|.++++.. .+
T Consensus 26 g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~-----~l 97 (303)
T 3hmm_A 26 GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TV 97 (303)
T ss_dssp TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-----CB
T ss_pred CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC-----CC
Confidence 6789999997532 233344 555566789999999999998754 579999999999999999864 48
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCC-----CCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee---eccceeccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVA-----SIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL---TTQVKVTFG 147 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~-----~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~g~~~ 147 (290)
+++.+..++.|++.||+|||++. .++||||||||+|||++.++++||+|||+++......... .....||+.
T Consensus 98 ~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ 177 (303)
T 3hmm_A 98 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177 (303)
T ss_dssp CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGG
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccccccccc
Confidence 99999999999999999999871 2239999999999999999999999999987654333222 234679999
Q ss_pred ccCccccccC------CCCCcccchhhHHHHHHHhcCCCCcccchhh-------------hhhhHHHh-----h-----h
Q 044846 148 YVDPKYFRSS------QFTEKSDVYSFSVVLVELNWTKPIHLVDVEE-------------NRSLAAYF-----S-----K 198 (290)
Q Consensus 148 y~aPE~~~~~------~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~-------------~~~~~~~~-----~-----~ 198 (290)
|||||++.+. .++.++|||||||++|||++|.+++...... ........ . .
T Consensus 178 ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~ 257 (303)
T 3hmm_A 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 257 (303)
T ss_dssp GCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred ccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCcc
Confidence 9999999764 3677999999999999999998765322110 01111110 0 0
Q ss_pred hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 044846 199 EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239 (290)
Q Consensus 199 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~ 239 (290)
.........+.+|+.+||+.||++||||.||++.|+.+...
T Consensus 258 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 258 WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11224556789999999999999999999999999988653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=355.26 Aligned_cols=226 Identities=19% Similarity=0.235 Sum_probs=181.4
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLET------EVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||||+++.. .....+.+.+|+++|+.|+|||||++++++... +.+||||||| +|+|.+++....
T Consensus 79 ~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~-~g~L~~~i~~~~---- 153 (398)
T 4b99_A 79 GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ---- 153 (398)
T ss_dssp CCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECC-SEEHHHHHTSSS----
T ss_pred CCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCC-CCCHHHHHHhcC----
Confidence 789999999643 344567899999999999999999999998643 5679999999 478999998654
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC---CceeeccceecccccC
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID---RTHLTTQVKVTFGYVD 150 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~g~~~y~a 150 (290)
++++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++..... ......+..||+.|+|
T Consensus 154 ~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~A 230 (398)
T 4b99_A 154 PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230 (398)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcC
Confidence 6999999999999999999999999 999999999999999999999999998754322 1223456789999999
Q ss_pred ccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhhh-----------------------------
Q 044846 151 PKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFSK----------------------------- 198 (290)
Q Consensus 151 PE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~~----------------------------- 198 (290)
||++.+. .|+.++||||+||++|||++|.+||......... +......
T Consensus 231 PEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
T 4b99_A 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPW 310 (398)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCH
T ss_pred HHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCH
Confidence 9998875 4689999999999999999999998654322111 1000000
Q ss_pred -hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 199 -EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 199 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
......+.++.+||.+||+.||++|||+.|+++|-+-
T Consensus 311 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 311 ETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348 (398)
T ss_dssp HHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred HHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence 0001124678999999999999999999999988654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=344.58 Aligned_cols=221 Identities=18% Similarity=0.213 Sum_probs=176.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.||+|++... ....++.+|+++|+.+ +|||||+++++|.+.+++|||||||++|+|.+++. .+++..+
T Consensus 49 ~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~ 119 (361)
T 4f9c_A 49 EEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEV 119 (361)
T ss_dssp EEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHH
T ss_pred CCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHH
Confidence 467999998653 3345688999999998 79999999999999999999999999999999984 4889999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC-CcEEEeccccccccccCC------------------------
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-YQAKISDFRTFKSRAIDR------------------------ 135 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~------------------------ 135 (290)
+.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+......
T Consensus 120 ~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (361)
T 4f9c_A 120 REYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSIC 196 (361)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-----------------
T ss_pred HHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccccccccc
Confidence 999999999999999999 9999999999999876 799999999987432211
Q ss_pred ---ceeeccceecccccCccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-------------
Q 044846 136 ---THLTTQVKVTFGYVDPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK------------- 198 (290)
Q Consensus 136 ---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~------------- 198 (290)
.....+..||+.|+|||++.+. .|+.++||||+||++|+|++|.+||....+....+......
T Consensus 197 ~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~ 276 (361)
T 4f9c_A 197 LSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTF 276 (361)
T ss_dssp ---------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhc
Confidence 1112345799999999999875 58999999999999999999998886543322211111000
Q ss_pred -------------------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 199 -------------------------------------------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 199 -------------------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
......+.++.+||.+||+.||++|||++|+++|.+
T Consensus 277 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 277 GKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp TEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred cccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 000112456889999999999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=360.85 Aligned_cols=224 Identities=17% Similarity=0.188 Sum_probs=190.9
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+++.....+.+.+.+|+++|+.|+|||||+++++|.+.+.+|||||||.||+|.+++..... .+++..+.
T Consensus 182 g~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~---~l~e~~~~ 258 (573)
T 3uto_A 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAV 258 (573)
T ss_dssp CCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTS---CEEHHHHH
T ss_pred CCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCC---CCCHHHHH
Confidence 788999999877777788899999999999999999999999999999999999999999999975432 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC--CcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK--YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++..... .......||+.|||||++.+..|
T Consensus 259 ~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~~~~~~~GT~~y~APEv~~~~~y 333 (573)
T 3uto_A 259 EYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPV 333 (573)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--SEEEEECSSGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC--CceeeeEECccccCHHHhCCCCC
Confidence 99999999999999999 9999999999999854 89999999998764322 23345679999999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.++||||+||++|+|++|.+||........ +..... .......+.++.+||.+||+.||.+|||+.|+++|-
T Consensus 334 ~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 9999999999999999999999875443221 111111 122234567899999999999999999999999885
Q ss_pred H
Q 044846 234 A 234 (290)
Q Consensus 234 ~ 234 (290)
+
T Consensus 413 w 413 (573)
T 3uto_A 413 W 413 (573)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=357.96 Aligned_cols=223 Identities=14% Similarity=0.122 Sum_probs=181.3
Q ss_pred CceEEEEeeccc---CchhHHHHHHH---HHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSV---HESNVEQFINE---VVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E---~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||+++.. .......+.+| +.+++.++|||||+++++|.+.+.+|||||||+||+|.+++.... .+
T Consensus 214 g~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~----~l 289 (689)
T 3v5w_A 214 GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VF 289 (689)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC----CC
T ss_pred CCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC----CC
Confidence 788999998531 12223334444 566677899999999999999999999999999999999998765 69
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
++..++.++.||+.||.|||+++ ||||||||+|||++.+|++||+|||+|+..... ...+..||+.|||||++.
T Consensus 290 ~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~---~~~t~~GTp~YmAPEvl~ 363 (689)
T 3v5w_A 290 SEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQ 363 (689)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---CCCSCCSCGGGCCHHHHS
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC---CCCCccCCcCccCHHHHh
Confidence 99999999999999999999999 999999999999999999999999998754322 234578999999999996
Q ss_pred c-CCCCCcccchhhHHHHHHHhcCCCCcccchhhh--hhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCCC-----
Q 044846 156 S-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEEN--RSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQPT----- 225 (290)
Q Consensus 156 ~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps----- 225 (290)
. ..|+.++|+||+||++|||++|.+||....... ....... ....+...+.++.+||.+||+.||.+|++
T Consensus 364 ~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~g 443 (689)
T 3v5w_A 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443 (689)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSST
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCC
Confidence 4 579999999999999999999999996543211 1111111 11233446778999999999999999998
Q ss_pred HHHHHHHHH
Q 044846 226 MKEVTLELA 234 (290)
Q Consensus 226 ~~el~~~l~ 234 (290)
++||++|.+
T Consensus 444 a~ei~~Hpf 452 (689)
T 3v5w_A 444 AQEVKESPF 452 (689)
T ss_dssp HHHHTTSGG
T ss_pred HHHHhcCcc
Confidence 789988754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=320.24 Aligned_cols=235 Identities=21% Similarity=0.373 Sum_probs=194.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++...+....+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... .+++..+.
T Consensus 35 ~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~ 111 (310)
T 3s95_A 35 GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRV 111 (310)
T ss_dssp CCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCT---TSCHHHHH
T ss_pred CcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccC---CCCHHHHH
Confidence 678999999877788888999999999999999999999999999999999999999999999987433 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee-------------eccceecccc
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL-------------TTQVKVTFGY 148 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-------------~~~~~g~~~y 148 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......... .....||+.|
T Consensus 112 ~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 188 (310)
T 3s95_A 112 SFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188 (310)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGG
T ss_pred HHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcce
Confidence 99999999999999999 9999999999999999999999999987543221111 1145689999
Q ss_pred cCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh----hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 149 VDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR----SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 149 ~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
+|||++.+..++.++||||||+++|+|++|..++........ ..........+...+..+.+++.+||+.||++||
T Consensus 189 ~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 268 (310)
T 3s95_A 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRP 268 (310)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSC
T ss_pred eCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999999999999999887754322111 1111111222334456799999999999999999
Q ss_pred CHHHHHHHHHhhHhhhCc
Q 044846 225 TMKEVTLELAGIRASIGA 242 (290)
Q Consensus 225 s~~el~~~l~~~~~~~~~ 242 (290)
|+.++++.|+.+......
T Consensus 269 s~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 269 SFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp CHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhccC
Confidence 999999999999876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=315.56 Aligned_cols=224 Identities=21% Similarity=0.268 Sum_probs=188.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+.+|+|.+++... .+++..+.
T Consensus 45 ~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~ 119 (297)
T 3fxz_A 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIA 119 (297)
T ss_dssp CCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-----CCCHHHHH
T ss_pred CcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-----CCCHHHHH
Confidence 6789999997666666788999999999999999999999999999999999999999999999864 38899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.
T Consensus 120 ~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 195 (297)
T 3fxz_A 120 AVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGP 195 (297)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHHCSCBCT
T ss_pred HHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cccCCccCCcCccChhhhcCCCCCc
Confidence 99999999999999999 9999999999999999999999999976543322 2234467899999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++|||||||++|+|++|..||............... ...+...+..+.+||.+||+.||++|||+.|++++.+
T Consensus 196 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 999999999999999999988654332221111111 1123345667899999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=315.85 Aligned_cols=234 Identities=34% Similarity=0.550 Sum_probs=195.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++........+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++.........+++..++
T Consensus 63 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 142 (321)
T 2qkw_B 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142 (321)
T ss_dssp CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHH
T ss_pred CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHH
Confidence 67899999987777778899999999999999999999999999999999999999999999997665444468999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC-CceeeccceecccccCccccccCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID-RTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..... .........||+.|+|||++.+..++
T Consensus 143 ~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 219 (321)
T 2qkw_B 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT 219 (321)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCC
T ss_pred HHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCC
Confidence 99999999999999999 999999999999999999999999998653321 22223445689999999999988999
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhh-hhHH-----------------HhhhhhhHHHHHHHHHHHHHhhccCCCC
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENR-SLAA-----------------YFSKEAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~-~~~~-----------------~~~~~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
.++||||||+++|+|++|..|+........ .... ..........+..+.+++.+||+.||++
T Consensus 220 ~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 299 (321)
T 2qkw_B 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299 (321)
T ss_dssp THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGG
T ss_pred cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCccc
Confidence 999999999999999999988754321110 0000 0011223567788999999999999999
Q ss_pred CCCHHHHHHHHHhhHh
Q 044846 223 QPTMKEVTLELAGIRA 238 (290)
Q Consensus 223 Rps~~el~~~l~~~~~ 238 (290)
|||+.|++++|+.+..
T Consensus 300 Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 300 RPSMGDVLWKLEYALR 315 (321)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHhh
Confidence 9999999999998865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=317.05 Aligned_cols=235 Identities=32% Similarity=0.488 Sum_probs=191.5
Q ss_pred CceEEEEeecccCc-hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHE-SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|+++.... .....+.+|+++++.++||||+++++++...+..++||||+.+|+|.+++.........+++..+
T Consensus 54 ~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 133 (326)
T 3uim_A 54 GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133 (326)
T ss_dssp SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHH
T ss_pred CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHH
Confidence 67899999875332 22336889999999999999999999999999999999999999999999887655556999999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.|++.||.|||++...+|+||||||+|||++.++.+||+|||++...............||+.|+|||++.+..++
T Consensus 134 ~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 213 (326)
T 3uim_A 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 213 (326)
T ss_dssp HHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEEC
T ss_pred HHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCC
Confidence 99999999999999999111199999999999999999999999999876554444445556689999999999988899
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhh---hhhH-----------------HHhhhhhhHHHHHHHHHHHHHhhccCC
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEEN---RSLA-----------------AYFSKEAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~---~~~~-----------------~~~~~~~~~~~~~~~~~li~~cl~~dp 220 (290)
.++||||||+++|+|++|..||....... .... ...........+..+.+++.+||+.||
T Consensus 214 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 293 (326)
T 3uim_A 214 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 293 (326)
T ss_dssp HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCG
T ss_pred ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCC
Confidence 99999999999999999999885221100 0000 001122345667889999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 044846 221 KKQPTMKEVTLELAGI 236 (290)
Q Consensus 221 ~~Rps~~el~~~l~~~ 236 (290)
.+|||+.|++++|+..
T Consensus 294 ~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 294 MERPKMSEVVRMLEGD 309 (326)
T ss_dssp GGSCCHHHHHHHHHTS
T ss_pred ccCCCHHHHHHHhcCc
Confidence 9999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=316.51 Aligned_cols=224 Identities=19% Similarity=0.228 Sum_probs=187.2
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++... +....+.+.+|+++++.++||||+++++++...+..|+||||+++|+|.+++.... .+++..
T Consensus 40 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~ 115 (328)
T 3fe3_A 40 GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG----RMKEKE 115 (328)
T ss_dssp CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC----CCCHHH
T ss_pred CCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC----CCCHHH
Confidence 678999998643 45567789999999999999999999999999999999999999999999998765 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+..+
T Consensus 116 ~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 190 (328)
T 3fe3_A 116 ARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKY 190 (328)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGGGTTSSSGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC--CccccccCCcceeCcccccCCCc
Confidence 9999999999999999999 999999999999999999999999998654322 23345678999999999998887
Q ss_pred C-CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 160 T-EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 160 ~-~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
. .++||||+||++|+|++|..||........ ...... ...+...+..+.+|+.+||+.||.+|||++|++++.+-
T Consensus 191 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-RERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp CSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred CCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 5 689999999999999999998865432211 111111 11222346678999999999999999999999988553
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=319.51 Aligned_cols=234 Identities=20% Similarity=0.316 Sum_probs=189.6
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC---------
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD--------- 71 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------- 71 (290)
..||+|+++... ....+.+.+|+++++.+ +||||++++++|...+..|+||||+++|+|.+++......
T Consensus 114 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 193 (370)
T 2psq_A 114 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193 (370)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC---------
T ss_pred eeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCcccccccccc
Confidence 469999997543 44567899999999999 8999999999999999999999999999999999875421
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceeccc
Q 044846 72 ---QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFG 147 (290)
Q Consensus 72 ---~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~ 147 (290)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......+++.
T Consensus 194 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~ 270 (370)
T 2psq_A 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 270 (370)
T ss_dssp --CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGG
T ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccc
Confidence 124788999999999999999999999 99999999999999999999999999875432211 12233456788
Q ss_pred ccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 148 YVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 148 y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
|+|||++.+..++.++|||||||++|||++ |..|+...... ...... .....+...+..+.++|.+||+.||.+|
T Consensus 271 y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 349 (370)
T 2psq_A 271 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349 (370)
T ss_dssp GCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred eECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 999999999999999999999999999998 77777543221 111111 1112233456689999999999999999
Q ss_pred CCHHHHHHHHHhhHhhh
Q 044846 224 PTMKEVTLELAGIRASI 240 (290)
Q Consensus 224 ps~~el~~~l~~~~~~~ 240 (290)
||+.|++++|+.+....
T Consensus 350 pt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 350 PTFKQLVEDLDRILTLT 366 (370)
T ss_dssp CCHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHh
Confidence 99999999999886543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=312.73 Aligned_cols=233 Identities=25% Similarity=0.386 Sum_probs=187.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++.......+.+.+|+++++.++||||+++++++.. ....++||||+++|+|.+++..... .+++..
T Consensus 39 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~ 115 (295)
T 3ugc_A 39 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIK 115 (295)
T ss_dssp CEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG---GCCHHH
T ss_pred CcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc---ccCHHH
Confidence 57899999988777778899999999999999999999999865 3568999999999999999987542 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc--eeeccceecccccCccccccC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~ 157 (290)
++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .......++..|+|||++.+.
T Consensus 116 ~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 192 (295)
T 3ugc_A 116 LLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192 (295)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC
Confidence 9999999999999999999 99999999999999999999999999875432221 122334567789999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--------------HHHh----hhhhhHHHHHHHHHHHHHhhccC
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--------------AAYF----SKEAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--------------~~~~----~~~~~~~~~~~~~~li~~cl~~d 219 (290)
.++.++||||||+++|+|++|..++.......... .... ....+...+..+.+||.+||+.|
T Consensus 193 ~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 272 (295)
T 3ugc_A 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNN 272 (295)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSS
T ss_pred CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCC
Confidence 99999999999999999999988765432211100 0000 01112334577999999999999
Q ss_pred CCCCCCHHHHHHHHHhhHhhh
Q 044846 220 GKKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 220 p~~Rps~~el~~~l~~~~~~~ 240 (290)
|++|||+.|+++.|+.+...+
T Consensus 273 p~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 273 VNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp GGGSCCHHHHHHHHHHHHHC-
T ss_pred hhhCCCHHHHHHHHHHHHHhc
Confidence 999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=311.28 Aligned_cols=236 Identities=25% Similarity=0.329 Sum_probs=183.5
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++|+|.+++...... ..+++..
T Consensus 60 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~ 138 (309)
T 3p86_A 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERR 138 (309)
T ss_dssp TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHH-HHSCHHH
T ss_pred CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCC-CCCCHHH
Confidence 6789999986543 445678999999999999999999999999999999999999999999999864311 1388999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
++.++.|++.||.|||+++. +|+||||||+||+++.++.+||+|||+++..... ........||+.|+|||++.+..+
T Consensus 139 ~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 216 (309)
T 3p86_A 139 RLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPS 216 (309)
T ss_dssp HHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC------------------CCTTSCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCcccccc-ccccccCCCCccccChhhhcCCCC
Confidence 99999999999999999863 3999999999999999999999999998643321 122334678999999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
+.++|||||||++|+|++|..||............. .....+...+..+.+||.+||+.||.+|||+.++++.|+.+
T Consensus 217 ~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999886443322211111 11122334567799999999999999999999999999988
Q ss_pred Hhhh
Q 044846 237 RASI 240 (290)
Q Consensus 237 ~~~~ 240 (290)
....
T Consensus 297 ~~~~ 300 (309)
T 3p86_A 297 IKSA 300 (309)
T ss_dssp HC--
T ss_pred HHhC
Confidence 7543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=311.43 Aligned_cols=228 Identities=18% Similarity=0.268 Sum_probs=181.3
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC---------------------------------
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETE--------------------------------- 47 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--------------------------------- 47 (290)
|+.||||+++.. .....+.+.+|+++++.++||||++++++|....
T Consensus 31 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 110 (332)
T 3qd2_B 31 DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSV 110 (332)
T ss_dssp CCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-----------------------
T ss_pred CcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCccccccc
Confidence 678999999743 3445778999999999999999999999986643
Q ss_pred ------------------------cceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 044846 48 ------------------------VPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIY 103 (290)
Q Consensus 48 ------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~ii 103 (290)
..++|||||++|+|.+++...... ...++..++.++.||+.||.|||+++ |+
T Consensus 111 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 186 (332)
T 3qd2_B 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL-EDREHGVCLHIFIQIAEAVEFLHSKG---LM 186 (332)
T ss_dssp ---------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-cchhhHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 279999999999999999875432 24567778999999999999999999 99
Q ss_pred eccCCCCceEeccCCcEEEeccccccccccCCc-----------eeeccceecccccCccccccCCCCCcccchhhHHHH
Q 044846 104 HLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-----------HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVL 172 (290)
Q Consensus 104 Hrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il 172 (290)
||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++
T Consensus 187 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 266 (332)
T 3qd2_B 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266 (332)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHH
T ss_pred ecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHH
Confidence 999999999999999999999999875443211 122345689999999999999999999999999999
Q ss_pred HHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 173 VELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 173 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
|+|++|..++......................+..+.+||.+||+.||++|||+.|++++.
T Consensus 267 ~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 267 FELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred HHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence 9999988765432222221111111223344556789999999999999999999998763
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=313.98 Aligned_cols=232 Identities=20% Similarity=0.285 Sum_probs=187.7
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..||||+++.. .....+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++..... .+++..++
T Consensus 78 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~ 154 (325)
T 3kul_A 78 VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLV 154 (325)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTT---CSCHHHHH
T ss_pred ceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhccc---CCCHHHHH
Confidence 35999999754 455577899999999999999999999999999999999999999999999976532 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce--eeccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--LTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..+
T Consensus 155 ~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 231 (325)
T 3kul_A 155 GMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231 (325)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCC
Confidence 99999999999999999 999999999999999999999999998754332211 2223445778999999998899
Q ss_pred CCcccchhhHHHHHHHhc-CCCCcccchhhhhh--hHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 160 TEKSDVYSFSVVLVELNW-TKPIHLVDVEENRS--LAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
+.++||||||+++|+|++ |..||......... .........+...+..+.+||.+||+.||++|||+.++++.|+.+
T Consensus 232 ~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 232 SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999998 88877543322111 111111222334567899999999999999999999999999988
Q ss_pred Hhhh
Q 044846 237 RASI 240 (290)
Q Consensus 237 ~~~~ 240 (290)
....
T Consensus 312 ~~~~ 315 (325)
T 3kul_A 312 IRSP 315 (325)
T ss_dssp HHSC
T ss_pred HhCc
Confidence 7643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=305.99 Aligned_cols=230 Identities=23% Similarity=0.290 Sum_probs=185.3
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.. ......+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... ++++.
T Consensus 36 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~ 111 (294)
T 4eqm_A 36 NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVD 111 (294)
T ss_dssp CSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC----SCCHH
T ss_pred CCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC----CCCHH
Confidence 67899999853 334456789999999999999999999999999999999999999999999998765 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..............||+.|+|||++.+..
T Consensus 112 ~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (294)
T 4eqm_A 112 TAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCC
Confidence 99999999999999999999 999999999999999999999999998754433333334567899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh------hhhHHHHHHHHHHHHHhhccCCCCCC-CHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK------EAEKEEVITFAMVAKRCLNLNGKKQP-TMKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~el~~ 231 (290)
++.++||||||+++|+|++|..||................ ......+..+.++|.+||+.||.+|| +++++.+
T Consensus 189 ~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~ 268 (294)
T 4eqm_A 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKD 268 (294)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHH
T ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHH
Confidence 9999999999999999999999986544332222211111 11123456799999999999999998 7899998
Q ss_pred HHHhhHh
Q 044846 232 ELAGIRA 238 (290)
Q Consensus 232 ~l~~~~~ 238 (290)
.|+.+..
T Consensus 269 ~l~~~~~ 275 (294)
T 4eqm_A 269 DLSSVLH 275 (294)
T ss_dssp HHHTSSS
T ss_pred HHHHHHh
Confidence 8887654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=313.14 Aligned_cols=224 Identities=18% Similarity=0.186 Sum_probs=187.6
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++...+..|+||||+++|+|..++.... .+++.
T Consensus 30 ~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~ 105 (337)
T 1o6l_A 30 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEE 105 (337)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHH
T ss_pred CCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHH
Confidence 678999998642 34457788999999999999999999999999999999999999999999998765 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..... ........||+.|+|||++.+..
T Consensus 106 ~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~ 181 (337)
T 1o6l_A 106 RARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDND 181 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCBCCCEECGGGCCGGGGSSSC
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC-CCcccccccChhhCChhhhcCCC
Confidence 99999999999999999999 999999999999999999999999998753222 22334567999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~~ 231 (290)
++.++|+|||||++|+|++|.+||........ ...... ...+...+.++.+||.+||+.||.+|| ++.|+++
T Consensus 182 ~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCchhhcccchhHHHHHhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 99999999999999999999998865432211 111111 112234567899999999999999999 8999998
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
|.+
T Consensus 261 h~~ 263 (337)
T 1o6l_A 261 HRF 263 (337)
T ss_dssp SGG
T ss_pred CCC
Confidence 854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=304.98 Aligned_cols=229 Identities=23% Similarity=0.346 Sum_probs=188.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|+++.... ..+.+.+|++++++++||||+++++++...+..++||||+++|+|.+++..... .+++..++
T Consensus 34 ~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~ 109 (269)
T 4hcu_A 34 KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLL 109 (269)
T ss_dssp TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTT---CCCHHHHH
T ss_pred CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCc---ccCHHHHH
Confidence 45799999975433 346799999999999999999999999999999999999999999999976443 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..............+++.|+|||++.+..++.
T Consensus 110 ~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 186 (269)
T 4hcu_A 110 GMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 186 (269)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCc
Confidence 99999999999999999 999999999999999999999999998754332222333455677899999999999999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
++||||+|+++|+|++ |..|+........ ..... ....+...+..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus 187 ~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 187 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV-VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-HHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 9999999999999998 7777754332211 11111 11222334667999999999999999999999999999886
Q ss_pred h
Q 044846 238 A 238 (290)
Q Consensus 238 ~ 238 (290)
.
T Consensus 266 ~ 266 (269)
T 4hcu_A 266 E 266 (269)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=313.77 Aligned_cols=228 Identities=17% Similarity=0.164 Sum_probs=185.3
Q ss_pred CceEEEEeeccc-----CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSV-----HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++...+..|+|||||++|+|.+++.........++
T Consensus 49 ~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~ 128 (351)
T 3c0i_A 49 GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS 128 (351)
T ss_dssp CCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCC
T ss_pred CCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCC
Confidence 678999998532 122467899999999999999999999999999999999999999999988876543333589
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc---EEEeccccccccccCCceeeccceecccccCccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ---AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
+..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++....... .......||+.|+|||+
T Consensus 129 ~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~ 204 (351)
T 3c0i_A 129 EAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEV 204 (351)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS-CBCCCCCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC-eeecCCcCCcCccCHHH
Confidence 9999999999999999999999 999999999999986654 9999999986543221 22344678999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
+.+..++.++|||||||++|+|++|.+||....... ...... .......+..+.+||.+||+.||++|||+.
T Consensus 205 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 282 (351)
T 3c0i_A 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL--FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVY 282 (351)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH--HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH--HHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 999999999999999999999999999987543221 111111 111123456799999999999999999999
Q ss_pred HHHHHHHh
Q 044846 228 EVTLELAG 235 (290)
Q Consensus 228 el~~~l~~ 235 (290)
|++++.+-
T Consensus 283 e~l~hp~~ 290 (351)
T 3c0i_A 283 EALNHPWL 290 (351)
T ss_dssp HHHTSHHH
T ss_pred HHhcChhh
Confidence 99987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=321.47 Aligned_cols=231 Identities=19% Similarity=0.296 Sum_probs=187.2
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||+++.. .....+.|.+|+++|+.++||||+++++++...+..++||||+++|+|.+++..... .+++..+
T Consensus 139 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~ 215 (377)
T 3cbl_A 139 NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTL 215 (377)
T ss_dssp CCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGG---GCCHHHH
T ss_pred CeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCC---CCCHHHH
Confidence 678999998753 334456789999999999999999999999999999999999999999999986542 5889999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee-ccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT-TQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.......... ....++..|+|||++.+..+
T Consensus 216 ~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 292 (377)
T 3cbl_A 216 LQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292 (377)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCC
Confidence 999999999999999999 99999999999999999999999999865332211111 22345778999999998889
Q ss_pred CCcccchhhHHHHHHHhc-CCCCcccchhhhhh--hHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 160 TEKSDVYSFSVVLVELNW-TKPIHLVDVEENRS--LAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
+.++|||||||++|||++ |..|+......... .........+..++..+.+||.+||+.||++|||+.++++.|+.+
T Consensus 293 ~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 293 SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 999999999999999997 77776543222111 111111122334566799999999999999999999999999988
Q ss_pred Hh
Q 044846 237 RA 238 (290)
Q Consensus 237 ~~ 238 (290)
..
T Consensus 373 ~~ 374 (377)
T 3cbl_A 373 RK 374 (377)
T ss_dssp HH
T ss_pred Hh
Confidence 65
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.35 Aligned_cols=224 Identities=21% Similarity=0.232 Sum_probs=185.7
Q ss_pred CceEEEEeecccCch------hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHES------NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|+++..... ..+.+.+|+.+|+.++||||+++++++...+..++||||+++|+|.+++.... .+
T Consensus 37 ~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~l 112 (361)
T 2yab_A 37 GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE----SL 112 (361)
T ss_dssp CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS----CC
T ss_pred CCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC----CC
Confidence 678999998643321 35789999999999999999999999999999999999999999999997644 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC----cEEEeccccccccccCCceeeccceecccccCc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY----QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++..... .......||+.|+||
T Consensus 113 ~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~--~~~~~~~gt~~y~aP 187 (361)
T 2yab_A 113 SEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAP 187 (361)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT--CCCCCCCSCGGGCCH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC--CccccCCCCccEECc
Confidence 99999999999999999999999 99999999999998777 7999999998654322 223446789999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
|++.+..++.++|||||||++|+|++|.+||........ ...... .......+..+.+||.+||..||.+|||
T Consensus 188 E~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 266 (361)
T 2yab_A 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT 266 (361)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred hHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcC
Confidence 999998999999999999999999999999865433211 111111 1112234567999999999999999999
Q ss_pred HHHHHHHHHh
Q 044846 226 MKEVTLELAG 235 (290)
Q Consensus 226 ~~el~~~l~~ 235 (290)
+.|+++|.+-
T Consensus 267 ~~e~l~hp~~ 276 (361)
T 2yab_A 267 IQEALRHPWI 276 (361)
T ss_dssp HHHHHTSTTT
T ss_pred HHHHhcCcCc
Confidence 9999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=315.49 Aligned_cols=235 Identities=22% Similarity=0.280 Sum_probs=189.0
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC-cceEEEEeCCCCCHHHHHhhcCCC-------
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETE-VPLLVYEFIPNGSLYQYIHEQTDD------- 71 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------- 71 (290)
|+.||||+++.. .....+.+.+|++++..+ +||||+++++++...+ ..++|||||++|+|.+++......
T Consensus 52 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~ 131 (359)
T 3vhe_A 52 CRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131 (359)
T ss_dssp EEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--
T ss_pred ceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccc
Confidence 367999999753 344567899999999999 8999999999998755 489999999999999999875421
Q ss_pred -------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhh
Q 044846 72 -------------------------------------------------------QLPITWEMRLRITVEVSRVLSYLHS 96 (290)
Q Consensus 72 -------------------------------------------------------~~~~~~~~~~~~~~~i~~~l~ylH~ 96 (290)
...+++..++.++.||+.||.|||+
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~ 211 (359)
T 3vhe_A 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 211 (359)
T ss_dssp ----------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred cchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH
Confidence 1128899999999999999999999
Q ss_pred CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceecccccCccccccCCCCCcccchhhHHHHHHH
Q 044846 97 VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175 (290)
Q Consensus 97 ~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l 175 (290)
++ |+||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|
T Consensus 212 ~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 288 (359)
T 3vhe_A 212 RK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288 (359)
T ss_dssp TT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHH
Confidence 99 9999999999999999999999999987543222 2233456788999999999999999999999999999999
Q ss_pred hc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 044846 176 NW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239 (290)
Q Consensus 176 ~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~ 239 (290)
++ |..|+............. .....+...+..+.+++.+||+.||.+|||+.|++++|+.+..+
T Consensus 289 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 289 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp TTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 98 888875433221111111 11122334566799999999999999999999999999988754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=309.27 Aligned_cols=226 Identities=21% Similarity=0.257 Sum_probs=189.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||||+++.......+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++... .+++..+.
T Consensus 70 g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~ 144 (321)
T 2c30_A 70 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIA 144 (321)
T ss_dssp CCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHH
T ss_pred CcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHH
Confidence 7889999998777777888999999999999999999999999999999999999999999998753 48999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......||+.|+|||++.+..++.
T Consensus 145 ~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 220 (321)
T 2c30_A 145 TVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYAT 220 (321)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCc
Confidence 99999999999999999 9999999999999999999999999976543221 2234467899999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
++||||||+++|+|++|..|+........ ....... ......+..+.+++.+||+.||++|||+.|++++.+..
T Consensus 221 ~~Dv~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 99999999999999999998865432211 1111110 11223456789999999999999999999999887654
Q ss_pred H
Q 044846 237 R 237 (290)
Q Consensus 237 ~ 237 (290)
.
T Consensus 300 ~ 300 (321)
T 2c30_A 300 Q 300 (321)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=316.60 Aligned_cols=235 Identities=21% Similarity=0.311 Sum_probs=191.7
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC---------
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD--------- 71 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------- 71 (290)
..||+|+++.. .....+.+.+|+++++.+ +||||+++++++...+..++||||+++|+|.+++......
T Consensus 102 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 181 (382)
T 3tt0_A 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181 (382)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCC
T ss_pred eEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccc
Confidence 46999999753 345567899999999999 9999999999999999999999999999999999875421
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceeccc
Q 044846 72 ---QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFG 147 (290)
Q Consensus 72 ---~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~ 147 (290)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......+|+.
T Consensus 182 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~ 258 (382)
T 3tt0_A 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 258 (382)
T ss_dssp SSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGG
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcc
Confidence 125899999999999999999999999 99999999999999999999999999875432221 22334567889
Q ss_pred ccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 148 YVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 148 y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
|+|||++.+..++.++|||||||++|+|++ |..|+...... ....... ....+...+..+.+|+.+||+.||++|
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 337 (382)
T 3tt0_A 259 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 337 (382)
T ss_dssp GSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred eeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhC
Confidence 999999999999999999999999999998 87777543221 1111111 112223456779999999999999999
Q ss_pred CCHHHHHHHHHhhHhhhC
Q 044846 224 PTMKEVTLELAGIRASIG 241 (290)
Q Consensus 224 ps~~el~~~l~~~~~~~~ 241 (290)
||+.|++++|+.+.....
T Consensus 338 ps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 338 PTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp CCHHHHHHHHHHHHHHSC
T ss_pred cCHHHHHHHHHHHHHHHh
Confidence 999999999999976553
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=302.02 Aligned_cols=230 Identities=20% Similarity=0.273 Sum_probs=188.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|+++.... ..+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... .+++..++
T Consensus 32 ~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~ 107 (268)
T 3sxs_A 32 QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK---GLEPSQLL 107 (268)
T ss_dssp TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGG---GCCHHHHH
T ss_pred ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCC---CCCHHHHH
Confidence 35699999976443 356789999999999999999999999999999999999999999999987542 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...............+++.|+|||++.+..++.
T Consensus 108 ~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 184 (268)
T 3sxs_A 108 EMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184 (268)
T ss_dssp HHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEET
T ss_pred HHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCch
Confidence 99999999999999999 999999999999999999999999998755443333334455677899999999888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH--hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY--FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++||||||+++|+|++ |..|+............. .....+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 185 ~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp THHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred hhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 9999999999999998 887775433222111111 1111222345679999999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=317.55 Aligned_cols=235 Identities=20% Similarity=0.248 Sum_probs=189.5
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC---CCCCCCH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD---DQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~ 77 (290)
++.||||+++.. .......+.+|+.+++.++||||+++++++......++|||||++|+|.+++..... ....+++
T Consensus 101 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 180 (367)
T 3l9p_A 101 PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180 (367)
T ss_dssp CEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCH
T ss_pred ceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccH
Confidence 457999998643 455566899999999999999999999999999999999999999999999987642 2235889
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC---cEEEeccccccccccC-CceeeccceecccccCccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY---QAKISDFRTFKSRAID-RTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~ 153 (290)
..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++..... .........+|+.|+|||+
T Consensus 181 ~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~ 257 (367)
T 3l9p_A 181 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 257 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHH
Confidence 999999999999999999999 99999999999999555 5999999998643211 1122234567889999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
+.+..++.++|||||||++|+|++ |.+||...... ........ ...+...+..+.+|+.+||+.||.+|||+.++
T Consensus 258 ~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ei 336 (367)
T 3l9p_A 258 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 336 (367)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 999999999999999999999997 87777543322 11111111 12233456679999999999999999999999
Q ss_pred HHHHHhhHhhh
Q 044846 230 TLELAGIRASI 240 (290)
Q Consensus 230 ~~~l~~~~~~~ 240 (290)
+++|+.+....
T Consensus 337 l~~l~~~~~~~ 347 (367)
T 3l9p_A 337 LERIEYCTQDP 347 (367)
T ss_dssp HHHHHHHHHCH
T ss_pred HHHHHHHhhCh
Confidence 99999887643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=308.56 Aligned_cols=226 Identities=20% Similarity=0.351 Sum_probs=185.8
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
..||+|+++.......+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... .+++..++.
T Consensus 41 ~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~ 117 (289)
T 4fvq_A 41 TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN---CINILWKLE 117 (289)
T ss_dssp EEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHH
T ss_pred hhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHH
Confidence 46999999877777788999999999999999999999999999999999999999999999987542 488999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc--------EEEeccccccccccCCceeeccceecccccCcccc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ--------AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++..... .....+++.|+|||++
T Consensus 118 i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~ 189 (289)
T 4fvq_A 118 VAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQERIPWVPPECI 189 (289)
T ss_dssp HHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHH
T ss_pred HHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccccccC-----ccccCCcCcccCHHHh
Confidence 9999999999999999 999999999999998887 99999999754321 1234578899999999
Q ss_pred cc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh-hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 155 RS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF-SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 155 ~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
.+ ..++.++||||||+++|+|++|..++.............. ....+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 190 ~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 190 ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 87 6789999999999999999996655554433222221111 111122235568899999999999999999999999
Q ss_pred HHhhHhh
Q 044846 233 LAGIRAS 239 (290)
Q Consensus 233 l~~~~~~ 239 (290)
|+.+...
T Consensus 270 l~~l~~p 276 (289)
T 4fvq_A 270 LNSLFTP 276 (289)
T ss_dssp HHTCC--
T ss_pred HHHhcCC
Confidence 9988543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=315.07 Aligned_cols=227 Identities=23% Similarity=0.259 Sum_probs=183.2
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||||++|+|.+++.... .+++..+
T Consensus 32 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~ 107 (323)
T 3tki_A 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDA 107 (323)
T ss_dssp CCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT----BCCHHHH
T ss_pred CcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC----CCCHHHH
Confidence 6789999986433 2334678899999999999999999999999999999999999999999987554 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+..+
T Consensus 108 ~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 184 (323)
T 3tki_A 108 QRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184 (323)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSB
T ss_pred HHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCC
Confidence 999999999999999999 9999999999999999999999999986543222 122345678999999999988775
Q ss_pred -CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 160 -TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 160 -~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.++|||||||++|+|++|..||............... .......+..+.+||.+||+.||++|||+.|++++.+
T Consensus 185 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 67899999999999999999988654332222222111 1112345667889999999999999999999998765
Q ss_pred h
Q 044846 235 G 235 (290)
Q Consensus 235 ~ 235 (290)
.
T Consensus 265 ~ 265 (323)
T 3tki_A 265 Y 265 (323)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=315.63 Aligned_cols=228 Identities=18% Similarity=0.192 Sum_probs=181.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||||+++.. .....+.+.+|+.+++.++|||||++++++...+..++|||||++|+|.+++...... .+++..
T Consensus 52 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~ 129 (389)
T 3gni_B 52 GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELA 129 (389)
T ss_dssp CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTT--CCCHHH
T ss_pred CCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhccc--CCCHHH
Confidence 678999998643 3455678889999999999999999999999999999999999999999999875332 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc------eeeccceecccccCccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT------HLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~ 153 (290)
+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+........ .......||..|+|||+
T Consensus 130 ~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 206 (389)
T 3gni_B 130 IAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206 (389)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHH
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHH
Confidence 9999999999999999999 99999999999999999999999998754321111 11123467889999999
Q ss_pred ccc--CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh-----------------------------------
Q 044846 154 FRS--SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF----------------------------------- 196 (290)
Q Consensus 154 ~~~--~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~----------------------------------- 196 (290)
+.+ ..++.++|||||||++|+|++|.+||..............
T Consensus 207 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (389)
T 3gni_B 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLT 286 (389)
T ss_dssp HSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------------------------------
T ss_pred HhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccc
Confidence 987 5789999999999999999999998864322111110000
Q ss_pred ------------hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 197 ------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 197 ------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
........+..+.+||.+||+.||++|||+.|++++.+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 287 TSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 00011223456899999999999999999999998843
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=307.58 Aligned_cols=224 Identities=23% Similarity=0.263 Sum_probs=185.2
Q ss_pred CceEEEEeecccCc------hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHE------SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... .+
T Consensus 36 ~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~ 111 (326)
T 2y0a_A 36 GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SL 111 (326)
T ss_dssp CCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS----CC
T ss_pred CcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC----Cc
Confidence 67899999864332 146789999999999999999999999999999999999999999999997644 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC----cEEEeccccccccccCCceeeccceecccccCc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY----QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++..... .......||+.|+||
T Consensus 112 ~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aP 186 (326)
T 2y0a_A 112 TEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAP 186 (326)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT--SCCCCCCSCTTTCCH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC--CccccccCCcCcCCc
Confidence 99999999999999999999999 99999999999999887 7999999998654322 222345689999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
|++.+..++.++|||||||++|+|++|.+||........ ...... .......+..+.+||.+||+.||.+|||
T Consensus 187 E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 265 (326)
T 2y0a_A 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 265 (326)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred eeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCC
Confidence 999999999999999999999999999998865432221 111111 1112234567899999999999999999
Q ss_pred HHHHHHHHHh
Q 044846 226 MKEVTLELAG 235 (290)
Q Consensus 226 ~~el~~~l~~ 235 (290)
+.|++++.+-
T Consensus 266 ~~e~l~hp~~ 275 (326)
T 2y0a_A 266 IQDSLQHPWI 275 (326)
T ss_dssp HHHHHHSTTT
T ss_pred HHHHhcCCCc
Confidence 9999988653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=308.24 Aligned_cols=225 Identities=19% Similarity=0.213 Sum_probs=186.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|.++.. ......+.+|+.+++.++||||+++++++...+..++|||||++|+|.+++..... .+++..+.
T Consensus 30 ~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~ 105 (321)
T 1tki_A 30 KKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNEREIV 105 (321)
T ss_dssp TEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC---CCCHHHHH
T ss_pred CcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCC---CCCHHHHH
Confidence 578999998753 34566789999999999999999999999999999999999999999999976432 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc--CCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD--KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++..... .......||+.|+|||++.+..+
T Consensus 106 ~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 180 (321)
T 1tki_A 106 SYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQHDVV 180 (321)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEEEEESCGGGSCHHHHTTCEE
T ss_pred HHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--CccccccCChhhcCcHHhcCCCC
Confidence 99999999999999999 999999999999987 789999999998654322 22344678999999999998888
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.++|||||||++|+|++|.+||........ ...... .......+.++.+||.+||+.||.+|||+.|++++.
T Consensus 181 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 181 STATDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-HHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 9999999999999999999998865433221 111111 111223467799999999999999999999999986
Q ss_pred Hhh
Q 044846 234 AGI 236 (290)
Q Consensus 234 ~~~ 236 (290)
+-.
T Consensus 260 ~~~ 262 (321)
T 1tki_A 260 WLK 262 (321)
T ss_dssp HHH
T ss_pred hhc
Confidence 643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=327.44 Aligned_cols=230 Identities=20% Similarity=0.314 Sum_probs=189.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||||+++... ...+.|.+|+.+|++++||||++++++|...+..+||||||++|+|.+++...... .+++..++
T Consensus 245 ~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~--~~~~~~~~ 321 (495)
T 1opk_A 245 SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLL 321 (495)
T ss_dssp TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTT--TSCHHHHH
T ss_pred CeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcC--CCCHHHHH
Confidence 5679999997543 34778999999999999999999999999999999999999999999999865432 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............++..|+|||++.+..++.
T Consensus 322 ~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 398 (495)
T 1opk_A 322 YMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398 (495)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECH
T ss_pred HHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCc
Confidence 99999999999999999 999999999999999999999999998765433322333455678899999999889999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
++|||||||++|||++ |..|+...... ...... .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 399 ~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 399 KSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 9999999999999998 77766533211 111111 112223345678999999999999999999999999998774
Q ss_pred h
Q 044846 238 A 238 (290)
Q Consensus 238 ~ 238 (290)
.
T Consensus 478 ~ 478 (495)
T 1opk_A 478 Q 478 (495)
T ss_dssp S
T ss_pred h
Confidence 3
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=315.47 Aligned_cols=232 Identities=19% Similarity=0.294 Sum_probs=179.7
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
+..||+|+++.. .....+.|.+|+.++++++||||+++++++...+..++||||+++|+|.+++..... .+++..+
T Consensus 73 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~ 149 (373)
T 2qol_A 73 EISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQL 149 (373)
T ss_dssp BCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT---CSCHHHH
T ss_pred ceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCC---CCCHHHH
Confidence 456999999754 345567899999999999999999999999999999999999999999999986532 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee--ccceecccccCccccccCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT--TQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~ 158 (290)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......... ....+++.|+|||++.+..
T Consensus 150 ~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 226 (373)
T 2qol_A 150 VGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226 (373)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCC
Confidence 999999999999999999 99999999999999999999999999875443222111 2233567899999999999
Q ss_pred CCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++.++||||||+++||+++ |..|+....... ..... .....+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 227 ~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~ 305 (373)
T 2qol_A 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence 9999999999999999887 887775432221 11111 111222345677999999999999999999999999999
Q ss_pred hhHhhh
Q 044846 235 GIRASI 240 (290)
Q Consensus 235 ~~~~~~ 240 (290)
.+....
T Consensus 306 ~~~~~~ 311 (373)
T 2qol_A 306 KLIRNP 311 (373)
T ss_dssp HHHHCG
T ss_pred HHHhCc
Confidence 887643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=310.97 Aligned_cols=229 Identities=21% Similarity=0.253 Sum_probs=182.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc----ceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEV----PLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||||+++... .....+.+|+.+++.++||||+++++++..... +++||||+++|+|.+++... .+++
T Consensus 47 ~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~ 120 (322)
T 3soc_A 47 NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSW 120 (322)
T ss_dssp TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-----CBCH
T ss_pred CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-----CCCH
Confidence 5789999997543 334456679999999999999999999987553 69999999999999999764 4899
Q ss_pred HHHHHHHHHHHHHHHHHhhC----------CCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecc
Q 044846 78 EMRLRITVEVSRVLSYLHSV----------ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTF 146 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~----------~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~ 146 (290)
..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++........ ......||+
T Consensus 121 ~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~ 197 (322)
T 3soc_A 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197 (322)
T ss_dssp HHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCG
T ss_pred HHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCc
Confidence 99999999999999999998 8 999999999999999999999999998654332221 233467899
Q ss_pred cccCccccccC-----CCCCcccchhhHHHHHHHhcCCCCcccchhh--------------hhhhHHHhh----------
Q 044846 147 GYVDPKYFRSS-----QFTEKSDVYSFSVVLVELNWTKPIHLVDVEE--------------NRSLAAYFS---------- 197 (290)
Q Consensus 147 ~y~aPE~~~~~-----~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--------------~~~~~~~~~---------- 197 (290)
.|+|||++.+. .++.++|||||||++|+|++|..||...... .........
T Consensus 198 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (322)
T 3soc_A 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD 277 (322)
T ss_dssp GGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred cccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccc
Confidence 99999999863 4556889999999999999998887543211 000000000
Q ss_pred hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 044846 198 KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239 (290)
Q Consensus 198 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~ 239 (290)
.......+..+.+||.+||+.||++|||+.|+++.|+.+.+.
T Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 278 YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 001223456699999999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=319.06 Aligned_cols=225 Identities=15% Similarity=0.172 Sum_probs=186.9
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..|+|||||.+|+|.+.+.... .+++..
T Consensus 36 ~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~----~~~e~~ 111 (444)
T 3soa_A 36 GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE----YYSEAD 111 (444)
T ss_dssp TEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS----CCCHHH
T ss_pred CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC----CCCHHH
Confidence 6789999986433 3456779999999999999999999999999999999999999999999998765 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec---cCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV---DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....... .......||+.|+|||++.+
T Consensus 112 ~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~ 187 (444)
T 3soa_A 112 ASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRK 187 (444)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-CBCCCSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC-ceeecccCCcccCCHHHhcC
Confidence 9999999999999999999 99999999999998 45789999999986543222 22345678999999999999
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
..++.++||||+||++|+|++|.+||........ ...... .......+..+.+||.+||+.||.+|||+.|++
T Consensus 188 ~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L 266 (444)
T 3soa_A 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266 (444)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 9999999999999999999999999865432211 111111 111234567899999999999999999999999
Q ss_pred HHHHh
Q 044846 231 LELAG 235 (290)
Q Consensus 231 ~~l~~ 235 (290)
++.+-
T Consensus 267 ~hp~~ 271 (444)
T 3soa_A 267 KHPWI 271 (444)
T ss_dssp HSCTT
T ss_pred cCccc
Confidence 88543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=312.15 Aligned_cols=223 Identities=18% Similarity=0.216 Sum_probs=185.0
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++.. .....+.+.+|+.+++.|+||||+++++++...+..|+||||+++|+|.+++.... .+++..
T Consensus 54 ~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~ 129 (362)
T 2bdw_A 54 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEAD 129 (362)
T ss_dssp CCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS----CCCHHH
T ss_pred CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC----CCCHHH
Confidence 678999998643 34556789999999999999999999999999999999999999999999997654 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC---CcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK---YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..... ........||+.|+|||++.+
T Consensus 130 ~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~ 204 (362)
T 2bdw_A 130 ASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLKK 204 (362)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT--CCSCCCSCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC--CcccccCCCCccccCHHHHcc
Confidence 9999999999999999999 9999999999999865 4599999999865432 222344678999999999999
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
..++.++|||||||++|+|++|.+||....... ....... .......+..+.+||.+||+.||++|||+.|++
T Consensus 205 ~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 205 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 899999999999999999999999986543221 1111111 111234467799999999999999999999999
Q ss_pred HHHH
Q 044846 231 LELA 234 (290)
Q Consensus 231 ~~l~ 234 (290)
++.+
T Consensus 284 ~hp~ 287 (362)
T 2bdw_A 284 KVPW 287 (362)
T ss_dssp TSHH
T ss_pred cCcc
Confidence 8754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=302.36 Aligned_cols=229 Identities=19% Similarity=0.277 Sum_probs=175.9
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..||+|+.+.. .....+.+.+|+.+++.++||||+++++++. .+..++||||+++|+|.+++..... .+++..+.
T Consensus 44 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~ 119 (281)
T 1mp8_A 44 LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY---SLDLASLI 119 (281)
T ss_dssp EEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTT---TSCHHHHH
T ss_pred eEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCC---CCCHHHHH
Confidence 45899988753 3445678999999999999999999999984 5678999999999999999986542 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..............+++.|+|||++.+..++.
T Consensus 120 ~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 196 (281)
T 1mp8_A 120 LYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196 (281)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSH
T ss_pred HHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCC
Confidence 99999999999999999 999999999999999999999999998754433222233445678899999999889999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
++||||||+++|+|++ |.+||....... ...... ....+...+..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus 197 ~~Di~slG~~l~ell~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 197 ASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCchHHHHHHHHHHhcCCCCCCcCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999996 777775432221 111111 11223345677999999999999999999999999999886
Q ss_pred hh
Q 044846 238 AS 239 (290)
Q Consensus 238 ~~ 239 (290)
..
T Consensus 276 ~~ 277 (281)
T 1mp8_A 276 EE 277 (281)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=316.66 Aligned_cols=225 Identities=19% Similarity=0.252 Sum_probs=182.2
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+.+|..++.++ +||||++++++|...+..|+|||||++|+|..++.... .+++
T Consensus 77 ~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----~l~~ 152 (396)
T 4dc2_A 77 DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPE 152 (396)
T ss_dssp TEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCH
T ss_pred CCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC----CCCH
Confidence 578999998643 233455688999999987 89999999999999999999999999999999998765 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... .........||+.|+|||++.+.
T Consensus 153 ~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~-~~~~~~~~~gt~~Y~aPE~l~~~ 228 (396)
T 4dc2_A 153 EHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFCGTPNYIAPEILRGE 228 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-TTCCBCCCCBCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc-CCCccccccCCcccCCchhhcCC
Confidence 999999999999999999999 99999999999999999999999999874222 22234557799999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhh-------hh-hhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCCCH-
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEE-------NR-SLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQPTM- 226 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~-------~~-~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~- 226 (290)
.++.++|||||||++|+|++|.+||...... .. ...... ....+...+..+.+||.+||+.||.+||++
T Consensus 229 ~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 308 (396)
T 4dc2_A 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCH 308 (396)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCS
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCC
Confidence 9999999999999999999999998532110 00 111111 112223456779999999999999999985
Q ss_pred -----HHHHHHHH
Q 044846 227 -----KEVTLELA 234 (290)
Q Consensus 227 -----~el~~~l~ 234 (290)
.|+++|.+
T Consensus 309 ~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 309 PQTGFADIQGHPF 321 (396)
T ss_dssp TTTHHHHHHHSTT
T ss_pred CCCCHHHHhcCcc
Confidence 68877753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=306.08 Aligned_cols=233 Identities=22% Similarity=0.310 Sum_probs=189.1
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-----------
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD----------- 70 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------- 70 (290)
+.||+|+++.. .....+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++.....
T Consensus 54 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 133 (314)
T 2ivs_A 54 TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133 (314)
T ss_dssp EEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC-----
T ss_pred ceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccccccc
Confidence 67999998753 355677899999999999999999999999999999999999999999999987542
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eec
Q 044846 71 ---------DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTT 140 (290)
Q Consensus 71 ---------~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~ 140 (290)
....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......... ...
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 210 (314)
T 2ivs_A 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRS 210 (314)
T ss_dssp -----------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSS
T ss_pred ccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceecc
Confidence 1124889999999999999999999999 999999999999999999999999998654332222 123
Q ss_pred cceecccccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhc
Q 044846 141 QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLN 217 (290)
Q Consensus 141 ~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~ 217 (290)
...+++.|+|||++.+..++.++||||||+++|+|++ |..|+........ ..........+...+..+.+++.+||+
T Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 290 (314)
T 2ivs_A 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWK 290 (314)
T ss_dssp CCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHcc
Confidence 3456788999999998889999999999999999998 8877754322111 111111112233456789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhHh
Q 044846 218 LNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 218 ~dp~~Rps~~el~~~l~~~~~ 238 (290)
.||.+|||+.+++++|+.+..
T Consensus 291 ~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 291 QEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp SSGGGSCCHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=310.61 Aligned_cols=234 Identities=18% Similarity=0.272 Sum_probs=188.0
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC----------
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD---------- 71 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------- 71 (290)
+.||+|+++.. .....+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++......
T Consensus 78 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 157 (343)
T 1luf_A 78 TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157 (343)
T ss_dssp EEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC-----------
T ss_pred eeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccc
Confidence 67999999754 3445678999999999999999999999999999999999999999999999874321
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeec
Q 044846 72 ----------QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTT 140 (290)
Q Consensus 72 ----------~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~ 140 (290)
...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++....... ....
T Consensus 158 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 234 (343)
T 1luf_A 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 234 (343)
T ss_dssp -----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC---
T ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccC
Confidence 136899999999999999999999999 99999999999999999999999999864332211 2223
Q ss_pred cceecccccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhh
Q 044846 141 QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCL 216 (290)
Q Consensus 141 ~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl 216 (290)
...+++.|+|||++.+..++.++||||||+++|+|++ |..|+........ ...... ...+...+..+.+|+.+||
T Consensus 235 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l 313 (343)
T 1luf_A 235 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-IYYVRDGNILACPENCPLELYNLMRLCW 313 (343)
T ss_dssp -CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH-HHHHhCCCcCCCCCCCCHHHHHHHHHHc
Confidence 4567889999999999999999999999999999998 8877754332211 111111 1122345667999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhHhhh
Q 044846 217 NLNGKKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 217 ~~dp~~Rps~~el~~~l~~~~~~~ 240 (290)
+.||.+|||+.+++++|+.+....
T Consensus 314 ~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 314 SKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp CSSGGGSCCHHHHHHHHHHTTC--
T ss_pred ccCcccCCCHHHHHHHHHHHHhhh
Confidence 999999999999999999886543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=303.07 Aligned_cols=230 Identities=20% Similarity=0.304 Sum_probs=187.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|+++..... .+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... .+++..++
T Consensus 48 ~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~ 123 (283)
T 3gen_A 48 QYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLL 123 (283)
T ss_dssp TEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGG---CCCHHHHH
T ss_pred CCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhcc---CCCHHHHH
Confidence 357999999864333 46789999999999999999999999999999999999999999999986432 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...............+++.|+|||++.+..++.
T Consensus 124 ~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 200 (283)
T 3gen_A 124 EMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200 (283)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSH
T ss_pred HHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCc
Confidence 99999999999999999 999999999999999999999999998654332222233345677899999999899999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhh--hHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRS--LAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++||||||+++|+|++ |..||......... +........+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 201 ~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 9999999999999998 88777543322111 11111112223345678999999999999999999999999988764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=320.40 Aligned_cols=225 Identities=24% Similarity=0.379 Sum_probs=184.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-cceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE-VPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||+++... ..+.|.+|+++|++++||||+++++++.... ..++|||||++|+|.+++...... .+++..+
T Consensus 216 ~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~--~~~~~~~ 291 (450)
T 1k9a_A 216 GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCL 291 (450)
T ss_dssp TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTT--TCCHHHH
T ss_pred CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCC--CCCHHHH
Confidence 5789999998643 5678999999999999999999999987765 789999999999999999876432 4788999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....+++.|+|||++.+..++
T Consensus 292 ~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~ 364 (450)
T 1k9a_A 292 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFS 364 (450)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----------CCCTTTSCHHHHHSSCCC
T ss_pred HHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc----ccCCCCCcceeCHHHhcCCCCC
Confidence 999999999999999999 999999999999999999999999998643211 1223567889999999999999
Q ss_pred CcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 161 EKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.++||||||+++|||++ |..|+...... ...... .....+..++..+.+||.+||+.||.+|||+.++++.|+.+
T Consensus 365 ~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTSCTT-THHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999997 88777533211 111111 11223345567899999999999999999999999999987
Q ss_pred Hh
Q 044846 237 RA 238 (290)
Q Consensus 237 ~~ 238 (290)
..
T Consensus 444 ~~ 445 (450)
T 1k9a_A 444 RT 445 (450)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=314.28 Aligned_cols=224 Identities=20% Similarity=0.223 Sum_probs=182.8
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+.+|..+++.+ +||||+++++++...+..|+|||||++|+|..++.... .+++
T Consensus 48 ~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~ 123 (353)
T 3txo_A 48 GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDE 123 (353)
T ss_dssp CCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCH
T ss_pred CCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCH
Confidence 678999998742 344567788999999998 79999999999999999999999999999999998765 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+.
T Consensus 124 ~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 199 (353)
T 3txo_A 124 ARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GVTTATFCGTPDYIAPEILQEM 199 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----------CCGGGCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC-CccccccCCCcCeEChhhcCCC
Confidence 999999999999999999999 999999999999999999999999998743222 2233456799999999999998
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCCCH------HHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQPTM------KEV 229 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~------~el 229 (290)
.++.++|||||||++|+|++|.+||....... ........ ..+...+..+.+||.+||+.||.+||++ .|+
T Consensus 200 ~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~i 278 (353)
T 3txo_A 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAI 278 (353)
T ss_dssp HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHH
T ss_pred CcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHH
Confidence 99999999999999999999999986543321 11111111 1223356678999999999999999998 788
Q ss_pred HHHHH
Q 044846 230 TLELA 234 (290)
Q Consensus 230 ~~~l~ 234 (290)
++|.+
T Consensus 279 l~hp~ 283 (353)
T 3txo_A 279 LRHPF 283 (353)
T ss_dssp HTSGG
T ss_pred hhCCc
Confidence 87754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=309.45 Aligned_cols=235 Identities=20% Similarity=0.304 Sum_probs=186.2
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC---------
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD--------- 71 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------- 71 (290)
+.||+|+++.. .....+.+.+|+.+++.+ +||||+++++++...+..++||||+++|+|.+++......
T Consensus 76 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 155 (344)
T 1rjb_A 76 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155 (344)
T ss_dssp EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------
T ss_pred eEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchh
Confidence 46999998743 344567899999999999 9999999999999999999999999999999999865421
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeec
Q 044846 72 ----------QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTT 140 (290)
Q Consensus 72 ----------~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~ 140 (290)
...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 156 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 232 (344)
T 1rjb_A 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 232 (344)
T ss_dssp -------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEET
T ss_pred hhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceecc
Confidence 124789999999999999999999999 99999999999999999999999999875433222 2234
Q ss_pred cceecccccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhh---HHHhhhhhhHHHHHHHHHHHHHhh
Q 044846 141 QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSL---AAYFSKEAEKEEVITFAMVAKRCL 216 (290)
Q Consensus 141 ~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl 216 (290)
...+|+.|+|||++.+..++.++||||||+++|+|++ |..|+.......... ........+...+..+.+|+.+||
T Consensus 233 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 312 (344)
T 1rjb_A 233 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCW 312 (344)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 4667889999999999999999999999999999997 887775432211111 111111223345678999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhHhhh
Q 044846 217 NLNGKKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 217 ~~dp~~Rps~~el~~~l~~~~~~~ 240 (290)
+.||.+|||+.+++++|+.+....
T Consensus 313 ~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 313 AFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCCchhCcCHHHHHHHHHHHHHHH
Confidence 999999999999999999886654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=325.13 Aligned_cols=230 Identities=19% Similarity=0.284 Sum_probs=186.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||||+++... ...+.|.+|+.+|+.++||||+++++++. .+..++|||||++|+|.+++...... .+++..+.
T Consensus 212 ~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~ 287 (454)
T 1qcf_A 212 HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGS--KQPLPKLI 287 (454)
T ss_dssp TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHH--TCCHHHHH
T ss_pred ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCC--CCCHHHHH
Confidence 4579999998643 45778999999999999999999999986 66789999999999999999854321 47888999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............++..|+|||++....++.
T Consensus 288 ~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 364 (454)
T 1qcf_A 288 DFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364 (454)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCc
Confidence 99999999999999999 999999999999999999999999998754322111223344677899999999899999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++|||||||++|||++ |..|+........ .+........+..++..+.+||.+||+.||++|||+.+|+..|+.+..
T Consensus 365 ~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 9999999999999998 8877754322111 111111122234456789999999999999999999999999988754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=309.35 Aligned_cols=225 Identities=20% Similarity=0.256 Sum_probs=183.9
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+.+|..++..+ +||||+++++++...+..|+||||+++|+|..++.... .+++
T Consensus 34 ~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~l~~ 109 (345)
T 3a8x_A 34 DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPE 109 (345)
T ss_dssp TEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCH
T ss_pred CCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCH
Confidence 678999998643 344567788999999998 89999999999999999999999999999999998765 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+.
T Consensus 110 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 185 (345)
T 3a8x_A 110 EHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGE 185 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-TCCBCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC-CCcccccCCCccccCccccCCC
Confidence 999999999999999999999 999999999999999999999999998743211 2233456789999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchh-------hhhhh-HHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCH-
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVE-------ENRSL-AAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTM- 226 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~-------~~~~~-~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~- 226 (290)
.++.++|+|||||++|+|++|.+||..... ..... ..... ...+...+..+.+||.+||+.||.+||++
T Consensus 186 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 265 (345)
T 3a8x_A 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCH 265 (345)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCC
T ss_pred CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCC
Confidence 999999999999999999999998853110 00011 11111 11223356679999999999999999995
Q ss_pred -----HHHHHHHH
Q 044846 227 -----KEVTLELA 234 (290)
Q Consensus 227 -----~el~~~l~ 234 (290)
.|++.|.+
T Consensus 266 ~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 266 PQTGFADIQGHPF 278 (345)
T ss_dssp TTTHHHHHHTSGG
T ss_pred CcCCHHHHhcCCc
Confidence 68877654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=313.04 Aligned_cols=225 Identities=19% Similarity=0.171 Sum_probs=187.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+++.......+.+.+|+++++.++||||+++++++...+..+|||||+++|+|.+++..... .+++..+.
T Consensus 114 g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---~l~~~~~~ 190 (373)
T 2x4f_A 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY---NLTELDTI 190 (373)
T ss_dssp CCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGG---GCCHHHHH
T ss_pred CcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC---CCCHHHHH
Confidence 678999999876667788899999999999999999999999999999999999999999999876432 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe--ccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILL--VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..... .......||+.|+|||++.+..+
T Consensus 191 ~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 265 (373)
T 2x4f_A 191 LFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYDFV 265 (373)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--CBCCCCCSSCTTCCHHHHTTCBC
T ss_pred HHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--cccccccCCCcEeChhhccCCCC
Confidence 99999999999999999 9999999999999 56678999999998754322 22234568999999999998889
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.++|||||||++|+|++|..||........ +..... .......+..+.+||.+||+.||.+|||+.|++++.
T Consensus 266 ~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-LNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 9999999999999999999998865433221 111111 111234567899999999999999999999999875
Q ss_pred Hh
Q 044846 234 AG 235 (290)
Q Consensus 234 ~~ 235 (290)
+-
T Consensus 345 ~~ 346 (373)
T 2x4f_A 345 WL 346 (373)
T ss_dssp HH
T ss_pred Cc
Confidence 53
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=306.21 Aligned_cols=221 Identities=19% Similarity=0.223 Sum_probs=185.5
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+....|+||||+++|+|.+++.... .+++.
T Consensus 31 ~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~ 106 (318)
T 1fot_A 31 GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----RFPNP 106 (318)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS----SCCHH
T ss_pred CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC----CCCHH
Confidence 678999998642 23456778899999999999999999999999999999999999999999998754 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++.... ......||+.|+|||++.+..
T Consensus 107 ~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~ 179 (318)
T 1fot_A 107 VAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKP 179 (318)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS----CBCCCCSCTTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC----ccccccCCccccCHhHhcCCC
Confidence 99999999999999999999 99999999999999999999999999875432 223467899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~~ 231 (290)
++.++|+|||||++|+|++|.+||....... ....... ...+...+.++.++|.+||+.||.+|| +++++++
T Consensus 180 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 180 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 9999999999999999999999886543221 1111111 112233456799999999999999999 8999988
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
|.+
T Consensus 259 hp~ 261 (318)
T 1fot_A 259 HPW 261 (318)
T ss_dssp SGG
T ss_pred Ccc
Confidence 754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=300.00 Aligned_cols=229 Identities=20% Similarity=0.250 Sum_probs=185.2
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--cceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETE--VPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||||+++... ....+.+.+|+++++.++||||+++++++.... ..++||||+++|+|.+++...... ..+++.
T Consensus 34 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~ 112 (319)
T 4euu_A 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPES 112 (319)
T ss_dssp CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGT-TCCCHH
T ss_pred CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccc-cCCCHH
Confidence 6789999997533 345678889999999999999999999998765 779999999999999999875432 248999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe----ccCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL----VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
.++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..... .......||..|+|||++
T Consensus 113 ~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~ 187 (319)
T 4euu_A 113 EFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMY 187 (319)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT--CCBCCCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC--CceeecccCCCccCHHHh
Confidence 99999999999999999999 9999999999999 77888999999998654322 223345689999999998
Q ss_pred c--------cCCCCCcccchhhHHHHHHHhcCCCCcccchhh---hhhhHHHhhh-------------------------
Q 044846 155 R--------SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE---NRSLAAYFSK------------------------- 198 (290)
Q Consensus 155 ~--------~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~---~~~~~~~~~~------------------------- 198 (290)
. +..++.++|||||||++|+|++|..||...... ..........
T Consensus 188 ~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 267 (319)
T 4euu_A 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV 267 (319)
T ss_dssp HHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCT
T ss_pred hhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCc
Confidence 6 467889999999999999999999988532211 1111111110
Q ss_pred --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 199 --EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 199 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.........+.+++.+||+.||++|||++|++++..+.
T Consensus 268 ~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 268 SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 12245667899999999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=307.69 Aligned_cols=233 Identities=21% Similarity=0.275 Sum_probs=189.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEE--eCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCL--ETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++........+.+.+|+++++.++||||+++++++. ..+..++||||+++|+|.+++..... .+++..
T Consensus 52 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~ 128 (327)
T 3lxl_A 52 GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASR 128 (327)
T ss_dssp SEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG---GCCHHH
T ss_pred ceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc---CCCHHH
Confidence 5789999998877777888999999999999999999999987 45668999999999999999987542 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce--eeccceecccccCccccccC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--LTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~ 157 (290)
++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ......++..|+|||++.+.
T Consensus 129 ~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (327)
T 3lxl_A 129 LLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205 (327)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccC
Confidence 9999999999999999999 999999999999999999999999998754433222 22335678889999999988
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh-------------HHHh----hhhhhHHHHHHHHHHHHHhhccCC
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL-------------AAYF----SKEAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~-------------~~~~----~~~~~~~~~~~~~~li~~cl~~dp 220 (290)
.++.++||||||+++|+|++|..|+.......... .... ....+...+..+.+||.+||+.||
T Consensus 206 ~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 285 (327)
T 3lxl_A 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSP 285 (327)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCCh
Confidence 89999999999999999999998876443221110 0000 011122345679999999999999
Q ss_pred CCCCCHHHHHHHHHhhHhhh
Q 044846 221 KKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 221 ~~Rps~~el~~~l~~~~~~~ 240 (290)
.+|||+.|++++|+.+....
T Consensus 286 ~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 286 QDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp GGSCCHHHHHHHHHHC----
T ss_pred hhCcCHHHHHHHHHHHHhhh
Confidence 99999999999999886544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=303.36 Aligned_cols=223 Identities=18% Similarity=0.178 Sum_probs=178.1
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||||++... .......+..|+..+..+ +||||++++++|...+..++||||+ +++|.+++..... .+++.
T Consensus 82 ~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~l~~~ 157 (311)
T 3p1a_A 82 GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA---SLPEA 157 (311)
T ss_dssp SCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCS---CCCHH
T ss_pred CeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCC---CCCHH
Confidence 678999998643 334455667777777766 9999999999999999999999999 7799999987653 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... ........||+.|+|||++.+ .
T Consensus 158 ~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~-~ 231 (311)
T 3p1a_A 158 QVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT--AGAGEVQEGDPRYMAPELLQG-S 231 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGGGT-C
T ss_pred HHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc--CCCCcccCCCccccCHhHhcC-C
Confidence 99999999999999999999 99999999999999999999999999765432 223344568999999999876 7
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++.++|||||||++|+|++|..++......................+..+.+||.+||+.||++|||+.|++++.+
T Consensus 232 ~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp CSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 8999999999999999999977665443322221111112223334677999999999999999999999997643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=300.07 Aligned_cols=233 Identities=21% Similarity=0.314 Sum_probs=193.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+++. +....+.+.+|+++++.++||||+++++++...+..++||||+.+|+|.+++...... .+++..++
T Consensus 38 ~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~ 114 (288)
T 3kfa_A 38 SLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLL 114 (288)
T ss_dssp TEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTT--TSCHHHHH
T ss_pred CEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccC--CccHhHHH
Confidence 56799999875 3445778999999999999999999999999999999999999999999999875432 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...............+++.|+|||++.+..++.
T Consensus 115 ~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 191 (288)
T 3kfa_A 115 YMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191 (288)
T ss_dssp HHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCc
Confidence 99999999999999999 999999999999999999999999998765544444455566788999999999999999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++||||||+++|+|++ |.+|+........ ..........+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 192 ~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999998 7777654322111 111111122233456779999999999999999999999999988876
Q ss_pred hh
Q 044846 239 SI 240 (290)
Q Consensus 239 ~~ 240 (290)
..
T Consensus 272 ~~ 273 (288)
T 3kfa_A 272 ES 273 (288)
T ss_dssp HH
T ss_pred hc
Confidence 53
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=299.42 Aligned_cols=229 Identities=21% Similarity=0.313 Sum_probs=183.0
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.||+|+++.. .....+.+.+|+.+++.++||||+++++++.. +..++||||+++++|.+++..... .+++..+..
T Consensus 42 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~ 117 (281)
T 3cc6_A 42 NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKN---SLKVLTLVL 117 (281)
T ss_dssp EEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTT---TCCHHHHHH
T ss_pred eEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccc---cCCHHHHHH
Confidence 5899998754 44567789999999999999999999999865 457899999999999999987543 588999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...............+++.|+|||++.+..++.+
T Consensus 118 ~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 194 (281)
T 3cc6_A 118 YSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 194 (281)
T ss_dssp HHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCch
Confidence 9999999999999999 9999999999999999999999999987544332222334556788999999998899999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~ 239 (290)
+||||||+++|+|++ |..|+........ ..........+...+..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus 195 ~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 195 SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 999999999999997 8888753322111 1111111122233556799999999999999999999999999988653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=302.62 Aligned_cols=236 Identities=22% Similarity=0.312 Sum_probs=191.5
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC--------
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD-------- 71 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------- 71 (290)
++.||+|+++... ....+.+.+|+++++.+ +||||+++++++...+..++||||+++|+|.+++......
T Consensus 53 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 132 (313)
T 1t46_A 53 AMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132 (313)
T ss_dssp EEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-------
T ss_pred hhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccc
Confidence 4679999997543 34567899999999999 9999999999999999999999999999999999875421
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeecccee
Q 044846 72 ------QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKV 144 (290)
Q Consensus 72 ------~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g 144 (290)
...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ .......+
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 209 (313)
T 1t46_A 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209 (313)
T ss_dssp -------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEE
T ss_pred cccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCC
Confidence 124899999999999999999999999 99999999999999999999999999875443322 22334567
Q ss_pred cccccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhh---hHHHhhhhhhHHHHHHHHHHHHHhhccCC
Q 044846 145 TFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRS---LAAYFSKEAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 145 ~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~dp 220 (290)
++.|+|||++.+..++.++||||||+++|+|++ |..|+......... .........+...+..+.+++.+||+.||
T Consensus 210 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 289 (313)
T 1t46_A 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289 (313)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred cceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCc
Confidence 889999999999999999999999999999998 88777543221111 11111112223456779999999999999
Q ss_pred CCCCCHHHHHHHHHhhHhhh
Q 044846 221 KKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 221 ~~Rps~~el~~~l~~~~~~~ 240 (290)
.+|||+.|++++|+.+....
T Consensus 290 ~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 290 LKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp GGSCCHHHHHHHHHHHHHHT
T ss_pred hhCcCHHHHHHHHHHHHHHh
Confidence 99999999999999886543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=302.60 Aligned_cols=230 Identities=13% Similarity=0.089 Sum_probs=186.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||++..... .+.+.+|+++++.| +||||+++++++...+..++||||+ +++|.+++..... .+++..+
T Consensus 34 ~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~ 107 (330)
T 2izr_A 34 NEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDR---TFSLKTV 107 (330)
T ss_dssp TEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHH
T ss_pred CcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCC---CCCHHHH
Confidence 67899999875332 34588999999999 9999999999999999999999999 9999999986532 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc-----EEEeccccccccccCCce------eeccceeccccc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ-----AKISDFRTFKSRAIDRTH------LTTQVKVTFGYV 149 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~-----~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~ 149 (290)
+.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++........ ......||+.|+
T Consensus 108 ~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 184 (330)
T 2izr_A 108 LMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184 (330)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred HHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCcccc
Confidence 999999999999999999 999999999999998887 999999998754322211 123567899999
Q ss_pred CccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhh--hhhhHHHhh--hhhh-----HHHHHHHHHHHHHhhccCC
Q 044846 150 DPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSLAAYFS--KEAE-----KEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 150 aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~~~~~~--~~~~-----~~~~~~~~~li~~cl~~dp 220 (290)
|||++.+..++.++|||||||++|+|++|..||...... ......... ...+ ...+ .+.+++.+||+.||
T Consensus 185 aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p 263 (330)
T 2izr_A 185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDF 263 (330)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCT
T ss_pred ChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCC
Confidence 999999999999999999999999999999988653211 111111100 0011 1123 89999999999999
Q ss_pred CCCCCHHHHHHHHHhhHhhhC
Q 044846 221 KKQPTMKEVTLELAGIRASIG 241 (290)
Q Consensus 221 ~~Rps~~el~~~l~~~~~~~~ 241 (290)
.+||++++|.+.|+.+....+
T Consensus 264 ~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 264 FEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp TCCCCHHHHHHHHHHHHHHTT
T ss_pred CCCCCHHHHHHHHHHHHHHcC
Confidence 999999999999988876553
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=297.67 Aligned_cols=229 Identities=23% Similarity=0.337 Sum_probs=187.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|+++.... ..+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++..... .+++..+.
T Consensus 32 ~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~ 107 (267)
T 3t9t_A 32 KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLL 107 (267)
T ss_dssp TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTT---CCCHHHHH
T ss_pred CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcc---cCCHHHHH
Confidence 46799999976443 346799999999999999999999999999999999999999999999986542 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...............++..|+|||++.+..++.
T Consensus 108 ~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 184 (267)
T 3t9t_A 108 GMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184 (267)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccc
Confidence 99999999999999999 999999999999999999999999997654322222223345677899999999889999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
++||||||+++|+|++ |..|+....... ...... ....+...+..+.+++.+||+.||++|||+.+++++|+.+.
T Consensus 185 ~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhchhhhHHHHHHHhccCCCCCCCCCHHH-HHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999998 777775432221 111111 11122334667899999999999999999999999999886
Q ss_pred h
Q 044846 238 A 238 (290)
Q Consensus 238 ~ 238 (290)
.
T Consensus 264 ~ 264 (267)
T 3t9t_A 264 E 264 (267)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=308.76 Aligned_cols=222 Identities=16% Similarity=0.168 Sum_probs=186.5
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.+..|+||||+++|+|.+++.... .+++.
T Consensus 66 ~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~ 141 (350)
T 1rdq_E 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEP 141 (350)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC----CCCHH
T ss_pred CCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC----CCCHH
Confidence 678999998642 23456788999999999999999999999999999999999999999999998765 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+..
T Consensus 142 ~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~ 214 (350)
T 1rdq_E 142 HARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKG 214 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC----cccccCCccccCHHHhcCCC
Confidence 99999999999999999999 999999999999999999999999998754321 23467899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPT-----MKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~el~~ 231 (290)
++.++|||||||++|+|++|.+||....... ....... ...+...+..+.+||.+||+.||.+||+ ++|+++
T Consensus 215 ~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 9999999999999999999999886543221 1111111 1122345677999999999999999998 899987
Q ss_pred HHHh
Q 044846 232 ELAG 235 (290)
Q Consensus 232 ~l~~ 235 (290)
|.+.
T Consensus 294 h~~f 297 (350)
T 1rdq_E 294 HKWF 297 (350)
T ss_dssp SGGG
T ss_pred CcCc
Confidence 7543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=300.67 Aligned_cols=224 Identities=22% Similarity=0.300 Sum_probs=176.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHh--cCCCceeeEEeEEEeC----CcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQ--INHRNVVKILGCCLET----EVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~--l~Hpniv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||++.. .....+..|.+++.. ++||||+++++++... ...++||||+++|+|.++++.. .+
T Consensus 31 ~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~ 102 (301)
T 3q4u_A 31 GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TL 102 (301)
T ss_dssp TEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC-----CB
T ss_pred CEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc-----cc
Confidence 67899999864 344566778888777 7999999999997653 4579999999999999999643 48
Q ss_pred CHHHHHHHHHHHHHHHHHHh--------hCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee---ecccee
Q 044846 76 TWEMRLRITVEVSRVLSYLH--------SVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL---TTQVKV 144 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH--------~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~g 144 (290)
++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+|||+++......... .....|
T Consensus 103 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 179 (301)
T 3q4u_A 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179 (301)
T ss_dssp CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccccc
Confidence 99999999999999999999 777 9999999999999999999999999986543332222 233478
Q ss_pred cccccCccccccC------CCCCcccchhhHHHHHHHhcC----------CCCcccchhhh---hhhHHHhh--------
Q 044846 145 TFGYVDPKYFRSS------QFTEKSDVYSFSVVLVELNWT----------KPIHLVDVEEN---RSLAAYFS-------- 197 (290)
Q Consensus 145 ~~~y~aPE~~~~~------~~~~~~DiwS~G~il~~l~~~----------~~~~~~~~~~~---~~~~~~~~-------- 197 (290)
|+.|+|||++.+. .++.++|||||||++|+|++| .+||....... ........
T Consensus 180 t~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (301)
T 3q4u_A 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNI 259 (301)
T ss_dssp CGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred ccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCC
Confidence 9999999999876 345689999999999999999 66664322111 11111100
Q ss_pred --hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 198 --KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 198 --~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.......+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 260 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 260 PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 112234667899999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=297.86 Aligned_cols=227 Identities=23% Similarity=0.358 Sum_probs=175.9
Q ss_pred CceEEEEeecccC----chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVH----ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++... ....+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++... .+++
T Consensus 30 ~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~ 104 (271)
T 3dtc_A 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPP 104 (271)
T ss_dssp TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS-----CCCH
T ss_pred CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC-----CCCH
Confidence 5779999986432 233578899999999999999999999999999999999999999999998643 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc--------CCcEEEeccccccccccCCceeeccceeccccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD--------KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYV 149 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~--------~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 149 (290)
..++.++.|++.||.|||+++..+|+||||||+||+++. ++.+||+|||++...... ......|++.|+
T Consensus 105 ~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~ 181 (271)
T 3dtc_A 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMSAAGAYAWM 181 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccc---cccCCCCcccee
Confidence 999999999999999999988555889999999999986 678999999997643321 122456899999
Q ss_pred CccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 150 DPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 150 aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
|||++.+..++.++||||||+++|+|++|..||............... ...+...+..+.+++.+||+.||.+|||+
T Consensus 182 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 261 (271)
T 3dtc_A 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF 261 (271)
T ss_dssp CHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCH
Confidence 999999999999999999999999999999988654332222111111 12223455679999999999999999999
Q ss_pred HHHHHHHHhh
Q 044846 227 KEVTLELAGI 236 (290)
Q Consensus 227 ~el~~~l~~~ 236 (290)
.|++++|+.+
T Consensus 262 ~e~l~~L~~l 271 (271)
T 3dtc_A 262 TNILDQLTTI 271 (271)
T ss_dssp HHHHHHHHC-
T ss_pred HHHHHHHhcC
Confidence 9999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=299.51 Aligned_cols=225 Identities=18% Similarity=0.244 Sum_probs=180.4
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++...+..++||||+. |++.+.+..... .+++..
T Consensus 27 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~l~~~~ 102 (292)
T 3o0g_A 27 HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNG---DLDPEI 102 (292)
T ss_dssp CCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHTTT---CCCHHH
T ss_pred CceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC-CCHHHHHHhCCC---CCCHHH
Confidence 678999998643 33445788999999999999999999999999999999999996 477777765432 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC-
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ- 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~- 158 (290)
++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..... ........||+.|+|||++.+..
T Consensus 103 ~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~ 178 (292)
T 3o0g_A 103 VKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKL 178 (292)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCCCSCCSCGGGCCHHHHTTCSC
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-cccccCCccccCCcChHHHcCCCC
Confidence 9999999999999999999 999999999999999999999999998654322 22234456799999999998765
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-------------------------------hhhHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-------------------------------EAEKEEVIT 207 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~ 207 (290)
++.++|||||||++|+|++|..|+.........+...... ......+..
T Consensus 179 ~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (292)
T 3o0g_A 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNAT 258 (292)
T ss_dssp CCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHH
T ss_pred cCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChH
Confidence 7999999999999999998777765443332222221110 001124567
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 208 FAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 208 ~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.+||.+||+.||++|||++|+++|-+
T Consensus 259 ~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 259 GRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 889999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=311.79 Aligned_cols=223 Identities=19% Similarity=0.234 Sum_probs=183.2
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.. ......+.+.+|+++|+.++|||||+++++|...+..|+||||+.||+|..++.... .+++.
T Consensus 40 ~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~ 115 (384)
T 4fr4_A 40 KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV----HFKEE 115 (384)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC----CCCHH
T ss_pred CCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC----CCCHH
Confidence 67899999863 234456789999999999999999999999999999999999999999999998654 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc--
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-- 156 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 156 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........||+.|+|||++.+
T Consensus 116 ~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~ 190 (384)
T 4fr4_A 116 TVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITTMAGTKPYMAPEMFSSRK 190 (384)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT--TCCBCCCCSCGGGCCGGGTCCCS
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC--CCceeccCCCccccCCeeeccCC
Confidence 99999999999999999999 99999999999999999999999999875432 223345679999999999874
Q ss_pred -CCCCCcccchhhHHHHHHHhcCCCCcccchhh--hhhhHHH--hhhhhhHHHHHHHHHHHHHhhccCCCCCCC-HHHHH
Q 044846 157 -SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSLAAY--FSKEAEKEEVITFAMVAKRCLNLNGKKQPT-MKEVT 230 (290)
Q Consensus 157 -~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~el~ 230 (290)
..++.++|||||||++|+|++|.+||...... ....... .....+...+..+.+||.+||+.||.+||+ +++++
T Consensus 191 ~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp SCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred CCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 45889999999999999999999998643221 1111111 111223345678999999999999999998 77777
Q ss_pred HHH
Q 044846 231 LEL 233 (290)
Q Consensus 231 ~~l 233 (290)
.+.
T Consensus 271 ~hp 273 (384)
T 4fr4_A 271 NFP 273 (384)
T ss_dssp TSG
T ss_pred cCh
Confidence 653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.54 Aligned_cols=225 Identities=17% Similarity=0.224 Sum_probs=177.9
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++.. .....+.+.+|+++++.++||||+++++++...+..++||||++ |+|.+++..... .+++..
T Consensus 45 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~ 120 (311)
T 3niz_A 45 GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKT---GLQDSQ 120 (311)
T ss_dssp SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTT---CCCHHH
T ss_pred CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccC---CCCHHH
Confidence 678999998743 23345778999999999999999999999999999999999996 589998876543 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-CC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-SQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~ 158 (290)
+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+ ..
T Consensus 121 ~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~ 196 (311)
T 3niz_A 121 IKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVVTLWYRAPDVLMGSKK 196 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C---CCCCCCTTCCHHHHTTCCS
T ss_pred HHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-ccccCCcccCCcCCHHHhcCCCC
Confidence 9999999999999999999 9999999999999999999999999987543221 22334567999999999876 56
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhhh-----------------------------hhhHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFSK-----------------------------EAEKEEVIT 207 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~~-----------------------------~~~~~~~~~ 207 (290)
++.++|||||||++|+|++|.+||......... ....... ......+.+
T Consensus 197 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (311)
T 3niz_A 197 YSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQE 276 (311)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHH
T ss_pred CCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHH
Confidence 899999999999999999999888643322111 1100000 001123457
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 208 FAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 208 ~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.+||.+||+.||++|||+.|+++|.+
T Consensus 277 ~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 277 GIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 889999999999999999999998744
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=305.98 Aligned_cols=230 Identities=20% Similarity=0.317 Sum_probs=181.5
Q ss_pred eEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.||+|+++. ......+.+.+|+.+++.++||||++++++|.... .++|+||+.+|+|.+++..... .+++..++.
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~ 121 (327)
T 3poz_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD---NIGSQYLLN 121 (327)
T ss_dssp EEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTT---SCCHHHHHH
T ss_pred EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCC---CCCHHHHHH
Confidence 368888753 33455778999999999999999999999998765 7899999999999999987543 589999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccccccCCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ......+|..|+|||++.+..++.
T Consensus 122 ~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 198 (327)
T 3poz_A 122 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198 (327)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCc
Confidence 9999999999999999 999999999999999999999999998754332222 223345678999999999999999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++|||||||++|+|++ |..|+........ .+........+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 199 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred hhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 9999999999999998 8887754322211 111111112233456679999999999999999999999999998865
Q ss_pred hh
Q 044846 239 SI 240 (290)
Q Consensus 239 ~~ 240 (290)
..
T Consensus 279 ~~ 280 (327)
T 3poz_A 279 DP 280 (327)
T ss_dssp SH
T ss_pred hh
Confidence 43
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=296.52 Aligned_cols=232 Identities=32% Similarity=0.485 Sum_probs=187.6
Q ss_pred CceEEEEeeccc----CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV----HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|++... .....+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++...... ..+++
T Consensus 54 ~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~ 132 (307)
T 2nru_A 54 NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSW 132 (307)
T ss_dssp SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC-CCCCH
T ss_pred CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC-CCCCH
Confidence 578999998642 2345678999999999999999999999999999999999999999999999754322 25899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceecccccCcccccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~ 156 (290)
..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ........|++.|+|||++.+
T Consensus 133 ~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 209 (307)
T 2nru_A 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG 209 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC
Confidence 999999999999999999999 9999999999999999999999999986543222 222334578999999998865
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhH-----------HHhh---hhhhHHHHHHHHHHHHHhhccCC
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLA-----------AYFS---KEAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~-----------~~~~---~~~~~~~~~~~~~li~~cl~~dp 220 (290)
.++.++||||||+++|+|++|.+|+........ .+. .... .......+..+.+++.+||+.||
T Consensus 210 -~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 288 (307)
T 2nru_A 210 -EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKK 288 (307)
T ss_dssp -EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSST
T ss_pred -CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCc
Confidence 478899999999999999999988864322110 000 0000 11234566789999999999999
Q ss_pred CCCCCHHHHHHHHHhhHh
Q 044846 221 KKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 221 ~~Rps~~el~~~l~~~~~ 238 (290)
.+|||+.+++++|+.+..
T Consensus 289 ~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 289 NKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTSCCHHHHHHHHHHHC-
T ss_pred ccCcCHHHHHHHHHHHhc
Confidence 999999999999988753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=310.34 Aligned_cols=224 Identities=20% Similarity=0.197 Sum_probs=185.2
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+..|..++..+ +||||+++++++.+.+..|+||||++||+|.+++.... .+++
T Consensus 42 ~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~ 117 (345)
T 1xjd_A 42 NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDL 117 (345)
T ss_dssp TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCH
T ss_pred CCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCH
Confidence 678999998742 234567788999999987 99999999999999999999999999999999998765 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+.
T Consensus 118 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 193 (345)
T 1xjd_A 118 SRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEILLGQ 193 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccC-CCcccCCCCCcccCChhhhcCC
Confidence 999999999999999999999 999999999999999999999999998753322 1223456789999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMK-EVTLELA 234 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-el~~~l~ 234 (290)
.++.++|+|||||++|+|++|.+||....... ....... ...+...+..+.+||.+||+.||.+||++. ++++|.+
T Consensus 194 ~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-LFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 99999999999999999999999886543221 1111111 112223467799999999999999999997 8876643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=304.08 Aligned_cols=231 Identities=22% Similarity=0.313 Sum_probs=188.2
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++... ....+.+.+|+++++.++||||+++++++... ...++||||+++|+|.+++... .+++.
T Consensus 60 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~ 134 (318)
T 3lxp_A 60 GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLA 134 (318)
T ss_dssp CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-----CCCHH
T ss_pred CcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-----CCCHH
Confidence 5679999997543 45577899999999999999999999999884 5789999999999999999764 38899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce--eeccceecccccCcccccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--LTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~ 156 (290)
.++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ......++..|+|||++.+
T Consensus 135 ~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 211 (318)
T 3lxp_A 135 QLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcC
Confidence 99999999999999999999 999999999999999999999999998765433221 2234557888999999998
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh-------------HHHh----hhhhhHHHHHHHHHHHHHhhccC
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL-------------AAYF----SKEAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~-------------~~~~----~~~~~~~~~~~~~~li~~cl~~d 219 (290)
..++.++||||||+++|+|++|..|+.......... .... ....+...+..+.+||.+||+.|
T Consensus 212 ~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 291 (318)
T 3lxp_A 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETE 291 (318)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCC
Confidence 889999999999999999999998876443221110 0000 01122334567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhHhhh
Q 044846 220 GKKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 220 p~~Rps~~el~~~l~~~~~~~ 240 (290)
|.+|||+.|+++.|+.+....
T Consensus 292 P~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 292 ASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp GGGSCCHHHHHHHHHHHHHHH
T ss_pred cccCcCHHHHHHHHHHHHHhh
Confidence 999999999999999887655
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=298.42 Aligned_cols=230 Identities=23% Similarity=0.332 Sum_probs=184.4
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+++++.++||||+++++++... +..++||||+++|+|.+++..... .+++.
T Consensus 50 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~ 126 (302)
T 4e5w_A 50 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLK 126 (302)
T ss_dssp SEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT---TCCHH
T ss_pred CeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc---cCCHH
Confidence 678999998743 344567899999999999999999999999876 678999999999999999976543 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc--eeeccceecccccCcccccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~ 156 (290)
.++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .......+|..|+|||++.+
T Consensus 127 ~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 203 (302)
T 4e5w_A 127 QQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203 (302)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC
Confidence 99999999999999999999 99999999999999999999999999876543322 12234567888999999999
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh-------------hHHHh----hhhhhHHHHHHHHHHHHHhhccC
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS-------------LAAYF----SKEAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~-------------~~~~~----~~~~~~~~~~~~~~li~~cl~~d 219 (290)
..++.++||||||+++|+|++|..++......... ..... ....+...+..+.+|+.+||+.|
T Consensus 204 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 283 (302)
T 4e5w_A 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQ 283 (302)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 88999999999999999999998875433211110 00000 01112234567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhH
Q 044846 220 GKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 220 p~~Rps~~el~~~l~~~~ 237 (290)
|.+|||+.++++.|+.+.
T Consensus 284 p~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 284 PSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHh
Confidence 999999999999998763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=311.83 Aligned_cols=224 Identities=17% Similarity=0.173 Sum_probs=186.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++..........+.+|+.+|+.++||||+++++++...+..++||||+.+|+|.+++..... .+++..+.
T Consensus 76 ~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~l~~~~~~ 152 (387)
T 1kob_A 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVI 152 (387)
T ss_dssp CCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC---CBCHHHHH
T ss_pred CCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcC---CCCHHHHH
Confidence 678999999876666677899999999999999999999999999999999999999999999975432 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc--CCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD--KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+++..... .......||+.|+|||++.+..+
T Consensus 153 ~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 227 (387)
T 1kob_A 153 NYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPV 227 (387)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCEEEECSSGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC--cceeeeccCCCccCchhccCCCC
Confidence 99999999999999999 999999999999974 577999999998754322 22234568999999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.++|||||||++|+|++|.+||........ +..... .......+..+.+||.+||+.||.+|||+.|++++.
T Consensus 228 ~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 9999999999999999999998865432211 111111 111223467799999999999999999999999885
Q ss_pred H
Q 044846 234 A 234 (290)
Q Consensus 234 ~ 234 (290)
+
T Consensus 307 ~ 307 (387)
T 1kob_A 307 W 307 (387)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=295.46 Aligned_cols=230 Identities=12% Similarity=0.032 Sum_probs=187.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++......++||||+ +++|.+++..... .+++..+
T Consensus 35 ~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~~~~~~ 108 (298)
T 1csn_A 35 NQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR---KFSVKTV 108 (298)
T ss_dssp TEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHH
T ss_pred CcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhcc---CCCHHHH
Confidence 6789999986432 334678999999999 8999999999999999999999999 9999999986542 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc-----EEEeccccccccccCCce------eeccceeccccc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ-----AKISDFRTFKSRAIDRTH------LTTQVKVTFGYV 149 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~-----~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~ 149 (290)
..++.||+.||.|||+++ |+||||||+||+++.++. +||+|||+++........ ......||+.|+
T Consensus 109 ~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 185 (298)
T 1csn_A 109 AMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185 (298)
T ss_dssp HHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred HHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccC
Confidence 999999999999999999 999999999999987776 999999998754432221 124466899999
Q ss_pred CccccccCCCCCcccchhhHHHHHHHhcCCCCcccchh--hhhhhHHHhh----h---hhhHHHHHHHHHHHHHhhccCC
Q 044846 150 DPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVE--ENRSLAAYFS----K---EAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 150 aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~--~~~~~~~~~~----~---~~~~~~~~~~~~li~~cl~~dp 220 (290)
|||++.+..++.++||||||+++|+|++|..||..... .......... . ......+..+.+++.+||+.||
T Consensus 186 aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 265 (298)
T 1csn_A 186 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAF 265 (298)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred CchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCc
Confidence 99999999999999999999999999999998865321 1111111101 0 1111345689999999999999
Q ss_pred CCCCCHHHHHHHHHhhHhhh
Q 044846 221 KKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 221 ~~Rps~~el~~~l~~~~~~~ 240 (290)
++|||+.++++.|+.+....
T Consensus 266 ~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 266 DATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp TCCCCHHHHHHHHHHHHHHT
T ss_pred ccCCCHHHHHHHHHHHHHhc
Confidence 99999999999999987755
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=318.26 Aligned_cols=225 Identities=19% Similarity=0.213 Sum_probs=185.3
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||++++++|.+.+..|+|||||+||+|.+++... .+++.
T Consensus 94 ~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~ 168 (410)
T 3v8s_A 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEK 168 (410)
T ss_dssp CCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC-----CCCHH
T ss_pred CcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC-----CCCHH
Confidence 678999998641 2233445889999999999999999999999999999999999999999999754 48899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............||+.|+|||++.+..
T Consensus 169 ~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 245 (410)
T 3v8s_A 169 WARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245 (410)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTT
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccC
Confidence 99999999999999999999 999999999999999999999999998765433333345678999999999998765
Q ss_pred ----CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCC--CCCH
Q 044846 159 ----FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKK--QPTM 226 (290)
Q Consensus 159 ----~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~--Rps~ 226 (290)
++.++|||||||++|+|++|.+||........ ...... .+.....+..+.+||.+||..+|.+ ||++
T Consensus 246 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~ 324 (410)
T 3v8s_A 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGV 324 (410)
T ss_dssp TTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCH
T ss_pred CCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-HHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCH
Confidence 78899999999999999999999875432211 111111 1111235678999999999999988 9999
Q ss_pred HHHHHHHHh
Q 044846 227 KEVTLELAG 235 (290)
Q Consensus 227 ~el~~~l~~ 235 (290)
+|+++|.+.
T Consensus 325 ~ei~~Hp~f 333 (410)
T 3v8s_A 325 EEIKRHLFF 333 (410)
T ss_dssp HHHHTSGGG
T ss_pred HHHhcCccc
Confidence 999998654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=320.41 Aligned_cols=229 Identities=20% Similarity=0.288 Sum_probs=180.8
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
..||||+++... ...+.|.+|+++|+.++||||+++++++.. +..++||||+++|+|.+++...... .+++..+..
T Consensus 209 ~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~ 284 (452)
T 1fmk_A 209 TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVD 284 (452)
T ss_dssp EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHT--TCCHHHHHH
T ss_pred ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCC--CCCHHHHHH
Confidence 469999998643 346789999999999999999999999876 6789999999999999999754321 488999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............++..|+|||++.+..++.+
T Consensus 285 i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 361 (452)
T 1fmk_A 285 MAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361 (452)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCcc
Confidence 9999999999999999 9999999999999999999999999987543322222233456788999999999999999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
+||||||+++|+|++ |..|+...... ....... ....+..++..+.+||.+||+.||++|||++++++.|+.+..
T Consensus 362 sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 362 SDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ccHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 999999999999998 77776533221 1111111 112234456789999999999999999999999999988754
Q ss_pred h
Q 044846 239 S 239 (290)
Q Consensus 239 ~ 239 (290)
.
T Consensus 441 ~ 441 (452)
T 1fmk_A 441 S 441 (452)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=304.52 Aligned_cols=228 Identities=20% Similarity=0.239 Sum_probs=176.7
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcc----eEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVP----LLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|+++.. +......+.+|+++++.++||||+++++++...... |+||||+++|+|.+++.... .
T Consensus 37 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~ 112 (311)
T 3ork_A 37 HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----P 112 (311)
T ss_dssp TEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC----S
T ss_pred CceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC----C
Confidence 678999999753 334466789999999999999999999999876544 99999999999999998765 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc--eeeccceecccccCcc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYVDPK 152 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE 152 (290)
+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .......||+.|+|||
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 189 (311)
T 3ork_A 113 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHH
Confidence 899999999999999999999999 99999999999999999999999999865432221 1223456899999999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhh-----hHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEA-----EKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
++.+..++.++||||||+++|+|++|..||.................. ....+..+.++|.+||+.||++||++.
T Consensus 190 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~ 269 (311)
T 3ork_A 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 269 (311)
T ss_dssp HHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhH
Confidence 999999999999999999999999999988654433222221111111 122456799999999999999999866
Q ss_pred HHHHH-HHhh
Q 044846 228 EVTLE-LAGI 236 (290)
Q Consensus 228 el~~~-l~~~ 236 (290)
+++.+ +...
T Consensus 270 ~~l~~~l~~~ 279 (311)
T 3ork_A 270 AEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 66544 4443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=306.12 Aligned_cols=233 Identities=13% Similarity=0.141 Sum_probs=181.5
Q ss_pred CceEEEEeecccCchh-----------HHHHHHHHHHHHhcCCCceeeEEeEEEeC----CcceEEEEeCCCCCHHHHHh
Q 044846 2 EELWLLKKSKSVHESN-----------VEQFINEVVILSQINHRNVVKILGCCLET----EVPLLVYEFIPNGSLYQYIH 66 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~-----------~~~~~~E~~~l~~l~Hpniv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~ 66 (290)
++.||+|++....... ...+..|+..+..++||||+++++++... ...+|||||+ +++|.+++.
T Consensus 65 ~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~ 143 (364)
T 3op5_A 65 DAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYE 143 (364)
T ss_dssp TCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHH
T ss_pred ccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHH
Confidence 5789999987543221 11234455667777899999999999875 4589999999 999999998
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec--cCCcEEEeccccccccccCCcee------
Q 044846 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV--DKYQAKISDFRTFKSRAIDRTHL------ 138 (290)
Q Consensus 67 ~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~--~~~~~kl~dfg~~~~~~~~~~~~------ 138 (290)
.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.........
T Consensus 144 ~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 217 (364)
T 3op5_A 144 ANAK---RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217 (364)
T ss_dssp HTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCS
T ss_pred hccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCc
Confidence 7532 5899999999999999999999999 99999999999999 88999999999986543221111
Q ss_pred eccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhhhh---h------HHHHH
Q 044846 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSKEA---E------KEEVI 206 (290)
Q Consensus 139 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~---~------~~~~~ 206 (290)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||............. ..... . ...+.
T Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (364)
T 3op5_A 218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPG 297 (364)
T ss_dssp SCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCH
T ss_pred ccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHH
Confidence 123458999999999999999999999999999999999999887432221111110 00000 0 12256
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhhC
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLELAGIRASIG 241 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~~~ 241 (290)
.+.+++.+||+.||.+||++.+|++.|+.+....+
T Consensus 298 ~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 298 EIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 79999999999999999999999999998877653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=311.39 Aligned_cols=224 Identities=21% Similarity=0.276 Sum_probs=177.0
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCC--cceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQIN-HRNVVKILGCCLETE--VPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||+|++.. ......+.+.+|+.+++.+. ||||+++++++...+ ..|+|||||. |+|..++... .++
T Consensus 34 ~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~ 107 (388)
T 3oz6_A 34 GEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN-----ILE 107 (388)
T ss_dssp CCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT-----CCC
T ss_pred CCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC-----CCC
Confidence 67899999854 34556778899999999996 999999999998654 6899999996 6999999863 488
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC--------------------Cc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID--------------------RT 136 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~--------------------~~ 136 (290)
+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 108 ~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (388)
T 3oz6_A 108 PVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184 (388)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC----------
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999 999999999999999999999999998753210 11
Q ss_pred eeeccceecccccCcccccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHhhhh--------------
Q 044846 137 HLTTQVKVTFGYVDPKYFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYFSKE-------------- 199 (290)
Q Consensus 137 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~~~~-------------- 199 (290)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.......... ......+
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 264 (388)
T 3oz6_A 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAK 264 (388)
T ss_dssp -----CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHH
Confidence 12344678999999999986 678999999999999999999999886543221110 0000000
Q ss_pred --------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 200 --------------------------------AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 200 --------------------------------~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.....+..+.+|+.+||+.||++|||++|+++|.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 265 TMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF 331 (388)
T ss_dssp HHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTT
T ss_pred HHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHH
Confidence 00022457899999999999999999999998854
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=303.85 Aligned_cols=225 Identities=18% Similarity=0.206 Sum_probs=176.5
Q ss_pred CceEEEEeeccc----CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV----HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .......+.+|+.+++.++||||+++++++...+..|+||||+++|+|.+++.... .+++
T Consensus 45 ~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~ 120 (327)
T 3a62_A 45 GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG----IFME 120 (327)
T ss_dssp TCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS----SCCH
T ss_pred CcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC----CCCH
Confidence 678999998753 23345678899999999999999999999999999999999999999999998765 5889
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+.
T Consensus 121 ~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 196 (327)
T 3a62_A 121 DTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHTFCGTIEYMAPEILMRS 196 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHTTS
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccC-CccccccCCCcCccCHhhCcCC
Confidence 999999999999999999999 999999999999999999999999997643221 1223446789999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVT 230 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~ 230 (290)
.++.++|||||||++|+|++|..||........ ...... ...+...+..+.+||.+||+.||.+|| ++.|++
T Consensus 197 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l 275 (327)
T 3a62_A 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-IDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275 (327)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHH
T ss_pred CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHH
Confidence 999999999999999999999998865432211 111111 112233467799999999999999999 788998
Q ss_pred HHHHh
Q 044846 231 LELAG 235 (290)
Q Consensus 231 ~~l~~ 235 (290)
+|.+.
T Consensus 276 ~hp~f 280 (327)
T 3a62_A 276 AHPFF 280 (327)
T ss_dssp HSGGG
T ss_pred cCCcc
Confidence 87553
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=299.70 Aligned_cols=237 Identities=21% Similarity=0.242 Sum_probs=183.6
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++. .+....+.+.+|+.+++.++||||+++++++...+..++||||+.+|+|.+++.........+++.
T Consensus 57 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 136 (310)
T 2wqm_A 57 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER 136 (310)
T ss_dssp CCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHH
T ss_pred CceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHH
Confidence 67899999874 335567789999999999999999999999999999999999999999999997643333368999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... ........|+..|+|||++.+..
T Consensus 137 ~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 212 (310)
T 2wqm_A 137 TVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLVGTPYYMSPERIHENG 212 (310)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------------------CCSSCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCC-CccccccCCCeeEeChHHhCCCC
Confidence 99999999999999999999 999999999999999999999999997643322 12223456889999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
++.++||||||+++|+|++|..|+................ ......+..+.+|+.+||+.||.+|||+.++++.|
T Consensus 213 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l 292 (310)
T 2wqm_A 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292 (310)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 9999999999999999999998886432221111111111 11123456799999999999999999999999999
Q ss_pred HhhHhhhCc
Q 044846 234 AGIRASIGA 242 (290)
Q Consensus 234 ~~~~~~~~~ 242 (290)
+.+......
T Consensus 293 ~~l~~~~~~ 301 (310)
T 2wqm_A 293 KRMHACTAS 301 (310)
T ss_dssp HHHHHHHC-
T ss_pred HHHHHhhhh
Confidence 999876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=296.92 Aligned_cols=233 Identities=21% Similarity=0.294 Sum_probs=189.9
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
++.||+|+++.. .....+.+.+|+++++.++||||+++++++ ..+..++||||+++++|.+++..... .+++..+
T Consensus 37 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~ 112 (287)
T 1u59_A 37 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNV 112 (287)
T ss_dssp CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTT---TSCHHHH
T ss_pred cceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCc---cCCHHHH
Confidence 456999999764 345677899999999999999999999999 55678999999999999999975432 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee--eccceecccccCccccccCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL--TTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~ 158 (290)
..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......... .....+++.|+|||++.+..
T Consensus 113 ~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (287)
T 1u59_A 113 AELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189 (287)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCC
Confidence 999999999999999999 9999999999999999999999999987543322221 12344678899999998888
Q ss_pred CCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++.++||||||+++|+|++ |..|+....... ...... ....+...+..+.++|.+||+.||++|||+.+++++|+
T Consensus 190 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999998 888875433221 111111 11223345678999999999999999999999999999
Q ss_pred hhHhhhCc
Q 044846 235 GIRASIGA 242 (290)
Q Consensus 235 ~~~~~~~~ 242 (290)
.+..+...
T Consensus 269 ~~~~~~~~ 276 (287)
T 1u59_A 269 ACYYSLAS 276 (287)
T ss_dssp HHHHHHHT
T ss_pred HHHHhcCC
Confidence 99876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=302.73 Aligned_cols=226 Identities=20% Similarity=0.222 Sum_probs=179.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||+++.......+.+.+|++++.++ +||||+++++++...+..++||||+++|+|.+++.... .+++..+
T Consensus 38 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~ 113 (316)
T 2ac3_A 38 SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR----HFNELEA 113 (316)
T ss_dssp CCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS----SCCHHHH
T ss_pred CcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC----CCCHHHH
Confidence 678999999876666778899999999996 89999999999999999999999999999999998765 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc---EEEeccccccccccCCc------eeeccceecccccCc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ---AKISDFRTFKSRAIDRT------HLTTQVKVTFGYVDP 151 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~---~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~aP 151 (290)
..++.||+.||.|||+++ |+||||||+||+++.++. +||+|||++........ .......||+.|+||
T Consensus 114 ~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 190 (316)
T 2ac3_A 114 SVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190 (316)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCH
T ss_pred HHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccCh
Confidence 999999999999999999 999999999999998776 99999999765432111 112234589999999
Q ss_pred ccccc-----CCCCCcccchhhHHHHHHHhcCCCCcccchhhh-------------hhh-HHHhhh------hhhHHHHH
Q 044846 152 KYFRS-----SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEEN-------------RSL-AAYFSK------EAEKEEVI 206 (290)
Q Consensus 152 E~~~~-----~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~-------------~~~-~~~~~~------~~~~~~~~ 206 (290)
|++.+ ..++.++|||||||++|+|++|.+||....... ..+ ...... ......+.
T Consensus 191 E~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (316)
T 2ac3_A 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC 270 (316)
T ss_dssp HHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred HHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCH
Confidence 99875 457889999999999999999999886532110 111 111110 01112456
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.+.+||.+||+.||.+|||+.|++++.+
T Consensus 271 ~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 271 AAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 7999999999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=299.56 Aligned_cols=230 Identities=19% Similarity=0.180 Sum_probs=179.4
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. +....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.... .+++.
T Consensus 59 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~ 134 (309)
T 2h34_A 59 ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAPP 134 (309)
T ss_dssp TEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC----SCCHH
T ss_pred CeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC----CCCHH
Confidence 578999998643 23345789999999999999999999999999999999999999999999998764 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...............|++.|+|||++.+..
T Consensus 135 ~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 211 (309)
T 2h34_A 135 RAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC--
T ss_pred HHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCC
Confidence 99999999999999999999 999999999999999999999999997654433223334466899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCC-CHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQP-TMKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~el~~ 231 (290)
++.++||||||+++|+|++|..||....... ...... .......+..+.++|.+||+.||++|| |++++++
T Consensus 212 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 212 ATYRADIYALTCVLYECLTGSPPYQGDQLSV--MGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --CCCHHHHHHHHHHHHHHSSCSSCSCHHHH--HHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCchHhHHHHHHHHHHHHHCCCCCCCchHHH--HHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999999999999886544321 111111 111233456799999999999999999 8999999
Q ss_pred HHHhhHhhh
Q 044846 232 ELAGIRASI 240 (290)
Q Consensus 232 ~l~~~~~~~ 240 (290)
.|+......
T Consensus 290 ~l~~~l~~~ 298 (309)
T 2h34_A 290 AAHAALATA 298 (309)
T ss_dssp HHHHTCC--
T ss_pred HHHHHHHhh
Confidence 998775543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=315.07 Aligned_cols=226 Identities=22% Similarity=0.254 Sum_probs=172.5
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----CcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLET-----EVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||||++.. .+....+++.+|+++|+.++||||+++++++... ...|+||||+ +|+|.+++.... .
T Consensus 78 ~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~ 152 (458)
T 3rp9_A 78 KRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPV----Y 152 (458)
T ss_dssp -CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSC----C
T ss_pred CcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCC----C
Confidence 67899999864 3345567899999999999999999999999543 4689999998 679999998654 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc------------------
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT------------------ 136 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~------------------ 136 (290)
+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 153 l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (458)
T 3rp9_A 153 LTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229 (458)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccccc
Confidence 899999999999999999999999 99999999999999999999999999875432111
Q ss_pred --------eeeccceecccccCcccc-ccCCCCCcccchhhHHHHHHHhc-----------CCCCcccchh---------
Q 044846 137 --------HLTTQVKVTFGYVDPKYF-RSSQFTEKSDVYSFSVVLVELNW-----------TKPIHLVDVE--------- 187 (290)
Q Consensus 137 --------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwS~G~il~~l~~-----------~~~~~~~~~~--------- 187 (290)
.......||+.|+|||++ ....|+.++|||||||++|||++ +.++|.....
T Consensus 230 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~ 309 (458)
T 3rp9_A 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKA 309 (458)
T ss_dssp ---------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC-------------
T ss_pred ccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccc
Confidence 122446789999999986 45679999999999999999998 5555532210
Q ss_pred ----------hhhhhHHH---hhh------------------------------hhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 188 ----------ENRSLAAY---FSK------------------------------EAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 188 ----------~~~~~~~~---~~~------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
....+... ... ......+.++.+||.+||..||++||
T Consensus 310 ~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 389 (458)
T 3rp9_A 310 GNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRI 389 (458)
T ss_dssp -------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred cccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccC
Confidence 00000000 000 00112256789999999999999999
Q ss_pred CHHHHHHHHHh
Q 044846 225 TMKEVTLELAG 235 (290)
Q Consensus 225 s~~el~~~l~~ 235 (290)
|++|+++|.+-
T Consensus 390 t~~e~L~Hp~f 400 (458)
T 3rp9_A 390 TINECLAHPFF 400 (458)
T ss_dssp CHHHHHHSGGG
T ss_pred CHHHHhcCHhh
Confidence 99999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=308.53 Aligned_cols=223 Identities=20% Similarity=0.211 Sum_probs=170.9
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+++.. ...+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++.... .+++..+.
T Consensus 78 ~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~ 151 (349)
T 2w4o_A 78 QKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG----YYSERDAA 151 (349)
T ss_dssp CCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS----SCCHHHHH
T ss_pred CcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC----CCCHHHHH
Confidence 578999999753 245678899999999999999999999999999999999999999999997654 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.... ........||+.|+|||++.+..
T Consensus 152 ~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~ 226 (349)
T 2w4o_A 152 DAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPEILRGCA 226 (349)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------------------CGGGSCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc--ccccccccCCCCccCHHHhcCCC
Confidence 99999999999999999 999999999999975 88999999999765332 22234467899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++.++|||||||++|+|++|..||................ ......+..+.+||.+||+.||++|||+.|++++
T Consensus 227 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999886544332222222111 1123456679999999999999999999999987
Q ss_pred HHh
Q 044846 233 LAG 235 (290)
Q Consensus 233 l~~ 235 (290)
.+-
T Consensus 307 p~~ 309 (349)
T 2w4o_A 307 PWV 309 (349)
T ss_dssp TTT
T ss_pred ccc
Confidence 543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=292.95 Aligned_cols=224 Identities=18% Similarity=0.185 Sum_probs=185.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|++........+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++.... .+++..+.
T Consensus 34 ~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~ 109 (277)
T 3f3z_A 34 RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR----VFRESDAA 109 (277)
T ss_dssp CCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHH
T ss_pred CcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC----CCCHHHHH
Confidence 46789999987666678889999999999999999999999999999999999999999999998765 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---ccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILL---VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++...... .......||+.|+|||++.+.
T Consensus 110 ~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~- 183 (277)
T 3f3z_A 110 RIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQVLEGL- 183 (277)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTTC-
T ss_pred HHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc--cchhccCCCCCccChHHhccc-
Confidence 99999999999999999 9999999999999 78889999999997654322 223345689999999998654
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
++.++||||||+++|+|++|..|+............... .......+..+.+||.+||+.||.+|||+.+++++.
T Consensus 184 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 899999999999999999999988654332221111111 011113467799999999999999999999999875
Q ss_pred Hh
Q 044846 234 AG 235 (290)
Q Consensus 234 ~~ 235 (290)
+-
T Consensus 264 ~~ 265 (277)
T 3f3z_A 264 WF 265 (277)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=314.71 Aligned_cols=226 Identities=16% Similarity=0.177 Sum_probs=184.4
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|..++..++||||++++++|.+.+..|+||||++||+|.+++..... .+++.
T Consensus 86 ~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~ 162 (412)
T 2vd5_A 86 GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE---RIPAE 162 (412)
T ss_dssp CCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---CCCHH
T ss_pred CCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHH
Confidence 678999998642 233445688999999999999999999999999999999999999999999987542 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR--- 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--- 155 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++..............||+.|+|||++.
T Consensus 163 ~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~ 239 (412)
T 2vd5_A 163 MARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239 (412)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcc
Confidence 99999999999999999999 999999999999999999999999998765443333344567999999999987
Q ss_pred ----cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------hhhhHHHHHHHHHHHHHhhccCCCCC-
Q 044846 156 ----SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------KEAEKEEVITFAMVAKRCLNLNGKKQ- 223 (290)
Q Consensus 156 ----~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~R- 223 (290)
...++.++|||||||++|||++|.+||........ ...... .......+.++.+||.+||. +|.+|
T Consensus 240 ~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rl 317 (412)
T 2vd5_A 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRL 317 (412)
T ss_dssp TCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCT
T ss_pred cCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcC
Confidence 35689999999999999999999999875433221 111111 01112356789999999999 99998
Q ss_pred --CCHHHHHHHHHh
Q 044846 224 --PTMKEVTLELAG 235 (290)
Q Consensus 224 --ps~~el~~~l~~ 235 (290)
|+++|+++|-+.
T Consensus 318 gr~~~~ei~~Hpff 331 (412)
T 2vd5_A 318 GRGGAGDFRTHPFF 331 (412)
T ss_dssp TTTTHHHHHTSGGG
T ss_pred CCCCHHHHhcCCCc
Confidence 589999988553
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=303.46 Aligned_cols=234 Identities=20% Similarity=0.304 Sum_probs=187.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|++........+.+.+|+++++.++||||+++++++.. ....++||||+.+|+|.+++.........+++
T Consensus 54 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 133 (317)
T 2buj_A 54 GHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133 (317)
T ss_dssp CCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCH
T ss_pred CcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCH
Confidence 67899999987777778899999999999999999999999873 34789999999999999999875333346899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce--------eeccceeccccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--------LTTQVKVTFGYV 149 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--------~~~~~~g~~~y~ 149 (290)
..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ......|++.|+
T Consensus 134 ~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 210 (317)
T 2buj_A 134 DQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccC
Confidence 999999999999999999999 999999999999999999999999987643211100 012245688999
Q ss_pred CccccccCC---CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH----hhhhhhHHHHHHHHHHHHHhhccCCCC
Q 044846 150 DPKYFRSSQ---FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY----FSKEAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 150 aPE~~~~~~---~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
|||++.+.. ++.++||||||+++|+|++|..||............. .........+..+.++|.+||+.||.+
T Consensus 211 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 290 (317)
T 2buj_A 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQ 290 (317)
T ss_dssp CGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhh
Confidence 999987654 6889999999999999999999875322211111111 111112234567999999999999999
Q ss_pred CCCHHHHHHHHHhhHh
Q 044846 223 QPTMKEVTLELAGIRA 238 (290)
Q Consensus 223 Rps~~el~~~l~~~~~ 238 (290)
|||+.+++++|+.+..
T Consensus 291 Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 291 RPHIPLLLSQLEALQP 306 (317)
T ss_dssp SCCHHHHHHHHHHTCC
T ss_pred CCCHHHHHHHhhhcCC
Confidence 9999999999988754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=302.87 Aligned_cols=233 Identities=26% Similarity=0.380 Sum_probs=189.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--cceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE--VPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++........+.+.+|+++++.++||||+++++++...+ ..++||||+++|+|.+++..... .+++..
T Consensus 70 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~ 146 (326)
T 2w1i_A 70 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIK 146 (326)
T ss_dssp CEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTT---SSCHHH
T ss_pred ceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhccc---CCCHHH
Confidence 6789999998777777889999999999999999999999987644 78999999999999999987543 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee--eccceecccccCccccccC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL--TTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~ 157 (290)
++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......... .....++..|+|||++.+.
T Consensus 147 ~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 223 (326)
T 2w1i_A 147 LLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223 (326)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCC
Confidence 9999999999999999999 9999999999999999999999999987654332221 2234567789999999988
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhh--------------hhHHHhh----hhhhHHHHHHHHHHHHHhhccC
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--------------SLAAYFS----KEAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--------------~~~~~~~----~~~~~~~~~~~~~li~~cl~~d 219 (290)
.++.++||||||+++|+|++|..++........ .+..... ...+...+..+.++|.+||+.|
T Consensus 224 ~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 303 (326)
T 2w1i_A 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNN 303 (326)
T ss_dssp EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSS
T ss_pred CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCC
Confidence 899999999999999999999887753321110 0001100 1112334567999999999999
Q ss_pred CCCCCCHHHHHHHHHhhHhhh
Q 044846 220 GKKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 220 p~~Rps~~el~~~l~~~~~~~ 240 (290)
|++|||+.|+++.|+.+...+
T Consensus 304 P~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 304 VNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp GGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHHHh
Confidence 999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=307.93 Aligned_cols=225 Identities=20% Similarity=0.199 Sum_probs=174.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++||||+.+|+|.+++.... .+++..++
T Consensus 45 ~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~ 119 (361)
T 3uc3_A 45 KELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG----RFSEDEAR 119 (361)
T ss_dssp CCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHH
T ss_pred CcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC----CCCHHHHH
Confidence 67899999975332 34568899999999999999999999999999999999999999999998765 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc--EEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ--AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++.... ........||+.|+|||++.+..+
T Consensus 120 ~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~ 194 (361)
T 3uc3_A 120 FFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLLRQEY 194 (361)
T ss_dssp HHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----------------CTTSCHHHHHCSSC
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc--cCCCCCCcCCCCcCChhhhcCCCC
Confidence 99999999999999999 999999999999987765 99999999764322 122234568999999999988887
Q ss_pred CCc-ccchhhHHHHHHHhcCCCCcccchhhh---hhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 160 TEK-SDVYSFSVVLVELNWTKPIHLVDVEEN---RSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 160 ~~~-~DiwS~G~il~~l~~~~~~~~~~~~~~---~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
+.+ +|||||||++|+|++|..||....... ........ .+.....+..+.+||.+||+.||.+|||+.|+++
T Consensus 195 ~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 665 899999999999999999886433211 11111111 1111134567899999999999999999999999
Q ss_pred HHHhh
Q 044846 232 ELAGI 236 (290)
Q Consensus 232 ~l~~~ 236 (290)
|.+..
T Consensus 275 hp~f~ 279 (361)
T 3uc3_A 275 HSWFL 279 (361)
T ss_dssp SHHHH
T ss_pred Ccchh
Confidence 87653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=318.93 Aligned_cols=226 Identities=17% Similarity=0.157 Sum_probs=176.6
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++. ........+.+|+.+++.++||||++++++|...+..++||||+++|+|..++.... .+++.
T Consensus 173 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~ 248 (446)
T 4ejn_A 173 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSED 248 (446)
T ss_dssp CCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS----CCCHH
T ss_pred CCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC----CCCHH
Confidence 67899999864 244556778899999999999999999999999999999999999999999998765 58999
Q ss_pred HHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 79 MRLRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
.+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+.
T Consensus 249 ~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 324 (446)
T 4ejn_A 249 RARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTPEYLAPEVLEDN 324 (446)
T ss_dssp HHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------CCSSSCGGGCCHHHHHTS
T ss_pred HHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC-CcccccccCCccccCHhhcCCC
Confidence 999999999999999998 88 999999999999999999999999998643222 2223456789999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhH-HHhhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA-AYFSKEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVTL 231 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~~ 231 (290)
.++.++|||||||++|+|++|..||........... .......+...+..+.+||.+||+.||.+|| |+.|+++
T Consensus 325 ~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 999999999999999999999998865432211111 1111112234567799999999999999999 9999998
Q ss_pred HHHh
Q 044846 232 ELAG 235 (290)
Q Consensus 232 ~l~~ 235 (290)
|.+.
T Consensus 405 hp~f 408 (446)
T 4ejn_A 405 HRFF 408 (446)
T ss_dssp SGGG
T ss_pred Cccc
Confidence 7543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=301.69 Aligned_cols=233 Identities=17% Similarity=0.289 Sum_probs=177.5
Q ss_pred eEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcc------eEEEEeCCCCCHHHHHhhcCC--CCC
Q 044846 4 LWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVP------LLVYEFIPNGSLYQYIHEQTD--DQL 73 (290)
Q Consensus 4 ~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~~--~~~ 73 (290)
.||+|+++.. .....+.+.+|+++++.++||||+++++++...... ++||||+.+|+|.+++..... ...
T Consensus 53 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~ 132 (323)
T 3qup_A 53 KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132 (323)
T ss_dssp EEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CC
T ss_pred eEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcccccc
Confidence 6899998753 455678899999999999999999999999877655 999999999999999976432 222
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccCcc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVDPK 152 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE 152 (290)
.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|||
T Consensus 133 ~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 133 NLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence 5889999999999999999999999 99999999999999999999999999865432221 1223345677899999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
++.+..++.++|||||||++|+|++ |.+|+...... ....... ....+...+..+.+|+.+||+.||.+|||+.+
T Consensus 210 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 288 (323)
T 3qup_A 210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTC 288 (323)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-HHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999999999999999 77776543222 1111111 11223345577999999999999999999999
Q ss_pred HHHHHHhhHhhh
Q 044846 229 VTLELAGIRASI 240 (290)
Q Consensus 229 l~~~l~~~~~~~ 240 (290)
+++.|+.+....
T Consensus 289 l~~~l~~~l~~~ 300 (323)
T 3qup_A 289 LRMELENILGHL 300 (323)
T ss_dssp HHHHHHHHHHC-
T ss_pred HHHHHHHHHHHh
Confidence 999999887644
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=303.74 Aligned_cols=234 Identities=20% Similarity=0.298 Sum_probs=188.3
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC----------
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD---------- 70 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------- 70 (290)
..||+|+++.. .....+.+.+|+.+++.+ +||||+++++++...+..++||||+++|+|.+++.....
T Consensus 77 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 156 (333)
T 2i1m_A 77 LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156 (333)
T ss_dssp CEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-----
T ss_pred hHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccc
Confidence 46999998754 344567899999999999 899999999999999999999999999999999976421
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceeccccc
Q 044846 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYV 149 (290)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~ 149 (290)
....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ .......+++.|+
T Consensus 157 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 233 (333)
T 2i1m_A 157 ANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM 233 (333)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGS
T ss_pred cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCcccc
Confidence 0125789999999999999999999999 99999999999999999999999999875433222 2233456788999
Q ss_pred CccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhh---hHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 150 DPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRS---LAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 150 aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
|||++.+..++.++||||||+++|+|++ |.+|+......... .........+...+..+.+++.+||+.||.+|||
T Consensus 234 aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 313 (333)
T 2i1m_A 234 APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 313 (333)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcC
Confidence 9999999999999999999999999998 77776543221111 1111111122234567899999999999999999
Q ss_pred HHHHHHHHHhhHhh
Q 044846 226 MKEVTLELAGIRAS 239 (290)
Q Consensus 226 ~~el~~~l~~~~~~ 239 (290)
+.+++++|+.+...
T Consensus 314 ~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 314 FQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999887654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=302.40 Aligned_cols=231 Identities=19% Similarity=0.274 Sum_probs=182.7
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..||+|+++.. .......+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... .+++..++
T Consensus 74 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~ 150 (333)
T 1mqb_A 74 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLV 150 (333)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT---CSCHHHHH
T ss_pred ccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCC---CCCHHHHH
Confidence 35999998753 344566799999999999999999999999999999999999999999999986532 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee--eccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL--TTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++......... .....++..|+|||++.+..+
T Consensus 151 ~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (333)
T 1mqb_A 151 GMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227 (333)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred HHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCC
Confidence 99999999999999999 9999999999999999999999999986543222111 122345778999999999999
Q ss_pred CCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 160 TEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+.++||||||+++|+|++ |..|+...... ....... ....+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 228 ~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 228 TSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CchhhhHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 999999999999999998 88877543221 1111111 112223456679999999999999999999999999998
Q ss_pred hHhhh
Q 044846 236 IRASI 240 (290)
Q Consensus 236 ~~~~~ 240 (290)
+....
T Consensus 307 ~~~~~ 311 (333)
T 1mqb_A 307 LIRAP 311 (333)
T ss_dssp HHHSG
T ss_pred HHhcc
Confidence 87643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=304.10 Aligned_cols=229 Identities=20% Similarity=0.334 Sum_probs=179.3
Q ss_pred EEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHH
Q 044846 5 WLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI 83 (290)
Q Consensus 5 ~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 83 (290)
||+|.++. ......+.+.+|+.+++.++||||+++++++.... .++|+||+.+|+|.+++..... .+++..++.+
T Consensus 47 v~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i 122 (327)
T 3lzb_A 47 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD---NIGSQYLLNW 122 (327)
T ss_dssp EEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTT---CCCHHHHHHH
T ss_pred EEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCC---CCCHHHHHHH
Confidence 57777753 34556788999999999999999999999998765 7899999999999999987543 5899999999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccccccCCCCCc
Q 044846 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 84 ~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ......+++.|+|||++.+..++.+
T Consensus 123 ~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 199 (327)
T 3lzb_A 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199 (327)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChH
Confidence 999999999999999 999999999999999999999999998754322221 2233456778999999999999999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhhh--hHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENRS--LAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~ 239 (290)
+|||||||++|+|++ |..||......... +........+...+..+.++|.+||+.||.+|||+.|+++.|+.+...
T Consensus 200 ~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 200 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 999999999999998 88877543222111 111111122334566799999999999999999999999999988754
Q ss_pred h
Q 044846 240 I 240 (290)
Q Consensus 240 ~ 240 (290)
.
T Consensus 280 ~ 280 (327)
T 3lzb_A 280 P 280 (327)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=301.37 Aligned_cols=228 Identities=20% Similarity=0.260 Sum_probs=181.4
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC--CCCCCCHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD--DQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~ 78 (290)
|+.||+|+++... ....+.+.+|+++++.++||||+++++++...+..++||||+. |+|.+++..... ....+++.
T Consensus 30 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~ 108 (317)
T 2pmi_A 30 GVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELN 108 (317)
T ss_dssp CCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHH
T ss_pred CcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHH
Confidence 6789999987533 3345678899999999999999999999999999999999996 699999976532 11258899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS- 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 157 (290)
.+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+.
T Consensus 109 ~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~ 184 (317)
T 2pmi_A 109 LVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVVTLWYRAPDVLMGSR 184 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-CCCCCCCSCCTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCc-ccCCCCcccccccCchHhhCCC
Confidence 99999999999999999999 9999999999999999999999999986543221 122345679999999999764
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHh---------------------------------hhhhhH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYF---------------------------------SKEAEK 202 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~---------------------------------~~~~~~ 202 (290)
.++.++|||||||++|+|++|.+||......... +.... ......
T Consensus 185 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2pmi_A 185 TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKE 264 (317)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSS
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccc
Confidence 5899999999999999999999988654322111 00000 000011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 203 EEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 203 ~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
..+..+.+||.+||+.||++|||+.|++++.+
T Consensus 265 ~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 265 PLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 23457999999999999999999999987754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=325.87 Aligned_cols=231 Identities=22% Similarity=0.287 Sum_probs=185.2
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..||||+++.. .....+.+.+|+++|+.++|||||++++++.. +..++|||||++|+|.+++..... .+++..+.
T Consensus 364 ~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~---~l~~~~~~ 439 (613)
T 2ozo_A 364 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVA 439 (613)
T ss_dssp EEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTT---TSCHHHHH
T ss_pred EEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccC---CCCHHHHH
Confidence 46899999754 34467889999999999999999999999976 568999999999999999975432 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee--ccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT--TQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......... ....+++.|+|||++.+..+
T Consensus 440 ~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~ 516 (613)
T 2ozo_A 440 ELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516 (613)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCC
Confidence 99999999999999999 99999999999999999999999999875433222111 22345678999999999999
Q ss_pred CCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 160 TEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+.++|||||||++|||++ |..|+....... ...... ....+..++..+.+||.+||+.||++|||+.++++.|+.
T Consensus 517 ~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 999999999999999997 888775433221 111111 112234466789999999999999999999999999998
Q ss_pred hHhhhC
Q 044846 236 IRASIG 241 (290)
Q Consensus 236 ~~~~~~ 241 (290)
+.....
T Consensus 596 ~~~~~~ 601 (613)
T 2ozo_A 596 CYYSLA 601 (613)
T ss_dssp HHHHHS
T ss_pred HHHHhc
Confidence 876653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=305.98 Aligned_cols=224 Identities=19% Similarity=0.212 Sum_probs=185.1
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+..|..++..+ +||||+++++++...+..|+||||++||+|.+++.... .+++
T Consensus 45 ~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~ 120 (353)
T 2i0e_A 45 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKE 120 (353)
T ss_dssp EEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCH
T ss_pred CCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC----CCCH
Confidence 567999998642 234567788999999988 89999999999999999999999999999999998765 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..... ........||+.|+|||++.+.
T Consensus 121 ~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 196 (353)
T 2i0e_A 121 PHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKTFCGTPDYIAPEIIAYQ 196 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC-CcccccccCCccccChhhhcCC
Confidence 999999999999999999999 999999999999999999999999998753221 2223456789999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPT-----MKEVT 230 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~el~ 230 (290)
.++.++|+|||||++|+|++|.+||...... ........ ...+...+.++.+||.+||+.||.+||+ +.+++
T Consensus 197 ~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred CcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 9999999999999999999999988654322 11111111 1122345678999999999999999995 58887
Q ss_pred HHHH
Q 044846 231 LELA 234 (290)
Q Consensus 231 ~~l~ 234 (290)
+|.+
T Consensus 276 ~h~~ 279 (353)
T 2i0e_A 276 EHAF 279 (353)
T ss_dssp TSGG
T ss_pred cCcc
Confidence 7643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=300.74 Aligned_cols=236 Identities=20% Similarity=0.310 Sum_probs=189.4
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC--------
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD-------- 71 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------- 71 (290)
++.||+|+++.. .....+.+.+|+++++.+ +||||+++++++...+..++||||+++|+|.+++......
T Consensus 67 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 146 (334)
T 2pvf_A 67 AVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146 (334)
T ss_dssp -CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--
T ss_pred ceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccc
Confidence 457999998753 345577899999999999 9999999999999999999999999999999999875421
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecc
Q 044846 72 ----QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTF 146 (290)
Q Consensus 72 ----~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~ 146 (290)
...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++....... .......+++
T Consensus 147 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~ 223 (334)
T 2pvf_A 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223 (334)
T ss_dssp ------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCG
T ss_pred cccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCccc
Confidence 124889999999999999999999999 99999999999999999999999999865433221 1223345678
Q ss_pred cccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 147 GYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 147 ~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
.|+|||++.+..++.++||||||+++|+|++ |..|+........ .+........+...+..+.+++.+||+.||.+|
T Consensus 224 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 303 (334)
T 2pvf_A 224 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303 (334)
T ss_dssp GGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred ceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence 8999999998889999999999999999998 8777754322111 111111112223456679999999999999999
Q ss_pred CCHHHHHHHHHhhHhhh
Q 044846 224 PTMKEVTLELAGIRASI 240 (290)
Q Consensus 224 ps~~el~~~l~~~~~~~ 240 (290)
||+.|++++|+.+....
T Consensus 304 ps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 304 PTFKQLVEDLDRILTLT 320 (334)
T ss_dssp CCHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHhcc
Confidence 99999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=299.46 Aligned_cols=207 Identities=20% Similarity=0.256 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 044846 18 VEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLH 95 (290)
Q Consensus 18 ~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH 95 (290)
.+.+.+|+++++.++||||+++++++.. .+..++||||+++|+|.+++... .+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH 154 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLH 154 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-----CCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH
Confidence 4578999999999999999999999987 56789999999999998765422 5899999999999999999999
Q ss_pred hCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC---CCCcccchhhHHHH
Q 044846 96 SVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ---FTEKSDVYSFSVVL 172 (290)
Q Consensus 96 ~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwS~G~il 172 (290)
+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++
T Consensus 155 ~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l 230 (298)
T 2zv2_A 155 YQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230 (298)
T ss_dssp HTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred HCC---eeccCCCHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence 999 9999999999999999999999999987543322 2234467899999999998765 36789999999999
Q ss_pred HHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 173 VELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 173 ~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
|+|++|..||........ ...... .+.....+..+.+||.+||+.||++|||+.|+++|.+
T Consensus 231 ~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 231 YCFVFGQCPFMDERIMCL-HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHCCCCCCCccHHHH-HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 999999998865432211 111101 1111234567999999999999999999999987754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=304.63 Aligned_cols=230 Identities=19% Similarity=0.156 Sum_probs=178.7
Q ss_pred CceEEEEeeccc-----CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC-----
Q 044846 2 EELWLLKKSKSV-----HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD----- 71 (290)
Q Consensus 2 ~~~~avK~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----- 71 (290)
|+.||+|+++.. .....+.+.+|+++++.++||||+++++++...+..++|||||++|+|.+++......
T Consensus 51 ~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~ 130 (345)
T 3hko_A 51 RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130 (345)
T ss_dssp CCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEE
T ss_pred CceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccc
Confidence 567999988642 4556788999999999999999999999999999999999999999999999531100
Q ss_pred -------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC--
Q 044846 72 -------------------------------QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-- 118 (290)
Q Consensus 72 -------------------------------~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-- 118 (290)
...+++..++.++.||+.||.|||+++ |+||||||+||+++.++
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~ 207 (345)
T 3hko_A 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSF 207 (345)
T ss_dssp EEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCc
Confidence 112456778899999999999999999 99999999999998776
Q ss_pred cEEEeccccccccccCCc---eeeccceecccccCcccccc--CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhH
Q 044846 119 QAKISDFRTFKSRAIDRT---HLTTQVKVTFGYVDPKYFRS--SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA 193 (290)
Q Consensus 119 ~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~ 193 (290)
.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 208 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 287 (345)
T 3hko_A 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ 287 (345)
T ss_dssp CEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 899999999875332111 12345678999999999875 6788999999999999999999998865433222111
Q ss_pred HHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 194 AYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 194 ~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.... .......+..+.+||.+||+.||.+|||+.+++++.+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~ 333 (345)
T 3hko_A 288 VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333 (345)
T ss_dssp HHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHH
T ss_pred HHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChh
Confidence 1111 1122234678999999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=295.91 Aligned_cols=232 Identities=20% Similarity=0.291 Sum_probs=187.5
Q ss_pred eEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcc-eEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 4 LWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVP-LLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 4 ~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~-~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
.||+|+++.. .....+.+.+|+.+++.++||||+++++++...+.. ++||||+.+|+|.+++..... .+++..+.
T Consensus 51 ~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~ 127 (298)
T 3pls_A 51 QCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLI 127 (298)
T ss_dssp EEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTC---CCBHHHHH
T ss_pred eeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcccc---CCCHHHHH
Confidence 6899998753 345577899999999999999999999999876655 999999999999999986432 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC---ceeeccceecccccCccccccCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR---THLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...... ........+++.|+|||.+.+..
T Consensus 128 ~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 204 (298)
T 3pls_A 128 SFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204 (298)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCC
Confidence 99999999999999999 9999999999999999999999999986433211 12223456788999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
++.++||||||+++|+|++|..++............... ...+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 205 ~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 205 FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 999999999999999999966555433322222111111 12223345679999999999999999999999999999
Q ss_pred hHhhhC
Q 044846 236 IRASIG 241 (290)
Q Consensus 236 ~~~~~~ 241 (290)
+.....
T Consensus 285 ~~~~l~ 290 (298)
T 3pls_A 285 IVSALL 290 (298)
T ss_dssp HHHHCC
T ss_pred HHHHHh
Confidence 887653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.17 Aligned_cols=227 Identities=18% Similarity=0.192 Sum_probs=182.2
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+.+|+.+++.+ .||||+++++++...+..++||||+.+|+|.+++...... .+++.
T Consensus 54 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~ 131 (327)
T 3lm5_A 54 GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE--MVSEN 131 (327)
T ss_dssp CCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-C--CCCHH
T ss_pred CCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhccc--CCCHH
Confidence 678999998642 334477899999999999 5799999999999999999999999999999998654322 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
.++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||+++.... ........||+.|+|||++.
T Consensus 132 ~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~ 206 (327)
T 3lm5_A 132 DVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELREIMGTPEYLAPEILN 206 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCC--ccccccccCCcCccCCeeec
Confidence 99999999999999999999 999999999999987 78999999999865432 12223457899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh-----hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF-----SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
+..++.++||||||+++|+|++|..||.............. ........+..+.+||.+||+.||.+|||+++++
T Consensus 207 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 99999999999999999999999998865433222111110 1112234566799999999999999999999999
Q ss_pred HHHHh
Q 044846 231 LELAG 235 (290)
Q Consensus 231 ~~l~~ 235 (290)
++.+-
T Consensus 287 ~h~~~ 291 (327)
T 3lm5_A 287 SHSWL 291 (327)
T ss_dssp TCGGG
T ss_pred CCHhh
Confidence 87553
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=299.26 Aligned_cols=236 Identities=22% Similarity=0.277 Sum_probs=189.1
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCC-cceEEEEeCCCCCHHHHHhhcCCC-------
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQI-NHRNVVKILGCCLETE-VPLLVYEFIPNGSLYQYIHEQTDD------- 71 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------- 71 (290)
|+.||+|+++... ....+.+.+|++++..+ +||||+++++++...+ ..++||||+++|+|.+++......
T Consensus 57 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 136 (316)
T 2xir_A 57 CRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136 (316)
T ss_dssp EEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC---
T ss_pred ceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhccccccccccc
Confidence 4679999997533 44567899999999999 7999999999998754 589999999999999999875431
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceec
Q 044846 72 -----QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVT 145 (290)
Q Consensus 72 -----~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~ 145 (290)
...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....... .......+|
T Consensus 137 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t 213 (316)
T 2xir_A 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213 (316)
T ss_dssp ----CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred chhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcc
Confidence 112789999999999999999999999 99999999999999999999999999875433222 233446678
Q ss_pred ccccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCC
Q 044846 146 FGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGK 221 (290)
Q Consensus 146 ~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~ 221 (290)
+.|+|||++.+..++.++||||||+++|+|++ |..|+............. .....+...+..+.+++.+||+.||.
T Consensus 214 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 293 (316)
T 2xir_A 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 293 (316)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred eeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChh
Confidence 89999999999999999999999999999997 887775432221111111 11112233456799999999999999
Q ss_pred CCCCHHHHHHHHHhhHhhh
Q 044846 222 KQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 222 ~Rps~~el~~~l~~~~~~~ 240 (290)
+|||+.|++++|+.+....
T Consensus 294 ~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 294 QRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp GSCCHHHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHhhh
Confidence 9999999999999887643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=297.02 Aligned_cols=228 Identities=21% Similarity=0.258 Sum_probs=177.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc--CCCceeeEEeEEEeC----CcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI--NHRNVVKILGCCLET----EVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l--~Hpniv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||++... ....+.+|.+++..+ +||||+++++++... ...++||||+++|+|.++++.. .+
T Consensus 60 ~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~ 131 (337)
T 3mdy_A 60 GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TL 131 (337)
T ss_dssp TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-----CB
T ss_pred CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-----CC
Confidence 678999998643 334556677777665 899999999999887 6789999999999999999764 48
Q ss_pred CHHHHHHHHHHHHHHHHHHhhC--------CCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee---ecccee
Q 044846 76 TWEMRLRITVEVSRVLSYLHSV--------ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL---TTQVKV 144 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~--------~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~g 144 (290)
++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+++......... .....|
T Consensus 132 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 208 (337)
T 3mdy_A 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208 (337)
T ss_dssp CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCS
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCcc
Confidence 9999999999999999999998 7 9999999999999999999999999986543222211 124578
Q ss_pred cccccCccccccCCCCCc------ccchhhHHHHHHHhcC----------CCCcccchhhh---hhhHHHh-----h---
Q 044846 145 TFGYVDPKYFRSSQFTEK------SDVYSFSVVLVELNWT----------KPIHLVDVEEN---RSLAAYF-----S--- 197 (290)
Q Consensus 145 ~~~y~aPE~~~~~~~~~~------~DiwS~G~il~~l~~~----------~~~~~~~~~~~---~~~~~~~-----~--- 197 (290)
|+.|+|||++.+..++.. +|||||||++|||++| ..|+....... ....... .
T Consensus 209 t~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (337)
T 3mdy_A 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF 288 (337)
T ss_dssp CGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred CcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccc
Confidence 999999999988776665 9999999999999999 44443211110 0111100 0
Q ss_pred --hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhh
Q 044846 198 --KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 198 --~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~~ 240 (290)
.......+..+.+|+.+||+.||.+|||+.+++++|+.+..+.
T Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 0112356778999999999999999999999999999988754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=302.54 Aligned_cols=221 Identities=21% Similarity=0.243 Sum_probs=179.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC-----CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN-----HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-----Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||||+++. .....+.+..|+.+++.+. ||||+++++++...+..++||||+ +++|.+++...... .++
T Consensus 60 ~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~ 135 (360)
T 3llt_A 60 KKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN--GFH 135 (360)
T ss_dssp CCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC--CCC
T ss_pred CeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC--CCC
Confidence 67899999974 3445667788999999996 999999999999999999999999 89999999876533 488
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-------------------------CCcEEEecccccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-------------------------KYQAKISDFRTFKSR 131 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-------------------------~~~~kl~dfg~~~~~ 131 (290)
+..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++..
T Consensus 136 ~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~ 212 (360)
T 3llt_A 136 IEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceec
Confidence 9999999999999999999999 999999999999975 788999999998653
Q ss_pred ccCCceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhhhh----------
Q 044846 132 AIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFSKE---------- 199 (290)
Q Consensus 132 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~~~---------- 199 (290)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ........
T Consensus 213 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 288 (360)
T 3llt_A 213 SD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATK 288 (360)
T ss_dssp TS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTT
T ss_pred CC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhh
Confidence 32 223467899999999999999999999999999999999999988643321110 00000000
Q ss_pred -----------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 200 -----------------------------------AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 200 -----------------------------------~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
........+.+||.+||+.||.+|||+.|++++.
T Consensus 289 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 289 TNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp SGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred ccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCc
Confidence 0000125678999999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=302.57 Aligned_cols=223 Identities=19% Similarity=0.230 Sum_probs=164.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|++.. .....+.+|+.+++.+. ||||+++++++.+....|+||||+++|+|.+++.... .+++..+
T Consensus 36 ~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~ 108 (325)
T 3kn6_A 36 NQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK----HFSETEA 108 (325)
T ss_dssp CCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS----CCCHHHH
T ss_pred CCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC----CCCHHHH
Confidence 67899999864 34556789999999996 9999999999999999999999999999999998754 6899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC---cEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY---QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++...... .......||+.|+|||++.+.
T Consensus 109 ~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~ 184 (325)
T 3kn6_A 109 SYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQN 184 (325)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------------C
T ss_pred HHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-CcccccCCCcCccCHHHhcCC
Confidence 999999999999999999 99999999999998766 89999999986543222 223345679999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhh------hhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEE------NRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~------~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
.++.++|||||||++|+|++|..||...... ......... .......+..+.+||.+||+.||.+|||
T Consensus 185 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 264 (325)
T 3kn6_A 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK 264 (325)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC
Confidence 9999999999999999999999988643221 111111111 1112335678999999999999999999
Q ss_pred HHHHHHHHHh
Q 044846 226 MKEVTLELAG 235 (290)
Q Consensus 226 ~~el~~~l~~ 235 (290)
+.|++++.+-
T Consensus 265 ~~ell~h~w~ 274 (325)
T 3kn6_A 265 MSGLRYNEWL 274 (325)
T ss_dssp TTTSTTCGGG
T ss_pred HHHHhcChhh
Confidence 9999877543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=297.19 Aligned_cols=225 Identities=20% Similarity=0.256 Sum_probs=176.9
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++... ....+.+.+|+++++.++||||+++++++...+..++||||+. ++|.+++..... .+++..
T Consensus 26 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~ 101 (288)
T 1ob3_A 26 GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEG---GLESVT 101 (288)
T ss_dssp SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTSTT---CCCHHH
T ss_pred CCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHhccc---CCCHHH
Confidence 6789999986533 2335678899999999999999999999999999999999996 599999976432 588999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-C
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-Q 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 158 (290)
+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+. .
T Consensus 102 ~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~ 177 (288)
T 1ob3_A 102 AKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKK 177 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCS
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-cccccccccccccCchheeCCCC
Confidence 9999999999999999999 9999999999999999999999999986543221 122345679999999998764 5
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH--hhh----------------------------hhhHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY--FSK----------------------------EAEKEEVITF 208 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~--~~~----------------------------~~~~~~~~~~ 208 (290)
++.++|||||||++|+|++|.+||............. ... ......+..+
T Consensus 178 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (288)
T 1ob3_A 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESG 257 (288)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHH
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHH
Confidence 8999999999999999999999886543221111100 000 0001235678
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 209 AMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 209 ~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.+||.+||+.||++|||+.|++++.+
T Consensus 258 ~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 258 IDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 89999999999999999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=316.42 Aligned_cols=227 Identities=15% Similarity=0.190 Sum_probs=185.6
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+.++..++||||++++++|.+.+..|+|||||++|+|.+++..... .+++.
T Consensus 99 ~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~---~l~e~ 175 (437)
T 4aw2_A 99 DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED---RLPEE 175 (437)
T ss_dssp TEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTT---CCCHH
T ss_pred CcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccC---CCCHH
Confidence 578999998642 222334588999999999999999999999999999999999999999999986432 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR--- 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--- 155 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............||+.|+|||++.
T Consensus 176 ~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 252 (437)
T 4aw2_A 176 MARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252 (437)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcc
Confidence 99999999999999999999 999999999999999999999999998765444444445568999999999987
Q ss_pred --cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhh---HHHHHHHHHHHHHhhccCCCC--CC
Q 044846 156 --SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAE---KEEVITFAMVAKRCLNLNGKK--QP 224 (290)
Q Consensus 156 --~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~---~~~~~~~~~li~~cl~~dp~~--Rp 224 (290)
...++.++|||||||++|||++|.+||........ ....... ..+ ...+..+.+||.+||..+|++ ||
T Consensus 253 ~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~ 331 (437)
T 4aw2_A 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQN 331 (437)
T ss_dssp TSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTT
T ss_pred cCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCC
Confidence 45689999999999999999999999875432211 1111110 111 125678999999999988888 99
Q ss_pred CHHHHHHHHHh
Q 044846 225 TMKEVTLELAG 235 (290)
Q Consensus 225 s~~el~~~l~~ 235 (290)
+++|+++|.+.
T Consensus 332 ~~~eil~Hpff 342 (437)
T 4aw2_A 332 GIEDFKKHPFF 342 (437)
T ss_dssp TTHHHHTSGGG
T ss_pred CHHHHhCCCcc
Confidence 99999988654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=303.93 Aligned_cols=229 Identities=15% Similarity=0.147 Sum_probs=182.5
Q ss_pred CceEEEEeecccCch-----------hHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHh
Q 044846 2 EELWLLKKSKSVHES-----------NVEQFINEVVILSQINHRNVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIH 66 (290)
Q Consensus 2 ~~~~avK~~~~~~~~-----------~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~ 66 (290)
++.||+|+....... ....+.+|+..++.++||||+++++++.. ....++||||+ +++|.+++.
T Consensus 65 ~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~ 143 (345)
T 2v62_A 65 DARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISG 143 (345)
T ss_dssp GCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCB
T ss_pred cceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHH
Confidence 467899998754322 12346678889999999999999999988 67899999999 999999998
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC--cEEEeccccccccccCCc------ee
Q 044846 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY--QAKISDFRTFKSRAIDRT------HL 138 (290)
Q Consensus 67 ~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~------~~ 138 (290)
... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....... ..
T Consensus 144 ~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 216 (345)
T 2v62_A 144 QNG----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216 (345)
T ss_dssp GGG----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCG
T ss_pred hcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhcc
Confidence 765 6899999999999999999999999 99999999999999887 999999999865432211 11
Q ss_pred eccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh---HHHhhhhhhH---------HHHH
Q 044846 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL---AAYFSKEAEK---------EEVI 206 (290)
Q Consensus 139 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~---------~~~~ 206 (290)
.....||..|+|||++.+..++.++|||||||++|+|++|..||.......... ........+. ..+.
T Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (345)
T 2v62_A 217 RKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCC 296 (345)
T ss_dssp GGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCH
T ss_pred ccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHH
Confidence 134578999999999999999999999999999999999999885432211111 1111111111 3445
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
.+.++|.+||+.||++|||+.++++.|+.+..
T Consensus 297 ~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 297 EIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 89999999999999999999999999987643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=313.79 Aligned_cols=220 Identities=19% Similarity=0.243 Sum_probs=174.0
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||||++... .....+++.+|+.+|+.++||||+++++++...+ ..||||||+.+ +|.+.+..
T Consensus 87 ~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~------ 159 (464)
T 3ttj_A 87 DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM------ 159 (464)
T ss_dssp TEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS------
T ss_pred CCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh------
Confidence 678999999643 4555778999999999999999999999997654 45999999964 67777753
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........||+.|+|||+
T Consensus 160 ~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~~~~~~~~gt~~y~aPE~ 234 (464)
T 3ttj_A 160 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 234 (464)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-------CCCC----CCCTTCCHHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCC--CcccCCCcccccccCHHH
Confidence 3788999999999999999999999 99999999999999999999999999865432 223345678999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------------------------------------
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------------------------------------ 197 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------------------------------------ 197 (290)
+.+..|+.++||||+||++|+|++|.+||........ +.....
T Consensus 235 ~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (464)
T 3ttj_A 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLF 313 (464)
T ss_dssp HTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHS
T ss_pred HcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhC
Confidence 9999999999999999999999999998865432111 100000
Q ss_pred --------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 198 --------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 198 --------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.......+..+.+||.+||+.||++|||++|+++|.+
T Consensus 314 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 314 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp CGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred cccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 0011122567899999999999999999999998854
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=326.93 Aligned_cols=231 Identities=22% Similarity=0.270 Sum_probs=184.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
++.||||+++.. +....+.+.+|+++|+.++|||||++++++.. +..++|||||++|+|.+++.... .+++..
T Consensus 396 ~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~----~l~~~~ 470 (635)
T 4fl3_A 396 VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKN 470 (635)
T ss_dssp EEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT----TCCHHH
T ss_pred ceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC----CCCHHH
Confidence 467999999753 34457889999999999999999999999964 56789999999999999998654 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc--eeeccceecccccCccccccC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~ 157 (290)
++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+.
T Consensus 471 ~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~ 547 (635)
T 4fl3_A 471 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547 (635)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCC
Confidence 9999999999999999999 99999999999999999999999999875443222 122334567889999999999
Q ss_pred CCCCcccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.++.++|||||||++|||++ |..||........ .+........+..++..+.+||.+||+.||++|||+.+|++.|+
T Consensus 548 ~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 548 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 99999999999999999998 8888764432211 11111112223456678999999999999999999999999999
Q ss_pred hhHhhh
Q 044846 235 GIRASI 240 (290)
Q Consensus 235 ~~~~~~ 240 (290)
.+...+
T Consensus 628 ~~~~~l 633 (635)
T 4fl3_A 628 NYYYDV 633 (635)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=309.39 Aligned_cols=231 Identities=23% Similarity=0.338 Sum_probs=177.1
Q ss_pred eEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 4 LWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 4 ~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
.||+|.++. ......+.+.+|+.+++.++||||+++++++.. .+..++||||+++|+|.+++..... .+++..+.
T Consensus 119 ~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~ 195 (373)
T 3c1x_A 119 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLI 195 (373)
T ss_dssp EEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTC---CCBHHHHH
T ss_pred EEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhccc---CCCHHHHH
Confidence 578998864 345567889999999999999999999998754 5688999999999999999976543 57889999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc---eeeccceecccccCccccccCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT---HLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|||++.+..
T Consensus 196 ~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 272 (373)
T 3c1x_A 196 GFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272 (373)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCC
Confidence 99999999999999999 99999999999999999999999999875432211 1123345678899999999999
Q ss_pred CCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++.++|||||||++|+|++ |.+|+.... .......... ...+...+..+.++|.+||+.||++|||+.|++++|+
T Consensus 273 ~~~~~DvwSlG~il~ellt~~~~p~~~~~-~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 351 (373)
T 3c1x_A 273 FTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSCTTSC-SSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcHHHHHHHHHHHHHHHhCcCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999999 555553322 1111111111 1122345667999999999999999999999999999
Q ss_pred hhHhhhC
Q 044846 235 GIRASIG 241 (290)
Q Consensus 235 ~~~~~~~ 241 (290)
.+.....
T Consensus 352 ~i~~~~~ 358 (373)
T 3c1x_A 352 AIFSTFI 358 (373)
T ss_dssp HHHHTCC
T ss_pred HHHHhcc
Confidence 9887653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=304.76 Aligned_cols=223 Identities=23% Similarity=0.281 Sum_probs=182.6
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||||+. |+|.+++..... .+++.
T Consensus 79 ~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~---~l~~~ 154 (348)
T 1u5q_A 79 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEV 154 (348)
T ss_dssp TEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTS---CCCHH
T ss_pred CeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcC---CCCHH
Confidence 6789999986432 3345678999999999999999999999999999999999996 689988865443 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR--- 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--- 155 (290)
.+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..... .....||+.|+|||++.
T Consensus 155 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-----~~~~~gt~~y~aPE~~~~~~ 226 (348)
T 1u5q_A 155 EIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMD 226 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHHTTS
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-----CCcccCCcceeCHhhhcccc
Confidence 99999999999999999999 99999999999999999999999999765332 23456899999999985
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
...++.++|||||||++|+|++|.+|+.......... ..... ......+..+.+||.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 5678899999999999999999999886543322211 11111 112234567899999999999999999999998
Q ss_pred HHHhhH
Q 044846 232 ELAGIR 237 (290)
Q Consensus 232 ~l~~~~ 237 (290)
+.+...
T Consensus 306 h~~~~~ 311 (348)
T 1u5q_A 306 HRFVLR 311 (348)
T ss_dssp CHHHHS
T ss_pred Chhhhc
Confidence 876543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=295.23 Aligned_cols=231 Identities=24% Similarity=0.365 Sum_probs=183.2
Q ss_pred eEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEE-eCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 4 LWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCL-ETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 4 ~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
.||+|+++. ......+.+.+|+.++++++||||+++++++. ..+..++||||+.+|+|.+++..... .+++..++
T Consensus 55 ~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~ 131 (298)
T 3f66_A 55 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLI 131 (298)
T ss_dssp EEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTC---CCCHHHHH
T ss_pred EEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhccc---CCCHHHHH
Confidence 478898875 33455778999999999999999999999865 45688999999999999999976432 57899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc---eeeccceecccccCccccccCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT---HLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..
T Consensus 132 ~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (298)
T 3f66_A 132 GFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208 (298)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCC
Confidence 99999999999999999 99999999999999999999999999875432211 1223456778899999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
++.++||||||+++|+|++|..++............... ...+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 209 ~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 209 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 999999999999999999955444433222221111111 11223345679999999999999999999999999998
Q ss_pred hHhhh
Q 044846 236 IRASI 240 (290)
Q Consensus 236 ~~~~~ 240 (290)
+....
T Consensus 289 ~~~~~ 293 (298)
T 3f66_A 289 IFSTF 293 (298)
T ss_dssp HHHTS
T ss_pred HHHhh
Confidence 87654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=293.87 Aligned_cols=225 Identities=24% Similarity=0.416 Sum_probs=179.3
Q ss_pred CceEEEEeecccCchh-------HHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVHESN-------VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~-------~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|++....... .+.+.+|+.+++.++||||+++++++.... ++||||+++|+|.+++..... .
T Consensus 44 ~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~---~ 118 (287)
T 4f0f_A 44 KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH---P 118 (287)
T ss_dssp CCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTS---C
T ss_pred ceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccC---C
Confidence 6789999986433221 167899999999999999999999986554 799999999999999876543 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc-----EEEeccccccccccCCceeeccceeccccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ-----AKISDFRTFKSRAIDRTHLTTQVKVTFGYV 149 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~-----~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 149 (290)
+++..++.++.|++.||.|||+++. +|+||||||+||+++.++. +||+|||+++.... ......|++.|+
T Consensus 119 ~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~ 193 (287)
T 4f0f_A 119 IKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWM 193 (287)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTS
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc----cccccCCCcccc
Confidence 8999999999999999999999863 3999999999999988776 99999999764321 233467899999
Q ss_pred Cccccc--cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh-----hhhhhHHHHHHHHHHHHHhhccCCCC
Q 044846 150 DPKYFR--SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF-----SKEAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 150 aPE~~~--~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
|||++. ...++.++|||||||++|+|++|..||.............. ....+...+..+.++|.+||+.||.+
T Consensus 194 aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 273 (287)
T 4f0f_A 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKK 273 (287)
T ss_dssp CGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhh
Confidence 999984 44578899999999999999999998864332222111111 11223345677999999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 044846 223 QPTMKEVTLELAGI 236 (290)
Q Consensus 223 Rps~~el~~~l~~~ 236 (290)
|||+.|+++.|+.+
T Consensus 274 Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 274 RPHFSYIVKELSEL 287 (287)
T ss_dssp SCCHHHHHHHHHTC
T ss_pred CcCHHHHHHHHHhC
Confidence 99999999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=300.14 Aligned_cols=227 Identities=19% Similarity=0.202 Sum_probs=186.7
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++.... .+++.
T Consensus 66 ~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~l~~~ 141 (335)
T 2owb_A 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEP 141 (335)
T ss_dssp CCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC----SCCHH
T ss_pred CCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC----CCCHH
Confidence 578999998642 34567789999999999999999999999999999999999999999999998764 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......|+..|+|||++.+..
T Consensus 142 ~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~ 217 (335)
T 2owb_A 142 EARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKG 217 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHHTSC
T ss_pred HHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc-ccccccCCCccccCHHHhccCC
Confidence 99999999999999999999 9999999999999999999999999986543221 2223456889999999999989
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH-hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY-FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
++.++||||||+++|+|++|..+|............. .....+...+..+.+||.+||+.||++|||+.|++++.+..
T Consensus 218 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~ 296 (335)
T 2owb_A 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296 (335)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 9999999999999999999999886543222111110 01111223456788999999999999999999999876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=292.98 Aligned_cols=227 Identities=20% Similarity=0.299 Sum_probs=184.2
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC--CcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLET--EVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++... +..++||||+++|+|.+++..... ..+++
T Consensus 33 ~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~ 110 (271)
T 3kmu_A 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQ 110 (271)
T ss_dssp TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSS--CCCCH
T ss_pred CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhccc--CCCCH
Confidence 567999998753 345567899999999999999999999999887 788999999999999999986543 25899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.++.|++.||.|||+++.. |+||||||+||+++.++.++|+|||++.... .....||+.|+|||++.+.
T Consensus 111 ~~~~~i~~qi~~~l~~lH~~~~~-i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~ 183 (271)
T 3kmu_A 111 SQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKK 183 (271)
T ss_dssp HHHHHHHHHHHHHHHHHTTSSSC-CTTCCCSGGGEEECTTSCEEEEGGGSCCTTS------CTTCBSCGGGSCHHHHHSC
T ss_pred HHHHHHHHHHHHHHHHHhcCCCc-eecCCCccceEEEcCCcceeEEeccceeeec------ccCccCCccccChhhhccC
Confidence 99999999999999999997643 9999999999999999999999888754322 2235678999999999876
Q ss_pred CCCC---cccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 158 QFTE---KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 158 ~~~~---~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
.++. ++||||||+++|+|++|..|+............. .....+...+..+.+++.+||+.||++|||+.++++
T Consensus 184 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5544 7999999999999999999886443322211111 111223345677999999999999999999999999
Q ss_pred HHHhhH
Q 044846 232 ELAGIR 237 (290)
Q Consensus 232 ~l~~~~ 237 (290)
.|+.+.
T Consensus 264 ~L~~l~ 269 (271)
T 3kmu_A 264 ILEKMQ 269 (271)
T ss_dssp HHHHHC
T ss_pred HHHHhh
Confidence 998774
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=307.98 Aligned_cols=224 Identities=18% Similarity=0.184 Sum_probs=182.9
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+ +|+|.+++.... .+++.
T Consensus 34 ~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~----~l~~~ 108 (336)
T 3h4j_B 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK----RMTED 108 (336)
T ss_dssp CCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC----SCCHH
T ss_pred CCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC----CCCHH
Confidence 678999998642 1223457889999999999999999999999999999999999 789999998765 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+..
T Consensus 109 ~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 183 (336)
T 3h4j_B 109 EGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKL 183 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--BTTCCCTTSTTTSCGGGSCCSG
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC--cccccccCCcCcCCHHHHcCCC
Confidence 99999999999999999999 999999999999999999999999998654322 2234456899999999998877
Q ss_pred C-CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 159 F-TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 159 ~-~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+ +.++|||||||++|+|++|..||........ ..... ....+...+..+.+||.+||+.||.+|||+.|++++.+.
T Consensus 184 ~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-FKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp GGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-BCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred CCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-HHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 6 6799999999999999999998864322111 00000 011122345678999999999999999999999988764
Q ss_pred h
Q 044846 236 I 236 (290)
Q Consensus 236 ~ 236 (290)
.
T Consensus 263 ~ 263 (336)
T 3h4j_B 263 N 263 (336)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=293.81 Aligned_cols=225 Identities=23% Similarity=0.327 Sum_probs=183.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe----------------CCcceEEEEeCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLE----------------TEVPLLVYEFIPNGSLYQYI 65 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----------------~~~~~lv~e~~~~g~L~~~l 65 (290)
|+.||+|+++... +.+.+|+++++.++||||+++++++.. ....++||||+++|+|.+++
T Consensus 36 ~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 111 (284)
T 2a19_B 36 GKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI 111 (284)
T ss_dssp CCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHH
T ss_pred CeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHH
Confidence 6789999997543 246789999999999999999999864 34579999999999999999
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceec
Q 044846 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVT 145 (290)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~ 145 (290)
...... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... .......|+
T Consensus 112 ~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~ 184 (284)
T 2a19_B 112 EKRRGE--KLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--GKRTRSKGT 184 (284)
T ss_dssp HHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCC--SCCCCCCSC
T ss_pred hhccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccc--ccccccCCc
Confidence 765322 5889999999999999999999999 999999999999999999999999997654322 122345689
Q ss_pred ccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 146 FGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 146 ~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
+.|+|||++.+..++.++||||||+++|+|++|..++........ .......+...+..+.++|.+||+.||.+|||
T Consensus 185 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 261 (284)
T 2a19_B 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT---DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPN 261 (284)
T ss_dssp CTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH---HHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH---HhhcccccccCCHHHHHHHHHHccCChhhCcC
Confidence 999999999999999999999999999999999987753322111 11111122234567889999999999999999
Q ss_pred HHHHHHHHHhhHhhh
Q 044846 226 MKEVTLELAGIRASI 240 (290)
Q Consensus 226 ~~el~~~l~~~~~~~ 240 (290)
+.|++++|+.+....
T Consensus 262 ~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 262 TSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHHHHHHHHHTC--
T ss_pred HHHHHHHHHHHhhCC
Confidence 999999999886544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=295.56 Aligned_cols=228 Identities=21% Similarity=0.314 Sum_probs=174.4
Q ss_pred ceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 3 ELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 3 ~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
..||+|+++.. .....+.+.+|+++++.++||||+++++++ ..+..++||||+.+++|.+++..... .+++..+
T Consensus 47 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~ 122 (289)
T 3og7_A 47 GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASET---KFEMKKL 122 (289)
T ss_dssp SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC------CCHHHH
T ss_pred CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccC---CCCHHHH
Confidence 45899998643 345567899999999999999999999965 55678999999999999999975432 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC-CceeeccceecccccCccccc---c
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID-RTHLTTQVKVTFGYVDPKYFR---S 156 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~---~ 156 (290)
+.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... .........||+.|+|||++. +
T Consensus 123 ~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 199 (289)
T 3og7_A 123 IDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199 (289)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----
T ss_pred HHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCC
Confidence 999999999999999999 999999999999999999999999997643321 112223456899999999986 5
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
..++.++||||||+++|+|++|..||................ ......+..+.+|+.+||+.||.+|||+.++
T Consensus 200 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 279 (289)
T 3og7_A 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279 (289)
T ss_dssp CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 668889999999999999999999886533222221111111 1112455779999999999999999999999
Q ss_pred HHHHHhhH
Q 044846 230 TLELAGIR 237 (290)
Q Consensus 230 ~~~l~~~~ 237 (290)
++.|+.+.
T Consensus 280 l~~L~~l~ 287 (289)
T 3og7_A 280 LAEIEELA 287 (289)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHHh
Confidence 99998874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=295.72 Aligned_cols=223 Identities=21% Similarity=0.219 Sum_probs=182.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+++.......+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... .+++..+.
T Consensus 34 ~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~ 109 (304)
T 2jam_A 34 GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG----VYTEKDAS 109 (304)
T ss_dssp CCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----CCCHHHHH
T ss_pred CCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC----CCCHHHHH
Confidence 67899999986555556778999999999999999999999999999999999999999999998765 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---ccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILL---VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++..... .......|++.|+|||++.+..
T Consensus 110 ~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~ 183 (304)
T 2jam_A 110 LVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGTPGYVAPEVLAQKP 183 (304)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---BTTHHHHSCCCBCCTTTBSSCS
T ss_pred HHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---CccccccCCCCccChHHhccCC
Confidence 99999999999999999 9999999999999 7788999999999764332 1223456889999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
++.++||||||+++|+|++|..|+........ ...... .......+..+.++|.+||+.||++|||+.|++++
T Consensus 184 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 184 YSKAVDCWSIGVITYILLCGYPPFYEETESKL-FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999998865432211 111111 11123346779999999999999999999999987
Q ss_pred HHh
Q 044846 233 LAG 235 (290)
Q Consensus 233 l~~ 235 (290)
.+-
T Consensus 263 ~~~ 265 (304)
T 2jam_A 263 PWI 265 (304)
T ss_dssp HHH
T ss_pred ccc
Confidence 653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=297.75 Aligned_cols=230 Identities=27% Similarity=0.358 Sum_probs=178.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++.. ....+.+.+|+++++.++||||+++++++. +..++||||+++|+|.+++..... ...++...++
T Consensus 31 ~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 105 (307)
T 2eva_A 31 AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAM 105 (307)
T ss_dssp TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSS-EECCCHHHHH
T ss_pred CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCC-CCccCHHHHH
Confidence 56799999864 445678999999999999999999999886 458999999999999999986532 1247888999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc-EEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ-AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
.++.|++.||.|||+.+..+|+||||||+||+++.++. +||+|||++..... ......||+.|+|||++.+..++
T Consensus 106 ~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~ 181 (307)
T 2eva_A 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSNYS 181 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------------CCTTSSCHHHHTCCCCC
T ss_pred HHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----ccccCCCCCceEChhhhCCCCCC
Confidence 99999999999999932222999999999999998886 79999999764321 12334689999999999999999
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhH-HH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA-AY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.++||||||+++|+|++|..|+........... .. .........+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 182 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999998853322111111 11 11112234456789999999999999999999999999988
Q ss_pred Hhhh
Q 044846 237 RASI 240 (290)
Q Consensus 237 ~~~~ 240 (290)
....
T Consensus 262 ~~~~ 265 (307)
T 2eva_A 262 MRYF 265 (307)
T ss_dssp GGGC
T ss_pred HHhc
Confidence 6544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=291.82 Aligned_cols=225 Identities=17% Similarity=0.204 Sum_probs=185.2
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++.. ......+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+.+.... .+++..
T Consensus 31 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~ 106 (284)
T 3kk8_A 31 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEAD 106 (284)
T ss_dssp CCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHH
T ss_pred CceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC----CCCHHH
Confidence 67899999864 344556788999999999999999999999999999999999999999999998765 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc---EEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ---AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++..... ........|++.|+|||++.+
T Consensus 107 ~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~ 181 (284)
T 3kk8_A 107 ASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLKK 181 (284)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS--SCBCCCSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc--CccccCCCCCcCCcCchhhcC
Confidence 9999999999999999999 999999999999986655 99999999764432 222334678999999999999
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
..++.++||||||+++|+|++|..||............... .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 182 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99999999999999999999999988654332211111100 1111234567999999999999999999999998
Q ss_pred HHHh
Q 044846 232 ELAG 235 (290)
Q Consensus 232 ~l~~ 235 (290)
+.+-
T Consensus 262 h~~~ 265 (284)
T 3kk8_A 262 VPWI 265 (284)
T ss_dssp SHHH
T ss_pred Cccc
Confidence 7653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=310.61 Aligned_cols=224 Identities=20% Similarity=0.235 Sum_probs=174.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||||+++. ...+.+|+.++.++ +||||++++++|.. ...+|||||||.+|+|.+++..... ..++
T Consensus 87 ~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~l~ 159 (400)
T 1nxk_A 87 QEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFT 159 (400)
T ss_dssp CCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC-----CCB
T ss_pred CCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCC--CCCC
Confidence 67899999863 23567899987554 89999999999876 5678999999999999999986532 2589
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
+..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.... ........||+.|+|||+
T Consensus 160 ~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~--~~~~~~~~gt~~y~aPE~ 234 (400)
T 1nxk_A 160 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTPYYVAPEV 234 (400)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------------CTTCCGGG
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCC--CCccccCCCCCCccCHhh
Confidence 9999999999999999999999 999999999999997 78899999999875332 122345678999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh---hhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR---SLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~---~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
+.+..++.++|||||||++|+|++|.+||........ ....... .......+.++.+||.+||+.||++||
T Consensus 235 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 314 (400)
T 1nxk_A 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 314 (400)
T ss_dssp SCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred cCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCc
Confidence 9999999999999999999999999998865432110 0011100 111134567799999999999999999
Q ss_pred CHHHHHHHHHhhH
Q 044846 225 TMKEVTLELAGIR 237 (290)
Q Consensus 225 s~~el~~~l~~~~ 237 (290)
|+.|++++.+...
T Consensus 315 t~~eil~hp~~~~ 327 (400)
T 1nxk_A 315 TITEFMNHPWIMQ 327 (400)
T ss_dssp CHHHHHHSHHHHT
T ss_pred CHHHHhcCccccC
Confidence 9999999976543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=297.25 Aligned_cols=223 Identities=22% Similarity=0.246 Sum_probs=184.2
Q ss_pred CceEEEEeecccCch------hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHES------NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|+++..... ..+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.... .+
T Consensus 37 ~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~ 112 (321)
T 2a2a_A 37 GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE----SL 112 (321)
T ss_dssp CCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS----CE
T ss_pred CeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC----CC
Confidence 678999998643321 36789999999999999999999999999999999999999999999998644 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC----cEEEeccccccccccCCceeeccceecccccCc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY----QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++...... .......||+.|+||
T Consensus 113 ~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aP 187 (321)
T 2a2a_A 113 SEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAP 187 (321)
T ss_dssp EHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT--CCCCCCCSCGGGCCH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCcc--ccccccCCCCCccCc
Confidence 99999999999999999999999 99999999999999887 7999999998654322 222345689999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
|++.+..++.++||||||+++|+|++|..||........ ...... .......+..+.+||.+||+.||++|||
T Consensus 188 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 266 (321)
T 2a2a_A 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT 266 (321)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCC
T ss_pred ccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcC
Confidence 999999999999999999999999999998865432211 111111 1111234567899999999999999999
Q ss_pred HHHHHHHHH
Q 044846 226 MKEVTLELA 234 (290)
Q Consensus 226 ~~el~~~l~ 234 (290)
+.|++++.+
T Consensus 267 ~~e~l~hp~ 275 (321)
T 2a2a_A 267 IQEALRHPW 275 (321)
T ss_dssp HHHHHHSTT
T ss_pred HHHHhcCcc
Confidence 999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=297.13 Aligned_cols=234 Identities=19% Similarity=0.310 Sum_probs=178.9
Q ss_pred ceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----cceEEEEeCCCCCHHHHHhhcC--CCCC
Q 044846 3 ELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETE-----VPLLVYEFIPNGSLYQYIHEQT--DDQL 73 (290)
Q Consensus 3 ~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~--~~~~ 73 (290)
+.||+|+++.. .....+.+.+|+.+++.++||||+++++++...+ ..++||||+++|+|.+++.... ....
T Consensus 63 ~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~ 142 (313)
T 3brb_A 63 LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK 142 (313)
T ss_dssp EEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCC
T ss_pred eEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCc
Confidence 47999998743 3455678999999999999999999999998754 3499999999999999995432 1223
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceecccccCcc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVDPK 152 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE 152 (290)
.+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++....... .......+++.|+|||
T Consensus 143 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 219 (313)
T 3brb_A 143 HIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 219 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCch
Confidence 6899999999999999999999999 99999999999999999999999999865432221 1123345678899999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
++.+..++.++||||||+++|+|++ |.+|+...... ....... ....+...+..+.+++.+||+.||.+|||+.+
T Consensus 220 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 298 (313)
T 3brb_A 220 SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-EMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSV 298 (313)
T ss_dssp HHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred hhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999999999999999999999 76666433221 1111111 11223345577999999999999999999999
Q ss_pred HHHHHHhhHhhh
Q 044846 229 VTLELAGIRASI 240 (290)
Q Consensus 229 l~~~l~~~~~~~ 240 (290)
++++|+.+...+
T Consensus 299 l~~~L~~l~~~l 310 (313)
T 3brb_A 299 LRLQLEKLLESL 310 (313)
T ss_dssp HHHHHHHHHHHC
T ss_pred HHHHHHHHHHhc
Confidence 999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=293.88 Aligned_cols=230 Identities=22% Similarity=0.281 Sum_probs=185.2
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
++.||+|+++... ....+.+.+|+++++.++||||+++++++ ..+..++||||+++++|.+++.... .+++..
T Consensus 44 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~ 118 (291)
T 1xbb_A 44 VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR----HVKDKN 118 (291)
T ss_dssp EEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT----TCCHHH
T ss_pred eeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc----CCCHHH
Confidence 4679999987532 33467899999999999999999999999 5677899999999999999998754 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceee--ccceecccccCccccccC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLT--TQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~ 157 (290)
++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........... ....+++.|+|||++.+.
T Consensus 119 ~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 195 (291)
T 1xbb_A 119 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195 (291)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC
Confidence 9999999999999999999 99999999999999999999999999875443322221 223456889999999988
Q ss_pred CCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.++.++||||||+++|+|++ |..|+........ ...... ...+...+..+.++|.+||+.||.+|||+.++++.|
T Consensus 196 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 274 (291)
T 1xbb_A 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 274 (291)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 89999999999999999998 8887764332211 111111 112234567899999999999999999999999999
Q ss_pred HhhHhhh
Q 044846 234 AGIRASI 240 (290)
Q Consensus 234 ~~~~~~~ 240 (290)
+.+....
T Consensus 275 ~~~~~~~ 281 (291)
T 1xbb_A 275 RNYYYDV 281 (291)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9887654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=292.80 Aligned_cols=226 Identities=22% Similarity=0.250 Sum_probs=183.0
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... .+++.
T Consensus 34 ~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~ 109 (279)
T 3fdn_A 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQ 109 (279)
T ss_dssp CCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS----SCCHH
T ss_pred CcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC----CCCHH
Confidence 567999998542 22335678999999999999999999999999999999999999999999998765 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++..... .......|++.|+|||++.+..
T Consensus 110 ~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~ 183 (279)
T 3fdn_A 110 RTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTDLCGTLDYLPPEMIEGRM 183 (279)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-----------CCCCTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc---ccccccCCCCCccCHhHhccCC
Confidence 99999999999999999999 99999999999999999999999998754322 2223456889999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhh-HHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL-AAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
++.++||||||+++|+|++|..|+.......... ........+...+..+.+||.+||+.||.+|||+.|++++.+-..
T Consensus 184 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 9999999999999999999999886443221111 111111222335567899999999999999999999999876443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=295.74 Aligned_cols=225 Identities=18% Similarity=0.196 Sum_probs=176.7
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+++++|..++.... .+++..
T Consensus 28 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~ 103 (311)
T 4agu_A 28 GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR----GVPEHL 103 (311)
T ss_dssp CCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS----CCCHHH
T ss_pred CcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc----CCCHHH
Confidence 6789999986433 3346678899999999999999999999999999999999999999998887554 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-CC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-SQ 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~ 158 (290)
+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... ........|+..|+|||++.+ ..
T Consensus 104 ~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 179 (311)
T 4agu_A 104 VKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP-SDYYDDEVATRWYRSPELLVGDTQ 179 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-------------GGGCCHHHHHTCSC
T ss_pred HHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-ccccCCCcCCccccChHHHhcCCC
Confidence 9999999999999999999 999999999999999999999999998654322 122334568899999999876 56
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHH--Hhhh------------------------------hhhHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA--YFSK------------------------------EAEKEEVI 206 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~--~~~~------------------------------~~~~~~~~ 206 (290)
++.++||||||+++|+|++|.+|+............ .... ......+.
T Consensus 180 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (311)
T 4agu_A 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISY 259 (311)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCH
T ss_pred CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccH
Confidence 899999999999999999999988654332211110 0000 00012345
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.+.+|+.+||+.||.+|||++|++++.+
T Consensus 260 ~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 260 PALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp HHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 6889999999999999999999998744
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=293.20 Aligned_cols=231 Identities=18% Similarity=0.282 Sum_probs=186.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||+|+++... ...+.+.+|+++++.++||||+++++++. .+..++||||+++++|.+++..... ..+++..+.
T Consensus 37 ~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~ 112 (279)
T 1qpc_A 37 HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLL 112 (279)
T ss_dssp TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHH
T ss_pred CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCC--CCCCHHHHH
Confidence 4579999987543 34678999999999999999999999986 4568999999999999999975431 148899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...............++..|+|||++.+..++.
T Consensus 113 ~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 189 (279)
T 1qpc_A 113 DMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189 (279)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECH
T ss_pred HHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCc
Confidence 99999999999999999 999999999999999999999999998755433323333455678899999999888999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
++||||||+++|+|++ |..|+...... ....... ....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 190 ~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 190 KSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhHHHHHHHHHHHhCCCCCCcccCHH-HHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 9999999999999998 77776533221 1111111 11122344567999999999999999999999999999887
Q ss_pred hhh
Q 044846 238 ASI 240 (290)
Q Consensus 238 ~~~ 240 (290)
...
T Consensus 269 ~~~ 271 (279)
T 1qpc_A 269 TAT 271 (279)
T ss_dssp HHC
T ss_pred Hhc
Confidence 654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=294.59 Aligned_cols=224 Identities=17% Similarity=0.226 Sum_probs=180.0
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++. ........+.+|+..+..+ +||||+++++++...+..++||||+++|+|.+++.........+++.
T Consensus 36 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 115 (289)
T 1x8b_A 36 GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115 (289)
T ss_dssp CCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHH
T ss_pred CceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHH
Confidence 67899999874 3344567889999999999 99999999999999999999999999999999998753222258999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC-------------------CcEEEeccccccccccCCceee
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-------------------YQAKISDFRTFKSRAIDRTHLT 139 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~-------------------~~~kl~dfg~~~~~~~~~~~~~ 139 (290)
.++.++.||+.||.|||+++ |+||||||+||+++.+ ..+||+|||.+......
T Consensus 116 ~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----- 187 (289)
T 1x8b_A 116 ELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----- 187 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS-----
T ss_pred HHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc-----
Confidence 99999999999999999999 9999999999999844 47999999997654322
Q ss_pred ccceecccccCccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhcc
Q 044846 140 TQVKVTFGYVDPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNL 218 (290)
Q Consensus 140 ~~~~g~~~y~aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 218 (290)
....|+..|+|||++.+. .++.++|||||||++|+|++|.+++........ +........+...+..+.+++.+||+.
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~ 266 (289)
T 1x8b_A 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE-IRQGRLPRIPQVLSQEFTELLKVMIHP 266 (289)
T ss_dssp CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH-HHTTCCCCCSSCCCHHHHHHHHHHTCS
T ss_pred cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH-HHcCCCCCCCcccCHHHHHHHHHHhCC
Confidence 224588999999999876 566799999999999999999887654332211 111111122234567799999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 044846 219 NGKKQPTMKEVTLELA 234 (290)
Q Consensus 219 dp~~Rps~~el~~~l~ 234 (290)
||++|||+.|++++.+
T Consensus 267 dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 267 DPERRPSAMALVKHSV 282 (289)
T ss_dssp SGGGSCCHHHHHTCTT
T ss_pred CcccCCCHHHHhhChH
Confidence 9999999999997754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=314.55 Aligned_cols=223 Identities=17% Similarity=0.196 Sum_probs=184.3
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||||+++... ....+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... .+++.
T Consensus 41 g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~l~~~ 116 (476)
T 2y94_A 41 GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG----RLDEK 116 (476)
T ss_dssp CCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS----SCCHH
T ss_pred CCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC----CCCHH
Confidence 6789999986432 2346688999999999999999999999999999999999999999999997644 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... ........||+.|+|||++.+..
T Consensus 117 ~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~ 191 (476)
T 2y94_A 117 ESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCGSPNYAAPEVISGRL 191 (476)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT--TCCBCCCCSCSTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc--cccccccCCCcCeEChhhccCCC
Confidence 99999999999999999999 99999999999999999999999999865432 22234567899999999998877
Q ss_pred C-CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 159 F-TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 159 ~-~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+ +.++|||||||++|+|++|..||....... ........ ..+...+..+.+||.+||+.||.+|||+.|++++.+
T Consensus 192 ~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-HHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred CCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 5 679999999999999999999886443221 11111111 112234567899999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=297.25 Aligned_cols=233 Identities=19% Similarity=0.294 Sum_probs=186.5
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC------CCCC
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD------DQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~ 74 (290)
++.||+|++... .......+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... ....
T Consensus 55 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 134 (322)
T 1p4o_A 55 ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134 (322)
T ss_dssp EEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCC
T ss_pred ceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCC
Confidence 356999998743 344566799999999999999999999999999999999999999999999976421 1124
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKY 153 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~ 153 (290)
+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++........ ......+++.|+|||+
T Consensus 135 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 211 (322)
T 1p4o_A 135 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 211 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhh
Confidence 688999999999999999999999 999999999999999999999999998654322211 2233456888999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
+.+..++.++||||||+++|+|++ |..|+...... ........ ...+...+..+.++|.+||+.||.+|||+.|+
T Consensus 212 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~ 290 (322)
T 1p4o_A 212 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 290 (322)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 999999999999999999999998 66666433221 11111111 11223456679999999999999999999999
Q ss_pred HHHHHhhHh
Q 044846 230 TLELAGIRA 238 (290)
Q Consensus 230 ~~~l~~~~~ 238 (290)
+++|+....
T Consensus 291 l~~L~~~~~ 299 (322)
T 1p4o_A 291 ISSIKEEME 299 (322)
T ss_dssp HHHHGGGSC
T ss_pred HHHHHHhhc
Confidence 999987643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=301.51 Aligned_cols=236 Identities=20% Similarity=0.295 Sum_probs=170.9
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC-CCceeeEEeEEEe--------CCcceEEEEeCCCCCHHHHHhhcCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN-HRNVVKILGCCLE--------TEVPLLVYEFIPNGSLYQYIHEQTDDQ 72 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~ 72 (290)
|+.||+|++........+.+.+|+.+++++. ||||+++++++.. ....++||||+ +|+|.+++......
T Consensus 53 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~- 130 (337)
T 3ll6_A 53 GREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESR- 130 (337)
T ss_dssp CCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTT-
T ss_pred CcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEec-CCCHHHHHHHhhcc-
Confidence 6789999997777777888999999999995 9999999999953 33579999999 57999999763322
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-----------eecc
Q 044846 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-----------LTTQ 141 (290)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-----------~~~~ 141 (290)
..+++..++.++.||+.||.|||+.+. +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 131 ~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (337)
T 3ll6_A 131 GPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209 (337)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-----------------
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhcc
Confidence 258999999999999999999999763 3999999999999999999999999998754322111 1113
Q ss_pred ceecccccCcccc---ccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhcc
Q 044846 142 VKVTFGYVDPKYF---RSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNL 218 (290)
Q Consensus 142 ~~g~~~y~aPE~~---~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 218 (290)
..||+.|+|||++ .+..++.++|||||||++|+|++|..||....... ..............+..+.+||.+||+.
T Consensus 210 ~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~ 288 (337)
T 3ll6_A 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-IVNGKYSIPPHDTQYTVFHSLIRAMLQV 288 (337)
T ss_dssp --------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------CCCCTTCCSSGGGHHHHHHHSCS
T ss_pred ccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-hhcCcccCCcccccchHHHHHHHHHccC
Confidence 4588999999998 56678889999999999999999999885432221 1111111112222334588999999999
Q ss_pred CCCCCCCHHHHHHHHHhhHhhhC
Q 044846 219 NGKKQPTMKEVTLELAGIRASIG 241 (290)
Q Consensus 219 dp~~Rps~~el~~~l~~~~~~~~ 241 (290)
||.+|||+.|++++|+.+.....
T Consensus 289 ~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 289 NPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp SGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ChhhCcCHHHHHHHHHHHHhccC
Confidence 99999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=302.30 Aligned_cols=226 Identities=19% Similarity=0.267 Sum_probs=177.5
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCC--CceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINH--RNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~H--pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|++... .....+.+.+|+.+|+.++| |||+++++++...+..++|||+ .+|+|.+++.... .+++
T Consensus 33 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~----~~~~ 107 (343)
T 3dbq_A 33 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK----SIDP 107 (343)
T ss_dssp SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSC----CCCH
T ss_pred CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcC----CCCH
Confidence 578999998643 34456789999999999976 9999999999999999999995 5889999998754 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCcccccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~ 156 (290)
..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++........ ......||+.|+|||++.+
T Consensus 108 ~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 108 WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhh
Confidence 999999999999999999999 99999999999997 688999999998754332221 2335678999999999865
Q ss_pred -----------CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCC
Q 044846 157 -----------SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGK 221 (290)
Q Consensus 157 -----------~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~ 221 (290)
..++.++|||||||++|+|++|..||................ ..+...+..+.+|+.+||+.||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~ 263 (343)
T 3dbq_A 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 263 (343)
T ss_dssp CC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred ccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChh
Confidence 668889999999999999999999886433322222222111 11222345788999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 044846 222 KQPTMKEVTLELAGI 236 (290)
Q Consensus 222 ~Rps~~el~~~l~~~ 236 (290)
+|||+.|++++.+.-
T Consensus 264 ~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 264 QRISIPELLAHPYVQ 278 (343)
T ss_dssp TSCCHHHHHTSHHHH
T ss_pred HCCCHHHHHhCcccc
Confidence 999999999887643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=317.12 Aligned_cols=229 Identities=17% Similarity=0.141 Sum_probs=187.0
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||++++++|......|+||||++||+|..++.........+++.
T Consensus 210 g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~ 289 (543)
T 3c4z_A 210 GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289 (543)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHH
T ss_pred CcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHH
Confidence 688999998642 23446788999999999999999999999999999999999999999999998765434469999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...... .......||+.|+|||++.+..
T Consensus 290 ~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~ 365 (543)
T 3c4z_A 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLLGEE 365 (543)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CCBCCCCSCTTTSCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCC-cccccccCCccccChhhhcCCC
Confidence 99999999999999999999 9999999999999999999999999987543222 2233457899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhh---hhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEE---NRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTM-----KE 228 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~e 228 (290)
++.++|||||||++|||++|.+||...... ......... ...+...+..+.+||.+||+.||.+||++ ++
T Consensus 366 ~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~e 445 (543)
T 3c4z_A 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDG 445 (543)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHH
T ss_pred CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHH
Confidence 999999999999999999999998654211 111111111 11233456789999999999999999964 67
Q ss_pred HHHHHH
Q 044846 229 VTLELA 234 (290)
Q Consensus 229 l~~~l~ 234 (290)
++.|..
T Consensus 446 i~~Hpf 451 (543)
T 3c4z_A 446 LRTHPL 451 (543)
T ss_dssp HHTSGG
T ss_pred HHcCcc
Confidence 776643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=300.92 Aligned_cols=220 Identities=18% Similarity=0.215 Sum_probs=178.9
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||+|++.. ......+++.+|+++++.++||||+++++++...+ .+|+||||+ +++|.+++...
T Consensus 50 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----- 123 (367)
T 1cm8_A 50 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE----- 123 (367)
T ss_dssp CCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC-----
T ss_pred CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC-----
Confidence 67899999854 23445678999999999999999999999998753 459999999 88999999863
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||+
T Consensus 124 ~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~ 196 (367)
T 1cm8_A 124 KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEV 196 (367)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc----cCcCcCCCCcCCHHH
Confidence 4889999999999999999999999 999999999999999999999999998754321 234578999999999
Q ss_pred ccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhhh------------------------------hh
Q 044846 154 FRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFSK------------------------------EA 200 (290)
Q Consensus 154 ~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~~------------------------------~~ 200 (290)
+.+ ..++.++||||+||++|+|++|.+||......... ....... ..
T Consensus 197 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (367)
T 1cm8_A 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 276 (367)
T ss_dssp HHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGT
T ss_pred HhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHH
Confidence 887 67999999999999999999999988654322111 0000000 00
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
....+..+.+|+.+||+.||.+|||+.|+++|..
T Consensus 277 ~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 277 LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 0122567899999999999999999999998854
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=321.82 Aligned_cols=229 Identities=20% Similarity=0.288 Sum_probs=184.6
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
..||||+++... ...+.|.+|+++|+.|+||||+++++++.. +..+||||||.+|+|.+++...... .+++..++.
T Consensus 292 ~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~--~l~~~~~~~ 367 (535)
T 2h8h_A 292 TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVD 367 (535)
T ss_dssp EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHT--TCCHHHHHH
T ss_pred ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCC--CCCHHHHHH
Confidence 469999998643 346789999999999999999999999876 6789999999999999999764321 488999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCCc
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............++..|+|||++.+..++.+
T Consensus 368 i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 444 (535)
T 2h8h_A 368 MAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444 (535)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCch
Confidence 9999999999999999 9999999999999999999999999986543221111223456778999999999999999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
+|||||||++|||++ |..|+...... ....... ....+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 445 sDvwSlGv~l~el~t~g~~P~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 445 SDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHHHHHHHHHTTTTCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 999999999999998 77776533221 1111111 112233456779999999999999999999999999988754
Q ss_pred h
Q 044846 239 S 239 (290)
Q Consensus 239 ~ 239 (290)
.
T Consensus 524 ~ 524 (535)
T 2h8h_A 524 S 524 (535)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=306.18 Aligned_cols=225 Identities=19% Similarity=0.269 Sum_probs=178.4
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcC--CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQIN--HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~--Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||||++.. .+....+.+.+|+++|+.|+ ||||+++++++...+..++||| +.+++|.+++.... .+++
T Consensus 80 ~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~----~~~~ 154 (390)
T 2zmd_A 80 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK----SIDP 154 (390)
T ss_dssp CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS----SCCH
T ss_pred CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC----CCCH
Confidence 57899999864 34456778999999999996 5999999999999999999999 55889999998754 5888
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCcccccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~ 156 (290)
..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++........ ......||+.|+|||++.+
T Consensus 155 ~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 155 WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhh
Confidence 899999999999999999999 99999999999995 689999999998754332221 2345678999999999875
Q ss_pred -----------CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCC
Q 044846 157 -----------SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGK 221 (290)
Q Consensus 157 -----------~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~ 221 (290)
..++.++|||||||++|+|++|.+||.........+...... ..+...+..+.+||.+||+.||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 310 (390)
T 2zmd_A 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 310 (390)
T ss_dssp C------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred ccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChh
Confidence 368889999999999999999999986543322222222211 11122245789999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 044846 222 KQPTMKEVTLELAG 235 (290)
Q Consensus 222 ~Rps~~el~~~l~~ 235 (290)
+|||+.|++++.+.
T Consensus 311 ~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 311 QRISIPELLAHPYV 324 (390)
T ss_dssp TSCCHHHHHTSHHH
T ss_pred hCCCHHHHhhCcCc
Confidence 99999999988654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=292.95 Aligned_cols=226 Identities=21% Similarity=0.219 Sum_probs=177.3
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|++... .....+.+.+|+++++.++||||+++++++......++||||+++|+|.+++.........+++..+
T Consensus 47 ~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 126 (285)
T 3is5_A 47 GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126 (285)
T ss_dssp CCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHH
T ss_pred CceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHH
Confidence 568999998643 3445778999999999999999999999999999999999999999999999664322236899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---ccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILL---VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
+.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++...... .......|++.|+|||++. .
T Consensus 127 ~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~-~ 200 (285)
T 3is5_A 127 AELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPEVFK-R 200 (285)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHT-T
T ss_pred HHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc--ccCcCcccccCcCChHHhc-c
Confidence 999999999999999999 9999999999999 45678999999998643322 2234466899999999985 5
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-h---hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-E---AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.++.++||||||+++|+|++|..||................ . .....+..+.+|+.+||+.||++|||+.|++++.
T Consensus 201 ~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 201 DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 68899999999999999999999886543222211111110 0 1112356788999999999999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=293.80 Aligned_cols=226 Identities=21% Similarity=0.276 Sum_probs=178.7
Q ss_pred CceEEEEeecccC-----chhHHHHHHHHHHHHhc---CCCceeeEEeEEEeCC-----cceEEEEeCCCCCHHHHHhhc
Q 044846 2 EELWLLKKSKSVH-----ESNVEQFINEVVILSQI---NHRNVVKILGCCLETE-----VPLLVYEFIPNGSLYQYIHEQ 68 (290)
Q Consensus 2 ~~~~avK~~~~~~-----~~~~~~~~~E~~~l~~l---~Hpniv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~ 68 (290)
|+.||+|+++... ......+.+|+++++.+ +||||+++++++.... ..++||||+. |+|.+++...
T Consensus 34 ~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~ 112 (308)
T 3g33_A 34 GHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA 112 (308)
T ss_dssp CCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTC
T ss_pred CcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhc
Confidence 6789999986422 12234567788887776 4999999999998765 5799999995 6999999876
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccc
Q 044846 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGY 148 (290)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y 148 (290)
... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........||+.|
T Consensus 113 ~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y 185 (308)
T 3g33_A 113 PPP--GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALTPVVVTLWY 185 (308)
T ss_dssp CTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTT--CCCSGGGGCCCSS
T ss_pred cCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCC--CcccCCccccccc
Confidence 532 4899999999999999999999999 99999999999999999999999999864332 2223456789999
Q ss_pred cCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH--hh--------------------------hhh
Q 044846 149 VDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY--FS--------------------------KEA 200 (290)
Q Consensus 149 ~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~--~~--------------------------~~~ 200 (290)
+|||++.+..++.++|||||||++|+|++|.+||............. .. ...
T Consensus 186 ~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (308)
T 3g33_A 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSV 265 (308)
T ss_dssp CCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHH
T ss_pred cCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHh
Confidence 99999999999999999999999999999999886543322111110 00 000
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
....+..+.+||.+||+.||++|||+.|+++|.+-
T Consensus 266 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 266 VPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300 (308)
T ss_dssp SCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred CccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence 11234678999999999999999999999987543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=301.56 Aligned_cols=224 Identities=19% Similarity=0.256 Sum_probs=171.4
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++... ....+.+.+|+++++.++||||+++++++...+..++||||+. |+|.+++.... .+++..
T Consensus 59 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~ 133 (329)
T 3gbz_A 59 NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP----DVSMRV 133 (329)
T ss_dssp TEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCT----TCCHHH
T ss_pred CceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcC----CCCHHH
Confidence 6789999997533 2335678899999999999999999999999999999999996 59999998765 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec-----cCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-----DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~-----~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+++..... ........||..|+|||++
T Consensus 134 ~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~ 209 (329)
T 3gbz_A 134 IKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTHEIITLWYRPPEIL 209 (329)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------------CCTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc-ccccCCCcCCccccCHHHh
Confidence 9999999999999999999 99999999999994 4556999999998654322 1223345678999999999
Q ss_pred ccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------------------------------hhhhH
Q 044846 155 RSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------------------------------KEAEK 202 (290)
Q Consensus 155 ~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~ 202 (290)
.+. .++.++|||||||++|+|++|.+||............... .....
T Consensus 210 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (329)
T 3gbz_A 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGA 289 (329)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGG
T ss_pred cCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhccc
Confidence 875 4899999999999999999999988654332221111000 00011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 203 EEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 203 ~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
..+..+.+||.+||+.||.+|||+.|+++|.+
T Consensus 290 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 290 LLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 13467899999999999999999999997754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=311.11 Aligned_cols=224 Identities=21% Similarity=0.226 Sum_probs=183.4
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++.. ........+.+|+++++.++||||+++++++...+..++|||||.+|+|.+.+.... .+++..
T Consensus 47 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~ 122 (486)
T 3mwu_A 47 QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHD 122 (486)
T ss_dssp CCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHH
T ss_pred CCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC----CCCHHH
Confidence 67899999853 223456789999999999999999999999999999999999999999999998765 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec---cCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV---DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+
T Consensus 123 ~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~ 197 (486)
T 3mwu_A 123 AARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLRG 197 (486)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS
T ss_pred HHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--CccCCCcCCCCCCCHHHhCC
Confidence 9999999999999999999 99999999999995 4567999999998644322 22344568999999999876
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.++.++||||+||++|+|++|.+||........ +..... .+.....+..+.+||.+||+.||.+|||+.|++
T Consensus 198 -~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l 275 (486)
T 3mwu_A 198 -TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275 (486)
T ss_dssp -CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 589999999999999999999999865433221 111111 122234567899999999999999999999999
Q ss_pred HHHHhh
Q 044846 231 LELAGI 236 (290)
Q Consensus 231 ~~l~~~ 236 (290)
++.+-.
T Consensus 276 ~hp~~~ 281 (486)
T 3mwu_A 276 EHPWIQ 281 (486)
T ss_dssp HCHHHH
T ss_pred cCHhhc
Confidence 986543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=301.76 Aligned_cols=226 Identities=20% Similarity=0.245 Sum_probs=183.8
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... .+++..+
T Consensus 58 ~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~ 133 (360)
T 3eqc_A 58 GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQIL 133 (360)
T ss_dssp CCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS----SCCHHHH
T ss_pred CcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC----CCCHHHH
Confidence 678999998754 44556789999999999999999999999999999999999999999999998765 5889999
Q ss_pred HHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++..... .......||+.|+|||++.+..+
T Consensus 134 ~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~ 207 (360)
T 3eqc_A 134 GKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 207 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---HC----CCCCTTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc---ccccCCCCCCCeECHHHHcCCCC
Confidence 99999999999999986 8 99999999999999999999999998754321 12234578999999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH-----------------------------------------hh-
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY-----------------------------------------FS- 197 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~- 197 (290)
+.++|||||||++|+|++|..||............. ..
T Consensus 208 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (360)
T 3eqc_A 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287 (360)
T ss_dssp SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHS
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhcc
Confidence 999999999999999999998886433221110000 00
Q ss_pred ---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 198 ---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 198 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
.......+..+.+||.+||+.||++|||+.|+++|.+--.
T Consensus 288 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 288 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp CCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 0000113557899999999999999999999999876544
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=302.19 Aligned_cols=229 Identities=12% Similarity=0.138 Sum_probs=183.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceee---------------EEeEEEe-CCcceEEEEeCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVK---------------ILGCCLE-TEVPLLVYEFIPNGSLYQYI 65 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~---------------~~~~~~~-~~~~~lv~e~~~~g~L~~~l 65 (290)
|+.||+|++... +.+.+|+++++.++||||++ +++++.. ....++||||+ +++|.+++
T Consensus 75 ~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l 148 (352)
T 2jii_A 75 KQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSAL 148 (352)
T ss_dssp --CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHH
T ss_pred CceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHH
Confidence 578999998753 35789999999999999988 5677766 67889999999 99999999
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC--cEEEeccccccccccCCce------
Q 044846 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY--QAKISDFRTFKSRAIDRTH------ 137 (290)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~------ 137 (290)
..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++........
T Consensus 149 ~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 223 (352)
T 2jii_A 149 DVSPK--HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223 (352)
T ss_dssp HHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTT
T ss_pred HhCCc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccc
Confidence 87521 15899999999999999999999999 99999999999999998 8999999998654322111
Q ss_pred eeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hh-h--h------HHHH
Q 044846 138 LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KE-A--E------KEEV 205 (290)
Q Consensus 138 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~-~--~------~~~~ 205 (290)
......||+.|+|||++.+..++.++|||||||++|+|++|..||............... .. . . ...+
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (352)
T 2jii_A 224 SRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPS 303 (352)
T ss_dssp SSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCC
T ss_pred ccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCc
Confidence 113357899999999999999999999999999999999999888654312111111111 00 0 0 1235
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhhC
Q 044846 206 ITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRASIG 241 (290)
Q Consensus 206 ~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~~~ 241 (290)
..+.+|+.+||+.||++|||+.++++.|+.+....+
T Consensus 304 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 304 ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 779999999999999999999999999999877653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=302.49 Aligned_cols=228 Identities=19% Similarity=0.297 Sum_probs=180.0
Q ss_pred EEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHH
Q 044846 5 WLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRI 83 (290)
Q Consensus 5 ~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 83 (290)
||+|++... .....+.+.+|+.+++.++||||+++++++. .+..++||||+.+|+|.+++..... .+++..++.+
T Consensus 45 v~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~ 120 (325)
T 3kex_A 45 VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNW 120 (325)
T ss_dssp EEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGG---GSCTTHHHHH
T ss_pred EEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccc---cCCHHHHHHH
Confidence 777877532 2344556789999999999999999999986 4568999999999999999986432 5888899999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccccccCCCCCc
Q 044846 84 TVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRSSQFTEK 162 (290)
Q Consensus 84 ~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~ 162 (290)
+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.+
T Consensus 121 ~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (325)
T 3kex_A 121 GVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ 197 (325)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChh
Confidence 999999999999999 999999999999999999999999998765433222 2344567889999999999999999
Q ss_pred ccchhhHHHHHHHhc-CCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 044846 163 SDVYSFSVVLVELNW-TKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239 (290)
Q Consensus 163 ~DiwS~G~il~~l~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~ 239 (290)
+|||||||++|+|++ |..||........ .+........+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 198 ~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 198 SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred hHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999 8888754322111 1111111112223455788999999999999999999999999888654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=297.71 Aligned_cols=234 Identities=20% Similarity=0.256 Sum_probs=186.7
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC---CCCCCH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD---QLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~ 77 (290)
|+.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++...... ...+++
T Consensus 60 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 139 (327)
T 2yfx_A 60 PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139 (327)
T ss_dssp CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCH
T ss_pred cceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccH
Confidence 457999999643 4555678999999999999999999999999999999999999999999999876421 124889
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCc-eeeccceecccccCccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRT-HLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~ 153 (290)
..++.++.|++.||.|||+++ |+||||||+||+++. +..+||+|||++........ .......+++.|+|||+
T Consensus 140 ~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 216 (327)
T 2yfx_A 140 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhH
Confidence 999999999999999999999 999999999999984 44699999998764322211 12234567889999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
+.+..++.++||||||+++|+|++ |..|+....... ....... ...+...+..+.++|.+||+.||.+|||+.++
T Consensus 217 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 295 (327)
T 2yfx_A 217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 295 (327)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 999999999999999999999997 777775432221 1111111 11223455679999999999999999999999
Q ss_pred HHHHHhhHhh
Q 044846 230 TLELAGIRAS 239 (290)
Q Consensus 230 ~~~l~~~~~~ 239 (290)
+++|+.+...
T Consensus 296 l~~l~~~~~~ 305 (327)
T 2yfx_A 296 LERIEYCTQD 305 (327)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHHhcC
Confidence 9999988654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=318.51 Aligned_cols=226 Identities=19% Similarity=0.175 Sum_probs=186.4
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++... .......+.+|+.+|+.++||||+++++++.+.+..|+||||++||+|.+++...... .+++.
T Consensus 209 g~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~--~l~e~ 286 (576)
T 2acx_A 209 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA--GFPEA 286 (576)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSC--CCCHH
T ss_pred CCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCC--CCCHH
Confidence 678999998642 2344667889999999999999999999999999999999999999999999865422 48999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..... .......||+.|+|||++.+..
T Consensus 287 ~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~--~~~~~~~GT~~Y~APEvl~~~~ 361 (576)
T 2acx_A 287 RAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVGYMAPEVVKNER 361 (576)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT--CCEECCCSCGGGCCHHHHTTCE
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC--ccccccCCCccccCHHHHcCCC
Confidence 99999999999999999999 999999999999999999999999998754322 2233457899999999999989
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhh--hhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKE 228 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~e 228 (290)
++.++|||||||++|+|++|.+||...... ...+... .....+...+..+.+||.+||+.||.+|| ++.|
T Consensus 362 ~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~e 441 (576)
T 2acx_A 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSARE 441 (576)
T ss_dssp ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHH
T ss_pred CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHH
Confidence 999999999999999999999998754221 1111111 11122234567899999999999999999 7899
Q ss_pred HHHHHH
Q 044846 229 VTLELA 234 (290)
Q Consensus 229 l~~~l~ 234 (290)
+++|.+
T Consensus 442 il~Hpf 447 (576)
T 2acx_A 442 VKEHPL 447 (576)
T ss_dssp HHTSGG
T ss_pred HHhChh
Confidence 988754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=307.90 Aligned_cols=226 Identities=18% Similarity=0.195 Sum_probs=173.9
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----CcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLET-----EVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||||+++. ......+++.+|+++|+.++||||+++++++... +..|+||||+. |+|.+++.... .
T Consensus 51 ~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~ 125 (432)
T 3n9x_A 51 EKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPI----F 125 (432)
T ss_dssp TEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSC----C
T ss_pred CcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccC----C
Confidence 67899999975 3344567899999999999999999999999876 56899999994 69999998654 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc------------------
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT------------------ 136 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~------------------ 136 (290)
+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 126 l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (432)
T 3n9x_A 126 LTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202 (432)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-----------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccccccccccccccc
Confidence 899999999999999999999999 99999999999999999999999999875432211
Q ss_pred ---eeeccceecccccCcccc-ccCCCCCcccchhhHHHHHHHhcC-----------CCCcccchh--------------
Q 044846 137 ---HLTTQVKVTFGYVDPKYF-RSSQFTEKSDVYSFSVVLVELNWT-----------KPIHLVDVE-------------- 187 (290)
Q Consensus 137 ---~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwS~G~il~~l~~~-----------~~~~~~~~~-------------- 187 (290)
.......||+.|+|||++ ....++.++||||+||++|||++| .++|.....
T Consensus 203 ~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~ 282 (432)
T 3n9x_A 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHE 282 (432)
T ss_dssp --------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CH
T ss_pred chhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccc
Confidence 123456789999999986 556799999999999999999974 333322110
Q ss_pred --hhhhhHHH---hhh------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 188 --ENRSLAAY---FSK------------------------------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 188 --~~~~~~~~---~~~------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
....+... ... ......+..+.+||.+||+.||.+|||++|+++|
T Consensus 283 ~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 283 KSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred cchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 000 0001245678999999999999999999999988
Q ss_pred HHh
Q 044846 233 LAG 235 (290)
Q Consensus 233 l~~ 235 (290)
.+-
T Consensus 363 p~f 365 (432)
T 3n9x_A 363 PYL 365 (432)
T ss_dssp GGG
T ss_pred hhh
Confidence 543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=305.96 Aligned_cols=228 Identities=21% Similarity=0.209 Sum_probs=183.8
Q ss_pred CceEEEEeeccc----CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSV----HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~----~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||||+++.. .....+.+.+|+++++.+ +||||+++++++...+..++||||+++|+|.+++.... .++
T Consensus 82 ~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~ 157 (355)
T 1vzo_A 82 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE----RFT 157 (355)
T ss_dssp TCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS----CCC
T ss_pred CeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC----CCC
Confidence 678999998642 223455678899999999 79999999999999999999999999999999998765 589
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............||+.|+|||++.+
T Consensus 158 ~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 158 EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcC
Confidence 9999999999999999999999 9999999999999999999999999987544333333445678999999999986
Q ss_pred C--CCCCcccchhhHHHHHHHhcCCCCcccchhh--hhhhH-HHh--hhhhhHHHHHHHHHHHHHhhccCCCCCC-----
Q 044846 157 S--QFTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSLA-AYF--SKEAEKEEVITFAMVAKRCLNLNGKKQP----- 224 (290)
Q Consensus 157 ~--~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~~-~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rp----- 224 (290)
. .++.++|||||||++|+|++|..||...... ...+. ... ....+...+..+.+||.+||+.||.+||
T Consensus 235 ~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~ 314 (355)
T 1vzo_A 235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 314 (355)
T ss_dssp CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTT
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCC
Confidence 3 4788999999999999999999988643211 11111 111 1122234456789999999999999999
Q ss_pred CHHHHHHHHHhh
Q 044846 225 TMKEVTLELAGI 236 (290)
Q Consensus 225 s~~el~~~l~~~ 236 (290)
|+.|++++....
T Consensus 315 s~~ell~h~~f~ 326 (355)
T 1vzo_A 315 DADEIKEHLFFQ 326 (355)
T ss_dssp THHHHHTSGGGT
T ss_pred CHHHHHcCcchh
Confidence 999999887543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=305.35 Aligned_cols=217 Identities=18% Similarity=0.240 Sum_probs=169.8
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHH-HHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVI-LSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~-l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .......+.+|..+ ++.++||||++++++|...+..|+||||++||+|..++.... .+++
T Consensus 63 ~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~ 138 (373)
T 2r5t_A 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLE 138 (373)
T ss_dssp CCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCH
T ss_pred CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC----CCCH
Confidence 578999998643 23345567778877 466899999999999999999999999999999999998765 5889
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..... ........||+.|+|||++.+.
T Consensus 139 ~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 214 (373)
T 2r5t_A 139 PRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NSTTSTFCGTPEYLAPEVLHKQ 214 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-CCCCCSBSCCCCCCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC-CCccccccCCccccCHHHhCCC
Confidence 999999999999999999999 999999999999999999999999998753221 2233456789999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQPTMK 227 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 227 (290)
.++.++|+|||||++|||++|.+||....... ........ ..+...+..+.+||.+||+.||.+||++.
T Consensus 215 ~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 99999999999999999999999886543221 11111111 11233556789999999999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=302.39 Aligned_cols=220 Identities=18% Similarity=0.236 Sum_probs=181.8
Q ss_pred CceEEEEeecccC--------chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCC-CHHHHHhhcCCCC
Q 044846 2 EELWLLKKSKSVH--------ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNG-SLYQYIHEQTDDQ 72 (290)
Q Consensus 2 ~~~~avK~~~~~~--------~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~ 72 (290)
|+.||+|+++... ....+.+.+|+.+++.++||||+++++++...+..++||||+.+| +|.+++....
T Consensus 49 ~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--- 125 (335)
T 3dls_A 49 NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--- 125 (335)
T ss_dssp TEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC---
T ss_pred CcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC---
Confidence 6789999987532 123446788999999999999999999999999999999999766 9999998654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcc
Q 044846 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPK 152 (290)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 152 (290)
.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .......||+.|+|||
T Consensus 126 -~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE 199 (335)
T 3dls_A 126 -RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYCAPE 199 (335)
T ss_dssp -CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT--CCBCEECSCGGGCCHH
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCC--CceeccCCCccccChh
Confidence 5899999999999999999999999 999999999999999999999999998654322 2233466899999999
Q ss_pred ccccCCC-CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 153 YFRSSQF-TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 153 ~~~~~~~-~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
++.+..+ +.++|||||||++|+|++|..||......... ....+...+..+.+||.+||+.||++|||+.++++
T Consensus 200 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA-----AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTT-----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhh-----ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9988876 77899999999999999999988643221110 01112224567899999999999999999999998
Q ss_pred HHHh
Q 044846 232 ELAG 235 (290)
Q Consensus 232 ~l~~ 235 (290)
+.+-
T Consensus 275 hp~~ 278 (335)
T 3dls_A 275 DPWV 278 (335)
T ss_dssp CTTT
T ss_pred Cccc
Confidence 8653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.25 Aligned_cols=230 Identities=20% Similarity=0.320 Sum_probs=181.9
Q ss_pred EEEEeecc-cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcC------------C
Q 044846 5 WLLKKSKS-VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT------------D 70 (290)
Q Consensus 5 ~avK~~~~-~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~ 70 (290)
+|+|+++. ......+.+.+|+++++.+ +||||+++++++...+..++||||+++|+|.+++.... .
T Consensus 55 v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 134 (327)
T 1fvr_A 55 AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 134 (327)
T ss_dssp EEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTT
T ss_pred eeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhccccccccccccccc
Confidence 48888864 3344566799999999999 99999999999999999999999999999999998653 1
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccC
Q 044846 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVD 150 (290)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 150 (290)
....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.... ........+++.|+|
T Consensus 135 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~a 209 (327)
T 1fvr_A 135 TASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKTMGRLPVRWMA 209 (327)
T ss_dssp BSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCE--ECCC----CCTTTCC
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCccccc--cccccCCCCCccccC
Confidence 2236899999999999999999999999 99999999999999999999999999763221 111233456788999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
||++.+..++.++||||||+++|+|++ |..|+....... ...... ....+...+..+.+||.+||+.||.+|||+
T Consensus 210 PE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 288 (327)
T 1fvr_A 210 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF 288 (327)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence 999998889999999999999999997 888775432221 111111 112223445779999999999999999999
Q ss_pred HHHHHHHHhhHhhh
Q 044846 227 KEVTLELAGIRASI 240 (290)
Q Consensus 227 ~el~~~l~~~~~~~ 240 (290)
.+++++|+.+....
T Consensus 289 ~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 289 AQILVSLNRMLEER 302 (327)
T ss_dssp HHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHhh
Confidence 99999999887654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=313.14 Aligned_cols=224 Identities=21% Similarity=0.191 Sum_probs=185.5
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..++|||||.+|+|.+++.... .+++.
T Consensus 51 ~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~ 126 (484)
T 3nyv_A 51 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK----RFSEV 126 (484)
T ss_dssp CCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS----CCBHH
T ss_pred CCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC----CCCHH
Confidence 678999998542 24457789999999999999999999999999999999999999999999998654 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---ccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL---VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
.+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..... .......||+.|+|||++.
T Consensus 127 ~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~ 201 (484)
T 3nyv_A 127 DAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPEVLH 201 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC--CSHHHHTTGGGTCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc--cccccCCCCccccCceeec
Confidence 99999999999999999999 9999999999999 46789999999997654322 2234456899999999987
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 229 (290)
+ .++.++||||+||++|+|++|.+||........ ...... .+.....+..+.+||.+||+.||.+|||+.|+
T Consensus 202 ~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~ 279 (484)
T 3nyv_A 202 G-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279 (484)
T ss_dssp T-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred C-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 6 689999999999999999999999865433221 111111 12223456789999999999999999999999
Q ss_pred HHHHHhh
Q 044846 230 TLELAGI 236 (290)
Q Consensus 230 ~~~l~~~ 236 (290)
++|.+-.
T Consensus 280 l~h~~~~ 286 (484)
T 3nyv_A 280 LDHEWIQ 286 (484)
T ss_dssp HTSHHHH
T ss_pred hhChhhc
Confidence 9886543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=300.01 Aligned_cols=228 Identities=19% Similarity=0.280 Sum_probs=174.7
Q ss_pred CceEEEEeecccCchh-HHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESN-VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~-~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|+++...... ...+.+|+++++.++||||+++++++...+..++||||+. |+|.+++..... .+++..+
T Consensus 27 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~ 102 (324)
T 3mtl_A 27 DNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN---IINMHNV 102 (324)
T ss_dssp CCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTT---CCCHHHH
T ss_pred CcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCC---CCCHHHH
Confidence 6789999987533222 2245689999999999999999999999999999999996 699999987543 5889999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc-CCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-SQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~ 159 (290)
..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......||+.|+|||++.+ ..+
T Consensus 103 ~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~ 178 (324)
T 3mtl_A 103 KLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDY 178 (324)
T ss_dssp HHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------------CGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cccccccCcccccChhhhcCCCCC
Confidence 999999999999999999 9999999999999999999999999976433221 22234567999999999876 568
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhH--HHhh-----------------------------hhhhHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA--AYFS-----------------------------KEAEKEEVITF 208 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~--~~~~-----------------------------~~~~~~~~~~~ 208 (290)
+.++|||||||++|+|++|.+||........... .... .......+..+
T Consensus 179 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (324)
T 3mtl_A 179 STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDG 258 (324)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHH
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHH
Confidence 9999999999999999999998865432211110 0000 00011234678
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 209 AMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 209 ~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
.+||.+||+.||.+|||++|++++.+-..
T Consensus 259 ~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 259 ADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 89999999999999999999998866543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=288.95 Aligned_cols=226 Identities=23% Similarity=0.264 Sum_probs=183.8
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.... .+++..+
T Consensus 32 ~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~ 107 (276)
T 2yex_A 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDA 107 (276)
T ss_dssp CCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT----BCCHHHH
T ss_pred CcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc----CCCHHHH
Confidence 678999998643 34456789999999999999999999999999999999999999999999987543 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+....... ........|+..|+|||++.+..+
T Consensus 108 ~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (276)
T 2yex_A 108 QRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184 (276)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSB
T ss_pred HHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCC
Confidence 999999999999999999 9999999999999999999999999976543221 122344568899999999987765
Q ss_pred -CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 160 -TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 160 -~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.++||||||+++|+|++|..||............... .......+..+.+||.+||+.||.+|||+.|++++.+
T Consensus 185 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 67899999999999999999988654332222221111 1112234667899999999999999999999987643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=291.48 Aligned_cols=228 Identities=21% Similarity=0.259 Sum_probs=182.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++..... ...+++..+.
T Consensus 47 ~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 125 (295)
T 2clq_A 47 QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIG 125 (295)
T ss_dssp CCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTC-CCTTCHHHHH
T ss_pred CeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhcc-CCCccHHHHH
Confidence 578999999876667778899999999999999999999999999999999999999999999987532 2356788899
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCceeeccceecccccCccccccCC--
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ-- 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-- 158 (290)
.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||++...... ........|+..|+|||++.+..
T Consensus 126 ~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~ 201 (295)
T 2clq_A 126 FYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-NPCTETFTGTLQYMAPEIIDKGPRG 201 (295)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGG
T ss_pred HHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC-CCcccccCCCccccChhhhcCCCCC
Confidence 99999999999999999 999999999999987 899999999997654321 12233456899999999987653
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH----hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY----FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++.++||||||+++|+|++|..|+............. .....+...+..+.++|.+||+.||++|||+.+++.+-.
T Consensus 202 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 202 YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp CSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 7889999999999999999999886432222111111 011222345677899999999999999999999987643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=287.59 Aligned_cols=223 Identities=21% Similarity=0.247 Sum_probs=180.9
Q ss_pred CceEEEEeecccCc------hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHE------SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.... .+
T Consensus 30 ~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~ 105 (283)
T 3bhy_A 30 GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE----SL 105 (283)
T ss_dssp CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SC
T ss_pred CCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC----CC
Confidence 67899999864321 236789999999999999999999999999999999999999999999998754 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC----cEEEeccccccccccCCceeeccceecccccCc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY----QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
++..+..++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++...... .......|++.|+||
T Consensus 106 ~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aP 180 (283)
T 3bhy_A 106 TEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEFVAP 180 (283)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCC--CcccccCCCcCccCc
Confidence 99999999999999999999999 99999999999998877 8999999997643321 222345688999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
|++.+..++.++||||||+++|+|++|..|+........ ...... .......+..+.+++.+||+.||++|||
T Consensus 181 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 259 (283)
T 3bhy_A 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT 259 (283)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred ceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcC
Confidence 999999999999999999999999999998865432211 111111 1111234567899999999999999999
Q ss_pred HHHHHHHHH
Q 044846 226 MKEVTLELA 234 (290)
Q Consensus 226 ~~el~~~l~ 234 (290)
+.|++++.+
T Consensus 260 ~~~~l~h~~ 268 (283)
T 3bhy_A 260 IAQSLEHSW 268 (283)
T ss_dssp HHHHHHCHH
T ss_pred HHHHHhCHH
Confidence 999998743
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=310.68 Aligned_cols=223 Identities=21% Similarity=0.215 Sum_probs=182.2
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++... ......+.+|+.+++.++||||++++++|...+..|+|||||++|+|.+++.... .+++..
T Consensus 62 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~----~~~~~~ 137 (494)
T 3lij_A 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM----KFNEVD 137 (494)
T ss_dssp CCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHH
T ss_pred CcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC----CCCHHH
Confidence 5679999986432 3446778999999999999999999999999999999999999999999998765 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++...... .......||+.|+|||++.
T Consensus 138 ~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~- 211 (494)
T 3lij_A 138 AAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPEVLR- 211 (494)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--BCBCCCCSCTTTCCHHHHT-
T ss_pred HHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--ccccccCCCcCeeCHHHHc-
Confidence 9999999999999999999 999999999999976 455999999998654322 2234467899999999986
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
..++.++||||+||++|+|++|.+||........ ...... .......+..+.+||.+||+.||.+|||+.|++
T Consensus 212 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 290 (494)
T 3lij_A 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290 (494)
T ss_dssp TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHh
Confidence 5689999999999999999999999865433221 111111 122234567799999999999999999999999
Q ss_pred HHHHh
Q 044846 231 LELAG 235 (290)
Q Consensus 231 ~~l~~ 235 (290)
+|.+-
T Consensus 291 ~hp~~ 295 (494)
T 3lij_A 291 EHPWI 295 (494)
T ss_dssp TCHHH
T ss_pred cCccc
Confidence 87543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=305.01 Aligned_cols=224 Identities=19% Similarity=0.193 Sum_probs=180.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc------CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI------NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l------~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||+++. .....+.+.+|+++++.+ +|+||+++++++...+..++||||+ +++|.+++...... .+
T Consensus 122 ~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~--~~ 197 (429)
T 3kvw_A 122 HQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQ--GF 197 (429)
T ss_dssp TEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC--CC
T ss_pred CcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc-CCCHHHHHHhccCC--CC
Confidence 67899999975 344456788899998887 5779999999999999999999999 46999999876533 48
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc--EEEeccccccccccCCceeeccceecccccCccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ--AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++..... ......||+.|+|||+
T Consensus 198 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~----~~~~~~gt~~y~aPE~ 270 (429)
T 3kvw_A 198 SLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYTYIQSRFYRAPEV 270 (429)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTC----CCCSSCSCGGGCCHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCC----cccccCCCCCccChHH
Confidence 99999999999999999999999 999999999999999887 99999999864332 2234678999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHhhhh--------------------------------
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYFSKE-------------------------------- 199 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~~~~-------------------------------- 199 (290)
+.+..++.++|||||||++|+|++|.+||.......... .......
T Consensus 271 ~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (429)
T 3kvw_A 271 ILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDG 350 (429)
T ss_dssp HHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC-
T ss_pred HhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccc
Confidence 999999999999999999999999999886543321111 0000000
Q ss_pred --------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 200 --------------------------AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 200 --------------------------~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.....+..+.+||.+||+.||++|||+.|+++|.+-.
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~ 413 (429)
T 3kvw_A 351 SVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413 (429)
T ss_dssp -CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC
T ss_pred cccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhc
Confidence 0001145689999999999999999999999886543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=299.86 Aligned_cols=230 Identities=13% Similarity=0.178 Sum_probs=185.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-CCCCCCH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN---HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD-DQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~---Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~ 77 (290)
|+.||+|+++... ...+..|+++++.+. |+||+++++++...+..++|||||++|+|.+++..... ....+++
T Consensus 95 ~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~ 171 (365)
T 3e7e_A 95 KQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171 (365)
T ss_dssp CCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCH
T ss_pred CcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCH
Confidence 6789999997543 446778888888886 99999999999999999999999999999999975322 1236999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-----------CCcEEEecccccccccc-CCceeeccceec
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-----------KYQAKISDFRTFKSRAI-DRTHLTTQVKVT 145 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-----------~~~~kl~dfg~~~~~~~-~~~~~~~~~~g~ 145 (290)
..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.... ..........||
T Consensus 172 ~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 248 (365)
T 3e7e_A 172 GLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248 (365)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCT
T ss_pred HHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCC
Confidence 999999999999999999999 999999999999998 89999999999865331 223344556799
Q ss_pred ccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCC-C
Q 044846 146 FGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQ-P 224 (290)
Q Consensus 146 ~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R-p 224 (290)
+.|+|||++.+..++.++|||||||++|+|++|..||................. .....+.+++.+||+.+|.+| |
T Consensus 249 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp TSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCC
T ss_pred CCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeechhcccc---CcHHHHHHHHHHHcCCCCCCcch
Confidence 999999999999999999999999999999999988865433221111111111 224567889999999999999 5
Q ss_pred CHHHHHHHHHhhHhhh
Q 044846 225 TMKEVTLELAGIRASI 240 (290)
Q Consensus 225 s~~el~~~l~~~~~~~ 240 (290)
++.++.+.|+......
T Consensus 326 ~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 326 SLDLLRQKLKKVFQQH 341 (365)
T ss_dssp CHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHh
Confidence 6888888888776543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=287.95 Aligned_cols=224 Identities=18% Similarity=0.281 Sum_probs=180.7
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
++.||+|++.. ......+.+.+|+.+++.++||||+++++++.. ....++||||+++|+|.+++.... .+
T Consensus 51 ~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~ 126 (290)
T 1t4h_A 51 TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VM 126 (290)
T ss_dssp CCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS----SC
T ss_pred ceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc----CC
Confidence 56789998864 345567789999999999999999999999875 356899999999999999998765 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec-cCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
++..++.++.|++.||.|||+.+. +|+||||||+||+++ .++.+||+|||++...... ......|++.|+|||++
T Consensus 127 ~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~ 202 (290)
T 1t4h_A 127 KIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMY 202 (290)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGG
T ss_pred CHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCccccccc---ccccccCCcCcCCHHHH
Confidence 899999999999999999999863 399999999999998 7899999999997643322 22345689999999988
Q ss_pred ccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
. ..++.++||||||+++|+|++|..||................ ......+..+.+||.+||+.||.+|||+.|++
T Consensus 203 ~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 203 E-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp G-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred h-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 6 458999999999999999999998886533332222222111 12223346799999999999999999999999
Q ss_pred HHHH
Q 044846 231 LELA 234 (290)
Q Consensus 231 ~~l~ 234 (290)
++.+
T Consensus 282 ~h~~ 285 (290)
T 1t4h_A 282 NHAF 285 (290)
T ss_dssp TSGG
T ss_pred hCcc
Confidence 7654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=302.02 Aligned_cols=223 Identities=19% Similarity=0.204 Sum_probs=180.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|+++..... ..+|++++..+ +||||+++++++.+.+..|+|||||.+|+|.+++.... .+++..+
T Consensus 47 ~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~----~~~~~~~ 118 (342)
T 2qr7_A 47 NMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----FFSEREA 118 (342)
T ss_dssp TEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT----TCCHHHH
T ss_pred CCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHH
Confidence 678999999754332 34788899888 89999999999999999999999999999999998654 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC----CcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK----YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
..++.||+.||.|||+++ |+||||||+|||+... +.+||+|||+++...... .......||+.|+|||++.+
T Consensus 119 ~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 194 (342)
T 2qr7_A 119 SAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVAPEVLER 194 (342)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-CCBCCSSCCSSCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-CceeccCCCccccCHHHhcC
Confidence 999999999999999999 9999999999998543 359999999987543222 22344678999999999988
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchh--hhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVE--ENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~--~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
..++.++|||||||++|+|++|.+||..... .......... .......+..+.+||.+||+.||++|||+.+
T Consensus 195 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~ 274 (342)
T 2qr7_A 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAAL 274 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 8889999999999999999999998864321 1111111111 1112345678999999999999999999999
Q ss_pred HHHHHHhh
Q 044846 229 VTLELAGI 236 (290)
Q Consensus 229 l~~~l~~~ 236 (290)
+++|.+-.
T Consensus 275 il~hp~~~ 282 (342)
T 2qr7_A 275 VLRHPWIV 282 (342)
T ss_dssp HTTSHHHH
T ss_pred HhcCCeec
Confidence 99887653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=290.31 Aligned_cols=224 Identities=19% Similarity=0.186 Sum_probs=184.6
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++... .....+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++.... .+++.
T Consensus 39 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~ 114 (284)
T 2vgo_A 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG----RFDEQ 114 (284)
T ss_dssp TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS----SCCHH
T ss_pred CcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC----CCCHH
Confidence 567999998642 22335678999999999999999999999999999999999999999999998765 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... ......|+..|+|||++.+..
T Consensus 115 ~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 188 (284)
T 2vgo_A 115 RSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RRRTMCGTLDYLPPEMIEGKT 188 (284)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS---CBCCCCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc---ccccccCCCCcCCHHHhccCC
Confidence 99999999999999999999 999999999999999999999999987543321 123456889999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
++.++||||||+++|+|++|..|+........ ..... ....+...+..+.++|.+||+.||.+|||+.+++++.+-.
T Consensus 189 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-HRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred CCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-HHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 99999999999999999999998864432211 11111 1112233456789999999999999999999999876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=291.65 Aligned_cols=225 Identities=21% Similarity=0.238 Sum_probs=162.7
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++..... .+++.
T Consensus 36 ~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~ 112 (278)
T 3cok_A 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSEN 112 (278)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSS---CCCHH
T ss_pred CceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccC---CCCHH
Confidence 6789999986422 23357899999999999999999999999999999999999999999999986532 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......|++.|+|||++.+..
T Consensus 113 ~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 188 (278)
T 3cok_A 113 EARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-EKHYTLCGTPNYISPEIATRSA 188 (278)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-CcceeccCCCCcCCcchhcCCC
Confidence 99999999999999999999 9999999999999999999999999976543221 1223456889999999999888
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++.++||||||+++|+|++|.+|+........ ...... ...+...+..+.++|.+||+.||++|||+.+++++.+
T Consensus 189 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp ---CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 99999999999999999999998864322111 111000 0112234567899999999999999999999987654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=289.97 Aligned_cols=227 Identities=19% Similarity=0.202 Sum_probs=186.5
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++.... .+++.
T Consensus 40 ~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~ 115 (294)
T 2rku_A 40 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEP 115 (294)
T ss_dssp CCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC----SCCHH
T ss_pred CceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC----CCCHH
Confidence 578999988642 34557789999999999999999999999999999999999999999999998765 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......|++.|+|||++.+..
T Consensus 116 ~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 191 (294)
T 2rku_A 116 EARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKG 191 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHTTSC
T ss_pred HHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc-cccccccCCCCcCCcchhccCC
Confidence 99999999999999999999 9999999999999999999999999986543221 2223456889999999999988
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh-hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF-SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
++.++||||||+++|+|++|..|+.............. ....+...+..+.+++.+||+.||++|||+.|++++..-.
T Consensus 192 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 99999999999999999999998865432221111110 1111223456789999999999999999999999876543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=294.16 Aligned_cols=225 Identities=20% Similarity=0.259 Sum_probs=178.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++........+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++..... .+++..+.
T Consensus 44 ~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~ 120 (302)
T 2j7t_A 44 GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQ 120 (302)
T ss_dssp CCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTS---CCCHHHHH
T ss_pred CcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhcc---CCCHHHHH
Confidence 678999999877777788999999999999999999999999999999999999999999999876543 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc-----c
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-----S 156 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~ 156 (290)
.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... ........|+..|+|||++. +
T Consensus 121 ~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 196 (302)
T 2j7t_A 121 VVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWMAPEVVMCETMKD 196 (302)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC-----CCGGGCCHHHHHHHHTTS
T ss_pred HHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccccccccCChhhcCCeeeccccCCC
Confidence 99999999999999999 999999999999999999999999986432111 11123356889999999983 5
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
..++.++||||||+++|+|++|.+|+......... ...... ..+...+..+.++|.+||+.||.+|||+.++++
T Consensus 197 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp TTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-HHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 67889999999999999999999888644322211 111111 112344667999999999999999999999987
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
+.+
T Consensus 276 h~~ 278 (302)
T 2j7t_A 276 HPF 278 (302)
T ss_dssp STT
T ss_pred ChH
Confidence 643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=288.71 Aligned_cols=231 Identities=18% Similarity=0.147 Sum_probs=181.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEE-EeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCC-LETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|++..... .+.+.+|+++++.++|++++..++.+ ...+..++||||+ +++|.+++..... .+++..+
T Consensus 34 ~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~ 107 (296)
T 4hgt_A 34 GEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR---KFSLKTV 107 (296)
T ss_dssp TEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTS---CCCHHHH
T ss_pred CceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcC---CCCHHHH
Confidence 57899998754322 23578999999999887766666555 6677889999999 9999999985433 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---ccCCcEEEeccccccccccCCc------eeeccceecccccCc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILL---VDKYQAKISDFRTFKSRAIDRT------HLTTQVKVTFGYVDP 151 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~aP 151 (290)
+.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++....... .......||+.|+||
T Consensus 108 ~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 184 (296)
T 4hgt_A 108 LLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184 (296)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccch
Confidence 999999999999999999 9999999999999 7889999999999875443222 112346789999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhh--hhhhHH----Hhhhhh---hHHHHHHHHHHHHHhhccCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSLAA----YFSKEA---EKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~~~----~~~~~~---~~~~~~~~~~li~~cl~~dp~~ 222 (290)
|++.+..++.++|||||||++|+|++|..||...... ...... ...... ....+..+.+++.+||+.||++
T Consensus 185 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 264 (296)
T 4hgt_A 185 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDD 264 (296)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred HHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999999988643211 111111 111111 1223568999999999999999
Q ss_pred CCCHHHHHHHHHhhHhhhC
Q 044846 223 QPTMKEVTLELAGIRASIG 241 (290)
Q Consensus 223 Rps~~el~~~l~~~~~~~~ 241 (290)
|||+.++++.|+.+....+
T Consensus 265 Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 265 KPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp CCCHHHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHHHHHHHHHhC
Confidence 9999999999999887654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=294.85 Aligned_cols=228 Identities=20% Similarity=0.256 Sum_probs=180.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHh--cCCCceeeEEeEEEeCC----cceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQ--INHRNVVKILGCCLETE----VPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~--l~Hpniv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|++.. ...+.+.+|++++.. ++||||+++++++.... ..++||||+++|+|.+++... .+
T Consensus 65 ~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~ 136 (342)
T 1b6c_B 65 GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TV 136 (342)
T ss_dssp TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CB
T ss_pred CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-----Cc
Confidence 67899999864 345678889999988 69999999999998876 789999999999999999764 48
Q ss_pred CHHHHHHHHHHHHHHHHHHh--------hCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce---eecccee
Q 044846 76 TWEMRLRITVEVSRVLSYLH--------SVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH---LTTQVKV 144 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH--------~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g 144 (290)
++..++.++.|++.||.||| +.+ |+||||||+||+++.++.+||+|||++......... ......|
T Consensus 137 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~g 213 (342)
T 1b6c_B 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213 (342)
T ss_dssp CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCC
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCc
Confidence 89999999999999999999 777 999999999999999999999999998654433222 1234578
Q ss_pred cccccCccccccCC------CCCcccchhhHHHHHHHhcC----------CCCcccchhh---hhhhHHHh-----hhh-
Q 044846 145 TFGYVDPKYFRSSQ------FTEKSDVYSFSVVLVELNWT----------KPIHLVDVEE---NRSLAAYF-----SKE- 199 (290)
Q Consensus 145 ~~~y~aPE~~~~~~------~~~~~DiwS~G~il~~l~~~----------~~~~~~~~~~---~~~~~~~~-----~~~- 199 (290)
|+.|+|||++.+.. ++.++||||||+++|+|++| ..|+...... ...+.... ...
T Consensus 214 t~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (342)
T 1b6c_B 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI 293 (342)
T ss_dssp CGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred CcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCC
Confidence 99999999987653 33689999999999999998 4444332110 11111111 010
Q ss_pred ----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhh
Q 044846 200 ----AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 200 ----~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~~ 240 (290)
........+.+|+.+||+.||++|||+.+++++|+.+....
T Consensus 294 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 294 PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 12355678999999999999999999999999999987643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=292.06 Aligned_cols=226 Identities=23% Similarity=0.358 Sum_probs=177.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLET-EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|+++.. ...+.+.+|+++++.++||||+++++++... +..++||||+++|+|.+++...... .+++..+
T Consensus 44 ~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~ 119 (278)
T 1byg_A 44 GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCL 119 (278)
T ss_dssp TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHH--HCCHHHH
T ss_pred CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccc--cCCHHHH
Confidence 578999998753 3567899999999999999999999997654 5789999999999999999865321 3788999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... .....++..|+|||++.+..++
T Consensus 120 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~ 192 (278)
T 1byg_A 120 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFS 192 (278)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc----ccCCCccccccCHHHhCCCCCC
Confidence 999999999999999999 999999999999999999999999987643321 1234567889999999999999
Q ss_pred CcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 161 EKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.++||||||+++|+|++ |..|+...... ....... ....+...+..+.++|.+||+.||.+|||+.++++.|+.+
T Consensus 193 ~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 193 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 99999999999999997 88777543221 1111111 1122234567799999999999999999999999999988
Q ss_pred Hhh
Q 044846 237 RAS 239 (290)
Q Consensus 237 ~~~ 239 (290)
...
T Consensus 272 ~~~ 274 (278)
T 1byg_A 272 KTH 274 (278)
T ss_dssp HHH
T ss_pred Hhh
Confidence 653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.41 Aligned_cols=220 Identities=14% Similarity=0.156 Sum_probs=170.2
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHH---HHHhcCCCceeeEE-------eEEEeCC-----------------cceE
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVV---ILSQINHRNVVKIL-------GCCLETE-----------------VPLL 51 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~---~l~~l~Hpniv~~~-------~~~~~~~-----------------~~~l 51 (290)
|+.||||+++. ......+.+.+|+. .++.++|||||+++ +++...+ ..|+
T Consensus 98 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~l 177 (377)
T 3byv_A 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 177 (377)
T ss_dssp CCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEE
T ss_pred CcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEE
Confidence 67899999873 34556788999995 55555899999998 6665543 2789
Q ss_pred EEEeCCCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccc
Q 044846 52 VYEFIPNGSLYQYIHEQTDD---QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 52 v~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
||||+ +|+|.+++.....- ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 178 v~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a 253 (377)
T 3byv_A 178 LYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL 253 (377)
T ss_dssp EEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred EEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhh
Confidence 99999 68999999865310 112345788889999999999999999 999999999999999999999999998
Q ss_pred cccccCCceeeccceecccccCccccccC-----------CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh
Q 044846 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSS-----------QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS 197 (290)
Q Consensus 129 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~ 197 (290)
+... .......| +.|+|||++.+. .++.++|||||||++|+|++|..||........ ......
T Consensus 254 ~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~-~~~~~~ 327 (377)
T 3byv_A 254 VRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG-SEWIFR 327 (377)
T ss_dssp EETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC-SGGGGS
T ss_pred eecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc-hhhhhh
Confidence 7432 22344566 899999999887 799999999999999999999998864332211 111111
Q ss_pred hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 198 KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 198 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.....+..+.+||.+||+.||++|||+.|++++.
T Consensus 328 --~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 361 (377)
T 3byv_A 328 --SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 361 (377)
T ss_dssp --SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred --hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence 1123456789999999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=297.36 Aligned_cols=223 Identities=20% Similarity=0.284 Sum_probs=181.5
Q ss_pred CceEEEEeecccCc--------hhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCC
Q 044846 2 EELWLLKKSKSVHE--------SNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQ 72 (290)
Q Consensus 2 ~~~~avK~~~~~~~--------~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 72 (290)
|+.||||+++.... ...+.+.+|+.+++.+ +||||+++++++......++||||+++|+|.+++....
T Consensus 119 g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--- 195 (365)
T 2y7j_A 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--- 195 (365)
T ss_dssp CCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS---
T ss_pred CcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---
Confidence 67899999864331 2255788999999999 89999999999999999999999999999999998764
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcc
Q 044846 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPK 152 (290)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 152 (290)
.+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...... .......||+.|+|||
T Consensus 196 -~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~--~~~~~~~gt~~y~aPE 269 (365)
T 2y7j_A 196 -ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPE 269 (365)
T ss_dssp -SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTT--CCBCCCCSCGGGCCHH
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCC--cccccCCCCCCccChh
Confidence 5899999999999999999999999 999999999999999999999999987654322 2234467899999999
Q ss_pred cccc------CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh------hhhHHHHHHHHHHHHHhhccCC
Q 044846 153 YFRS------SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK------EAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 153 ~~~~------~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~dp 220 (290)
++.+ ..++.++|||||||++|+|++|..||........ ....... +.....+..+.+||.+||+.||
T Consensus 270 ~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 348 (365)
T 2y7j_A 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM-LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDP 348 (365)
T ss_dssp HHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSST
T ss_pred hccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCCh
Confidence 9863 3578899999999999999999998865432211 1111111 1112335679999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 044846 221 KKQPTMKEVTLELA 234 (290)
Q Consensus 221 ~~Rps~~el~~~l~ 234 (290)
++|||+.|++++.+
T Consensus 349 ~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 349 EARLTAEQALQHPF 362 (365)
T ss_dssp TTSCCHHHHHHSGG
T ss_pred hHCcCHHHHhcCcc
Confidence 99999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=297.25 Aligned_cols=227 Identities=19% Similarity=0.198 Sum_probs=177.9
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEe--------CCcceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLE--------TEVPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||+|++.... ......+.+|+++++.++||||+++++++.. .+..++||||+. |+|.+.+.....
T Consensus 42 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~- 119 (351)
T 3mi9_A 42 GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLV- 119 (351)
T ss_dssp CCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTTS-
T ss_pred CCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhccC-
Confidence 6789999885432 3335578899999999999999999999987 346899999996 588888876543
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC---Cceeeccceecccc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID---RTHLTTQVKVTFGY 148 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~g~~~y 148 (290)
.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .........||+.|
T Consensus 120 --~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 194 (351)
T 3mi9_A 120 --KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194 (351)
T ss_dssp --CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGG
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCc
Confidence 5899999999999999999999999 999999999999999999999999998654321 12223446689999
Q ss_pred cCcccccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHH--Hhh---h------------------------
Q 044846 149 VDPKYFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA--YFS---K------------------------ 198 (290)
Q Consensus 149 ~aPE~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~--~~~---~------------------------ 198 (290)
+|||++.+ ..++.++|||||||++|+|++|.++|............ ... .
T Consensus 195 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (351)
T 3mi9_A 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 274 (351)
T ss_dssp CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCC
T ss_pred cCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccC
Confidence 99999876 45899999999999999999999988654322111100 000 0
Q ss_pred ----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 199 ----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 199 ----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
......+..+.+||.+||+.||++|||++|++++.+-
T Consensus 275 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 275 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp HHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 0000124568899999999999999999999988654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=295.26 Aligned_cols=226 Identities=19% Similarity=0.274 Sum_probs=178.2
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+.+++|..++.... .+++..
T Consensus 50 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~ 125 (331)
T 4aaa_A 50 GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN----GLDYQV 125 (331)
T ss_dssp CCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT----CCCHHH
T ss_pred CceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc----CCCHHH
Confidence 6789999985433 3345678899999999999999999999999999999999999988888766543 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-C
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-Q 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 158 (290)
+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......|+..|+|||++.+. .
T Consensus 126 ~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~ 201 (331)
T 4aaa_A 126 VQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYDDEVATRWYRAPELLVGDVK 201 (331)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------------CCCCCTTCCHHHHTTCTT
T ss_pred HHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cccCCCcCCccccCcccccCCCC
Confidence 9999999999999999999 9999999999999999999999999986433211 222345688999999999875 6
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--------------------------------hhhhHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--------------------------------KEAEKEEVI 206 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~ 206 (290)
++.++|||||||++|+|++|.+||............... .......+.
T Consensus 202 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (331)
T 4aaa_A 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSE 281 (331)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCH
T ss_pred cchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhH
Confidence 889999999999999999999988654332211111000 000112356
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.+.+||.+||+.||.+|||+.|++++.+-
T Consensus 282 ~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 282 VVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 79999999999999999999999988654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=291.05 Aligned_cols=225 Identities=20% Similarity=0.217 Sum_probs=184.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|++... ...+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++..... .+++..+.
T Consensus 54 ~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~ 128 (314)
T 3com_A 54 GQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIA 128 (314)
T ss_dssp CCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTC---CCCHHHHH
T ss_pred CCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCC---CCCHHHHH
Confidence 678999998753 3456789999999999999999999999999999999999999999999975432 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .......|+..|+|||++.+..++.
T Consensus 129 ~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 204 (314)
T 3com_A 129 TILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYNC 204 (314)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBCCCCSCGGGCCHHHHSSSCBCT
T ss_pred HHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccCccCCCCCccChhhcCCCCCCc
Confidence 99999999999999999 9999999999999999999999999986543221 1223456889999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
++||||||+++|+|++|..|+............... ...+...+..+.+||.+||+.||.+|||+.+++++.+-
T Consensus 205 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp THHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 999999999999999999888643322211111000 01122345679999999999999999999999987543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.61 Aligned_cols=231 Identities=18% Similarity=0.154 Sum_probs=182.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEE-EeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCC-LETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|++..... .+.+.+|+.+++.++|++++..+..+ ...+..++||||+ +++|.+++..... .+++..+
T Consensus 34 ~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~ 107 (296)
T 3uzp_A 34 GEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR---KFSLKTV 107 (296)
T ss_dssp TEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHH
T ss_pred CcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhcc---CCCHHHH
Confidence 67899999865332 34688999999999888766655555 5677889999999 8999999975432 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---ccCCcEEEeccccccccccCCce------eeccceecccccCc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILL---VDKYQAKISDFRTFKSRAIDRTH------LTTQVKVTFGYVDP 151 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aP 151 (290)
+.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++......... ......||+.|+||
T Consensus 108 ~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 184 (296)
T 3uzp_A 108 LLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184 (296)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCH
T ss_pred HHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCCh
Confidence 999999999999999999 9999999999999 48899999999998754433221 12345789999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhh--hhhhHH----Hhhhh---hhHHHHHHHHHHHHHhhccCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSLAA----YFSKE---AEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~~~----~~~~~---~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
|++.+..++.++|||||||++|+|++|..||...... ...... ..... .....+..+.+++.+||+.||.+
T Consensus 185 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 264 (296)
T 3uzp_A 185 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDD 264 (296)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCc
Confidence 9999999999999999999999999999988642211 111111 11111 11234567999999999999999
Q ss_pred CCCHHHHHHHHHhhHhhhC
Q 044846 223 QPTMKEVTLELAGIRASIG 241 (290)
Q Consensus 223 Rps~~el~~~l~~~~~~~~ 241 (290)
|||+.++++.|+.+.....
T Consensus 265 Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 265 KPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp CCCHHHHHHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHHHHHhcC
Confidence 9999999999999876653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=302.07 Aligned_cols=232 Identities=19% Similarity=0.242 Sum_probs=186.3
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC--cceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETE--VPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++... ....+.+.+|+++++.++||||+++++++...+ ..++|||||++|+|.+++...... ..+++.
T Consensus 34 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~ 112 (396)
T 4eut_A 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPES 112 (396)
T ss_dssp CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGT-TCCCHH
T ss_pred CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcc-cCCCHH
Confidence 6789999997533 344677889999999999999999999998755 679999999999999999875432 238999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe----ccCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL----VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
.++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..... .......||..|+|||++
T Consensus 113 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~ 187 (396)
T 4eut_A 113 EFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMY 187 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG--GGSSCSSSCCTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC--CccccccCCccccCHHHh
Confidence 99999999999999999999 9999999999999 77788999999998654322 223345689999999998
Q ss_pred cc--------CCCCCcccchhhHHHHHHHhcCCCCcccchhh---hhhhHHHhhh-------------------------
Q 044846 155 RS--------SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE---NRSLAAYFSK------------------------- 198 (290)
Q Consensus 155 ~~--------~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~---~~~~~~~~~~------------------------- 198 (290)
.+ ..++.++|||||||++|+|++|..||...... ..........
T Consensus 188 ~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 267 (396)
T 4eut_A 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV 267 (396)
T ss_dssp HHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCT
T ss_pred hccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCc
Confidence 65 45778999999999999999999988632211 1111111111
Q ss_pred --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhh
Q 044846 199 --EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239 (290)
Q Consensus 199 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~ 239 (290)
.........+.+++.+||+.||++|||+.|+++.+..+...
T Consensus 268 ~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 268 SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred ccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11245677899999999999999999999999999887653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=289.73 Aligned_cols=228 Identities=23% Similarity=0.286 Sum_probs=187.2
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++... .+++..+
T Consensus 47 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~ 121 (303)
T 3a7i_A 47 QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQI 121 (303)
T ss_dssp CCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS-----CCCHHHH
T ss_pred CcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC-----CCCHHHH
Confidence 6789999986433 455788999999999999999999999999999999999999999999999753 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......|+..|+|||++.+..++
T Consensus 122 ~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 197 (303)
T 3a7i_A 122 ATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYD 197 (303)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-cccCccCCCcCccCHHHHhcCCCC
Confidence 999999999999999999 9999999999999999999999999976543221 122345688999999999999999
Q ss_pred CcccchhhHHHHHHHhcCCCCcccchhhhhhhHH--HhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 161 EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA--YFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
.++||||||+++|+|++|.+|+............ ..........+..+.+|+.+||+.||.+|||+.+++++.+....
T Consensus 198 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 198 SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 9999999999999999999887543322111110 00111122345678999999999999999999999998765544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.71 Aligned_cols=224 Identities=23% Similarity=0.214 Sum_probs=183.3
Q ss_pred CceEEEEeecccCc-------------hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhc
Q 044846 2 EELWLLKKSKSVHE-------------SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68 (290)
Q Consensus 2 ~~~~avK~~~~~~~-------------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 68 (290)
|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++......++|||||++|+|.+++...
T Consensus 61 ~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~ 140 (504)
T 3q5i_A 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR 140 (504)
T ss_dssp CCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred CcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc
Confidence 57899999864321 34678999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC---cEEEeccccccccccCCceeeccceec
Q 044846 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY---QAKISDFRTFKSRAIDRTHLTTQVKVT 145 (290)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~g~ 145 (290)
. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++...... .......||
T Consensus 141 ~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt 211 (504)
T 3q5i_A 141 H----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGT 211 (504)
T ss_dssp S----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT--SCBCCCCSC
T ss_pred C----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC--CccccccCC
Confidence 5 5899999999999999999999999 99999999999998776 6999999998654322 223445689
Q ss_pred ccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccC
Q 044846 146 FGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 146 ~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~d 219 (290)
+.|+|||++. ..++.++||||+||++|+|++|.+||........ ...... .......+..+.+||.+||+.|
T Consensus 212 ~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 289 (504)
T 3q5i_A 212 AYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYD 289 (504)
T ss_dssp TTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSS
T ss_pred cCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCC
Confidence 9999999987 4689999999999999999999998865433221 111111 1112234678999999999999
Q ss_pred CCCCCCHHHHHHHHHhh
Q 044846 220 GKKQPTMKEVTLELAGI 236 (290)
Q Consensus 220 p~~Rps~~el~~~l~~~ 236 (290)
|.+|||+.|++++.+-.
T Consensus 290 p~~R~t~~e~l~h~~~~ 306 (504)
T 3q5i_A 290 YNKRCTAEEALNSRWIK 306 (504)
T ss_dssp TTTSCCHHHHHTSHHHH
T ss_pred hhHCCCHHHHhcCHhhh
Confidence 99999999999886543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=297.88 Aligned_cols=221 Identities=19% Similarity=0.234 Sum_probs=171.8
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||||++.. ......+.+.+|+.+++.++||||+++++++...+ ..++||||+. |+|.+++..
T Consensus 50 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------ 122 (371)
T 2xrw_A 50 ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ 122 (371)
T ss_dssp TEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS------
T ss_pred CceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh------
Confidence 67899999864 23445678899999999999999999999998765 6799999995 589888862
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........||+.|+|||+
T Consensus 123 ~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~ 197 (371)
T 2xrw_A 123 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 197 (371)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC------------------CTTCCHHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccc--ccccCCceecCCccCHHH
Confidence 4788999999999999999999999 99999999999999999999999999864332 222344678999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------------------------------------
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------------------------------------ 197 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------------------------------------ 197 (290)
+.+..++.++|||||||++|+|++|..||........ +.....
T Consensus 198 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (371)
T 2xrw_A 198 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLF 276 (371)
T ss_dssp HTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHS
T ss_pred hcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhc
Confidence 9999999999999999999999999998864432111 000000
Q ss_pred --------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 198 --------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 198 --------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.......+..+.+||.+||+.||.+|||++|++++.+-
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 277 PDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp CGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred ccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 00112336679999999999999999999999998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=306.43 Aligned_cols=230 Identities=19% Similarity=0.271 Sum_probs=170.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcC-----CCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQT-----DDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~ 74 (290)
++.||+|+++... ....+.+|+++|+.|+||||+++++++.. ....++||||+. |+|.+++.... .....
T Consensus 48 ~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~ 124 (405)
T 3rgf_A 48 DKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQ 124 (405)
T ss_dssp CCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------
T ss_pred CeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccC
Confidence 5679999997533 23467899999999999999999999965 668899999995 68998886432 11224
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe----ccCCcEEEeccccccccccCCc--eeeccceecccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL----VDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGY 148 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~----~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y 148 (290)
+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++....... .......||+.|
T Consensus 125 l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y 201 (405)
T 3rgf_A 125 LPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201 (405)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcc
Confidence 889999999999999999999999 9999999999999 6778999999999875432211 223446789999
Q ss_pred cCccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhh--------hhhHHHhh----------------------
Q 044846 149 VDPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEEN--------RSLAAYFS---------------------- 197 (290)
Q Consensus 149 ~aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~--------~~~~~~~~---------------------- 197 (290)
+|||++.+. .++.++|||||||++|+|++|.+||....... ..+.....
T Consensus 202 ~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~ 281 (405)
T 3rgf_A 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTL 281 (405)
T ss_dssp CCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHH
T ss_pred cCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhh
Confidence 999999874 48999999999999999999999885332110 00000000
Q ss_pred -----hh-h----h--------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 198 -----KE-A----E--------KEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 198 -----~~-~----~--------~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
.. . . ...+..+.+||.+||+.||.+|||++|+++|.+...
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~ 339 (405)
T 3rgf_A 282 MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339 (405)
T ss_dssp HHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTS
T ss_pred hhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhcc
Confidence 00 0 0 001456889999999999999999999999977654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=291.39 Aligned_cols=218 Identities=17% Similarity=0.201 Sum_probs=176.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC-CCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN-HRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. ..+.+.+|+++++.++ ||||+++++++.. ....++||||+.+++|.+++. .+++.
T Consensus 61 ~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~ 130 (330)
T 3nsz_A 61 NEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDY 130 (330)
T ss_dssp CCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG-------GCCHH
T ss_pred CcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH-------hCCHH
Confidence 678999998743 3467889999999996 9999999999988 667899999999999999985 37888
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-cEEEeccccccccccCCceeeccceecccccCcccccc-
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS- 156 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 156 (290)
.+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++..... .......++..|+|||++.+
T Consensus 131 ~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 205 (330)
T 3nsz_A 131 DIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDY 205 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT--CCCCSCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC--CccccccccccccChhhhcCC
Confidence 99999999999999999999 99999999999999777 8999999998654322 22334568889999999887
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--------------------------------------
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-------------------------------------- 198 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------------------------------------- 198 (290)
..++.++|||||||++|+|++|..|+.........+......
T Consensus 206 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (330)
T 3nsz_A 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 285 (330)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCC
T ss_pred CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhcc
Confidence 668999999999999999999998885443222211111100
Q ss_pred -hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 199 -EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 199 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
......+..+.+||.+||+.||.+|||++|+++|.+
T Consensus 286 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 286 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 001113577899999999999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=298.20 Aligned_cols=226 Identities=21% Similarity=0.204 Sum_probs=178.0
Q ss_pred CceEEEEeecccCch-----hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVHES-----NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~~~-----~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||+|+++..... ..+.+.+|+++++.++||||+++++++...+..++||||+.+ +|..++..... .++
T Consensus 35 ~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~ 110 (346)
T 1ua2_A 35 NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL---VLT 110 (346)
T ss_dssp CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCS---SCC
T ss_pred CcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCc---CCC
Confidence 678999998743222 134688999999999999999999999999999999999965 89999876432 578
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+
T Consensus 111 ~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~ 186 (346)
T 1ua2_A 111 PSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFG 186 (346)
T ss_dssp SSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCCCCCSCCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCC-cccCCcccccccccCchHhhC
Confidence 8899999999999999999999 999999999999999999999999998654322 222344668999999999876
Q ss_pred C-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh------------------------------hhhHHHH
Q 044846 157 S-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK------------------------------EAEKEEV 205 (290)
Q Consensus 157 ~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~ 205 (290)
. .++.++|||||||++|+|++|.+++........ +...... ......+
T Consensus 187 ~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (346)
T 1ua2_A 187 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAG 265 (346)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCC
T ss_pred CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCC
Confidence 4 488899999999999999999988765433221 1111100 0002234
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 206 ITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 206 ~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
..+.+||.+||+.||.+|||+.|++++.+-.
T Consensus 266 ~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~ 296 (346)
T 1ua2_A 266 DDLLDLIQGLFLFNPCARITATQALKMKYFS 296 (346)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence 6799999999999999999999999886543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=289.15 Aligned_cols=227 Identities=22% Similarity=0.314 Sum_probs=179.5
Q ss_pred eEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 4 LWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 4 ~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
.||+|+++.. .....+.+.+|+++++.++||||+++++++.... .++||||+++|+|.+++..... .+++..+
T Consensus 48 ~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~ 123 (291)
T 1u46_A 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG---HFLLGTL 123 (291)
T ss_dssp EEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGG---GSCHHHH
T ss_pred EEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccC---CcCHHHH
Confidence 5899988643 3456778999999999999999999999998765 8999999999999999987532 5889999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee--eccceecccccCccccccCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL--TTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~ 158 (290)
..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......... .....++..|+|||++.+..
T Consensus 124 ~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (291)
T 1u46_A 124 SRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200 (291)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCC
Confidence 999999999999999999 9999999999999999999999999987544332221 23345677899999999888
Q ss_pred CCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
++.++||||||+++|+|++ |..|+...... ........ .......+..+.+++.+||+.||.+|||+.++++.|
T Consensus 201 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 279 (291)
T 1u46_A 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279 (291)
T ss_dssp EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCcccCCHH-HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 9999999999999999998 88877543322 11111111 112234567799999999999999999999999999
Q ss_pred HhhHh
Q 044846 234 AGIRA 238 (290)
Q Consensus 234 ~~~~~ 238 (290)
+.+..
T Consensus 280 ~~~~~ 284 (291)
T 1u46_A 280 LEAQP 284 (291)
T ss_dssp HHHC-
T ss_pred HHhCc
Confidence 87653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=291.91 Aligned_cols=235 Identities=20% Similarity=0.283 Sum_probs=183.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|++... .....+.+.+|+++++.++||||+++++++.. ....++||||+++|+|.+++.........+++
T Consensus 31 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 110 (279)
T 2w5a_A 31 GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110 (279)
T ss_dssp CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCH
T ss_pred CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCH
Confidence 678999998643 34557789999999999999999999998854 56789999999999999999875443345899
Q ss_pred HHHHHHHHHHHHHHHHHhhCC--CCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVA--SIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~--~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
..++.++.|++.||.|||+.+ ..+|+||||||+||+++.++.+||+|||++....... .......|+..|+|||++.
T Consensus 111 ~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 189 (279)
T 2w5a_A 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMN 189 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C-HHHHHHHSCCTTCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc-ccccccCCCccccChHHhc
Confidence 999999999999999999876 2349999999999999999999999999976533211 1123456789999999999
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+..++.++||||||+++|+|++|..|+........ .+........+...+..+.++|.+||+.||.+|||+.|+++++
T Consensus 190 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 98999999999999999999999988764432211 1111111112234567799999999999999999999999887
Q ss_pred HhhH
Q 044846 234 AGIR 237 (290)
Q Consensus 234 ~~~~ 237 (290)
+...
T Consensus 270 ~~~~ 273 (279)
T 2w5a_A 270 LILE 273 (279)
T ss_dssp TCCG
T ss_pred hhhh
Confidence 6543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=317.90 Aligned_cols=229 Identities=19% Similarity=0.276 Sum_probs=182.3
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..||+|+.+.. .....+.+.+|+.+++.++||||+++++++. .+..++||||+++|+|.+++..... .+++..++
T Consensus 419 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~---~l~~~~~~ 494 (656)
T 2j0j_A 419 MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKF---SLDLASLI 494 (656)
T ss_dssp EEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTT---TCCHHHHH
T ss_pred EEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccC---CCCHHHHH
Confidence 46899988753 3445678999999999999999999999985 4678999999999999999986542 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..............+++.|+|||++.+..++.
T Consensus 495 ~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 571 (656)
T 2j0j_A 495 LYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571 (656)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCc
Confidence 99999999999999999 999999999999999999999999998754433222233455678899999999899999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
++|||||||++|||++ |.+||....... ...... ....+...+..+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 572 ~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 572 ASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 9999999999999986 777775432221 111111 11223345678999999999999999999999999999886
Q ss_pred hh
Q 044846 238 AS 239 (290)
Q Consensus 238 ~~ 239 (290)
..
T Consensus 651 ~~ 652 (656)
T 2j0j_A 651 EE 652 (656)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=320.83 Aligned_cols=223 Identities=19% Similarity=0.218 Sum_probs=186.4
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+.+||||||+++|+|..++.... .+++
T Consensus 366 ~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----~~~~ 441 (674)
T 3pfq_A 366 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKE 441 (674)
T ss_dssp CCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS----SCCH
T ss_pred CcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC----CCCH
Confidence 578999998742 344567788999999998 79999999999999999999999999999999998765 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+.
T Consensus 442 ~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~~~~~~GT~~Y~APE~l~~~ 517 (674)
T 3pfq_A 442 PHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKTFCGTPDYIAPEIIAYQ 517 (674)
T ss_dssp HHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT-TCCBCCCCSCSSSCCHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC-CcccccccCCCcccCHhhhcCC
Confidence 999999999999999999999 999999999999999999999999998753222 2234457799999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTM-----KEVT 230 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~el~ 230 (290)
.|+.++|||||||++|||++|.+||...... ........ ...+...+.++.+||.+||+.||.+||++ +||+
T Consensus 518 ~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred CCCccceEechHHHHHHHHcCCCCCCCCCHH-HHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 9999999999999999999999998754332 11222111 12233456789999999999999999997 7887
Q ss_pred HHH
Q 044846 231 LEL 233 (290)
Q Consensus 231 ~~l 233 (290)
+|.
T Consensus 597 ~h~ 599 (674)
T 3pfq_A 597 EHA 599 (674)
T ss_dssp SSG
T ss_pred cCc
Confidence 664
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=305.61 Aligned_cols=224 Identities=21% Similarity=0.175 Sum_probs=169.9
Q ss_pred CceEEEEeecccC--------chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSVH--------ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~~--------~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||+|++.... ......+.+|+++|++++||||+++++++.. +..++||||+++|+|.+++....
T Consensus 160 ~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---- 234 (419)
T 3i6u_A 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK---- 234 (419)
T ss_dssp CCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSC----
T ss_pred CcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccC----
Confidence 5789999986421 2223358899999999999999999999854 45799999999999999887544
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC---cEEEeccccccccccCCceeeccceecccccC
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY---QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVD 150 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 150 (290)
.+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++... .........||+.|+|
T Consensus 235 ~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~--~~~~~~~~~gt~~y~a 309 (419)
T 3i6u_A 235 RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLA 309 (419)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecC--CCccccccCCCCCccC
Confidence 6899999999999999999999999 99999999999997544 59999999987543 2223345678999999
Q ss_pred cccccc---CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCC
Q 044846 151 PKYFRS---SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGK 221 (290)
Q Consensus 151 PE~~~~---~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~ 221 (290)
||++.+ ..++.++|||||||++|+|++|.+||............... .......+..+.+||.+||+.||+
T Consensus 310 PE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 389 (419)
T 3i6u_A 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 389 (419)
T ss_dssp TTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred ceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChh
Confidence 999864 56788999999999999999999988643322111111111 111223466799999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 044846 222 KQPTMKEVTLELAG 235 (290)
Q Consensus 222 ~Rps~~el~~~l~~ 235 (290)
+|||+.|+++|.+-
T Consensus 390 ~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 390 ARFTTEEALRHPWL 403 (419)
T ss_dssp TSCCHHHHHHSGGG
T ss_pred HCcCHHHHhCCccc
Confidence 99999999988653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=298.37 Aligned_cols=228 Identities=23% Similarity=0.302 Sum_probs=173.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHH--hcCCCceeeEEeEEEe-----CCcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILS--QINHRNVVKILGCCLE-----TEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~--~l~Hpniv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||||+++.. ....+..|.+++. .++||||+++++.+.. ....++|||||++|+|.+++....
T Consensus 36 ~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----- 107 (336)
T 3g2f_A 36 ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----- 107 (336)
T ss_dssp TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC-----
T ss_pred CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc-----
Confidence 678999998743 2344555555544 5799999999986643 235689999999999999997653
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhC---------CCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-------cee
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSV---------ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-------THL 138 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~---------~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-------~~~ 138 (290)
.++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 108 ~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~ 184 (336)
T 3g2f_A 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184 (336)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC--------
T ss_pred cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccc
Confidence 58889999999999999999998 7 9999999999999999999999999987543221 111
Q ss_pred eccceecccccCcccccc-------CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh----------------hhHHH
Q 044846 139 TTQVKVTFGYVDPKYFRS-------SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR----------------SLAAY 195 (290)
Q Consensus 139 ~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~----------------~~~~~ 195 (290)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..++........ .....
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (336)
T 3g2f_A 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVL 264 (336)
T ss_dssp -CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHH
T ss_pred cccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhh
Confidence 234568999999999986 3466789999999999999999766543221100 00000
Q ss_pred hh-----h------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhh
Q 044846 196 FS-----K------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 196 ~~-----~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~~ 240 (290)
.. . ......+..+.+||.+||+.||++|||+.|+++.|+.+....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 265 VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp HTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 00 0 011235567999999999999999999999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=295.50 Aligned_cols=225 Identities=20% Similarity=0.263 Sum_probs=178.7
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----CcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLET-----EVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|++.... ....+.+.+|+++++.++||||+++++++... ...++||||+. |+|.+++... .+
T Consensus 52 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~-----~~ 125 (364)
T 3qyz_A 52 KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ-----HL 125 (364)
T ss_dssp TEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC-----CC
T ss_pred CeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC-----CC
Confidence 5679999997533 44457899999999999999999999999765 36799999995 6999999764 48
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce--eeccceecccccCccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--LTTQVKVTFGYVDPKY 153 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~ 153 (290)
++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......... ......||+.|+|||+
T Consensus 126 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~ 202 (364)
T 3qyz_A 126 SNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202 (364)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHH
Confidence 99999999999999999999999 999999999999999999999999998754432221 1234578999999998
Q ss_pred cccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhhh------------------------------hh
Q 044846 154 FRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFSK------------------------------EA 200 (290)
Q Consensus 154 ~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~~------------------------------~~ 200 (290)
+.+. .++.++|||||||++|+|++|.+||......... ....... ..
T Consensus 203 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (364)
T 3qyz_A 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 282 (364)
T ss_dssp HHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred hcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHh
Confidence 7654 5899999999999999999999988644322111 1000000 00
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
....+..+.+||.+||+.||++|||+.|++++.+-
T Consensus 283 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 283 FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 01234678999999999999999999999988653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=284.45 Aligned_cols=223 Identities=17% Similarity=0.185 Sum_probs=175.1
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.... .+++.
T Consensus 36 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~ 111 (276)
T 2h6d_A 36 GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG----RVEEM 111 (276)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC----SCCHH
T ss_pred CceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC----CCCHH
Confidence 678999998643 23346688999999999999999999999999999999999999999999998765 58899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... .......+++.|+|||++.+..
T Consensus 112 ~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 186 (276)
T 2h6d_A 112 EARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRL 186 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---------------CCTGGGTTSC
T ss_pred HHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC--cceecccCCccccCHHHHcCCC
Confidence 99999999999999999999 999999999999999999999999997654322 2223456889999999998876
Q ss_pred C-CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 159 F-TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 159 ~-~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+ +.++||||||+++|+|++|..|+....... ....... ...+...+..+.++|.+||+.||.+|||+.|++++.+
T Consensus 187 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 5 578999999999999999998885432211 1111111 0112233567899999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=298.31 Aligned_cols=221 Identities=19% Similarity=0.191 Sum_probs=165.9
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLET------EVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||+|++... .....+.+.+|+++++.++||||+++++++... ...++|+|++ +++|.+++...
T Consensus 54 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----- 127 (367)
T 2fst_X 54 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----- 127 (367)
T ss_dssp TEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----C-----
T ss_pred CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC-----
Confidence 678999998643 344567889999999999999999999999754 5679999999 78999998752
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ......||..|+|||+
T Consensus 128 ~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~ 200 (367)
T 2fst_X 128 KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD----EMTGYVATRWYRAPEI 200 (367)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------------------CCCTTCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccccc----cCCCcCcCcCccChHH
Confidence 5899999999999999999999999 99999999999999999999999999865331 1234678999999999
Q ss_pred ccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhh-----------hh-------------------h
Q 044846 154 FRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFS-----------KE-------------------A 200 (290)
Q Consensus 154 ~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~-----------~~-------------------~ 200 (290)
+.+ ..++.++|||||||++|+|++|.+||......... +..... .. .
T Consensus 201 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (367)
T 2fst_X 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 280 (367)
T ss_dssp HTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred HcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHH
Confidence 887 67899999999999999999999988654322111 000000 00 0
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
....+..+.+||.+||+.||.+|||+.|+++|.+-
T Consensus 281 ~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~ 315 (367)
T 2fst_X 281 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315 (367)
T ss_dssp TTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence 01124568899999999999999999999988553
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=285.40 Aligned_cols=223 Identities=21% Similarity=0.264 Sum_probs=181.8
Q ss_pred CceEEEEeecccC---------chhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSVH---------ESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~~---------~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||+|+++... ....+.+.+|+++++++. ||||+++++++...+..++||||+++++|.+++....
T Consensus 42 ~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 119 (298)
T 1phk_A 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-- 119 (298)
T ss_dssp TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--
T ss_pred CceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--
Confidence 6789999986533 123567889999999995 9999999999999999999999999999999998764
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
.+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++...... .......|++.|+||
T Consensus 120 --~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aP 192 (298)
T 1phk_A 120 --TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAP 192 (298)
T ss_dssp --SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTT--CCBCCCCSCGGGCCH
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCC--cccccccCCccccCH
Confidence 5899999999999999999999999 999999999999999999999999997654322 223345688999999
Q ss_pred cccc------cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccC
Q 044846 152 KYFR------SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 152 E~~~------~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~d 219 (290)
|++. ...++.++||||||+++|+|++|..|+........ ...... .......+..+.+++.+||+.|
T Consensus 193 E~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 271 (298)
T 1phk_A 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ 271 (298)
T ss_dssp HHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSS
T ss_pred HHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-HHHHhcCCcccCcccccccCHHHHHHHHHHccCC
Confidence 9985 45678899999999999999999998864432211 111111 1112345677999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 044846 220 GKKQPTMKEVTLELA 234 (290)
Q Consensus 220 p~~Rps~~el~~~l~ 234 (290)
|.+|||+.|++++..
T Consensus 272 p~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 272 PQKRYTAEEALAHPF 286 (298)
T ss_dssp GGGSCCHHHHTTSGG
T ss_pred cccCCCHHHHHhChH
Confidence 999999999987643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=287.72 Aligned_cols=230 Identities=18% Similarity=0.224 Sum_probs=169.3
Q ss_pred CceEEEEeecccC-chhHHH-HHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQ-FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~-~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++... ...... +..+...++.++||||+++++++...+..++||||+. |+|.+++.........+++..
T Consensus 32 ~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~ 110 (290)
T 3fme_A 32 GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDI 110 (290)
T ss_dssp TEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHH
T ss_pred CeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHH
Confidence 6789999997532 223333 4444455777899999999999999999999999996 599888876433333699999
Q ss_pred HHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccc----
Q 044846 80 RLRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF---- 154 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~---- 154 (290)
++.++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++...... .......||+.|+|||++
T Consensus 111 ~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~ 185 (290)
T 3fme_A 111 LGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--VAKDIDAGCKPYMAPERINPEL 185 (290)
T ss_dssp HHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----------------CCCCCCSCHHHHSCCT
T ss_pred HHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccc--ccccccCCCccccChhhcChhh
Confidence 999999999999999998 8 999999999999999999999999997654322 222334688999999996
Q ss_pred ccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.+..++.++||||||+++|+|++|..|+................ ......+..+.+++.+||+.||++|||+.|++
T Consensus 186 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l 265 (290)
T 3fme_A 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265 (290)
T ss_dssp TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHH
Confidence 45678889999999999999999999886432222222222111 11223566799999999999999999999999
Q ss_pred HHHHhhH
Q 044846 231 LELAGIR 237 (290)
Q Consensus 231 ~~l~~~~ 237 (290)
++.+.-.
T Consensus 266 ~hp~f~~ 272 (290)
T 3fme_A 266 QHPFFTL 272 (290)
T ss_dssp TSHHHHH
T ss_pred hCccccc
Confidence 8765443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=287.73 Aligned_cols=221 Identities=19% Similarity=0.286 Sum_probs=179.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCc------eeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRN------VVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|+++.. ....+.+.+|+++++.++|+| |+++++++...+..++||||+ +++|.+++..... .++
T Consensus 40 ~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~ 115 (339)
T 1z57_A 40 GRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGF--LPF 115 (339)
T ss_dssp TEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCC
T ss_pred CcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCC--CCC
Confidence 578999999753 345677889999999987654 999999999999999999999 8899999987543 258
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-------------------CCcEEEeccccccccccCCc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-------------------KYQAKISDFRTFKSRAIDRT 136 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-------------------~~~~kl~dfg~~~~~~~~~~ 136 (290)
++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 116 ~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--- 189 (339)
T 1z57_A 116 RLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--- 189 (339)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS---
T ss_pred cHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc---
Confidence 89999999999999999999999 999999999999987 66899999999865332
Q ss_pred eeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhhh----------------
Q 044846 137 HLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFSK---------------- 198 (290)
Q Consensus 137 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~~---------------- 198 (290)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||......... .......
T Consensus 190 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 268 (339)
T 1z57_A 190 -HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH 268 (339)
T ss_dssp -CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEE
T ss_pred -ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHh
Confidence 223457899999999999999999999999999999999999988654322111 0000000
Q ss_pred ---------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 199 ---------------------------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 199 ---------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
......+..+.+||.+||+.||.+|||+.|++++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 330 (339)
T 1z57_A 269 HDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHP 330 (339)
T ss_dssp TTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSG
T ss_pred hccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCH
Confidence 00123456789999999999999999999999774
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.95 Aligned_cols=223 Identities=20% Similarity=0.185 Sum_probs=174.2
Q ss_pred CceEEEEeecccC--------chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSVH--------ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~~--------~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||||++.... ......+.+|+++++.++||||+++++++.... .++||||+++|+|.+++....
T Consensus 35 ~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~---- 109 (322)
T 2ycf_A 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK---- 109 (322)
T ss_dssp TEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC----
T ss_pred CcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC----
Confidence 5789999986422 223446889999999999999999999987655 899999999999999997644
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc---EEEeccccccccccCCceeeccceecccccC
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ---AKISDFRTFKSRAIDRTHLTTQVKVTFGYVD 150 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 150 (290)
.+++..++.++.||+.||.|||+++ |+||||||+||+++.++. +||+|||+++.... ........|++.|+|
T Consensus 110 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~gt~~y~a 184 (322)
T 2ycf_A 110 RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLA 184 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC--CHHHHHHHSCCTTCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceeccc--ccccccccCCcCccC
Confidence 5899999999999999999999999 999999999999987654 99999999765332 122234568999999
Q ss_pred ccccc---cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCC
Q 044846 151 PKYFR---SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGK 221 (290)
Q Consensus 151 PE~~~---~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~ 221 (290)
||++. ...++.++|||||||++|+|++|..||............... .......+..+.+||.+||+.||+
T Consensus 185 PE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 264 (322)
T 2ycf_A 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264 (322)
T ss_dssp HHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred chhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHh
Confidence 99974 456889999999999999999999988643322111111111 111123456799999999999999
Q ss_pred CCCCHHHHHHHHH
Q 044846 222 KQPTMKEVTLELA 234 (290)
Q Consensus 222 ~Rps~~el~~~l~ 234 (290)
+|||+.+++++.+
T Consensus 265 ~Rps~~~~l~h~~ 277 (322)
T 2ycf_A 265 ARFTTEEALRHPW 277 (322)
T ss_dssp TSCCHHHHHTSGG
T ss_pred hCCCHHHHhhCcC
Confidence 9999999997744
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=291.51 Aligned_cols=230 Identities=21% Similarity=0.252 Sum_probs=167.8
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcC----CCCCCCC
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT----DDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~ 76 (290)
|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... .....++
T Consensus 40 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 119 (303)
T 2vwi_A 40 KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119 (303)
T ss_dssp -CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSC
T ss_pred CcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCC
Confidence 6789999986433 3446678899999999999999999999999999999999999999999997521 1122589
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC----ceeeccceecccccCcc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR----THLTTQVKVTFGYVDPK 152 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~g~~~y~aPE 152 (290)
+..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... ........|++.|+|||
T Consensus 120 ~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 196 (303)
T 2vwi_A 120 ESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHH
Confidence 9999999999999999999999 9999999999999999999999999876433211 11223456889999999
Q ss_pred cccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-----------hhhHHHHHHHHHHHHHhhccCC
Q 044846 153 YFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-----------EAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 153 ~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~cl~~dp 220 (290)
++.+ ..++.++||||||+++|+|++|..|+................ ......+..+.+++.+||+.||
T Consensus 197 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 276 (303)
T 2vwi_A 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDP 276 (303)
T ss_dssp HHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSG
T ss_pred HhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCCh
Confidence 9876 568999999999999999999999886433222111111100 0011234578999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 044846 221 KKQPTMKEVTLELA 234 (290)
Q Consensus 221 ~~Rps~~el~~~l~ 234 (290)
.+|||+.+++++.+
T Consensus 277 ~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 277 EKRPTAAELLRHKF 290 (303)
T ss_dssp GGSCCHHHHHTSTT
T ss_pred hhCcCHHHHhhChh
Confidence 99999999997643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=301.67 Aligned_cols=222 Identities=10% Similarity=0.048 Sum_probs=161.1
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhc--CCCceeeEE-------eEEEeCC-----------------cceEE
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQI--NHRNVVKIL-------GCCLETE-----------------VPLLV 52 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l--~Hpniv~~~-------~~~~~~~-----------------~~~lv 52 (290)
|+.||+|+++... ....+.+.+|+.+++.| +||||++++ +++...+ ..|||
T Consensus 87 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv 166 (371)
T 3q60_A 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166 (371)
T ss_dssp TEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEE
T ss_pred CceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEE
Confidence 6789999997643 34466788886655555 699988755 4444332 37999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccc
Q 044846 53 YEFIPNGSLYQYIHEQTDDQLPITWEMR------LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126 (290)
Q Consensus 53 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~------~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg 126 (290)
||||. |+|.+++..... .++...+ ..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 167 ~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG 239 (371)
T 3q60_A 167 MPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVS 239 (371)
T ss_dssp ECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGG
T ss_pred ecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecc
Confidence 99997 899999987532 2344445 677799999999999999 9999999999999999999999999
Q ss_pred cccccccCCceeeccceecccccCcccccc--CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHH----------
Q 044846 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRS--SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA---------- 194 (290)
Q Consensus 127 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~---------- 194 (290)
+++.... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 240 ~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 315 (371)
T 3q60_A 240 ALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD 315 (371)
T ss_dssp GEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCC
T ss_pred eeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhcccc
Confidence 9875431 1213455689999999987 67999999999999999999999988655322110000
Q ss_pred HhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 195 YFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 195 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
..........+..+.+||.+||+.||++|||+.+++++.+
T Consensus 316 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 316 SLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp SCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred ccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 0001111244677999999999999999999999987754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=288.02 Aligned_cols=224 Identities=19% Similarity=0.230 Sum_probs=177.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEE--------------eCCcceEEEEeCCCCCHHHHHhh
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCL--------------ETEVPLLVYEFIPNGSLYQYIHE 67 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~--------------~~~~~~lv~e~~~~g~L~~~l~~ 67 (290)
|+.||+|++...+....+.+.+|+++++.++||||+++++++. ..+..++||||+. |+|.+++..
T Consensus 36 ~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~ 114 (320)
T 2i6l_A 36 DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ 114 (320)
T ss_dssp TEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT
T ss_pred CeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc
Confidence 6789999998777777889999999999999999999999874 3467799999996 699999964
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec-cCCcEEEeccccccccccCC--ceeecccee
Q 044846 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISDFRTFKSRAIDR--THLTTQVKV 144 (290)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~--~~~~~~~~g 144 (290)
. ++++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||+++...... ........+
T Consensus 115 ~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 186 (320)
T 2i6l_A 115 G-----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186 (320)
T ss_dssp C-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGS
T ss_pred C-----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccc
Confidence 3 4889999999999999999999999 99999999999997 56799999999987543211 112233456
Q ss_pred cccccCcccccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-------------------------
Q 044846 145 TFGYVDPKYFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK------------------------- 198 (290)
Q Consensus 145 ~~~y~aPE~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~------------------------- 198 (290)
+..|+|||++.+ ..++.++||||||+++|+|++|..||........ .......
T Consensus 187 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (320)
T 2i6l_A 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILESIPVVHEEDRQELLSVIPVYIRNDMT 265 (320)
T ss_dssp CCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTT
T ss_pred cccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCchhhhhhhhhcCccccccccc
Confidence 888999998875 6788999999999999999999998865432211 1100000
Q ss_pred -------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 199 -------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 199 -------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
......+..+.+||.+||+.||++|||+.|++++.+-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 266 EPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp SCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred CCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 0011235679999999999999999999999987653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=301.05 Aligned_cols=226 Identities=16% Similarity=0.165 Sum_probs=168.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCC---CCH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLP---ITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---~~~ 77 (290)
|+.||||++... ..+.+.+|+++++.+ +||||+++++++...+..+|||||| +|+|.+++......... .++
T Consensus 39 g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~ 114 (434)
T 2rio_A 39 GRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKE 114 (434)
T ss_dssp SSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHTC------------
T ss_pred CeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC-CCCHHHHHhccCCCchhhhhccc
Confidence 678999998642 345678999999987 8999999999999999999999999 46999999865422111 122
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC-------------CcEEEeccccccccccCCce---eecc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-------------YQAKISDFRTFKSRAIDRTH---LTTQ 141 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~-------------~~~kl~dfg~~~~~~~~~~~---~~~~ 141 (290)
..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++........ ....
T Consensus 115 ~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~ 191 (434)
T 2rio_A 115 YNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191 (434)
T ss_dssp CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-----------
T ss_pred hhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecC
Confidence 345679999999999999999 9999999999999754 48999999998765432221 1234
Q ss_pred ceecccccCcccccc-------CCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh-h-----hhhhHHHHHH
Q 044846 142 VKVTFGYVDPKYFRS-------SQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF-S-----KEAEKEEVIT 207 (290)
Q Consensus 142 ~~g~~~y~aPE~~~~-------~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~ 207 (290)
..||+.|+|||++.+ ..++.++|||||||++|+|++ |..|+.............. . .......+.+
T Consensus 192 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 271 (434)
T 2rio_A 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAE 271 (434)
T ss_dssp ---CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHH
T ss_pred CCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHH
Confidence 578999999999976 568899999999999999998 7877754432222111110 0 1112356678
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 208 FAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 208 ~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.+||.+||+.||.+|||+.+++++..
T Consensus 272 ~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 272 ATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 999999999999999999999997643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=284.29 Aligned_cols=223 Identities=23% Similarity=0.371 Sum_probs=170.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe-------------CCcceEEEEeCCCCCHHHHHhhc
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLE-------------TEVPLLVYEFIPNGSLYQYIHEQ 68 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~ 68 (290)
|+.||+|+++.. ....+.+.+|+.+++.++||||+++++++.. .+..++||||+++|+|.+++...
T Consensus 31 ~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 109 (303)
T 1zy4_A 31 SRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE 109 (303)
T ss_dssp CCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHS
T ss_pred CeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc
Confidence 678999999653 4456789999999999999999999999865 34679999999999999999864
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-------------
Q 044846 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR------------- 135 (290)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~------------- 135 (290)
. ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 110 ~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 183 (303)
T 1zy4_A 110 N---LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183 (303)
T ss_dssp C---GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC---------------
T ss_pred c---cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccccc
Confidence 3 25788899999999999999999999 9999999999999999999999999976533211
Q ss_pred ceeeccceecccccCccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHH
Q 044846 136 THLTTQVKVTFGYVDPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITF 208 (290)
Q Consensus 136 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 208 (290)
........|+..|+|||++.+. .++.++|||||||++|+|+++ +............... .......+..+
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (303)
T 1zy4_A 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE 260 (303)
T ss_dssp ----------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC---CSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHH
T ss_pred ccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc---cCCchhHHHHHHhccccccccCccccccchHHH
Confidence 1122345688999999999865 689999999999999999983 2222111111111111 11222344568
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 209 AMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 209 ~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.++|.+||+.||.+|||+.+++++.+
T Consensus 261 ~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 261 KKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred HHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 89999999999999999999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=300.70 Aligned_cols=230 Identities=16% Similarity=0.133 Sum_probs=183.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINH-RNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||++..... ...+.+|+++++.|.| ++|+.+..++...+..+|||||+ +++|.+++..... .+++..+
T Consensus 32 ~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~---~l~~~~~ 105 (483)
T 3sv0_A 32 NEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR---KLSLKTV 105 (483)
T ss_dssp CCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHH
T ss_pred CcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcC---CCCHHHH
Confidence 67899998765332 2357899999999976 66667777777888899999999 9999999986433 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe---ccCCcEEEeccccccccccCCce------eeccceecccccCc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILL---VDKYQAKISDFRTFKSRAIDRTH------LTTQVKVTFGYVDP 151 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aP 151 (290)
+.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++........ ......||..|+||
T Consensus 106 ~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 182 (483)
T 3sv0_A 106 LMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182 (483)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred HHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCH
Confidence 999999999999999999 9999999999999 68899999999998754432221 12256789999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhh--hhhhHHHhh-------hhhhHHHHHHHHHHHHHhhccCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE--NRSLAAYFS-------KEAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~--~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
|++.+..++.++|||||||++|+|++|..||...... ...+..... .......+.++.+||.+||+.||++
T Consensus 183 E~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~ 262 (483)
T 3sv0_A 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDD 262 (483)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTC
T ss_pred HHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhh
Confidence 9999999999999999999999999999988643221 111111100 1111234567999999999999999
Q ss_pred CCCHHHHHHHHHhhHhhh
Q 044846 223 QPTMKEVTLELAGIRASI 240 (290)
Q Consensus 223 Rps~~el~~~l~~~~~~~ 240 (290)
||++.+|++.|+.+....
T Consensus 263 RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 263 KPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp CCCHHHHHHHHHHHHHHT
T ss_pred CcCHHHHHHHHHHHHHHc
Confidence 999999999998887644
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=295.92 Aligned_cols=225 Identities=19% Similarity=0.263 Sum_probs=181.4
Q ss_pred CceEEEEeecccCch-----------------hHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHES-----------------NVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQY 64 (290)
Q Consensus 2 ~~~~avK~~~~~~~~-----------------~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 64 (290)
|+.||+|++...... ..+.+.+|+++++.++||||+++++++...+..++||||+++|+|.++
T Consensus 54 ~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 133 (348)
T 2pml_X 54 NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF 133 (348)
T ss_dssp TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEE
T ss_pred CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHH
Confidence 678999998642211 127899999999999999999999999999999999999999999998
Q ss_pred ------HhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce
Q 044846 65 ------IHEQTDDQLPITWEMRLRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH 137 (290)
Q Consensus 65 ------l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 137 (290)
+.... ...+++..++.++.|++.||.|||+ ++ |+||||||+||+++.++.+||+|||.+......
T Consensus 134 ~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 205 (348)
T 2pml_X 134 DEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--- 205 (348)
T ss_dssp SSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT---
T ss_pred HHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEeccccccccccc---
Confidence 54421 2368999999999999999999999 88 999999999999999999999999997654322
Q ss_pred eeccceecccccCccccccC-CCCC-cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhh------------
Q 044846 138 LTTQVKVTFGYVDPKYFRSS-QFTE-KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAE------------ 201 (290)
Q Consensus 138 ~~~~~~g~~~y~aPE~~~~~-~~~~-~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~------------ 201 (290)
......|+..|+|||++.+. .++. ++||||||+++|+|++|..|+................ ..+
T Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 285 (348)
T 2pml_X 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTN 285 (348)
T ss_dssp EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC
T ss_pred cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccc
Confidence 33446789999999999877 5666 8999999999999999999886543312222111111 001
Q ss_pred -------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 202 -------KEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 202 -------~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
...+..+.+||.+||+.||.+|||+.|++++.+
T Consensus 286 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 286 KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp --------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 334677999999999999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=297.12 Aligned_cols=223 Identities=18% Similarity=0.221 Sum_probs=173.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----------------------------------
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLET----------------------------------- 46 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~----------------------------------- 46 (290)
|+.||+|++...... ..+|+++++.++||||++++++|...
T Consensus 32 ~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (383)
T 3eb0_A 32 GKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNP 107 (383)
T ss_dssp CCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----------------------------------
T ss_pred CCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccC
Confidence 678999998643222 23799999999999999999998543
Q ss_pred ---CcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec-cCCcEEE
Q 044846 47 ---EVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKI 122 (290)
Q Consensus 47 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~-~~~~~kl 122 (290)
...++||||++ |+|.+.+.........+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 108 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl 183 (383)
T 3eb0_A 108 SQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKL 183 (383)
T ss_dssp --CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEE
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEE
Confidence 34789999996 5888888754333336899999999999999999999999 99999999999998 6889999
Q ss_pred eccccccccccCCceeeccceecccccCccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH--hh--
Q 044846 123 SDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY--FS-- 197 (290)
Q Consensus 123 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~--~~-- 197 (290)
+|||+++..... .......+|..|+|||++.+. .++.++||||+||++|+|++|.+||............. ..
T Consensus 184 ~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p 261 (383)
T 3eb0_A 184 CDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTP 261 (383)
T ss_dssp CCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999998754322 223345678999999998775 48999999999999999999999886543322111110 00
Q ss_pred --------------------------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 198 --------------------------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 198 --------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
...+...+..+.+||.+||+.||.+|||+.|+++|.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 262 TKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp CHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence 0011123456899999999999999999999998744
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=295.15 Aligned_cols=222 Identities=23% Similarity=0.232 Sum_probs=177.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC--------CCceeeEEeEEE----eCCcceEEEEeCCCCCHHHHHhhcC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN--------HRNVVKILGCCL----ETEVPLLVYEFIPNGSLYQYIHEQT 69 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~--------Hpniv~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~ 69 (290)
|+.||||+++.. ....+.+.+|+++++.++ ||||+++++++. .....++||||+ +++|.+.+....
T Consensus 62 ~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~ 139 (397)
T 1wak_A 62 KKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN 139 (397)
T ss_dssp TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT
T ss_pred CeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc
Confidence 678999999743 445678899999999985 788999999998 456789999999 678888776643
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeccCC------------------------------
Q 044846 70 DDQLPITWEMRLRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVDKY------------------------------ 118 (290)
Q Consensus 70 ~~~~~~~~~~~~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~~~------------------------------ 118 (290)
.. .+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 140 ~~--~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (397)
T 1wak_A 140 YQ--GLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214 (397)
T ss_dssp TS--CCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC-------------------
T ss_pred cC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCC
Confidence 22 589999999999999999999998 8 99999999999999775
Q ss_pred -------------------cEEEeccccccccccCCceeeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCC
Q 044846 119 -------------------QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTK 179 (290)
Q Consensus 119 -------------------~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~ 179 (290)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 290 (397)
T 1wak_A 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290 (397)
T ss_dssp --CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCC
Confidence 7999999998654321 23456899999999999999999999999999999999999
Q ss_pred CCcccchhh-----hhh---hHHHhh-----------------------------------------hhhhHHHHHHHHH
Q 044846 180 PIHLVDVEE-----NRS---LAAYFS-----------------------------------------KEAEKEEVITFAM 210 (290)
Q Consensus 180 ~~~~~~~~~-----~~~---~~~~~~-----------------------------------------~~~~~~~~~~~~~ 210 (290)
.||...... ... ...... .......+..+.+
T Consensus 291 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (397)
T 1wak_A 291 YLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTD 370 (397)
T ss_dssp CSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHH
T ss_pred CCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHH
Confidence 988532210 000 000000 0112445677999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHH
Q 044846 211 VAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 211 li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
||.+||+.||++|||+.|+++|.+
T Consensus 371 li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 371 FLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp HHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHhccChhhcCCHHHHhhCcc
Confidence 999999999999999999997643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=293.14 Aligned_cols=224 Identities=18% Similarity=0.179 Sum_probs=170.2
Q ss_pred CceEEEEeecccCc-----------hhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----CcceEEEEeCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHE-----------SNVEQFINEVVILSQINHRNVVKILGCCLET-----EVPLLVYEFIPNGSLYQYI 65 (290)
Q Consensus 2 ~~~~avK~~~~~~~-----------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l 65 (290)
|+.||+|++..... ...+.+.+|+++++.++||||+++++++... ...++||||+. |+|.+++
T Consensus 46 ~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~ 124 (362)
T 3pg1_A 46 GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVI 124 (362)
T ss_dssp SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHH
T ss_pred CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHH
Confidence 67899999854222 2247899999999999999999999999653 35799999996 6999998
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceec
Q 044846 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVT 145 (290)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~ 145 (290)
..... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..... ........|+
T Consensus 125 ~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~t 196 (362)
T 3pg1_A 125 HDQRI---VISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTA--DANKTHYVTH 196 (362)
T ss_dssp HCTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC-----------------C
T ss_pred Hhccc---CCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCccccccc--ccccceeccc
Confidence 75432 5899999999999999999999999 99999999999999999999999999764322 2223445688
Q ss_pred ccccCcccccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhhh------------------------
Q 044846 146 FGYVDPKYFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFSK------------------------ 198 (290)
Q Consensus 146 ~~y~aPE~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~~------------------------ 198 (290)
+.|+|||++.+ ..++.++|||||||++|+|++|..||......... .......
T Consensus 197 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (362)
T 3pg1_A 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSN 276 (362)
T ss_dssp GGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCC
T ss_pred ceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhccc
Confidence 99999999887 67899999999999999999999988654321111 0000000
Q ss_pred -------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 199 -------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 199 -------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
......+..+.+||.+||+.||.+|||+.|++++.+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 277 VPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp CCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 001122456889999999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=292.43 Aligned_cols=220 Identities=19% Similarity=0.200 Sum_probs=174.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcc------eEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVP------LLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++...+.. ++||||+. |+|.+++..
T Consensus 67 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------ 139 (371)
T 4exu_A 67 GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM------ 139 (371)
T ss_dssp TEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS------
T ss_pred CCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc------
Confidence 678999999753 344467899999999999999999999999877654 99999995 689888742
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ......||+.|+|||+
T Consensus 140 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~~~t~~y~aPE~ 212 (371)
T 4exu_A 140 EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEV 212 (371)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC------------CTTCCCTTSCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccccc----CcCCcccCccccCHHH
Confidence 4889999999999999999999999 99999999999999999999999999864332 2234567999999999
Q ss_pred ccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--h------------------------------hhh
Q 044846 154 FRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--S------------------------------KEA 200 (290)
Q Consensus 154 ~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~------------------------------~~~ 200 (290)
+.+ ..++.++|||||||++|+|++|..||.............. . ...
T Consensus 213 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (371)
T 4exu_A 213 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQL 292 (371)
T ss_dssp HSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHH
T ss_pred hcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHh
Confidence 887 6789999999999999999999998865432211110000 0 000
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
....+..+.+||.+||+.||++|||+.|++++.+.
T Consensus 293 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 293 FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp STTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred ccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 11235678999999999999999999999988653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=298.80 Aligned_cols=224 Identities=21% Similarity=0.222 Sum_probs=172.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLET------EVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||++..... .+.+|+++|+.|+|||||+++++|... ..+++||||++ ++|..++.........+
T Consensus 79 ~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l 153 (420)
T 1j1b_A 79 GELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTL 153 (420)
T ss_dssp CCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCC
T ss_pred CcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhhccCCC
Confidence 67899999864322 234799999999999999999998642 23679999996 47877776532223368
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC-CcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++..... .......||+.|+|||++
T Consensus 154 ~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~ 228 (420)
T 1j1b_A 154 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELI 228 (420)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT--CCCCSCCSCTTSCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccC--CCceeeeeCCCcCCHHHH
Confidence 99999999999999999999999 9999999999999965 56899999998754322 122345689999999998
Q ss_pred ccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHhhh----------------------------hhhHH
Q 044846 155 RSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYFSK----------------------------EAEKE 203 (290)
Q Consensus 155 ~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~~~----------------------------~~~~~ 203 (290)
.+. .++.++|||||||++|||++|.+||.......... ...... .....
T Consensus 229 ~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 308 (420)
T 1j1b_A 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR 308 (420)
T ss_dssp TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTT
T ss_pred cCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCC
Confidence 765 78999999999999999999999886543221111 110000 00112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 204 EVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 204 ~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.+.++.+||.+||+.||.+|||+.|+++|.+.
T Consensus 309 ~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 309 TPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 34679999999999999999999999988553
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=291.18 Aligned_cols=225 Identities=19% Similarity=0.210 Sum_probs=177.1
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC-----CcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLET-----EVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||+++.. .......+.+|+++++.++||||+++++++... ...++||||+. |+|.+++... .+
T Consensus 36 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~ 109 (353)
T 2b9h_A 36 GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ-----ML 109 (353)
T ss_dssp TEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC-----CC
T ss_pred CcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc-----CC
Confidence 678999999743 344566788999999999999999999988764 67899999995 6999999763 48
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce---------eeccceecc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH---------LTTQVKVTF 146 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---------~~~~~~g~~ 146 (290)
++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ......||+
T Consensus 110 ~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~ 186 (353)
T 2b9h_A 110 SDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186 (353)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCG
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccc
Confidence 99999999999999999999999 999999999999999999999999998754321111 112346799
Q ss_pred cccCcccccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH-----------------------hh-----
Q 044846 147 GYVDPKYFRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY-----------------------FS----- 197 (290)
Q Consensus 147 ~y~aPE~~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~-----------------------~~----- 197 (290)
.|+|||++.+ ..++.++|||||||++|+|++|.+||............. ..
T Consensus 187 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (353)
T 2b9h_A 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMY 266 (353)
T ss_dssp GGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCC
T ss_pred cccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCC
Confidence 9999998765 678899999999999999999999886543221110000 00
Q ss_pred -----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 198 -----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 198 -----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.......+..+.+||.+||+.||.+|||+.|++++.+-
T Consensus 267 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 267 PAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp CCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 00011345678899999999999999999999987553
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=287.99 Aligned_cols=225 Identities=22% Similarity=0.251 Sum_probs=174.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEe------CCcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLE------TEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|++.... ...+.+.+|+.+++.+ +||||+++++++.. .+..++||||+.+|+|.+++..... ..
T Consensus 49 ~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~ 125 (326)
T 2x7f_A 49 GQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NT 125 (326)
T ss_dssp CCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--GC
T ss_pred CCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc--CC
Confidence 6789999987533 3456788999999999 89999999999987 4678999999999999999987532 25
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...... ........|++.|+|||++
T Consensus 126 ~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~ 201 (326)
T 2x7f_A 126 LKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFIGTPYWMAPEVI 201 (326)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC-ccccccccCCccccChhhh
Confidence 889999999999999999999999 999999999999999999999999997643321 1122345689999999998
Q ss_pred c-----cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 155 R-----SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 155 ~-----~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
. +..++.++|||||||++|+|++|..|+........ ....... ......+..+.+||.+||..||.+|||
T Consensus 202 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 280 (326)
T 2x7f_A 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPA 280 (326)
T ss_dssp C--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCC
T ss_pred ccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCC
Confidence 7 45688999999999999999999988854332221 1111111 111234567999999999999999999
Q ss_pred HHHHHHHHH
Q 044846 226 MKEVTLELA 234 (290)
Q Consensus 226 ~~el~~~l~ 234 (290)
+.+++++..
T Consensus 281 ~~~ll~hp~ 289 (326)
T 2x7f_A 281 TEQLMKHPF 289 (326)
T ss_dssp HHHHHTSHH
T ss_pred HHHHhhChH
Confidence 999998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=282.84 Aligned_cols=227 Identities=16% Similarity=0.119 Sum_probs=177.8
Q ss_pred CceEEEEeecccC----chhHHHHHHHHHHHHhcCCCceeeEEeEEE--eCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVH----ESNVEQFINEVVILSQINHRNVVKILGCCL--ETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|+++... ....+.+.+|+++++.++||||+++++++. ..+..++||||+.++ |.+++...... .+
T Consensus 30 ~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~--~~ 106 (305)
T 2wtk_C 30 LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEK--RF 106 (305)
T ss_dssp CCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTC--SC
T ss_pred CcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCccc--cc
Confidence 5789999986432 345678999999999999999999999984 456789999999765 88888764432 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC-CceeeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID-RTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~ 154 (290)
++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...... .........|+..|+|||++
T Consensus 107 ~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 183 (305)
T 2wtk_C 107 PVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183 (305)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhc
Confidence 99999999999999999999999 999999999999999999999999998654321 12223445689999999998
Q ss_pred ccCC--CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 155 RSSQ--FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 155 ~~~~--~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.+.. ++.++||||||+++|+|++|..|+........ ...... ...+...+..+.++|.+||+.||.+|||+.|++
T Consensus 184 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 262 (305)
T 2wtk_C 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-FENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIR 262 (305)
T ss_dssp TCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-HHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 7654 36799999999999999999998864432211 111111 111223456789999999999999999999999
Q ss_pred HHHHh
Q 044846 231 LELAG 235 (290)
Q Consensus 231 ~~l~~ 235 (290)
++.+.
T Consensus 263 ~~~~~ 267 (305)
T 2wtk_C 263 QHSWF 267 (305)
T ss_dssp HSHHH
T ss_pred cCccc
Confidence 88654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=289.80 Aligned_cols=227 Identities=17% Similarity=0.150 Sum_probs=175.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc-------ceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEV-------PLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~-------~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||||++... ......+.+|++.+..++||||++++++|...+. .++||||+.+ +|...+.........
T Consensus 48 ~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~ 125 (360)
T 3e3p_A 48 GMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVA 125 (360)
T ss_dssp CCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCC
T ss_pred CCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccC
Confidence 678999998643 2334456788889999999999999999976443 7899999965 676666543333346
Q ss_pred CCHHHHHHHHHHHHHHHHHHh--hCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 75 ITWEMRLRITVEVSRVLSYLH--SVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH--~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+||+|||+++..... .......||+.|+||
T Consensus 126 ~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aP 200 (360)
T 3e3p_A 126 PPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--EPNVAYICSRYYRAP 200 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT--SCCCSTTSCGGGCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC--CCcccccCCcceeCH
Confidence 889999999999999999999 888 999999999999996 899999999998654322 223345679999999
Q ss_pred cccccCC-CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---h-----------------------------
Q 044846 152 KYFRSSQ-FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---K----------------------------- 198 (290)
Q Consensus 152 E~~~~~~-~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~----------------------------- 198 (290)
|++.+.. ++.++|||||||++|+|++|.+||......... ..... .
T Consensus 201 E~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
T 3e3p_A 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL-HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNV 279 (360)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHH
T ss_pred HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH-HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccc
Confidence 9987654 899999999999999999999988654322111 11100 0
Q ss_pred --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 199 --EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 199 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
......+..+.+||.+||+.||.+|||+.|+++|.+--
T Consensus 280 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 319 (360)
T 3e3p_A 280 FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319 (360)
T ss_dssp TTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGG
T ss_pred cchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccc
Confidence 00011356799999999999999999999999885543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=279.04 Aligned_cols=223 Identities=21% Similarity=0.236 Sum_probs=181.3
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|++... .....+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++.... .+++..
T Consensus 47 ~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~ 122 (287)
T 2wei_A 47 QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHD 122 (287)
T ss_dssp CCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHH
T ss_pred CcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC----CCCHHH
Confidence 678999998642 34457789999999999999999999999999999999999999999999997765 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC---CcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK---YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
++.++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++...... .......+++.|+|||++.+
T Consensus 123 ~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 197 (287)
T 2wei_A 123 AARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLRG 197 (287)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC--SSCSCHHHHHTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC--CccccccCcccccChHHhcC
Confidence 9999999999999999999 9999999999999754 46999999987643322 12233457889999999875
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
. ++.++||||||+++|+|++|.+|+........ ...... .......+..+.++|.+||+.||++|||+.|++
T Consensus 198 ~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 275 (287)
T 2wei_A 198 T-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275 (287)
T ss_dssp C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred C-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 4 88999999999999999999998865432211 111111 111223466799999999999999999999999
Q ss_pred HHHHh
Q 044846 231 LELAG 235 (290)
Q Consensus 231 ~~l~~ 235 (290)
++.+-
T Consensus 276 ~hp~~ 280 (287)
T 2wei_A 276 EHPWI 280 (287)
T ss_dssp HSHHH
T ss_pred cCHHH
Confidence 87543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=297.31 Aligned_cols=222 Identities=21% Similarity=0.221 Sum_probs=167.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||++...... .+.+|+++|+.+ +|||||++++++......|||||||. |+|.+++..... .+....+
T Consensus 48 ~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~---~~~~~~~ 120 (432)
T 3p23_A 48 NRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF---AHLGLEP 120 (432)
T ss_dssp SSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSC---CCCSSCH
T ss_pred CeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCC---CccchhH
Confidence 678999998654333 356899999999 89999999999999999999999995 699999986543 2444456
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-----CCcEEEeccccccccccCCc--eeeccceecccccCccc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-----KYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-----~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~ 153 (290)
..++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+++....... .......||+.|+|||+
T Consensus 121 ~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~ 197 (432)
T 3p23_A 121 ITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197 (432)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGG
T ss_pred HHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhh
Confidence 789999999999999999 999999999999953 23578999999875443221 12344678999999999
Q ss_pred cc---cCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh----hhhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 154 FR---SSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF----SKEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 154 ~~---~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
+. ...++.++|||||||++|+|++ |..|+.............. ........+..+.+||.+||+.||.+|||
T Consensus 198 l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 277 (432)
T 3p23_A 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS 277 (432)
T ss_dssp TSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred hhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCC
Confidence 97 4567789999999999999999 7766643322221111100 01112344566889999999999999999
Q ss_pred HHHHHHHH
Q 044846 226 MKEVTLEL 233 (290)
Q Consensus 226 ~~el~~~l 233 (290)
+.|+++|.
T Consensus 278 ~~evl~hp 285 (432)
T 3p23_A 278 AKHVLKHP 285 (432)
T ss_dssp HHHHHTST
T ss_pred HHHHHhCc
Confidence 99999763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=288.44 Aligned_cols=222 Identities=19% Similarity=0.244 Sum_probs=176.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC-CC-----ceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN-HR-----NVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||+++.. ......+..|+.+++.++ |+ +|+++++++...+..++||||+. |+|.+++...... .+
T Consensus 79 ~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~ 154 (382)
T 2vx3_A 79 QEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFR--GV 154 (382)
T ss_dssp TEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTS--CC
T ss_pred CcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcC--CC
Confidence 578999999743 344667888999999884 55 49999999999999999999995 6999999876432 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhh--CCCCCeEeccCCCCceEec--cCCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 76 TWEMRLRITVEVSRVLSYLHS--VASIPIYHLDIKSANILLV--DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~--~~~~~iiHrdlkp~Nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
++..+..++.|++.||.|||. .+ |+||||||+|||++ .++.+||+|||+++.... ......||+.|+||
T Consensus 155 ~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aP 227 (382)
T 2vx3_A 155 SLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQYIQSRFYRSP 227 (382)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTC----CCCSSCSCGGGCCH
T ss_pred CHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceeccc----ccccccCCccccCh
Confidence 899999999999999999994 56 99999999999995 477899999999865432 22346789999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhhh-------------------------------
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFSK------------------------------- 198 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~~------------------------------- 198 (290)
|++.+..++.++|||||||++|+|++|.+||......... .......
T Consensus 228 E~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (382)
T 2vx3_A 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKD 307 (382)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCT
T ss_pred HHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccc
Confidence 9999999999999999999999999999988654322111 0000000
Q ss_pred --------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 199 --------------------------------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 199 --------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.........+.+||.+||+.||++|||+.|+++|.+
T Consensus 308 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~ 375 (382)
T 2vx3_A 308 GKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSF 375 (382)
T ss_dssp TCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcc
Confidence 001123357899999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=285.30 Aligned_cols=221 Identities=17% Similarity=0.245 Sum_probs=177.9
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCc------eeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRN------VVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
+.||+|+++.. ....+.+.+|+.+++.++|++ ++.+++++...+..++||||+ +++|.+++...... .++
T Consensus 46 ~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~--~~~ 121 (355)
T 2eu9_A 46 SQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQ--PYP 121 (355)
T ss_dssp EEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTC--CCC
T ss_pred eEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCC--CCC
Confidence 57999999753 445677889999999997766 999999999999999999999 77888888765432 589
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEe-------------------ccCCcEEEeccccccccccCCce
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL-------------------VDKYQAKISDFRTFKSRAIDRTH 137 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~-------------------~~~~~~kl~dfg~~~~~~~~~~~ 137 (290)
+..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 122 ~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---- 194 (355)
T 2eu9_A 122 LPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE---- 194 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS----
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc----
Confidence 9999999999999999999999 9999999999999 6678999999999865322
Q ss_pred eeccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHhhh-----------------
Q 044846 138 LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYFSK----------------- 198 (290)
Q Consensus 138 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~~~----------------- 198 (290)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||.......... ......
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 274 (355)
T 2eu9_A 195 HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK 274 (355)
T ss_dssp CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEET
T ss_pred cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcc
Confidence 2234578999999999999999999999999999999999999886543221111 000000
Q ss_pred --------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 199 --------------------------EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 199 --------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
......+..+.+||.+||+.||.+|||+.|++++.+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 275 GGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPF 336 (355)
T ss_dssp TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred cccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 001123457889999999999999999999987754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=293.77 Aligned_cols=222 Identities=20% Similarity=0.206 Sum_probs=169.4
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc------ceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEV------PLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
..||+|++...... ..+|+++++.++||||++++++|...+. .++||||+++ ++...+.........++
T Consensus 65 ~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~ 139 (394)
T 4e7w_A 65 DEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP 139 (394)
T ss_dssp EEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCC
T ss_pred CeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCC
Confidence 34888887543221 2379999999999999999999976443 7899999965 55555543222223689
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec-cCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
+..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.
T Consensus 140 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~ 214 (394)
T 4e7w_A 140 MLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICSRYYRAPELIF 214 (394)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSSCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC--CCcccccCcCccCHHHHc
Confidence 9999999999999999999999 99999999999999 79999999999987543222 223456799999999987
Q ss_pred cC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHhh----------------------------hhhhHHH
Q 044846 156 SS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYFS----------------------------KEAEKEE 204 (290)
Q Consensus 156 ~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~~----------------------------~~~~~~~ 204 (290)
+. .++.++|||||||++|+|++|.+||.......... ..... .......
T Consensus 215 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (394)
T 4e7w_A 215 GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRT 294 (394)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTC
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccC
Confidence 65 58999999999999999999999887543221111 11000 0001124
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 205 VITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 205 ~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.++.+||.+||+.||.+|||+.|+++|.+
T Consensus 295 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 295 PPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 467999999999999999999999998854
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=283.25 Aligned_cols=225 Identities=20% Similarity=0.272 Sum_probs=175.7
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcC--CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQIN--HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~--Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|++.. ......+.+.+|+++++.++ ||||+++++++...+..++||| +.+++|.+++.... .+++
T Consensus 52 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~ 126 (313)
T 3cek_A 52 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK----SIDP 126 (313)
T ss_dssp CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS----SCCH
T ss_pred CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC----CCCH
Confidence 57899999864 34456778999999999996 5999999999999999999999 45889999998754 5889
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCcccccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~ 156 (290)
..++.++.|++.||.|||+++ |+||||||+||+++ ++.+||+|||+++........ ......|++.|+|||++.+
T Consensus 127 ~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 127 WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhh
Confidence 999999999999999999999 99999999999996 489999999998754322211 2234568999999999875
Q ss_pred -----------CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCC
Q 044846 157 -----------SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGK 221 (290)
Q Consensus 157 -----------~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~ 221 (290)
..++.++||||||+++|+|++|..|+................ ..+...+..+.++|.+||+.||.
T Consensus 203 ~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 282 (313)
T 3cek_A 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 282 (313)
T ss_dssp CC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred cccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcc
Confidence 467889999999999999999999886443322222222111 11122346789999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 044846 222 KQPTMKEVTLELAG 235 (290)
Q Consensus 222 ~Rps~~el~~~l~~ 235 (290)
+|||+.|++++.+.
T Consensus 283 ~Rps~~ell~h~~~ 296 (313)
T 3cek_A 283 QRISIPELLAHPYV 296 (313)
T ss_dssp TSCCHHHHHTSHHH
T ss_pred cCcCHHHHhcCccc
Confidence 99999999988654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=284.17 Aligned_cols=224 Identities=22% Similarity=0.315 Sum_probs=176.6
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhc---CCCceeeEEeEEE-----eCCcceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQI---NHRNVVKILGCCL-----ETEVPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l---~Hpniv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||+|+++... ......+.+|+.+++.+ +||||+++++++. .....++||||+. |+|.+++......
T Consensus 37 ~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~ 115 (326)
T 1blx_A 37 GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP 115 (326)
T ss_dssp TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTT
T ss_pred CEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccC
Confidence 5679999986422 22233566788877766 8999999999987 4567899999996 6999999875432
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... .......|+..|+||
T Consensus 116 --~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aP 188 (326)
T 1blx_A 116 --GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAP 188 (326)
T ss_dssp --CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCH
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCC--CCccccccccceeCH
Confidence 4889999999999999999999999 999999999999999999999999997643321 222345688999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----------------------------hhhhH
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----------------------------KEAEK 202 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~ 202 (290)
|++.+..++.++||||||+++|+|++|.+||........ +..... .....
T Consensus 189 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 1blx_A 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT 267 (326)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCC
T ss_pred HHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccc
Confidence 999999999999999999999999999998865432211 111100 00112
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 203 EEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 203 ~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
..+..+.+||.+||+.||.+|||+.|++++.+
T Consensus 268 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 268 DIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp SCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 24567889999999999999999999997644
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=290.46 Aligned_cols=231 Identities=18% Similarity=0.247 Sum_probs=177.3
Q ss_pred ceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 3 ELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 3 ~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
..+|+|+++.. .....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++..... .+++..+
T Consensus 56 ~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---~~~~~~~ 132 (319)
T 2y4i_B 56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKT 132 (319)
T ss_dssp SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCC---CCCSHHH
T ss_pred CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCC---CCCHHHH
Confidence 35888988642 233456688999999999999999999999999999999999999999999976432 5888999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC----CceeeccceecccccCcccccc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID----RTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+.++.||+.||.|||+++ |+||||||+||+++ ++.+||+|||++...... .........|++.|+|||++.+
T Consensus 133 ~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 133 RQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred HHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhh
Confidence 999999999999999999 99999999999998 689999999987643211 1112233458899999999875
Q ss_pred ---------CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 157 ---------SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 157 ---------~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
..++.++||||||+++|+|++|..|+............... .......+..+.+++.+||+.||.+||
T Consensus 209 ~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 288 (319)
T 2y4i_B 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERP 288 (319)
T ss_dssp BSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSC
T ss_pred ccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCc
Confidence 34788999999999999999999888654332211111100 001112445789999999999999999
Q ss_pred CHHHHHHHHHhhHhhh
Q 044846 225 TMKEVTLELAGIRASI 240 (290)
Q Consensus 225 s~~el~~~l~~~~~~~ 240 (290)
|+.++++.|+.+....
T Consensus 289 t~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 289 TFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CHHHHHHHHTTC----
T ss_pred CHHHHHHHHHHHHHhh
Confidence 9999999999887543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=285.59 Aligned_cols=219 Identities=20% Similarity=0.218 Sum_probs=173.7
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc------ceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEV------PLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||||++... .....+.+.+|+.+++.++||||+++++++..... .++||||+. |+|.+++..
T Consensus 49 ~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------ 121 (353)
T 3coi_A 49 GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL------ 121 (353)
T ss_dssp TEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS------
T ss_pred CCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC------
Confidence 678999998653 34446788999999999999999999999987654 499999996 688877642
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..... ......+|+.|+|||+
T Consensus 122 ~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~ 194 (353)
T 3coi_A 122 KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEV 194 (353)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCC----CccccccCcCcCCHHH
Confidence 4889999999999999999999999 99999999999999999999999999765332 1234567899999999
Q ss_pred ccc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---------------------------------hh
Q 044846 154 FRS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---------------------------------KE 199 (290)
Q Consensus 154 ~~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~ 199 (290)
+.+ ..++.++|||||||++|+|++|..||........ +..... ..
T Consensus 195 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (353)
T 3coi_A 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ 273 (353)
T ss_dssp HSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTT
T ss_pred HhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHH
Confidence 887 6789999999999999999999998865432211 110000 00
Q ss_pred hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 200 AEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 200 ~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.....+..+.+||.+||+.||++|||+.|++++.+-
T Consensus 274 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 274 LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 011335679999999999999999999999987553
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=286.06 Aligned_cols=223 Identities=19% Similarity=0.202 Sum_probs=176.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC-----------CCceeeEEeEEEeCC----cceEEEEeCCCCCHHHHHh
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN-----------HRNVVKILGCCLETE----VPLLVYEFIPNGSLYQYIH 66 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpniv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~ 66 (290)
|+.||+|+++. +....+.+.+|+++++.++ ||||+++++++...+ ..++|||++ +++|.+++.
T Consensus 44 ~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~ 121 (373)
T 1q8y_A 44 NTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIK 121 (373)
T ss_dssp TEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHH
T ss_pred CcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHH
Confidence 67899999874 3445667889999999886 899999999998654 789999999 899999998
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEecc------CCcEEEeccccccccccCCceee
Q 044846 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVD------KYQAKISDFRTFKSRAIDRTHLT 139 (290)
Q Consensus 67 ~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~------~~~~kl~dfg~~~~~~~~~~~~~ 139 (290)
..... .+++..+..++.||+.||.|||++ + |+||||||+|||++. .+.+||+|||++..... ..
T Consensus 122 ~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~----~~ 192 (373)
T 1q8y_A 122 KYEHR--GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HY 192 (373)
T ss_dssp HTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB----CC
T ss_pred Hhhcc--CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCC----CC
Confidence 75432 588999999999999999999998 8 999999999999953 34799999999865432 12
Q ss_pred ccceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhh-----hhhhHHHh------------------
Q 044846 140 TQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE-----NRSLAAYF------------------ 196 (290)
Q Consensus 140 ~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~-----~~~~~~~~------------------ 196 (290)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+....
T Consensus 193 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 272 (373)
T 1q8y_A 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTR 272 (373)
T ss_dssp CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHH
T ss_pred CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhh
Confidence 3356899999999999999999999999999999999999988643210 00000000
Q ss_pred --------------------------hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 197 --------------------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 197 --------------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
....+...+..+.+||.+||+.||++|||+.|++++.+-
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 337 (373)
T 1q8y_A 273 TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337 (373)
T ss_dssp HHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGG
T ss_pred hhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhh
Confidence 001124566789999999999999999999999987653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=285.63 Aligned_cols=222 Identities=19% Similarity=0.200 Sum_probs=154.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHH-HHHhcCCCceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVV-ILSQINHRNVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~-~l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||+|++... . ...+|+. .++.+.||||+++++++.. ....++||||+++|+|.+++...... .++
T Consensus 54 ~~~vavK~~~~~-~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~--~l~ 126 (336)
T 3fhr_A 54 GQKCALKLLYDS-P----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ--AFT 126 (336)
T ss_dssp CCEEEEEEEESS-H----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CC--CCB
T ss_pred CCEEEEEEecCc-H----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCC--CCC
Confidence 678999998642 1 1223333 4556799999999999976 44589999999999999999875432 589
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
+..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||+++.... .......+|+.|+|||+
T Consensus 127 ~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~t~~y~aPE~ 200 (336)
T 3fhr_A 127 EREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPCYTPYYVAPEV 200 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccc---cccccCCCCcCccChhh
Confidence 9999999999999999999999 999999999999986 45599999999864332 22234567899999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHH-------hhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAY-------FSKEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
+.+..++.++||||||+++|+|++|..||.......... ... .........+..+.+||.+||+.||.+||
T Consensus 201 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 280 (336)
T 3fhr_A 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL 280 (336)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCc
Confidence 988889999999999999999999999886443221100 000 00111123466799999999999999999
Q ss_pred CHHHHHHHHHhh
Q 044846 225 TMKEVTLELAGI 236 (290)
Q Consensus 225 s~~el~~~l~~~ 236 (290)
|+.|++++.+-.
T Consensus 281 t~~ell~hp~~~ 292 (336)
T 3fhr_A 281 TITQFMNHPWIN 292 (336)
T ss_dssp CHHHHHHSHHHH
T ss_pred CHHHHhcCcccc
Confidence 999999987644
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=283.46 Aligned_cols=218 Identities=22% Similarity=0.244 Sum_probs=173.0
Q ss_pred CceEEEEeecccCc------hhHHHHHHHHHHHHhc----CCCceeeEEeEEEeCCcceEEEEe-CCCCCHHHHHhhcCC
Q 044846 2 EELWLLKKSKSVHE------SNVEQFINEVVILSQI----NHRNVVKILGCCLETEVPLLVYEF-IPNGSLYQYIHEQTD 70 (290)
Q Consensus 2 ~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l----~Hpniv~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~ 70 (290)
|+.||+|+++.... .....+.+|+.++.++ +||||+++++++...+..++|||+ +.+++|.+++....
T Consensus 56 ~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~- 134 (312)
T 2iwi_A 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG- 134 (312)
T ss_dssp CCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-
T ss_pred CeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-
Confidence 67899999865432 2334566799999998 899999999999999999999999 78999999998765
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec-cCCcEEEeccccccccccCCceeeccceeccccc
Q 044846 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYV 149 (290)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 149 (290)
.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++...... ......|+..|+
T Consensus 135 ---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~ 205 (312)
T 2iwi_A 135 ---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVYS 205 (312)
T ss_dssp ---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSS---CBCCCCSCTTTS
T ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccC---cccccCCccccc
Confidence 5899999999999999999999999 99999999999999 8899999999997654322 223456889999
Q ss_pred CccccccCCCC-CcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 150 DPKYFRSSQFT-EKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 150 aPE~~~~~~~~-~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
|||++.+..+. .++||||||+++|+|++|..+|........ . ........+..+.++|.+||+.||++|||+.|
T Consensus 206 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 280 (312)
T 2iwi_A 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE---A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEE 280 (312)
T ss_dssp CHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH---T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh---h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999877764 489999999999999999998854322111 0 11112234567899999999999999999999
Q ss_pred HHHHHH
Q 044846 229 VTLELA 234 (290)
Q Consensus 229 l~~~l~ 234 (290)
++++.+
T Consensus 281 ~l~~~~ 286 (312)
T 2iwi_A 281 ILLDPW 286 (312)
T ss_dssp HHHSTT
T ss_pred HhcChh
Confidence 998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=283.95 Aligned_cols=230 Identities=20% Similarity=0.204 Sum_probs=160.7
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHH-HHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcC-CCCCCCCHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVV-ILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT-DDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~-~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~ 78 (290)
|+.||+|+++.. .......+..|+. +++.++||||+++++++...+..++||||+. |+|.+++.... .....+++.
T Consensus 47 ~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~ 125 (327)
T 3aln_A 47 GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEE 125 (327)
T ss_dssp TEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHH
T ss_pred CCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHH
Confidence 678999999754 3444556777777 6667799999999999999999999999996 58888876421 111258899
Q ss_pred HHHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccc---
Q 044846 79 MRLRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF--- 154 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~--- 154 (290)
.+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++..... .......|+..|+|||++
T Consensus 126 ~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~ 200 (327)
T 3aln_A 126 ILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPERIDPS 200 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------
T ss_pred HHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccc--cccccCCCCccccCceeeccc
Confidence 9999999999999999998 8 999999999999999999999999997654321 122334688999999998
Q ss_pred -ccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh-------hhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 155 -RSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK-------EAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 155 -~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
.+..++.++||||||+++|+|++|..|+................ ......+..+.+|+.+||+.||.+|||+
T Consensus 201 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 280 (327)
T 3aln_A 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY 280 (327)
T ss_dssp -----CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCH
Confidence 45668999999999999999999998886432221111111111 0112345679999999999999999999
Q ss_pred HHHHHHHHhhH
Q 044846 227 KEVTLELAGIR 237 (290)
Q Consensus 227 ~el~~~l~~~~ 237 (290)
.+++++.+-..
T Consensus 281 ~ell~hp~~~~ 291 (327)
T 3aln_A 281 KELLKHPFILM 291 (327)
T ss_dssp HHHTTSHHHHH
T ss_pred HHHHhChHHHH
Confidence 99998765544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=278.12 Aligned_cols=225 Identities=19% Similarity=0.257 Sum_probs=166.2
Q ss_pred CceEEEEeecccCc-hhHHH-HHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHE-SNVEQ-FINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~-~~~~~-~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||+|+++.... ....+ +..+..+++.++||||+++++++...+..++||||+ ++.+..+...... .+++..
T Consensus 50 ~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~---~~~~~~ 125 (318)
T 2dyl_A 50 GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG---PIPERI 125 (318)
T ss_dssp CCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTS---CCCHHH
T ss_pred CeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhcc---CCCHHH
Confidence 67899999975432 22333 444455677789999999999999999999999999 5566666554332 589999
Q ss_pred HHHHHHHHHHHHHHHhhC-CCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc---
Q 044846 80 RLRITVEVSRVLSYLHSV-ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR--- 155 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~-~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--- 155 (290)
+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++...... .......+++.|+|||++.
T Consensus 126 ~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 200 (318)
T 2dyl_A 126 LGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--KAKDRSAGCAAYMAPERIDPPD 200 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----------------CCTTCCHHHHC---
T ss_pred HHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC--ccccccCCCccccChhhccccc
Confidence 999999999999999995 8 999999999999999999999999997643321 2223456889999999985
Q ss_pred --cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhh-----hhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 156 --SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKE-----AEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 156 --~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
...++.++||||||+++|+|++|..||................. .....+..+.++|.+||+.||.+|||+.+
T Consensus 201 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 280 (318)
T 2dyl_A 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280 (318)
T ss_dssp -----CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred ccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 45688899999999999999999988864322222222221111 11124567999999999999999999999
Q ss_pred HHHHHHh
Q 044846 229 VTLELAG 235 (290)
Q Consensus 229 l~~~l~~ 235 (290)
++++..-
T Consensus 281 ll~h~~~ 287 (318)
T 2dyl_A 281 LLEHSFI 287 (318)
T ss_dssp HTTSHHH
T ss_pred HhhCHHH
Confidence 9987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=284.56 Aligned_cols=218 Identities=20% Similarity=0.243 Sum_probs=177.4
Q ss_pred CceEEEEeecccCc------hhHHHHHHHHHHHHhcC--CCceeeEEeEEEeCCcceEEEEeCCC-CCHHHHHhhcCCCC
Q 044846 2 EELWLLKKSKSVHE------SNVEQFINEVVILSQIN--HRNVVKILGCCLETEVPLLVYEFIPN-GSLYQYIHEQTDDQ 72 (290)
Q Consensus 2 ~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l~--Hpniv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~ 72 (290)
|+.||+|+++.... ...+.+.+|+.+++.++ ||||+++++++...+..++|||++.+ ++|.+++....
T Consensus 68 ~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--- 144 (320)
T 3a99_A 68 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--- 144 (320)
T ss_dssp TEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---
T ss_pred CcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC---
Confidence 67899999864322 12345778999999995 69999999999999999999999975 89999998764
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec-cCCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.... .......||+.|+||
T Consensus 145 -~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~---~~~~~~~gt~~y~aP 217 (320)
T 3a99_A 145 -ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPP 217 (320)
T ss_dssp -SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCS---SCBCCCCSCGGGSCH
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccccc---ccccCCCCCccCCCh
Confidence 5899999999999999999999999 99999999999999 789999999999765432 122345689999999
Q ss_pred cccccCCC-CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 152 KYFRSSQF-TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 152 E~~~~~~~-~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
|++.+..+ +.++||||||+++|+|++|..||......... ........+..+.+||.+||+.||++|||+.|++
T Consensus 218 E~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 292 (320)
T 3a99_A 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG-----QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 292 (320)
T ss_dssp HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC-----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcc-----cccccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 99987765 67899999999999999999988543221110 0111123456789999999999999999999998
Q ss_pred HHHH
Q 044846 231 LELA 234 (290)
Q Consensus 231 ~~l~ 234 (290)
++.+
T Consensus 293 ~hp~ 296 (320)
T 3a99_A 293 NHPW 296 (320)
T ss_dssp TSGG
T ss_pred cCHh
Confidence 7654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=299.61 Aligned_cols=216 Identities=19% Similarity=0.261 Sum_probs=171.5
Q ss_pred CceEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCc-----ceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLETEV-----PLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||++.. ......+.+.+|+++++.++||||+++++++...+. .||||||++|++|.+++.. .+
T Consensus 106 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l 179 (681)
T 2pzi_A 106 GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KL 179 (681)
T ss_dssp TEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C------CC
T ss_pred CcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC------CC
Confidence 57899998864 334556788999999999999999999999988765 6999999999999987753 48
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++..... ....||+.|+|||++.
T Consensus 180 ~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~ 250 (681)
T 2pzi_A 180 PVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVR 250 (681)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC-----CccCCCccccCHHHHc
Confidence 89999999999999999999999 9999999999999875 8999999998654322 3456899999999987
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPT-MKEVTLELA 234 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~el~~~l~ 234 (290)
+. ++.++|||||||++|+|++|.+++........ .........+..+.+||.+||+.||.+||+ ++++...|.
T Consensus 251 ~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 251 TG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp HC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 65 48899999999999999999887653221110 011122234567899999999999999996 566666666
Q ss_pred hhHh
Q 044846 235 GIRA 238 (290)
Q Consensus 235 ~~~~ 238 (290)
.+..
T Consensus 325 ~~~~ 328 (681)
T 2pzi_A 325 GVLR 328 (681)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=296.68 Aligned_cols=224 Identities=21% Similarity=0.239 Sum_probs=176.7
Q ss_pred CceEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe------CCcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLE------TEVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||+|+++. ......+.+.+|+++++.++||||+++++++.. .+..++|||||++|+|.+++...... ..
T Consensus 39 g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~-~~ 117 (676)
T 3qa8_A 39 GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC-CG 117 (676)
T ss_dssp TCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT-TC
T ss_pred CcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccC-CC
Confidence 67899999875 345567789999999999999999999998765 67789999999999999999875432 25
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCc---EEEeccccccccccCCceeeccceecccccCc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ---AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++...... .......|++.|+||
T Consensus 118 lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~--~~~~~~~gt~~Y~AP 192 (676)
T 3qa8_A 118 LKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAP 192 (676)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC--CCCCCCCSCCTTCSS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccccccccccc--cccccccCCcccCCh
Confidence 888899999999999999999999 999999999999997665 899999998654322 223446789999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh-------------hHHHh------------hhhhhHHHHH
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS-------------LAAYF------------SKEAEKEEVI 206 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~-------------~~~~~------------~~~~~~~~~~ 206 (290)
|++.+..++.++||||||+++|+|++|..||......... ..... ........+.
T Consensus 193 E~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~ 272 (676)
T 3qa8_A 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG 272 (676)
T ss_dssp CSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHH
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhH
Confidence 9999999999999999999999999999888543111000 00000 0011223567
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
.+.++|.+||..||++|||+.+++.
T Consensus 273 ~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 273 KLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp HHHHHHHHHSCSSCC---CCTTCCC
T ss_pred HHHHHHHHHccCCHhhCcCHHHHhc
Confidence 8999999999999999999988653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=264.09 Aligned_cols=200 Identities=13% Similarity=0.071 Sum_probs=161.9
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++... ....+.+.+|+.++..++||||+++++++...+..|+||||++|++|.+++... ....
T Consensus 56 ~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~------~~~~ 129 (286)
T 3uqc_A 56 DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPV 129 (286)
T ss_dssp TEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC------CCHH
T ss_pred CceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC------CChH
Confidence 6789999997533 344678999999999999999999999999999999999999999999999642 3455
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.+..++.|++.||.|||+++ |+||||||+|||++.++.+||++++. ++ .
T Consensus 130 ~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~---------------------~~-------~ 178 (286)
T 3uqc_A 130 GAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT---------------------MP-------D 178 (286)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC---------------------CT-------T
T ss_pred HHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc---------------------cC-------C
Confidence 67889999999999999999 99999999999999999999986543 22 3
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhh------hHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS------LAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~------~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
++.++|||||||++|+|++|..||......... ...... .......+..+.+||.+||+.||++| |+.|++
T Consensus 179 ~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~ 257 (286)
T 3uqc_A 179 ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLL 257 (286)
T ss_dssp CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHH
T ss_pred CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHH
Confidence 688999999999999999999888654321100 000000 11112345679999999999999999 999999
Q ss_pred HHHHhhHhh
Q 044846 231 LELAGIRAS 239 (290)
Q Consensus 231 ~~l~~~~~~ 239 (290)
+.|+.+...
T Consensus 258 ~~L~~~~~~ 266 (286)
T 3uqc_A 258 NLMQQATAV 266 (286)
T ss_dssp HHHHHHHC-
T ss_pred HHHHHHhcc
Confidence 999988654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=265.39 Aligned_cols=203 Identities=21% Similarity=0.280 Sum_probs=160.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHH-hcCCCceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILS-QINHRNVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~-~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||+|+++. ...+.+|+.++. .++||||+++++++.. ....++||||+++|+|.+++...... .++
T Consensus 43 ~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~ 115 (299)
T 3m2w_A 43 QEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--AFT 115 (299)
T ss_dssp CCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTC--CCB
T ss_pred CcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCC--CCC
Confidence 67899999864 235678999884 4599999999999987 67889999999999999999875432 589
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
+..++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||++....
T Consensus 116 ~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--------------------- 171 (299)
T 3m2w_A 116 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--------------------- 171 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------
Confidence 9999999999999999999999 999999999999998 7889999999864321
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHH-------hhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAY-------FSKEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
+..++.++|||||||++|+|++|..||......... .... .........+..+.+|+.+||+.||.+||
T Consensus 172 --~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 249 (299)
T 3m2w_A 172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 249 (299)
T ss_dssp --TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred --cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC
Confidence 234677899999999999999999988543321110 0000 00111123467799999999999999999
Q ss_pred CHHHHHHHHHhhH
Q 044846 225 TMKEVTLELAGIR 237 (290)
Q Consensus 225 s~~el~~~l~~~~ 237 (290)
|+.|++++.+-..
T Consensus 250 s~~e~l~hp~~~~ 262 (299)
T 3m2w_A 250 TITEFMNHPWIMQ 262 (299)
T ss_dssp CHHHHHTSHHHHT
T ss_pred CHHHHhcChhhcc
Confidence 9999998866443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.85 Aligned_cols=219 Identities=13% Similarity=0.160 Sum_probs=160.8
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCC-Cceee---------------------EEeEEEe-----CCcceE
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINH-RNVVK---------------------ILGCCLE-----TEVPLL 51 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~H-pniv~---------------------~~~~~~~-----~~~~~l 51 (290)
|+.||||+++... ....+.+.+|+.+++.+.| +|... +...+.. ....++
T Consensus 103 g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (413)
T 3dzo_A 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182 (413)
T ss_dssp CCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEE
T ss_pred CCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEE
Confidence 7889999987332 2336789999999999977 22111 1111111 123567
Q ss_pred EEEeCCCCCHHHHHhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccc
Q 044846 52 VYEFIPNGSLYQYIHEQ---TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 52 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
+|+++ +++|.+++... ......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 183 ~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a 258 (413)
T 3dzo_A 183 LYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL 258 (413)
T ss_dssp EEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred Eeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccce
Confidence 77776 78999998522 112225778889999999999999999999 999999999999999999999999997
Q ss_pred cccccCCceeeccceecccccCcccc----------ccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh
Q 044846 129 KSRAIDRTHLTTQVKVTFGYVDPKYF----------RSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK 198 (290)
Q Consensus 129 ~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~ 198 (290)
+.... ......| +.|+|||++ ....++.++|||||||++|+|++|..||........ .......
T Consensus 259 ~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~-~~~~~~~ 332 (413)
T 3dzo_A 259 VRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG-SEWIFRS 332 (413)
T ss_dssp EETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC-SGGGGSS
T ss_pred eecCC----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh-HHHHHhh
Confidence 65332 1344566 899999999 555688899999999999999999998865432211 1111111
Q ss_pred hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 199 EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 199 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
....+..+.+||.+||+.||++|||+.+++++
T Consensus 333 --~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 333 --CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp --CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11335679999999999999999999999876
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=272.30 Aligned_cols=212 Identities=13% Similarity=0.079 Sum_probs=162.9
Q ss_pred CceEEEEeecccC--------chhHHHHHHHHHHHHhcC---------CCceeeEEeEEE-----------------e--
Q 044846 2 EELWLLKKSKSVH--------ESNVEQFINEVVILSQIN---------HRNVVKILGCCL-----------------E-- 45 (290)
Q Consensus 2 ~~~~avK~~~~~~--------~~~~~~~~~E~~~l~~l~---------Hpniv~~~~~~~-----------------~-- 45 (290)
|+.||||+++... ....+.+.+|+.+++.|+ |||||++.+.+. .
T Consensus 43 ~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~ 122 (336)
T 2vuw_A 43 HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122 (336)
T ss_dssp TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHT
T ss_pred CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhc
Confidence 6789999997542 334578999999999886 667766666543 2
Q ss_pred -----------CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEeccCCCCceE
Q 044846 46 -----------TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLH-SVASIPIYHLDIKSANIL 113 (290)
Q Consensus 46 -----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH-~~~~~~iiHrdlkp~Nil 113 (290)
.+..|||||||++|++.+.+... .+++..++.++.||+.||.||| +++ |+||||||+|||
T Consensus 123 ~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NIL 194 (336)
T 2vuw_A 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVL 194 (336)
T ss_dssp CCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEE
T ss_pred cccccCccccccCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEE
Confidence 67899999999999777766442 4899999999999999999999 899 999999999999
Q ss_pred eccCC--------------------cEEEeccccccccccCCceeeccceecccccCccccccCCCCCcccchhhHHH-H
Q 044846 114 LVDKY--------------------QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVV-L 172 (290)
Q Consensus 114 ~~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~i-l 172 (290)
++.++ .+||+|||+++.... ....||+.|+|||++.+.. +.++||||+|++ .
T Consensus 195 l~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~ 267 (336)
T 2vuw_A 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKEN 267 (336)
T ss_dssp EEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHH
T ss_pred EeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhhhcCCC-ccceehhhhhCCCC
Confidence 99887 899999999875432 2357899999999998766 889999998877 6
Q ss_pred HHHhcCCCCcccchhhhhhhHHHh---------hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHH
Q 044846 173 VELNWTKPIHLVDVEENRSLAAYF---------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT-LEL 233 (290)
Q Consensus 173 ~~l~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~-~~l 233 (290)
++++.|..|+.............. ........+.++.+||.+||+.| |+.|++ +|.
T Consensus 268 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp 333 (336)
T 2vuw_A 268 NNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHS 333 (336)
T ss_dssp TTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCG
T ss_pred cccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCC
Confidence 667778877743211011111111 12234467788999999999977 999998 664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=280.15 Aligned_cols=166 Identities=19% Similarity=0.164 Sum_probs=125.8
Q ss_pred CceEEEEeeccc----------CchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC
Q 044846 2 EELWLLKKSKSV----------HESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD 70 (290)
Q Consensus 2 ~~~~avK~~~~~----------~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 70 (290)
|+.||+|.+... .+...++|.+|+++|+++ .|+||+++++++.+++..|||||||+||+|.++|....
T Consensus 259 g~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~- 337 (569)
T 4azs_A 259 GEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE- 337 (569)
T ss_dssp CSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-
T ss_pred cceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-
Confidence 678999998532 123456799999999999 79999999999999999999999999999999998765
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccC
Q 044846 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVD 150 (290)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 150 (290)
+++.. .++.||+.||.|+|++| ||||||||+|||++.+|++||+|||+++...... ....+..||+.|+|
T Consensus 338 ---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmA 407 (569)
T 4azs_A 338 ---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFV 407 (569)
T ss_dssp ---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHH
T ss_pred ---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC-ccccCceechhhcc
Confidence 56654 47899999999999999 9999999999999999999999999987654322 23345779999999
Q ss_pred ccccccCCCCCcccchhhHHHHHHHhcCC
Q 044846 151 PKYFRSSQFTEKSDVYSFSVVLVELNWTK 179 (290)
Q Consensus 151 PE~~~~~~~~~~~DiwS~G~il~~l~~~~ 179 (290)
||++.+. +..++|+||+|++++++.++.
T Consensus 408 PE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 408 NELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHC------------------CCCCTTH
T ss_pred HHHhCCC-CCCcccccccccchhhhcccc
Confidence 9998754 667899999999988875544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=214.51 Aligned_cols=162 Identities=13% Similarity=0.134 Sum_probs=129.9
Q ss_pred CceEEEEeecccCc--------hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKSVHE--------SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~~~~--------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
++.+++|+...... ...+++.+|++++++++||||+++..++...+..|||||||++|+|.+++..
T Consensus 359 ~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------ 432 (540)
T 3en9_A 359 DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED------ 432 (540)
T ss_dssp SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT------
T ss_pred CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH------
Confidence 56678887643211 1245689999999999999999766666678888999999999999999875
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce------eeccceeccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH------LTTQVKVTFG 147 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~ 147 (290)
+..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++........ ......||+.
T Consensus 433 ------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~ 501 (540)
T 3en9_A 433 ------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHH 501 (540)
T ss_dssp ------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCG
T ss_pred ------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCC
Confidence 3478999999999999999 999999999999998 9999999998765432111 1235678999
Q ss_pred ccCcccccc--CCCCCcccchhhHHHHHHHhcCCC
Q 044846 148 YVDPKYFRS--SQFTEKSDVYSFSVVLVELNWTKP 180 (290)
Q Consensus 148 y~aPE~~~~--~~~~~~~DiwS~G~il~~l~~~~~ 180 (290)
|+|||++.. ..|+..+|+||.++-..+-+.++.
T Consensus 502 y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~ 536 (540)
T 3en9_A 502 EKFDEIWERFLEGYKSVYDRWEIILELMKDVERRA 536 (540)
T ss_dssp GGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCS
T ss_pred cCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcc
Confidence 999999987 567888999998887666554443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-21 Score=166.96 Aligned_cols=121 Identities=17% Similarity=0.087 Sum_probs=96.1
Q ss_pred CceEEEEeecccCc------------------hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHH
Q 044846 2 EELWLLKKSKSVHE------------------SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQ 63 (290)
Q Consensus 2 ~~~~avK~~~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~ 63 (290)
|+.||+|+++.... .....+.+|+++|+.++ | +++.+++.. +..++||||++||+|.+
T Consensus 114 g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~ 189 (282)
T 1zar_A 114 FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR 189 (282)
T ss_dssp TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG
T ss_pred CCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH
Confidence 67899999864322 13567899999999998 4 666665544 56799999999999988
Q ss_pred HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccce
Q 044846 64 YIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVK 143 (290)
Q Consensus 64 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 143 (290)
+.. .....++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||+++.
T Consensus 190 -l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~------------- 241 (282)
T 1zar_A 190 -VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE------------- 241 (282)
T ss_dssp -CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEE-------------
T ss_pred -cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeE-------------
Confidence 421 123468999999999999999 99999999999999 99999999999752
Q ss_pred ecccccCccccc
Q 044846 144 VTFGYVDPKYFR 155 (290)
Q Consensus 144 g~~~y~aPE~~~ 155 (290)
+..++|||++.
T Consensus 242 -~~~~~a~e~l~ 252 (282)
T 1zar_A 242 -VGEEGWREILE 252 (282)
T ss_dssp -TTSTTHHHHHH
T ss_pred -CCCCCHHHHHH
Confidence 33478888874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.8e-17 Score=138.84 Aligned_cols=96 Identities=19% Similarity=0.141 Sum_probs=75.9
Q ss_pred HHHHHHHHHHHhcCCCce--eeEEeEEEeCCcceEEEEeCCC-C----CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 044846 19 EQFINEVVILSQINHRNV--VKILGCCLETEVPLLVYEFIPN-G----SLYQYIHEQTDDQLPITWEMRLRITVEVSRVL 91 (290)
Q Consensus 19 ~~~~~E~~~l~~l~Hpni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l 91 (290)
..+.+|+.+|..|.|+++ +..++. +..+|||||+.+ | +|.++... .++..+..++.|++.||
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l 183 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENV 183 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHH
Confidence 367899999999987754 344432 367899999942 3 77776543 12345678999999999
Q ss_pred HHHh-hCCCCCeEeccCCCCceEeccCCcEEEeccccccc
Q 044846 92 SYLH-SVASIPIYHLDIKSANILLVDKYQAKISDFRTFKS 130 (290)
Q Consensus 92 ~ylH-~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~ 130 (290)
.||| +.+ |+||||||+|||++. .++|+|||++..
T Consensus 184 ~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 184 KRLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp HHHHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred HHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999 998 999999999999988 899999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-14 Score=128.57 Aligned_cols=93 Identities=13% Similarity=0.155 Sum_probs=65.4
Q ss_pred HHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 044846 23 NEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPI 102 (290)
Q Consensus 23 ~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~i 102 (290)
+|...|.+|.+.++. ....+.. ...+|||||+.|++|..+.. . .....++.|++.+|.|||..+ |
T Consensus 162 kE~~nL~rL~~~gv~-vp~p~~~-~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~g---I 226 (397)
T 4gyi_A 162 KEFAFMKALYEEGFP-VPEPIAQ-SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHG---L 226 (397)
T ss_dssp HHHHHHHHHHHTTCS-CCCEEEE-ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHHhcCCC-CCeeeec-cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCC---C
Confidence 456666666433321 1111111 23479999999888765432 1 123467899999999999999 9
Q ss_pred EeccCCCCceEeccCC----------cEEEeccccccc
Q 044846 103 YHLDIKSANILLVDKY----------QAKISDFRTFKS 130 (290)
Q Consensus 103 iHrdlkp~Nil~~~~~----------~~kl~dfg~~~~ 130 (290)
|||||||.|||++.++ .+.|+||+.+..
T Consensus 227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 9999999999998776 489999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=6.8e-12 Score=105.62 Aligned_cols=118 Identities=15% Similarity=0.083 Sum_probs=90.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.+++|............+.+|+++++.| .+..++++++++...+..|+|||+++|.+|.+.... ....
T Consensus 37 ~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~ 107 (263)
T 3tm0_A 37 NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---------EQSP 107 (263)
T ss_dssp SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT---------TTCH
T ss_pred CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC---------cccH
Confidence 467889998753222334588999999999 577888999999988899999999999998876321 1123
Q ss_pred HHHHHHHHHHHHHHhhCC--------------------------------------------------------CCCeEe
Q 044846 81 LRITVEVSRVLSYLHSVA--------------------------------------------------------SIPIYH 104 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~--------------------------------------------------------~~~iiH 104 (290)
..++.+++.+|..||+.. +..++|
T Consensus 108 ~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~H 187 (263)
T 3tm0_A 108 EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSH 187 (263)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEEC
T ss_pred HHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEEC
Confidence 467889999999999811 123899
Q ss_pred ccCCCCceEeccCCcEEEeccccc
Q 044846 105 LDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 105 rdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
+|++|.||+++....+.|+||+.+
T Consensus 188 gDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 188 GDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SSCCTTSEEEETTEEEEECCCTTC
T ss_pred CCCCcCcEEEECCcEEEEEEchhc
Confidence 999999999987655679999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.06 E-value=3.6e-10 Score=94.49 Aligned_cols=112 Identities=15% Similarity=0.193 Sum_probs=82.2
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCc--eeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRN--VVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.+++|..... ....+.+|+.+++.+.+.+ ++++++++...+..++||||++|.+|. .. ..+
T Consensus 44 g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~-------~~~--- 108 (264)
T 1nd4_A 44 RPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS-------HLA--- 108 (264)
T ss_dssp SCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS-------CCC---
T ss_pred CCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC-------cCC---
Confidence 456888887643 2245778999999994333 567888888877889999999998874 21 111
Q ss_pred HHHHHHHHHHHHHHHhhCC-------------------------------------------------------CCCeEe
Q 044846 80 RLRITVEVSRVLSYLHSVA-------------------------------------------------------SIPIYH 104 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~-------------------------------------------------------~~~iiH 104 (290)
...++.+++..|..||... +..++|
T Consensus 109 ~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H 188 (264)
T 1nd4_A 109 PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTH 188 (264)
T ss_dssp HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEEC
T ss_pred HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEEC
Confidence 1246677888888888643 112999
Q ss_pred ccCCCCceEeccCCcEEEeccccc
Q 044846 105 LDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 105 rdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
+|++|.||+++.++.+.|+||+.+
T Consensus 189 gDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 189 GDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp SSCCGGGEEEETTEEEEECCCTTC
T ss_pred CCCCCCcEEEECCcEEEEEcchhc
Confidence 999999999987766779999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.2e-09 Score=96.19 Aligned_cols=122 Identities=16% Similarity=0.252 Sum_probs=88.4
Q ss_pred ceEEEEeec--ccC-chhHHHHHHHHHHHHhcC--CCceeeEEeEEEeC---CcceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 3 ELWLLKKSK--SVH-ESNVEQFINEVVILSQIN--HRNVVKILGCCLET---EVPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 3 ~~~avK~~~--~~~-~~~~~~~~~E~~~l~~l~--Hpniv~~~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
+.+++|+.. ... ......+.+|..+++.|. +..+++++.++.+. +..|+||||++|..+.+... ..
T Consensus 62 ~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~------~~ 135 (359)
T 3dxp_A 62 QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSL------PG 135 (359)
T ss_dssp CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTC------TT
T ss_pred ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCcc------cc
Confidence 456777765 322 122346788999999995 45688889888776 45899999999877643111 13
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------------------------C
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVA-------------------------------------------------------S 99 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~-------------------------------------------------------~ 99 (290)
++......++.+++..|..||... +
T Consensus 136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 215 (359)
T 3dxp_A 136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL 215 (359)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence 677888889999999999999731 2
Q ss_pred CCeEeccCCCCceEeccCCc--EEEeccccccc
Q 044846 100 IPIYHLDIKSANILLVDKYQ--AKISDFRTFKS 130 (290)
Q Consensus 100 ~~iiHrdlkp~Nil~~~~~~--~kl~dfg~~~~ 130 (290)
..++|+|+++.||+++.++. +.|+||+.+..
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 34999999999999997753 68999998653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.9e-09 Score=92.73 Aligned_cols=171 Identities=19% Similarity=0.244 Sum_probs=105.7
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhc-CCCc--eeeEEeEEEeCC---cceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQI-NHRN--VVKILGCCLETE---VPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpn--iv~~~~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
+.+++|+-.. ......+.+|.++|+.+ .+.. +.+.+......+ ..|+|||+++|.+|...... .++
T Consensus 41 ~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~------~l~ 112 (304)
T 3sg8_A 41 RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN------NLP 112 (304)
T ss_dssp TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH------TSC
T ss_pred CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc------cCC
Confidence 4577887653 24466788999999988 4332 344554443333 35899999999888654331 366
Q ss_pred HHHHHHHHHHHHHHHHHHhhCC-------------------------------------------------------CCC
Q 044846 77 WEMRLRITVEVSRVLSYLHSVA-------------------------------------------------------SIP 101 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~-------------------------------------------------------~~~ 101 (290)
...+..++.+++..|..||... ...
T Consensus 113 ~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 192 (304)
T 3sg8_A 113 KQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPC 192 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCE
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCce
Confidence 6777788888888888888511 123
Q ss_pred eEeccCCCCceEecc--CCcEEEeccccccccccCCce--eecc-----------ceecccccC-ccccccCCCCCcccc
Q 044846 102 IYHLDIKSANILLVD--KYQAKISDFRTFKSRAIDRTH--LTTQ-----------VKVTFGYVD-PKYFRSSQFTEKSDV 165 (290)
Q Consensus 102 iiHrdlkp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~--~~~~-----------~~g~~~y~a-PE~~~~~~~~~~~Di 165 (290)
++|+|++|.||+++. ...+.|+||+.+......... .... ....+.... |+.... ...-.+.
T Consensus 193 ~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~ 270 (304)
T 3sg8_A 193 LIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKY 270 (304)
T ss_dssp EECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHH
T ss_pred eEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHH
Confidence 899999999999998 456789999876533210000 0000 000000111 111110 0112578
Q ss_pred hhhHHHHHHHhcCCCCcc
Q 044846 166 YSFSVVLVELNWTKPIHL 183 (290)
Q Consensus 166 wS~G~il~~l~~~~~~~~ 183 (290)
|++|.++|.+.+|.+++.
T Consensus 271 ~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 271 WSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHHHcCCHHHH
Confidence 999999999999887553
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=8e-07 Score=74.65 Aligned_cols=116 Identities=18% Similarity=0.185 Sum_probs=83.6
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
+.++||+-... ....+.+|...|+.| .+--+.++++++...+..|+|||+++|.++.+...... ....
T Consensus 51 ~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~--------~~~~ 119 (272)
T 4gkh_A 51 PELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP--------DSGE 119 (272)
T ss_dssp CCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG--------GGHH
T ss_pred eEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH--------HHHH
Confidence 45677776532 345678899999988 34347788889988899999999999988877654321 1223
Q ss_pred HHHHHHHHHHHHHhhCC-------------------------------------------------------CCCeEecc
Q 044846 82 RITVEVSRVLSYLHSVA-------------------------------------------------------SIPIYHLD 106 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~-------------------------------------------------------~~~iiHrd 106 (290)
.+..+++..|.-||... +..++|+|
T Consensus 120 ~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGD 199 (272)
T 4gkh_A 120 NIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGD 199 (272)
T ss_dssp HHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSC
T ss_pred HHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCC
Confidence 45566667777777421 01279999
Q ss_pred CCCCceEeccCCcEEEecccccc
Q 044846 107 IKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 107 lkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
+.+.||+++.++.+-|+||+.+.
T Consensus 200 l~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 200 FSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCeEEEECCeEEEEEECcccc
Confidence 99999999987767799998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.4e-06 Score=74.76 Aligned_cols=120 Identities=14% Similarity=0.193 Sum_probs=79.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCC---ceeeEEeEEE-eCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHR---NVVKILGCCL-ETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hp---niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.+++|+-.. ......+.+|.++|+.|.+. .+.+.+.+.. ..+..++|||+++|.++...... .++.
T Consensus 39 g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~------~l~~ 110 (306)
T 3tdw_A 39 NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA------VLPD 110 (306)
T ss_dssp TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT------TSCH
T ss_pred CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh------hCCH
Confidence 45677887532 34456788999999999542 3556666664 34567899999999888763221 1344
Q ss_pred HHHHHHHHHHHHHHHHHhhC---------------------------------------------------------CCC
Q 044846 78 EMRLRITVEVSRVLSYLHSV---------------------------------------------------------ASI 100 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~---------------------------------------------------------~~~ 100 (290)
.....++.+++..|..||.. .+.
T Consensus 111 ~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~ 190 (306)
T 3tdw_A 111 DAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTP 190 (306)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCC
Confidence 44445555555555555532 122
Q ss_pred CeEeccCCCCceEecc---CCc-EEEecccccc
Q 044846 101 PIYHLDIKSANILLVD---KYQ-AKISDFRTFK 129 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~---~~~-~kl~dfg~~~ 129 (290)
.++|+|+++.||+++. ++. +.|+||+.+.
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3799999999999987 455 4899998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=5.6e-06 Score=72.40 Aligned_cols=61 Identities=3% Similarity=0.047 Sum_probs=39.6
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhc-CC--CceeeEEeEEEeC---CcceEEEEeCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQI-NH--RNVVKILGCCLET---EVPLLVYEFIPNGSLY 62 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l-~H--pniv~~~~~~~~~---~~~~lv~e~~~~g~L~ 62 (290)
|+.+++|.-.... ......+.+|+.+++.| .+ -.+.+++.++... +..|+|||+++|..+.
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 3457777764321 00123567899999888 33 3577788777655 3568999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.0018 Score=55.71 Aligned_cols=29 Identities=28% Similarity=0.295 Sum_probs=25.9
Q ss_pred CCeEeccCCCCceEeccCCcEEEeccccc
Q 044846 100 IPIYHLDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 100 ~~iiHrdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
..++|+|+.+.||+++.++.+.|+||+.+
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 34999999999999988888999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00079 Score=57.73 Aligned_cols=57 Identities=18% Similarity=0.127 Sum_probs=43.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC---CCceeeEEeEEEeCCcceEEEEeCCCCCH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN---HRNVVKILGCCLETEVPLLVYEFIPNGSL 61 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~---Hpniv~~~~~~~~~~~~~lv~e~~~~g~L 61 (290)
++.++||.... .....+..|.+.|+.|. ...+++.+.+....+..++|||++++..+
T Consensus 59 ~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 59 VQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp SCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 34577777653 23567889999999883 35688888888877889999999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0013 Score=52.95 Aligned_cols=98 Identities=15% Similarity=0.009 Sum_probs=63.1
Q ss_pred CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee
Q 044846 59 GSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL 138 (290)
Q Consensus 59 g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 138 (290)
-+|.++|..... ++++++++.++.|.+.+|.-+-..... ..+=+-|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 379999988765 799999999999999998776221100 1222346889999999888664 1110
Q ss_pred eccceecccccCccccccCCCCCcccchhhHHHHHHHh
Q 044846 139 TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELN 176 (290)
Q Consensus 139 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~ 176 (290)
.....|.+||... ...+.+.=|||+|+++|.-+
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~AL 130 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKAL 130 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHH
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHh
Confidence 1122467888763 33456778999999999865
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.001 Score=58.85 Aligned_cols=27 Identities=19% Similarity=0.274 Sum_probs=23.3
Q ss_pred eEeccCCCCceEeccCCcEEEecccccc
Q 044846 102 IYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 102 iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
++|+|+.+.||+++.+ .++++||..+.
T Consensus 229 L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 229 LIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp EECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 9999999999999765 48999997653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0017 Score=55.96 Aligned_cols=29 Identities=24% Similarity=0.403 Sum_probs=25.2
Q ss_pred CeEeccCCCCceEeccC----CcEEEecccccc
Q 044846 101 PIYHLDIKSANILLVDK----YQAKISDFRTFK 129 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~----~~~kl~dfg~~~ 129 (290)
.++|+|+.+.||+++.+ +.+.|+||+.+.
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 49999999999999874 678999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0033 Score=56.07 Aligned_cols=29 Identities=10% Similarity=0.194 Sum_probs=25.3
Q ss_pred CeEeccCCCCceEeccCCcEEEeccccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTFKS 130 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~ 130 (290)
.++|+|+++.|||++.++ ++++||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 399999999999998776 99999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0024 Score=56.23 Aligned_cols=122 Identities=19% Similarity=0.234 Sum_probs=71.5
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHH--------------HHhh
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQ--------------YIHE 67 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~--------------~l~~ 67 (290)
+.+++|+-.. .........+|.++++.| .+.-..++++.+.. .+||||++|.+|.. .+..
T Consensus 83 ~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~ 157 (379)
T 3feg_A 83 REVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQ 157 (379)
T ss_dssp SEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHH
T ss_pred CeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHH
Confidence 5677777532 122355667899999988 44444677776643 39999998754431 1111
Q ss_pred ---cC--CCCCCC-CHHHHHHHHHHHHH-------------------HHHHHh----hC-CCCCeEeccCCCCceEeccC
Q 044846 68 ---QT--DDQLPI-TWEMRLRITVEVSR-------------------VLSYLH----SV-ASIPIYHLDIKSANILLVDK 117 (290)
Q Consensus 68 ---~~--~~~~~~-~~~~~~~~~~~i~~-------------------~l~ylH----~~-~~~~iiHrdlkp~Nil~~~~ 117 (290)
.. ....+. -+.++..+..++.. .+..|. .. .+..++|+|+.+.||+++.+
T Consensus 158 LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~ 237 (379)
T 3feg_A 158 FHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSE 237 (379)
T ss_dssp HHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESC
T ss_pred HhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCC
Confidence 00 001011 23455555544422 233332 22 12338999999999999876
Q ss_pred ----CcEEEecccccc
Q 044846 118 ----YQAKISDFRTFK 129 (290)
Q Consensus 118 ----~~~kl~dfg~~~ 129 (290)
+.+.++||..+.
T Consensus 238 ~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 238 PENADSLMLVDFEYSS 253 (379)
T ss_dssp C---CCEEECCCTTCE
T ss_pred CCccCcEEEEecccCC
Confidence 789999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0017 Score=58.31 Aligned_cols=52 Identities=19% Similarity=0.215 Sum_probs=33.4
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCC
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGS 60 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~ 60 (290)
+.+++|+...... ...+..|..+++.| .+.-.+++++.+.. .+|+||++|.+
T Consensus 106 ~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 106 NKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp SEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred ceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence 5677887743111 24566899999988 34334677766532 38999997633
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0092 Score=50.51 Aligned_cols=28 Identities=21% Similarity=0.108 Sum_probs=23.8
Q ss_pred CeEeccCCCCceEeccCCcEEEecccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
.++|+|+.+.||+ ..++.+.++||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 3899999999999 566788999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.023 Score=47.67 Aligned_cols=55 Identities=15% Similarity=0.119 Sum_probs=36.9
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC-C-C-ceeeEEeEEEeCCcceEEEEeCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN-H-R-NVVKILGCCLETEVPLLVYEFIPNGS 60 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-H-p-niv~~~~~~~~~~~~~lv~e~~~~g~ 60 (290)
|+.|++|+-..........|..|++.|+.|. . + -+++++++ +..++|||++.++.
T Consensus 39 G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 39 GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 6788999876544444456789999999883 2 1 24445543 23479999997654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.27 E-value=0.013 Score=53.01 Aligned_cols=54 Identities=15% Similarity=0.089 Sum_probs=32.7
Q ss_pred ceEEEEeecccCchhHHHHHHHHHHHHhcCCC-ceeeEEeEEEeCCcceEEEEeCCCCCH
Q 044846 3 ELWLLKKSKSVHESNVEQFINEVVILSQINHR-NVVKILGCCLETEVPLLVYEFIPNGSL 61 (290)
Q Consensus 3 ~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hp-niv~~~~~~~~~~~~~lv~e~~~~g~L 61 (290)
+.+++|+.........+ -.+|..+++.|... -.+++++.+. + .+|+||++|.+|
T Consensus 134 ~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 134 AKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred ceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 56778876432222111 14899999998533 3467777763 2 369999987443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.25 E-value=0.032 Score=47.52 Aligned_cols=27 Identities=22% Similarity=0.212 Sum_probs=23.4
Q ss_pred CeEeccCCCCceEeccCCcEEEecccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
.++|+|+++.||+++ + .+.++||+.+.
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 389999999999998 4 89999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0096 Score=51.97 Aligned_cols=28 Identities=25% Similarity=0.381 Sum_probs=23.0
Q ss_pred CeEeccCCCCceEeccCCcEEEecccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
.++|+|+.+.|||++.++ +.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 389999999999997554 8999998654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.26 E-value=0.1 Score=46.47 Aligned_cols=28 Identities=18% Similarity=0.317 Sum_probs=24.6
Q ss_pred CeEeccCCCCceEeccCCcEEEecccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
.++|+|+.+.||+ +.++.+.++||..+.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 3899999999998 778899999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.83 E-value=0.068 Score=45.36 Aligned_cols=29 Identities=17% Similarity=0.258 Sum_probs=24.7
Q ss_pred CeEeccCCCCceEeccCCcEEEecccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
.++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 38999999999999877666899998653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=88.45 E-value=0.41 Score=41.10 Aligned_cols=30 Identities=23% Similarity=0.300 Sum_probs=26.1
Q ss_pred CCeEeccCCCCceEeccCCcEEEecccccc
Q 044846 100 IPIYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 100 ~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
..++|+|+.+.||+++.++.+.++||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 349999999999999988889999997653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=81.36 E-value=0.77 Score=40.36 Aligned_cols=28 Identities=32% Similarity=0.426 Sum_probs=23.5
Q ss_pred eEeccCCCCceEe------ccCCcEEEecccccc
Q 044846 102 IYHLDIKSANILL------VDKYQAKISDFRTFK 129 (290)
Q Consensus 102 iiHrdlkp~Nil~------~~~~~~kl~dfg~~~ 129 (290)
++|+|+.+.|||+ +.+..+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 345679999998754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.06 E-value=4.5 Score=32.29 Aligned_cols=82 Identities=9% Similarity=0.007 Sum_probs=54.8
Q ss_pred CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEeccCCCC
Q 044846 32 NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLRITVEVSRVLS-YLHSVASIPIYHLDIKSA 110 (290)
Q Consensus 32 ~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~-ylH~~~~~~iiHrdlkp~ 110 (290)
.||++. ...-.+.+.+.+.++.-+++.=+..++ .++...+++++..|+.-.. +++. -+|--|.|+
T Consensus 48 ~~~~f~--~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCIV--RDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSSE--EEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCCC--eEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 577772 222345566566666543332223333 3677888888888776655 4433 457789999
Q ss_pred ceEeccCCcEEEecccc
Q 044846 111 NILLVDKYQAKISDFRT 127 (290)
Q Consensus 111 Nil~~~~~~~kl~dfg~ 127 (290)
|++++.++.+++.-.|+
T Consensus 114 NL~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGV 130 (219)
T ss_dssp GEEECTTCCEEESCCEE
T ss_pred eEEEeCCCcEEEEEcCC
Confidence 99999999999998886
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 290 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-38 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-37 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-21 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-20 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-18 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-45
Identities = 49/245 (20%), Positives = 99/245 (40%), Gaps = 20/245 (8%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHE 67
+ ++ F NEV +L + H N++ +G ++ +V ++ SLY ++H
Sbjct: 38 LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHI 96
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
+ + I + ++ + YLH + I H D+KS NI L + KI DF
Sbjct: 97 I---ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGL 150
Query: 128 FKSRA-IDRTHLTTQVKVTFGYVDPKYFRSSQ---FTEKSDVYSFSVVLVEL-------- 175
++ +H Q+ + ++ P+ R ++ +SDVY+F +VL EL
Sbjct: 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210
Query: 176 NWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235
N ++ + L+ S + + CL ++P ++ +
Sbjct: 211 NINNRDQIIFMVGRGYLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
Query: 236 IRASI 240
+ S+
Sbjct: 270 LARSL 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-45
Identities = 53/236 (22%), Positives = 99/236 (41%), Gaps = 25/236 (10%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE--VPLLVYEFIPNGSLYQYIH 66
S+ E+ + ++EV +L ++ H N+V+ ++ +V E+ G L I
Sbjct: 38 DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT 97
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLH--SVASIPIYHLDIKSANILLVDKYQAKISD 124
+ T ++ + E LR+ +++ L H S + H D+K AN+ L K K+ D
Sbjct: 98 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157
Query: 125 FRTFKSRAIDR-THLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP--- 180
F +R ++ T T Y+ P+ + EKSD++S +L EL P
Sbjct: 158 FGL--ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215
Query: 181 -------IHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
+ + R + +S E + + R LNL +P+++E+
Sbjct: 216 AFSQKELAGKIREGKFRRIPYRYSDELNE--------IITRMLNLKDYHRPSVEEI 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-44
Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 11/234 (4%)
Query: 11 KSVHESNV--EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K++ E + E FI E ++ +++H +V++ G CLE LV+EF+ +G L Y+ Q
Sbjct: 35 KTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ 94
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
E L + ++V ++YL + H D+ + N L+ + K+SDF
Sbjct: 95 RG---LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMT 148
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE 188
+ D+ +T K + P+ F S+++ KSDV+SF V++ E+ I +
Sbjct: 149 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208
Query: 189 N---RSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239
+ ++ F + + C + +P + +LA I S
Sbjct: 209 SEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-44
Identities = 45/228 (19%), Positives = 96/228 (42%), Gaps = 9/228 (3%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
KS + + F+ E ++ Q+ H+ +V++ + + ++ E++ NGSL ++
Sbjct: 43 KSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTP 101
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ +L T L + +++ ++++ H D+++ANIL+ D KI+DF
Sbjct: 102 SGIKL--TINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLA 156
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPI---HLVD 185
+ + K + P+ FT KSDV+SF ++L E+ I + +
Sbjct: 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
Query: 186 VEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233
E ++L + + + C + +PT + L
Sbjct: 217 PEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 5e-43
Identities = 49/236 (20%), Positives = 104/236 (44%), Gaps = 29/236 (12%)
Query: 14 HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHEQTDDQ 72
+++ + F+ E +++Q+ H N+V++LG +E + L +V E++ GSL Y+ + +
Sbjct: 40 NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GR 97
Query: 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRA 132
+ + L+ +++V + YL H D+ + N+L+ + AK+SDF
Sbjct: 98 SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDF----GLT 150
Query: 133 IDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-----------NWTKPI 181
+ + K+ + P+ R +F+ KSDV+SF ++L E+ +
Sbjct: 151 KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 210
Query: 182 HLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237
V+ + V K C +L+ +P+ ++ +L I+
Sbjct: 211 PRVEKGYKMDAPDGCPPAVYE--------VMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-41
Identities = 46/223 (20%), Positives = 89/223 (39%), Gaps = 10/223 (4%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT 69
+ + Q I E+ +L + N +V G + E + GSL Q + +
Sbjct: 40 HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 99
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129
I ++ ++++ V + L+YL I H D+K +NIL+ + + K+ DF
Sbjct: 100 ----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV-- 151
Query: 130 SRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIHLVDVEE 188
S + + + V T Y+ P+ + + ++ +SD++S + LVE PI D +E
Sbjct: 152 SGQLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 189 NRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231
+ + E + + +P M L
Sbjct: 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFEL 253
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-41
Identities = 46/248 (18%), Positives = 97/248 (39%), Gaps = 28/248 (11%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT 69
+ +++ E+ + E I+ Q+++ +V+++G C + E +LV E G L++++ +
Sbjct: 45 KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR 103
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129
+ I + +VS + YL H D+ + N+LLV+++ AKISDF K
Sbjct: 104 E---EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSK 157
Query: 130 --SRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-----------N 176
+ K + P+ +F+ +SDV+S+ V + E
Sbjct: 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217
Query: 177 WTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236
+ + ++ + E + C + +P V +
Sbjct: 218 GPEVMAFIEQGKRMECPPECPPELYA--------LMSDCWIYKWEDRPDFLTVEQRMRAC 269
Query: 237 RASIGASV 244
S+ + V
Sbjct: 270 YYSLASKV 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-41
Identities = 43/228 (18%), Positives = 98/228 (42%), Gaps = 9/228 (3%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K+ + E F+ E ++ ++ H +V++ E + +V E++ GSL ++ +
Sbjct: 47 KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE 105
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
T + + + +++ ++Y+ + H D+++ANIL+ + K++DF
Sbjct: 106 TGK--YLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLA 160
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPI---HLVD 185
+ + K + P+ +FT KSDV+SF ++L EL + +V+
Sbjct: 161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 220
Query: 186 VEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233
E + + E + + +C +++PT + + L
Sbjct: 221 REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 5e-41
Identities = 49/231 (21%), Positives = 100/231 (43%), Gaps = 8/231 (3%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K+ VE+F+ E ++ +I H N+V++LG C ++ EF+ G+L Y+ E
Sbjct: 48 KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 107
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
++ ++ + L + ++S + YL H D+ + N L+ + + K++DF
Sbjct: 108 --NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLS 162
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTK--PIHLVDV 186
+ D K + P+ ++F+ KSDV++F V+L E+ P +D+
Sbjct: 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
Query: 187 EE-NRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236
+ L + E + + + C N +P+ E+ +
Sbjct: 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-41
Identities = 52/238 (21%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K+++ + ++ + E ++ Q+++ +V+++G C E E +LV E G L +Y+ +
Sbjct: 43 KNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN 101
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ + + + +VS + YL H D+ + N+LLV ++ AKISDF
Sbjct: 102 R----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLS 154
Query: 129 KSRAIDRTHLTTQ--VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL----------- 175
K+ D + Q K + P+ +F+ KSDV+SF V++ E
Sbjct: 155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214
Query: 176 NWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233
++ +++ E A +E + C + + +P V L L
Sbjct: 215 KGSEVTAMLEKGERMGCPAGCPREMYD--------LMNLCWTYDVENRPGFAAVELRL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-40
Identities = 51/247 (20%), Positives = 101/247 (40%), Gaps = 23/247 (9%)
Query: 10 SKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
S H + E ++E+ +LS + NH N+V +LG C L++ E+ G L ++ +
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 69 --------------TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL 114
DD+L + E L + +V++ +++L S H D+ + NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178
Query: 115 VDKYQAKISDFRTFKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLV 173
KI DF + + + ++ ++ P+ + +T +SDV+S+ + L
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 174 ELNWTKPIHLVDVEENRSLAAY----FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
EL + + F + + + K C + + K+PT K++
Sbjct: 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 230 TLELAGI 236
+
Sbjct: 299 VQLIEKQ 305
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-40
Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 13/225 (5%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
L K++ Q EV I S + H N++++ G + L+ E+ P G++Y+ +
Sbjct: 39 LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 98
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ + + E++ LSY H S + H DIK N+LL + KI+DF
Sbjct: 99 KLS----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 151
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDV 186
S + TT T Y+ P+ EK D++S V+ E KP +
Sbjct: 152 W--SVHAPSSRRTTLC-GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN- 207
Query: 187 EENRSLAAYFSKEAEKEEVIT--FAMVAKRCLNLNGKKQPTMKEV 229
+ E + +T + R L N ++P ++EV
Sbjct: 208 TYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 252
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (348), Expect = 1e-39
Identities = 43/236 (18%), Positives = 90/236 (38%), Gaps = 13/236 (5%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHE 67
E F++E I+ Q +H NV+ + G ++ +++ EF+ NGSL ++ +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
T + + ++ + YL + H D+ + NIL+ K+SDF
Sbjct: 121 NDG---QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 128 FKSRAIDRTHLTTQVKV----TFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHL 183
+ D + T + + P+ + +FT SDV+S+ +V+ E+
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234
Query: 184 VDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236
D+ + A + + + C + +P ++ L +
Sbjct: 235 WDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 2e-39
Identities = 40/252 (15%), Positives = 100/252 (39%), Gaps = 29/252 (11%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT 69
+ F E ++++ ++ N+VK+LG C + L++E++ G L +++ +
Sbjct: 52 KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 111
Query: 70 DDQL--------------------PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKS 109
+ P++ +L I +V+ ++YL H D+ +
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLAT 168
Query: 110 ANILLVDKYQAKISDFRTFKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSF 168
N L+ + KI+DF ++ + D + ++ P+ +++T +SDV+++
Sbjct: 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228
Query: 169 SVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQP 224
VVL E+ ++ + + + Y + + + + C + +P
Sbjct: 229 GVVLWEI-FSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP 287
Query: 225 TMKEVTLELAGI 236
+ + L +
Sbjct: 288 SFCSIHRILQRM 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-39
Identities = 46/225 (20%), Positives = 96/225 (42%), Gaps = 13/225 (5%)
Query: 11 KSVHESNV--EQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K + E ++ ++FI E ++ ++H +V++ G C + ++ E++ NG L Y+ E
Sbjct: 34 KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 93
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ L + +V + YL S H D+ + N L+ D+ K+SDF
Sbjct: 94 RH---RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLS 147
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEE 188
+ D + K + P+ S+F+ KSD+++F V++ E+ ++ +
Sbjct: 148 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI-YSLGKMPYERFT 206
Query: 189 NRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
N A + ++ + C + ++PT K +
Sbjct: 207 NSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-39
Identities = 55/239 (23%), Positives = 112/239 (46%), Gaps = 13/239 (5%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE-VPLLVYEFIPNGSLYQYIH 66
++ V QF+ E +I+ +H NV+ +LG CL +E PL+V ++ +G L +I
Sbjct: 62 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF- 125
+T T + + ++V++ + +L S H D+ + N +L +K+ K++DF
Sbjct: 122 NETH---NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFG 175
Query: 126 --RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE-LNWTKPIH 182
R + D H T K+ ++ + ++ +FT KSDV+SF V+L E + P +
Sbjct: 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 183 LVDVEENRSLAAYFSKEAEKEEVIT--FAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239
+ ++ + + E V +C + + +P+ E+ ++ I ++
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 9e-39
Identities = 42/230 (18%), Positives = 95/230 (41%), Gaps = 18/230 (7%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLET----EVPLLVYEFIPNGSLYQY 64
+ + + +S ++F E +L + H N+V+ T + +LV E + +G+L Y
Sbjct: 43 QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 102
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK-YQAKIS 123
+ + ++ ++ + L +LH+ + PI H D+K NI + KI
Sbjct: 103 LKRFK----VMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIG 157
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP--- 180
D + R V T ++ P+ + ++ E DVY+F + ++E+ ++
Sbjct: 158 DLGLAT---LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS 213
Query: 181 -IHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
R + +K + + + C+ N ++ ++K++
Sbjct: 214 ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-38
Identities = 43/252 (17%), Positives = 100/252 (39%), Gaps = 28/252 (11%)
Query: 8 KKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+ S E ++E+ +++Q+ +H N+V +LG C + L++E+ G L Y+
Sbjct: 74 MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133
Query: 67 EQ-------------------TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDI 107
+ +D +T+E L +V++ + +L H D+
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 190
Query: 108 KSANILLVDKYQAKISDFRTFK-SRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVY 166
+ N+L+ KI DF + + + ++ ++ P+ +T KSDV+
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250
Query: 167 SFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVIT----FAMVAKRCLNLNGKK 222
S+ ++L E+ + + + + ++ ++ + C + +K
Sbjct: 251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 310
Query: 223 QPTMKEVTLELA 234
+P+ +T L
Sbjct: 311 RPSFPNLTSFLG 322
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-38
Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 15/230 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LK ++ FI EV + ++HRN++++ G L + +V E P GSL +
Sbjct: 44 LKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLR 102
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ R V+V+ + YL S H D+ + N+LL + KI DF
Sbjct: 103 KHQG---HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFG 156
Query: 127 TFKS--RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLV 184
++ + D + KV F + P+ ++ F+ SD + F V L E+ +T
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM-FTYGQEPW 215
Query: 185 DVEENRSLAAYFSKEAEKEEVIT-----FAMVAKRCLNLNGKKQPTMKEV 229
+ KE E+ V +C + +PT +
Sbjct: 216 IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-38
Identities = 46/274 (16%), Positives = 91/274 (33%), Gaps = 46/274 (16%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE----VPLLVYEFIPNGSLYQY 64
K S E E+ + H N++ + + LV ++ +GSL+ Y
Sbjct: 32 KIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY 91
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVA-----SIPIYHLDIKSANILLVDKYQ 119
++ +T E +++ + + L++LH I H D+KS NIL+
Sbjct: 92 LNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146
Query: 120 AKISDF---RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS------QFTEKSDVYSFSV 170
I+D S T Y+ P+ S + +++D+Y+ +
Sbjct: 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206
Query: 171 VLVEL-----------------------NWTKPIHLVDVEENRSLAAYFSKEAEKEEVIT 207
V E+ + + V E + ++ E +
Sbjct: 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 266
Query: 208 FAMVAKRCLNLNGKKQPTMKEVTLELAGIRASIG 241
A + + C NG + T + L+ + G
Sbjct: 267 MAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 4e-38
Identities = 47/227 (20%), Positives = 98/227 (43%), Gaps = 13/227 (5%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+++ + E INE++++ + + N+V L L + +V E++ GSL +
Sbjct: 50 IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
E + + E + L +LH S + H DIKS NILL K++DF
Sbjct: 110 ET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP----IH 182
+++ +T V T ++ P+ + K D++S ++ +E+ +P +
Sbjct: 162 FCAQITPEQSKRSTMVG-TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
Query: 183 LVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
+ + + ++ F RCL+++ +K+ + KE+
Sbjct: 221 PLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-38
Identities = 44/242 (18%), Positives = 93/242 (38%), Gaps = 26/242 (10%)
Query: 6 LLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+ +S E+F+ E + + Q +H ++VK++G E V ++ E G L ++
Sbjct: 40 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL 98
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ + + + ++S L+YL S H DI + N+L+ K+ DF
Sbjct: 99 QVR---KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDF 152
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL---------- 175
+ + ++ K+ ++ P+ +FT SDV+ F V + E+
Sbjct: 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212
Query: 176 -NWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234
I ++ E + + +C + ++P E+ +L+
Sbjct: 213 VKNNDVIGRIENGERLPMPPNCPPTLYS--------LMTKCWAYDPSRRPRFTELKAQLS 264
Query: 235 GI 236
I
Sbjct: 265 TI 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-38
Identities = 42/235 (17%), Positives = 97/235 (41%), Gaps = 11/235 (4%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT 69
E F+ E I+ Q +H N++++ G + + +++ E++ NG+L +++ E+
Sbjct: 45 KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD 104
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR--T 127
+ + + ++ + YL ++ H D+ + NIL+ K+SDF
Sbjct: 105 G---EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158
Query: 128 FKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVE 187
+ T+ T+ K+ + P+ +FT SDV+SF +V+ E+ ++
Sbjct: 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 218
Query: 188 ENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRAS 239
+ + A F + + +C ++P ++ L + +
Sbjct: 219 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 8e-38
Identities = 52/226 (23%), Positives = 84/226 (37%), Gaps = 13/226 (5%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT 69
E E+ I +NH NVVK G E + L E+ G L+ I
Sbjct: 39 DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI 98
Query: 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFK 129
+ R ++ + YLH I I H DIK N+LL ++ KISDF
Sbjct: 99 ----GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT 151
Query: 130 S-RAIDRTHLTTQVKVTFGYVDPKYFRSSQF-TEKSDVYSFSVVLVELNWTKPIHLVDVE 187
R +R L ++ T YV P+ + +F E DV+S +VL + + +
Sbjct: 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211
Query: 188 ENRSLAAYFSKEAEKEEVITFAMVAK----RCLNLNGKKQPTMKEV 229
+ + + K+ + L N + T+ ++
Sbjct: 212 SCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-37
Identities = 48/246 (19%), Positives = 101/246 (41%), Gaps = 21/246 (8%)
Query: 8 KKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+ + + + F E+ +L ++ +H N++ +LG C L E+ P+G+L ++
Sbjct: 44 RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 103
Query: 67 EQTDDQL------------PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL 114
+ + ++ + L +V+R + YL H D+ + NIL+
Sbjct: 104 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 160
Query: 115 VDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
+ Y AKI+DF SR + T ++ ++ + S +T SDV+S+ V+L E
Sbjct: 161 GENYVAKIADFGL--SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 218
Query: 175 L--NWTKPIHLVDVEE-NRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231
+ P + E L + E + ++C ++P+ ++ +
Sbjct: 219 IVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278
Query: 232 ELAGIR 237
L +
Sbjct: 279 SLNRML 284
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 6e-37
Identities = 49/237 (20%), Positives = 85/237 (35%), Gaps = 34/237 (14%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
+ S + I EV L ++ H N ++ GC L LV E+ +
Sbjct: 48 MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV 107
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ P+ +T + L+YLH S + H D+K+ NILL + K+ DF
Sbjct: 108 HKK----PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFG 160
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS---QFTEKSDVYSFSVVLVEL-------- 175
+ T ++ P+ + Q+ K DV+S + +EL
Sbjct: 161 SAS-----IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
Query: 176 NWTKPIHLVDVEENRSLA---AYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
N L + +N S A ++S+ CL + +PT + +
Sbjct: 216 NMNAMSALYHIAQNESPALQSGHWSEYFRN--------FVDSCLQKIPQDRPTSEVL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-36
Identities = 50/267 (18%), Positives = 116/267 (43%), Gaps = 13/267 (4%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHE 67
+ ++ ++ ++E +++ +++ +V ++LG CL + V L+ + +P G L Y+ E
Sbjct: 45 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVRE 103
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRT 127
D+ + L V++++ ++YL + H D+ + N+L+ KI+DF
Sbjct: 104 HKDNI---GSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGL 157
Query: 128 FKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDV 186
K A ++ + KV ++ + +T +SDV+S+ V + EL T D
Sbjct: 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL-MTFGSKPYDG 216
Query: 187 EENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRASIGA 242
+++ K I M+ +C ++ +P +E+ +E + +
Sbjct: 217 IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276
Query: 243 SVLLQCEEINFVDYDNARHFKTSSSST 269
+++Q +E + +F +
Sbjct: 277 YLVIQGDERMHLPSPTDSNFYRALMDE 303
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 8e-36
Identities = 47/232 (20%), Positives = 92/232 (39%), Gaps = 16/232 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
K + E +E ++ E+ IL+ +H N+VK+L ++ EF G++ +
Sbjct: 42 AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 101
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
E + P+T + + L+YLH I H D+K+ NIL K++DF
Sbjct: 102 EL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFG 155
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ-----FTEKSDVYSFSVVLVELNWTKP- 180
+ + T ++ P+ + K+DV+S + L+E+ +P
Sbjct: 156 VSAKNTRTIQRRDSFIG-TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
Query: 181 ---IHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
++ + V + + + F K+CL N + T ++
Sbjct: 215 HHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 127 bits (321), Expect = 3e-35
Identities = 39/238 (16%), Positives = 88/238 (36%), Gaps = 31/238 (13%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
K + HES+ E E+ +S + H +V + + +++YEF+ G L++ +
Sbjct: 56 AKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 115
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY--QAKISD 124
++ ++ + + +V + L ++H HLD+K NI+ K + K+ D
Sbjct: 116 DE---HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLID 169
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP---- 180
F + +D T + P+ +D++S V+ L
Sbjct: 170 F--GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227
Query: 181 ---------IHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
+ D + S + S++ + ++ L + + T+ +
Sbjct: 228 ENDDETLRNVKSCDWNMDDSAFSGISEDGKD--------FIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-34
Identities = 48/233 (20%), Positives = 87/233 (37%), Gaps = 25/233 (10%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
L+K + E+ V E ++S+++H VK+ + E + NG L +YI
Sbjct: 41 LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 100
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ T E+ L YLH I H D+K NILL + +I+DF
Sbjct: 101 KIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 153
Query: 127 TFKSRAID-RTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVD 185
T K + + + T YV P+ + SD+++ ++ +L P
Sbjct: 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213
Query: 186 ---------VEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
++ F +A + ++ L L+ K+ +E+
Sbjct: 214 NEYLIFQKIIKLEYDFPEKFFPKARD--------LVEKLLVLDATKRLGCEEM 258
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 7e-34
Identities = 43/237 (18%), Positives = 94/237 (39%), Gaps = 13/237 (5%)
Query: 10 SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH--- 66
+++ +F+NE ++ + N +VV++LG + + L++ E + G L Y+
Sbjct: 59 NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 118
Query: 67 ---EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKIS 123
P + +++ E++ ++YL+ + H D+ + N ++ + + KI
Sbjct: 119 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175
Query: 124 DFRTFKS-RAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIH 182
DF + D + + ++ P+ + FT SDV+SF VVL E+
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235
Query: 183 LVDVEENRSLAAYFSK---EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236
+ + L + + + C N K +P+ E+ +
Sbjct: 236 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-33
Identities = 52/246 (21%), Positives = 105/246 (42%), Gaps = 20/246 (8%)
Query: 10 SKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
E ++ I+E+ ++ I H+N++ +LG C + ++ E+ G+L +Y+ +
Sbjct: 54 KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 113
Query: 69 TDDQL------------PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD 116
L ++ + + +V+R + YL S H D+ + N+L+ +
Sbjct: 114 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE 170
Query: 117 KYQAKISDFRTFKSRAIDRTHLTTQV-KVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
KI+DF + + T ++ ++ P+ +T +SDV+SF V+L E+
Sbjct: 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230
Query: 176 NWTK--PIHLVDVEE-NRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232
P V VEE + L + M+ + C + ++PT K++ +
Sbjct: 231 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 233 LAGIRA 238
L I A
Sbjct: 291 LDRIVA 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (305), Expect = 1e-33
Identities = 51/243 (20%), Positives = 93/243 (38%), Gaps = 19/243 (7%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETE----VPLLVYEFIPNGSLY 62
L+ + S +F E + +NH +V + +P +V E++ +L
Sbjct: 40 LRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR 99
Query: 63 QYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
+H + P+T + + + + + L++ H I H D+K ANI++ K+
Sbjct: 100 DIVHTEG----PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKV 152
Query: 123 SDFRTFK--SRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
DF + + + + T V T Y+ P+ R +SDVYS VL E+ +P
Sbjct: 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212
Query: 181 I----HLVDVEENRSLAAYFSKEAEKEEV-ITFAMVAKRCLNLNGKKQP-TMKEVTLELA 234
V V A E + V + L N + + T E+ +L
Sbjct: 213 PFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
Query: 235 GIR 237
+
Sbjct: 273 RVH 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 2e-33
Identities = 44/237 (18%), Positives = 82/237 (34%), Gaps = 28/237 (11%)
Query: 7 LKK-SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+K +K E NE+ +L +I H N+V + L+ + + G L+ I
Sbjct: 39 IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
E+ T R+ +V + YLH + + L + + ISDF
Sbjct: 99 VEKG----FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 154
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP----- 180
S+ D + + T GYV P+ +++ D +S V+ L P
Sbjct: 155 GL--SKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212
Query: 181 --------IHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
I + E + S A+ + + + +K+ T ++
Sbjct: 213 NDAKLFEQILKAEYEFDSPYWDDISDSAKD--------FIRHLMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-32
Identities = 45/228 (19%), Positives = 85/228 (37%), Gaps = 15/228 (6%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
K V ++ E+ IL+ HRN++ + E ++++EFI +++ I+
Sbjct: 36 KFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS 95
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK--YQAKISDFR 126
+ + +V L +LH S I H DI+ NI+ + KI +F
Sbjct: 96 ---AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFG 149
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL-----NWTKPI 181
+R + + Y P+ + + +D++S ++ L +
Sbjct: 150 Q--ARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207
Query: 182 HLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
+ +E + F +EA KE I R L K + T E
Sbjct: 208 NQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 119 bits (300), Expect = 3e-32
Identities = 40/238 (16%), Positives = 83/238 (34%), Gaps = 31/238 (13%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
K + + + NE+ I++Q++H ++ + + +L+ EF+ G L+ I
Sbjct: 59 AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 118
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILL--VDKYQAKISD 124
+ ++ + + L ++H I HLDIK NI+ KI D
Sbjct: 119 AE---DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIID 172
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP---- 180
F + ++ + T + P+ +D+++ V+ L
Sbjct: 173 FGL--ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230
Query: 181 ---------IHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
+ D E + + S EA+ K L +K+ T+ +
Sbjct: 231 EDDLETLQNVKRCDWEFDEDAFSSVSPEAKD--------FIKNLLQKEPRKRLTVHDA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 8e-32
Identities = 58/246 (23%), Positives = 103/246 (41%), Gaps = 22/246 (8%)
Query: 10 SKSVHESNVEQFINEVVILSQINHR-NVVKILGCCLETEVPL-LVYEFIPNGSLYQYIHE 67
+ S ++E+ IL I H NVV +LG C + PL ++ EF G+L Y+
Sbjct: 52 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 111
Query: 68 QTDDQLP------------ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV 115
+ ++ +P +T E + + +V++ + +L S H D+ + NILL
Sbjct: 112 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168
Query: 116 DKYQAKISDFRTFKSRAIDRTHL-TTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVE 174
+K KI DF + D ++ ++ ++ P+ +T +SDV+SF V+L E
Sbjct: 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 228
Query: 175 L--NWTKPIHLVDVEEN--RSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230
+ P V ++E R L A C + ++PT E+
Sbjct: 229 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288
Query: 231 LELAGI 236
L +
Sbjct: 289 EHLGNL 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 114 bits (285), Expect = 1e-30
Identities = 49/242 (20%), Positives = 94/242 (38%), Gaps = 37/242 (15%)
Query: 8 KKSKSVHESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
S + E + EV IL +++ H N++++ LV++ + G L+ Y+
Sbjct: 43 SFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT 102
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
E+ ++ + +I + V+ LH + I H D+K NILL D K++DF
Sbjct: 103 EKV----TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF- 154
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ------FTEKSDVYSFSVVLVELNWTKP 180
S +D +V T Y+ P+ S + ++ D++S V++ L P
Sbjct: 155 -GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213
Query: 181 -------------IHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMK 227
I + + +S + + R L + +K+ T +
Sbjct: 214 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD--------LVSRFLVVQPQKRYTAE 265
Query: 228 EV 229
E
Sbjct: 266 EA 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 1e-27
Identities = 42/229 (18%), Positives = 83/229 (36%), Gaps = 20/229 (8%)
Query: 16 SNVEQFINEVVILSQI-NHRNVVKILGCC----LETEVPLLVYEFIPNGSLYQYIHEQTD 70
+ + EV + + ++V+I+ + L+V E + G L+ I ++ D
Sbjct: 46 QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 105
Query: 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF-K 129
T I + + YLH SI I H D+K N+L K I F
Sbjct: 106 Q--AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160
Query: 130 SRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP-------IH 182
++ + T T YV P+ ++ + D++S V++ L P +
Sbjct: 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220
Query: 183 LVDVEENRSLAAYFSKEAEKEEVIT--FAMVAKRCLNLNGKKQPTMKEV 229
+ + R + + ++ M+ + L ++ T+ E
Sbjct: 221 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-27
Identities = 47/232 (20%), Positives = 81/232 (34%), Gaps = 26/232 (11%)
Query: 7 LKKSKSVHESNVEQFINEVVILS-QINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
LKK + + +VE + E +LS H + + E V E++ G L +I
Sbjct: 35 LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 94
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
E+ L +LH S I + D+K NILL KI+DF
Sbjct: 95 QSCH----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADF 147
Query: 126 RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP----- 180
K + T T Y+ P+ ++ D +SF V+L E+ +
Sbjct: 148 GMCKENMLGDAKTNTFCG-TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206
Query: 181 ----IHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228
+ +N + KEA+ + + +K+ ++
Sbjct: 207 DEEELFHSIRMDNPFYPRWLEKEAKD--------LLVKLFVREPEKRLGVRG 250
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (262), Expect = 4e-27
Identities = 44/228 (19%), Positives = 88/228 (38%), Gaps = 14/228 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
LKK V VE +E ++LS + H ++++ G + + ++ ++I G L+ +
Sbjct: 37 LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR 96
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ + EV L YLH S I + D+K NILL KI+DF
Sbjct: 97 KSQ----RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFG 149
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDV 186
++ + T + T Y+ P+ + + + D +SF +++ E+ D
Sbjct: 150 --FAKYVPDVTYT--LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM-LAGYTPFYDS 204
Query: 187 EENRSLAAYFSKEAEKEEVIT--FAMVAKRCLNLNGKKQPTMKEVTLE 232
++ + E + R + + ++ + E
Sbjct: 205 NTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTE 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 6e-26
Identities = 51/243 (20%), Positives = 97/243 (39%), Gaps = 37/243 (15%)
Query: 7 LKKSKSVHESN---VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQ 63
+KK ++ E EV IL +I H NV+ + +L+ E + G L+
Sbjct: 43 IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 64 YIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD----KYQ 119
++ E+ +T E + ++L+ ++ + S+ I H D+K NI+L+D K +
Sbjct: 103 FLAEKE----SLTEEEATEF---LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 120 AKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTK 179
KI DF + ID + + T +V P+ ++D++S V+ L
Sbjct: 156 IKIIDF--GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
Query: 180 P-------------IHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTM 226
+ V+ E + S A+ +R L + KK+ T+
Sbjct: 214 SPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD--------FIRRLLVKDPKKRMTI 265
Query: 227 KEV 229
++
Sbjct: 266 QDS 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 4e-25
Identities = 48/254 (18%), Positives = 85/254 (33%), Gaps = 38/254 (14%)
Query: 9 KSKSVHESNVEQFINEVVILSQI---NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+ ++ E I EV +L + H NVV++ C + + + Q +
Sbjct: 42 RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL 101
Query: 66 HEQTD--DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKIS 123
D + + E + ++ R L +LHS + H D+K NIL+ Q K++
Sbjct: 102 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 158
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPI-- 181
DF +R T V VT Y P+ S + D++S + E+ KP+
Sbjct: 159 DFGL--ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
Query: 182 ------------------HLVDVEENRSLAAYFSKEAEKEEVITFAMVA--------KRC 215
D + +L + + F +C
Sbjct: 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
Query: 216 LNLNGKKQPTMKEV 229
L N K+ +
Sbjct: 277 LTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 5e-25
Identities = 41/252 (16%), Positives = 74/252 (29%), Gaps = 36/252 (14%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
L + + E+ +L +++H N++ +L LV++F+
Sbjct: 33 LGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD 92
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
L +T + + L YLH I H D+K N+LL + K++DF
Sbjct: 93 NS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFG 145
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL----------- 175
KS T QV + F + + D+++ +L EL
Sbjct: 146 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205
Query: 176 ------------------NWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLN 217
W L D +S + +
Sbjct: 206 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFL 265
Query: 218 LNGKKQPTMKEV 229
N + T +
Sbjct: 266 FNPCARITATQA 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.0 bits (246), Expect = 2e-24
Identities = 34/234 (14%), Positives = 82/234 (35%), Gaps = 18/234 (7%)
Query: 7 LKKSKSVHESNVEQFINEVV---ILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQ 63
L K + + +NE + ++S + +V + + + + + G L+
Sbjct: 37 LDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY 96
Query: 64 YIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKIS 123
++ + + E+ L ++H + + + D+K ANILL + +IS
Sbjct: 97 HLSQHG----VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRIS 149
Query: 124 DFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ-FTEKSDVYSFSVVLVEL----NWT 178
D + + H + T GY+ P+ + + +D +S +L +L +
Sbjct: 150 DLGLACDFSKKKPHASVG---THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 206
Query: 179 KPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232
+ D E + + E + + L + ++ +
Sbjct: 207 RQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 1e-23
Identities = 42/226 (18%), Positives = 89/226 (39%), Gaps = 18/226 (7%)
Query: 8 KKSKSVHESNVEQFINEVVILSQIN--HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYI 65
+ S N + EVV+L +++ V+++L + +L+ E
Sbjct: 41 RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 100
Query: 66 HEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISD 124
+ + + E+ +V + + H + + H DIK NIL+ ++ + K+ D
Sbjct: 101 ITE---RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 154
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF-TEKSDVYSFSVVLVELNWTKPIHL 183
F + + + + T T Y P++ R ++ + V+S ++L ++ I
Sbjct: 155 FGSGA---LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM-VCGDIPF 210
Query: 184 VDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEV 229
EE +F + E + + CL L +PT +E+
Sbjct: 211 EHDEEIIRGQVFFRQRVSSE----CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 94.6 bits (234), Expect = 2e-23
Identities = 38/251 (15%), Positives = 88/251 (35%), Gaps = 37/251 (14%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
+ + E I E+ IL ++ H N+VK+ + +LV+E + +
Sbjct: 35 RLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE 94
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ +++ ++Y H + H D+K N+L+ + + KI+DF
Sbjct: 95 G----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL------------- 175
++ I T ++ + S +++ D++S + E+
Sbjct: 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207
Query: 176 ----------------NWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAM-VAKRCLNL 218
NW L + N ++ E+ + + + + + L L
Sbjct: 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKL 267
Query: 219 NGKKQPTMKEV 229
+ ++ T K+
Sbjct: 268 DPNQRITAKQA 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 4e-23
Identities = 39/228 (17%), Positives = 79/228 (34%), Gaps = 11/228 (4%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
L+K + + V + E +L H + + + V E+ G L+ ++
Sbjct: 38 LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ T E E ++S L + S + + DIK N++L KI+DF
Sbjct: 98 RER----VFTEERARFYGAE---IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDV 186
K D + T T Y+ P+ + + D + VV+ E+ + +
Sbjct: 151 LCKEGISDGATMKTFCG-TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL-PFYNQ 208
Query: 187 EENRSLAAYFSKEAEKEEVITFAMVA--KRCLNLNGKKQPTMKEVTLE 232
+ R +E ++ + L + K++ +
Sbjct: 209 DHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 4e-23
Identities = 32/167 (19%), Positives = 70/167 (41%), Gaps = 6/167 (3%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
+ + E I E+ +L ++NH N+VK+L LV+EF + L +++
Sbjct: 36 RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDAS 94
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+P + ++ + L++ HS + H D+K N+L+ + K++DF
Sbjct: 95 ALTGIP--LPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLA 149
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
++ + T +V + ++ D++S + E+
Sbjct: 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.8 bits (232), Expect = 7e-23
Identities = 37/234 (15%), Positives = 67/234 (28%), Gaps = 26/234 (11%)
Query: 15 ESNVEQFINEVVILSQINHRNVVKILG-CCLETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73
++ Q E I + + + C E + ++V E + +
Sbjct: 43 KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---- 98
Query: 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK---YQAKISDFRTFKS 130
+ + L + ++ + Y+HS H D+K N L+ I DF K
Sbjct: 99 KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155
Query: 131 RAIDRTH------LTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLV 184
RTH + T Y + + + D+ S VL+ N
Sbjct: 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 215
Query: 185 DVEENRSLAAYFSKEAEKEEVIT---------FAMVAKRCLNLNGKKQPTMKEV 229
+ E + I FA C +L +P +
Sbjct: 216 LKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 1e-22
Identities = 41/182 (22%), Positives = 79/182 (43%), Gaps = 16/182 (8%)
Query: 7 LKK-SKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFI----PNGSL 61
+KK S H++ ++ + E+ IL + H N++ I + + ++ L
Sbjct: 38 IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADL 97
Query: 62 YQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAK 121
Y+ + Q ++ + ++ R L Y+HS + H D+K +N+LL K
Sbjct: 98 YKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 149
Query: 122 ISDFRTFKSRAIDRTHLT--TQVKVTFGYVDPKYFRSSQ-FTEKSDVYSFSVVLVELNWT 178
I DF + D H T+ T Y P+ +S+ +T+ D++S +L E+
Sbjct: 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
Query: 179 KP 180
+P
Sbjct: 210 RP 211
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.6 bits (226), Expect = 4e-22
Identities = 29/167 (17%), Positives = 66/167 (39%), Gaps = 7/167 (4%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
+ E + E+ +L ++ H+N+V++ + LV+EF +
Sbjct: 36 RLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN 95
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
D E+ ++ + L + HS + H D+K N+L+ + K+++F
Sbjct: 96 GDLD----PEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLA 148
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
++ I + +V + F + ++ D++S + EL
Sbjct: 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 89.9 bits (222), Expect = 3e-21
Identities = 33/174 (18%), Positives = 68/174 (39%), Gaps = 11/174 (6%)
Query: 7 LKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIH 66
L K K V +E +NE IL +N +VK+ + +V E++ G ++ ++
Sbjct: 74 LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFR 126
+ ++ YLH S+ + + D+K N+L+ + +++DF
Sbjct: 134 RIG----RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
K L + P+ S + + D ++ V++ E+ P
Sbjct: 187 FAKRVKGRTWTLCGTP----EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 6e-21
Identities = 28/172 (16%), Positives = 62/172 (36%), Gaps = 6/172 (3%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
E ++ E+ +L + H NV+ +L E +F +
Sbjct: 52 YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK 111
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+ + + ++ + L Y+H+ I H D+K N+ + + + KI DF
Sbjct: 112 LMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
+ + +T V + ++T+ D++S ++ E+ K
Sbjct: 169 RQA---DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 1e-20
Identities = 37/166 (22%), Positives = 66/166 (39%), Gaps = 12/166 (7%)
Query: 17 NVEQFINEVVILSQINHRNVVKILGCCLETEVP------LLVYEFIPNGSLYQYIHEQTD 70
+ E+ I+ +++H N+V++ + LV +++P H
Sbjct: 56 DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115
Query: 71 DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISDFRTFK 129
Q + ++ R L+Y+HS I H DIK N+LL D K+ DF + K
Sbjct: 116 KQ-TLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171
Query: 130 SRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVEL 175
+ + + + F ++ +T DV+S VL EL
Sbjct: 172 Q-LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 2e-20
Identities = 36/179 (20%), Positives = 68/179 (37%), Gaps = 19/179 (10%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVP--------LLVYEFIPNGS 60
++ E + E+ IL + H NVV ++ C P LV++F +
Sbjct: 44 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL 103
Query: 61 LYQYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQA 120
+ T R+ + L+ L+ + I H D+K+AN+L+
Sbjct: 104 AGLLSNVLV----KFTLSEIKRVMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVL 156
Query: 121 KISDF---RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ-FTEKSDVYSFSVVLVEL 175
K++DF R F + + T VT Y P+ + + D++ ++ E+
Sbjct: 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 215
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 86.0 bits (212), Expect = 3e-20
Identities = 24/238 (10%), Positives = 62/238 (26%), Gaps = 30/238 (12%)
Query: 14 HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQL 73
S+ Q +E + + + + + ++ + SL +
Sbjct: 40 RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--- 96
Query: 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQ-----AKISDF--- 125
+ + ++ + +H + + DIK N L+ + DF
Sbjct: 97 KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153
Query: 126 ---RTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIH 182
R ++ + T Y+ + + + D+ + V +
Sbjct: 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213
Query: 183 LVDVEENRSLAAYFSKEAEKEEVIT-----------FAMVAKRCLNLNGKKQPTMKEV 229
+ + + + EK++ F NL P +
Sbjct: 214 --QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 81.8 bits (201), Expect = 2e-18
Identities = 29/175 (16%), Positives = 64/175 (36%), Gaps = 17/175 (9%)
Query: 11 KSVHESNVEQFINEVVILSQIN-HRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHE 67
K + ++ E+ IL + N++ + + + P LV+E + N Q
Sbjct: 66 KILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ- 124
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISDFR 126
+T E+ + L Y H S+ I H D+K N+++ + + ++ D+
Sbjct: 125 ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG 175
Query: 127 TFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ-FTEKSDVYSFSVVLVELNWTKP 180
+ + + P+ Q + D++S +L + + K
Sbjct: 176 L--AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 3e-18
Identities = 48/236 (20%), Positives = 82/236 (34%), Gaps = 18/236 (7%)
Query: 7 LKKSKSVHESN-VEQFINEVVILSQINHR-NVVKILGCCLETEVPLLVYEFIPNGSLYQY 64
LKK+ V ++ E E +L I +V + L+ ++I G L+ +
Sbjct: 60 LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH 119
Query: 65 IHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISD 124
+ ++ V ++ L + + I + DIK NILL ++D
Sbjct: 120 LSQRERFTEHEVQIY-------VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 172
Query: 125 FRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ--FTEKSDVYSFSVVLVELNWTKPIH 182
F K D T T Y+ P R + D +S V++ EL
Sbjct: 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232
Query: 183 LVDVEENRSLAAYFSKEAEKEEVI------TFAMVAKRCLNLNGKKQPTMKEVTLE 232
VD E+N S A + + E + +R L + KK+ +
Sbjct: 233 TVDGEKN-SQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.5 bits (187), Expect = 2e-16
Identities = 36/178 (20%), Positives = 71/178 (39%), Gaps = 18/178 (10%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCL------ETEVPLLVYEFIPNGSLY 62
++++ ++ E+V++ +NH+N++ +L E + LV E +
Sbjct: 51 SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ 110
Query: 63 QYIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKI 122
E E + ++ + +LHS I H D+K +NI++ KI
Sbjct: 111 VIQMEL-------DHERMSYLLYQMLCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKI 160
Query: 123 SDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
DF +R + + T VT Y P+ + E D++S ++ E+ K
Sbjct: 161 LDF--GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 6e-15
Identities = 30/172 (17%), Positives = 60/172 (34%), Gaps = 6/172 (3%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQ 68
+ ++ E+ +L + H NV+ +L + L
Sbjct: 52 SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 111
Query: 69 TDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTF 128
+T + + ++ R L Y+HS I H D+K +N+ + + + KI DF
Sbjct: 112 IVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF--G 166
Query: 129 KSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKP 180
+R D T V + + + D++S ++ EL +
Sbjct: 167 LARHTDDEM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 67.0 bits (162), Expect = 2e-13
Identities = 30/184 (16%), Positives = 59/184 (32%), Gaps = 12/184 (6%)
Query: 9 KSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVY--EFIPNGSLYQYIH 66
K + E +E+ +L ++N + K + LL + PNG +
Sbjct: 44 KIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVF 103
Query: 67 EQTDDQLPITWEMRLRITVEVSRVLSYLHSVAS--------IPIYHLDIKSANILL-VDK 117
E + L + + + V + I H DIK N+L+ +
Sbjct: 104 EVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163
Query: 118 YQAKISDFRTFK-SRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELN 176
+ + A T T Y P+ + + +D++S + ++ EL
Sbjct: 164 SPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 223
Query: 177 WTKP 180
Sbjct: 224 TGDF 227
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 44.0 bits (103), Expect = 5e-06
Identities = 21/118 (17%), Positives = 40/118 (33%), Gaps = 11/118 (9%)
Query: 8 KKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHE 67
KK K + F + ++ R + K+ G + Y + N L + I
Sbjct: 40 KKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELID- 93
Query: 68 QTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDF 125
+ + E + + ++ + I H D+ N+ LV + I DF
Sbjct: 94 -AKELYRVRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNV-LVSEEGIWIIDF 146
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 290 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.27 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.64 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=361.92 Aligned_cols=230 Identities=23% Similarity=0.379 Sum_probs=181.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||||+++.. ....++|.+|++++++++|||||+++|+|...+..++|||||++|+|.+++..... .+++..++
T Consensus 29 ~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---~~~~~~~~ 104 (263)
T d1sm2a_ 29 KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLL 104 (263)
T ss_dssp TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT---CCCHHHHH
T ss_pred CCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcccc---CCCHHHHH
Confidence 467999999754 33457899999999999999999999999999999999999999999999876542 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............||+.|+|||++.+..|+.
T Consensus 105 ~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 181 (263)
T d1sm2a_ 105 GMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181 (263)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCH
T ss_pred HHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCc
Confidence 99999999999999999 999999999999999999999999998765443333344567899999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++|||||||++|||+++..++............. .....+..++.++.+||.+||+.||++|||++|++++|+.+.+
T Consensus 182 k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999998544444332222222221 1122334456789999999999999999999999999998865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-53 Score=363.90 Aligned_cols=231 Identities=20% Similarity=0.339 Sum_probs=195.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||||+++.. ....++|.+|+++|+.++|||||+++++|.+.+..+||||||++|+|.+++...... .+++..++
T Consensus 42 ~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~--~~~~~~~~ 118 (287)
T d1opja_ 42 SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLL 118 (287)
T ss_dssp TEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTT--TSCHHHHH
T ss_pred CeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhcccc--chHHHHHH
Confidence 678999998753 445778999999999999999999999999999999999999999999999765432 68999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............|++.|+|||++.+..|+.
T Consensus 119 ~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 195 (287)
T d1opja_ 119 YMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195 (287)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSH
T ss_pred HHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCc
Confidence 99999999999999999 999999999999999999999999999876555555555667899999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++|||||||++|||+++..|+............. .....+...+..+.+||.+||+.||++|||++|+++.|+.+..
T Consensus 196 k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 196 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred hhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999776665443332222211 1122334566789999999999999999999999999987643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=362.66 Aligned_cols=224 Identities=21% Similarity=0.270 Sum_probs=190.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||||+++..+....+.+.+|+++|+.++|||||+++++|...+..|||||||+||+|.+++... .+++..++
T Consensus 45 ~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~-----~l~~~~~~ 119 (293)
T d1yhwa1 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIA 119 (293)
T ss_dssp CCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-----CCCHHHHH
T ss_pred CCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc-----CCCHHHHH
Confidence 7889999998666666788999999999999999999999999999999999999999999988753 48999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..|+.
T Consensus 120 ~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~ 195 (293)
T d1yhwa1 120 AVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGP 195 (293)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHSSSCBCT
T ss_pred HHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-ccccccccCCCccChhhhcCCCCCc
Confidence 99999999999999999 9999999999999999999999999987543322 2334567999999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++||||+||++|+|++|.+||............... ...+...+..+.+||.+||+.||++|||+.|+++|-+
T Consensus 196 ~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred hhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 999999999999999999998654332221111111 1123345678999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-53 Score=358.33 Aligned_cols=232 Identities=20% Similarity=0.276 Sum_probs=185.0
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
+..||||+++. .+....+.|.+|+++|++++|||||++++++.. +.++||||||++|+|.+++..... .+++..
T Consensus 30 ~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~---~~~~~~ 105 (276)
T d1uwha_ 30 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIK 105 (276)
T ss_dssp SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCC---CCCHHH
T ss_pred CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccC---CCCHHH
Confidence 34699999864 345667889999999999999999999998754 568999999999999999976443 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceecccccCccccccC-
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFGYVDPKYFRSS- 157 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~- 157 (290)
+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+.
T Consensus 106 ~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 182 (276)
T d1uwha_ 106 LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182 (276)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCS
T ss_pred HHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhccc
Confidence 9999999999999999999 9999999999999999999999999987544322 2233456789999999998643
Q ss_pred --CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044846 158 --QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKE 228 (290)
Q Consensus 158 --~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 228 (290)
.|+.++|||||||++|||++|..||............... ......++..+.+||.+||+.||++|||++|
T Consensus 183 ~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~ 262 (276)
T d1uwha_ 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQ 262 (276)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 4888999999999999999999988643222221111111 1122345678999999999999999999999
Q ss_pred HHHHHHhhHhhh
Q 044846 229 VTLELAGIRASI 240 (290)
Q Consensus 229 l~~~l~~~~~~~ 240 (290)
++++|+.+.+++
T Consensus 263 il~~Le~l~~~~ 274 (276)
T d1uwha_ 263 ILASIELLARSL 274 (276)
T ss_dssp HHHHHHHHHHTC
T ss_pred HHHHHHHHHHcC
Confidence 999999887654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=356.64 Aligned_cols=223 Identities=22% Similarity=0.257 Sum_probs=188.9
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|++.. .+....+.+.+|+++++.++|||||++++++.+.+.+|||||||++|+|.+++.... .+++.
T Consensus 31 ~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~----~l~e~ 106 (263)
T d2j4za1 31 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQ 106 (263)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHH
T ss_pred CcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC----CCCHH
Confidence 67899999863 233456789999999999999999999999999999999999999999999998765 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ......||+.|+|||++.+..
T Consensus 107 ~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~~~~~~Gt~~Y~APE~~~~~~ 180 (263)
T d2j4za1 107 RTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGRM 180 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---CCEETTEEGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC---cccccCCCCcccCHHHHcCCC
Confidence 99999999999999999999 999999999999999999999999998754432 234467999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
|+.++|||||||++|+|++|.+||...... ......... ..+...+.++.+||.+||+.||++|||++|+++|.+-
T Consensus 181 ~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred CCchhhhhhHhHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 999999999999999999999998644322 122221111 1223456789999999999999999999999987653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=360.69 Aligned_cols=226 Identities=23% Similarity=0.266 Sum_probs=185.0
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||+++... .+..+.+.+|+++|++++|||||++++++.+.+..|||||||++|+|.+++.... .+++..+
T Consensus 30 ~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~ 105 (271)
T d1nvra_ 30 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDA 105 (271)
T ss_dssp CCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT----BCCHHHH
T ss_pred CCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC----CCCHHHH
Confidence 7889999986433 3345678999999999999999999999999999999999999999999997544 6999999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...... ........||+.|+|||++.+..+
T Consensus 106 ~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 182 (271)
T d1nvra_ 106 QRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182 (271)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSB
T ss_pred HHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCC
Confidence 999999999999999999 9999999999999999999999999987654332 223455789999999999988876
Q ss_pred -CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 160 -TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 160 -~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
+.++||||+||++|+|++|.+||............... .......+.++.+||.+||+.||++|||++|+++|-+
T Consensus 183 ~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 56899999999999999999998654433222222211 1122344677899999999999999999999987644
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=359.67 Aligned_cols=225 Identities=22% Similarity=0.254 Sum_probs=188.3
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+++.......+.+.+|+++|++++|||||++++++.+.+..|+|||||++|+|.+++.+... ++++..+.
T Consensus 37 ~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~---~l~e~~~~ 113 (288)
T d2jfla1 37 SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQ 113 (288)
T ss_dssp CCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTS---CCCHHHHH
T ss_pred CeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCC---CCCHHHHH
Confidence 678999999877777788999999999999999999999999999999999999999999999876542 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc-----c
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR-----S 156 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~ 156 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++. +
T Consensus 114 ~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~ 189 (288)
T d2jfla1 114 VVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKD 189 (288)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHHTCCCSCCTTCCHHHHTTCSTTT
T ss_pred HHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC-cccccccccccccCCHHHHhhcccCC
Confidence 99999999999999999 999999999999999999999999998643221 11233567899999999984 4
Q ss_pred CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 157 SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 157 ~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
..|+.++|||||||++|+|++|.+||....... .+..... ...+...+.++.+||.+||+.||++|||++|+++
T Consensus 190 ~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 558899999999999999999999886543222 1221111 1123345678999999999999999999999988
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
|-+
T Consensus 269 hp~ 271 (288)
T d2jfla1 269 HPF 271 (288)
T ss_dssp SGG
T ss_pred Ccc
Confidence 743
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=354.20 Aligned_cols=230 Identities=19% Similarity=0.296 Sum_probs=189.1
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||||+++... ...+.|.+|+++|++++|||||++++++.. +..++|||||++|+|.+++...... .+++..++
T Consensus 37 ~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~--~l~~~~~~ 112 (272)
T d1qpca_ 37 HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI--KLTINKLL 112 (272)
T ss_dssp TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHH--TCCHHHHH
T ss_pred CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCC--CCCHHHHH
Confidence 4679999997543 446789999999999999999999998754 5679999999999999988654422 48999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............||+.|+|||++.+..++.
T Consensus 113 ~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ 189 (272)
T d1qpca_ 113 DMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189 (272)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECH
T ss_pred HHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCc
Confidence 99999999999999999 999999999999999999999999999866544444445567899999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++|||||||++|||+++..++............... ...+...+.++.+||.+||+.||++|||++||++.|+.+-.
T Consensus 190 ~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999999999866555443332222222211 22234556789999999999999999999999999987643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-52 Score=357.10 Aligned_cols=229 Identities=20% Similarity=0.312 Sum_probs=180.3
Q ss_pred eEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.||||++.. ......+.|.+|+++|++|+|||||+++|+|...+..++|||||++|+|.+++..... .+++..++.
T Consensus 56 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~---~l~~~~~~~ 132 (299)
T d1jpaa_ 56 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVG 132 (299)
T ss_dssp EEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT---CSCHHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC---CCCHHHHHH
Confidence 588888764 3455677899999999999999999999999999999999999999999999886543 589999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce----eeccceecccccCccccccCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH----LTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~ 158 (290)
++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..
T Consensus 133 i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 209 (299)
T d1jpaa_ 133 MLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 209 (299)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC
Confidence 9999999999999999 999999999999999999999999998754332211 112345788999999999999
Q ss_pred CCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++.++|||||||++|||++ |.+||...... ...... ...+.+...+..+.+||.+||+.||++|||+.||++.|+
T Consensus 210 ~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 210 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCcccccccchHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 9999999999999999997 77777543322 111111 112233456678999999999999999999999999998
Q ss_pred hhHhh
Q 044846 235 GIRAS 239 (290)
Q Consensus 235 ~~~~~ 239 (290)
.+...
T Consensus 289 ~~l~~ 293 (299)
T d1jpaa_ 289 KMIRN 293 (299)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 87653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=350.04 Aligned_cols=223 Identities=18% Similarity=0.285 Sum_probs=182.3
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||+|++.. ......+.+.+|+++|++++|||||+++++|.. .+.+|+|||||++|+|.+++.+.. .+
T Consensus 34 ~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~----~~ 109 (270)
T d1t4ha_ 34 TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VM 109 (270)
T ss_dssp CCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS----SC
T ss_pred CeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc----cc
Confidence 57899999864 345567789999999999999999999999875 346799999999999999998765 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec-cCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV-DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
++..++.++.||+.||.|||+++. +|+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++
T Consensus 110 ~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~ 185 (270)
T d1t4ha_ 110 KIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMY 185 (270)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGG
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---ccCCcccCccccCHHHh
Confidence 999999999999999999999763 399999999999996 5789999999998754322 23456799999999998
Q ss_pred ccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 155 RSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 155 ~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
.+ .++.++|||||||++|||++|..||................ ..+...++++.+||.+||+.||++|||++|++
T Consensus 186 ~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell 264 (270)
T d1t4ha_ 186 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264 (270)
T ss_dssp GT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 65 59999999999999999999999886433332222222211 12233456799999999999999999999998
Q ss_pred HHH
Q 044846 231 LEL 233 (290)
Q Consensus 231 ~~l 233 (290)
+|-
T Consensus 265 ~Hp 267 (270)
T d1t4ha_ 265 NHA 267 (270)
T ss_dssp TSG
T ss_pred CCc
Confidence 764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=363.75 Aligned_cols=224 Identities=19% Similarity=0.237 Sum_probs=184.0
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||+|+++.. +....+++.+|+.+|++++|||||+++++|.+.+.+|||||||+||+|.+++.+.. .+++..+
T Consensus 31 ~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~----~l~~~~~ 106 (322)
T d1s9ja_ 31 GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQIL 106 (322)
T ss_dssp TEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS----SCCHHHH
T ss_pred CcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC----CCCHHHH
Confidence 678999998643 34556789999999999999999999999999999999999999999999998765 5899999
Q ss_pred HHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 81 LRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
+.++.|++.||.|||+ ++ |+||||||+|||++.++++||+|||+|+.... ....+..||+.|+|||++.+..|
T Consensus 107 ~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~~~~~GT~~Y~APEvl~~~~y 180 (322)
T d1s9ja_ 107 GKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 180 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---HTC---CCSSCCCCHHHHHCSCC
T ss_pred HHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC---CccccccCCccccCchHHcCCCC
Confidence 9999999999999997 48 99999999999999999999999999875432 22345689999999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--h--------------------------------------h-
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--S--------------------------------------K- 198 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~--------------------------------------~- 198 (290)
+.++||||+||++|||++|+.||.............. . .
T Consensus 181 ~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T d1s9ja_ 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE 260 (322)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTS
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhcc
Confidence 9999999999999999999998865432111000000 0 0
Q ss_pred ----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 199 ----EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 199 ----~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
......+.++.+||.+||+.||++|||++|+++|.+-
T Consensus 261 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 261 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 0000124578999999999999999999999998543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-53 Score=356.91 Aligned_cols=230 Identities=21% Similarity=0.301 Sum_probs=176.4
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||+|+++.. .....+.+.+|+++|++++|||||++++++.+ .+.+|||||||++|+|.+++.........+++
T Consensus 29 ~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e 108 (269)
T d2java1 29 GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 108 (269)
T ss_dssp CCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCH
T ss_pred CCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCH
Confidence 788999998643 34557789999999999999999999999865 45789999999999999999764333336999
Q ss_pred HHHHHHHHHHHHHHHHHhhCCC--CCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 78 EMRLRITVEVSRVLSYLHSVAS--IPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~--~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
..++.++.||+.||.|||+++. .+|+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.
T Consensus 109 ~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~-~~~~~~~~gt~~Y~APE~l~ 187 (269)
T d2java1 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMN 187 (269)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC-CCccccCCCCcccCCHHHHc
Confidence 9999999999999999998642 23999999999999999999999999998764322 22334577899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044846 156 SSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLE 232 (290)
Q Consensus 156 ~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~ 232 (290)
+..|+.++|||||||++|||++|.+||....... ....... ...+...+.++.+||.+||+.||++|||++|+++|
T Consensus 188 ~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 9999999999999999999999999886543221 1111111 12233456789999999999999999999999876
Q ss_pred H
Q 044846 233 L 233 (290)
Q Consensus 233 l 233 (290)
.
T Consensus 267 p 267 (269)
T d2java1 267 P 267 (269)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=353.78 Aligned_cols=230 Identities=22% Similarity=0.291 Sum_probs=188.9
Q ss_pred ceEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..||||+++. ......++|.+|+++|++++|||||+++|++.. +..|||||||++|+|.+++..... .+++..+.
T Consensus 37 ~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~---~l~~~~~~ 112 (285)
T d1u59a_ 37 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVA 112 (285)
T ss_dssp EEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTT---TSCHHHHH
T ss_pred EEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhcccc---CCCHHHHH
Confidence 3699999974 345567889999999999999999999999865 568999999999999999865443 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee--eccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL--TTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......... .....||+.|+|||++.+..+
T Consensus 113 ~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 189 (285)
T d1u59a_ 113 ELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189 (285)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCC
Confidence 99999999999999999 9999999999999999999999999987654332222 234568899999999999999
Q ss_pred CCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 160 TEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
+.++|||||||++|||++ |.+||...... ....... ....+...+.++.+||.+||+.||++|||+.+|++.|+.
T Consensus 190 ~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CccchhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 999999999999999987 78877543222 1111111 122334567789999999999999999999999999987
Q ss_pred hHhhh
Q 044846 236 IRASI 240 (290)
Q Consensus 236 ~~~~~ 240 (290)
...+.
T Consensus 269 ~~~~~ 273 (285)
T d1u59a_ 269 CYYSL 273 (285)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 76544
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=352.09 Aligned_cols=227 Identities=22% Similarity=0.274 Sum_probs=184.1
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
++.||||+++. .+....++|.+|+++|++++|||||+++++|.. +..+||||||++|+|.+++.... .+++..
T Consensus 34 ~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~----~l~~~~ 108 (277)
T d1xbba_ 34 VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKN 108 (277)
T ss_dssp EEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT----TCCHHH
T ss_pred CeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhcc----CCCHHH
Confidence 45799999864 334456789999999999999999999999965 45789999999999999998755 599999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCcee--eccceecccccCccccccC
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHL--TTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~ 157 (290)
++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......... .....||+.|+|||++.+.
T Consensus 109 ~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 185 (277)
T d1xbba_ 109 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC
Confidence 9999999999999999999 9999999999999999999999999987654333222 2345689999999999999
Q ss_pred CCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.++.++|||||||++|||++ |.+||...... ...... .....+..++.++.+||.+||+.||++|||+++|++.|
T Consensus 186 ~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L 264 (277)
T d1xbba_ 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264 (277)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCchhhhccchhhhhHHhhCCCCCCCCCCHH-HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 99999999999999999987 78777543222 111111 11223345677899999999999999999999999888
Q ss_pred HhhH
Q 044846 234 AGIR 237 (290)
Q Consensus 234 ~~~~ 237 (290)
+...
T Consensus 265 ~~~~ 268 (277)
T d1xbba_ 265 RNYY 268 (277)
T ss_dssp HHHH
T ss_pred hCHH
Confidence 7654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=345.68 Aligned_cols=226 Identities=20% Similarity=0.301 Sum_probs=188.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||||+++.... ..+.|.+|+.++++++||||++++|+|.+++.+++||||+++|+|..++..... .+++..+.
T Consensus 28 ~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~---~~~~~~~~ 103 (258)
T d1k2pa_ 28 QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLL 103 (258)
T ss_dssp TEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGG---CCCHHHHH
T ss_pred CCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhcccc---CCcHHHHH
Confidence 45799999986443 456799999999999999999999999999999999999999999999876553 58899999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..............||+.|+|||++.+..++.
T Consensus 104 ~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 180 (258)
T d1k2pa_ 104 EMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180 (258)
T ss_dssp HHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCc
Confidence 99999999999999999 999999999999999999999999998755443333344567899999999999999999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
++|||||||++|||++ |+.||...... ...... .....+...+..+.+||.+||+.||++|||+++++++|.+
T Consensus 181 ksDiwS~G~~l~el~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 181 KSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ceeecccchhhHhHHhcCCCCCCCCCHH-HHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 9999999999999997 67776543322 111111 1123334556789999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=348.43 Aligned_cols=231 Identities=19% Similarity=0.288 Sum_probs=184.4
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..||||+++.. .......|.+|+++|++++|||||+++|++...+..++|||||.+|++.+++..... .+++..+.
T Consensus 37 ~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~ 113 (283)
T d1mqba_ 37 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLV 113 (283)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT---CSCHHHHH
T ss_pred EEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccc---cccHHHHH
Confidence 36899998643 344566799999999999999999999999999999999999999999998876543 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc--eeeccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..+
T Consensus 114 ~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 190 (283)
T d1mqba_ 114 GMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190 (283)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred HHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCC
Confidence 99999999999999999 99999999999999999999999999876443222 12234568899999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
+.++|||||||++|||+++..++.............. ..+.+...+..+.+||.+||+.||++|||+.||++.|+.+
T Consensus 191 ~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 191 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999986655554433322222221 2233344667899999999999999999999999999887
Q ss_pred Hhh
Q 044846 237 RAS 239 (290)
Q Consensus 237 ~~~ 239 (290)
...
T Consensus 271 ~~~ 273 (283)
T d1mqba_ 271 IRA 273 (283)
T ss_dssp HHS
T ss_pred hhC
Confidence 654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-52 Score=354.00 Aligned_cols=224 Identities=21% Similarity=0.242 Sum_probs=185.4
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||||+++. .+....+.+.+|+++|++++|||||+++++|.+.+..|+|||||+||+|.+++.... .+++.
T Consensus 33 ~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~----~l~e~ 108 (288)
T d1uu3a_ 33 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDET 108 (288)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS----SCCHH
T ss_pred CCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC----CCCHH
Confidence 67899999863 234456789999999999999999999999999999999999999999999998765 69999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeeccceecccccCccccccC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
.++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+.
T Consensus 109 ~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~ 185 (288)
T d1uu3a_ 109 CTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccC
Confidence 99999999999999999999 9999999999999999999999999987654322 2233456799999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhh--hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSK--EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.|+.++||||+||++|+|++|.+||....... ........ ..+...+.++.+||.+||+.||++|||++|++.+.
T Consensus 186 ~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred CCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 99999999999999999999999987543221 11111111 12334567899999999999999999999986553
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-51 Score=352.76 Aligned_cols=221 Identities=23% Similarity=0.252 Sum_probs=183.6
Q ss_pred CceEEEEeecccC---chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVH---ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||||+++... ....+.+.+|+++|++|+|||||++++++.+.+..|+|||||.+|+|..++.... ++++.
T Consensus 40 ~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~----~l~e~ 115 (309)
T d1u5ra_ 40 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEV 115 (309)
T ss_dssp TEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS----CCCHH
T ss_pred CcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCC----CCCHH
Confidence 6789999986433 3345679999999999999999999999999999999999999999987766544 69999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc--
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS-- 156 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 156 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... .....||+.|+|||++.+
T Consensus 116 ~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~~~GT~~Y~APE~~~~~~ 187 (309)
T d1u5ra_ 116 EIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMD 187 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHTTTT
T ss_pred HHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-----CCccccCccccCHHHHhccC
Confidence 99999999999999999999 99999999999999999999999999875432 234679999999999864
Q ss_pred -CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 157 -SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 157 -~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
..|+.++|||||||++|||++|.+||........ +..... .......+..+.+||.+||+.||++|||++|+++
T Consensus 188 ~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 4588999999999999999999998865433222 211111 1122345678999999999999999999999998
Q ss_pred HHHh
Q 044846 232 ELAG 235 (290)
Q Consensus 232 ~l~~ 235 (290)
|.+-
T Consensus 267 Hp~~ 270 (309)
T d1u5ra_ 267 HRFV 270 (309)
T ss_dssp CHHH
T ss_pred CHHh
Confidence 7543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=353.95 Aligned_cols=228 Identities=20% Similarity=0.330 Sum_probs=184.2
Q ss_pred eEEEEeecc-cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC----------
Q 044846 4 LWLLKKSKS-VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD---------- 71 (290)
Q Consensus 4 ~~avK~~~~-~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------- 71 (290)
.||+|++.. ........+.+|+.+|.++ +|||||+++++|...+..++|||||++|+|.++++.....
T Consensus 69 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 148 (325)
T d1rjba_ 69 QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148 (325)
T ss_dssp EEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhcc
Confidence 588998854 3445566899999999998 8999999999999999999999999999999999765321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeecc
Q 044846 72 ---------QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQ 141 (290)
Q Consensus 72 ---------~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 141 (290)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....... ....+
T Consensus 149 ~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 225 (325)
T d1rjba_ 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 225 (325)
T ss_dssp ------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETT
T ss_pred ccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeecc
Confidence 125889999999999999999999999 99999999999999999999999999876543332 23345
Q ss_pred ceecccccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhh---hhHHHhhhhhhHHHHHHHHHHHHHhhc
Q 044846 142 VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENR---SLAAYFSKEAEKEEVITFAMVAKRCLN 217 (290)
Q Consensus 142 ~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~ 217 (290)
..||+.|+|||++.+..|+.++|||||||++|||++ |.+||........ .+........+...+.++.+||.+||+
T Consensus 226 ~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~ 305 (325)
T d1rjba_ 226 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWA 305 (325)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcC
Confidence 678999999999999999999999999999999997 7877754322111 111111222334567789999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 044846 218 LNGKKQPTMKEVTLELA 234 (290)
Q Consensus 218 ~dp~~Rps~~el~~~l~ 234 (290)
.||++|||++||+++|.
T Consensus 306 ~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 306 FDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SSGGGSCCHHHHHHHHH
T ss_pred CChhHCcCHHHHHHHHh
Confidence 99999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-51 Score=351.64 Aligned_cols=223 Identities=20% Similarity=0.236 Sum_probs=171.6
Q ss_pred CceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.+.+|||||||+||+|.+++.... .+++..+
T Consensus 34 ~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~----~l~e~~~ 109 (307)
T d1a06a_ 34 QKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDA 109 (307)
T ss_dssp CCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS----CCCHHHH
T ss_pred CCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc----CCCHHHH
Confidence 6889999986433 3334578899999999999999999999999999999999999999999998654 6999999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec---cCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV---DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.||+.||.|||+++ |+||||||+|||+. .++.+||+|||+++.... .....+..||+.|+|||++.+.
T Consensus 110 ~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--~~~~~~~~GT~~y~APE~~~~~ 184 (307)
T d1a06a_ 110 SRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQK 184 (307)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------------------CTTSCHHHHTTC
T ss_pred HHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC--CCeeeeeeeCccccCcHHHcCC
Confidence 999999999999999999 99999999999995 478999999999875432 2233456799999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTL 231 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~ 231 (290)
.|+.++|||||||++|+|++|.+||........ ...... .......+.++.+||.+||+.||++|||++|+++
T Consensus 185 ~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 999999999999999999999999865433221 111111 1122345678999999999999999999999998
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
|.+
T Consensus 264 hp~ 266 (307)
T d1a06a_ 264 HPW 266 (307)
T ss_dssp STT
T ss_pred CHh
Confidence 744
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-50 Score=354.43 Aligned_cols=224 Identities=17% Similarity=0.184 Sum_probs=189.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||||++........+.+.+|+++|++|+|||||+++++|.+.+.+|||||||+||+|.+++..... .+++..++
T Consensus 51 g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~---~l~e~~~~ 127 (350)
T d1koaa2 51 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAV 127 (350)
T ss_dssp TEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTS---CBCHHHHH
T ss_pred CCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcC---CCCHHHHH
Confidence 678999999877777788899999999999999999999999999999999999999999999965432 59999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc--CCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD--KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.... ........||+.|+|||++.+..|
T Consensus 128 ~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--~~~~~~~~gT~~Y~aPEv~~~~~~ 202 (350)
T d1koaa2 128 EYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEGKPV 202 (350)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--TSCEEEECSCTTTCCHHHHHTCCB
T ss_pred HHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc--ccccceecCcccccCHHHHcCCCC
Confidence 99999999999999999 999999999999964 57899999999875432 233445778999999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.++||||+||++|+|++|..||...... ..+..... .......+.++.+||.+||+.||++|||++|+++|-
T Consensus 203 ~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 281 (350)
T d1koaa2 203 GYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281 (350)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred ChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 99999999999999999999998654322 11221111 112234567899999999999999999999999884
Q ss_pred H
Q 044846 234 A 234 (290)
Q Consensus 234 ~ 234 (290)
+
T Consensus 282 ~ 282 (350)
T d1koaa2 282 W 282 (350)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.1e-51 Score=357.06 Aligned_cols=223 Identities=17% Similarity=0.180 Sum_probs=189.4
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||||+++.....+.+.+.+|+++|++|+|||||+++++|.+.+.+|||||||+||+|.+++..... ++++..++
T Consensus 54 ~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~---~l~e~~~~ 130 (352)
T d1koba_ 54 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVI 130 (352)
T ss_dssp CCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC---CBCHHHHH
T ss_pred CCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCC---CCCHHHHH
Confidence 788999999876666777899999999999999999999999999999999999999999998875442 59999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec--cCCcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLV--DKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+..|
T Consensus 131 ~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 205 (352)
T d1koba_ 131 NYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPV 205 (352)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCEEEECSSGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC--CceeeccCcccccCHHHHcCCCC
Confidence 99999999999999999 99999999999998 6789999999998764432 33445678999999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.++||||+||++|+|++|.+||........ +..... .......+.++.+||.+||+.||.+|||+.|+++|-
T Consensus 206 ~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp 284 (352)
T d1koba_ 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284 (352)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 9999999999999999999999865433221 211111 112234567899999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=350.74 Aligned_cols=224 Identities=18% Similarity=0.187 Sum_probs=190.0
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||+|+++.. .....+.+.+|+.+|+.++|||||+++++|.+.+.+|+|||||+||+|.+++.... .+++.
T Consensus 30 ~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~----~~~e~ 105 (337)
T d1o6la_ 30 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEE 105 (337)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHH
T ss_pred CCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc----CCcHH
Confidence 789999998632 34457789999999999999999999999999999999999999999999998876 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+..... ........||+.|+|||++.+..
T Consensus 106 ~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~~~~~~~GT~~Y~aPE~~~~~~ 181 (337)
T d1o6la_ 106 RARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDND 181 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCBCCCEECGGGCCGGGGSSSC
T ss_pred HHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC-CcccccceeCHHHhhhhhccCCC
Confidence 99999999999999999999 999999999999999999999999998754322 23345578999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQPT-----MKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~el~~ 231 (290)
|+.++||||+||++|||++|.+||........ ..... ....+...+.++.+||.+||+.||.+|++ +.|+++
T Consensus 182 y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CChhhcccchhhHHHHHHHCCCCCCCcCHHHH-HHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 99999999999999999999998875543221 11111 12233456778999999999999999995 888988
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
|-+
T Consensus 261 Hp~ 263 (337)
T d1o6la_ 261 HRF 263 (337)
T ss_dssp SGG
T ss_pred Ccc
Confidence 744
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=345.22 Aligned_cols=230 Identities=19% Similarity=0.295 Sum_probs=182.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
++.||||+++.. ....+.|.+|+.+|++++|||||+++++|.. +..++|||||++|+|..++...... .+++..++
T Consensus 41 ~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~--~l~~~~~~ 116 (285)
T d1fmka3 41 TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLV 116 (285)
T ss_dssp TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHT--TCCHHHHH
T ss_pred CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccc--cchHHHHH
Confidence 357999999754 3446789999999999999999999999854 5689999999999999998765432 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..............||+.|+|||++....++.
T Consensus 117 ~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 193 (285)
T d1fmka3 117 DMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193 (285)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCc
Confidence 99999999999999999 999999999999999999999999998765433333334467899999999999999999
Q ss_pred cccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh---hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF---SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++|||||||++|||++|..++.........+.... ..+.+...+.++.+||.+||+.||++|||+++|++.|+....
T Consensus 194 ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 194 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 99999999999999987666554433332222222 123344566789999999999999999999999988877543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=341.94 Aligned_cols=229 Identities=19% Similarity=0.275 Sum_probs=177.6
Q ss_pred ceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 3 ELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 3 ~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
..||+|+++.. .....+.|.+|+++|++++|||||++++++. .+..|+|||||++|+|.+++..... .+++..++
T Consensus 36 ~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~ 111 (273)
T d1mp8a_ 36 LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY---SLDLASLI 111 (273)
T ss_dssp EEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTT---TSCHHHHH
T ss_pred EEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCC---CCCHHHHH
Confidence 35888888643 3445678999999999999999999999996 5678999999999999998876543 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..............||+.|+|||++.+..++.
T Consensus 112 ~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~ 188 (273)
T d1mp8a_ 112 LYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188 (273)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSH
T ss_pred HHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCC
Confidence 99999999999999999 999999999999999999999999998765544444445567899999999999999999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhH
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~ 237 (290)
++|||||||++|||++ |.+|+...... ........ ...+...+..+.+||.+||+.||++|||+.||+++|+.+.
T Consensus 189 ~~DiwSlGvil~e~lt~g~~P~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 189 ASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccccchHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 9999999999999987 77766543222 22221111 2234456778999999999999999999999999998875
Q ss_pred hh
Q 044846 238 AS 239 (290)
Q Consensus 238 ~~ 239 (290)
..
T Consensus 268 ~~ 269 (273)
T d1mp8a_ 268 EE 269 (273)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=342.58 Aligned_cols=223 Identities=23% Similarity=0.270 Sum_probs=186.1
Q ss_pred CceEEEEeecccC------chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVH------ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~------~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||+++... ....+.+.+|+++|++|+|||||+++++|.+.+.+|||||||++|+|.+++.... .+
T Consensus 35 ~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~----~l 110 (293)
T d1jksa_ 35 GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SL 110 (293)
T ss_dssp CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS----SC
T ss_pred CCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc----cc
Confidence 7889999985321 2236789999999999999999999999999999999999999999999998765 69
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC----cEEEeccccccccccCCceeeccceecccccCc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY----QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+|++|||+++..... .......||+.|+||
T Consensus 111 ~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~--~~~~~~~~t~~y~AP 185 (293)
T d1jksa_ 111 TEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAP 185 (293)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS--CBCSCCCCCGGGCCH
T ss_pred chhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCC--ccccccCCCCcccCH
Confidence 99999999999999999999999 99999999999998776 4999999998754322 233456789999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPT 225 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps 225 (290)
|++.+..++.++||||+||++|+|++|..||........ +..... .......+..+.+||.+||+.||++|||
T Consensus 186 E~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s 264 (293)
T d1jksa_ 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT 264 (293)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcC
Confidence 999999999999999999999999999998875433221 111111 1122334667999999999999999999
Q ss_pred HHHHHHHHH
Q 044846 226 MKEVTLELA 234 (290)
Q Consensus 226 ~~el~~~l~ 234 (290)
++|+++|-+
T Consensus 265 ~~eil~hp~ 273 (293)
T d1jksa_ 265 IQDSLQHPW 273 (293)
T ss_dssp HHHHHHSTT
T ss_pred HHHHhcCcc
Confidence 999987643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=342.30 Aligned_cols=234 Identities=23% Similarity=0.305 Sum_probs=180.0
Q ss_pred CceEEEEeecc-cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeC-CcceEEEEeCCCCCHHHHHhhcCC--------
Q 044846 2 EELWLLKKSKS-VHESNVEQFINEVVILSQI-NHRNVVKILGCCLET-EVPLLVYEFIPNGSLYQYIHEQTD-------- 70 (290)
Q Consensus 2 ~~~~avK~~~~-~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------- 70 (290)
++.||||+++. ......+.+.+|...+.++ +|+|||.+++++... +..++|||||++|+|.+++.....
T Consensus 43 ~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~ 122 (299)
T d1ywna1 43 CRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122 (299)
T ss_dssp EEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC----
T ss_pred CeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccc
Confidence 35799999874 3455577889999999888 789999999998764 468999999999999999976432
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceec
Q 044846 71 ----DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVT 145 (290)
Q Consensus 71 ----~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~ 145 (290)
....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......||
T Consensus 123 ~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp -------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred hhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeC
Confidence 1224889999999999999999999999 99999999999999999999999999875443222 233456799
Q ss_pred ccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH----hhhhhhHHHHHHHHHHHHHhhccCCC
Q 044846 146 FGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY----FSKEAEKEEVITFAMVAKRCLNLNGK 221 (290)
Q Consensus 146 ~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dp~ 221 (290)
+.|+|||++.+..++.++|||||||++|||+++..+++........+... .....+...+.++.+||.+||+.||+
T Consensus 200 ~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 279 (299)
T d1ywna1 200 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 279 (299)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChh
Confidence 99999999999999999999999999999998754433332222222111 11222334567899999999999999
Q ss_pred CCCCHHHHHHHHHhhHh
Q 044846 222 KQPTMKEVTLELAGIRA 238 (290)
Q Consensus 222 ~Rps~~el~~~l~~~~~ 238 (290)
+|||++|++++|+.+.+
T Consensus 280 ~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 280 QRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp GSCCHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHHh
Confidence 99999999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-49 Score=342.31 Aligned_cols=232 Identities=17% Similarity=0.279 Sum_probs=187.7
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC-----------
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD----------- 70 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------- 70 (290)
+.||||+++... .+..++|.+|+++|++++||||++++++|...+..+++|||+++|+|.+++.....
T Consensus 44 ~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 123 (301)
T d1lufa_ 44 TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123 (301)
T ss_dssp EEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC-----------
T ss_pred eEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCcccccccccccc
Confidence 579999997533 34467899999999999999999999999999999999999999999999975421
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccC-Cceeec
Q 044846 71 ---------DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAID-RTHLTT 140 (290)
Q Consensus 71 ---------~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~ 140 (290)
....+++..++.++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+++..... ......
T Consensus 124 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~ 200 (301)
T d1lufa_ 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 200 (301)
T ss_dssp -----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC---
T ss_pred chhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccC
Confidence 1224888999999999999999999999 999999999999999999999999998754322 222334
Q ss_pred cceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhc
Q 044846 141 QVKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLN 217 (290)
Q Consensus 141 ~~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~ 217 (290)
...|++.|+|||++.+..|+.++|||||||++|||+++..+++.............. ...+...+.++.+||.+||+
T Consensus 201 ~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~ 280 (301)
T d1lufa_ 201 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWS 280 (301)
T ss_dssp -CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcC
Confidence 567889999999999999999999999999999999886443333332222222221 12233556789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhH
Q 044846 218 LNGKKQPTMKEVTLELAGIR 237 (290)
Q Consensus 218 ~dp~~Rps~~el~~~l~~~~ 237 (290)
.||++||||.||++.|+++.
T Consensus 281 ~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 281 KLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp SSGGGSCCHHHHHHHHHHTT
T ss_pred CChhHCcCHHHHHHHHHHhc
Confidence 99999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-50 Score=338.02 Aligned_cols=225 Identities=23% Similarity=0.382 Sum_probs=178.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||+++. ....+.|.+|++++++++||||++++|+|.. .+.+++||||+++|+|.+++...... .+++..+
T Consensus 30 ~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~--~l~~~~~ 105 (262)
T d1byga_ 30 GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCL 105 (262)
T ss_dssp TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHH--HCCHHHH
T ss_pred CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCC--CCCHHHH
Confidence 67899999975 3456789999999999999999999999865 56789999999999999999764321 4899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCCCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQFT 160 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 160 (290)
+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ......++..|+|||++.+..++
T Consensus 106 ~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----~~~~~~~~~~y~aPE~l~~~~~t 178 (262)
T d1byga_ 106 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKKFS 178 (262)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCC
T ss_pred HHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC----CCccccccccCCChHHHhCCCCC
Confidence 999999999999999999 99999999999999999999999999865332 22335678899999999999999
Q ss_pred CcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHH---hhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 044846 161 EKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAY---FSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGI 236 (290)
Q Consensus 161 ~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~ 236 (290)
.++|||||||++|||++ |.+|+... ......... .....+...+..+.+||.+||+.||.+|||+.+++++|+.+
T Consensus 179 ~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 179 TKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 99999999999999997 56655433 222222211 12233344567899999999999999999999999999988
Q ss_pred Hh
Q 044846 237 RA 238 (290)
Q Consensus 237 ~~ 238 (290)
+.
T Consensus 258 ~~ 259 (262)
T d1byga_ 258 KT 259 (262)
T ss_dssp HH
T ss_pred Hh
Confidence 64
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-49 Score=342.19 Aligned_cols=221 Identities=19% Similarity=0.229 Sum_probs=187.3
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||||+++. ......+.+.+|+.+|+.++|||||++++++.+.+..|+|||||.||+|..++.... .+++.
T Consensus 29 g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~----~~~~~ 104 (316)
T d1fota_ 29 GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----RFPNP 104 (316)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS----SCCHH
T ss_pred CCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc----ccccc
Confidence 78899999863 234457789999999999999999999999999999999999999999999998766 57889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++.... ......||+.|+|||++.+..
T Consensus 105 ~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----~~~~~~Gt~~Y~APE~l~~~~ 177 (316)
T d1fota_ 105 VAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKP 177 (316)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS----CBCCCCSCTTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc----ccccccCcccccCHHHHcCCC
Confidence 99999999999999999999 99999999999999999999999999876432 223567999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~~ 231 (290)
|+.++||||+||++|+|++|..||........ ...... ...+...+.++.+++.+||+.||.+|+ |++++++
T Consensus 178 y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCchhhccccchhHHHHHhCCCCCCCcCHHHH-HHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 99999999999999999999999865433221 222111 122334567899999999999999996 8999998
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
|.+
T Consensus 257 Hp~ 259 (316)
T d1fota_ 257 HPW 259 (316)
T ss_dssp SGG
T ss_pred Ccc
Confidence 743
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=342.78 Aligned_cols=229 Identities=20% Similarity=0.326 Sum_probs=182.5
Q ss_pred eEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 044846 4 LWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRLR 82 (290)
Q Consensus 4 ~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 82 (290)
.||+|+++. .+....++|.+|++++++++|||||+++|+|.++ ..++++|++.+|+|.+++..... .+++..++.
T Consensus 40 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~ 115 (317)
T d1xkka_ 40 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD---NIGSQYLLN 115 (317)
T ss_dssp EEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSS---SCCHHHHHH
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccccccc---CCCHHHHHH
Confidence 589998864 3455678899999999999999999999999865 56788999999999999887543 689999999
Q ss_pred HHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccccccCCCCC
Q 044846 83 ITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKYFRSSQFTE 161 (290)
Q Consensus 83 ~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 161 (290)
++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..|+.
T Consensus 116 i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 192 (317)
T d1xkka_ 116 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 192 (317)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCCh
Confidence 9999999999999999 999999999999999999999999998765433322 223456899999999999999999
Q ss_pred cccchhhHHHHHHHhc-CCCCcccchhhh--hhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHh
Q 044846 162 KSDVYSFSVVLVELNW-TKPIHLVDVEEN--RSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 162 ~~DiwS~G~il~~l~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~ 238 (290)
++|||||||++|||++ |.+|+....... ..+........+...+..+.+||.+||+.||.+|||+.|++.+|+.+..
T Consensus 193 ~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 193 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999998 566554322111 1111111122334566789999999999999999999999999988764
Q ss_pred h
Q 044846 239 S 239 (290)
Q Consensus 239 ~ 239 (290)
.
T Consensus 273 ~ 273 (317)
T d1xkka_ 273 D 273 (317)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.7e-49 Score=334.01 Aligned_cols=229 Identities=21% Similarity=0.275 Sum_probs=181.6
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----cceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILSQINHRNVVKILGCCLETE----VPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||||+++.. +....+.+.+|+++++.++|||||++++++...+ ..|||||||+||+|.+++.... +
T Consensus 32 ~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~----~ 107 (277)
T d1o6ya_ 32 HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----P 107 (277)
T ss_dssp TEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC----S
T ss_pred CCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC----C
Confidence 788999999643 3445668999999999999999999999998754 3789999999999999998765 6
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc--eeeccceecccccCcc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYVDPK 152 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE 152 (290)
+++..++.++.||+.||.|||+++ |+||||||+|||++.++..+++|||.++....... .......||+.|+|||
T Consensus 108 l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 184 (277)
T d1o6ya_ 108 MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHH
Confidence 899999999999999999999999 99999999999999999999999998764432222 2334567999999999
Q ss_pred ccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----hhhhHHHHHHHHHHHHHhhccCCCCCC-CH
Q 044846 153 YFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----KEAEKEEVITFAMVAKRCLNLNGKKQP-TM 226 (290)
Q Consensus 153 ~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~ 226 (290)
++.+..++.++|||||||++|+|++|.+||............... .......+..+.+||.+||+.||.+|| |+
T Consensus 185 ~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa 264 (277)
T d1o6ya_ 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 264 (277)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred HHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHH
Confidence 999999999999999999999999999998654433221111111 111223567899999999999999999 79
Q ss_pred HHHHHHHHhhH
Q 044846 227 KEVTLELAGIR 237 (290)
Q Consensus 227 ~el~~~l~~~~ 237 (290)
++++..|.++.
T Consensus 265 ~~l~~~l~r~~ 275 (277)
T d1o6ya_ 265 AEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99998887764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=339.16 Aligned_cols=223 Identities=19% Similarity=0.226 Sum_probs=185.9
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
|+.||+|+++... .+...+.+|+++|+.++|||||+++++|.+.+.+|||||||+||+|.+++..... .+++..++
T Consensus 30 ~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~---~l~e~~~~ 105 (321)
T d1tkia_ 30 KKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNEREIV 105 (321)
T ss_dssp TEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC---CCCHHHHH
T ss_pred CcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC---CCCHHHHH
Confidence 6789999997643 3456688999999999999999999999999999999999999999999976542 58999999
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccC--CcEEEeccccccccccCCceeeccceecccccCccccccCCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDK--YQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQF 159 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 159 (290)
.++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||+++.... ........+++.|+|||.+.+..|
T Consensus 106 ~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--~~~~~~~~~t~~y~ape~~~~~~~ 180 (321)
T d1tkia_ 106 SYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEVHQHDVV 180 (321)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--TCEEEEEESCGGGSCHHHHTTCEE
T ss_pred HHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc--CCcccccccccccccchhccCCCC
Confidence 99999999999999999 9999999999999854 4799999999875432 233445678899999999999999
Q ss_pred CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 160 TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 160 ~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.++||||+||++|+|++|.+||........ +..... .......+.++.+||.+||+.||++|||++|+++|-
T Consensus 181 ~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 181 STATDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CchhhcccHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 9999999999999999999999875543221 111111 111223467799999999999999999999999875
Q ss_pred H
Q 044846 234 A 234 (290)
Q Consensus 234 ~ 234 (290)
+
T Consensus 260 ~ 260 (321)
T d1tkia_ 260 W 260 (321)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-48 Score=343.09 Aligned_cols=221 Identities=16% Similarity=0.182 Sum_probs=187.7
Q ss_pred CceEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||||+++. .+....+.+.+|+++|+.++|||||++++++...+..++||||+.+|+|..++.... .+++.
T Consensus 66 g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~----~l~e~ 141 (350)
T d1rdqe_ 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEP 141 (350)
T ss_dssp CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC----CCCHH
T ss_pred CCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC----CCCHH
Confidence 78899999863 234456789999999999999999999999999999999999999999999998765 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+++.... ......||+.|+|||++.+..
T Consensus 142 ~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~----~~~~~~Gt~~Y~APE~~~~~~ 214 (350)
T d1rdqe_ 142 HARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKG 214 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS----CBCCCEECGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc----ccccccCccccCCHHHHcCCC
Confidence 99999999999999999999 99999999999999999999999999876432 234567999999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQP-----TMKEVTL 231 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~el~~ 231 (290)
|+.++|||||||++|+|++|.+||....... ....... ...+...+.++.+||.+||+.||.+|+ |++++++
T Consensus 215 ~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCccccccchhHHHHHHHhCCCCCCCcCHHH-HHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 9999999999999999999999986543221 1111111 122334567899999999999999994 8999998
Q ss_pred HHH
Q 044846 232 ELA 234 (290)
Q Consensus 232 ~l~ 234 (290)
|-+
T Consensus 294 Hp~ 296 (350)
T d1rdqe_ 294 HKW 296 (350)
T ss_dssp SGG
T ss_pred Ccc
Confidence 744
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=332.40 Aligned_cols=225 Identities=22% Similarity=0.318 Sum_probs=179.6
Q ss_pred eEEEEeecc---cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 4 LWLLKKSKS---VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 4 ~~avK~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
.||||+++. .+.+..+.|.+|+.+|++++|||||+++|+|.+ +..++|||||++|++.+++..... .+++..+
T Consensus 38 ~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~---~l~~~~~ 113 (273)
T d1u46a_ 38 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG---HFLLGTL 113 (273)
T ss_dssp EEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGG---GSCHHHH
T ss_pred EEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccC---CCCHHHH
Confidence 589999864 234456789999999999999999999999965 467899999999999998876543 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce--eeccceecccccCccccccCC
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH--LTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~ 158 (290)
+.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++........ ......|+..|+|||++.+..
T Consensus 114 ~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 190 (273)
T d1u46a_ 114 SRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190 (273)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC
Confidence 999999999999999999 999999999999999999999999998865433222 223456788999999999999
Q ss_pred CCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh----hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS----KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
++.++|||||||++|||++ |.+||...... ........ .+.+...+..+.+||.+||+.||++|||+.||++.|
T Consensus 191 ~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-HHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999999999999999997 78777543322 22222211 122344567899999999999999999999999888
Q ss_pred Hhh
Q 044846 234 AGI 236 (290)
Q Consensus 234 ~~~ 236 (290)
++.
T Consensus 270 ~~~ 272 (273)
T d1u46a_ 270 LEA 272 (273)
T ss_dssp HHH
T ss_pred Hhc
Confidence 754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=337.37 Aligned_cols=225 Identities=19% Similarity=0.175 Sum_probs=176.2
Q ss_pred CceEEEEeecccCchh-----HHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVHESN-----VEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~-----~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||||+++...... .+.+.+|+.+|++++|||||+++++|...+..|||||||.++++..+..... .++
T Consensus 23 ~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~----~l~ 98 (299)
T d1ua2a_ 23 NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL----VLT 98 (299)
T ss_dssp CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCS----SCC
T ss_pred CcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhccc----CCC
Confidence 7889999986433222 3468899999999999999999999999999999999998876665554332 588
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++..
T Consensus 99 ~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 174 (299)
T d1ua2a_ 99 PSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFG 174 (299)
T ss_dssp SSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-ccccceecChhhccHHHHcc
Confidence 8899999999999999999999 9999999999999999999999999987544322 22334678999999999875
Q ss_pred C-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhh--HHHhh---------------------------hhhhHHHHH
Q 044846 157 S-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSL--AAYFS---------------------------KEAEKEEVI 206 (290)
Q Consensus 157 ~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~--~~~~~---------------------------~~~~~~~~~ 206 (290)
. .|+.++|||||||++|||++|.+||.......... ..... .......+.
T Consensus 175 ~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 254 (299)
T d1ua2a_ 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 254 (299)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCH
T ss_pred CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCH
Confidence 4 57999999999999999999998886543322111 00000 000112356
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 207 TFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 207 ~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
++.+||.+||+.||++|||++|+++|-+
T Consensus 255 ~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 255 DLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 7999999999999999999999987743
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=335.80 Aligned_cols=230 Identities=23% Similarity=0.353 Sum_probs=187.4
Q ss_pred eEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEe-CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHHH
Q 044846 4 LWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLE-TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMRL 81 (290)
Q Consensus 4 ~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 81 (290)
.||||+++. .+....++|.+|+++|++++|||||+++|++.. ++..++|||||++|+|.+++..... .+++..++
T Consensus 57 ~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~---~~~~~~~~ 133 (311)
T d1r0pa_ 57 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLI 133 (311)
T ss_dssp EEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTC---CCBHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccc---cchHHHHH
Confidence 589999874 456677889999999999999999999999876 4578999999999999999886543 47788899
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce---eeccceecccccCccccccCC
Q 044846 82 RITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH---LTTQVKVTFGYVDPKYFRSSQ 158 (290)
Q Consensus 82 ~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~ 158 (290)
.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+....
T Consensus 134 ~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 210 (311)
T d1r0pa_ 134 GFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210 (311)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC
T ss_pred HHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCC
Confidence 99999999999999999 999999999999999999999999998754432222 223356899999999999999
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
++.++||||||+++|||+++..||............... ...+...+..+.+||.+||+.||++|||+.||+++|+.
T Consensus 211 ~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~ 290 (311)
T d1r0pa_ 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 999999999999999999877766554332222222111 12233456789999999999999999999999999998
Q ss_pred hHhh
Q 044846 236 IRAS 239 (290)
Q Consensus 236 ~~~~ 239 (290)
+...
T Consensus 291 i~~~ 294 (311)
T d1r0pa_ 291 IFST 294 (311)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 8764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-48 Score=330.40 Aligned_cols=222 Identities=21% Similarity=0.263 Sum_probs=184.7
Q ss_pred CceEEEEeecccCc---------hhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSVHE---------SNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~~~---------~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||||+++.... ...+.+.+|+.++++|+ |||||++++++.+++.+|||||||++|+|.++++...
T Consensus 28 ~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-- 105 (277)
T d1phka_ 28 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-- 105 (277)
T ss_dssp TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--
T ss_pred CCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC--
Confidence 67899999864321 22456889999999996 9999999999999999999999999999999998765
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.... ........||+.|+||
T Consensus 106 --~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~--~~~~~~~~gt~~y~~P 178 (277)
T d1phka_ 106 --TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLAP 178 (277)
T ss_dssp --SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT--TCCBCCCCSCGGGCCH
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccC--CCceeeeeccCCCCCH
Confidence 6999999999999999999999999 99999999999999999999999999875432 2233456789999999
Q ss_pred ccccc------CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------hhhhHHHHHHHHHHHHHhhccC
Q 044846 152 KYFRS------SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------KEAEKEEVITFAMVAKRCLNLN 219 (290)
Q Consensus 152 E~~~~------~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~d 219 (290)
|++.+ ..++.++||||+||++|+|++|..||........ ...... .......++++.+|+.+||+.|
T Consensus 179 E~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~ 257 (277)
T d1phka_ 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ 257 (277)
T ss_dssp HHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSS
T ss_pred HHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-HHHHHhCCCCCCCcccccCCHHHHHHHHHHccCC
Confidence 99863 3467899999999999999999999876543321 111111 1223356778999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 044846 220 GKKQPTMKEVTLEL 233 (290)
Q Consensus 220 p~~Rps~~el~~~l 233 (290)
|.+|||++|+++|-
T Consensus 258 p~~R~s~~eil~h~ 271 (277)
T d1phka_ 258 PQKRYTAEEALAHP 271 (277)
T ss_dssp GGGSCCHHHHTTSG
T ss_pred hhHCcCHHHHHcCH
Confidence 99999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=337.34 Aligned_cols=231 Identities=19% Similarity=0.329 Sum_probs=184.1
Q ss_pred eEEEEeecc-cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcC------------
Q 044846 4 LWLLKKSKS-VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT------------ 69 (290)
Q Consensus 4 ~~avK~~~~-~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------ 69 (290)
.||||+++. ......+.|.+|+++|.++ +|||||+++++|...+..++|||||++|+|.+++....
T Consensus 39 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 118 (309)
T d1fvra_ 39 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118 (309)
T ss_dssp EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccc
Confidence 477888753 3445677899999999999 79999999999999999999999999999999997541
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceeccccc
Q 044846 70 DDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYV 149 (290)
Q Consensus 70 ~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 149 (290)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .......||..|+
T Consensus 119 ~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~ 193 (309)
T d1fvra_ 119 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWM 193 (309)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE--CCC----CCTTTC
T ss_pred cccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEcccccccccccc--ccccceecCCccc
Confidence 12236899999999999999999999999 999999999999999999999999998654322 1223456889999
Q ss_pred CccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044846 150 DPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTM 226 (290)
Q Consensus 150 aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 226 (290)
|||.+.+..++.++|||||||++|||++|..+++.............. ...+...+.++.+||.+||+.||++|||+
T Consensus 194 aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 273 (309)
T d1fvra_ 194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF 273 (309)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred chHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence 999999999999999999999999999977654433333222222211 22334566789999999999999999999
Q ss_pred HHHHHHHHhhHhh
Q 044846 227 KEVTLELAGIRAS 239 (290)
Q Consensus 227 ~el~~~l~~~~~~ 239 (290)
.|++++|+.+...
T Consensus 274 ~eil~~L~~i~~~ 286 (309)
T d1fvra_ 274 AQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHhc
Confidence 9999999988653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=334.21 Aligned_cols=234 Identities=23% Similarity=0.345 Sum_probs=190.7
Q ss_pred CceEEEEeecc-cCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC---------
Q 044846 2 EELWLLKKSKS-VHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD--------- 70 (290)
Q Consensus 2 ~~~~avK~~~~-~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------- 70 (290)
++.||||+++. ........|.+|+.+++.+ +|||||+++++|...+..++|||||++|+|.+++.....
T Consensus 53 ~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~ 132 (311)
T d1t46a_ 53 AMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132 (311)
T ss_dssp EEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-------
T ss_pred CeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcccccccccccc
Confidence 35799999975 3445667899999999999 799999999999999999999999999999999976532
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCC-ceeecccee
Q 044846 71 -----DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDR-THLTTQVKV 144 (290)
Q Consensus 71 -----~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g 144 (290)
....+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+|++|||+++...... ........|
T Consensus 133 ~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~g 209 (311)
T d1t46a_ 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209 (311)
T ss_dssp -------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEE
T ss_pred ccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeeccc
Confidence 2235889999999999999999999999 9999999999999999999999999988654332 233455788
Q ss_pred cccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH----hhhhhhHHHHHHHHHHHHHhhccCC
Q 044846 145 TFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY----FSKEAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 145 ~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dp 220 (290)
|+.|+|||++.+..++.++|||||||++|||+++..++.........+... .....+...+..+.+||.+||+.||
T Consensus 210 t~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP 289 (311)
T d1t46a_ 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289 (311)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred ChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCCh
Confidence 999999999999999999999999999999998544444332222222222 2222233456789999999999999
Q ss_pred CCCCCHHHHHHHHHhhHh
Q 044846 221 KKQPTMKEVTLELAGIRA 238 (290)
Q Consensus 221 ~~Rps~~el~~~l~~~~~ 238 (290)
++|||++||++.|+....
T Consensus 290 ~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 290 LKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHhhc
Confidence 999999999999987643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=337.37 Aligned_cols=222 Identities=21% Similarity=0.262 Sum_probs=179.9
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEe----CCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLE----TEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||||+++. ...+.+|++++.++ +|||||+++++|.+ ...+|||||||+||+|.+++...... .++
T Consensus 37 ~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~--~l~ 109 (335)
T d2ozaa1 37 QEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--AFT 109 (335)
T ss_dssp CCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCC--CEE
T ss_pred CCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCC--CcC
Confidence 67899999864 23567899987665 89999999999976 45789999999999999999865332 699
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc---CCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD---KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
+..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+++..... .......||+.|+|||+
T Consensus 110 e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~ 184 (335)
T d2ozaa1 110 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEV 184 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC--CCCCCCSCCCSSCCCCC
T ss_pred HHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCC--CccccccCCcccCCcHH
Confidence 9999999999999999999999 999999999999985 567999999998754432 23345679999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHH-------hhhhhhHHHHHHHHHHHHHhhccCCCCCC
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAY-------FSKEAEKEEVITFAMVAKRCLNLNGKKQP 224 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~-------~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 224 (290)
+.+..|+.++|||||||++|+|++|.+||........ .+... .........+.++.+||.+||+.||++||
T Consensus 185 ~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 264 (335)
T d2ozaa1 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 264 (335)
T ss_dssp CCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC
T ss_pred HcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCc
Confidence 9999999999999999999999999999865432211 11111 01122334567899999999999999999
Q ss_pred CHHHHHHHHHh
Q 044846 225 TMKEVTLELAG 235 (290)
Q Consensus 225 s~~el~~~l~~ 235 (290)
|+.|+++|-+-
T Consensus 265 s~~eil~hp~~ 275 (335)
T d2ozaa1 265 TITEFMNHPWI 275 (335)
T ss_dssp CHHHHHHSHHH
T ss_pred CHHHHHcCHHh
Confidence 99999987543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=331.29 Aligned_cols=232 Identities=21% Similarity=0.315 Sum_probs=190.2
Q ss_pred ceEEEEeecccC-chhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCC----------
Q 044846 3 ELWLLKKSKSVH-ESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTD---------- 70 (290)
Q Consensus 3 ~~~avK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------- 70 (290)
..||||+++... ......+.+|+..+.++ +|||||+++++|.+++..++|||||.+|+|.+++.....
T Consensus 46 ~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~ 125 (299)
T d1fgka_ 46 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125 (299)
T ss_dssp EEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC---------
T ss_pred eEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccc
Confidence 368999997533 45567899999999998 899999999999999999999999999999999976532
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc-eeeccceeccc
Q 044846 71 --DQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT-HLTTQVKVTFG 147 (290)
Q Consensus 71 --~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~ 147 (290)
....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......+++.
T Consensus 126 ~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 202 (299)
T d1fgka_ 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 202 (299)
T ss_dssp ---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGG
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChh
Confidence 1235899999999999999999999999 99999999999999999999999999876543322 23345678999
Q ss_pred ccCccccccCCCCCcccchhhHHHHHHHhc-CCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCC
Q 044846 148 YVDPKYFRSSQFTEKSDVYSFSVVLVELNW-TKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQ 223 (290)
Q Consensus 148 y~aPE~~~~~~~~~~~DiwS~G~il~~l~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~R 223 (290)
|+|||++.++.|+.++|||||||++|||++ |.+|+.... .......... ...+...+.++.+||.+||+.||++|
T Consensus 203 y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R 281 (299)
T d1fgka_ 203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281 (299)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred hhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-HHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHC
Confidence 999999999999999999999999999997 566654332 2222222111 22233456789999999999999999
Q ss_pred CCHHHHHHHHHhhHh
Q 044846 224 PTMKEVTLELAGIRA 238 (290)
Q Consensus 224 ps~~el~~~l~~~~~ 238 (290)
||+.||++.|+.+.+
T Consensus 282 ps~~eil~~L~~i~a 296 (299)
T d1fgka_ 282 PTFKQLVEDLDRIVA 296 (299)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHhh
Confidence 999999999988854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.2e-48 Score=340.56 Aligned_cols=223 Identities=14% Similarity=0.142 Sum_probs=179.5
Q ss_pred CceEEEEeeccc---CchhHHHHHHH---HHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSV---HESNVEQFINE---VVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E---~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||++... .......+.+| +++++.++|||||+++++|...+.+|+|||||+||+|.+++.... .+
T Consensus 29 ~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~----~~ 104 (364)
T d1omwa3 29 GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VF 104 (364)
T ss_dssp CCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC----SC
T ss_pred CCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc----cc
Confidence 788999998531 12223334444 667777789999999999999999999999999999999998765 58
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFR 155 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 155 (290)
++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+..... ......||+.|+|||++.
T Consensus 105 ~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~---~~~~~~GT~~y~APE~~~ 178 (364)
T d1omwa3 105 SEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQ 178 (364)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS---CCCSCCSCGGGCCHHHHS
T ss_pred cHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC---cccccccccccchhHHhh
Confidence 89999999999999999999999 999999999999999999999999998754322 234467999999999987
Q ss_pred c-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhh-hhHHH-hh--hhhhHHHHHHHHHHHHHhhccCCCCCCC-----
Q 044846 156 S-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR-SLAAY-FS--KEAEKEEVITFAMVAKRCLNLNGKKQPT----- 225 (290)
Q Consensus 156 ~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~-~~~~~-~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps----- 225 (290)
. ..|+.++|||||||++|+|++|.+||........ .+... .. ...+...+.++.+||.+||+.||++|||
T Consensus 179 ~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~ 258 (364)
T d1omwa3 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 258 (364)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSST
T ss_pred cCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccC
Confidence 5 5689999999999999999999999865432211 11111 11 1122345678999999999999999999
Q ss_pred HHHHHHHHH
Q 044846 226 MKEVTLELA 234 (290)
Q Consensus 226 ~~el~~~l~ 234 (290)
++|+++|-+
T Consensus 259 a~eil~Hp~ 267 (364)
T d1omwa3 259 AQEVKESPF 267 (364)
T ss_dssp HHHHHTSGG
T ss_pred HHHHHcCcc
Confidence 789988744
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=336.63 Aligned_cols=222 Identities=20% Similarity=0.204 Sum_probs=184.6
Q ss_pred CceEEEEeeccc---CchhHHHHHHHHHHHH-hcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCH
Q 044846 2 EELWLLKKSKSV---HESNVEQFINEVVILS-QINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITW 77 (290)
Q Consensus 2 ~~~~avK~~~~~---~~~~~~~~~~E~~~l~-~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 77 (290)
|+.||||+++.. .....+.+..|..++. .++|||||++++++.+++..|+|||||++|+|.+++.... .+++
T Consensus 27 ~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~----~~~e 102 (320)
T d1xjda_ 27 NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDL 102 (320)
T ss_dssp TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCH
T ss_pred CCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC----CCCH
Confidence 688999999632 2445667788888776 5799999999999999999999999999999999998766 5899
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 78 EMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 78 ~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+.
T Consensus 103 ~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~ 178 (320)
T d1xjda_ 103 SRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEILLGQ 178 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc-cccccccCCCCCcCCHHHHcCC
Confidence 999999999999999999999 999999999999999999999999998754322 2233456789999999999999
Q ss_pred CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--hhhhHHHHHHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 044846 158 QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--KEAEKEEVITFAMVAKRCLNLNGKKQPTMK-EVTLE 232 (290)
Q Consensus 158 ~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-el~~~ 232 (290)
.|+.++||||+||++|+|++|..||........ ...... ...+...+.++.+||.+||+.||.+|||+. |+++|
T Consensus 179 ~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 999999999999999999999999865433221 111111 122234567899999999999999999985 78765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=331.22 Aligned_cols=234 Identities=19% Similarity=0.301 Sum_probs=190.9
Q ss_pred CceEEEEeecc-cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcC------CCCCC
Q 044846 2 EELWLLKKSKS-VHESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQT------DDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~ 74 (290)
++.||||+++. ........|.+|++++++++|||||+++++|...+..++|||||++|+|.+++.... .....
T Consensus 50 ~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~ 129 (308)
T d1p4oa_ 50 ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129 (308)
T ss_dssp EEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCC
T ss_pred CcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCC
Confidence 35789999964 345556679999999999999999999999999999999999999999999986532 11224
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce-eeccceecccccCccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH-LTTQVKVTFGYVDPKY 153 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~ 153 (290)
+++..+..++.|++.||.|||+++ |+||||||+|||++.++++||+|||+++........ ......||+.|+|||.
T Consensus 130 ~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~ 206 (308)
T d1p4oa_ 130 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 206 (308)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHH
Confidence 788999999999999999999999 999999999999999999999999998755433222 2344578999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
+.+..++.++|||||||++|||+++..++.........+..... ...+...+..+.+||.+||+.||++|||+.+|+
T Consensus 207 l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il 286 (308)
T d1p4oa_ 207 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286 (308)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99999999999999999999999986555444333333332222 122344567899999999999999999999999
Q ss_pred HHHHhhHh
Q 044846 231 LELAGIRA 238 (290)
Q Consensus 231 ~~l~~~~~ 238 (290)
++|+...+
T Consensus 287 ~~L~~~~~ 294 (308)
T d1p4oa_ 287 SSIKEEME 294 (308)
T ss_dssp HHHGGGSC
T ss_pred HHHHHhcC
Confidence 99976643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=328.73 Aligned_cols=231 Identities=19% Similarity=0.244 Sum_probs=175.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHH--HHhcCCCceeeEEeEEEeCC----cceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVI--LSQINHRNVVKILGCCLETE----VPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~--l~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||+++.. ..+.+.+|.++ +..++|||||++++++...+ .+|+|||||++|+|.+++++. .+
T Consensus 26 g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~l 97 (303)
T d1vjya_ 26 GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TV 97 (303)
T ss_dssp TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-----CB
T ss_pred CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-----CC
Confidence 678999998643 23344555554 45679999999999998754 579999999999999999864 48
Q ss_pred CHHHHHHHHHHHHHHHHHHhhC-----CCCCeEeccCCCCceEeccCCcEEEeccccccccccCCce---eeccceeccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSV-----ASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTH---LTTQVKVTFG 147 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~-----~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~ 147 (290)
++..++.++.|++.||.|||+. +..+|+||||||+|||++.++.+||+|||+++........ ......||+.
T Consensus 98 ~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~ 177 (303)
T d1vjya_ 98 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177 (303)
T ss_dssp CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGG
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccC
Confidence 9999999999999999999973 1122999999999999999999999999998765433322 2234678999
Q ss_pred ccCccccccCC------CCCcccchhhHHHHHHHhcCCCCcccchhh-------------hhhhHHHhh----------h
Q 044846 148 YVDPKYFRSSQ------FTEKSDVYSFSVVLVELNWTKPIHLVDVEE-------------NRSLAAYFS----------K 198 (290)
Q Consensus 148 y~aPE~~~~~~------~~~~~DiwS~G~il~~l~~~~~~~~~~~~~-------------~~~~~~~~~----------~ 198 (290)
|+|||++.+.. ++.++|||||||++|||++|.+++...... ......... .
T Consensus 178 y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 257 (303)
T d1vjya_ 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 257 (303)
T ss_dssp GCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred cCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcc
Confidence 99999987653 566899999999999999998765322110 000111100 1
Q ss_pred hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhHhhh
Q 044846 199 EAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 199 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~~~~~~ 240 (290)
.........+.+|+.+||+.||++|||+.||+++|+.+.+..
T Consensus 258 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 258 WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 112334566899999999999999999999999999887653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=324.98 Aligned_cols=225 Identities=20% Similarity=0.269 Sum_probs=177.6
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||||+++... ....+++.+|+++|++++|||||+++++|.+.+..|+|||||. |++..++...... .+++..
T Consensus 27 ~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~-~~~~~~~~~~~~~--~l~e~~ 103 (298)
T d1gz8a_ 27 GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT--GIPLPL 103 (298)
T ss_dssp CCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHTTTT--CCCHHH
T ss_pred CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC-Cchhhhhhhhccc--CCCHHH
Confidence 7889999996433 2346789999999999999999999999999999999999995 4666666543322 589999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC-
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ- 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~- 158 (290)
+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++...... .......||+.|+|||++....
T Consensus 104 ~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~ 179 (298)
T d1gz8a_ 104 IKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKY 179 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-ccceeecccceeeehhhhccccC
Confidence 9999999999999999999 9999999999999999999999999987543222 2334467899999999987765
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh------------------------------hhhhHHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS------------------------------KEAEKEEVITF 208 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~ 208 (290)
++.++||||+||++|+|++|+.||............... .......+.++
T Consensus 180 ~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 259 (298)
T d1gz8a_ 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259 (298)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHH
T ss_pred CCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHH
Confidence 478999999999999999999998654322211110000 00011234678
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 209 AMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 209 ~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
.+|+.+||+.||++|||++|+++|-
T Consensus 260 ~dll~~mL~~dP~~R~t~~ell~H~ 284 (298)
T d1gz8a_ 260 RSLLSQMLHYDPNKRISAKAALAHP 284 (298)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHHHHHccCChhHCcCHHHHhCCH
Confidence 9999999999999999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=324.80 Aligned_cols=218 Identities=20% Similarity=0.234 Sum_probs=177.7
Q ss_pred CceEEEEeecccCc------hhHHHHHHHHHHHHhcC--CCceeeEEeEEEeCCcceEEEEeCCC-CCHHHHHhhcCCCC
Q 044846 2 EELWLLKKSKSVHE------SNVEQFINEVVILSQIN--HRNVVKILGCCLETEVPLLVYEFIPN-GSLYQYIHEQTDDQ 72 (290)
Q Consensus 2 ~~~~avK~~~~~~~------~~~~~~~~E~~~l~~l~--Hpniv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~ 72 (290)
|+.||||+++.... ....++.+|+.+|++++ |||||++++++.+.+..++||||+.+ +++.+++....
T Consensus 29 ~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--- 105 (273)
T d1xwsa_ 29 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--- 105 (273)
T ss_dssp CCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---
T ss_pred CCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC---
Confidence 68899999863211 12334678999999996 99999999999999999999999975 68888887765
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-CCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 73 LPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-KYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
.+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.... .......||+.|+||
T Consensus 106 -~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~---~~~~~~~GT~~y~aP 178 (273)
T d1xwsa_ 106 -ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPP 178 (273)
T ss_dssp -SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCS---SCBCCCCSCGGGSCH
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceeccc---ccccccccCCCcCCH
Confidence 6899999999999999999999999 999999999999985 47999999999875432 233456799999999
Q ss_pred cccccCCC-CCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhhhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044846 152 KYFRSSQF-TEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFSKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVT 230 (290)
Q Consensus 152 E~~~~~~~-~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~ 230 (290)
|++.+..+ +.++||||+||++|+|++|..||........ . ....+...+.++.+||.+||+.||++|||++|++
T Consensus 179 E~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~---~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR---G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH---C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhh---c--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 99987775 5679999999999999999998864322111 0 1112223467799999999999999999999999
Q ss_pred HHHH
Q 044846 231 LELA 234 (290)
Q Consensus 231 ~~l~ 234 (290)
+|.+
T Consensus 254 ~hp~ 257 (273)
T d1xwsa_ 254 NHPW 257 (273)
T ss_dssp TSGG
T ss_pred cCHh
Confidence 8743
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.8e-46 Score=316.74 Aligned_cols=223 Identities=21% Similarity=0.244 Sum_probs=175.3
Q ss_pred CceEEEEeecccC--chhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSVH--ESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||||+++... ....+++.+|+.+|++++|||||+++++|...+..+++||++.++.+..+..... .+++..
T Consensus 26 ~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~----~l~~~~ 101 (286)
T d1ob3a_ 26 GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVT 101 (286)
T ss_dssp SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTT----CCCHHH
T ss_pred CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcC----Ccchhh
Confidence 6889999996543 3346789999999999999999999999999999999999997766655554433 699999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccC-C
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS-Q 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 158 (290)
+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||.+...... ........+++.|+|||.+.+. .
T Consensus 102 ~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~ 177 (286)
T d1ob3a_ 102 AKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSKK 177 (286)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCS
T ss_pred hHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC-ccccceecccchhhhHHHHhCCCC
Confidence 9999999999999999999 999999999999999999999999998654322 2223345688899999998765 4
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------------------------------hhhhHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------------------------------KEAEKEEVIT 207 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 207 (290)
++.++||||+||++|||++|.+||........ +..... .......+..
T Consensus 178 ~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 256 (286)
T d1ob3a_ 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256 (286)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHH
T ss_pred CCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHH
Confidence 68999999999999999999998864332211 111000 0011123567
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 208 FAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 208 ~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.+||.+||+.||++|||++|+++|.
T Consensus 257 ~~dli~~~L~~dP~~R~s~~ell~Hp 282 (286)
T d1ob3a_ 257 GIDLLSKMLKLDPNQRITAKQALEHA 282 (286)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCc
Confidence 89999999999999999999998763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=319.24 Aligned_cols=224 Identities=21% Similarity=0.270 Sum_probs=174.3
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhc---CCCceeeEEeEEEe-----CCcceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQI---NHRNVVKILGCCLE-----TEVPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l---~Hpniv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||||+++.. .......+.+|+.+|+.| +||||++++++|.. ....+++||||.++.+........
T Consensus 33 ~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~-- 110 (305)
T d1blxa_ 33 GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-- 110 (305)
T ss_dssp TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT--
T ss_pred CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccC--
Confidence 467999998642 222344567888887766 79999999999864 246799999997766554443322
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDP 151 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 151 (290)
..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.... ........||+.|+||
T Consensus 111 -~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~--~~~~~~~~gT~~Y~AP 184 (305)
T d1blxa_ 111 -PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAP 184 (305)
T ss_dssp -TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCG--GGGGCCCCCCCTTCCH
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhcc--cccCCCcccChhhcCc
Confidence 25899999999999999999999999 99999999999999999999999999765332 2233557799999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-----------------------------hhhhH
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-----------------------------KEAEK 202 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~ 202 (290)
|++.+..|+.++||||+||++|||++|.+||........ +..... .....
T Consensus 185 E~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (305)
T d1blxa_ 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT 263 (305)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCC
T ss_pred chhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCchhcccccccchhhhhccccccchhhccc
Confidence 999999999999999999999999999999865432211 111000 00112
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 203 EEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 203 ~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
..+..+.+||.+||+.||++|||++|+++|.+
T Consensus 264 ~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 264 DIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp SCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 23567889999999999999999999998743
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=318.36 Aligned_cols=219 Identities=18% Similarity=0.208 Sum_probs=177.6
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC------cceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLETE------VPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||||+++. .+....+.+.+|+++|+.++|||||+++++|...+ .+|+||||| +++|..+++..
T Consensus 43 ~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----- 116 (346)
T d1cm8a_ 43 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE----- 116 (346)
T ss_dssp CCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC-----
T ss_pred CCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc-----
Confidence 78899999974 33445678999999999999999999999998654 569999999 67888887653
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++|||+++..... .+...||+.|+|||+
T Consensus 117 ~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~ 189 (346)
T d1cm8a_ 117 KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEV 189 (346)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHH
T ss_pred cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCc----cccccccccccCHHH
Confidence 4999999999999999999999999 999999999999999999999999998764422 245678999999999
Q ss_pred cccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHh--h------------------------------hhh
Q 044846 154 FRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYF--S------------------------------KEA 200 (290)
Q Consensus 154 ~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~--~------------------------------~~~ 200 (290)
+.+. .++.++||||+||++|+|++|.+||.............. . ...
T Consensus 190 ~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (346)
T d1cm8a_ 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 269 (346)
T ss_dssp HHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGT
T ss_pred HcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHh
Confidence 8764 568899999999999999999998865432211100000 0 000
Q ss_pred hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 201 EKEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 201 ~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
....+..+.+||.+||..||.+|||+.|+++|-
T Consensus 270 ~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp 302 (346)
T d1cm8a_ 270 LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302 (346)
T ss_dssp CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 112345788999999999999999999999884
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=315.66 Aligned_cols=224 Identities=19% Similarity=0.238 Sum_probs=176.4
Q ss_pred CceEEEEeeccc-CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC----cceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSV-HESNVEQFINEVVILSQINHRNVVKILGCCLETE----VPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||||+++.. .....+.+++|+++|++|+||||+++++++.... ..+++++++.+|+|.+++... .++
T Consensus 33 ~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~-----~l~ 107 (345)
T d1pmea_ 33 KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-----HLS 107 (345)
T ss_dssp CSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC-----CCC
T ss_pred CcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC-----CCC
Confidence 788999999753 3455778999999999999999999999997653 234555666799999999754 489
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc--eeeccceecccccCcccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT--HLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~ 154 (290)
+..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++....... .......||+.|+|||++
T Consensus 108 ~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l 184 (345)
T d1pmea_ 108 NDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHh
Confidence 9999999999999999999999 99999999999999999999999999875433222 123456789999999998
Q ss_pred cc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh--h------------------------------hhh
Q 044846 155 RS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--K------------------------------EAE 201 (290)
Q Consensus 155 ~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--~------------------------------~~~ 201 (290)
.. ..++.++||||+||++|+|++|.+||............... . ...
T Consensus 185 ~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (345)
T d1pmea_ 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF 264 (345)
T ss_dssp TTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC
T ss_pred hcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhC
Confidence 55 45788999999999999999999988654322111111000 0 000
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 202 KEEVITFAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 202 ~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
...+.++.+|+.+||+.||.+|||++|+++|-
T Consensus 265 ~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 265 PNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 11234688999999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=311.44 Aligned_cols=227 Identities=19% Similarity=0.201 Sum_probs=172.8
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEe--------CCcceEEEEeCCCCCHHHHHhhcCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLE--------TEVPLLVYEFIPNGSLYQYIHEQTDD 71 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~ 71 (290)
|+.||||++... .....+++.+|+++|++++||||+++++++.. .+..|+|||||.++.+........
T Consensus 35 ~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~-- 112 (318)
T d3blha1 35 GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-- 112 (318)
T ss_dssp CCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTC--
T ss_pred CCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhccc--
Confidence 688999998532 34456778999999999999999999999865 346799999997665544433222
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCc---eeeccceecccc
Q 044846 72 QLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRT---HLTTQVKVTFGY 148 (290)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y 148 (290)
.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 113 --~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y 187 (318)
T d3blha1 113 --KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187 (318)
T ss_dssp --CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGG
T ss_pred --ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHH
Confidence 5889999999999999999999999 99999999999999999999999999865432211 122345689999
Q ss_pred cCccccccC-CCCCcccchhhHHHHHHHhcCCCCcccchhhhhh--hHHHhh----------------------------
Q 044846 149 VDPKYFRSS-QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRS--LAAYFS---------------------------- 197 (290)
Q Consensus 149 ~aPE~~~~~-~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~--~~~~~~---------------------------- 197 (290)
+|||++.+. .|+.++||||+||++|+|++|.+||......... ......
T Consensus 188 ~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T d3blha1 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 267 (318)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBC
T ss_pred hhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccccccccc
Confidence 999998765 6899999999999999999999988643322111 000000
Q ss_pred ---hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 198 ---KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 198 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
.......+..+.+||.+||+.||++|||++|+++|-+.
T Consensus 268 ~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp HHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred chhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 00011124567899999999999999999999988653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=317.71 Aligned_cols=226 Identities=22% Similarity=0.224 Sum_probs=184.6
Q ss_pred CceEEEEeeccc----CchhHHHHHHHHHHHHhcCC-CceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCC
Q 044846 2 EELWLLKKSKSV----HESNVEQFINEVVILSQINH-RNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPIT 76 (290)
Q Consensus 2 ~~~~avK~~~~~----~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 76 (290)
|+.||||+++.. +....+.+.+|+++|++++| |||+++++++.+.+..+++|||+.+|+|.+++.... .++
T Consensus 52 g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~----~~~ 127 (322)
T d1vzoa_ 52 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE----RFT 127 (322)
T ss_dssp TCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS----CCC
T ss_pred CcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc----ccc
Confidence 678999998632 23345678899999999966 899999999999999999999999999999998876 478
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccccc
Q 044846 77 WEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRS 156 (290)
Q Consensus 77 ~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 156 (290)
+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..............|++.|++||.+.+
T Consensus 128 e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~ 204 (322)
T d1vzoa_ 128 EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhc
Confidence 8899999999999999999999 9999999999999999999999999987655444444556778999999999976
Q ss_pred C--CCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hh-HHHh--hhhhhHHHHHHHHHHHHHhhccCCCCCCC----
Q 044846 157 S--QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SL-AAYF--SKEAEKEEVITFAMVAKRCLNLNGKKQPT---- 225 (290)
Q Consensus 157 ~--~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~-~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps---- 225 (290)
. .++.++||||+||++|+|++|..||........ .+ .... ....+...+.++.+|+.+||+.||++|||
T Consensus 205 ~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~ 284 (322)
T d1vzoa_ 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284 (322)
T ss_dssp CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTT
T ss_pred CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcc
Confidence 5 367799999999999999999999865432211 11 1111 11223356788999999999999999994
Q ss_pred -HHHHHHHHH
Q 044846 226 -MKEVTLELA 234 (290)
Q Consensus 226 -~~el~~~l~ 234 (290)
++|+++|.+
T Consensus 285 t~~eil~Hpf 294 (322)
T d1vzoa_ 285 DADEIKEHLF 294 (322)
T ss_dssp THHHHHTSGG
T ss_pred cHHHHHcCHh
Confidence 788987644
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=316.63 Aligned_cols=222 Identities=22% Similarity=0.233 Sum_probs=171.5
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CcceEEEEeCCCCCHHHHHhhcCCCCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNVVKILGCCLET------EVPLLVYEFIPNGSLYQYIHEQTDDQLPI 75 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 75 (290)
|+.||||+++..... ..+|+++|++|+||||++++++|... .++|||||||+++ +...+.........+
T Consensus 45 ~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l 119 (350)
T d1q5ka_ 45 GELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTL 119 (350)
T ss_dssp CCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCC
T ss_pred CCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCC
Confidence 788999999754322 34799999999999999999999643 3478999999654 544444322223369
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-cEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 76 TWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 76 ~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..... ....+..|+..|+|||.+
T Consensus 120 ~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~ 194 (350)
T d1q5ka_ 120 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELI 194 (350)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTT--SCCCSCCSCTTSCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCC--cccccccccccccChHHh
Confidence 99999999999999999999999 99999999999999775 8999999998754322 233446789999999987
Q ss_pred cc-CCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------------------------------hhhhH
Q 044846 155 RS-SQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------------------------------KEAEK 202 (290)
Q Consensus 155 ~~-~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~ 202 (290)
.+ ..|+.++||||+||++|||++|.+||......... ..... .....
T Consensus 195 ~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l-~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (350)
T d1q5ka_ 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL-VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 273 (350)
T ss_dssp TTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCT
T ss_pred hcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH-HHHHHHhCCChHHhhhhhccchhhccccccccCchhhhccc
Confidence 75 46899999999999999999999988654332211 11100 00011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 203 EEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 203 ~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
..+.++.+|+.+||+.||++|||+.|+++|-+
T Consensus 274 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305 (350)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 23567899999999999999999999998743
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=305.51 Aligned_cols=224 Identities=17% Similarity=0.216 Sum_probs=181.4
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHH
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEM 79 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 79 (290)
|+.||||+++.. .....+++.+|+.+|+.++||||++++++|......++|+|++.+++|..++.... .+++..
T Consensus 27 ~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~----~~~~~~ 102 (292)
T d1unla_ 27 HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG----DLDPEI 102 (292)
T ss_dssp CCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT----CCCHHH
T ss_pred CcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccccc----ccchhH
Confidence 678999998643 34457789999999999999999999999999999999999999988888877554 588999
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccccccCC-
Q 044846 80 RLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSSQ- 158 (290)
Q Consensus 80 ~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~- 158 (290)
+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++...... .......++..|+|||++....
T Consensus 103 ~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~ 178 (292)
T d1unla_ 103 VKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKL 178 (292)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSC
T ss_pred HHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-ccceeeccccchhhhhHhccCCC
Confidence 9999999999999999999 9999999999999999999999999987644322 2233345678899999987665
Q ss_pred CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh-------------------------------hhhhHHHHHH
Q 044846 159 FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS-------------------------------KEAEKEEVIT 207 (290)
Q Consensus 159 ~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 207 (290)
++.++||||+||++|+|++|+.||............... .......+..
T Consensus 179 ~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 258 (292)
T d1unla_ 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNAT 258 (292)
T ss_dssp CCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHH
T ss_pred CCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHH
Confidence 688999999999999999998877544332222211110 0011223457
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHH
Q 044846 208 FAMVAKRCLNLNGKKQPTMKEVTLEL 233 (290)
Q Consensus 208 ~~~li~~cl~~dp~~Rps~~el~~~l 233 (290)
+.+|+.+||+.||++|||++|+++|-
T Consensus 259 ~~dll~~mL~~dP~~R~sa~e~L~Hp 284 (292)
T d1unla_ 259 GRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCh
Confidence 88999999999999999999998774
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-43 Score=308.62 Aligned_cols=218 Identities=17% Similarity=0.200 Sum_probs=173.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWE 78 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 78 (290)
|+.||||+++.. ..+++.+|+++|+.+ .||||++++++|.. ...+++|||||.+|+|..+.+ .+++.
T Consensus 60 ~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-------~l~e~ 129 (328)
T d3bqca1 60 NEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDY 129 (328)
T ss_dssp TEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT-------SCCHH
T ss_pred CCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc-------CCCHH
Confidence 678999998753 356788999999999 59999999999985 456899999999999876532 58999
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCC-cEEEeccccccccccCCceeeccceecccccCccccccC
Q 044846 79 MRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKY-QAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYFRSS 157 (290)
Q Consensus 79 ~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 157 (290)
.++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++..... .......+|+.|+|||.+.+.
T Consensus 130 ~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 204 (328)
T d3bqca1 130 DIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDY 204 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--CCCCSCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC--CcccccccCccccCcccccCC
Confidence 99999999999999999999 99999999999998665 5899999998754322 233456789999999998765
Q ss_pred -CCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHHhh---------------------------------------
Q 044846 158 -QFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAYFS--------------------------------------- 197 (290)
Q Consensus 158 -~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~~~--------------------------------------- 197 (290)
.++.++||||+||++|++++|..|+...............
T Consensus 205 ~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (328)
T d3bqca1 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 284 (328)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCC
T ss_pred CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhccc
Confidence 4789999999999999999999888654322111110000
Q ss_pred hhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 198 KEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 198 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
.......+.++.+||.+||..||++|||++|+++|-+
T Consensus 285 ~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 285 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp TTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0011123467899999999999999999999998754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-43 Score=301.88 Aligned_cols=228 Identities=18% Similarity=0.140 Sum_probs=175.8
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCc-eeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRN-VVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||++.... ..+++..|+++++.++|+| |+.+.+++...+..++||||+ +|+|...+..... .+++..+
T Consensus 32 ~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~---~~~~~~~ 105 (299)
T d1ckia_ 32 GEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR---KFSLKTV 105 (299)
T ss_dssp TEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHH
T ss_pred CCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccC---CCcHHHH
Confidence 6789999886532 2345789999999997665 555566667788899999999 6688777765443 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEec---cCCcEEEeccccccccccCCce------eeccceecccccCc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLV---DKYQAKISDFRTFKSRAIDRTH------LTTQVKVTFGYVDP 151 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aP 151 (290)
..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++........ ......||+.|+||
T Consensus 106 ~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 182 (299)
T d1ckia_ 106 LLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182 (299)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCH
T ss_pred HHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCH
Confidence 999999999999999999 99999999999986 3557999999998865432211 22346799999999
Q ss_pred cccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhH--H----Hhhh---hhhHHHHHHHHHHHHHhhccCCCC
Q 044846 152 KYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLA--A----YFSK---EAEKEEVITFAMVAKRCLNLNGKK 222 (290)
Q Consensus 152 E~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~--~----~~~~---~~~~~~~~~~~~li~~cl~~dp~~ 222 (290)
|++.+..++.++|||||||++|||++|..||........... . .... ......+.++.++|.+||+.||++
T Consensus 183 E~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~ 262 (299)
T d1ckia_ 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDD 262 (299)
T ss_dssp HHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTC
T ss_pred HHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhH
Confidence 999999999999999999999999999998864332211110 0 0011 111234577999999999999999
Q ss_pred CCCHHHHHHHHHhhHh
Q 044846 223 QPTMKEVTLELAGIRA 238 (290)
Q Consensus 223 Rps~~el~~~l~~~~~ 238 (290)
||+++++.+.|+.+..
T Consensus 263 RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 263 KPDYSYLRQLFRNLFH 278 (299)
T ss_dssp CCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999888877644
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-43 Score=308.23 Aligned_cols=222 Identities=19% Similarity=0.227 Sum_probs=171.3
Q ss_pred CceEEEEeecc--cCchhHHHHHHHHHHHHhcCCCceeeEEeEEEeC------CcceEEEEeCCCCCHHHHHhhcCCCCC
Q 044846 2 EELWLLKKSKS--VHESNVEQFINEVVILSQINHRNVVKILGCCLET------EVPLLVYEFIPNGSLYQYIHEQTDDQL 73 (290)
Q Consensus 2 ~~~~avK~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~ 73 (290)
|+.||||+++. .+....+++.+|+.+++.++|||||+++++|... ...|+|||||.+ ++.+.+..
T Consensus 42 ~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~~------ 114 (355)
T d2b1pa1 42 DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM------ 114 (355)
T ss_dssp TEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS------
T ss_pred CCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhhc------
Confidence 78899999964 3345567899999999999999999999999643 578999999965 55555532
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCccc
Q 044846 74 PITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKY 153 (290)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 153 (290)
.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++|||+++.... ........+|+.|+|||+
T Consensus 115 ~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~--~~~~~~~~~t~~y~aPE~ 189 (355)
T d2b1pa1 115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 189 (355)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCTTCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccc--ccccccccccccccChhh
Confidence 4889999999999999999999999 99999999999999999999999998764332 233345678999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHHH---------------------h----------------
Q 044846 154 FRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAAY---------------------F---------------- 196 (290)
Q Consensus 154 ~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~~---------------------~---------------- 196 (290)
+.+..++.++||||+||++++|++|++||............. .
T Consensus 190 l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (355)
T d2b1pa1 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269 (355)
T ss_dssp HTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSC
T ss_pred hcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccc
Confidence 999999999999999999999999999885432211100000 0
Q ss_pred ------hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 044846 197 ------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELAG 235 (290)
Q Consensus 197 ------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~~ 235 (290)
........+.++.+||.+||..||++|||++|+++|-+-
T Consensus 270 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~ 314 (355)
T d2b1pa1 270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314 (355)
T ss_dssp GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred cccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 011223456789999999999999999999999988543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-42 Score=297.21 Aligned_cols=230 Identities=12% Similarity=0.036 Sum_probs=183.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC-CCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN-HRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.||||+++... ....+.+|++.++.|. |+|++.+++++......++||||+ +|+|.+++..... .++...+
T Consensus 30 ~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~---~~~~~~~ 103 (293)
T d1csna_ 30 NQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR---KFSVKTV 103 (293)
T ss_dssp TEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCHHHH
T ss_pred CCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhcc---chhhHHH
Confidence 6789999886432 2345778999999995 589999999999999999999999 7899999876543 5899999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEecc-----CCcEEEeccccccccccCCc------eeeccceeccccc
Q 044846 81 LRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVD-----KYQAKISDFRTFKSRAIDRT------HLTTQVKVTFGYV 149 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~-----~~~~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~ 149 (290)
..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++....... .......||+.|+
T Consensus 104 ~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~ 180 (293)
T d1csna_ 104 AMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180 (293)
T ss_dssp HHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred HHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhc
Confidence 999999999999999999 999999999999974 57899999999976432211 1223467999999
Q ss_pred CccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhhh--hhHHH----hh---hhhhHHHHHHHHHHHHHhhccCC
Q 044846 150 DPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEENR--SLAAY----FS---KEAEKEEVITFAMVAKRCLNLNG 220 (290)
Q Consensus 150 aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~--~~~~~----~~---~~~~~~~~~~~~~li~~cl~~dp 220 (290)
|||++.+..++.++|||||||++|||++|..||........ ..... .. .......+.++.+++..|+..+|
T Consensus 181 aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~ 260 (293)
T d1csna_ 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAF 260 (293)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred CHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCc
Confidence 99999999999999999999999999999999864322111 11110 00 01112345679999999999999
Q ss_pred CCCCCHHHHHHHHHhhHhhh
Q 044846 221 KKQPTMKEVTLELAGIRASI 240 (290)
Q Consensus 221 ~~Rps~~el~~~l~~~~~~~ 240 (290)
++||+++.+.+.|+.+....
T Consensus 261 ~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 261 DATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp TCCCCHHHHHHHHHHHHHHT
T ss_pred ccCcCHHHHHHHHHHHHHHc
Confidence 99999999988887775543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=306.92 Aligned_cols=221 Identities=17% Similarity=0.173 Sum_probs=172.7
Q ss_pred CceEEEEeeccc--CchhHHHHHHHHHHHHhcCCCceeeEEeEEEeCC-----cceEEEEeCCCCCHHHHHhhcCCCCCC
Q 044846 2 EELWLLKKSKSV--HESNVEQFINEVVILSQINHRNVVKILGCCLETE-----VPLLVYEFIPNGSLYQYIHEQTDDQLP 74 (290)
Q Consensus 2 ~~~~avK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~ 74 (290)
|+.||||+++.. +....+++.+|+++|+.|+|||||++++++.... ..+++++++.+|+|.+++... .
T Consensus 43 ~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~-----~ 117 (348)
T d2gfsa1 43 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-----K 117 (348)
T ss_dssp TEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC-----C
T ss_pred CCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc-----c
Confidence 688999999743 3445668899999999999999999999986432 346677778899999999643 4
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccceecccccCcccc
Q 044846 75 ITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVKVTFGYVDPKYF 154 (290)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 154 (290)
+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.... ....+..|+..|+|||++
T Consensus 118 l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~----~~~~~~~g~~~y~apE~~ 190 (348)
T d2gfsa1 118 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIM 190 (348)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT----GGGSSSCHHHHTSCHHHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC----cccccccccccccCchhh
Confidence 999999999999999999999999 9999999999999999999999999976432 223456788999999987
Q ss_pred ccCC-CCCcccchhhHHHHHHHhcCCCCcccchhhhhhhHH--Hhhh------------------------------hhh
Q 044846 155 RSSQ-FTEKSDVYSFSVVLVELNWTKPIHLVDVEENRSLAA--YFSK------------------------------EAE 201 (290)
Q Consensus 155 ~~~~-~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~~~~~~--~~~~------------------------------~~~ 201 (290)
.+.. ++.++||||+||++|+|++|.+||............ .... ...
T Consensus 191 ~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (348)
T d2gfsa1 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 270 (348)
T ss_dssp TTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHS
T ss_pred cCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhc
Confidence 7654 688999999999999999999988644322111000 0000 000
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 202 KEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 202 ~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
...+..+.+||.+||..||++|||+.|+++|-+
T Consensus 271 ~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 271 IGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 123467899999999999999999999998754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.8e-37 Score=269.01 Aligned_cols=224 Identities=18% Similarity=0.162 Sum_probs=166.6
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC-----------CCceeeEEeEEEe--CCcceEEEEeCCCCCHHHHHhhc
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN-----------HRNVVKILGCCLE--TEVPLLVYEFIPNGSLYQYIHEQ 68 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~ 68 (290)
|+.||||+++.. ....+.+.+|+++++.++ |+||+++++++.. ....+++++++..+.........
T Consensus 38 g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (362)
T d1q8ya_ 38 NTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK 116 (362)
T ss_dssp TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHH
T ss_pred CCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccccccccc
Confidence 688999999753 334567889999998875 5789999998865 34566777777554433332222
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeEeccCCCCceEeccCCc------EEEeccccccccccCCceeecc
Q 044846 69 TDDQLPITWEMRLRITVEVSRVLSYLHS-VASIPIYHLDIKSANILLVDKYQ------AKISDFRTFKSRAIDRTHLTTQ 141 (290)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~ylH~-~~~~~iiHrdlkp~Nil~~~~~~------~kl~dfg~~~~~~~~~~~~~~~ 141 (290)
. ....+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++. ++++|||.+..... ....
T Consensus 117 ~-~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~----~~~~ 188 (362)
T d1q8ya_ 117 Y-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTN 188 (362)
T ss_dssp T-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB----CCCS
T ss_pred c-cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeeccccccccc----cccc
Confidence 2 22268889999999999999999997 77 999999999999986653 89999999764432 2244
Q ss_pred ceecccccCccccccCCCCCcccchhhHHHHHHHhcCCCCcccchhhh-----hhhHHHh--------------------
Q 044846 142 VKVTFGYVDPKYFRSSQFTEKSDVYSFSVVLVELNWTKPIHLVDVEEN-----RSLAAYF-------------------- 196 (290)
Q Consensus 142 ~~g~~~y~aPE~~~~~~~~~~~DiwS~G~il~~l~~~~~~~~~~~~~~-----~~~~~~~-------------------- 196 (290)
..||+.|+|||++....++.++||||+||++++|++|+.||....... .......
T Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~ 268 (362)
T d1q8ya_ 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTF 268 (362)
T ss_dssp CCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHH
T ss_pred ccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccc
Confidence 678999999999999999999999999999999999999875432110 0000000
Q ss_pred ------------------------hhhhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044846 197 ------------------------SKEAEKEEVITFAMVAKRCLNLNGKKQPTMKEVTLELA 234 (290)
Q Consensus 197 ------------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el~~~l~ 234 (290)
........+..+.+|+.+||..||.+|||++|+++|-+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~ 330 (362)
T d1q8ya_ 269 FNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 330 (362)
T ss_dssp BCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred cccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 00112345678999999999999999999999998753
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=2.8e-20 Score=148.31 Aligned_cols=146 Identities=18% Similarity=0.147 Sum_probs=98.5
Q ss_pred CceEEEEeecccCc------------------hhHHHHHHHHHHHHhcCCCceeeEEeEEEeCCcceEEEEeCCCCCHHH
Q 044846 2 EELWLLKKSKSVHE------------------SNVEQFINEVVILSQINHRNVVKILGCCLETEVPLLVYEFIPNGSLYQ 63 (290)
Q Consensus 2 ~~~~avK~~~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~ 63 (290)
|+.||||+++.... .......+|...+.++.|++++..+++. ..+++|||+.++.+..
T Consensus 24 g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~ 99 (191)
T d1zara2 24 FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR 99 (191)
T ss_dssp TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG
T ss_pred CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccc
Confidence 67899998652111 1123455788999999999999877653 2479999997754422
Q ss_pred HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeccCCCCceEeccCCcEEEeccccccccccCCceeeccce
Q 044846 64 YIHEQTDDQLPITWEMRLRITVEVSRVLSYLHSVASIPIYHLDIKSANILLVDKYQAKISDFRTFKSRAIDRTHLTTQVK 143 (290)
Q Consensus 64 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ylH~~~~~~iiHrdlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 143 (290)
++......++.|++.+|.|||+++ |+||||||+|||++.+ .++|+|||++.............
T Consensus 100 -----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~-- 162 (191)
T d1zara2 100 -----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILE-- 162 (191)
T ss_dssp -----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHH--
T ss_pred -----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHH--
Confidence 333445678999999999999999 9999999999999865 58999999976543222111000
Q ss_pred ecccccCccccccCCCCCcccchhhHH
Q 044846 144 VTFGYVDPKYFRSSQFTEKSDVYSFSV 170 (290)
Q Consensus 144 g~~~y~aPE~~~~~~~~~~~DiwS~G~ 170 (290)
.....+ .+.+ ...|+.++|+||..-
T Consensus 163 rd~~~~-~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 163 RDVRNI-ITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp HHHHHH-HHHH-HHHHCCCCCHHHHHH
T ss_pred HHHHHH-HHHH-cCCCCCcccHHHHHH
Confidence 000000 0111 345788899999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.41 E-value=6.4e-07 Score=72.85 Aligned_cols=119 Identities=15% Similarity=0.085 Sum_probs=82.7
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCCHHHHHhhcCCCCCCCCHHHH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGSLYQYIHEQTDDQLPITWEMR 80 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 80 (290)
|+.++||+...........+.+|...++.| .+--+.+++.++...+..++||++++|.++.+...... ..
T Consensus 37 ~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~---------~~ 107 (263)
T d1j7la_ 37 NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ---------SP 107 (263)
T ss_dssp SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS---------CH
T ss_pred CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccccc---------cH
Confidence 455778887655444444577899988887 34446778888888888999999999888766543211 12
Q ss_pred HHHHHHHHHHHHHHhhCCC--------------------------------------------------------CCeEe
Q 044846 81 LRITVEVSRVLSYLHSVAS--------------------------------------------------------IPIYH 104 (290)
Q Consensus 81 ~~~~~~i~~~l~ylH~~~~--------------------------------------------------------~~iiH 104 (290)
..++.+++..+..||+... ..++|
T Consensus 108 ~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~H 187 (263)
T d1j7la_ 108 EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSH 187 (263)
T ss_dssp HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEEC
T ss_pred HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEE
Confidence 2345556666666664210 12799
Q ss_pred ccCCCCceEeccCCcEEEecccccc
Q 044846 105 LDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 105 rdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
+|+.|.||+++.++.+-|+||+.+.
T Consensus 188 gD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 188 GDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCCTTSEEEETTEEEEECCCTTCE
T ss_pred eeccCcceeecCCceEEEeechhcc
Confidence 9999999999877666799998743
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=1.4e-05 Score=64.29 Aligned_cols=57 Identities=18% Similarity=0.184 Sum_probs=40.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcC--CCceeeEEeEEEeCCcceEEEEeCCCCCH
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQIN--HRNVVKILGCCLETEVPLLVYEFIPNGSL 61 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~~~~~~~~~~~~~lv~e~~~~g~L 61 (290)
|+.+++|........ .+..|...++.|. .--+.+++.+....+..++||++++|.++
T Consensus 35 ~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 35 RPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 345677776544333 4567888888773 23367778888888888999999987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.06 E-value=0.0012 Score=56.39 Aligned_cols=27 Identities=19% Similarity=0.274 Sum_probs=23.5
Q ss_pred eEeccCCCCceEeccCCcEEEecccccc
Q 044846 102 IYHLDIKSANILLVDKYQAKISDFRTFK 129 (290)
Q Consensus 102 iiHrdlkp~Nil~~~~~~~kl~dfg~~~ 129 (290)
++|+|+.+.|||++.+ .++|+||..+.
T Consensus 225 LiHGDl~~gNIlv~~~-~~~vID~E~a~ 251 (392)
T d2pula1 225 LIHGDLHTGSIFASEH-ETKVIDPEFAF 251 (392)
T ss_dssp EECSCCCGGGEEECSS-CEEECCCTTCE
T ss_pred eeccCCcCCceeEcCC-ceEEechhhcc
Confidence 8999999999999866 48999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.51 E-value=0.0018 Score=55.14 Aligned_cols=37 Identities=22% Similarity=0.322 Sum_probs=27.1
Q ss_pred HHHHHHHHHHhc-CCCceeeEEeEEEeCCcceEEEEeCCCCC
Q 044846 20 QFINEVVILSQI-NHRNVVKILGCCLETEVPLLVYEFIPNGS 60 (290)
Q Consensus 20 ~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~g~ 60 (290)
...+|..+++.+ .+.-.++++++|.. .+|+||++|..
T Consensus 90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~ 127 (395)
T d1nw1a_ 90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 127 (395)
T ss_dssp HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEecccc
Confidence 456899999988 55555678887742 68999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.27 E-value=0.042 Score=45.00 Aligned_cols=57 Identities=12% Similarity=0.108 Sum_probs=35.0
Q ss_pred CceEEEEeecccCchhHHHHHHHHHHHHhcCCCce-----eeE--EeEEEeCCcceEEEEeCCCC
Q 044846 2 EELWLLKKSKSVHESNVEQFINEVVILSQINHRNV-----VKI--LGCCLETEVPLLVYEFIPNG 59 (290)
Q Consensus 2 ~~~~avK~~~~~~~~~~~~~~~E~~~l~~l~Hpni-----v~~--~~~~~~~~~~~lv~e~~~~g 59 (290)
|+.|++|+-+... ...+++..|...+..|....| +.. -..+...+..+.++++++|.
T Consensus 46 g~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 46 RRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred CCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 5678898876532 235667789988888732212 111 12234566778899998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.64 E-value=0.019 Score=46.69 Aligned_cols=28 Identities=18% Similarity=0.300 Sum_probs=25.2
Q ss_pred CeEeccCCCCceEeccCCcEEEeccccc
Q 044846 101 PIYHLDIKSANILLVDKYQAKISDFRTF 128 (290)
Q Consensus 101 ~iiHrdlkp~Nil~~~~~~~kl~dfg~~ 128 (290)
.+||+|+.++|++++.+...-|+||+.+
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred ccccCCcchhhhhcccccceeEeccccc
Confidence 4999999999999998877789999875
|